data_2lnj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lnj _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.745 0.307 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.531 HE22 ' N ' ' A' ' 48' ' ' ASN . 4.2 mp0 -115.41 155.06 28.11 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.014 0.435 . . . . 0.0 110.741 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -113.73 131.26 56.25 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.369 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -124.66 131.29 53.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.944 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -138.57 153.4 48.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.665 0.269 . . . . 0.0 110.757 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -144.2 109.61 5.16 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.787 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.0 m -61.74 -36.14 80.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.507 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -58.73 -51.41 70.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.938 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 38.4 t0 -85.86 -20.64 28.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.735 0.302 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.92 40.9 84.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.72 150.7 42.16 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.218 0.509 . . . . 0.0 110.17 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -151.12 143.07 23.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.598 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -151.74 160.06 43.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.176 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 mt -98.33 150.37 21.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.103 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -153.63 145.92 17.2 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.297 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.2 152.95 78.78 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.373 2.049 . . . . 0.0 112.151 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.531 ' N ' HE22 ' A' ' 33' ' ' GLN . 54.1 p30 -73.15 160.26 32.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.576 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.84 58.22 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.475 ' NE1' ' CG ' ' A' ' 68' ' ' ASP . 30.1 m0 -92.95 145.57 24.27 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.4 pt -118.73 145.03 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.35 128.79 9.68 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.7 135.46 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.756 0.312 . . . . 0.0 110.297 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -76.57 129.29 36.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.431 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.14 36.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.766 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -59.37 135.94 57.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.43 . . . . 0.0 110.693 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.06 10.02 72.57 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.45 -164.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.683 0.278 . . . . 0.0 110.548 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.16 140.86 42.21 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.084 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -44.98 132.11 10.85 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.59 1.526 . . . . 0.0 112.463 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.97 -31.04 7.28 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.4 t -61.04 128.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -119.07 -57.33 2.03 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.209 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.4 t -143.95 148.51 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.867 0.365 . . . . 0.0 110.92 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.47 140.01 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.45 134.11 53.26 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.107 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -127.15 130.74 50.35 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.463 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' CG ' ' NE1' ' A' ' 50' ' ' TRP . 60.3 t0 -87.86 117.96 27.06 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.662 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.9 tp -65.22 -38.99 92.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.555 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 70' ' ' ILE . 81.4 mt -60.86 -39.54 82.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.044 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.54 96.19 4.6 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.809 0.338 . . . . 0.0 110.593 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -61.33 -37.0 81.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.374 0.607 . . . . 0.0 109.856 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.27 -36.83 73.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.971 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -82.66 130.65 35.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.436 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -140.32 139.09 35.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.363 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.62 136.23 53.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.686 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.0 t -126.16 140.37 52.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.739 0.304 . . . . 0.0 110.608 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.94 125.52 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.914 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.9 mt -121.13 123.87 70.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.93 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.35 133.42 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.873 0.368 . . . . 0.0 110.682 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 159' ' ' LEU . 22.7 t -151.11 162.56 40.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.313 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.506 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 2.0 pm0 -105.06 130.23 53.31 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.111 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 pt -86.4 149.22 48.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.406 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 87' ' ' LYS . 36.2 Cg_endo -65.06 136.66 49.1 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.588 1.525 . . . . 0.0 110.753 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -60.96 -29.01 69.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.182 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -67.9 -31.44 71.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.898 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' PRO . 92.1 mttt -131.2 140.36 49.88 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.918 0.39 . . . . 0.0 111.169 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -105.96 -178.42 3.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.079 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.509 ' N ' ' OG1' ' A' ' 88' ' ' THR . 49.2 tp -52.18 -43.04 63.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.769 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.9 p -68.03 -43.76 78.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.093 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.52 -35.16 78.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.4 tt -55.17 -49.05 72.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.129 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.74 176.67 45.95 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 36.2 p -90.38 171.26 9.58 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.12 -42.32 76.67 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.165 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.7 m -72.06 -43.91 64.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.809 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -61.94 -51.38 68.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.151 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.2 t -61.7 -38.53 80.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.568 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.63 -44.54 93.93 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -68.14 -39.77 82.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.821 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -61.61 -41.34 97.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -61.43 -41.16 96.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.63 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.9 mmt -58.62 -43.76 89.75 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.838 0.352 . . . . 0.0 110.365 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -64.57 -40.08 94.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.356 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -60.05 -47.33 86.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.892 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.3 t -71.7 -45.74 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.011 0.434 . . . . 0.0 110.497 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 111' ' ' GLN . 88.9 m-20 -60.43 -32.56 71.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.069 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -44.19 -37.65 3.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.215 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -105.72 -10.8 16.57 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 114' ' ' ARG . 1.3 t -121.39 16.1 11.33 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.5 pt20 -79.83 6.98 9.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.086 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.35 -62.85 2.23 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.052 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -117.06 -41.23 3.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.634 0.254 . . . . 0.0 111.501 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' SER . 95.6 mtt180 -86.28 154.7 21.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.876 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -133.11 135.53 45.3 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.209 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.17 129.57 44.52 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.06 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -116.95 128.78 55.54 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.021 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.0 tp -83.66 110.85 18.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.024 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -55.25 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.104 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.544 ' C ' HD21 ' A' ' 120' ' ' ASN . 0.3 OUTLIER -161.4 168.57 23.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.921 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.68 122.44 4.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.232 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.96 162.9 34.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.583 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.414 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.48 148.28 50.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.571 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -130.67 150.14 52.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.775 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -120.45 116.36 25.3 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.847 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.45 142.27 39.47 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.456 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.3 t0 52.05 28.42 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.16 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.68 2.61 85.84 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 154' ' ' THR . 66.4 tp60 -104.02 135.99 44.5 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.02 129.89 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.964 0.411 . . . . 0.0 110.532 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.84 129.84 55.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.821 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.414 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.75 130.21 53.8 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.3 m -112.89 125.18 54.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.195 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.24 124.88 48.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.013 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.451 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 72.2 tt0 -119.72 124.2 45.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.86 169.75 20.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.38 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -138.88 160.31 40.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.394 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 63.4 t -104.42 126.35 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.008 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.1 mt -106.14 139.71 40.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.336 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.88 135.86 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.45 -112.63 1.41 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -118.23 22.88 11.92 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -142.63 157.1 45.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.219 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.3 123.86 32.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.102 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.445 ' CD ' ' NH1' ' A' ' 146' ' ' ARG . 85.3 tt0 -75.16 -53.28 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.111 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.445 ' NH1' ' CD ' ' A' ' 145' ' ' GLU . 33.6 ptt-85 -172.41 167.66 5.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -107.98 135.61 49.07 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.968 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -131.05 140.94 50.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.543 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.4 tp -111.2 132.23 54.49 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -129.2 132.48 47.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.387 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.4 m -121.79 139.78 53.18 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.36 131.51 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.972 0.415 . . . . 0.0 111.073 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.6 m -148.72 142.21 25.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.256 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.458 ' O ' ' NE2' ' A' ' 129' ' ' GLN . 13.0 p -106.41 149.56 26.9 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.343 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -150.39 106.68 3.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.077 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.413 ' NH2' ' OXT' ' A' ' 188' ' ' TYR . 17.0 ttm180 63.15 27.6 15.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.179 0.514 . . . . 0.0 110.579 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.13 3.08 73.38 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.804 -0.519 . . . . 0.0 111.804 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.49 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 11.5 mptt -94.95 126.11 40.06 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.417 -0.461 . . . . 0.0 109.81 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -88.54 118.62 28.31 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 160' ' ' ILE . 78.2 mt -120.02 127.98 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.823 0.344 . . . . 0.0 110.663 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 89.0 m -129.12 136.86 50.78 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.725 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.68 103.28 11.07 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -102.27 108.68 20.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.81 0.338 . . . . 0.0 110.414 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.05 140.04 48.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.3 p -133.63 139.65 46.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.855 0.36 . . . . 0.0 110.306 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.9 m -152.99 157.2 40.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.5 145.93 37.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.555 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.415 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 2.0 pp20? -70.87 -21.06 62.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.971 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.415 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 93.6 m-20 -58.84 -34.58 71.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.22 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -123.03 -1.34 8.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.576 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 59.9 t-105 -46.69 -40.25 12.91 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.812 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -64.56 -42.29 95.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.993 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.2 m -66.12 -39.67 90.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.728 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.9 m -106.53 21.64 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.246 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 176' ' ' SER . 12.2 ptmm? -51.22 -50.93 58.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.194 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.409 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 24.9 t -64.94 -30.69 71.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.889 0.376 . . . . 0.0 111.088 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.55 -45.79 66.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.849 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 23.1 m-85 -62.0 -49.83 74.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.049 0.452 . . . . 0.0 110.467 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -63.24 -37.8 88.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.471 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.455 ' O ' ' OG ' ' A' ' 184' ' ' SER . 56.2 m -61.37 -47.4 86.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.296 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.49 -44.17 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.519 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -65.74 -42.93 90.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.556 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 85.2 p -74.79 -30.9 61.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 180' ' ' THR . 58.0 m -63.14 -29.67 70.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -52.74 156.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.137 0.494 . . . . 0.0 110.813 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -138.67 155.18 48.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.199 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.0 m -127.91 151.68 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.922 0.392 . . . . 0.0 111.244 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.413 ' OXT' ' NH2' ' A' ' 156' ' ' ARG . 41.2 p90 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.661 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.545 ' C ' HD22 ' A' ' 48' ' ' ASN . 42.1 mt . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.519 ' NE2' ' OD1' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -102.61 170.85 7.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.099 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -139.68 146.03 39.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.656 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.68 141.78 45.03 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.137 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.0 p -149.75 155.38 40.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 110.592 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -148.08 119.14 7.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.624 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.6 p -71.55 -29.75 65.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.172 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -61.54 -48.93 78.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.983 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 50.5 t0 -92.12 -20.39 21.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.738 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.75 44.87 60.97 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.853 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.455 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -142.65 149.05 38.39 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.232 0.516 . . . . 0.0 110.336 179.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.73 143.48 22.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -152.47 158.85 43.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 111.059 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.6 mt -96.79 151.72 19.37 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.892 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' N ' ' CD1' ' A' ' 46' ' ' TYR . 10.3 p90 -157.95 136.56 7.81 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.846 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -43.29 157.3 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.045 1.83 . . . . 0.0 112.559 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.672 ' N ' HD21 ' A' ' 48' ' ' ASN . 0.7 OUTLIER -81.18 158.93 24.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.299 179.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.08 63.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 26.8 m0 -87.6 147.27 25.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.839 0.352 . . . . 0.0 110.175 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.7 132.31 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.043 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.89 133.2 11.61 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.33 134.24 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.964 0.412 . . . . 0.0 110.753 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 37.0 p30 -91.36 121.29 32.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.518 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.25 60.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.464 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -78.73 132.91 37.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.163 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.0 3.62 73.11 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.39 -163.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 t -40.53 125.95 1.83 Allowed Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.449 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -41.5 127.16 3.2 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.97 1.78 . . . . 0.0 113.025 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 63' ' ' ASP . . . 100.68 -36.18 4.34 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.533 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -63.63 127.02 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.174 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 61' ' ' GLY . 5.4 m-20 -119.57 -56.63 2.04 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.574 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.52 139.61 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.901 0.381 . . . . 0.0 111.098 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.3 t -123.08 132.63 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.127 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -112.28 134.27 53.92 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.41 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -124.76 143.36 50.83 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 73.8 m-20 -90.42 119.08 30.4 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.548 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.2 tp -65.4 -41.21 93.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.574 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.99 -45.03 99.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.048 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.67 120.67 37.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.863 0.363 . . . . 0.0 110.73 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -77.84 -40.38 40.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.56 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -58.7 -36.5 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.643 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.91 133.39 35.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -156.11 139.31 15.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.561 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.68 134.4 55.07 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.804 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.6 t -121.86 139.26 53.85 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.026 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.96 125.61 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.07 0.462 . . . . 0.0 110.279 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 mt -117.35 123.52 71.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.627 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.7 mt -120.21 128.42 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.396 . . . . 0.0 110.952 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 159' ' ' LEU . 61.3 m -149.03 166.0 29.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.3 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -105.64 138.41 41.88 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.2 pt -93.09 149.4 37.46 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.653 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -44.51 140.19 6.37 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.651 1.568 . . . . 0.0 111.383 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -67.94 -25.38 65.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.403 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.4 p30 -93.03 -15.28 26.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -131.43 150.44 52.15 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.096 0.474 . . . . 0.0 111.486 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 46.8 p -112.86 -179.23 3.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.222 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.9 tp -56.36 -41.56 76.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.448 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.5 p -72.16 -45.07 61.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.968 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' H ' ' A' ' 88' ' ' THR . 45.7 t0 -64.7 -37.28 87.04 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.787 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.0 tp -55.8 -43.32 76.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.745 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.5 179.19 47.62 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.309 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.406 ' HG1' ' H ' ' A' ' 97' ' ' ASP . 36.2 p -93.4 170.69 9.42 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.24 74.37 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.044 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 78.0 m -72.45 -45.67 58.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.406 ' H ' ' HG1' ' A' ' 94' ' ' THR . 45.6 t0 -61.25 -52.16 65.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.311 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.4 -38.62 82.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.713 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.71 -45.07 93.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -65.2 -41.45 94.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.541 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -63.11 -39.03 93.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.059 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.66 -41.49 98.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.699 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.8 mmt -58.38 -44.4 88.89 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.383 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -66.07 -42.48 89.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.359 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.5 m -59.24 -45.79 90.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.9 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.2 -47.48 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 0.0 110.478 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.646 ' O ' ' N ' ' A' ' 111' ' ' GLN . 93.4 m-20 -62.67 -34.65 77.53 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.451 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -46.61 -36.92 7.43 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.068 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.23 -47.11 71.78 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 112' ' ' GLY . 74.8 m -123.26 22.25 9.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.646 ' N ' ' O ' ' A' ' 107' ' ' ASN . 10.3 pt20 -49.41 -13.38 0.08 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.403 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -58.08 -61.42 7.44 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.86 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 35.1 p-10 -117.46 -35.66 3.93 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.902 0.351 . . . . 0.0 111.685 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 58.2 ttp180 -85.13 135.77 33.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.914 0.388 . . . . 0.0 111.28 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -127.97 144.37 51.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.191 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -107.09 138.07 43.96 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -119.81 129.06 54.26 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.98 110.08 16.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.204 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.538 ' C ' HD21 ' A' ' 120' ' ' ASN . 96.7 mt -77.02 -55.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.557 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.538 HD21 ' C ' ' A' ' 119' ' ' ILE . 1.7 m-80 -145.75 159.35 43.31 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.37 112.81 2.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.463 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.1 168.98 18.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.657 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.63 147.18 42.6 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.763 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -130.35 143.86 51.03 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.921 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 35.5 p30 -110.56 111.1 22.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.725 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -137.45 143.0 41.59 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.879 0.371 . . . . 0.0 110.839 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 51.38 37.97 20.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.317 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.24 2.61 41.78 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -107.67 149.47 28.07 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.964 0.411 . . . . 0.0 110.234 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.5 t -117.12 129.2 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.103 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 14.1 m-85 -119.31 128.15 53.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.067 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -100.62 120.04 39.46 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 63.2 m -95.17 127.46 41.24 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.94 110.76 11.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.53 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -107.28 126.58 52.61 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -150.79 170.45 19.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.349 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -136.97 156.8 47.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.041 0.448 . . . . 0.0 110.523 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.7 134.39 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.91 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 pp -135.77 136.26 40.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.161 0.505 . . . . 0.0 111.13 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.45 134.13 55.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.12 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.6 -121.06 19.05 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -113.91 14.17 18.47 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.926 -0.161 . . . . 0.0 111.275 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -127.15 153.6 45.84 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.901 0.382 . . . . 0.0 111.164 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.67 126.93 40.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.237 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -75.01 -52.75 10.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.773 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -175.21 173.97 2.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.028 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -109.84 136.78 48.61 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.16 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -132.88 141.57 48.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.892 0.377 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.9 tp -111.48 131.18 55.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.99 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.97 131.08 47.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.955 0.407 . . . . 0.0 110.486 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.0 m -120.69 138.15 54.1 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.6 t -119.85 129.16 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.033 0.444 . . . . 0.0 110.683 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.7 m -144.72 148.28 33.99 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.624 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -114.74 149.25 37.16 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.832 0.349 . . . . 0.0 110.303 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -149.82 107.04 3.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.032 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 65.07 26.26 12.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.12 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.4 1.44 71.78 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 2.4 mptp? -94.28 126.66 39.67 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -87.94 115.62 25.54 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 65.7 mt -121.45 123.52 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.005 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 72.7 m -122.45 132.11 54.19 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.52 113.12 26.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.817 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -115.04 124.85 52.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.905 0.383 . . . . 0.0 111.652 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.01 142.18 50.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.458 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 67.1 m -132.91 134.3 44.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.406 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.425 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 22.9 m -153.18 159.2 42.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.87 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.425 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -56.36 141.56 41.44 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.365 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.81 -39.09 90.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.963 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.48 -33.07 74.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.194 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -96.38 -17.56 20.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.35 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.59 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 47.9 t-105 -48.75 -41.73 33.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.713 0.292 . . . . 0.0 110.947 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.83 -41.69 97.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.136 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.7 m -65.56 -40.6 92.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.432 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.6 m -107.35 21.22 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.25 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 171' ' ' TRP . 19.0 ptmt -48.14 -47.4 34.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 111.111 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 27.0 t -64.83 -31.54 72.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.669 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.61 -45.64 73.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.044 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.59 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.2 m-85 -61.33 -50.11 74.26 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.263 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -63.28 -42.37 99.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.871 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.1 m -67.16 -49.01 66.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.777 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.9 t -70.01 -37.64 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.405 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.68 -37.03 84.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.317 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.0 t -84.62 -18.61 34.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.133 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 t -62.79 -35.87 81.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.629 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.433 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -55.89 147.23 19.85 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.931 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -134.44 157.72 45.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.37 151.19 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.767 0.317 . . . . 0.0 111.049 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.414 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 33.8 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.69 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.045 0.45 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.67 ' NE2' ' H ' ' A' ' 33' ' ' GLN . 1.3 pm0 -135.91 158.94 43.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.915 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -116.73 135.52 53.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.633 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -108.99 141.17 41.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.078 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.9 p -144.57 157.28 44.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.762 0.315 . . . . 0.0 110.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -146.96 112.32 5.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.766 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.7 m -62.0 -37.32 84.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.603 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -59.39 -52.33 66.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.227 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -84.49 -20.53 31.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.767 0.318 . . . . 0.0 110.77 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.65 43.17 86.17 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -142.37 151.88 42.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.235 0.517 . . . . 0.0 110.393 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -153.96 144.47 22.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.806 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -148.86 160.4 43.28 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.044 0.449 . . . . 0.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 tp -103.8 133.07 49.4 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.619 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -141.99 140.78 20.19 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.066 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -45.68 150.32 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.901 1.734 . . . . 0.0 112.217 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.63 ' N ' HE22 ' A' ' 33' ' ' GLN . 37.2 p-10 -81.02 160.03 24.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.301 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.43 3.19 65.05 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 32.9 m0 -81.3 147.12 30.05 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.8 pt -111.43 134.25 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.327 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.85 138.59 14.0 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.45 134.05 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.771 0.32 . . . . 0.0 110.22 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 48.7 p30 -84.45 145.57 28.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.72 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.1 m -151.66 51.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.353 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.45 133.5 46.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.048 0.451 . . . . 0.0 110.423 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.37 3.92 84.01 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.65 -164.24 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.8 m -40.49 117.88 1.43 Allowed Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.685 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.18 135.23 11.33 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.506 1.47 . . . . 0.0 111.895 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.84 -32.01 7.75 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.12 130.07 29.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -111.05 -57.79 2.19 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.708 0.289 . . . . 0.0 110.94 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -147.02 140.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.712 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.72 133.48 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.143 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.71 134.05 54.42 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.522 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -129.44 134.73 47.97 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.111 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 77.8 m-20 -86.61 119.1 26.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.836 0.35 . . . . 0.0 110.652 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.8 tt -65.11 -40.04 93.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.505 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 88.6 mt -61.37 -42.93 95.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.008 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -119.11 120.16 36.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.891 0.377 . . . . 0.0 110.659 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -82.82 -36.24 25.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.578 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 40.6 p-10 -62.37 -31.94 72.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.981 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 84.2 tt0 -87.13 130.47 34.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.62 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -139.57 139.5 36.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.297 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.39 134.76 52.03 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -129.53 138.91 51.61 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.13 128.3 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.405 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.8 mt -123.68 123.97 68.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.326 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.3 mt -123.23 130.83 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.392 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.4 m -145.74 165.86 27.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.297 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -105.46 135.81 46.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.1 pt -92.52 148.83 37.08 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.32 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' LYS . 37.3 Cg_endo -65.86 137.13 48.0 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.695 1.597 . . . . 0.0 110.69 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 t -60.88 -29.42 69.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.171 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -67.59 -31.34 71.32 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 84' ' ' PRO . 95.4 mttt -131.04 143.19 50.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.938 0.399 . . . . 0.0 111.007 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -111.87 179.82 3.9 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.086 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.484 ' N ' ' OG1' ' A' ' 88' ' ' THR . 45.8 tp -52.16 -45.16 64.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.079 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.3 p -68.51 -41.38 80.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.925 0.393 . . . . 0.0 110.882 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -66.41 -36.45 82.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.8 tt -55.62 -47.54 76.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.241 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.09 178.52 47.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.5 p -90.71 172.96 8.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.15 76.43 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.113 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.1 m -72.14 -45.3 61.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.55 -51.12 69.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.246 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.55 -38.63 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.404 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.08 -45.55 93.75 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -69.52 -40.26 77.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.813 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -61.5 -41.18 96.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.043 0.449 . . . . 0.0 110.76 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -60.74 -40.66 93.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.633 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.7 mmt -59.26 -44.16 92.43 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.507 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -64.59 -39.63 94.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.154 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.8 m -59.26 -46.84 87.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.922 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.15 -46.04 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.048 0.451 . . . . 0.0 110.383 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 111' ' ' GLN . 86.3 m-20 -61.99 -31.29 71.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -44.12 -37.56 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -110.34 -7.71 14.78 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.808 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.693 ' HG ' HH21 ' A' ' 114' ' ' ARG . 27.9 m -121.05 19.36 11.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.367 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.5 pt20 -84.39 6.26 23.9 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.15 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.98 -63.22 2.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.831 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -117.3 -46.14 2.71 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.903 0.382 . . . . 0.0 110.934 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.693 HH21 ' HG ' ' A' ' 110' ' ' SER . 93.2 mtm-85 -74.61 148.73 40.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.228 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -131.83 130.58 41.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.601 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.92 128.63 44.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 110.389 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -115.36 128.7 56.25 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.6 tp -82.71 111.6 18.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.929 0.395 . . . . 0.0 110.406 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.542 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.2 mt -77.74 -57.68 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.362 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.8 m-80 -146.35 161.3 40.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.647 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.41 112.93 2.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.388 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.37 167.37 22.27 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.896 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.418 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -136.93 149.7 47.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.754 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -132.52 143.04 49.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.778 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -111.82 115.03 28.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.428 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.12 144.76 36.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.983 0.42 . . . . 0.0 110.94 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.5 t0 54.74 22.1 3.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.41 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.54 -1.78 88.19 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -103.49 149.02 25.25 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.942 0.401 . . . . 0.0 110.077 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.67 128.42 67.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.995 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -117.49 127.73 54.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.873 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.31 124.78 49.78 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.7 m -105.78 122.76 46.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.299 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.3 mp -117.83 122.93 44.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.99 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -117.88 124.42 48.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.431 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -151.98 172.89 15.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.401 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -140.78 160.53 39.84 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.079 0.466 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.61 132.58 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.437 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pp -135.81 136.35 40.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 111.346 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.57 130.46 55.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.119 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.63 -116.95 10.08 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.518 ' C ' HD21 ' A' ' 143' ' ' ASN . 56.7 t0 -114.73 12.44 17.08 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.468 0.175 . . . . 0.0 111.025 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.518 HD21 ' C ' ' A' ' 142' ' ' ASP . 3.6 m120 -119.75 146.6 45.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.726 0.298 . . . . 0.0 110.951 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.57 125.19 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.434 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -75.21 -52.66 10.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.717 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -173.23 172.49 3.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -104.84 141.18 36.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.028 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -134.49 136.74 43.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.991 0.424 . . . . 0.0 111.206 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.1 tp -111.55 135.63 51.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.724 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.53 134.97 42.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.252 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.0 m -121.49 141.36 51.11 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.097 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.7 128.88 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.853 0.359 . . . . 0.0 110.871 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.8 m -146.31 148.86 32.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.415 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -112.54 151.1 30.4 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.833 0.349 . . . . 0.0 110.357 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -150.37 103.95 3.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 62.52 31.38 17.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.977 0.417 . . . . 0.0 110.68 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 89.01 2.27 78.22 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.306 -0.473 . . . . 0.0 111.925 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 1.7 mptp? -95.1 125.17 39.57 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.7 OUTLIER -88.62 118.22 28.13 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.411 HD12 HG23 ' A' ' 160' ' ' ILE . 77.4 mt -120.49 128.16 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.759 0.314 . . . . 0.0 110.499 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.5 m -130.52 136.51 49.02 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.723 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.86 110.47 20.82 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.976 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -105.47 111.88 24.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.559 0.219 . . . . 0.0 110.509 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.09 135.59 54.57 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.744 0.307 . . . . 0.0 110.483 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -129.82 138.2 50.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.368 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.6 m -153.05 156.52 38.92 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.48 145.07 34.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.453 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.39 -29.07 65.61 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.325 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.33 -34.05 71.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.256 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -113.79 -4.2 13.39 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.532 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 57.5 t-105 -49.54 -38.5 31.16 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.091 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.32 -43.11 99.59 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.183 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 77.9 m -65.58 -39.76 91.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.8 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.45 21.11 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.521 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 176' ' ' SER . 17.4 pttp -51.75 -50.5 60.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.459 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 27.2 t -65.17 -29.67 70.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.734 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.6 tp -55.75 -43.6 76.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.233 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.532 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 28.5 m-85 -61.53 -49.58 76.14 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.385 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.64 -39.66 91.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.459 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.456 ' O ' ' OG ' ' A' ' 184' ' ' SER . 43.8 m -65.39 -47.35 76.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.277 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.34 -44.88 99.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.494 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.475 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -66.52 -45.36 79.78 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.283 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.0 t -69.96 -32.34 70.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.235 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 180' ' ' THR . 63.8 m -62.03 -30.08 70.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.306 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -49.9 157.08 0.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.522 -179.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -138.59 153.99 48.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.581 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.6 m -127.12 151.15 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.107 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 42.6 p90 . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.75 -179.875 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.6 mt . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 120.917 0.389 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.61 ' NE2' ' N ' ' A' ' 33' ' ' GLN . 2.8 mp0 -109.92 151.89 26.51 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.272 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -120.24 143.14 48.45 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.565 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -130.43 133.63 46.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.068 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -140.81 151.2 44.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.401 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -140.73 120.26 13.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.408 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.8 p -71.33 -32.59 68.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.574 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.22 -49.45 74.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.115 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -87.37 -20.63 26.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.825 0.345 . . . . 0.0 110.729 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.34 41.16 91.58 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -139.75 152.71 46.84 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.264 0.532 . . . . 0.0 110.418 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -151.39 148.58 28.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -152.33 155.91 38.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.044 0.45 . . . . 0.0 111.53 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 45' ' ' LEU . 2.3 mm? -96.7 141.92 29.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.894 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -153.05 147.63 19.2 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.543 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.22 163.4 34.93 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.596 2.197 . . . . 0.0 112.968 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.596 ' ND2' ' NE2' ' A' ' 33' ' ' GLN . 68.6 m-80 -70.52 160.47 32.4 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.85 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.74 -6.19 57.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -97.08 141.84 29.73 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.4 pt -123.13 147.28 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.423 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.42 137.39 13.23 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.19 136.19 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.895 0.379 . . . . 0.0 110.655 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -77.78 133.98 38.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.241 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 m -132.06 56.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.256 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -73.65 137.78 44.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.13 3.57 69.77 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.48 -164.22 0.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.798 0.332 . . . . 0.0 110.65 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.5 157.04 1.89 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.155 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.74 131.03 27.92 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.425 2.083 . . . . 0.0 111.722 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.3 -22.43 36.98 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.84 132.16 27.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.413 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -118.67 -58.4 1.97 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.033 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 m -146.87 165.81 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.178 0.514 . . . . 0.0 111.308 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.13 140.86 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.028 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -111.99 130.38 55.88 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -127.6 133.6 49.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.917 0.389 . . . . 0.0 111.132 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 71' ' ' GLU . 60.2 t0 -93.49 118.27 31.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.452 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt -63.62 -39.09 93.49 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.14 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.06 -40.86 90.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' A' ' 68' ' ' ASP . 79.1 mm-40 -117.99 118.11 31.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.621 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -85.91 -43.0 13.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.417 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -58.43 -39.69 80.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.993 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 33.9 mp0 -82.95 135.94 34.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.355 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.84 157.77 38.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.904 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.5 tp -132.09 133.87 44.83 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.047 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.6 t -123.54 131.32 53.6 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.41 126.97 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.61 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.33 121.41 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.21 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.465 ' C ' ' HG ' ' A' ' 81' ' ' SER . 35.4 mm -116.77 129.92 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.01 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 159' ' ' LEU . 9.6 m -148.79 164.36 34.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.161 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -103.66 138.12 40.75 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.6 pt -92.92 149.26 37.37 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.788 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -43.77 139.64 5.18 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.76 1.64 . . . . 0.0 111.487 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -69.01 -23.9 64.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.557 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 56.3 t0 -90.68 -18.38 25.17 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -128.73 157.32 41.73 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.104 0.478 . . . . 0.0 111.617 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.9 t -122.92 176.91 5.74 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.515 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 tp -51.0 -45.09 61.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.972 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.9 p -66.92 -44.99 79.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.089 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.36 -37.18 84.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.8 tp -55.91 -41.94 75.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.67 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.83 -179.41 48.35 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.2 p -96.05 171.9 8.33 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.73 73.57 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.133 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.3 m -73.05 -46.16 53.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.87 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -62.6 -50.97 69.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.164 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.36 -38.79 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -57.94 -56.12 26.87 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -59.52 -36.64 76.48 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.479 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -56.27 -40.26 73.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.099 0.476 . . . . 0.0 110.577 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -63.8 -41.58 97.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.127 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.674 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -54.98 -55.27 32.7 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.307 0.575 . . . . 0.0 110.096 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -61.29 -39.56 90.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.766 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.1 m -57.97 -45.63 86.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.7 t -71.7 -46.57 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.504 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 111' ' ' GLN . 1.6 m120 -60.83 -33.9 73.75 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.879 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -45.63 -35.52 4.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.06 0.457 . . . . 0.0 110.439 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.47 -48.5 22.41 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 m -122.31 22.94 9.96 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.3 pt20 -47.39 -18.59 0.12 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.632 0.253 . . . . 0.0 111.483 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.26 -61.44 7.38 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.167 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 38.1 p-10 -117.31 -30.84 5.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.072 0.436 . . . . 0.0 111.781 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.527 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 55.1 ttm-85 -80.19 136.92 36.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 111.026 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -133.17 135.86 45.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.37 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.481 ' CB ' HD22 ' A' ' 107' ' ' ASN . . . -107.87 136.62 47.29 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.951 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -118.64 127.76 53.9 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.9 tp -82.84 108.18 15.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.899 0.38 . . . . 0.0 110.209 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.546 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 97.0 mt -71.0 -38.3 71.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.942 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.3 m-80 -178.52 163.7 1.57 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.165 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.9 120.53 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.197 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -137.6 170.71 15.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.035 0.445 . . . . 0.0 110.919 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -141.78 150.74 42.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.506 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.83 136.77 46.45 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.152 0.501 . . . . 0.0 110.802 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -103.97 113.62 27.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -138.26 137.62 37.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.429 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 129' ' ' GLN . 87.2 m-20 51.24 42.3 28.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.627 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.13 1.59 5.67 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.524 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 2.8 tm0? -102.28 130.71 49.06 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.13 130.0 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.524 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 45.8 m-85 -118.87 131.4 56.06 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.724 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.435 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.07 128.44 53.34 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 94.0 m -110.13 123.62 50.06 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.326 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -115.45 127.51 55.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.992 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -123.43 120.49 33.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.297 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -150.31 169.68 20.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.471 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -133.73 152.92 52.01 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 110.554 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.4 ' CG1' HH11 ' A' ' 114' ' ' ARG . 74.2 t -105.01 133.57 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.375 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.57 135.13 31.49 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.283 0.563 . . . . 0.0 111.087 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.6 t -115.02 134.27 58.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.131 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.54 -122.1 21.87 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -111.31 13.45 21.65 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -128.86 156.74 43.17 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.077 0.465 . . . . 0.0 111.475 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.62 126.98 41.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.63 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.412 ' OE1' ' NH1' ' A' ' 114' ' ' ARG . 84.2 tt0 -74.77 -54.63 6.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.472 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -174.46 173.83 2.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.207 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.416 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 51.2 m170 -103.99 138.66 40.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.025 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 81.5 m-20 -135.38 137.92 42.81 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.011 0.434 . . . . 0.0 111.291 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 tp -114.15 130.52 56.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.845 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.79 137.85 54.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.82 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.1 t -126.82 126.02 42.66 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 52.4 t -114.83 129.94 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.12 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.9 m -143.83 144.34 31.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.0 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 p -110.99 150.34 29.4 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.209 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -156.66 117.16 3.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.964 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.462 ' HE ' ' H ' ' A' ' 156' ' ' ARG . 4.8 mmp_? 58.94 24.85 13.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.11 7.88 72.92 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.1 125.82 43.27 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -88.97 121.47 31.35 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.415 HD12 HG22 ' A' ' 160' ' ' ILE . 76.5 mt -122.87 129.08 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.565 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 37.7 m -129.07 136.47 50.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.454 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.85 99.9 8.03 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -96.81 107.55 20.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.762 0.315 . . . . 0.0 110.616 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.54 133.42 54.6 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.801 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 89.0 p -128.46 135.8 49.97 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.788 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 5.9 m -152.97 154.82 35.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.549 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -54.89 141.0 35.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.239 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -67.77 -34.19 76.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.55 -33.78 68.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.994 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -109.9 -7.18 15.02 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.499 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 52.2 t-105 -49.51 -38.26 29.83 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.832 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.53 -42.96 99.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 58.6 m -65.53 -39.82 92.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.722 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 13.6 m -108.28 21.27 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.35 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 171' ' ' TRP . 50.8 pttt -52.22 -46.78 65.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 84.8 p -69.52 -25.83 64.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.602 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.99 -43.28 91.44 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.998 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.499 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 28.5 m-85 -61.7 -50.86 70.75 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.206 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.15 -41.05 99.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.558 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.463 ' O ' ' OG ' ' A' ' 184' ' ' SER . 41.8 m -67.22 -48.52 67.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.321 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.95 -45.1 99.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.731 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.514 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -66.48 -43.94 84.06 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.313 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.0 m -72.8 -31.13 64.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.342 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 180' ' ' THR . 40.3 m -61.82 -29.53 70.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.442 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -54.94 157.01 3.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.078 0.466 . . . . 0.0 110.944 -179.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -137.02 158.03 45.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.64 151.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.941 0.401 . . . . 0.0 111.008 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.524 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 38.1 p90 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.801 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 120.966 0.412 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.13 166.39 24.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.62 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.5 ptt-85 -115.84 144.68 43.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.708 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -124.13 132.44 53.64 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.189 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.9 m -139.15 151.18 46.43 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.544 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -141.61 118.48 11.15 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.32 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.6 p -72.31 -30.53 64.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.719 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -62.53 -47.61 83.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.722 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -90.21 -20.4 23.07 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.937 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.78 41.94 81.2 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -141.1 152.98 45.2 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.239 0.519 . . . . 0.0 110.22 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -153.26 148.17 26.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -157.22 157.57 34.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.162 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.6 mt -96.38 152.19 18.83 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -161.19 130.08 3.08 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.19 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -41.99 157.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.094 1.862 . . . . 0.0 112.507 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -80.8 160.31 24.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.869 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.84 12.53 63.91 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.532 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 28.2 m0 -91.24 151.68 20.82 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 110.479 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 51' ' ' ILE . 43.0 pt -117.29 151.07 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.377 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.73 134.51 9.97 Favored Glycine 0 N--CA 1.466 0.651 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.62 141.19 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.62 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -87.03 144.72 26.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.181 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.69 49.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.308 0.575 . . . . 0.0 109.878 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -54.12 129.42 34.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.16 4.65 68.53 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.01 -164.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.12 157.89 2.78 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.249 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.8 130.62 25.13 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.341 2.027 . . . . 0.0 111.465 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' ILE . . . 94.83 -22.47 37.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.85 126.74 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.783 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -119.05 -57.98 1.98 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.596 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.5 t -145.68 146.04 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.83 0.348 . . . . 0.0 111.035 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.8 t -120.67 135.9 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.123 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -111.25 132.07 54.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.276 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -122.74 141.31 51.94 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.388 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 49.0 m-20 -93.37 118.97 31.95 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.566 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.0 mt -68.47 -38.16 80.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 110.623 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.16 -44.47 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.688 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -126.57 98.69 5.5 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.918 0.39 . . . . 0.0 110.621 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.687 ' NE ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -61.77 -32.67 72.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.538 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.46 -36.25 73.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.575 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -86.76 131.5 34.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -146.66 138.86 24.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.445 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -118.89 134.56 55.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.688 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t -122.6 138.28 54.63 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.213 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.6 t -118.28 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 110.342 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.6 mt -122.28 122.83 67.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.475 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' GLY . 72.2 mt -122.88 133.85 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.907 0.384 . . . . 0.0 111.059 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 159' ' ' LEU . 15.9 t -148.46 167.77 24.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.097 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.435 ' H ' ' HG ' ' A' ' 81' ' ' SER . 3.0 pp20? -105.58 136.63 44.81 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.762 0.315 . . . . 0.0 110.318 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.1 pt -93.92 148.3 35.03 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.264 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 87' ' ' LYS . 38.8 Cg_endo -66.07 136.88 46.21 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.728 1.619 . . . . 0.0 110.968 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.3 t -61.44 -27.18 68.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.979 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -67.8 -30.86 70.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.023 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 84' ' ' PRO . 66.4 mttm -130.41 156.58 44.49 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.027 0.442 . . . . 0.0 111.119 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.466 ' HG1' ' H ' ' A' ' 89' ' ' LEU . 14.7 t -122.7 176.13 6.13 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.441 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.466 ' H ' ' HG1' ' A' ' 88' ' ' THR . 43.0 tp -52.65 -44.83 66.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.075 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.8 p -68.6 -46.51 69.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.24 -35.76 81.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.075 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -55.83 -43.07 76.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.505 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 175.05 44.48 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.0 p -92.82 170.69 9.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.61 77.99 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.118 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 74.7 m -72.03 -44.5 63.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -61.77 -51.26 69.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.405 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.22 -38.49 79.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.528 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.18 -46.78 92.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -67.24 -40.39 86.29 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.984 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -61.5 -41.4 97.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.028 0.442 . . . . 0.0 110.813 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -61.45 -40.33 94.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.755 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.7 mmt -58.64 -44.3 90.02 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.684 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.427 ' HZ2' HE22 ' A' ' 111' ' ' GLN . 41.1 tptt -65.55 -45.51 83.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.005 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.9 m -59.2 -45.81 90.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.98 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.14 -47.12 79.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.995 0.426 . . . . 0.0 110.406 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 111' ' ' GLN . 91.7 m-20 -63.36 -38.43 91.14 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -43.77 -36.28 2.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.337 . . . . 0.0 111.006 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.98 -47.65 67.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.011 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.5 m -123.66 23.44 8.8 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.6 tt0 -50.37 -28.72 8.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.596 0.236 . . . . 0.0 111.419 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.15 -61.72 2.62 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.098 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 34.3 p-10 -117.83 -35.27 3.95 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 117.046 0.423 . . . . 0.0 111.965 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.52 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 35.1 ttm180 -84.64 137.75 33.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 111.276 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -128.31 142.93 50.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.03 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.44 140.36 38.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.877 0.37 . . . . 0.0 110.421 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' CD ' ' CD2' ' A' ' 139' ' ' LEU . 93.3 mt-10 -121.32 123.54 42.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.459 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.7 tp -82.87 109.75 17.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.963 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.524 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.8 mt -72.44 -50.45 35.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.579 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 27.7 m120 -157.0 164.42 38.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.819 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.82 115.45 3.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.246 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -141.61 166.3 25.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.833 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.418 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -136.51 148.46 47.65 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -127.72 141.05 51.7 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.834 0.35 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -108.35 112.14 24.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.614 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 127' ' ' ASP . 79.4 mm-40 -138.28 144.07 40.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.432 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 126' ' ' GLU . 3.7 p-10 46.53 39.32 6.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.28 1.47 21.15 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 154' ' ' THR . 68.1 tp60 -105.95 132.36 52.14 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.43 130.44 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.987 0.422 . . . . 0.0 110.41 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -117.2 130.64 56.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.673 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -103.52 125.58 50.16 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.0 m -107.45 122.74 47.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.327 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.27 120.49 38.39 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.971 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -115.47 123.42 48.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -152.07 166.9 30.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.837 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -134.37 153.85 51.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.922 0.392 . . . . 0.0 110.486 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.01 136.42 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.755 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.402 ' CD2' ' CD ' ' A' ' 117' ' ' GLU . 2.7 pp -139.59 138.96 36.64 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.181 0.515 . . . . 0.0 111.225 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.6 m -110.5 134.01 54.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.243 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 62.04 -117.54 11.78 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 56.7 t0 -116.2 13.59 15.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.456 0.17 . . . . 0.0 110.963 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -121.98 148.0 45.34 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.753 0.311 . . . . 0.0 111.068 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.8 p -85.48 126.84 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.467 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -75.81 -53.4 8.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.407 HH21 ' N ' ' A' ' 166' ' ' THR . 14.7 ptm180 -174.19 171.08 3.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.0 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.412 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 35.7 m170 -103.11 140.53 37.2 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.203 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 78.6 m-20 -134.84 136.19 42.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.924 0.393 . . . . 0.0 111.043 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.6 tp -111.23 134.41 52.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.631 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.78 136.17 42.39 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 110.553 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 52.8 m -123.66 140.47 52.96 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.6 t -121.68 129.56 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.871 0.367 . . . . 0.0 110.537 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.2 m -146.55 142.67 28.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.532 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.44 ' O ' ' NE2' ' A' ' 129' ' ' GLN . 16.7 p -106.0 151.8 24.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.805 0.335 . . . . 0.0 110.491 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -148.32 106.02 3.68 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.015 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 55.39 32.71 19.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.28 6.63 68.51 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -98.42 124.82 43.32 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.16 113.97 25.21 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 160' ' ' ILE . 70.9 mt -120.02 126.5 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 89.6 m -122.68 132.26 54.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.295 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.56 111.15 22.19 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -114.6 133.98 55.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.962 0.411 . . . . 0.0 111.272 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 mp -129.87 144.33 51.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.426 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 82.5 p -134.98 134.04 40.11 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.298 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.423 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 20.7 m -152.98 159.33 42.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.676 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -56.78 141.42 44.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.227 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -66.18 -38.61 88.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.878 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -62.08 -33.38 74.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.298 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -96.38 -17.28 20.73 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.243 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.583 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 46.6 t-105 -48.53 -41.42 30.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.732 0.301 . . . . 0.0 110.784 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -63.0 -41.46 99.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.932 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.1 m -66.14 -40.61 90.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.7 m -108.08 21.41 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.266 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 171' ' ' TRP . 49.3 pttt -49.19 -45.9 44.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 111.38 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 83.8 p -67.91 -26.79 66.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.463 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.78 -45.35 86.11 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.926 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.583 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.1 m-85 -62.38 -49.73 74.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.244 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -62.35 -43.31 99.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.431 ' O ' ' OG ' ' A' ' 184' ' ' SER . 86.5 m -66.96 -50.62 61.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.824 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 76.1 t -67.49 -38.32 80.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.39 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.31 -36.67 82.86 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.055 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.7 t -85.02 -17.66 36.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.474 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 180' ' ' THR . 50.9 m -62.78 -36.13 82.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.388 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.451 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -58.66 148.82 27.8 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.39 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -138.71 160.18 40.28 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.4 m -128.18 151.66 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.952 0.406 . . . . 0.0 111.188 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.47 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 35.9 p90 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.587 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.2 mt . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.623 ' NE2' ' ND2' ' A' ' 48' ' ' ASN . 5.4 mp0 -106.83 159.07 16.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.581 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -128.27 138.87 52.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.352 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -129.56 136.29 49.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.943 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.7 p -144.3 157.77 44.1 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -147.91 117.7 7.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.313 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.2 p -70.23 -31.96 69.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 110.448 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -62.13 -48.68 79.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.065 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -88.24 -20.53 25.37 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.97 42.8 76.35 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.81 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -143.97 151.79 40.22 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 117.308 0.554 . . . . 0.0 110.629 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -154.84 144.49 21.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.966 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -149.55 157.38 43.22 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.859 0.361 . . . . 0.0 110.822 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tp -101.63 134.72 44.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.369 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -139.7 148.53 56.14 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.5 165.49 27.21 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.652 2.235 . . . . 0.0 112.945 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.623 ' ND2' ' NE2' ' A' ' 33' ' ' GLN . 70.3 m-80 -73.22 159.7 33.05 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.602 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.41 -5.11 62.5 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -93.45 143.83 25.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.725 0.297 . . . . 0.0 110.26 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.7 pt -122.17 147.49 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.701 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.85 132.53 11.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.33 133.76 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.929 0.395 . . . . 0.0 110.641 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -80.02 140.67 36.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.37 51.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.47 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -75.02 132.85 41.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.031 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.25 -3.36 84.11 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.45 -163.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.544 -0.328 . . . . 0.0 110.279 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.0 m -39.24 108.84 0.5 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.68 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -45.51 136.55 11.96 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.569 1.512 . . . . 0.0 111.703 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.16 -31.91 8.1 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.51 129.22 28.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.125 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -100.24 -58.77 1.84 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.306 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.1 t -150.13 149.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.152 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.71 135.72 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.4 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.08 138.69 48.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.298 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -131.01 129.83 42.56 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.302 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -87.58 118.26 26.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.559 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 mt -65.46 -37.79 87.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.58 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 70' ' ' ILE . 27.5 mm -63.49 -43.96 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.46 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -124.74 97.8 5.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.459 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -60.47 -37.35 80.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.308 0.575 . . . . 0.0 109.769 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -58.48 -36.04 73.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -81.06 127.75 32.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.93 0.395 . . . . 0.0 110.311 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -156.01 165.15 37.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.528 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 pp -162.42 160.9 26.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.466 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.1 t -143.87 143.89 31.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.413 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.55 130.17 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.5 mt -116.54 127.45 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.22 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.8 mt -118.23 127.95 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 110.425 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.1 m -143.3 164.76 29.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.772 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -106.23 131.52 53.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.707 0.289 . . . . 0.0 110.293 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -94.08 150.32 38.26 Favored Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 87' ' ' LYS . 55.8 Cg_endo -70.75 137.49 32.69 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.739 1.626 . . . . 0.0 110.878 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.6 t -63.54 -29.17 70.47 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.371 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 46.3 p30 -68.69 -29.29 67.71 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.599 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 99.1 mttt -132.03 144.89 51.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.025 0.44 . . . . 0.0 110.999 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -109.52 -179.8 3.92 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.31 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.6 tp -50.75 -44.63 58.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.82 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.2 p -66.27 -43.92 85.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.911 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -65.01 -38.92 92.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.2 tp -55.93 -43.15 77.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.504 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.75 173.86 43.58 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 36.1 p -91.72 171.61 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.08 -43.2 81.92 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.075 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.2 m -71.91 -44.21 64.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -61.43 -51.35 69.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.426 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.67 -38.53 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.573 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.78 -44.61 94.14 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -68.71 -43.08 76.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.101 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -61.37 -39.14 89.56 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.921 -0.311 . . . . 0.0 110.982 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -61.89 -40.65 96.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.526 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -59.22 -42.7 91.61 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.497 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 2.2 mptm? -67.99 -42.74 80.32 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.398 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.0 m -57.02 -44.52 82.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.71 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.55 -43.67 71.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.956 0.408 . . . . 0.0 110.142 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.97 -31.68 72.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.037 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 104' ' ' LYS . 94.9 m-20 -42.39 -32.28 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.915 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.28 -33.32 6.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.537 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 114' ' ' ARG . 5.7 p -88.55 -6.36 57.62 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -55.92 -28.59 57.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.531 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -41.97 -63.74 1.67 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.009 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.1 p-10 -119.36 -45.01 2.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.025 0.44 . . . . 0.0 111.47 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.494 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 83.5 mtm180 -81.69 148.77 28.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.96 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -129.83 142.01 50.74 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.729 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.96 136.75 45.05 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.657 0.265 . . . . 0.0 110.51 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -122.71 128.91 51.17 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.6 tp -82.69 108.15 15.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.906 0.384 . . . . 0.0 110.325 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.0 mt -74.21 -43.35 50.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.536 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.38 164.84 22.03 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.281 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.72 114.44 3.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.207 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -139.03 170.51 15.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -142.62 151.0 41.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -132.45 147.82 52.38 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.059 0.457 . . . . 0.0 111.016 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -114.51 114.63 26.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.561 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -138.22 142.53 39.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.7 t0 51.31 27.64 3.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.547 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.15 -2.37 84.51 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -100.37 146.95 26.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.055 0.455 . . . . 0.0 110.165 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.77 127.74 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.011 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 22.1 m-85 -116.88 126.77 53.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.841 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.4 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.69 126.4 51.73 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.7 m -108.43 122.15 46.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.214 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.76 113.8 22.37 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.134 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -108.94 123.19 48.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.572 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -150.03 169.13 21.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.599 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -132.58 156.59 46.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.049 0.452 . . . . 0.0 110.837 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 145' ' ' GLU . 48.7 t -106.38 129.75 59.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.167 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.16 135.81 54.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.043 0.449 . . . . 0.0 111.501 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.21 87.65 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.95 -106.02 2.82 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -112.79 7.49 18.5 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -122.62 137.14 54.99 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.006 0.431 . . . . 0.0 111.585 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.0 p -67.29 122.96 19.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.849 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 138' ' ' VAL . 81.3 tt0 -77.7 -56.17 4.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.343 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -169.57 169.58 8.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -103.49 134.87 46.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.075 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -129.71 137.76 50.76 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.042 0.448 . . . . 0.0 110.823 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.421 HD22 ' H ' ' A' ' 150' ' ' ALA . 3.2 tm? -111.99 138.78 48.16 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.707 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.421 ' H ' HD22 ' A' ' 149' ' ' LEU . . . -135.92 125.37 25.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.462 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t -118.34 124.46 47.81 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 44.6 t -110.61 128.91 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.902 0.382 . . . . 0.0 110.868 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 57.6 m -142.75 143.16 32.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.373 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.4 p -89.15 157.34 18.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.885 0.374 . . . . 0.0 110.596 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -150.26 93.97 2.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.602 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 57.91 33.61 23.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.583 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 93.16 3.8 65.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -101.6 137.59 39.71 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.787 0.327 . . . . 0.0 110.164 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.95 119.03 32.3 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.296 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 160' ' ' ILE . 76.1 mt -119.36 126.63 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.5 m -126.27 137.22 53.49 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.817 0.342 . . . . 0.0 110.571 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.32 98.01 7.01 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.794 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -96.37 113.74 25.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.856 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.8 mp -116.13 140.58 49.14 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.439 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.5 t -133.1 132.76 42.08 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.141 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 11.1 m -152.42 158.99 43.43 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.489 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.413 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -52.73 141.34 21.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.342 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -67.8 -39.48 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -61.5 -33.38 73.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.343 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -96.58 -17.27 20.56 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.17 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.523 ' O ' ' N ' ' A' ' 175' ' ' LYS . 52.2 t-105 -48.85 -40.08 28.13 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.931 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -61.22 -41.04 96.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.297 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 59.3 m -68.05 -38.92 83.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.629 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.44 21.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.378 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 171' ' ' TRP . 11.1 ptmm? -51.26 -50.41 59.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 29.8 m -65.07 -28.97 69.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.656 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.5 tp -56.14 -44.16 78.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.253 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.51 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 26.2 m-85 -63.35 -51.05 67.55 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.352 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.58 -41.15 98.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 184' ' ' SER . 44.1 m -66.6 -48.83 68.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.43 -43.55 98.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.432 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.55 -41.34 98.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.362 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 84.2 p -79.22 -25.65 42.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.874 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 180' ' ' THR . 41.4 t -62.75 -31.01 71.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.028 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -55.9 158.17 3.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.103 0.477 . . . . 0.0 110.576 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.523 ' CD2' ' N ' ' A' ' 187' ' ' VAL . 6.0 t-160 -136.97 145.5 44.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.368 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.523 ' N ' ' CD2' ' A' ' 186' ' ' HIS . 6.8 m -122.27 147.96 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.449 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 35.5 p90 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.722 -179.363 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.029 0.442 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 48' ' ' ASN . 2.1 mp0 -106.73 146.19 31.13 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.008 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -117.42 131.0 56.83 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.738 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -115.3 134.43 55.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.487 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 94.2 p -145.35 153.06 40.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.947 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 36' ' ' SER . 97.9 m-20 -143.04 119.43 10.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.27 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.1 p -69.16 -33.9 74.12 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.272 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.84 -48.45 78.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -84.25 -20.64 31.88 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.958 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.9 42.06 93.04 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -143.97 149.1 36.23 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.175 0.488 . . . . 0.0 110.467 179.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -153.66 145.39 23.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -151.28 158.52 43.96 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 tp -104.24 135.01 46.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.402 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 14.7 p90 -136.88 143.78 43.94 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.859 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.87 150.7 2.51 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.819 1.679 . . . . 0.0 112.149 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.419 ' CB ' ' NE2' ' A' ' 33' ' ' GLN . 51.1 p-10 -79.87 160.67 25.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.497 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.69 60.52 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.1 m0 -92.38 147.57 22.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.851 0.358 . . . . 0.0 110.201 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 51' ' ' ILE . 36.7 pt -116.5 144.44 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.415 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.33 133.49 11.4 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.22 133.67 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.331 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.16 124.64 32.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.227 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.93 59.47 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -77.15 135.19 38.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.063 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.79 3.69 73.65 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.46 -164.4 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.492 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -45.93 154.38 0.58 Allowed Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.412 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.31 130.77 23.26 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.36 2.04 . . . . 0.0 111.855 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' ILE . . . 96.47 -23.72 33.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.91 128.9 33.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.561 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -119.16 -57.88 1.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.502 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.2 t -143.49 141.66 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.884 0.373 . . . . 0.0 111.216 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.41 133.28 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.218 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -112.61 135.94 52.75 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.63 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -127.92 138.46 52.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.337 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -88.76 118.29 28.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.62 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.37 -37.03 84.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.684 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.62 -42.43 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.486 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.36 99.72 6.57 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.58 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -62.59 -37.43 86.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.39 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -58.77 -35.05 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.753 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -81.62 131.29 35.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -140.1 139.19 35.78 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.994 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -126.26 135.26 51.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.071 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 t -128.02 139.41 52.57 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.84 126.55 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.961 0.41 . . . . 0.0 110.231 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -124.11 119.24 56.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.274 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' GLY . 33.4 mm -116.07 131.92 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.289 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 159' ' ' LEU . 49.2 m -145.96 166.48 25.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.35 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -104.8 137.98 41.77 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.3 pt -93.51 149.32 37.04 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.656 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -45.38 134.96 12.22 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.641 1.561 . . . . 0.0 111.496 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.1 t -65.1 -26.75 68.35 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.307 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -85.11 -20.81 29.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -129.79 158.24 39.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.209 0.528 . . . . 0.0 111.863 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.9 t -122.69 175.65 6.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.468 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.5 tp -52.07 -45.06 64.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.017 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 p -66.01 -46.02 79.44 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.164 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -66.79 -35.26 79.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.5 tp -55.83 -43.43 76.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.75 178.79 47.57 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.4 p -94.13 173.04 7.85 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.43 -41.56 76.61 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.15 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.3 m -72.53 -46.25 55.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.002 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -61.64 -50.89 70.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.431 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.32 -38.27 80.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.694 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.73 -44.03 96.04 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -67.24 -42.61 83.66 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.665 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -61.45 -38.45 87.25 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.664 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.39 -41.61 98.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.38 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.55 -43.2 93.59 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.187 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -64.89 -38.51 91.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.35 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.9 m -58.56 -47.62 83.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.883 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.45 -46.41 56.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.052 0.453 . . . . 0.0 110.503 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.4 m-20 -60.82 -30.41 70.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.285 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -43.59 -38.93 3.23 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.329 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.29 -39.68 9.52 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.624 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.505 ' C ' ' H ' ' A' ' 112' ' ' GLY . 8.9 p -86.13 -1.19 57.18 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.4 pt20 -58.39 -0.55 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.438 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -73.7 -64.37 2.49 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.134 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -118.42 -45.23 2.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.79 0.329 . . . . 0.0 111.46 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 110' ' ' SER . 69.9 mtm180 -85.24 144.81 27.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.481 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -123.98 143.85 50.16 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.796 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.85 132.38 45.23 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -114.11 128.81 56.54 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 39.0 tp -81.78 109.86 16.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.67 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.419 ' CG1' ' HE ' ' A' ' 137' ' ' ARG . 88.2 mt -74.09 -53.33 17.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.237 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.549 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 9.2 p30 -160.69 176.51 11.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.84 127.14 5.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.225 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 57.6 mp0 -141.43 159.35 42.41 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.701 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -140.29 147.77 40.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.941 0.4 . . . . 0.0 110.651 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -132.57 146.4 51.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.572 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -121.01 114.95 22.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.3 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -142.19 144.68 33.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.6 t0 51.25 34.44 11.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.533 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.45 -0.24 55.73 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -101.85 146.87 27.21 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.988 0.423 . . . . 0.0 110.188 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.3 t -114.47 128.86 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.214 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -118.09 122.64 43.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.54 132.05 51.24 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 52.8 m -112.55 132.25 55.2 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.053 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.32 110.34 12.72 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.065 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.549 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 69.9 tt0 -104.19 122.95 46.43 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -147.47 170.07 18.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.306 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.516 ' NH1' ' HE2' ' A' ' 147' ' ' HIS . 18.7 ptp180 -138.14 161.26 37.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.946 0.403 . . . . 0.0 110.926 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.0 t -108.16 133.46 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.092 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.5 pp -136.4 135.47 38.76 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.149 0.5 . . . . 0.0 111.622 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.37 128.1 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.65 -118.2 13.68 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -109.66 9.27 25.03 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.87 -0.194 . . . . 0.0 110.949 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -114.93 143.85 44.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.854 0.359 . . . . 0.0 111.492 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.29 130.13 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.465 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -83.28 -54.68 4.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.443 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.595 HH21 ' CA ' ' A' ' 166' ' ' THR . 15.2 ptm180 -170.3 173.29 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.123 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.516 ' HE2' ' NH1' ' A' ' 137' ' ' ARG . 50.7 m80 -105.49 142.81 34.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.128 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 13.5 t70 -139.88 150.75 44.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.767 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.6 tp -125.49 136.32 53.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.041 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.02 119.81 19.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.847 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.1 t -106.03 138.36 42.35 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.35 130.06 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.908 0.385 . . . . 0.0 111.007 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -148.44 150.94 34.36 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.413 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.1 p -118.95 152.34 36.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.523 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -159.54 118.07 2.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.637 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 59.45 27.88 17.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.33 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.93 9.8 83.88 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -100.46 127.17 46.88 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.51 121.46 31.75 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.135 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 160' ' ' ILE . 77.4 mt -119.45 127.64 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.304 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 46.1 m -129.66 135.28 48.33 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.663 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.0 103.84 11.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.895 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -100.12 110.0 22.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.573 0.225 . . . . 0.0 110.432 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.432 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 5.3 mp -115.0 136.05 53.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.408 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.5 t -127.47 134.1 49.85 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.885 0.374 . . . . 0.0 110.546 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.595 ' CA ' HH21 ' A' ' 146' ' ' ARG . 9.5 m -152.53 154.9 36.38 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.611 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.14 144.29 35.5 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.547 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.431 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 1.2 pp20? -70.32 -30.55 67.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.024 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.431 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 92.5 m-20 -59.86 -33.9 72.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.957 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -111.88 -5.3 14.38 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.501 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 52.4 t-105 -49.55 -39.17 33.74 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.786 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.42 -41.64 98.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.19 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.0 m -65.72 -39.87 91.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.699 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.6 m -108.86 21.64 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.278 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 171' ' ' TRP . 10.2 ptmm? -51.38 -50.0 60.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.392 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.1 t -64.92 -30.7 71.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.17 -44.16 74.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.303 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 27.9 m-85 -60.95 -49.83 75.84 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.308 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -64.59 -38.91 92.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.492 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 42.7 m -65.38 -49.01 70.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.476 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.29 -45.16 99.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.659 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -64.85 -42.18 95.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 110.371 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 21.2 t -73.87 -31.47 63.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.231 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 91.7 p -63.12 -24.13 67.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.308 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -57.34 156.11 8.13 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.498 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -136.0 156.75 48.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.522 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.82 151.42 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.831 0.348 . . . . 0.0 111.107 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.519 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 38.3 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.736 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.9 mt . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 120.846 0.355 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.501 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 20.5 mp0 -108.42 154.26 22.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.497 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -125.96 143.71 50.98 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.312 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -130.07 139.87 50.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.046 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.441 ' OG ' ' OH ' ' A' ' 188' ' ' TYR . 12.6 t -149.75 148.57 29.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 110.63 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -137.89 121.45 17.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.481 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.5 p -70.98 -33.22 70.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.504 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -61.93 -48.25 81.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -88.6 -20.47 24.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.784 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.84 42.02 93.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.73 150.72 42.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.153 0.477 . . . . 0.0 110.662 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -149.67 147.15 27.74 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.717 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -146.75 154.86 41.89 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.935 0.398 . . . . 0.0 110.983 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.531 ' N ' ' CD2' ' A' ' 45' ' ' LEU . 3.1 mm? -98.02 141.66 30.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.101 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -151.31 146.84 19.42 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.317 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.12 160.02 51.09 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.455 2.103 . . . . 0.0 112.347 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -69.83 160.81 31.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.709 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.18 0.28 57.14 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.528 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 32.6 m0 -91.22 141.3 28.95 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.68 128.37 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.999 0.428 . . . . 0.0 110.141 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.53 137.33 13.21 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.52 141.75 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.72 0.295 . . . . 0.0 110.57 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.17 122.61 31.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.05 0.452 . . . . 0.0 110.413 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 m -121.56 32.07 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.676 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -50.09 136.82 18.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.94 4.1 69.64 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.11 -164.33 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.636 0.255 . . . . 0.0 110.541 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 m -46.36 137.08 6.93 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.65 130.47 9.61 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.708 1.606 . . . . 0.0 112.717 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.15 5.76 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.0 t -62.31 125.43 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.273 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -119.78 -57.22 1.98 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.68 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.7 t -136.32 142.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.082 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.01 132.97 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.419 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 76' ' ' LEU . 90.7 m-85 -112.78 133.19 54.91 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.263 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -124.82 140.93 52.48 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.443 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 81.9 m-20 -88.36 118.76 28.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.546 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 tp -67.35 -40.87 85.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.47 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.8 mt -61.62 -43.43 97.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.017 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -117.34 121.2 40.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.928 0.394 . . . . 0.0 110.371 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -80.95 -37.55 29.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.634 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 41.1 p-10 -62.57 -31.32 72.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.959 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 85.3 tt0 -85.89 131.3 34.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.939 0.399 . . . . 0.0 110.787 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -142.31 139.6 31.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.144 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PHE . 7.5 tt -123.78 134.81 53.58 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.7 t -128.74 138.91 52.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.334 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -113.18 123.82 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.4 mt -125.77 120.54 57.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.195 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.4 mt -121.1 132.64 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.172 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.4 m -136.15 164.7 27.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.47 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -103.73 135.36 45.43 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 9.6 pt -102.23 150.21 37.31 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.943 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -44.51 145.37 2.63 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.841 1.694 . . . . 0.0 111.222 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.6 p -80.08 -13.91 58.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.598 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -96.35 -20.93 18.12 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.765 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -124.06 157.14 35.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.099 0.476 . . . . 0.0 111.385 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -122.66 177.82 5.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.612 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 tp -51.66 -45.43 63.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.061 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.2 p -64.42 -44.55 90.87 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.098 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -65.76 -38.12 88.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.968 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.4 tp -56.23 -43.85 79.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.86 176.52 45.93 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 39.8 p -94.86 171.11 8.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.6 78.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.126 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.2 m -72.03 -44.93 62.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.747 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.84 -51.78 66.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.409 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.16 -38.01 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.668 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.33 -47.21 90.98 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.53 -41.63 84.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -62.35 -40.79 97.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.981 0.42 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -61.67 -41.3 97.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.857 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -58.99 -45.46 90.56 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.661 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -64.35 -43.01 95.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.873 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.1 m -60.85 -47.04 88.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.1 t -71.87 -46.11 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.602 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 111' ' ' GLN . 91.7 m-20 -61.43 -39.57 91.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.632 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -46.61 -36.25 6.74 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.533 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 -45.36 89.78 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.885 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 114' ' ' ARG . 8.6 m -123.7 22.18 9.08 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.6 tt0 -52.53 -28.48 20.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.673 0.273 . . . . 0.0 111.452 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.86 -62.1 2.75 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.138 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -117.74 -40.51 3.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.929 0.365 . . . . 0.0 111.681 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 110' ' ' SER . 52.6 ttp180 -92.09 146.2 23.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.046 0.451 . . . . 0.0 110.904 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.76 151.63 40.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.517 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.423 ' CB ' ' OD1' ' A' ' 107' ' ' ASN . . . -103.04 139.85 38.05 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.569 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -113.18 130.8 56.1 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.21 106.01 12.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.082 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.7 mt -70.8 -51.06 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.378 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.549 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 7.5 p30 -160.66 173.91 14.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.953 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.1 122.92 4.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.189 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -142.09 159.56 41.99 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.689 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.42 147.83 43.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.524 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.7 141.55 47.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.705 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -110.61 112.81 24.96 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.393 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -137.59 144.33 41.94 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.97 0.414 . . . . 0.0 110.76 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.3 t0 50.98 33.28 8.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.35 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.84 0.97 61.08 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -104.05 146.94 27.99 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.978 0.418 . . . . 0.0 110.252 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.05 128.53 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.142 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 27.8 m-85 -118.06 124.47 48.18 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.853 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.62 128.13 50.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.0 m -109.02 122.25 46.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.201 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.8 mp -118.36 112.74 20.41 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.102 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.549 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 60.7 tt0 -106.46 123.96 48.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.426 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.94 169.66 20.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.499 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -135.85 156.3 49.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.76 0.314 . . . . 0.0 110.541 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.1 m -102.89 125.78 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.993 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.7 mt -107.75 123.35 48.41 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.5 t -117.31 130.36 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.66 -122.27 22.02 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 88.4 m-20 -116.33 21.95 13.21 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.982 -0.128 . . . . 0.0 111.217 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 78.2 m-20 -144.1 161.87 37.72 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.893 0.377 . . . . 0.0 111.17 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.49 120.46 30.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.6 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -69.98 -51.77 29.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.06 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -173.56 171.37 3.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.083 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -104.83 140.91 37.42 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.07 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.421 ' OD1' ' OG ' ' A' ' 165' ' ' SER . 18.0 t70 -133.61 150.86 51.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.144 0.497 . . . . 0.0 110.543 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 150' ' ' ALA . 3.2 tm? -125.97 138.58 53.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.578 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.413 ' H ' HD22 ' A' ' 149' ' ' LEU . . . -136.54 117.47 14.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.356 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t -104.1 126.22 51.05 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 26.5 t -112.45 129.02 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.7 m -145.02 148.03 33.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.244 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 p -109.64 143.48 39.32 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.922 0.391 . . . . 0.0 110.551 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -152.64 112.97 4.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 62.44 33.45 16.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.65 11.57 84.59 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.34 131.59 54.92 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.721 0.296 . . . . 0.0 110.597 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.75 120.36 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.8 124.86 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.6 m -127.25 132.31 50.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.792 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.83 99.71 7.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.56 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -98.03 111.69 23.91 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.654 0.264 . . . . 0.0 110.572 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 5.4 mp -116.91 136.9 52.59 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.28 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.421 ' OG ' ' OD1' ' A' ' 148' ' ' ASP . 50.2 m -126.56 136.19 52.23 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.858 0.361 . . . . 0.0 110.592 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.4 m -152.87 155.69 37.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.283 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.24 143.57 27.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.093 0.473 . . . . 0.0 111.197 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -71.19 -28.77 64.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.028 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.11 -34.28 71.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.232 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -114.62 -3.07 12.94 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.482 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 50.3 t-105 -49.79 -38.21 33.37 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.851 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -61.58 -41.83 97.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.263 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.6 m -66.84 -39.2 87.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.79 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.2 m -108.4 21.32 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.294 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 176' ' ' SER . 19.4 ptmt -52.03 -49.73 62.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.331 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.41 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 25.0 t -65.67 -29.41 69.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.358 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 tt -54.76 -45.69 74.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.036 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.482 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 25.7 m-85 -61.9 -49.78 74.84 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.53 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.03 -38.39 90.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.478 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 39.2 m -64.33 -47.95 77.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.353 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.07 -45.08 99.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.624 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.47 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.45 -44.42 94.55 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.208 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.5 t -71.31 -32.76 69.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.1 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 95.3 p -63.1 -24.82 68.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -56.4 156.96 5.39 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.332 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -134.76 153.3 52.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.47 148.79 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 111.115 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.441 ' OH ' ' OG ' ' A' ' 36' ' ' SER . 40.4 p90 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.676 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 121.125 0.488 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.482 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 1.7 pm0 -127.54 164.77 21.23 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.861 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -125.61 144.38 50.61 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.815 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -122.2 133.22 54.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.797 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.446 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 92.4 p -145.63 153.48 41.08 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.867 0.365 . . . . 0.0 110.795 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 36' ' ' SER . 99.9 m-20 -143.06 113.23 7.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.278 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.0 p -65.43 -32.96 74.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.886 0.374 . . . . 0.0 110.075 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -62.24 -45.19 94.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -89.36 -20.47 23.96 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.09 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.72 40.63 90.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -143.48 150.81 39.51 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.286 0.543 . . . . 0.0 110.443 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -156.73 146.35 20.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.113 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -155.57 158.27 38.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.127 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.03 154.14 17.31 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.684 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 46' ' ' TYR . 13.0 p90 -156.85 142.94 12.98 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.53 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.9 153.83 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.993 1.795 . . . . 0.0 112.462 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 49' ' ' GLY . 32.4 t-20 -81.44 157.15 25.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.426 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . 92.64 6.79 63.69 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.539 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 30.5 m0 -89.16 149.13 23.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.851 0.357 . . . . 0.0 110.262 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.26 145.69 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.16 128.75 9.01 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 t -113.9 132.99 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 110.462 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.59 134.26 35.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.288 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.31 55.2 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -73.33 136.02 44.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.229 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.15 69.26 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.79 -164.32 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.708 0.29 . . . . 0.0 110.484 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.63 158.15 0.88 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.181 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.33 128.8 20.08 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.442 2.095 . . . . 0.0 111.922 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 80' ' ' ILE . . . 97.14 -24.05 33.02 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t -63.49 130.63 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -119.19 -58.75 1.91 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.537 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.2 t -151.45 151.44 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.753 0.311 . . . . 0.0 111.143 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.26 144.27 33.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.264 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -112.77 134.64 54.19 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.448 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.31 141.04 52.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.413 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.539 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 45.8 m-20 -89.28 118.99 29.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.587 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.67 -40.02 91.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.577 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.6 mm -61.86 -46.97 95.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.682 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.8 103.81 8.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.973 0.416 . . . . 0.0 110.413 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.43 -38.38 83.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.263 0.554 . . . . 0.0 110.007 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.53 -36.37 73.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.901 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.83 125.9 31.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.932 0.396 . . . . 0.0 110.454 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -161.01 174.05 14.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 pp -159.98 158.76 31.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.187 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.1 t -127.68 139.36 52.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.22 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 t -111.15 123.71 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.86 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 51.4 mt -121.59 124.86 72.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.962 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 61' ' ' GLY . 76.3 mt -122.91 131.89 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.81 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 159' ' ' LEU . 51.1 m -146.06 166.97 24.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.086 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 2.0 pm0 -106.14 132.44 52.21 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.8 pt -88.75 148.93 42.77 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.506 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.71 136.68 43.07 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.629 1.553 . . . . 0.0 110.866 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -61.17 -27.15 68.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.947 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -67.8 -30.9 70.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.134 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -130.14 150.5 51.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.221 0.534 . . . . 0.0 111.576 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 81.4 p -112.6 174.87 5.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.713 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.6 tp -56.85 -41.2 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.01 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.3 p -69.82 -44.32 70.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.418 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HB3' ' H ' ' A' ' 88' ' ' THR . 44.4 t0 -64.28 -34.81 78.99 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.92 -52.14 63.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.214 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.56 179.04 47.6 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.68 ' HG1' ' H ' ' A' ' 97' ' ' ASP . 34.8 p -88.09 170.64 10.9 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.51 -41.88 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.836 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.3 m -72.14 -44.1 63.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.748 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.68 ' H ' ' HG1' ' A' ' 94' ' ' THR . 48.0 t0 -61.71 -52.88 62.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.35 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.1 -38.6 79.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.678 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.99 -43.98 94.75 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -67.14 -41.65 85.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.82 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -61.87 -38.95 90.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.665 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -62.29 -40.84 97.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.655 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -58.12 -45.68 86.86 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.499 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -65.29 -43.03 92.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.4 m -60.79 -45.67 93.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.945 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.56 -47.99 68.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.636 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.643 ' O ' ' N ' ' A' ' 111' ' ' GLN . 93.5 m-20 -62.6 -37.58 86.8 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.676 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -44.26 -37.0 2.98 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.309 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.38 -47.26 70.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.135 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.3 m -123.71 23.22 8.83 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.8 tt0 -50.32 -28.83 8.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.579 0.228 . . . . 0.0 111.328 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.67 -61.39 2.95 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.083 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -117.08 -35.94 3.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.929 0.364 . . . . 0.0 111.933 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -83.98 137.55 33.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.962 0.41 . . . . 0.0 111.266 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -129.13 139.9 51.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.959 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.54 135.15 44.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.333 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -114.51 125.18 53.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.182 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 tt -84.58 109.83 18.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.252 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.518 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.9 mt -74.6 -53.84 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.683 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 27.7 m120 -155.08 164.41 38.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.728 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.83 115.79 3.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.486 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -139.76 170.52 15.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.882 0.372 . . . . 0.0 110.69 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.401 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -141.28 150.52 42.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.645 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -132.45 139.07 47.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -108.46 114.19 27.83 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.452 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.94 142.98 34.31 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.96 0.41 . . . . 0.0 110.782 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 51.67 37.37 19.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.282 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.85 0.77 35.41 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -104.46 147.87 27.08 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.897 0.38 . . . . 0.0 110.115 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.71 128.56 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.108 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -117.16 126.83 53.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.822 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.3 m-85 -104.41 126.3 51.38 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.9 m -109.26 122.66 47.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 110.321 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -116.78 122.22 43.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.826 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -116.77 119.45 35.49 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -148.97 167.32 26.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.589 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -135.53 152.93 51.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.927 0.394 . . . . 0.0 110.635 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 m -105.86 136.03 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.909 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.45 137.08 38.36 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.173 0.511 . . . . 0.0 111.2 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.25 133.35 60.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.393 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.42 -119.19 11.0 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -116.53 15.28 15.61 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.851 -0.205 . . . . 0.0 111.174 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -129.03 153.86 47.19 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.896 0.379 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.85 127.42 40.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.377 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -74.89 -52.22 11.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.631 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -174.55 173.9 2.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.087 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -109.2 137.31 47.28 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.163 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -130.87 142.65 50.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.884 0.373 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.2 tp -114.4 131.28 56.63 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.03 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -125.38 130.81 52.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.965 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.4 t -124.31 126.95 46.9 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.0 t -113.04 127.87 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 111.101 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.8 m -141.31 139.4 33.62 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.108 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.1 p -103.27 150.25 23.92 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.799 0.333 . . . . 0.0 110.342 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -149.14 106.07 3.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 57.04 30.89 18.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.814 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.06 5.22 68.12 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -95.61 123.56 39.22 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.06 118.0 28.47 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 160' ' ' ILE . 80.0 mt -120.76 126.68 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.863 0.364 . . . . 0.0 110.463 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.1 m -126.92 137.61 53.16 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.085 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.6 98.72 6.69 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.247 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -95.87 112.4 24.13 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.651 0.262 . . . . 0.0 110.58 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.6 mp -115.0 138.99 50.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.502 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 81.8 p -132.65 133.83 44.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.221 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 15.6 m -152.82 161.13 42.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.568 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.45 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -54.99 140.73 36.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.013 0.435 . . . . 0.0 111.181 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.66 -39.06 84.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 170' ' ' ARG . 37.8 p-10 -63.87 -32.58 74.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 15.1 tpt180 -94.65 -19.53 20.36 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.71 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.542 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 50.5 t-105 -47.95 -41.08 24.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.213 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.43 -42.09 98.2 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.172 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 46.9 m -66.68 -40.32 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.559 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.2 m -108.77 21.48 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.332 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 171' ' ' TRP . 11.1 ptmm? -50.43 -49.81 53.78 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.284 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 22.2 m -64.86 -29.72 70.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.661 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 tp -55.5 -44.49 76.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.368 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.542 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 25.3 m-85 -62.55 -50.29 71.91 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.308 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.22 -41.31 99.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.757 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 184' ' ' SER . 45.2 m -66.65 -49.04 67.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 68.7 t -62.7 -43.85 98.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.457 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -64.63 -39.65 94.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.424 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 t -80.2 -28.18 38.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.144 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 180' ' ' THR . 67.4 m -62.43 -30.97 71.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.385 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -55.22 156.8 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.468 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -139.25 160.65 39.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.621 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.41 150.21 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 111.035 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 39.5 p90 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.689 179.747 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.445 ' O ' ' OE1' ' A' ' 33' ' ' GLN . 55.9 mt . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.804 0.335 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.549 ' NE2' ' OD1' ' A' ' 48' ' ' ASN . 1.8 mp0 -110.16 156.64 20.34 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.77 140.56 51.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.384 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -125.03 135.36 52.68 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.037 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.429 ' OG ' ' OH ' ' A' ' 188' ' ' TYR . 21.2 t -146.02 147.89 32.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.903 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -138.37 118.35 13.37 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.9 p -70.99 -31.44 67.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.896 0.379 . . . . 0.0 110.247 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -62.29 -49.8 74.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.979 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -86.2 -20.61 28.29 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.37 40.24 80.26 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.83 149.91 39.21 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.219 0.509 . . . . 0.0 110.705 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -151.06 144.44 24.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.713 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -151.12 159.48 44.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.048 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.8 mt -100.2 151.28 21.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.394 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 11.2 p90 -150.91 146.74 19.62 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.535 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.24 161.36 44.73 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.441 2.094 . . . . 0.0 112.483 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.549 ' OD1' ' NE2' ' A' ' 33' ' ' GLN . 52.7 m-20 -73.5 159.29 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.553 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.9 -2.18 63.91 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -93.67 144.53 25.31 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 pt -118.47 141.78 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.309 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.84 133.67 11.48 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.8 t -111.68 133.19 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.924 0.392 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -83.45 138.86 33.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.201 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.69 54.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.152 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -78.29 129.21 34.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.645 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.95 -4.52 75.1 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.21 -162.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.518 -0.341 . . . . 0.0 110.141 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.0 m -36.79 111.19 0.5 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -45.2 134.47 11.59 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.752 1.635 . . . . 0.0 112.101 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.91 -35.97 4.57 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.28 134.32 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -115.48 -58.43 2.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.236 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.6 t -143.46 143.38 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.798 0.333 . . . . 0.0 111.113 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.35 131.75 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.417 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -112.81 133.39 54.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.418 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -131.56 138.91 49.08 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.54 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -87.4 118.73 27.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.358 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -61.41 -38.97 89.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.534 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.62 -48.44 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.451 ' CD ' HH12 ' A' ' 170' ' ' ARG . 96.0 mt-10 -126.85 102.71 7.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.568 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -69.56 -25.49 64.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.976 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -57.85 -38.97 76.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.204 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -98.29 139.59 33.84 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.718 0.294 . . . . 0.0 110.381 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.87 147.65 18.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.001 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.1 tt -115.11 134.7 54.94 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.193 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.1 t -131.8 144.47 50.94 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.33 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.44 132.5 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.072 0.463 . . . . 0.0 110.493 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.0 mt -120.95 126.06 74.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.684 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.86 130.83 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.851 0.358 . . . . 0.0 110.486 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.9 m -139.63 161.96 36.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.953 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -105.44 132.54 51.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.738 0.304 . . . . 0.0 110.369 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -96.22 150.54 37.3 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.361 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.43 137.94 31.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.018 1.812 . . . . 0.0 111.045 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.7 t -63.28 -28.2 69.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.074 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.67 -31.14 70.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -129.97 158.41 39.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.139 0.495 . . . . 0.0 111.599 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -122.6 176.34 5.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.449 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.8 tp -52.36 -44.72 65.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.179 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.9 p -66.13 -45.59 80.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.92 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -67.56 -35.44 79.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.737 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.0 tp -55.88 -42.09 75.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.5 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.95 175.79 45.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.656 ' HG1' ' H ' ' A' ' 97' ' ' ASP . 38.0 p -93.93 171.19 9.02 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.09 -42.01 76.06 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.186 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.0 m -72.39 -44.93 61.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.029 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.656 ' H ' ' HG1' ' A' ' 94' ' ' THR . 46.3 t0 -62.1 -51.24 68.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.45 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.94 -38.76 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.558 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.5 -45.91 93.86 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -66.03 -41.21 91.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.642 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -62.29 -38.56 89.82 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.685 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -62.41 -41.46 98.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.1 mmt -58.81 -44.41 90.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.949 0.404 . . . . 0.0 110.34 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -64.97 -39.87 94.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.495 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.0 m -59.48 -47.26 86.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.857 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.6 t -71.59 -45.61 66.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.993 0.425 . . . . 0.0 110.331 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 111' ' ' GLN . 86.6 m-20 -62.06 -31.96 72.43 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.277 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -42.61 -36.15 1.3 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.219 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.82 -16.25 14.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.016 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -101.48 -3.33 28.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 107' ' ' ASN . 32.7 tt0 -67.12 13.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.961 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -84.99 -64.25 1.55 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.208 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.2 p-10 -118.59 -39.06 3.03 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.521 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 20.2 ptp180 -101.43 159.79 14.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.01 0.433 . . . . 0.0 111.24 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -130.0 150.24 51.37 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.518 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.25 138.28 40.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.15 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -123.44 130.32 52.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.1 tt -84.13 108.88 17.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.014 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 119' ' ' ILE . 96.6 mt -71.12 -54.95 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.783 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.55 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 11.4 p30 -156.65 176.78 12.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.976 0.417 . . . . 0.0 111.122 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.6 128.4 6.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.327 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -142.07 160.74 39.61 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.505 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.29 144.68 42.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.904 0.383 . . . . 0.0 110.47 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -131.94 152.46 51.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -124.91 116.34 22.04 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.562 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.87 144.5 33.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.013 0.435 . . . . 0.0 110.825 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.1 t0 52.29 28.99 6.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.58 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.96 -1.79 77.86 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -100.83 146.6 27.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.263 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.8 129.72 65.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.159 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -118.45 123.65 45.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.322 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.63 124.2 48.39 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.3 m -102.76 133.12 48.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.822 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.91 108.0 9.8 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.963 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.55 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 70.6 tt0 -100.12 126.17 46.32 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -148.22 168.74 21.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.159 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -137.77 160.0 40.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.479 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.51 133.73 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.461 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.423 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 3.0 pp -134.06 143.86 48.3 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.335 0.588 . . . . 0.0 111.1 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.54 133.29 54.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.248 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 51.75 -108.34 0.6 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -116.96 12.53 14.67 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -119.13 146.15 45.37 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.858 0.361 . . . . 0.0 111.704 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.6 128.28 37.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.816 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.423 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 70.5 tt0 -83.48 -53.51 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.406 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.5 ptm85 -172.64 171.99 4.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.424 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 63.7 m80 -108.89 137.44 46.8 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.256 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 84.4 m-20 -135.85 141.4 44.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.9 0.381 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 57.7 tp -116.49 136.71 52.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.986 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.87 132.82 39.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.938 0.399 . . . . 0.0 110.56 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.8 t -119.08 135.75 54.49 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.692 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.413 ' C ' ' HG1' ' A' ' 153' ' ' THR . 40.8 t -114.87 130.16 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.963 0.411 . . . . 0.0 110.542 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.413 ' HG1' ' C ' ' A' ' 152' ' ' VAL . 59.8 m -148.86 146.26 27.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.84 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.3 p -90.7 156.63 17.95 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.579 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 158' ' ' LYS . 9.1 t-20 -150.87 95.9 2.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.787 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 55.65 39.24 30.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.8 7.57 77.98 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 155' ' ' ASN . 68.9 mmtt -110.61 137.73 47.91 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 110.017 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.24 117.46 26.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.816 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.1 mm -107.92 119.97 58.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.1 m -120.49 132.22 55.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.814 0.34 . . . . 0.0 110.185 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.01 103.95 11.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.622 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -103.37 120.19 40.32 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.899 0.38 . . . . 0.0 111.562 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 mp -115.58 142.92 46.08 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.083 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 31.1 t -137.06 131.95 33.48 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.432 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.425 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 21.3 m -152.87 159.06 42.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.696 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.425 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -54.31 145.41 17.89 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.28 -36.68 71.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.8 -33.14 75.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.183 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.451 HH12 ' CD ' ' A' ' 71' ' ' GLU . 80.1 mtp180 -97.53 -16.69 19.98 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.515 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.604 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 48.4 t-105 -48.03 -41.73 26.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 110.691 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.38 -41.69 98.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.062 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.3 m -65.68 -40.39 92.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.382 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.9 m -107.2 21.51 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 171' ' ' TRP . 20.8 pttm -48.94 -45.38 41.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.412 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 86.7 p -67.89 -27.49 66.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.574 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.63 -44.61 85.7 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.917 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.604 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.4 m-85 -62.29 -50.01 73.4 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.388 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.24 -41.53 98.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.665 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.8 m -68.75 -49.62 57.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.4 -38.55 79.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.348 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.89 -40.55 97.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.294 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.2 p -80.96 -17.77 49.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.346 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -62.77 -37.76 87.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.193 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.481 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -54.29 146.09 16.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.771 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -135.91 154.95 50.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.6 m -127.22 151.56 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.903 0.382 . . . . 0.0 111.336 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.429 ' OH ' ' OG ' ' A' ' 36' ' ' SER . 43.5 p90 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.768 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.932 0.396 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.5 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.3 pm0 -138.51 165.51 26.67 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.062 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -119.09 139.89 51.01 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.086 0.469 . . . . 0.0 111.411 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -122.44 130.15 52.78 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.73 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.9 m -131.2 150.18 52.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.829 0.347 . . . . 0.0 110.821 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -139.1 122.08 16.7 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.448 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.1 p -75.36 -29.09 59.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.287 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.25 -48.35 81.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 49.6 t0 -93.12 -20.06 20.87 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.85 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.52 42.6 72.3 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.02 148.49 40.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.056 0.428 . . . . 0.0 110.199 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -146.51 142.07 27.68 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -154.03 158.17 40.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.075 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mp -100.96 144.63 29.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.153 0.501 . . . . 0.0 110.424 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -148.4 148.15 27.84 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.866 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.59 155.86 68.45 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.298 1.999 . . . . 0.0 112.159 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.5 ' N ' HE22 ' A' ' 33' ' ' GLN . 20.6 p30 -72.71 160.69 31.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.93 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.28 1.77 59.26 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.519 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 33.2 m0 -92.76 145.12 24.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.659 0.266 . . . . 0.0 110.296 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.4 pt -121.26 145.1 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.356 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.27 131.0 10.42 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.57 132.19 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.951 0.405 . . . . 0.0 110.521 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -81.84 135.73 35.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.196 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.59 56.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.412 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -74.94 132.9 41.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.112 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.8 2.62 71.91 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.06 -164.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.445 ' OG ' ' CG2' ' A' ' 62' ' ' VAL . 79.5 p -39.96 123.65 1.6 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.51 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -42.04 121.48 1.84 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.957 1.772 . . . . 0.0 112.823 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.69 -42.39 1.95 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.445 ' CG2' ' OG ' ' A' ' 59' ' ' SER . 56.1 t -63.88 122.04 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -120.0 -48.57 2.34 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.516 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.6 t -128.64 137.93 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 110.889 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.56 135.03 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.646 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.74 132.95 54.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.071 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' NH1' ' OD1' ' A' ' 75' ' ' ASN . 53.4 ttt85 -130.86 132.56 45.25 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.434 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.519 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 75.3 m-20 -92.27 118.86 31.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.58 -36.92 83.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.548 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 70' ' ' ILE . 27.1 mm -62.84 -42.51 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.82 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -117.51 105.78 12.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.891 0.376 . . . . 0.0 110.693 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.72 -37.57 67.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.607 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 40.3 p-10 -62.59 -33.11 74.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.081 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 83.4 tt0 -87.16 130.42 34.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.888 0.375 . . . . 0.0 110.585 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.433 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 10.9 m-80 -140.85 139.18 34.42 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.089 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.9 tt -126.14 134.32 51.34 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.8 m -126.87 146.69 50.19 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.306 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.32 128.41 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.952 0.406 . . . . 0.0 110.278 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 mt -117.12 116.84 53.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.974 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.4 mm -116.01 123.97 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.922 0.392 . . . . 0.0 110.469 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 159' ' ' LEU . 75.3 m -146.67 160.59 42.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.05 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.9 pm0 -103.95 132.7 49.95 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.6 pt -88.54 148.33 41.79 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.661 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' LYS . 39.0 Cg_endo -66.7 138.02 47.78 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.716 1.611 . . . . 0.0 110.612 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.9 p -63.69 -26.11 68.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.994 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.08 -31.02 70.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.959 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 84' ' ' PRO . 97.4 mttt -130.62 155.63 46.24 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.046 0.45 . . . . 0.0 111.228 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.545 ' HG1' ' H ' ' A' ' 89' ' ' LEU . 14.8 t -122.82 174.97 6.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.346 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.545 ' H ' ' HG1' ' A' ' 88' ' ' THR . 49.3 tp -53.05 -43.53 66.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.125 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.6 p -67.39 -44.43 78.93 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.044 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -68.44 -34.81 76.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.979 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -55.57 -42.33 74.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.478 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.65 177.99 46.89 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.652 ' HG1' ' H ' ' A' ' 97' ' ' ASP . 35.0 p -92.69 172.22 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.39 76.0 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.222 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.5 m -72.68 -45.21 59.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.854 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.652 ' H ' ' HG1' ' A' ' 94' ' ' THR . 46.9 t0 -62.33 -51.62 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.68 -38.83 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.543 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -57.8 -53.26 46.74 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -62.24 -36.41 81.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.57 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -57.16 -38.37 73.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.599 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.37 -41.12 98.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.865 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.678 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -55.84 -54.06 49.18 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.396 0.617 . . . . 0.0 109.802 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -61.92 -38.42 88.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.802 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -59.42 -46.98 87.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.858 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.7 t -71.29 -46.23 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 0.0 110.384 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.0 m-20 -62.23 -31.02 71.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.053 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -43.99 -36.91 2.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.089 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.06 -11.1 14.98 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.234 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -121.32 18.11 11.44 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.506 -178.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.4 pt20 -75.64 2.13 12.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.563 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.67 -62.5 2.38 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.802 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.4 p-10 -117.25 -38.11 3.41 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.844 0.354 . . . . 0.0 111.477 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.517 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 40.4 ttm180 -79.2 141.28 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.28 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -129.5 132.48 46.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.959 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.77 134.11 46.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.895 0.378 . . . . 0.0 110.334 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.66 122.51 40.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.319 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 tp -81.29 111.11 17.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.327 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.525 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 97.0 mt -71.57 -42.75 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.891 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 4.0 m-80 177.76 174.47 0.52 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.297 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.81 144.15 22.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.161 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.411 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 57.5 mp0 -144.07 145.86 32.45 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.857 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.32 135.65 53.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.311 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -116.86 159.2 22.73 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -139.51 107.29 5.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.516 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.43 144.91 38.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.933 0.397 . . . . 0.0 111.052 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.1 t0 52.8 30.24 8.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.59 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.69 0.92 75.76 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -102.9 146.68 27.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.903 0.382 . . . . 0.0 110.154 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.34 129.23 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.344 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -117.63 127.97 54.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -105.88 122.44 46.12 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.1 m -105.55 123.33 47.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.234 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.38 125.01 53.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.93 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -120.36 117.99 29.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.362 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -146.48 162.5 38.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.27 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.485 ' HE ' ' CG1' ' A' ' 119' ' ' ILE . 19.8 ptp180 -124.54 149.05 47.37 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.015 0.436 . . . . 0.0 110.803 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.05 133.87 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.352 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -139.91 134.86 32.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.242 0.544 . . . . 0.0 110.923 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.442 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 32.0 t -116.57 135.64 56.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.387 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.27 -122.39 18.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -112.31 14.91 20.51 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 140' ' ' VAL . 21.7 p-10 -133.5 160.14 38.3 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 111.509 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.2 p -87.07 127.88 40.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.453 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -76.45 -55.2 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.756 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.475 ' NH1' ' O ' ' A' ' 73' ' ' ASP . 20.1 ptp180 -174.82 174.58 2.55 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.078 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 61.7 m170 -103.01 139.0 39.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.011 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -132.84 133.36 43.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.974 0.416 . . . . 0.0 111.161 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.5 tp -111.52 133.96 53.43 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.908 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.39 131.49 48.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.921 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.5 t -120.97 123.04 41.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.2 129.04 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.015 0.436 . . . . 0.0 111.186 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.5 m -143.69 146.19 33.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.29 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.5 p -111.15 152.02 27.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.751 0.31 . . . . 0.0 110.263 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -158.46 119.85 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 55.94 29.74 14.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.77 14.28 78.05 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -105.38 128.43 53.5 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -90.02 119.29 30.25 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 160' ' ' ILE . 75.8 mt -124.39 128.1 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.7 0.286 . . . . 0.0 110.738 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.8 m -131.18 139.44 49.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.394 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.75 103.99 11.76 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.224 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -99.31 110.27 22.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.627 0.251 . . . . 0.0 110.422 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.4 mp -116.2 134.63 54.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.58 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 55.7 m -125.91 136.63 53.26 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.058 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.6 m -152.86 157.33 40.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.46 142.28 49.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.375 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -69.09 -30.64 68.98 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.033 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.86 -34.12 71.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.053 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -113.24 -3.85 13.81 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.498 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.9 t-105 -49.78 -39.16 37.14 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.882 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.98 -42.18 99.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.091 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 56.9 m -64.78 -39.81 94.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.74 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.7 m -107.97 21.08 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.262 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -50.06 -49.48 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.285 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.3 t -64.63 -30.72 71.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.846 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -55.21 -44.06 75.03 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.217 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 24.3 m-85 -61.56 -50.33 73.07 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.348 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -64.47 -40.17 95.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.656 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 184' ' ' SER . 41.9 m -66.84 -47.11 72.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.501 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 63.9 t -62.7 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.664 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.47 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -67.01 -46.8 73.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.208 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.1 m -68.72 -33.14 73.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.382 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 180' ' ' THR . 17.8 t -62.2 -27.55 69.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.699 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -56.11 159.18 3.52 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.779 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -135.77 157.89 45.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.8 151.04 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.098 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.485 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 46.2 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.785 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' C ' ' NE2' ' A' ' 33' ' ' GLN . 19.2 mt . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 120.825 0.345 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.631 ' NE2' ' N ' ' A' ' 33' ' ' GLN . 1.0 OUTLIER -130.68 162.48 29.32 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.251 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -121.25 145.77 47.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.574 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -129.38 134.96 48.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.342 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.9 p -143.19 157.12 44.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.637 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -146.3 119.23 8.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.417 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.1 p -70.49 -32.82 70.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.586 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -62.65 -48.86 77.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.078 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -87.67 -20.75 25.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.869 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.03 39.83 88.8 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.31 151.45 45.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.299 0.549 . . . . 0.0 110.415 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -153.24 143.78 22.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.799 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -150.73 157.71 43.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 mt -98.5 150.96 21.13 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.558 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -152.17 146.11 18.19 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.003 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.48 153.62 69.96 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.397 2.065 . . . . 0.0 112.508 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -69.37 159.37 33.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.997 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.13 -2.51 63.65 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.533 ' CD1' ' OD1' ' A' ' 68' ' ' ASP . 35.8 m0 -94.91 147.13 23.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.772 0.32 . . . . 0.0 110.276 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.8 pt -120.4 149.88 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.324 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -114.98 141.8 17.25 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.7 144.9 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.756 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -84.38 134.87 34.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.379 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.91 55.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.491 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -70.89 135.01 47.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.82 2.34 69.58 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.44 -164.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.641 0.258 . . . . 0.0 110.485 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.76 154.36 1.24 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.215 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.18 131.24 24.6 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.277 1.985 . . . . 0.0 111.915 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 80' ' ' ILE . . . 95.47 -22.28 39.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.43 133.85 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.176 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -118.65 -58.3 1.98 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.639 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.2 t -145.16 148.99 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.928 0.394 . . . . 0.0 111.504 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.56 136.45 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.655 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -112.36 143.11 44.01 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.292 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -145.09 145.78 31.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.847 0.356 . . . . 0.0 110.682 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.533 ' OD1' ' CD1' ' A' ' 50' ' ' TRP . 62.8 m-20 -101.73 122.01 43.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.685 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.42 -39.92 95.78 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.231 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.6 -38.59 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.61 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -126.43 94.62 4.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.46 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -62.19 -38.44 89.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.15 0.5 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 42.1 p-10 -61.78 -32.48 72.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.198 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.525 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 14.0 tm-20 -86.21 125.94 33.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.946 0.403 . . . . 0.0 110.202 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.696 HD21 ' N ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -171.76 168.91 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.574 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.6 pp -157.23 157.12 33.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.509 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 m -131.16 147.86 52.65 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.67 128.19 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.188 0.518 . . . . 0.0 109.987 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.3 mt -117.08 124.37 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.805 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' GLY . 66.0 mt -118.25 128.8 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.473 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.3 m -138.38 163.38 32.02 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.93 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.77 134.72 47.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.688 0.28 . . . . 0.0 110.403 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.8 pt -103.23 149.21 36.72 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.679 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 87' ' ' LYS . 48.4 Cg_endo -68.24 137.57 40.67 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.105 1.87 . . . . 0.0 111.327 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.4 t -62.46 -27.66 69.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.15 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -67.48 -31.36 71.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.897 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 84' ' ' PRO . 67.9 mttm -128.73 151.96 48.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.077 0.465 . . . . 0.0 111.047 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.0 t -120.54 178.22 4.76 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.491 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.0 tp -50.12 -44.32 52.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.094 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.553 ' HG1' ' N ' ' A' ' 91' ' ' ASP . 44.0 p -65.33 -42.95 92.41 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.936 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.553 ' N ' ' HG1' ' A' ' 90' ' ' THR . 86.6 m-20 -65.45 -39.13 91.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.804 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.8 tp -56.4 -43.53 79.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.585 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.7 176.25 45.57 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.567 ' HG1' ' H ' ' A' ' 97' ' ' ASP . 33.5 p -93.2 172.58 8.21 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.74 79.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.1 m -72.26 -44.48 62.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.567 ' H ' ' HG1' ' A' ' 94' ' ' THR . 46.2 t0 -61.92 -50.98 69.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.303 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 82.1 t -60.49 -38.67 78.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.498 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.69 -44.02 94.21 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -69.33 -42.45 75.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.896 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -61.29 -39.05 89.01 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.961 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -62.03 -40.63 96.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.38 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.78 -44.26 94.01 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.404 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.28 -39.45 93.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.266 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.3 m -60.19 -47.63 85.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.811 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.52 -45.4 68.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.96 0.41 . . . . 0.0 110.496 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 111' ' ' GLN . 85.1 m-20 -62.41 -30.35 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.244 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -45.03 -39.91 6.09 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.972 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.48 -4.28 29.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.693 0.282 . . . . 0.0 110.8 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -121.44 14.65 11.17 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.052 -179.226 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 107' ' ' ASN . 6.5 tt0 -72.03 3.06 4.76 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.092 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.37 -64.6 1.44 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.67 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -117.71 -48.6 2.57 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.996 0.427 . . . . 0.0 111.379 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' SER . 84.4 mtt180 -70.12 149.02 48.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.508 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -134.43 129.83 35.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.849 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.76 128.21 46.89 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.76 0.314 . . . . 0.0 110.223 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -115.08 128.77 56.44 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.1 tp -81.98 108.99 15.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.081 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 119' ' ' ILE . 96.6 mt -70.39 -53.76 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.547 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.546 ' C ' HD21 ' A' ' 120' ' ' ASN . 0.3 OUTLIER -163.11 167.77 21.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.645 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.94 124.38 5.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.418 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -141.78 162.89 34.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.628 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.405 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.64 148.4 50.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.47 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -130.64 141.47 50.43 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.176 0.512 . . . . 0.0 111.258 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -107.65 112.69 25.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.275 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.25 141.47 35.86 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.945 0.403 . . . . 0.0 110.693 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.69 38.95 24.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.207 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.59 0.7 25.95 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -105.54 147.35 28.46 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.983 0.42 . . . . 0.0 110.189 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.19 128.38 72.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.011 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 21.2 m-85 -116.68 129.36 56.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.844 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.405 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.5 m-85 -104.11 128.23 51.75 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.3 m -110.93 123.89 51.04 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.248 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.6 mp -117.49 124.42 48.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.938 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.459 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 71.1 tt0 -118.07 120.2 37.06 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -147.05 170.02 18.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.075 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.726 HH21 ' HE2' ' A' ' 147' ' ' HIS . 11.6 ptm180 -138.18 155.56 48.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 110.8 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.62 133.52 47.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.374 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -142.71 136.37 28.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.197 0.522 . . . . 0.0 111.498 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.3 t -108.2 130.49 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.003 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.62 -119.52 18.98 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -110.02 10.52 24.14 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.816 -0.226 . . . . 0.0 111.228 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -117.74 147.35 43.05 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.761 0.315 . . . . 0.0 111.149 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 43.2 t -88.14 127.0 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.743 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -76.2 -54.03 7.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -173.7 174.36 3.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.181 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.726 ' HE2' HH21 ' A' ' 137' ' ' ARG . 29.9 m170 -104.87 139.86 38.99 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 83.9 m-20 -134.64 136.9 43.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -113.62 132.43 55.76 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.114 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -127.16 131.95 50.62 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.008 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.9 t -125.12 127.67 47.23 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.74 128.12 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.987 0.422 . . . . 0.0 110.939 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.8 m -139.72 141.84 36.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.035 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.7 p -104.76 152.6 22.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.909 0.385 . . . . 0.0 110.463 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -162.75 122.87 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 55.67 29.34 13.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.354 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.69 13.21 80.37 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -107.84 140.63 40.66 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.678 0.275 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.67 120.39 37.97 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.416 HD13 HG23 ' A' ' 160' ' ' ILE . 80.5 mt -118.46 124.48 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.049 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.2 m -125.93 136.18 52.74 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.314 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.07 99.85 7.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.061 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -97.2 111.63 23.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.668 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.07 138.25 51.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.831 0.348 . . . . 0.0 110.48 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.521 ' OG ' ' ND2' ' A' ' 75' ' ' ASN . 61.4 p -134.57 135.35 42.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.967 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 6.4 m -152.93 161.67 42.26 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.634 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.6 ' CB ' HH21 ' A' ' 170' ' ' ARG . . . -54.22 144.31 20.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.313 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -70.41 -36.34 73.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.055 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -62.76 -33.42 75.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.356 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.6 HH21 ' CB ' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -97.68 -19.89 17.96 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.896 -179.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.492 ' O ' ' N ' ' A' ' 175' ' ' LYS . 59.5 t-105 -45.58 -40.34 8.67 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.77 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.12 -42.61 99.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.199 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 55.0 m -66.96 -39.32 87.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.539 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 m -109.55 21.48 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 171' ' ' TRP . 16.9 pttm -51.69 -47.62 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.497 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 85.8 p -69.61 -24.09 63.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.467 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -59.07 -42.57 90.69 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.994 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.415 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 20.2 m-85 -66.9 -50.22 63.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.485 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.47 -41.22 98.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.579 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 184' ' ' SER . 47.8 m -67.91 -49.32 62.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.55 -42.99 96.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.462 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.61 -40.32 96.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.924 0.392 . . . . 0.0 110.287 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 39.1 m -79.63 -28.42 40.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.349 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 180' ' ' THR . 87.8 p -63.19 -23.55 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.505 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -63.24 157.55 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.437 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -139.6 160.26 40.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.731 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.46 151.12 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 38.0 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.72 -179.812 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 120.723 0.297 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.553 HE22 ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -131.16 152.52 50.36 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.229 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -109.67 128.4 55.23 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.008 0.432 . . . . 0.0 110.958 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -114.31 119.04 35.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.544 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 50.0 m -126.98 149.07 50.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.934 0.397 . . . . 0.0 110.949 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 36' ' ' SER . 87.4 m-20 -138.18 111.4 7.94 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.245 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.9 p -64.41 -34.05 77.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.46 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 26.2 mtpp -60.9 -43.87 97.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.51 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -89.6 -20.41 23.76 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.092 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.34 37.56 90.68 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.1 151.12 45.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.095 0.448 . . . . 0.0 110.384 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -150.54 147.28 27.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 45' ' ' LEU . 43.3 t80 -160.77 147.57 15.33 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.067 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.531 ' O ' ' CE2' ' A' ' 44' ' ' PHE . 9.9 mp -93.77 143.3 26.46 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.943 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -149.51 130.63 7.2 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.991 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.97 157.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.221 1.947 . . . . 0.0 112.892 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.553 ' N ' HE22 ' A' ' 33' ' ' GLN . 66.9 m-80 -81.41 158.13 24.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.987 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.24 0.83 61.27 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -81.05 149.73 29.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.5 pt -113.4 142.25 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.376 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.34 133.47 11.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.4 t -108.85 133.33 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.853 0.359 . . . . 0.0 110.412 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.63 124.39 32.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.271 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.84 55.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.606 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -80.48 130.17 34.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.744 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.66 -3.57 78.47 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 59' ' ' SER . . . -80.25 -162.84 0.48 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.299 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 58' ' ' ALA . 28.2 m -36.43 109.24 0.41 Allowed Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.76 135.04 10.13 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.865 1.71 . . . . 0.0 111.997 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.19 -36.0 4.57 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.96 127.08 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.116 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -103.55 -59.11 1.77 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.693 0.283 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.4 t -150.56 141.21 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.17 130.95 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.76 133.91 55.53 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.521 ' NH2' ' OD1' ' A' ' 75' ' ' ASN . 76.2 mtp85 -124.55 140.89 52.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.719 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -88.48 118.31 28.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.391 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -62.42 -39.23 92.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.335 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 70' ' ' ILE . 26.6 mm -63.46 -42.3 95.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.792 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -112.86 107.04 15.49 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.816 0.341 . . . . 0.0 110.85 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -73.76 -45.9 48.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.309 0.576 . . . . 0.0 110.278 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.41 -37.24 74.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.206 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -84.08 129.53 34.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.382 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.521 ' OD1' ' NH2' ' A' ' 67' ' ' ARG . 7.4 m-80 -130.29 148.07 52.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.007 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.63 133.75 53.14 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 p -136.31 138.23 41.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.96 0.409 . . . . 0.0 110.158 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.9 t -122.08 130.62 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.931 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.0 mt -121.02 131.83 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.462 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 60.8 mt -122.54 133.05 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.621 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' LEU . 49.2 m -143.53 164.1 31.3 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.239 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -105.5 138.23 42.04 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.522 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.82 153.37 38.28 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.253 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 87' ' ' LYS . 72.4 Cg_endo -75.68 141.49 24.81 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.379 2.052 . . . . 0.0 110.892 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.8 p -68.44 -26.45 65.52 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.918 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -69.22 -32.0 70.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.972 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 84' ' ' PRO . 64.9 mttm -130.87 157.95 41.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.999 0.428 . . . . 0.0 111.302 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.7 t -123.12 175.47 6.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.834 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.5 tp -49.98 -45.31 51.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.07 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.1 p -65.61 -44.45 86.52 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.79 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.72 -36.26 83.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.99 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.87 -47.7 76.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.429 . . . . 0.0 110.245 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.19 177.5 46.95 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.0 p -90.94 170.13 10.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.93 74.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.96 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.0 m -71.43 -45.07 63.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.5 -53.29 58.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.299 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 80.0 t -61.25 -39.73 83.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.705 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.09 -45.11 92.81 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -66.28 -41.62 89.58 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -62.21 -39.38 92.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -62.2 -40.54 96.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.703 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.8 mmt -58.16 -44.93 88.18 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.599 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.55 -44.49 90.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 110.066 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.7 m -60.2 -44.76 94.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.837 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.75 -46.21 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.461 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 111' ' ' GLN . 87.8 m-20 -64.36 -42.12 96.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.053 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -43.6 -20.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.37 . . . . 0.0 110.748 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 107' ' ' ASN . . . -91.1 -43.67 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.607 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.8 p -119.38 19.63 12.69 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.2 tt0 -56.38 -28.78 60.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.337 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -42.53 -62.64 2.12 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.23 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -117.63 -44.3 2.75 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.766 0.317 . . . . 0.0 111.336 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -80.47 144.95 32.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.469 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -131.53 142.55 49.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.162 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.16 135.41 44.86 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -116.73 129.64 56.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 tt -81.5 104.28 11.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.12 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 119' ' ' ILE . 96.4 mt -70.35 -45.88 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.334 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 3.1 m-80 -169.65 166.71 9.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.363 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.14 126.3 5.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.413 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -142.9 163.5 32.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.748 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.17 149.69 46.08 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.506 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -131.65 144.89 51.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.143 0.497 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -111.53 114.53 27.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.557 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.91 138.57 33.97 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.504 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 129' ' ' GLN . 85.8 m-20 52.05 40.97 29.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.788 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.78 2.29 7.7 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 127' ' ' ASP . 66.3 tp60 -103.32 133.19 48.81 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.63 130.45 55.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.389 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -118.02 128.39 54.73 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -105.51 129.83 53.71 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.4 m -113.21 122.92 48.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.607 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.3 mp -115.39 126.1 53.99 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.739 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -118.81 122.12 41.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.768 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -150.44 171.3 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.29 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.715 HH21 ' HE2' ' A' ' 147' ' ' HIS . 9.6 ptm180 -136.5 156.58 48.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 110.494 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.2 t -106.39 135.01 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.025 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.79 136.25 30.48 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.163 0.506 . . . . 0.0 111.58 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.2 t -97.79 121.79 48.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.74 -110.89 3.08 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -113.31 10.56 18.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.565 0.222 . . . . 0.0 110.871 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -113.34 137.16 51.91 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.684 0.278 . . . . 0.0 111.317 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.73 126.63 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.637 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -81.05 -55.04 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.474 ' NH2' ' C ' ' A' ' 166' ' ' THR . 6.5 ptm85 -172.56 174.22 3.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.715 ' HE2' HH21 ' A' ' 137' ' ' ARG . 56.2 m170 -105.05 138.38 41.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.131 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 82.2 m-20 -135.36 130.93 35.71 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.725 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 tp -110.89 128.16 55.7 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.9 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.6 134.84 55.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.24 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.0 t -125.68 121.73 34.3 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.1 t -105.67 129.44 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.934 0.397 . . . . 0.0 110.874 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 59.8 m -142.79 144.42 32.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.0 p -86.93 156.82 19.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.871 0.367 . . . . 0.0 110.762 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -150.35 95.94 2.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.721 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 54.2 43.32 30.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.479 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.43 18.25 66.89 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.728 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 40.9 mtpt -121.71 137.26 54.83 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.952 0.376 . . . . 0.0 111.108 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 81' ' ' SER . 1.2 mt -91.81 119.28 31.47 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 160' ' ' ILE . 72.1 mt -123.29 122.14 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.2 m -115.72 133.24 56.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 110.245 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -105.2 110.23 22.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.612 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.82 122.14 43.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.951 0.405 . . . . 0.0 111.675 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mt -115.64 132.91 56.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.543 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.4 m -130.26 130.62 44.8 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.859 0.361 . . . . 0.0 110.31 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.474 ' C ' ' NH2' ' A' ' 146' ' ' ARG . 3.7 m -153.02 158.12 41.52 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.34 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -57.0 143.38 38.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.205 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -69.85 -29.64 66.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.166 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.19 -33.77 72.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.215 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.84 -6.48 14.27 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.557 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 53.7 t-105 -48.25 -39.52 21.67 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.811 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.85 -42.04 97.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 56.6 m -65.47 -39.99 92.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.569 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.5 m -107.71 21.44 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.255 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -49.21 -48.19 45.57 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.447 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.0 m -64.2 -32.08 73.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.649 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.9 tp -53.81 -44.94 70.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.045 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.557 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 18.9 m-85 -62.45 -49.04 77.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.477 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.92 -41.58 99.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 184' ' ' SER . 48.8 m -67.72 -47.62 68.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.81 -43.73 99.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.627 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -61.6 -38.45 87.64 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.7 t -85.14 -20.4 30.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 180' ' ' THR . 45.5 t -62.11 -33.58 74.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.059 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.2 OUTLIER -57.21 159.56 4.42 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.321 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -138.28 152.77 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 13.9 m -128.0 151.49 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.082 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.623 -179.734 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 120.92 0.391 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.605 ' NE2' ' N ' ' A' ' 48' ' ' ASN . 2.1 pm0 -139.53 160.48 39.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.078 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -129.98 147.83 51.77 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.138 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.664 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -124.93 158.38 33.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.453 178.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -144.74 161.2 39.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.834 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 41' ' ' GLY . 45.0 t0 -145.52 109.06 4.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.646 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.6 m -59.64 -37.81 79.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.885 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 62.5 mttp -58.7 -47.06 85.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.25 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -89.75 -20.26 23.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.921 0.391 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . 66.66 40.27 93.96 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.503 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.2 150.11 43.77 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.139 0.47 . . . . 0.0 110.608 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -153.42 147.31 25.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.376 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.482 ' CZ ' ' OH ' ' A' ' 35' ' ' TYR . 28.6 p90 -161.27 158.91 27.93 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.619 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 mt -81.06 153.49 27.34 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.412 0.625 . . . . 0.0 111.667 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.664 ' CD1' ' CZ ' ' A' ' 35' ' ' TYR . 16.8 p90 -162.41 141.79 7.18 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.457 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.27 156.52 58.88 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.276 1.984 . . . . 0.0 112.422 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.605 ' N ' ' NE2' ' A' ' 33' ' ' GLN . 44.6 p30 -74.25 160.7 30.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.216 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.43 -4.78 56.93 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.532 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 36.0 m0 -85.02 139.63 31.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.1 pt -113.61 134.39 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.158 0.504 . . . . 0.0 110.638 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.99 127.81 9.09 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.3 t -105.26 135.35 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.324 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 51.3 p30 -71.0 149.16 46.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.243 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -152.66 48.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.42 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -76.68 128.24 34.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.022 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.53 7.6 78.74 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.14 -164.68 0.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.637 0.256 . . . . 0.0 110.568 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.78 156.39 1.64 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.115 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.2 127.84 17.42 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.499 2.133 . . . . 0.0 112.253 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 80' ' ' ILE . . . 97.51 -22.68 39.53 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.6 t -68.79 128.79 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -118.98 -57.5 2.02 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.8 t -142.21 142.54 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.86 0.362 . . . . 0.0 111.157 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.6 t -117.09 134.31 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.215 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -111.67 131.63 55.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.953 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -129.83 138.57 51.08 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.483 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 72.2 m-20 -89.26 118.77 29.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.625 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.8 tp -66.83 -39.3 87.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.981 0.42 . . . . 0.0 110.328 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 85.9 mt -62.11 -43.16 97.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.345 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -117.98 108.87 15.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.828 0.346 . . . . 0.0 110.817 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -65.43 -43.19 91.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.354 0.597 . . . . 0.0 110.379 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 91.4 m-20 -58.2 -37.42 74.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.338 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' OE2' ' OG1' ' A' ' 166' ' ' THR . 47.4 tp10 -74.85 132.38 41.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.32 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 19.7 m-80 -149.23 139.0 21.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.539 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -129.83 134.69 47.7 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.862 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.3 t -127.86 138.51 52.72 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.1 t -116.01 125.24 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.7 mt -124.5 122.04 62.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 61' ' ' GLY . 72.6 mt -120.88 135.33 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.703 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 159' ' ' LEU . 22.8 t -148.08 164.68 33.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.37 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -103.49 134.44 46.84 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.5 pt -92.8 148.77 36.63 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.455 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 87' ' ' LYS . 40.1 Cg_endo -66.51 136.51 43.19 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.541 1.494 . . . . 0.0 110.49 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.5 p -63.86 -26.09 68.46 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.854 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -68.57 -30.96 69.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.815 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 84' ' ' PRO . 28.5 mtmm -130.92 148.94 52.74 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.132 0.491 . . . . 0.0 111.544 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.421 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 71.6 p -109.35 179.06 4.26 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.652 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.69 -41.07 73.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.284 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.4 p -72.52 -44.66 61.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.014 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 88' ' ' THR . 44.4 t0 -64.68 -38.45 91.02 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.947 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.5 tp -55.9 -44.71 78.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 178.64 47.33 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.2 p -94.76 171.11 8.98 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.73 -38.23 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.044 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.3 m -72.03 -45.24 61.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.11 -50.84 64.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.353 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' CG2' HH21 ' A' ' 101' ' ' ARG . 72.0 t -59.4 -37.3 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.554 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -62.8 -63.6 4.49 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.557 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -46.96 -42.99 18.76 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.793 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.481 HH21 ' CG2' ' A' ' 98' ' ' VAL . 84.0 mtm180 -59.38 -43.34 92.93 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.533 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -59.45 -42.66 92.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.659 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -53.97 -54.86 33.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.301 0.572 . . . . 0.0 110.098 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -62.04 -39.22 91.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 m -58.43 -45.59 88.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.907 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.4 t -70.88 -46.73 66.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.619 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 111' ' ' GLN . 85.1 m-20 -60.59 -37.04 80.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.526 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 22.3 t70 -44.38 -17.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 107' ' ' ASN . . . -109.31 -27.2 9.65 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.383 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 114' ' ' ARG . 3.8 t -121.32 21.59 11.05 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.605 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -69.97 4.17 2.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.079 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -74.1 -63.07 2.76 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.206 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -117.24 -45.14 2.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.852 0.358 . . . . 0.0 111.419 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' SER . 93.4 mtm-85 -85.09 148.4 26.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.504 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -129.16 148.64 51.12 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.175 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.16 136.2 43.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.379 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -122.74 127.96 49.89 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.9 tt -82.66 108.74 16.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.854 0.359 . . . . 0.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.538 ' C ' HD21 ' A' ' 120' ' ' ASN . 96.1 mt -72.73 -58.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.836 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.538 HD21 ' C ' ' A' ' 119' ' ' ILE . 1.8 m-80 -146.29 164.0 33.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.132 0.491 . . . . 0.0 110.647 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.25 112.48 2.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.183 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -138.97 170.44 15.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -142.36 151.16 41.63 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.737 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.3 140.94 47.72 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.773 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 35.6 p30 -109.21 112.72 25.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -139.93 142.55 36.41 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.991 0.424 . . . . 0.0 110.738 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 52.35 37.73 23.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.316 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.17 1.77 36.26 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -106.28 147.86 28.65 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 110.092 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.33 128.19 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.003 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -116.52 127.77 54.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.72 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.41 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.09 126.22 51.03 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.2 m -107.12 124.45 49.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.247 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.3 123.61 45.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.839 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -119.25 122.46 41.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -149.15 168.57 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.299 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -138.64 160.03 40.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.752 0.311 . . . . 0.0 110.206 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 85.1 t -105.37 125.32 60.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.489 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.0 mt -104.85 137.73 42.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.168 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.63 136.39 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.92 -110.49 0.74 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -117.31 18.11 14.51 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -140.88 160.22 40.52 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.322 0.582 . . . . 0.0 112.432 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.7 p -72.37 122.51 25.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.39 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.526 ' OE1' ' NE ' ' A' ' 146' ' ' ARG . 2.0 tm-20 -75.11 -53.59 8.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 145' ' ' GLU . 15.0 ptp180 -172.46 169.64 5.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.127 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -109.04 136.07 49.16 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.04 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -135.17 135.89 41.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.888 0.375 . . . . 0.0 111.046 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.8 tp -111.11 133.94 53.09 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.004 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.37 131.14 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.503 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.7 m -119.31 136.71 54.12 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.36 127.69 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 111.288 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.5 m -144.83 144.21 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.08 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.0 p -107.48 145.59 32.88 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -146.73 111.45 5.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.138 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.452 ' CZ ' ' OXT' ' A' ' 188' ' ' TYR . 80.5 mtm180 55.74 31.86 18.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.81 8.71 75.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 31.7 mmtp -99.71 124.43 44.96 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -86.66 114.61 23.51 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.8 mm -109.76 128.6 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.5 m -130.42 134.46 47.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.729 0.299 . . . . 0.0 110.838 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.29 102.17 9.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.829 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -102.53 111.86 24.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.474 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.16 137.51 52.28 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.653 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 54.4 m -126.85 134.35 50.53 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.031 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.425 ' OG1' ' OE2' ' A' ' 74' ' ' GLU . 17.2 m -153.11 156.31 38.43 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.65 143.79 19.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.257 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.21 -36.98 72.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.295 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.9 -33.29 73.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.516 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -100.88 -12.51 18.93 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.601 0.239 . . . . 0.0 111.29 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.529 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.7 t-105 -50.36 -39.79 47.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.757 0.313 . . . . 0.0 111.01 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -60.3 -42.05 94.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.152 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.1 m -66.18 -39.67 89.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.634 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.18 21.35 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.406 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 171' ' ' TRP . 47.2 pttt -51.37 -48.76 62.41 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.39 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.1 t -65.98 -29.03 69.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.686 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.46 -44.25 80.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.191 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.529 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 28.3 m-85 -61.77 -50.95 70.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.122 0.486 . . . . 0.0 110.403 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -63.82 -40.91 97.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.562 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 184' ' ' SER . 41.6 m -66.26 -46.71 76.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.591 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.05 -46.16 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.097 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -65.96 -49.43 67.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.492 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.3 t -67.77 -34.04 76.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 180' ' ' THR . 16.5 t -62.61 -29.29 70.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.633 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -51.19 157.47 0.92 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.562 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -132.61 154.16 50.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.57 152.43 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 111.274 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.452 ' OXT' ' CZ ' ' A' ' 156' ' ' ARG . 38.2 p90 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.727 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.4 mt . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -131.47 159.07 39.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.289 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -121.35 146.38 46.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.602 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -129.88 137.64 50.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.921 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.427 ' OG ' ' OH ' ' A' ' 188' ' ' TYR . 22.2 t -149.5 149.24 30.45 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.644 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -142.76 110.59 5.89 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.706 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.9 m -61.54 -37.31 83.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.568 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -58.68 -52.57 65.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 38.9 t0 -83.08 -21.07 33.82 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.762 0.315 . . . . 0.0 110.709 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.58 42.12 81.86 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.16 147.94 37.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.359 0.58 . . . . 0.0 110.129 179.082 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -153.1 141.38 20.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.803 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.91 156.66 40.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.75 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.7 mt -96.7 152.03 19.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.447 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -154.86 146.43 16.9 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.488 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.07 161.77 41.22 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.23 1.953 . . . . 0.0 112.101 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -76.9 160.59 29.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.575 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.4 0.93 58.01 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.52 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 31.2 m0 -88.48 141.25 28.69 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.06 145.69 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.637 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.95 136.51 12.74 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.2 t -112.94 136.51 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.392 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -66.55 140.07 57.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.15 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.6 m -114.03 24.75 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.646 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -60.74 119.57 8.41 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.218 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.63 8.81 76.28 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.41 -164.58 0.65 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.14 157.77 67.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.503 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.45 128.32 16.13 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.382 2.054 . . . . 0.0 111.742 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.24 -17.79 58.05 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.08 123.99 25.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.641 -0.424 . . . . 0.0 109.891 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -100.87 -58.24 1.93 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.08 148.06 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 111.312 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.1 t -115.27 136.31 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.301 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -111.79 136.15 51.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.243 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -129.78 138.54 51.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.321 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 74.3 m-20 -82.46 118.58 23.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.79 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.04 -40.16 71.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.39 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.7 mm -61.4 -40.75 87.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.544 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' OE1' ' A' ' 74' ' ' GLU . 9.9 pt-20 -133.53 84.41 2.12 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.08 0.467 . . . . 0.0 110.284 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -52.16 -21.81 3.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.462 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -57.76 -37.82 74.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' OE1' ' OE2' ' A' ' 71' ' ' GLU . 97.7 mt-10 -84.33 141.35 30.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.991 0.424 . . . . 0.0 110.627 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -153.23 149.69 28.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.733 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 76' ' ' LEU . 1.7 pp -151.91 146.5 25.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.285 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.7 m -124.21 145.94 49.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.019 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.08 125.03 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.473 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.6 127.78 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.299 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.406 ' CD1' ' OD2' ' A' ' 40' ' ' ASP . 79.2 mt -122.65 132.08 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.664 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.3 m -145.82 167.25 23.65 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.115 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -106.05 137.21 44.36 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.9 pt -96.37 148.33 34.32 Favored Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.569 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 87' ' ' LYS . 36.9 Cg_endo -66.22 135.77 41.4 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.589 1.526 . . . . 0.0 110.759 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 t -62.1 -29.17 70.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.133 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -68.09 -31.3 70.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.037 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 84' ' ' PRO . 97.0 mttt -131.38 143.68 50.65 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.033 0.444 . . . . 0.0 111.008 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 13.9 t -110.46 -179.44 3.77 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.32 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 tp -51.05 -44.08 61.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.893 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.5 p -68.28 -43.35 77.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.433 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 88' ' ' THR . 89.0 m-20 -65.54 -40.45 92.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.41 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.2 mt -57.01 -41.29 78.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.639 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.87 178.18 47.2 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.394 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 32.9 p -93.37 173.83 7.51 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.7 -41.03 76.66 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.4 m -73.08 -46.0 54.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.034 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -63.14 -52.14 63.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.506 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.2 -37.93 71.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.72 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.539 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -60.15 -55.69 28.83 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -53.53 -39.77 64.96 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.875 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -58.58 -36.79 74.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.191 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -65.08 -41.98 94.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.721 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.654 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -54.22 -55.71 25.39 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.336 0.589 . . . . 0.0 109.826 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -62.1 -40.98 97.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.664 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.5 m -58.1 -47.09 84.28 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.929 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.2 t -72.19 -47.35 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.773 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 111' ' ' GLN . 95.8 m-20 -60.97 -39.51 89.86 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.792 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -44.41 -37.13 3.21 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.448 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.25 -45.06 74.22 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.9 p -123.37 22.09 9.36 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.633 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.8 tt0 -51.15 -28.88 12.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.5 0.19 . . . . 0.0 111.281 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -42.5 -61.74 2.39 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.287 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -117.2 -38.01 3.44 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.01 0.405 . . . . 0.0 111.74 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -88.39 138.33 31.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.019 0.437 . . . . 0.0 111.146 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -131.87 149.73 52.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.112 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.83 138.07 43.68 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.39 129.7 56.66 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.9 tp -82.61 111.99 19.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.909 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.494 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.5 mt -79.64 -50.29 18.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.569 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.9 m-80 -158.41 164.52 36.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.398 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.47 114.66 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.592 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.64 167.25 22.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.685 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.41 150.5 50.88 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.504 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -128.53 142.16 51.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.787 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -109.43 113.27 25.93 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.183 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -138.92 141.13 38.51 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.89 0.376 . . . . 0.0 110.755 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 50.52 38.9 19.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.366 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.42 0.34 29.93 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -105.21 147.41 28.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.916 0.389 . . . . 0.0 110.124 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -113.3 129.64 68.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.27 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 20.7 m-85 -117.06 130.49 56.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.755 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.4 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.13 124.48 49.16 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 54.2 m -103.29 130.26 50.5 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.59 106.37 8.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.234 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -101.14 124.5 46.95 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -152.71 172.77 16.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.408 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -141.2 158.78 43.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 110.448 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.16 137.32 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.501 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 141' ' ' GLY . 2.7 pp -135.04 131.69 37.34 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.049 0.452 . . . . 0.0 111.332 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.74 103.76 14.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 139' ' ' LEU . . . 74.02 -113.64 4.23 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -107.91 7.35 27.98 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.818 -0.225 . . . . 0.0 111.483 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -116.14 138.97 50.8 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.707 0.289 . . . . 0.0 111.249 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.72 122.21 33.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.344 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.13 -52.93 9.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.588 HH21 ' N ' ' A' ' 166' ' ' THR . 15.3 ptm180 -172.27 173.13 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.9 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -102.97 138.92 39.21 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -133.72 134.18 42.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.855 0.36 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.6 tp -111.32 131.21 55.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.079 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -127.65 125.72 40.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.029 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 27.8 t -118.74 132.57 56.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.678 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.07 127.56 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.99 0.424 . . . . 0.0 110.751 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.5 m -137.97 140.94 40.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.998 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.8 p -105.37 151.52 24.09 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.727 0.299 . . . . 0.0 110.364 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -161.53 119.07 2.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 55.17 32.1 17.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.67 14.31 80.06 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -105.26 128.8 53.62 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.42 119.06 31.58 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.3 mt -117.92 127.59 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.732 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 39.5 m -126.76 136.08 51.94 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.017 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.37 98.41 6.41 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -91.74 111.99 23.73 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.549 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.93 137.39 49.98 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.5 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 146' ' ' ARG . 32.3 t -136.27 129.45 31.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.365 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.588 ' N ' HH21 ' A' ' 146' ' ' ARG . 11.9 m -152.43 158.72 43.03 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.478 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -51.93 143.32 13.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -71.84 -36.78 70.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.043 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -63.32 -33.5 75.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.123 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.464 ' CD ' ' N ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER -96.95 -16.49 20.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.274 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.546 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 50.6 t-105 -48.56 -39.82 24.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.831 0.348 . . . . 0.0 110.769 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -61.69 -42.12 98.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 58.7 m -66.66 -40.0 88.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.657 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.2 m -109.55 21.17 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.149 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 171' ' ' TRP . 19.2 ptmt -50.59 -48.72 57.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.279 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.5 t -65.78 -29.75 70.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.773 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.8 tp -55.73 -44.45 77.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.374 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 26.3 m-85 -62.3 -50.47 71.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.088 0.47 . . . . 0.0 110.41 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.31 -41.41 98.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.605 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 184' ' ' SER . 50.7 m -66.07 -47.86 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.31 -43.63 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.523 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -62.94 -37.67 87.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.905 0.383 . . . . 0.0 110.306 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.2 t -83.62 -25.3 30.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 180' ' ' THR . 46.9 t -62.49 -30.03 70.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.17 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -59.76 157.58 11.86 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.463 -179.571 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -135.53 156.64 48.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.602 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.1 149.81 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.041 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.427 ' OH ' ' OG ' ' A' ' 36' ' ' SER . 38.9 p90 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.744 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 mt . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 120.979 0.419 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.668 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.4 pm0 -137.98 163.9 30.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.857 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -117.69 133.94 55.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.727 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -112.48 135.13 53.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.846 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 93.8 p -146.79 153.89 40.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 110.855 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 36' ' ' SER . 99.2 m-20 -141.2 114.18 8.51 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.15 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.6 p -64.89 -33.95 77.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.434 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -62.49 -48.44 79.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -85.91 -20.48 28.95 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.101 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.51 40.54 90.98 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.211 -0.518 . . . . 0.0 111.83 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -141.97 151.56 42.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.332 0.566 . . . . 0.0 110.61 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -155.6 146.52 22.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -151.74 161.58 42.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.994 0.426 . . . . 0.0 111.18 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.569 ' N ' ' CD2' ' A' ' 45' ' ' LEU . 2.0 mm? -92.61 143.5 26.26 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.116 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -154.71 147.25 17.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.518 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.73 157.98 58.58 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.282 1.988 . . . . 0.0 112.24 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.668 ' N ' HE22 ' A' ' 33' ' ' GLN . 47.3 p-10 -71.35 160.42 32.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.563 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.99 6.45 57.94 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.406 ' HE1' ' CG ' ' A' ' 68' ' ' ASP . 27.2 m0 -93.6 142.79 26.94 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.301 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 pt -126.02 146.31 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.334 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.63 139.32 15.06 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.69 134.64 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.856 0.36 . . . . 0.0 110.526 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -79.08 137.74 37.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.683 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.86 55.7 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.065 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -72.81 135.07 45.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.072 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.41 4.76 70.42 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.64 -164.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.698 0.285 . . . . 0.0 110.72 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.12 153.74 3.09 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.562 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.27 133.08 27.44 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.264 1.976 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.01 -21.88 42.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.2 t -62.22 122.22 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.92 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -99.11 -58.55 1.91 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.76 168.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.492 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.0 135.79 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.058 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -112.18 128.54 56.26 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -122.91 135.56 54.55 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.802 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 71' ' ' GLU . 60.3 t0 -88.53 118.43 28.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.849 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.11 -38.65 91.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.387 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.404 HG23 HD11 ' A' ' 70' ' ' ILE . 89.3 mt -61.35 -42.15 92.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.78 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 68' ' ' ASP . 96.1 mt-10 -117.86 120.62 38.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.457 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -88.93 -40.26 13.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.32 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -58.47 -36.27 73.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.548 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -89.22 129.77 35.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.421 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -129.75 149.04 51.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.997 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.84 134.12 51.75 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 t -136.82 142.79 42.9 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 t -129.4 132.86 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.933 0.396 . . . . 0.0 110.674 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.4 mt -121.89 123.38 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.34 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.92 132.18 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.314 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 159' ' ' LEU . 4.1 m -151.68 166.75 30.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.406 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -105.71 135.82 46.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.0 pt -91.47 148.93 38.55 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.97 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -43.73 143.21 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.869 1.712 . . . . 0.0 111.382 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -73.1 -20.64 60.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.636 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 57.2 t0 -94.98 -17.18 22.18 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -129.94 156.26 44.71 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.933 0.397 . . . . 0.0 111.348 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.8 t -122.88 176.36 6.04 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.823 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.2 tp -49.92 -45.73 51.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.944 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.3 p -66.43 -44.13 83.76 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.988 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.71 -37.55 86.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.98 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.9 tp -55.85 -43.26 76.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.577 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.68 178.92 47.61 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.396 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.646 ' HG1' ' H ' ' A' ' 97' ' ' ASP . 43.4 p -92.29 170.44 9.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.54 74.96 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.91 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.8 m -72.02 -44.43 63.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.804 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.646 ' H ' ' HG1' ' A' ' 94' ' ' THR . 47.3 t0 -62.22 -52.68 62.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.431 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.8 t -60.12 -39.11 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.595 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.73 -43.3 94.57 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -67.78 -41.41 83.28 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.04 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -60.72 -38.6 85.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -62.98 -39.61 95.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.585 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.5 mmt -59.1 -45.37 91.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.863 0.363 . . . . 0.0 110.536 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -64.72 -41.82 95.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.872 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.8 m -60.86 -46.13 91.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.7 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.99 -47.5 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.102 0.477 . . . . 0.0 110.472 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 111' ' ' GLN . 89.6 m-20 -61.05 -34.29 74.65 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.39 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -47.59 -38.71 15.02 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.189 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.41 73.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.53 0.566 . . . . 0.0 112.53 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -123.03 22.15 9.62 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.641 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.3 pt20 -51.23 -15.55 0.38 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.27 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.01 -61.27 7.63 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.814 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 38.0 p-10 -117.46 -35.51 3.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.035 0.417 . . . . 0.0 111.74 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.528 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 58.9 ttm-85 -84.62 137.89 33.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 111.24 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -129.03 139.29 52.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.106 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.9 136.53 42.56 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -116.54 128.28 55.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 tt -82.99 106.31 14.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.926 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.28 -43.47 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.362 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -179.7 173.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.452 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.67 139.62 15.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.19 163.99 32.03 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.453 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.8 146.87 46.2 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -133.13 139.6 47.17 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.655 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -109.67 113.44 26.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.55 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.74 144.33 39.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.014 0.435 . . . . 0.0 110.956 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 60.6 t0 51.59 32.11 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.405 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.03 1.58 68.81 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -105.57 148.95 26.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.94 0.4 . . . . 0.0 110.114 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.2 t -114.37 128.54 71.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.009 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -118.05 126.81 53.0 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.54 125.88 50.35 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.2 m -105.17 125.41 50.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.332 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.2 mp -115.69 126.53 54.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.928 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -119.52 122.67 42.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.433 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -152.9 171.65 17.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.522 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -139.94 157.92 44.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.186 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.24 135.28 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.979 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -136.04 136.9 40.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.109 0.481 . . . . 0.0 111.107 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.42 134.48 57.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.223 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.43 -120.95 16.46 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -114.47 14.42 17.82 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.92 -0.165 . . . . 0.0 111.415 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -129.05 155.6 45.17 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.92 0.391 . . . . 0.0 111.143 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.7 p -86.66 126.93 40.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.324 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.539 ' OE1' ' NE ' ' A' ' 146' ' ' ARG . 2.1 tm-20 -76.01 -51.69 11.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.68 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.539 ' NE ' ' OE1' ' A' ' 145' ' ' GLU . 10.5 ptp180 -172.31 174.02 4.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.992 0.425 . . . . 0.0 111.192 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.404 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 73.8 m80 -107.21 139.44 41.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.013 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 78.3 m-20 -134.41 136.92 43.65 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.02 0.438 . . . . 0.0 111.477 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.3 tp -112.81 138.93 48.91 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.632 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.98 147.08 43.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.34 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.5 t -131.55 138.48 48.91 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.552 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 52.8 t -119.05 126.9 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.533 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.6 m -142.42 148.09 37.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.475 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.2 p -113.61 152.81 29.83 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.831 0.348 . . . . 0.0 110.641 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -151.12 107.44 3.47 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.274 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 59.35 32.16 21.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.791 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 87.1 6.21 79.21 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -97.27 123.26 41.02 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 81' ' ' SER . 1.0 OUTLIER -85.39 118.01 24.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.424 HD13 HG22 ' A' ' 160' ' ' ILE . 81.4 mt -121.94 120.55 61.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.8 m -123.87 133.99 53.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.011 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.91 125.02 50.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.866 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -112.3 114.99 28.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.897 0.38 . . . . 0.0 110.654 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.8 mt -111.33 130.17 55.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.1 m -133.59 129.82 37.51 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.475 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 8.0 m -153.41 152.66 31.29 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.441 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.15 147.95 46.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.588 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -70.27 -24.05 62.99 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.268 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -55.54 -34.11 64.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.173 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.79 0.09 8.03 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.519 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 44.9 t-105 -48.22 -39.11 20.14 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.852 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -63.43 -41.95 98.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 49.3 m -65.4 -39.94 92.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.627 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.22 21.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.176 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.36 -47.97 55.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.384 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.6 m -65.51 -31.9 73.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.652 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -54.52 -44.03 72.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.091 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.519 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 23.4 m-85 -61.07 -49.84 75.7 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.356 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -64.3 -40.38 95.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.591 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 184' ' ' SER . 50.1 m -67.65 -47.54 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.35 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.23 -43.46 98.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.614 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.77 -40.15 96.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 110.287 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 42.2 m -80.32 -27.72 38.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.249 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 180' ' ' THR . 40.1 t -62.26 -29.8 70.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.524 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -58.22 157.79 7.93 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.295 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -138.57 159.47 42.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.61 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.48 149.5 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.996 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 38.3 p90 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.682 179.83 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.8 mt . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.843 0.354 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.485 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.6 pm0 -141.18 163.02 34.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.313 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -115.14 140.13 49.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.866 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -117.36 130.8 56.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.531 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.426 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 50.5 m -120.83 146.58 46.41 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.022 0.439 . . . . 0.0 111.022 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 36' ' ' SER . 98.8 m-20 -140.67 103.71 4.57 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.7 p -68.78 -15.1 63.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.52 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -57.25 -43.23 82.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.358 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -116.35 -13.33 11.03 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.058 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.79 50.04 6.19 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.64 148.76 30.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.033 0.444 . . . . 0.0 111.128 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -144.41 151.62 39.51 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.693 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -151.84 157.28 41.69 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mp -103.13 143.53 32.48 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.373 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.483 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 7.0 p90 -149.91 148.18 24.48 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.937 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.07 154.44 62.48 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.017 1.812 . . . . 0.0 111.849 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.485 ' N ' HE22 ' A' ' 33' ' ' GLN . 11.7 p30 -69.57 160.52 31.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.36 3.97 58.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.527 ' CD2' ' OD1' ' A' ' 68' ' ' ASP . 32.0 m0 -92.27 146.58 23.6 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.358 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.0 pt -117.92 139.93 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.301 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.29 139.87 14.79 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.8 t -113.6 134.76 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.895 0.378 . . . . 0.0 110.463 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -74.46 138.28 43.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.437 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 63' ' ' ASP . 26.8 m -132.84 46.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -76.75 124.38 27.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.055 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.3 11.83 82.91 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.65 -164.41 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.757 0.313 . . . . 0.0 110.658 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -54.13 153.54 9.17 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.173 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.92 128.56 17.99 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.384 2.056 . . . . 0.0 112.137 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.15 -25.1 29.04 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.13 131.39 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.985 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' O ' ' CG2' ' A' ' 55' ' ' VAL . 58.7 t0 -111.09 -58.01 2.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.0 t -147.81 145.26 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.868 0.366 . . . . 0.0 111.287 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.5 t -122.16 134.93 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.527 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.18 141.27 46.08 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.081 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' NH2' ' CD2' ' A' ' 69' ' ' LEU . 68.3 ttp85 -129.12 129.33 45.03 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.269 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.527 ' OD1' ' CD2' ' A' ' 50' ' ' TRP . 78.4 m-20 -92.23 118.89 31.32 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.7 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.572 ' CD2' ' NH2' ' A' ' 67' ' ' ARG . 70.2 mt -65.52 -37.45 86.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.256 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.4 mt -63.51 -38.07 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.754 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -128.56 88.84 2.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.461 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -61.17 -35.73 77.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.561 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 39.2 p-10 -62.38 -32.67 73.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 11.6 tm-20 -92.55 132.75 36.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.663 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -146.68 139.59 25.33 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.636 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 tt -114.26 133.51 55.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.086 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.0 m -133.07 149.01 52.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.37 129.7 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.176 0.513 . . . . 0.0 110.288 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.5 124.14 71.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.361 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.4 mm -113.78 136.42 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.437 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.474 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 32.2 t -139.86 161.03 38.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.233 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.474 ' N ' ' HG ' ' A' ' 81' ' ' SER . 22.9 pt-20 -104.73 134.31 48.1 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.421 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.7 pt -106.75 150.15 39.33 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.956 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.05 137.92 42.34 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.008 1.805 . . . . 0.0 111.337 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 t -63.42 -27.19 69.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.076 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -67.44 -31.31 71.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.927 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -128.8 152.0 48.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.154 0.502 . . . . 0.0 111.315 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.1 t -117.46 179.8 3.95 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.21 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.2 tp -50.92 -44.64 60.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.192 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 50.3 p -66.5 -44.83 81.49 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.147 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.2 m-20 -65.32 -38.41 90.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.9 tp -56.15 -43.43 78.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.646 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.69 177.99 46.93 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.9 p -93.6 172.33 8.33 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.31 -42.26 77.33 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.227 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.1 m -71.65 -44.91 63.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -62.3 -51.54 67.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.522 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.71 -39.99 83.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.22 -45.33 92.78 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.75 -41.78 87.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.994 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -61.62 -39.19 90.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.612 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -62.73 -40.27 96.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.74 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.1 mmt -58.14 -43.79 87.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.294 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -64.85 -45.28 86.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.302 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.4 m -59.91 -45.14 93.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.961 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.2 t -68.18 -47.52 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.644 ' O ' ' N ' ' A' ' 111' ' ' GLN . 96.0 m-20 -62.73 -36.52 83.27 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.233 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -43.61 -36.92 2.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.718 0.294 . . . . 0.0 111.004 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.54 -46.49 69.38 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.2 m -123.34 23.28 9.09 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.644 ' N ' ' O ' ' A' ' 107' ' ' ASN . 47.1 tt0 -51.96 -28.83 18.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.633 0.254 . . . . 0.0 111.357 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -41.55 -61.46 2.15 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.15 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -117.24 -38.97 3.26 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.93 0.365 . . . . 0.0 111.779 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -77.39 146.44 36.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.491 . . . . 0.0 111.793 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -135.01 133.47 39.46 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.927 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.14 134.29 43.29 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.52 ' OE1' ' NH2' ' A' ' 137' ' ' ARG . 75.8 tt0 -115.3 128.71 56.3 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.977 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.24 106.94 13.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.994 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.533 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 95.6 mt -71.03 -38.61 72.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.057 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.9 m-80 178.44 166.35 0.82 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.343 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.98 132.46 12.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -143.12 165.58 27.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.602 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.15 148.87 45.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.458 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -130.33 142.12 50.55 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 34.9 p30 -110.18 110.62 21.54 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.791 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -136.93 143.8 43.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.475 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 127' ' ' ASP . 22.6 t70 50.43 35.54 11.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.99 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.75 2.63 38.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.523 ' OE1' ' CE1' ' A' ' 131' ' ' TYR . 5.7 tm0? -106.43 136.54 46.0 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.458 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 44.7 t -106.69 129.41 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.852 0.358 . . . . 0.0 110.708 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.523 ' CE1' ' OE1' ' A' ' 129' ' ' GLN . 48.2 m-85 -117.24 131.11 56.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.57 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.13 130.14 51.85 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.8 m -110.42 124.33 51.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.181 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.73 125.32 52.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.982 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -117.58 122.34 43.37 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.537 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -150.82 172.74 15.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.562 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.52 ' NH2' ' OE1' ' A' ' 117' ' ' GLU . 38.3 ptt180 -140.4 158.09 44.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 110.729 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.37 132.84 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.122 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pp -140.52 135.7 32.15 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.05 0.452 . . . . 0.0 111.427 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.6 t -111.18 131.07 63.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.202 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.52 -120.6 21.21 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -109.38 11.17 25.29 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -124.1 152.68 42.45 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.024 0.44 . . . . 0.0 111.48 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.31 127.34 41.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.786 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -77.0 -53.64 7.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.544 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.538 HH21 ' CA ' ' A' ' 166' ' ' THR . 13.0 ptm180 -170.49 173.78 5.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.008 0.432 . . . . 0.0 111.384 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.418 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 52.2 m80 -108.02 137.7 45.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.055 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 79.1 m-20 -135.04 137.91 43.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.015 0.436 . . . . 0.0 111.018 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.5 tp -111.22 134.91 52.45 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.546 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -135.64 141.24 45.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.428 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.0 t -124.86 141.32 52.2 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.179 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.13 132.12 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.837 0.351 . . . . 0.0 110.438 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.0 m -146.21 153.49 40.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.555 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.6 p -116.84 145.19 43.72 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.858 0.361 . . . . 0.0 110.52 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.407 ' ND2' ' OXT' ' A' ' 188' ' ' TYR . 38.0 t30 -160.04 122.37 3.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.927 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 60.15 30.91 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.097 0.475 . . . . 0.0 110.276 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 77.47 11.8 85.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -109.89 135.26 51.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.52 114.74 26.31 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.9 mm -103.99 120.23 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 49.0 m -120.52 129.58 53.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.101 0.477 . . . . 0.0 110.561 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.28 117.32 32.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -120.1 122.96 42.2 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.978 0.418 . . . . 0.0 111.578 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.3 mp -119.93 140.57 50.69 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.382 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 63.1 m -130.87 135.65 47.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.365 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.538 ' CA ' HH21 ' A' ' 146' ' ' ARG . 16.6 m -153.06 153.93 33.85 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.57 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.27 145.71 42.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.358 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -69.98 -25.45 63.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.414 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 170' ' ' ARG . 55.4 p30 -60.56 -33.45 72.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.552 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 22.7 mmt85 -118.89 -1.12 11.07 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.576 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 46.9 t-105 -48.26 -40.62 25.32 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.693 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.98 -41.39 97.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.029 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 46.3 m -63.71 -39.41 94.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.438 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.9 m -105.85 21.17 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.964 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.412 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 19.1 ptmt -50.19 -45.19 53.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.823 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' SER . . . . . 0.435 ' O ' ' OG1' ' A' ' 180' ' ' THR . 24.2 t -63.13 -31.45 72.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.694 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.0 tp -59.43 -45.55 91.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.109 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 18.2 m-85 -60.89 -50.14 74.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.873 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 176' ' ' SER . 0.6 OUTLIER -69.27 -43.24 74.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.757 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 176' ' ' SER . 60.6 m -62.36 -48.36 80.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.704 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 80.5 t -71.57 -38.39 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.474 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.98 -38.98 93.33 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.353 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 81.4 p -80.18 -18.98 48.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.226 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.8 t -62.84 -39.04 93.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.699 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.493 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -54.77 149.03 11.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.08 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -133.88 159.02 41.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.3 m -126.57 150.45 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.67 0.272 . . . . 0.0 110.795 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.407 ' OXT' ' ND2' ' A' ' 155' ' ' ASN . 41.2 p90 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.882 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.4 mt . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 120.791 0.329 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 21.0 mp0 -103.58 148.45 25.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.908 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -119.3 136.49 54.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.184 0.516 . . . . 0.0 110.946 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -125.63 136.19 52.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.0 p -145.64 156.05 43.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.491 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -148.05 119.15 7.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.556 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.8 p -70.53 -32.61 70.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.879 0.371 . . . . 0.0 110.218 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 63.9 tttm -62.03 -49.94 74.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.799 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -86.87 -20.63 27.17 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.904 0.383 . . . . 0.0 110.567 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.28 43.34 93.1 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.16 147.61 36.91 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.225 0.513 . . . . 0.0 110.377 179.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -148.18 155.96 42.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.024 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.538 ' CZ ' ' O ' ' A' ' 45' ' ' LEU . 57.6 t80 -173.02 143.52 1.17 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.538 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . 9.9 mp -92.58 141.38 28.56 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -134.16 141.2 38.52 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.638 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.58 152.44 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.893 1.728 . . . . 0.0 112.484 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.2 p30 -81.41 158.75 24.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.234 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.29 8.84 74.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.437 ' NE1' ' OD1' ' A' ' 68' ' ' ASP . 27.7 m0 -94.1 149.03 21.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.451 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.2 pt -114.64 140.46 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.475 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.75 134.24 11.8 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.15 132.45 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.015 0.436 . . . . 0.0 110.569 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -83.88 137.96 33.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.339 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.83 52.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.371 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -72.81 134.06 44.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.357 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.64 4.72 82.58 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.81 -164.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.707 0.289 . . . . 0.0 110.694 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -45.1 152.1 0.62 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.556 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.78 132.98 26.19 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.23 1.953 . . . . 0.0 111.654 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 80' ' ' ILE . . . 95.76 -27.63 15.4 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.55 133.9 26.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.085 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -115.78 -58.57 2.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.646 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.8 t -149.49 147.28 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.057 0.456 . . . . 0.0 111.522 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.18 134.87 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.158 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -112.13 138.16 49.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.406 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -128.95 133.63 47.9 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.531 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' OD1' ' NE1' ' A' ' 50' ' ' TRP . 60.1 t0 -88.15 119.07 28.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.444 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.9 mt -60.24 -37.82 81.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.737 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.406 HD11 ' H ' ' A' ' 70' ' ' ILE . 4.9 mp -67.13 -42.21 87.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.822 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 68' ' ' ASP . 90.6 mt-10 -121.24 124.24 44.17 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.009 0.433 . . . . 0.0 110.639 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -87.19 -39.58 15.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.549 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.45 -37.02 77.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.984 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' OE1' ' OE1' ' A' ' 71' ' ' GLU . 84.6 tt0 -85.12 132.68 34.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.409 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -155.58 138.78 15.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.945 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 tt -112.57 133.29 54.7 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.044 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.9 m -128.44 147.0 50.64 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.015 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.07 131.45 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.105 0.478 . . . . 0.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 51.0 mt -119.13 124.26 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.587 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 61' ' ' GLY . 63.1 mt -119.07 128.26 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 110.788 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 74.5 m -149.09 166.31 29.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.043 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -104.57 137.01 43.04 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.4 pt -92.44 149.55 38.46 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.394 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -45.42 136.71 11.54 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.649 1.566 . . . . 0.0 111.862 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -27.3 68.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.392 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -88.61 -16.23 33.03 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -131.22 157.23 43.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.043 0.449 . . . . 0.0 111.375 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.4 t -122.81 176.61 5.89 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.49 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.6 tp -51.83 -44.74 63.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.171 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 91' ' ' ASP . 44.5 p -65.51 -44.61 86.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.933 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.444 ' N ' ' HG1' ' A' ' 90' ' ' THR . 85.3 m-20 -67.16 -34.27 77.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.866 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -50.01 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.893 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.37 179.18 47.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.3 p -90.91 171.69 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.26 -41.41 75.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.869 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.7 m -72.61 -45.17 60.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -61.57 -51.74 67.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.294 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.96 -38.77 81.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.514 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.02 -43.94 94.82 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -67.64 -42.36 82.38 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.945 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -62.33 -38.65 90.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.0 110.718 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.87 -40.77 96.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.541 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.6 mmt -58.9 -44.4 91.19 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.521 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 108' ' ' ASP . 43.9 tptt -65.46 -45.76 82.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.976 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.8 m -59.17 -46.12 89.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.015 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.29 -47.16 79.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 110.273 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.656 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.1 m-20 -63.39 -37.83 88.78 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.266 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 104' ' ' LYS . 88.8 m-20 -44.29 -38.31 3.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.729 0.299 . . . . 0.0 111.224 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.88 74.6 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.6 m -123.93 23.45 8.59 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.4 tt0 -48.5 -28.79 3.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.557 0.218 . . . . 0.0 111.544 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -44.05 -61.24 3.16 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.152 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -116.91 -36.01 3.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.956 0.378 . . . . 0.0 111.872 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -78.43 139.54 38.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 111.242 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -132.55 137.03 46.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.962 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.0 140.38 42.58 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.817 0.342 . . . . 0.0 110.458 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.418 ' OE1' ' NE ' ' A' ' 137' ' ' ARG . 83.4 mt-10 -124.8 123.4 39.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.734 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 tp -80.43 110.75 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.054 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.545 ' C ' HD21 ' A' ' 120' ' ' ASN . 96.9 mt -76.32 -55.71 10.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.846 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.545 HD21 ' C ' ' A' ' 119' ' ' ILE . 1.7 m-80 -145.23 163.22 35.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.083 0.468 . . . . 0.0 110.693 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.18 116.12 3.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.237 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.17 162.55 34.68 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.548 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.99 150.19 47.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 110.878 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -129.5 160.35 33.45 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.385 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -134.83 114.22 12.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.721 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.84 142.5 38.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.608 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 127' ' ' ASP . 22.3 t70 50.49 36.57 13.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.02 2.66 48.24 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.525 ' OE1' ' CE2' ' A' ' 131' ' ' TYR . 4.4 tm0? -101.29 134.74 43.88 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.436 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 46.2 t -106.22 130.08 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 110.565 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.525 ' CE2' ' OE1' ' A' ' 129' ' ' GLN . 58.1 m-85 -119.41 128.24 53.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.045 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -106.61 129.93 54.45 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.7 m -112.37 122.8 48.76 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.522 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.37 125.05 51.52 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.048 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -117.09 123.81 47.71 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -151.75 164.04 37.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.945 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.418 ' NE ' ' OE1' ' A' ' 117' ' ' GLU . 39.5 ptt180 -126.62 156.97 40.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.083 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.09 130.71 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.3 mt -112.25 125.3 54.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.883 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 79.5 t -123.49 129.68 74.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.04 -121.64 16.77 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -116.44 22.35 12.87 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -148.35 161.5 41.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.955 0.407 . . . . 0.0 111.486 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.5 t -71.34 125.52 29.96 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.271 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' A' ' 146' ' ' ARG . 83.3 tt0 -73.9 -52.71 12.06 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.014 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' A' ' 145' ' ' GLU . 11.4 ptp85 -172.41 170.43 4.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.609 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.466 ' HD1' ' CB ' ' A' ' 168' ' ' GLU . 76.7 m80 -105.0 138.96 40.41 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.007 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 164' ' ' LEU . 13.4 t70 -135.52 147.58 48.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.146 0.498 . . . . 0.0 110.563 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 tp -123.17 124.96 44.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.556 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -123.81 134.74 53.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.234 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.5 t -122.84 134.27 54.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.35 129.93 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.157 0.503 . . . . 0.0 110.852 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.438 ' CG2' ' NE2' ' A' ' 129' ' ' GLN . 24.0 m -143.76 142.71 31.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.101 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.1 p -108.36 149.6 28.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 110.215 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.575 HD22 ' CA ' ' A' ' 188' ' ' TYR . 56.5 t30 -147.46 106.71 3.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.735 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 57.42 31.74 20.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 89.59 4.89 72.59 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 32.1 mmtp -96.05 123.85 39.82 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -89.36 114.38 25.79 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.89 127.41 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.103 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.7 m -123.67 135.91 54.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.037 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.07 105.51 15.56 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.886 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.19 120.06 38.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.876 0.37 . . . . 0.0 111.47 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.432 ' O ' ' OD2' ' A' ' 148' ' ' ASP . 19.2 mt -117.62 135.3 54.07 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.9 t -133.56 134.07 42.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.419 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 14.6 m -152.52 158.88 43.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.295 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -59.18 144.31 46.29 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.07 0.462 . . . . 0.0 111.422 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.466 ' CB ' ' HD1' ' A' ' 147' ' ' HIS . 22.9 pt-20 -74.44 -17.81 60.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.071 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -77.93 -9.77 59.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.902 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -133.61 -6.8 2.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.729 0.299 . . . . 0.0 110.742 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.617 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 45.3 t-105 -49.19 -39.02 27.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.624 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -63.48 -42.32 98.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.08 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.7 m -65.37 -40.74 93.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.526 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 m -105.33 21.21 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.848 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.77 -47.24 41.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.203 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 91.8 p -67.08 -28.61 68.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.81 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.8 tp -56.23 -43.18 78.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.627 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.617 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 19.4 m-85 -62.78 -49.49 74.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.451 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.4 -40.85 98.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.706 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.4 m -68.09 -51.49 45.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.401 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.463 ' O ' ' OG ' ' A' ' 184' ' ' SER . 4.0 p -69.96 -32.52 51.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.683 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.56 -40.29 96.59 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.101 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 76.0 p -85.11 -16.1 41.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.743 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 181' ' ' VAL . 88.4 p -64.72 -34.09 77.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.492 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.7 150.37 7.3 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.558 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -130.75 149.93 52.16 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.0 m -126.48 151.99 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 110.814 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.575 ' CA ' HD22 ' A' ' 155' ' ' ASN . 43.7 p90 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.622 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.828 0.347 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -134.4 158.88 42.72 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.365 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.465 HH21 ' CD ' ' A' ' 43' ' ' GLU . 72.7 ttt180 -119.29 138.11 53.23 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.653 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -118.89 136.27 54.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.276 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 84.7 p -143.72 157.52 44.33 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.426 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.1 t0 -148.28 108.58 4.11 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.65 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.6 m -60.31 -36.76 78.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.694 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -58.66 -51.01 71.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.184 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -85.64 -20.17 29.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . 68.68 41.44 83.65 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 155.73 45.69 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.199 0.5 . . . . 0.0 110.727 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' CD ' HH21 ' A' ' 34' ' ' ARG . 3.0 pp20? -156.03 147.83 23.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.752 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -152.9 156.1 38.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt -94.4 158.96 15.33 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.397 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -170.57 144.88 2.03 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.689 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.01 158.73 56.12 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.349 2.033 . . . . 0.0 111.952 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -71.92 160.34 32.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.6 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.26 4.53 58.43 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.535 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 25.1 m0 -89.16 145.11 25.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.4 HD13 HG23 ' A' ' 51' ' ' ILE . 18.4 pt -115.11 138.29 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.503 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.73 121.98 7.43 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.53 134.75 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.942 0.401 . . . . 0.0 110.499 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 52.9 p30 -84.07 151.16 25.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.356 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.61 48.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.086 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -68.58 134.03 49.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.63 -0.63 83.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.3 -163.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 110.464 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.2 m -40.14 116.69 1.25 Allowed Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.586 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.04 132.89 8.6 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.703 1.602 . . . . 0.0 112.22 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.99 -40.48 2.41 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.2 135.18 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -118.55 -57.56 2.05 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.54 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -147.63 143.06 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.684 0.278 . . . . 0.0 111.048 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.47 137.93 54.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.928 0.395 . . . . 0.0 110.045 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.93 134.92 54.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.84 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -121.95 143.7 49.31 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.8 0.333 . . . . 0.0 110.758 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.535 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 11.2 m-20 -94.75 118.94 32.55 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.514 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.5 -38.7 90.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.559 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 70' ' ' ILE . 26.5 mm -65.12 -41.77 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.748 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -124.42 95.16 4.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.753 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -64.4 -34.8 79.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.349 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.21 -37.37 74.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.81 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -89.44 128.9 36.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.604 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -141.08 139.05 33.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.297 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.93 132.91 52.35 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 p -120.12 138.84 53.34 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 t -125.45 124.21 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-O 120.883 0.373 . . . . 0.0 110.446 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.7 mt -125.1 117.75 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.802 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.2 mm -114.94 135.87 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.995 0.426 . . . . 0.0 110.643 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.9 m -145.36 166.03 26.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.935 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -107.93 141.47 39.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.652 0.263 . . . . 0.0 110.673 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.2 pt -107.72 149.63 39.19 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.697 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' LYS . 54.9 Cg_endo -69.19 139.96 43.58 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.101 1.867 . . . . 0.0 111.141 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.8 p -65.98 -24.96 66.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.979 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.29 -31.28 70.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.635 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 84' ' ' PRO . 29.5 mtmm -130.33 157.48 42.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.121 0.486 . . . . 0.0 111.263 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -122.48 178.1 5.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.366 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 tp -50.99 -44.65 60.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.16 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.3 p -64.9 -45.53 85.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.037 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -68.02 -36.15 79.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -56.13 -42.77 77.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.776 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.67 174.68 44.24 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.8 p -91.72 168.87 11.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.3 76.09 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.998 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.7 m -71.82 -43.95 64.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.823 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -61.57 -52.69 63.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.486 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.48 -38.51 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.738 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.02 -47.35 89.65 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -65.17 -42.86 93.26 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -62.74 -37.76 87.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -62.92 -41.12 99.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.611 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.9 mmt -59.88 -44.29 94.29 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.299 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.76 -41.71 95.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.213 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.6 m -59.23 -46.25 88.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.704 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.87 -47.12 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.048 0.451 . . . . 0.0 110.498 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 111' ' ' GLN . 92.9 m-20 -61.54 -35.41 77.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.36 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -45.71 -36.74 5.21 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.193 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.04 -45.86 76.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 112' ' ' GLY . 48.1 m -123.39 22.65 9.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.625 ' N ' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -52.43 -10.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.133 -179.015 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -59.97 -61.47 7.14 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.718 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -117.17 -40.53 3.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.794 0.331 . . . . 0.0 111.452 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -86.37 138.9 31.44 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.167 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -132.72 150.68 52.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.154 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.05 139.69 38.27 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.422 ' OE1' ' NE ' ' A' ' 137' ' ' ARG . 79.1 tt0 -113.23 130.9 56.09 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.9 tp -83.79 117.94 23.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.434 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.3 mt -85.48 -59.42 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.313 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.536 ' C ' HD21 ' A' ' 120' ' ' ASN . 0.4 OUTLIER -158.53 172.17 18.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.35 134.68 11.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.34 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.88 161.1 39.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.728 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -139.36 143.49 37.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.427 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -135.65 146.23 47.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.482 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -120.05 112.68 19.45 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.515 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -136.6 139.61 42.24 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 51.2 40.71 26.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.724 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.07 2.3 17.45 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.522 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 2.9 tm0? -101.79 134.67 44.6 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 43.6 t -106.37 129.6 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.944 0.402 . . . . 0.0 110.542 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.522 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 70.0 m-85 -118.95 123.53 44.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.904 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -104.94 118.88 37.64 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 56.7 m -93.66 132.57 37.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.2 107.0 8.31 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.269 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.442 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 74.7 tt0 -103.37 126.02 50.3 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -153.38 171.23 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.315 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.422 ' NE ' ' OE1' ' A' ' 117' ' ' GLU . 40.0 ptt180 -141.5 161.49 37.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.865 0.364 . . . . 0.0 110.262 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.78 139.99 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.006 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 pp -145.0 150.63 37.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.188 0.518 . . . . 0.0 111.087 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.92 134.86 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.558 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.68 -107.04 0.23 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 56.1 t0 -117.46 13.3 14.4 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.323 0.12 . . . . 0.0 111.323 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.84 142.67 47.05 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.738 0.304 . . . . 0.0 111.019 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.69 125.77 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.016 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -78.05 -53.74 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.703 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.534 ' NH1' ' OG ' ' A' ' 165' ' ' SER . 44.8 ptt85 -173.83 171.81 3.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.011 0.434 . . . . 0.0 111.403 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -108.07 141.52 39.65 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.526 ' OD2' ' NH1' ' A' ' 146' ' ' ARG . 74.5 m-20 -135.57 144.02 45.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.006 0.431 . . . . 0.0 111.11 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.5 tp -116.79 134.47 54.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.53 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.43 ' CB ' ' OD1' ' A' ' 163' ' ' ASP . . . -134.1 128.21 33.72 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.008 0.433 . . . . 0.0 110.925 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.7 t -115.2 127.76 55.73 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.12 131.72 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.941 0.401 . . . . 0.0 110.875 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.52 ' OG1' ' NE2' ' A' ' 129' ' ' GLN . 6.8 t -146.67 161.93 39.53 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.687 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -122.22 152.79 39.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.23 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -165.74 123.25 1.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.618 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 58.67 26.09 14.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.004 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.72 9.12 83.52 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -106.69 141.19 38.35 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.898 0.38 . . . . 0.0 110.385 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.43 117.81 31.04 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.401 HG23 HD12 ' A' ' 160' ' ' ILE . 71.0 mt -117.44 121.88 68.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.8 m -122.55 130.1 52.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.27 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.01 110.43 21.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 150' ' ' ALA . 90.2 m-20 -115.48 124.84 52.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.919 0.39 . . . . 0.0 110.951 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 mp -116.56 146.12 42.87 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.681 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.534 ' OG ' ' NH1' ' A' ' 146' ' ' ARG . 45.7 t -132.08 131.31 42.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.583 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.8 m -152.4 155.7 38.07 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.647 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.57 144.68 16.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.254 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -71.5 -34.38 70.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.154 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.91 -33.61 74.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.712 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -103.01 -12.68 17.27 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.564 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.3 t-105 -47.69 -40.37 19.92 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.379 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -64.07 -42.28 97.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 50.5 m -65.52 -40.96 93.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.465 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 m -106.42 21.45 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.12 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 171' ' ' TRP . 24.0 pttm -49.45 -45.63 46.84 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.222 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 84.8 p -67.45 -28.56 67.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.457 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -56.1 -45.14 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.564 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.1 m-85 -62.5 -48.07 81.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.221 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -62.57 -42.55 99.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.547 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 91.7 m -67.49 -49.02 65.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.02 -37.32 72.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.511 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.24 -38.58 91.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.374 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.4 p -84.72 -16.03 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.217 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.4 t -62.78 -37.9 88.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.421 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -59.66 155.49 15.57 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.066 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -137.86 161.18 37.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -128.4 151.06 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.956 0.408 . . . . 0.0 111.257 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.468 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 39.3 p90 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.624 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.479 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 3.2 mp0 -116.89 154.49 30.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.547 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.55 138.53 50.96 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.34 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -126.73 131.07 51.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.944 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -141.12 152.36 44.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 110.769 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -143.58 118.69 10.1 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.388 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.4 p -71.31 -32.69 68.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.529 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.48 -47.58 83.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.025 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -88.36 -20.33 25.47 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.1 42.06 85.36 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -143.07 149.29 37.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.338 0.569 . . . . 0.0 110.356 179.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -151.66 144.19 24.21 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.77 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.71 158.09 41.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.52 150.01 22.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.093 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -158.17 145.99 13.74 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.359 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.19 156.4 66.43 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.309 2.006 . . . . 0.0 112.187 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.433 ' N ' HE22 ' A' ' 33' ' ' GLN . 39.2 p30 -71.78 160.36 32.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.57 2.13 58.8 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.53 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 33.9 m0 -91.81 144.5 25.43 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 110.436 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.6 pt -120.65 144.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.359 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.32 141.56 15.68 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -129.88 143.63 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -90.61 144.55 25.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.61 51.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.491 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -66.98 136.08 54.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.094 0.473 . . . . 0.0 110.337 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.36 1.62 71.66 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.86 -164.19 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.64 0.257 . . . . 0.0 110.53 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.1 m -41.54 124.29 2.33 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.337 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.03 132.32 6.0 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.785 1.657 . . . . 0.0 112.694 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.98 -33.69 5.76 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.9 t -62.42 122.84 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.114 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -120.22 -50.06 2.26 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.467 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.95 139.5 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.879 0.371 . . . . 0.0 110.91 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.82 138.35 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.49 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.66 135.01 52.83 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.859 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -121.64 134.77 54.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.26 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.53 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 66.1 m-20 -86.18 118.75 25.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.483 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -67.47 -39.36 85.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.593 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 70' ' ' ILE . 4.1 mp -61.11 -48.14 90.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.76 118.01 28.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.908 0.385 . . . . 0.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.42 -36.59 65.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.777 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 2.7 p30 -62.47 -34.62 77.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.864 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.516 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 84.3 tt0 -86.13 133.33 33.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.0 110.254 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.683 ' ND2' ' HG ' ' A' ' 165' ' ' SER . 1.7 p30 -154.25 139.66 17.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -114.54 134.62 54.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.932 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.7 m -120.13 145.1 47.25 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.17 127.63 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.002 0.429 . . . . 0.0 110.315 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.82 122.57 69.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.699 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.403 HD12 HG23 ' A' ' 80' ' ' ILE . 82.1 mt -122.08 127.88 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.996 0.427 . . . . 0.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 159' ' ' LEU . 21.9 t -153.29 164.29 38.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.045 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -103.47 136.42 43.25 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.0 pt -92.89 148.42 35.85 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.347 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' LYS . 37.1 Cg_endo -65.28 136.17 46.24 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.64 1.56 . . . . 0.0 110.821 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.8 t -60.99 -29.12 69.5 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.038 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -67.57 -31.52 71.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.999 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 84' ' ' PRO . 68.0 mttm -130.61 144.84 51.7 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.046 0.451 . . . . 0.0 111.138 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.416 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.1 t -113.24 179.18 4.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.173 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 tp -52.75 -43.83 66.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.859 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 47.1 p -69.04 -45.03 71.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.447 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 88' ' ' THR . 82.4 m-20 -68.77 -34.92 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.106 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.6 tp -55.39 -44.35 76.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.394 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.17 178.06 46.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.9 p -92.85 169.8 10.18 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.46 72.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.966 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.4 m -72.36 -44.64 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.851 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -62.54 -50.97 69.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.425 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG2' HH21 ' A' ' 101' ' ' ARG . 79.4 t -62.65 -38.56 81.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.604 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.27 -47.05 92.74 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.37 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -62.8 -45.36 92.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.82 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . 0.418 HH21 ' CG2' ' A' ' 98' ' ' VAL . 85.4 mtm180 -62.96 -43.86 97.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.041 0.448 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -57.0 -41.14 77.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.804 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.4 mmt -61.12 -43.46 98.85 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.143 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.93 -38.83 92.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.423 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.1 m -56.88 -45.71 82.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.599 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.28 -46.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.13 0.491 . . . . 0.0 110.449 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.657 ' O ' ' N ' ' A' ' 111' ' ' GLN . 1.4 m120 -62.43 -32.98 73.92 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.272 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -43.81 -37.64 2.87 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.675 0.274 . . . . 0.0 111.537 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.26 -47.27 71.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.6 m -123.53 24.17 8.66 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 107' ' ' ASN . 16.9 tt0 -46.55 -28.77 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.597 0.237 . . . . 0.0 111.536 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.71 -61.18 3.04 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.02 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 31.7 p-10 -117.02 -36.3 3.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.069 0.435 . . . . 0.0 111.711 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.566 HH11 ' CG1' ' A' ' 138' ' ' VAL . 59.7 ttm-85 -84.18 142.05 30.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 0.0 111.051 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -148.82 149.09 30.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.886 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.537 ' CB ' HD22 ' A' ' 107' ' ' ASN . . . -108.47 138.99 43.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.168 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -107.94 129.85 55.08 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.1 tt -81.54 108.09 14.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.953 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.4 mt -70.68 -56.32 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.112 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.539 ' C ' HD21 ' A' ' 120' ' ' ASN . 0.3 OUTLIER -156.29 169.9 23.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.901 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.7 119.85 4.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.336 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.34 163.18 33.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.73 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.402 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -139.12 149.45 44.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.473 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -131.72 144.49 51.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.1 0.476 . . . . 0.0 110.821 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -111.42 114.3 27.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.572 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -140.3 141.88 35.71 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.702 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 127' ' ' ASP . 22.6 t70 49.67 37.2 12.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.03 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.59 1.49 23.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 3.7 tm0? -103.18 133.48 48.21 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 46.6 t -105.59 130.43 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.855 0.359 . . . . 0.0 110.721 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 48.4 m-85 -119.04 129.59 55.19 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.823 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.4 127.47 53.0 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 55.6 m -105.03 129.66 53.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.69 107.12 9.42 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.12 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.467 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 79.4 tt0 -101.79 127.22 48.68 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -150.87 170.37 19.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.411 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.524 ' NH1' ' HE2' ' A' ' 147' ' ' HIS . 18.9 ptp180 -136.81 156.75 48.08 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.052 0.453 . . . . 0.0 110.37 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.566 ' CG1' HH11 ' A' ' 114' ' ' ARG . 58.3 t -104.7 135.17 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.443 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -145.2 135.02 23.59 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.189 0.518 . . . . 0.0 111.251 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.3 t -111.6 132.52 59.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.869 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.54 -122.05 25.56 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -110.73 11.83 22.58 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.854 -0.204 . . . . 0.0 111.139 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -120.02 149.97 41.31 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.829 0.347 . . . . 0.0 111.225 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.0 t -88.35 126.03 41.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.415 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -75.08 -53.85 8.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.416 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -173.94 173.6 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 111.26 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . 0.524 ' HE2' ' NH1' ' A' ' 137' ' ' ARG . 53.4 m80 -105.21 143.58 33.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.133 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 164' ' ' LEU . 12.0 t70 -141.21 151.16 43.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.841 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.8 tp -124.1 135.0 53.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.034 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.51 132.51 39.28 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.895 0.378 . . . . 0.0 110.431 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 69.3 m -119.93 137.39 54.07 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.59 130.29 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.985 0.421 . . . . 0.0 110.683 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.5 m -146.97 144.85 29.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.322 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -110.9 150.36 29.3 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.192 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -151.14 106.7 3.37 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.264 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 61.83 34.84 16.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.066 0.46 . . . . 0.0 110.526 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.06 8.29 86.74 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -98.42 127.17 44.23 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.81 113.13 24.65 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.405 HD11 HG21 ' A' ' 160' ' ' ILE . 67.9 mt -122.25 124.29 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.328 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.0 m -124.62 134.27 52.98 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.14 111.04 23.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.65 119.97 40.48 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 111.428 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.426 ' O ' ' OD2' ' A' ' 148' ' ' ASP . 2.9 mp -115.47 142.64 46.44 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.136 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' SER . . . . . 0.683 ' HG ' ' ND2' ' A' ' 75' ' ' ASN . 69.0 p -132.96 135.05 45.28 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.871 0.367 . . . . 0.0 110.547 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.0 m -152.88 157.02 40.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.248 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.29 143.69 55.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.04 0.448 . . . . 0.0 111.4 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.427 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 1.3 pp20? -69.82 -27.11 64.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.222 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.427 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 90.3 m-20 -59.36 -34.15 72.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.256 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -117.66 -1.59 11.59 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.554 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 44.5 t-105 -48.64 -39.34 23.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.554 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -63.26 -42.11 99.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.958 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 39.8 m -64.49 -40.47 95.73 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.11 20.87 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.902 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -49.33 -45.61 45.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.89 0.376 . . . . 0.0 110.952 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 85.1 p -68.07 -27.69 66.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.598 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.9 tp -56.84 -44.34 81.99 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.583 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.554 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.2 m-85 -63.59 -49.82 71.88 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.239 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -62.0 -42.28 98.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.579 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 65.0 m -67.6 -49.77 61.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.038 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.82 -37.92 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.38 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.46 -39.04 93.41 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.234 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.5 m -80.71 -19.54 44.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.273 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -62.53 -36.22 81.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.718 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -55.93 148.76 16.48 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.11 -179.555 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -136.85 155.53 49.67 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.22 150.61 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.183 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' TYR . . . . . 0.489 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 40.9 p90 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.548 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.543 ' H2 ' ' CD2' ' A' ' 21' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.54 31.75 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.919 2.413 . . . . 0.0 112.478 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.543 ' CD2' ' H2 ' ' A' ' 19' ' ' GLY . 2.9 mm? -61.02 -35.89 78.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.062 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.55 -173.64 51.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.9 t -149.55 149.12 30.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.808 0.337 . . . . 0.0 110.442 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.8 m -87.1 115.85 24.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.266 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.516 ' C ' ' H ' ' A' ' 27' ' ' VAL . . . -176.94 -172.65 41.76 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.28 39.34 0.45 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.516 ' H ' ' C ' ' A' ' 25' ' ' GLY . 8.5 p -54.66 -34.65 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 0.0 110.76 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.42 125.42 17.57 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 31' ' ' SER . 27.2 pt -126.39 161.97 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 110.554 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.95 75.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.48 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 29' ' ' ILE . 10.2 t -164.0 -133.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.359 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.1 mt -85.3 142.71 29.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.214 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.531 HE22 ' N ' ' A' ' 48' ' ' ASN . 4.2 mp0 -115.41 155.06 28.11 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.014 0.435 . . . . 0.0 110.741 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -113.73 131.26 56.25 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.369 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -124.66 131.29 53.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.944 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -138.57 153.4 48.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.665 0.269 . . . . 0.0 110.757 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -144.2 109.61 5.16 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.787 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.0 m -61.74 -36.14 80.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.507 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -58.73 -51.41 70.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.938 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 38.4 t0 -85.86 -20.64 28.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.735 0.302 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.92 40.9 84.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.72 150.7 42.16 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.218 0.509 . . . . 0.0 110.17 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -151.12 143.07 23.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.598 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -151.74 160.06 43.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.176 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 mt -98.33 150.37 21.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.103 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -153.63 145.92 17.2 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.297 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.2 152.95 78.78 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.373 2.049 . . . . 0.0 112.151 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.531 ' N ' HE22 ' A' ' 33' ' ' GLN . 54.1 p30 -73.15 160.26 32.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.576 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.84 58.22 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.475 ' NE1' ' CG ' ' A' ' 68' ' ' ASP . 30.1 m0 -92.95 145.57 24.27 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.4 pt -118.73 145.03 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.35 128.79 9.68 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.7 135.46 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.756 0.312 . . . . 0.0 110.297 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -76.57 129.29 36.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.431 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.14 36.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.766 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -59.37 135.94 57.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.43 . . . . 0.0 110.693 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.06 10.02 72.57 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.45 -164.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.683 0.278 . . . . 0.0 110.548 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.16 140.86 42.21 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.084 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -44.98 132.11 10.85 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.59 1.526 . . . . 0.0 112.463 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.97 -31.04 7.28 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.4 t -61.04 128.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -119.07 -57.33 2.03 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.209 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.4 t -143.95 148.51 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.867 0.365 . . . . 0.0 110.92 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.47 140.01 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.45 134.11 53.26 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.107 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -127.15 130.74 50.35 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.463 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' CG ' ' NE1' ' A' ' 50' ' ' TRP . 60.3 t0 -87.86 117.96 27.06 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.662 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.9 tp -65.22 -38.99 92.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.555 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.402 HG21 HD12 ' A' ' 70' ' ' ILE . 81.4 mt -60.86 -39.54 82.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.044 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.54 96.19 4.6 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.809 0.338 . . . . 0.0 110.593 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -61.33 -37.0 81.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.374 0.607 . . . . 0.0 109.856 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.27 -36.83 73.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.971 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -82.66 130.65 35.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.436 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -140.32 139.09 35.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.363 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.62 136.23 53.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.686 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.0 t -126.16 140.37 52.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.739 0.304 . . . . 0.0 110.608 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.94 125.52 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.914 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.9 mt -121.13 123.87 70.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.93 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.35 133.42 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.873 0.368 . . . . 0.0 110.682 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 159' ' ' LEU . 22.7 t -151.11 162.56 40.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.313 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.506 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 2.0 pm0 -105.06 130.23 53.31 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.111 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.4 pt -86.4 149.22 48.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.406 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 87' ' ' LYS . 36.2 Cg_endo -65.06 136.66 49.1 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.588 1.525 . . . . 0.0 110.753 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -60.96 -29.01 69.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.182 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -67.9 -31.44 71.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.898 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' PRO . 92.1 mttt -131.2 140.36 49.88 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.918 0.39 . . . . 0.0 111.169 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -105.96 -178.42 3.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.079 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.509 ' N ' ' OG1' ' A' ' 88' ' ' THR . 49.2 tp -52.18 -43.04 63.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.769 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.9 p -68.03 -43.76 78.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.093 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.52 -35.16 78.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.4 tt -55.17 -49.05 72.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.129 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.74 176.67 45.95 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 36.2 p -90.38 171.26 9.58 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.12 -42.32 76.67 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.165 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.7 m -72.06 -43.91 64.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.809 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -61.94 -51.38 68.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.151 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.2 t -61.7 -38.53 80.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.568 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.63 -44.54 93.93 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -68.14 -39.77 82.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.821 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -61.61 -41.34 97.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -61.43 -41.16 96.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.63 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.9 mmt -58.62 -43.76 89.75 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.838 0.352 . . . . 0.0 110.365 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -64.57 -40.08 94.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.356 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -60.05 -47.33 86.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.892 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.3 t -71.7 -45.74 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.011 0.434 . . . . 0.0 110.497 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 111' ' ' GLN . 88.9 m-20 -60.43 -32.56 71.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.069 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -44.19 -37.65 3.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.215 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -105.72 -10.8 16.57 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 114' ' ' ARG . 1.3 t -121.39 16.1 11.33 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.5 pt20 -79.83 6.98 9.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.086 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.35 -62.85 2.23 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.052 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -117.06 -41.23 3.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.634 0.254 . . . . 0.0 111.501 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' SER . 95.6 mtt180 -86.28 154.7 21.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.876 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -133.11 135.53 45.3 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.209 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.17 129.57 44.52 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.06 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -116.95 128.78 55.54 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.021 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.0 tp -83.66 110.85 18.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.024 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -55.25 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.104 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.544 ' C ' HD21 ' A' ' 120' ' ' ASN . 0.3 OUTLIER -161.4 168.57 23.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.921 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.68 122.44 4.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.232 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.96 162.9 34.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.583 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.414 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.48 148.28 50.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.571 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -130.67 150.14 52.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.775 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -120.45 116.36 25.3 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.847 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.45 142.27 39.47 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.456 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.3 t0 52.05 28.42 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.16 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.68 2.61 85.84 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 154' ' ' THR . 66.4 tp60 -104.02 135.99 44.5 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.02 129.89 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.964 0.411 . . . . 0.0 110.532 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.84 129.84 55.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.821 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.414 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.75 130.21 53.8 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.3 m -112.89 125.18 54.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.195 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.24 124.88 48.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.013 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.451 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 72.2 tt0 -119.72 124.2 45.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.86 169.75 20.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.38 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -138.88 160.31 40.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.394 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 63.4 t -104.42 126.35 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.008 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.1 mt -106.14 139.71 40.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.336 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.88 135.86 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.45 -112.63 1.41 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -118.23 22.88 11.92 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -142.63 157.1 45.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.219 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.3 123.86 32.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.102 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.445 ' CD ' ' NH1' ' A' ' 146' ' ' ARG . 85.3 tt0 -75.16 -53.28 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.111 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.445 ' NH1' ' CD ' ' A' ' 145' ' ' GLU . 33.6 ptt-85 -172.41 167.66 5.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -107.98 135.61 49.07 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.968 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -131.05 140.94 50.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.543 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.4 tp -111.2 132.23 54.49 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -129.2 132.48 47.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.387 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.4 m -121.79 139.78 53.18 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.36 131.51 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.972 0.415 . . . . 0.0 111.073 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.6 m -148.72 142.21 25.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.256 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.458 ' O ' ' NE2' ' A' ' 129' ' ' GLN . 13.0 p -106.41 149.56 26.9 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.343 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -150.39 106.68 3.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.077 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.413 ' NH2' ' OXT' ' A' ' 188' ' ' TYR . 17.0 ttm180 63.15 27.6 15.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.179 0.514 . . . . 0.0 110.579 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.13 3.08 73.38 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.804 -0.519 . . . . 0.0 111.804 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.49 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 11.5 mptt -94.95 126.11 40.06 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.417 -0.461 . . . . 0.0 109.81 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -88.54 118.62 28.31 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 160' ' ' ILE . 78.2 mt -120.02 127.98 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.823 0.344 . . . . 0.0 110.663 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 89.0 m -129.12 136.86 50.78 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.725 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.68 103.28 11.07 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -102.27 108.68 20.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.81 0.338 . . . . 0.0 110.414 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.3 mp -114.05 140.04 48.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.3 p -133.63 139.65 46.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.855 0.36 . . . . 0.0 110.306 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.9 m -152.99 157.2 40.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.5 145.93 37.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.555 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.415 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 2.0 pp20? -70.87 -21.06 62.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.971 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.415 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 93.6 m-20 -58.84 -34.58 71.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.22 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -123.03 -1.34 8.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.576 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 59.9 t-105 -46.69 -40.25 12.91 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.812 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -64.56 -42.29 95.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.993 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.2 m -66.12 -39.67 90.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.728 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.9 m -106.53 21.64 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.246 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 176' ' ' SER . 12.2 ptmm? -51.22 -50.93 58.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.194 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.409 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 24.9 t -64.94 -30.69 71.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.889 0.376 . . . . 0.0 111.088 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.55 -45.79 66.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.849 -178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 23.1 m-85 -62.0 -49.83 74.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.049 0.452 . . . . 0.0 110.467 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -63.24 -37.8 88.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.471 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.455 ' O ' ' OG ' ' A' ' 184' ' ' SER . 56.2 m -61.37 -47.4 86.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.296 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.49 -44.17 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.519 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -65.74 -42.93 90.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.556 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 85.2 p -74.79 -30.9 61.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 180' ' ' THR . 58.0 m -63.14 -29.67 70.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -52.74 156.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.137 0.494 . . . . 0.0 110.813 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -138.67 155.18 48.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.199 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.0 m -127.91 151.68 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.922 0.392 . . . . 0.0 111.244 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.413 ' OXT' ' NH2' ' A' ' 156' ' ' ARG . 41.2 p90 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.661 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.499 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 30.9 Cg_endo -62.69 145.86 95.12 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.73 2.287 . . . . 0.0 111.781 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.5 mt -89.9 142.77 27.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.231 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -83.73 176.29 52.22 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.7 t 179.59 5.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.733 0.301 . . . . 0.0 110.555 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.8 p -80.88 108.39 14.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.02 -42.23 2.83 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.47 21.5 64.29 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 m -60.75 146.06 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.78 0.324 . . . . 0.0 110.646 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.67 -175.54 38.15 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.6 pt -82.95 -177.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.232 0.539 . . . . 0.0 111.314 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.66 -117.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.685 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.415 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 31.9 t -127.53 113.74 16.53 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.759 0.314 . . . . 0.0 110.164 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.545 ' C ' HD22 ' A' ' 48' ' ' ASN . 42.1 mt -115.36 142.76 46.26 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.889 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.519 ' NE2' ' OD1' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -102.61 170.85 7.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.099 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -139.68 146.03 39.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.656 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.68 141.78 45.03 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.137 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.0 p -149.75 155.38 40.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 110.592 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -148.08 119.14 7.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.624 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.6 p -71.55 -29.75 65.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.172 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -61.54 -48.93 78.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.983 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 50.5 t0 -92.12 -20.39 21.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.738 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.75 44.87 60.97 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.853 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.455 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -142.65 149.05 38.39 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.232 0.516 . . . . 0.0 110.336 179.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.73 143.48 22.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -152.47 158.85 43.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 111.059 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.6 mt -96.79 151.72 19.37 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.892 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' N ' ' CD1' ' A' ' 46' ' ' TYR . 10.3 p90 -157.95 136.56 7.81 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.846 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -43.29 157.3 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.045 1.83 . . . . 0.0 112.559 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.672 ' N ' HD21 ' A' ' 48' ' ' ASN . 0.7 OUTLIER -81.18 158.93 24.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.299 179.514 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.08 63.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 26.8 m0 -87.6 147.27 25.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.839 0.352 . . . . 0.0 110.175 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.7 132.31 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.043 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.89 133.2 11.61 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.33 134.24 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.964 0.412 . . . . 0.0 110.753 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 37.0 p30 -91.36 121.29 32.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.518 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.25 60.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.464 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -78.73 132.91 37.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.163 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.0 3.62 73.11 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.39 -163.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 t -40.53 125.95 1.83 Allowed Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.449 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -41.5 127.16 3.2 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.97 1.78 . . . . 0.0 113.025 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 63' ' ' ASP . . . 100.68 -36.18 4.34 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.533 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -63.63 127.02 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.174 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 61' ' ' GLY . 5.4 m-20 -119.57 -56.63 2.04 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.574 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.52 139.61 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.901 0.381 . . . . 0.0 111.098 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.3 t -123.08 132.63 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.127 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -112.28 134.27 53.92 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.41 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -124.76 143.36 50.83 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 73.8 m-20 -90.42 119.08 30.4 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.548 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.2 tp -65.4 -41.21 93.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.574 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.99 -45.03 99.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.048 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.67 120.67 37.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.863 0.363 . . . . 0.0 110.73 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -77.84 -40.38 40.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.56 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -58.7 -36.5 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.643 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.91 133.39 35.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -156.11 139.31 15.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.561 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.68 134.4 55.07 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.804 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.6 t -121.86 139.26 53.85 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.026 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.96 125.61 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.07 0.462 . . . . 0.0 110.279 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 mt -117.35 123.52 71.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.627 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.7 mt -120.21 128.42 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.396 . . . . 0.0 110.952 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 159' ' ' LEU . 61.3 m -149.03 166.0 29.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.3 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -105.64 138.41 41.88 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.2 pt -93.09 149.4 37.46 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.653 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -44.51 140.19 6.37 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.651 1.568 . . . . 0.0 111.383 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -67.94 -25.38 65.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.403 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.4 p30 -93.03 -15.28 26.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -131.43 150.44 52.15 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.096 0.474 . . . . 0.0 111.486 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.4 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 46.8 p -112.86 -179.23 3.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.222 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.9 tp -56.36 -41.56 76.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.448 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.5 p -72.16 -45.07 61.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.968 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HB3' ' H ' ' A' ' 88' ' ' THR . 45.7 t0 -64.7 -37.28 87.04 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.787 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.0 tp -55.8 -43.32 76.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.745 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.5 179.19 47.62 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.309 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.406 ' HG1' ' H ' ' A' ' 97' ' ' ASP . 36.2 p -93.4 170.69 9.42 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.24 74.37 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.044 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 78.0 m -72.45 -45.67 58.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.406 ' H ' ' HG1' ' A' ' 94' ' ' THR . 45.6 t0 -61.25 -52.16 65.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.311 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.4 -38.62 82.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.713 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.71 -45.07 93.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -65.2 -41.45 94.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.541 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -63.11 -39.03 93.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.059 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.66 -41.49 98.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.699 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.8 mmt -58.38 -44.4 88.89 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.383 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -66.07 -42.48 89.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.359 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.5 m -59.24 -45.79 90.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.9 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.2 -47.48 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 0.0 110.478 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.646 ' O ' ' N ' ' A' ' 111' ' ' GLN . 93.4 m-20 -62.67 -34.65 77.53 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.451 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -46.61 -36.92 7.43 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.068 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.23 -47.11 71.78 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.432 ' C ' ' H ' ' A' ' 112' ' ' GLY . 74.8 m -123.26 22.25 9.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.646 ' N ' ' O ' ' A' ' 107' ' ' ASN . 10.3 pt20 -49.41 -13.38 0.08 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.403 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -58.08 -61.42 7.44 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.86 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 35.1 p-10 -117.46 -35.66 3.93 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.902 0.351 . . . . 0.0 111.685 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 58.2 ttp180 -85.13 135.77 33.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.914 0.388 . . . . 0.0 111.28 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -127.97 144.37 51.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.191 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -107.09 138.07 43.96 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -119.81 129.06 54.26 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.98 110.08 16.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.204 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.538 ' C ' HD21 ' A' ' 120' ' ' ASN . 96.7 mt -77.02 -55.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.557 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.538 HD21 ' C ' ' A' ' 119' ' ' ILE . 1.7 m-80 -145.75 159.35 43.31 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.37 112.81 2.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.463 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.1 168.98 18.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.657 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.63 147.18 42.6 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.763 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -130.35 143.86 51.03 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.921 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 35.5 p30 -110.56 111.1 22.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.725 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -137.45 143.0 41.59 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.879 0.371 . . . . 0.0 110.839 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 51.38 37.97 20.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.317 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.24 2.61 41.78 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -107.67 149.47 28.07 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.964 0.411 . . . . 0.0 110.234 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.5 t -117.12 129.2 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.103 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 14.1 m-85 -119.31 128.15 53.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.067 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -100.62 120.04 39.46 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 63.2 m -95.17 127.46 41.24 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.94 110.76 11.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.53 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -107.28 126.58 52.61 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -150.79 170.45 19.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.349 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -136.97 156.8 47.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.041 0.448 . . . . 0.0 110.523 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.7 134.39 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.91 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.8 pp -135.77 136.26 40.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.161 0.505 . . . . 0.0 111.13 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.45 134.13 55.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.12 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.6 -121.06 19.05 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -113.91 14.17 18.47 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.926 -0.161 . . . . 0.0 111.275 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -127.15 153.6 45.84 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.901 0.382 . . . . 0.0 111.164 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.67 126.93 40.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.237 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -75.01 -52.75 10.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.773 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -175.21 173.97 2.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.028 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -109.84 136.78 48.61 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.16 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -132.88 141.57 48.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.892 0.377 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.9 tp -111.48 131.18 55.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.99 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.97 131.08 47.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.955 0.407 . . . . 0.0 110.486 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.0 m -120.69 138.15 54.1 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.6 t -119.85 129.16 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.033 0.444 . . . . 0.0 110.683 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.7 m -144.72 148.28 33.99 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.624 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -114.74 149.25 37.16 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.832 0.349 . . . . 0.0 110.303 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -149.82 107.04 3.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.032 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 65.07 26.26 12.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.12 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.4 1.44 71.78 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 2.4 mptp? -94.28 126.66 39.67 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -87.94 115.62 25.54 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 65.7 mt -121.45 123.52 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.005 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 72.7 m -122.45 132.11 54.19 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.52 113.12 26.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.817 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -115.04 124.85 52.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.905 0.383 . . . . 0.0 111.652 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.01 142.18 50.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.458 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 67.1 m -132.91 134.3 44.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.406 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.425 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 22.9 m -153.18 159.2 42.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.87 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.425 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -56.36 141.56 41.44 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.365 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.81 -39.09 90.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.963 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.48 -33.07 74.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.194 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -96.38 -17.56 20.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.35 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.59 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 47.9 t-105 -48.75 -41.73 33.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.713 0.292 . . . . 0.0 110.947 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.83 -41.69 97.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.136 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.7 m -65.56 -40.6 92.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.432 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.6 m -107.35 21.22 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.25 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 171' ' ' TRP . 19.0 ptmt -48.14 -47.4 34.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 111.111 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 27.0 t -64.83 -31.54 72.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.669 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.61 -45.64 73.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.044 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.59 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.2 m-85 -61.33 -50.11 74.26 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.263 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -63.28 -42.37 99.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.871 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.1 m -67.16 -49.01 66.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.777 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.9 t -70.01 -37.64 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.405 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.68 -37.03 84.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.317 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.0 t -84.62 -18.61 34.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.133 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 t -62.79 -35.87 81.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.629 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.433 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -55.89 147.23 19.85 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.931 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -134.44 157.72 45.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.37 151.19 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.767 0.317 . . . . 0.0 111.049 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.414 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 33.8 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.69 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.78 -21.17 72.8 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.686 2.257 . . . . 0.0 111.77 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.9 mt -88.05 144.3 26.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.306 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.94 23.76 0.02 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.1 t -114.77 137.5 51.86 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.808 0.337 . . . . 0.0 110.487 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 93.0 m -65.15 -28.4 69.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.754 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.38 -105.0 2.32 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.62 -174.42 48.12 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.9 p -130.28 143.41 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.88 77.02 0.05 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.6 pt -126.38 167.85 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.187 0.518 . . . . 0.0 111.239 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.6 170.9 8.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.242 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.5 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 60.9 p -61.64 164.48 5.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.109 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.1 156.7 44.78 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.045 0.45 . . . . 0.0 111.224 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.67 ' NE2' ' H ' ' A' ' 33' ' ' GLN . 1.3 pm0 -135.91 158.94 43.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.915 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -116.73 135.52 53.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.633 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -108.99 141.17 41.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.078 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.9 p -144.57 157.28 44.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.762 0.315 . . . . 0.0 110.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -146.96 112.32 5.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.766 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.7 m -62.0 -37.32 84.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.603 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -59.39 -52.33 66.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.227 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -84.49 -20.53 31.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.767 0.318 . . . . 0.0 110.77 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.65 43.17 86.17 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -142.37 151.88 42.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.235 0.517 . . . . 0.0 110.393 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -153.96 144.47 22.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.806 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -148.86 160.4 43.28 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.044 0.449 . . . . 0.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 tp -103.8 133.07 49.4 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.619 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -141.99 140.78 20.19 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.066 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -45.68 150.32 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.901 1.734 . . . . 0.0 112.217 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.63 ' N ' HE22 ' A' ' 33' ' ' GLN . 37.2 p-10 -81.02 160.03 24.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.301 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.43 3.19 65.05 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 32.9 m0 -81.3 147.12 30.05 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.8 pt -111.43 134.25 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.327 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.85 138.59 14.0 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.45 134.05 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.771 0.32 . . . . 0.0 110.22 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 48.7 p30 -84.45 145.57 28.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.72 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.1 m -151.66 51.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.353 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.45 133.5 46.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.048 0.451 . . . . 0.0 110.423 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.37 3.92 84.01 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.65 -164.24 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.8 m -40.49 117.88 1.43 Allowed Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.685 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.18 135.23 11.33 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.506 1.47 . . . . 0.0 111.895 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.84 -32.01 7.75 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.12 130.07 29.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -111.05 -57.79 2.19 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.708 0.289 . . . . 0.0 110.94 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -147.02 140.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.712 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.72 133.48 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.143 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.71 134.05 54.42 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.522 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -129.44 134.73 47.97 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.111 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 77.8 m-20 -86.61 119.1 26.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.836 0.35 . . . . 0.0 110.652 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.8 tt -65.11 -40.04 93.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.505 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 88.6 mt -61.37 -42.93 95.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.008 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -119.11 120.16 36.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.891 0.377 . . . . 0.0 110.659 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -82.82 -36.24 25.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.578 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 40.6 p-10 -62.37 -31.94 72.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.981 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 84.2 tt0 -87.13 130.47 34.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.62 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -139.57 139.5 36.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.297 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.39 134.76 52.03 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -129.53 138.91 51.61 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.13 128.3 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.405 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.8 mt -123.68 123.97 68.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.326 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.3 mt -123.23 130.83 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.392 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.504 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.4 m -145.74 165.86 27.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.297 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -105.46 135.81 46.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.1 pt -92.52 148.83 37.08 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.32 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' LYS . 37.3 Cg_endo -65.86 137.13 48.0 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.695 1.597 . . . . 0.0 110.69 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 t -60.88 -29.42 69.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.171 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -67.59 -31.34 71.32 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 84' ' ' PRO . 95.4 mttt -131.04 143.19 50.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.938 0.399 . . . . 0.0 111.007 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -111.87 179.82 3.9 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.086 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.484 ' N ' ' OG1' ' A' ' 88' ' ' THR . 45.8 tp -52.16 -45.16 64.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.079 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.3 p -68.51 -41.38 80.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.925 0.393 . . . . 0.0 110.882 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -66.41 -36.45 82.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.943 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.8 tt -55.62 -47.54 76.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.241 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.09 178.52 47.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.5 p -90.71 172.96 8.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.15 76.43 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.113 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.1 m -72.14 -45.3 61.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.55 -51.12 69.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.246 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.55 -38.63 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.404 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.08 -45.55 93.75 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -69.52 -40.26 77.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.813 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -61.5 -41.18 96.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.043 0.449 . . . . 0.0 110.76 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -60.74 -40.66 93.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.633 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.7 mmt -59.26 -44.16 92.43 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.507 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -64.59 -39.63 94.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.154 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.8 m -59.26 -46.84 87.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.922 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.15 -46.04 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.048 0.451 . . . . 0.0 110.383 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 111' ' ' GLN . 86.3 m-20 -61.99 -31.29 71.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -44.12 -37.56 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -110.34 -7.71 14.78 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.808 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.693 ' HG ' HH21 ' A' ' 114' ' ' ARG . 27.9 m -121.05 19.36 11.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.367 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.5 pt20 -84.39 6.26 23.9 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.15 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.98 -63.22 2.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.831 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -117.3 -46.14 2.71 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.903 0.382 . . . . 0.0 110.934 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.693 HH21 ' HG ' ' A' ' 110' ' ' SER . 93.2 mtm-85 -74.61 148.73 40.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.228 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -131.83 130.58 41.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.601 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.92 128.63 44.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 110.389 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -115.36 128.7 56.25 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.6 tp -82.71 111.6 18.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.929 0.395 . . . . 0.0 110.406 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.542 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.2 mt -77.74 -57.68 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.362 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.8 m-80 -146.35 161.3 40.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.647 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.41 112.93 2.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.388 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.37 167.37 22.27 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.896 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.418 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -136.93 149.7 47.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.754 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -132.52 143.04 49.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.778 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -111.82 115.03 28.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.428 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.12 144.76 36.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.983 0.42 . . . . 0.0 110.94 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.5 t0 54.74 22.1 3.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.41 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.54 -1.78 88.19 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -103.49 149.02 25.25 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.942 0.401 . . . . 0.0 110.077 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.67 128.42 67.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.995 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -117.49 127.73 54.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.873 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.31 124.78 49.78 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.7 m -105.78 122.76 46.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.299 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.3 mp -117.83 122.93 44.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.99 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -117.88 124.42 48.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.431 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -151.98 172.89 15.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.401 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -140.78 160.53 39.84 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.079 0.466 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.61 132.58 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.437 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pp -135.81 136.35 40.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 111.346 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.57 130.46 55.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.119 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.63 -116.95 10.08 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.518 ' C ' HD21 ' A' ' 143' ' ' ASN . 56.7 t0 -114.73 12.44 17.08 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.468 0.175 . . . . 0.0 111.025 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.518 HD21 ' C ' ' A' ' 142' ' ' ASP . 3.6 m120 -119.75 146.6 45.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.726 0.298 . . . . 0.0 110.951 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.4 p -85.57 125.19 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.434 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -75.21 -52.66 10.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.717 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -173.23 172.49 3.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -104.84 141.18 36.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.028 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -134.49 136.74 43.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.991 0.424 . . . . 0.0 111.206 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.1 tp -111.55 135.63 51.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.724 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.53 134.97 42.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.252 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.0 m -121.49 141.36 51.11 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.097 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.7 128.88 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.853 0.359 . . . . 0.0 110.871 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.8 m -146.31 148.86 32.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.415 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -112.54 151.1 30.4 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.833 0.349 . . . . 0.0 110.357 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -150.37 103.95 3.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 62.52 31.38 17.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.977 0.417 . . . . 0.0 110.68 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 89.01 2.27 78.22 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.306 -0.473 . . . . 0.0 111.925 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 1.7 mptp? -95.1 125.17 39.57 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.7 OUTLIER -88.62 118.22 28.13 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.411 HD12 HG23 ' A' ' 160' ' ' ILE . 77.4 mt -120.49 128.16 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.759 0.314 . . . . 0.0 110.499 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.5 m -130.52 136.51 49.02 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.723 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.86 110.47 20.82 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.976 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -105.47 111.88 24.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.559 0.219 . . . . 0.0 110.509 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.5 mp -119.09 135.59 54.57 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.744 0.307 . . . . 0.0 110.483 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -129.82 138.2 50.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.368 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.6 m -153.05 156.52 38.92 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.48 145.07 34.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.453 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.39 -29.07 65.61 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.325 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.33 -34.05 71.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.256 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -113.79 -4.2 13.39 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.532 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 57.5 t-105 -49.54 -38.5 31.16 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.091 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.32 -43.11 99.59 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.183 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 77.9 m -65.58 -39.76 91.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.8 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.45 21.11 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.521 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 176' ' ' SER . 17.4 pttp -51.75 -50.5 60.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.459 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 27.2 t -65.17 -29.67 70.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.734 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.6 tp -55.75 -43.6 76.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.233 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.532 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 28.5 m-85 -61.53 -49.58 76.14 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.385 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.64 -39.66 91.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.459 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.456 ' O ' ' OG ' ' A' ' 184' ' ' SER . 43.8 m -65.39 -47.35 76.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.277 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.34 -44.88 99.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.494 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.475 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -66.52 -45.36 79.78 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.283 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.0 t -69.96 -32.34 70.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.235 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 180' ' ' THR . 63.8 m -62.03 -30.08 70.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.306 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -49.9 157.08 0.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.522 -179.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -138.59 153.99 48.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.581 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.6 m -127.12 151.15 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.107 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 42.6 p90 . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.75 -179.875 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.55 -20.8 71.74 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.667 2.245 . . . . 0.0 111.819 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 mt -91.36 137.72 32.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.434 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.93 -179.68 39.42 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.9 t -143.45 141.75 30.94 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.451 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.6 p -177.64 102.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.75 44.81 37.34 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.13 -37.97 55.34 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 m -131.66 151.25 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.843 0.354 . . . . 0.0 110.477 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.38 -179.96 42.26 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.3 mm -84.97 36.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.323 0.582 . . . . 0.0 109.731 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.86 159.06 44.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.233 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.427 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 51.8 p -67.08 153.86 42.64 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.401 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.6 mt -113.61 145.3 41.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.61 ' NE2' ' N ' ' A' ' 33' ' ' GLN . 2.8 mp0 -109.92 151.89 26.51 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.272 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -120.24 143.14 48.45 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.565 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -130.43 133.63 46.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.068 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -140.81 151.2 44.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.401 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -140.73 120.26 13.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.408 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.8 p -71.33 -32.59 68.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.574 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.22 -49.45 74.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.115 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -87.37 -20.63 26.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.825 0.345 . . . . 0.0 110.729 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.34 41.16 91.58 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -139.75 152.71 46.84 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.264 0.532 . . . . 0.0 110.418 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -151.39 148.58 28.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -152.33 155.91 38.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.044 0.45 . . . . 0.0 111.53 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 45' ' ' LEU . 2.3 mm? -96.7 141.92 29.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.894 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -153.05 147.63 19.2 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.543 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.22 163.4 34.93 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.596 2.197 . . . . 0.0 112.968 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.596 ' ND2' ' NE2' ' A' ' 33' ' ' GLN . 68.6 m-80 -70.52 160.47 32.4 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.85 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.74 -6.19 57.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -97.08 141.84 29.73 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.4 pt -123.13 147.28 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.423 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.42 137.39 13.23 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.19 136.19 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.895 0.379 . . . . 0.0 110.655 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -77.78 133.98 38.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.241 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 m -132.06 56.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.256 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -73.65 137.78 44.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.13 3.57 69.77 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.48 -164.22 0.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.798 0.332 . . . . 0.0 110.65 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.5 157.04 1.89 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.155 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.74 131.03 27.92 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.425 2.083 . . . . 0.0 111.722 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.3 -22.43 36.98 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.84 132.16 27.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.413 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -118.67 -58.4 1.97 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.033 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 m -146.87 165.81 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.178 0.514 . . . . 0.0 111.308 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.13 140.86 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.028 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -111.99 130.38 55.88 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -127.6 133.6 49.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.917 0.389 . . . . 0.0 111.132 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 71' ' ' GLU . 60.2 t0 -93.49 118.27 31.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.452 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt -63.62 -39.09 93.49 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.14 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.06 -40.86 90.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' A' ' 68' ' ' ASP . 79.1 mm-40 -117.99 118.11 31.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.621 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -85.91 -43.0 13.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.417 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -58.43 -39.69 80.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.993 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 33.9 mp0 -82.95 135.94 34.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.355 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.84 157.77 38.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.904 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.5 tp -132.09 133.87 44.83 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.047 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.6 t -123.54 131.32 53.6 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.41 126.97 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.61 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.4 mt -122.33 121.41 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.21 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.465 ' C ' ' HG ' ' A' ' 81' ' ' SER . 35.4 mm -116.77 129.92 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.01 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 159' ' ' LEU . 9.6 m -148.79 164.36 34.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.161 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -103.66 138.12 40.75 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.6 pt -92.92 149.26 37.37 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.788 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -43.77 139.64 5.18 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.76 1.64 . . . . 0.0 111.487 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -69.01 -23.9 64.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.557 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 56.3 t0 -90.68 -18.38 25.17 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -128.73 157.32 41.73 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.104 0.478 . . . . 0.0 111.617 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.9 t -122.92 176.91 5.74 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.515 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 tp -51.0 -45.09 61.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.972 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.9 p -66.92 -44.99 79.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.089 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.36 -37.18 84.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.8 tp -55.91 -41.94 75.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.67 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.83 -179.41 48.35 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.2 p -96.05 171.9 8.33 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.73 73.57 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.133 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.3 m -73.05 -46.16 53.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.87 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -62.6 -50.97 69.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.164 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.36 -38.79 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -57.94 -56.12 26.87 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -59.52 -36.64 76.48 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.479 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -56.27 -40.26 73.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.099 0.476 . . . . 0.0 110.577 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -63.8 -41.58 97.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.127 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.674 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -54.98 -55.27 32.7 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.307 0.575 . . . . 0.0 110.096 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -61.29 -39.56 90.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.766 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.1 m -57.97 -45.63 86.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.7 t -71.7 -46.57 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.504 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 111' ' ' GLN . 1.6 m120 -60.83 -33.9 73.75 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.879 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -45.63 -35.52 4.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.06 0.457 . . . . 0.0 110.439 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.47 -48.5 22.41 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 m -122.31 22.94 9.96 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.3 pt20 -47.39 -18.59 0.12 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.632 0.253 . . . . 0.0 111.483 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.26 -61.44 7.38 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.167 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 38.1 p-10 -117.31 -30.84 5.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.072 0.436 . . . . 0.0 111.781 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.527 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 55.1 ttm-85 -80.19 136.92 36.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 111.026 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -133.17 135.86 45.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.37 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.481 ' CB ' HD22 ' A' ' 107' ' ' ASN . . . -107.87 136.62 47.29 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.951 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -118.64 127.76 53.9 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.9 tp -82.84 108.18 15.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.899 0.38 . . . . 0.0 110.209 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.546 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 97.0 mt -71.0 -38.3 71.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.942 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.3 m-80 -178.52 163.7 1.57 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.165 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.9 120.53 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.197 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -137.6 170.71 15.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.035 0.445 . . . . 0.0 110.919 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -141.78 150.74 42.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.506 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.83 136.77 46.45 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.152 0.501 . . . . 0.0 110.802 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -103.97 113.62 27.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -138.26 137.62 37.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.429 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 129' ' ' GLN . 87.2 m-20 51.24 42.3 28.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.627 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.13 1.59 5.67 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.524 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 2.8 tm0? -102.28 130.71 49.06 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.13 130.0 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.524 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 45.8 m-85 -118.87 131.4 56.06 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.724 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.435 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.07 128.44 53.34 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 94.0 m -110.13 123.62 50.06 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.326 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.4 mp -115.45 127.51 55.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.992 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -123.43 120.49 33.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.297 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -150.31 169.68 20.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.471 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -133.73 152.92 52.01 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 110.554 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.4 ' CG1' HH11 ' A' ' 114' ' ' ARG . 74.2 t -105.01 133.57 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.375 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.57 135.13 31.49 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.283 0.563 . . . . 0.0 111.087 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.6 t -115.02 134.27 58.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.131 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.54 -122.1 21.87 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -111.31 13.45 21.65 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -128.86 156.74 43.17 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.077 0.465 . . . . 0.0 111.475 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.9 p -87.62 126.98 41.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.63 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.412 ' OE1' ' NH1' ' A' ' 114' ' ' ARG . 84.2 tt0 -74.77 -54.63 6.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.472 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -174.46 173.83 2.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.207 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.416 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 51.2 m170 -103.99 138.66 40.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.025 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 81.5 m-20 -135.38 137.92 42.81 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.011 0.434 . . . . 0.0 111.291 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 tp -114.15 130.52 56.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.845 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.79 137.85 54.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.82 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.1 t -126.82 126.02 42.66 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 52.4 t -114.83 129.94 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.12 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.9 m -143.83 144.34 31.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.0 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 p -110.99 150.34 29.4 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.209 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -156.66 117.16 3.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.964 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.462 ' HE ' ' H ' ' A' ' 156' ' ' ARG . 4.8 mmp_? 58.94 24.85 13.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.11 7.88 72.92 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.1 125.82 43.27 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -88.97 121.47 31.35 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.415 HD12 HG22 ' A' ' 160' ' ' ILE . 76.5 mt -122.87 129.08 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.565 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 37.7 m -129.07 136.47 50.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.454 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.85 99.9 8.03 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -96.81 107.55 20.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.762 0.315 . . . . 0.0 110.616 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.54 133.42 54.6 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.801 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 89.0 p -128.46 135.8 49.97 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.788 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 5.9 m -152.97 154.82 35.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.549 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -54.89 141.0 35.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.239 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -67.77 -34.19 76.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.55 -33.78 68.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.994 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 63.9 mtt85 -109.9 -7.18 15.02 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.499 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 52.2 t-105 -49.51 -38.26 29.83 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.832 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.53 -42.96 99.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 58.6 m -65.53 -39.82 92.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.722 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 13.6 m -108.28 21.27 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.35 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 171' ' ' TRP . 50.8 pttt -52.22 -46.78 65.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 84.8 p -69.52 -25.83 64.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.602 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.99 -43.28 91.44 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.998 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.499 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 28.5 m-85 -61.7 -50.86 70.75 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.206 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.15 -41.05 99.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.558 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.463 ' O ' ' OG ' ' A' ' 184' ' ' SER . 41.8 m -67.22 -48.52 67.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.321 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.95 -45.1 99.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.731 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.514 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -66.48 -43.94 84.06 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.313 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.0 m -72.8 -31.13 64.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.342 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 180' ' ' THR . 40.3 m -61.82 -29.53 70.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.442 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -54.94 157.01 3.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.078 0.466 . . . . 0.0 110.944 -179.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -137.02 158.03 45.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.64 151.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.941 0.401 . . . . 0.0 111.008 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.524 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 38.1 p90 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.801 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.98 144.85 35.1 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.703 2.268 . . . . 0.0 111.905 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.6 mt -90.18 140.42 29.69 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.454 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.14 4.77 74.06 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 p -77.22 156.93 31.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.0 t -138.52 127.6 24.07 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.344 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.42 176.58 48.36 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.63 135.96 13.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -122.3 133.97 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.308 . . . . 0.0 110.416 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.87 143.36 26.47 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.406 HG22 HD11 ' A' ' 29' ' ' ILE . 25.4 mm -59.57 -45.08 94.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.93 0.395 . . . . 0.0 110.133 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.76 150.13 15.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.445 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.545 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 20.8 t -148.48 155.5 41.26 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.234 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.72 160.49 37.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.966 0.412 . . . . 0.0 110.909 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.13 166.39 24.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.62 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.5 ptt-85 -115.84 144.68 43.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.708 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -124.13 132.44 53.64 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.189 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.9 m -139.15 151.18 46.43 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.544 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -141.61 118.48 11.15 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.32 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.6 p -72.31 -30.53 64.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.719 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -62.53 -47.61 83.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.722 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -90.21 -20.4 23.07 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.937 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.78 41.94 81.2 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -141.1 152.98 45.2 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.239 0.519 . . . . 0.0 110.22 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -153.26 148.17 26.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -157.22 157.57 34.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.162 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.6 mt -96.38 152.19 18.83 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -161.19 130.08 3.08 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.19 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -41.99 157.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.094 1.862 . . . . 0.0 112.507 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 31' ' ' SER . 6.1 p30 -80.8 160.31 24.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.869 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.84 12.53 63.91 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.532 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 28.2 m0 -91.24 151.68 20.82 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 110.479 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 51' ' ' ILE . 43.0 pt -117.29 151.07 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.377 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.73 134.51 9.97 Favored Glycine 0 N--CA 1.466 0.651 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.62 141.19 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.62 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -87.03 144.72 26.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.181 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.69 49.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.308 0.575 . . . . 0.0 109.878 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -54.12 129.42 34.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.16 4.65 68.53 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.01 -164.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.12 157.89 2.78 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.249 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.8 130.62 25.13 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.341 2.027 . . . . 0.0 111.465 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' ILE . . . 94.83 -22.47 37.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.1 t -58.85 126.74 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.783 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -119.05 -57.98 1.98 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.596 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.5 t -145.68 146.04 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.83 0.348 . . . . 0.0 111.035 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.8 t -120.67 135.9 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.123 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -111.25 132.07 54.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.276 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -122.74 141.31 51.94 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.388 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 49.0 m-20 -93.37 118.97 31.95 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.566 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.0 mt -68.47 -38.16 80.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 110.623 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.16 -44.47 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.688 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -126.57 98.69 5.5 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.918 0.39 . . . . 0.0 110.621 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.687 ' NE ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -61.77 -32.67 72.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.538 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.46 -36.25 73.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.575 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -86.76 131.5 34.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -146.66 138.86 24.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.445 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -118.89 134.56 55.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.688 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t -122.6 138.28 54.63 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.213 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.6 t -118.28 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 110.342 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.6 mt -122.28 122.83 67.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.475 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' GLY . 72.2 mt -122.88 133.85 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.907 0.384 . . . . 0.0 111.059 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 159' ' ' LEU . 15.9 t -148.46 167.77 24.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.097 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.435 ' H ' ' HG ' ' A' ' 81' ' ' SER . 3.0 pp20? -105.58 136.63 44.81 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.762 0.315 . . . . 0.0 110.318 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.1 pt -93.92 148.3 35.03 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.264 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 87' ' ' LYS . 38.8 Cg_endo -66.07 136.88 46.21 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.728 1.619 . . . . 0.0 110.968 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.3 t -61.44 -27.18 68.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.979 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -67.8 -30.86 70.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.023 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 84' ' ' PRO . 66.4 mttm -130.41 156.58 44.49 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.027 0.442 . . . . 0.0 111.119 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.466 ' HG1' ' H ' ' A' ' 89' ' ' LEU . 14.7 t -122.7 176.13 6.13 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.441 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.466 ' H ' ' HG1' ' A' ' 88' ' ' THR . 43.0 tp -52.65 -44.83 66.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.075 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.8 p -68.6 -46.51 69.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.24 -35.76 81.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.075 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -55.83 -43.07 76.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.505 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 175.05 44.48 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.0 p -92.82 170.69 9.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.61 77.99 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.118 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 74.7 m -72.03 -44.5 63.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -61.77 -51.26 69.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.405 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.22 -38.49 79.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.528 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.18 -46.78 92.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -67.24 -40.39 86.29 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.984 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -61.5 -41.4 97.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.028 0.442 . . . . 0.0 110.813 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -61.45 -40.33 94.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.755 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.7 mmt -58.64 -44.3 90.02 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.684 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.427 ' HZ2' HE22 ' A' ' 111' ' ' GLN . 41.1 tptt -65.55 -45.51 83.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.005 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.9 m -59.2 -45.81 90.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.98 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.14 -47.12 79.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.995 0.426 . . . . 0.0 110.406 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 111' ' ' GLN . 91.7 m-20 -63.36 -38.43 91.14 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -43.77 -36.28 2.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.337 . . . . 0.0 111.006 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.98 -47.65 67.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.011 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.5 m -123.66 23.44 8.8 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.6 tt0 -50.37 -28.72 8.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.596 0.236 . . . . 0.0 111.419 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.15 -61.72 2.62 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.098 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 34.3 p-10 -117.83 -35.27 3.95 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 117.046 0.423 . . . . 0.0 111.965 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.52 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 35.1 ttm180 -84.64 137.75 33.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 111.276 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -128.31 142.93 50.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.03 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.44 140.36 38.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.877 0.37 . . . . 0.0 110.421 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' CD ' ' CD2' ' A' ' 139' ' ' LEU . 93.3 mt-10 -121.32 123.54 42.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.459 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.7 tp -82.87 109.75 17.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.963 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.524 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.8 mt -72.44 -50.45 35.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.579 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 27.7 m120 -157.0 164.42 38.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.819 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.82 115.45 3.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.246 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -141.61 166.3 25.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.833 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.418 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -136.51 148.46 47.65 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -127.72 141.05 51.7 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.834 0.35 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -108.35 112.14 24.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.614 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 127' ' ' ASP . 79.4 mm-40 -138.28 144.07 40.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.432 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 126' ' ' GLU . 3.7 p-10 46.53 39.32 6.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.28 1.47 21.15 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 154' ' ' THR . 68.1 tp60 -105.95 132.36 52.14 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.43 130.44 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.987 0.422 . . . . 0.0 110.41 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -117.2 130.64 56.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.673 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -103.52 125.58 50.16 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.0 m -107.45 122.74 47.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.327 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.27 120.49 38.39 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.971 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -115.47 123.42 48.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -152.07 166.9 30.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.837 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -134.37 153.85 51.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.922 0.392 . . . . 0.0 110.486 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.01 136.42 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.755 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.402 ' CD2' ' CD ' ' A' ' 117' ' ' GLU . 2.7 pp -139.59 138.96 36.64 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.181 0.515 . . . . 0.0 111.225 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.6 m -110.5 134.01 54.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.243 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 62.04 -117.54 11.78 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 56.7 t0 -116.2 13.59 15.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.456 0.17 . . . . 0.0 110.963 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -121.98 148.0 45.34 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.753 0.311 . . . . 0.0 111.068 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.8 p -85.48 126.84 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.467 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -75.81 -53.4 8.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.407 HH21 ' N ' ' A' ' 166' ' ' THR . 14.7 ptm180 -174.19 171.08 3.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.0 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.412 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 35.7 m170 -103.11 140.53 37.2 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.203 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 78.6 m-20 -134.84 136.19 42.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.924 0.393 . . . . 0.0 111.043 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.6 tp -111.23 134.41 52.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.631 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.78 136.17 42.39 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 110.553 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 52.8 m -123.66 140.47 52.96 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.6 t -121.68 129.56 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.871 0.367 . . . . 0.0 110.537 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.2 m -146.55 142.67 28.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.532 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.44 ' O ' ' NE2' ' A' ' 129' ' ' GLN . 16.7 p -106.0 151.8 24.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.805 0.335 . . . . 0.0 110.491 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -148.32 106.02 3.68 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.015 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 55.39 32.71 19.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.28 6.63 68.51 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -98.42 124.82 43.32 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.5 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.16 113.97 25.21 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 160' ' ' ILE . 70.9 mt -120.02 126.5 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 89.6 m -122.68 132.26 54.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.295 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.56 111.15 22.19 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -114.6 133.98 55.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.962 0.411 . . . . 0.0 111.272 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 mp -129.87 144.33 51.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.426 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 82.5 p -134.98 134.04 40.11 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.298 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.423 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 20.7 m -152.98 159.33 42.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.676 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.423 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -56.78 141.42 44.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.227 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -66.18 -38.61 88.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.878 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -62.08 -33.38 74.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.298 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -96.38 -17.28 20.73 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.243 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.583 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 46.6 t-105 -48.53 -41.42 30.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.732 0.301 . . . . 0.0 110.784 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -63.0 -41.46 99.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.932 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.1 m -66.14 -40.61 90.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.7 m -108.08 21.41 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.266 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 171' ' ' TRP . 49.3 pttt -49.19 -45.9 44.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 111.38 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 83.8 p -67.91 -26.79 66.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.463 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.78 -45.35 86.11 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.926 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.583 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.1 m-85 -62.38 -49.73 74.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.244 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -62.35 -43.31 99.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.431 ' O ' ' OG ' ' A' ' 184' ' ' SER . 86.5 m -66.96 -50.62 61.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.824 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 76.1 t -67.49 -38.32 80.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.39 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.31 -36.67 82.86 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.055 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.7 t -85.02 -17.66 36.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.474 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 180' ' ' THR . 50.9 m -62.78 -36.13 82.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.388 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.451 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -58.66 148.82 27.8 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.39 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -138.71 160.18 40.28 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.4 m -128.18 151.66 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.952 0.406 . . . . 0.0 111.188 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.47 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 35.9 p90 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.587 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 47.2 Cg_exo -54.35 -17.3 11.85 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.766 2.311 . . . . 0.0 111.951 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.496 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 7.3 mp -82.48 139.19 34.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.355 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.29 -169.87 48.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.0 t -142.67 143.99 32.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.751 0.31 . . . . 0.0 110.543 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.1 m -90.04 115.38 27.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.229 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.75 -123.38 26.68 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 27.63 52.05 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -55.9 -36.09 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.555 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.93 144.7 0.11 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.469 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -67.45 -9.15 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.724 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.42 161.79 42.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.34 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.7 p -61.14 154.86 22.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 110.562 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.2 mt -108.23 144.81 35.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.57 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.623 ' NE2' ' ND2' ' A' ' 48' ' ' ASN . 5.4 mp0 -106.83 159.07 16.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.581 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -128.27 138.87 52.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.352 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -129.56 136.29 49.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.943 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.7 p -144.3 157.77 44.1 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -147.91 117.7 7.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.313 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.2 p -70.23 -31.96 69.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 110.448 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -62.13 -48.68 79.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.065 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -88.24 -20.53 25.37 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.97 42.8 76.35 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.81 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -143.97 151.79 40.22 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 117.308 0.554 . . . . 0.0 110.629 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -154.84 144.49 21.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.966 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -149.55 157.38 43.22 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.859 0.361 . . . . 0.0 110.822 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 tp -101.63 134.72 44.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.369 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -139.7 148.53 56.14 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.5 165.49 27.21 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.652 2.235 . . . . 0.0 112.945 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.623 ' ND2' ' NE2' ' A' ' 33' ' ' GLN . 70.3 m-80 -73.22 159.7 33.05 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.602 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.41 -5.11 62.5 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 41.5 m0 -93.45 143.83 25.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.725 0.297 . . . . 0.0 110.26 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.7 pt -122.17 147.49 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.701 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.85 132.53 11.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.33 133.76 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.929 0.395 . . . . 0.0 110.641 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -80.02 140.67 36.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.37 51.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.47 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -75.02 132.85 41.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.031 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.25 -3.36 84.11 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.45 -163.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.544 -0.328 . . . . 0.0 110.279 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.0 m -39.24 108.84 0.5 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.68 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -45.51 136.55 11.96 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.569 1.512 . . . . 0.0 111.703 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.16 -31.91 8.1 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.51 129.22 28.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.125 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -100.24 -58.77 1.84 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.306 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.1 t -150.13 149.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.152 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.71 135.72 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.4 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.08 138.69 48.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.298 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -131.01 129.83 42.56 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.302 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -87.58 118.26 26.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.559 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 mt -65.46 -37.79 87.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.58 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 70' ' ' ILE . 27.5 mm -63.49 -43.96 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.46 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -124.74 97.8 5.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.459 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -60.47 -37.35 80.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.308 0.575 . . . . 0.0 109.769 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -58.48 -36.04 73.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -81.06 127.75 32.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.93 0.395 . . . . 0.0 110.311 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -156.01 165.15 37.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.528 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 pp -162.42 160.9 26.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.466 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.1 t -143.87 143.89 31.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.413 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.55 130.17 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 25.5 mt -116.54 127.45 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.22 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 64.8 mt -118.23 127.95 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 110.425 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.1 m -143.3 164.76 29.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.772 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -106.23 131.52 53.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.707 0.289 . . . . 0.0 110.293 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -94.08 150.32 38.26 Favored Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 87' ' ' LYS . 55.8 Cg_endo -70.75 137.49 32.69 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.739 1.626 . . . . 0.0 110.878 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.6 t -63.54 -29.17 70.47 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.371 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 46.3 p30 -68.69 -29.29 67.71 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.599 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 99.1 mttt -132.03 144.89 51.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.025 0.44 . . . . 0.0 110.999 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -109.52 -179.8 3.92 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.31 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.6 tp -50.75 -44.63 58.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.82 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.2 p -66.27 -43.92 85.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.911 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -65.01 -38.92 92.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.2 tp -55.93 -43.15 77.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.504 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.75 173.86 43.58 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 36.1 p -91.72 171.61 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.08 -43.2 81.92 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.075 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.2 m -71.91 -44.21 64.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -61.43 -51.35 69.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.426 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.67 -38.53 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.573 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.78 -44.61 94.14 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -68.71 -43.08 76.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.101 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -61.37 -39.14 89.56 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.921 -0.311 . . . . 0.0 110.982 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -61.89 -40.65 96.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.526 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -59.22 -42.7 91.61 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.497 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 2.2 mptm? -67.99 -42.74 80.32 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.398 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.0 m -57.02 -44.52 82.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.71 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.55 -43.67 71.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.956 0.408 . . . . 0.0 110.142 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.97 -31.68 72.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.037 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 104' ' ' LYS . 94.9 m-20 -42.39 -32.28 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.915 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.28 -33.32 6.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.537 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 114' ' ' ARG . 5.7 p -88.55 -6.36 57.62 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -55.92 -28.59 57.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.531 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -41.97 -63.74 1.67 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.009 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.1 p-10 -119.36 -45.01 2.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.025 0.44 . . . . 0.0 111.47 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.494 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 83.5 mtm180 -81.69 148.77 28.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.96 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -129.83 142.01 50.74 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.729 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.96 136.75 45.05 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.657 0.265 . . . . 0.0 110.51 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -122.71 128.91 51.17 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.6 tp -82.69 108.15 15.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.906 0.384 . . . . 0.0 110.325 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.0 mt -74.21 -43.35 50.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.536 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.38 164.84 22.03 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.281 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.72 114.44 3.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.207 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -139.03 170.51 15.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -142.62 151.0 41.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -132.45 147.82 52.38 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.059 0.457 . . . . 0.0 111.016 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -114.51 114.63 26.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.561 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -138.22 142.53 39.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.7 t0 51.31 27.64 3.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.547 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.15 -2.37 84.51 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -100.37 146.95 26.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.055 0.455 . . . . 0.0 110.165 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.77 127.74 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.011 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 22.1 m-85 -116.88 126.77 53.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.841 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.4 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.69 126.4 51.73 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.7 m -108.43 122.15 46.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.214 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.76 113.8 22.37 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.134 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -108.94 123.19 48.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.572 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -150.03 169.13 21.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.599 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -132.58 156.59 46.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.049 0.452 . . . . 0.0 110.837 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 145' ' ' GLU . 48.7 t -106.38 129.75 59.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.167 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.16 135.81 54.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.043 0.449 . . . . 0.0 111.501 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.21 87.65 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.95 -106.02 2.82 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -112.79 7.49 18.5 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -122.62 137.14 54.99 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.006 0.431 . . . . 0.0 111.585 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.0 p -67.29 122.96 19.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.849 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' A' ' 138' ' ' VAL . 81.3 tt0 -77.7 -56.17 4.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.343 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -169.57 169.58 8.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -103.49 134.87 46.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.075 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -129.71 137.76 50.76 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.042 0.448 . . . . 0.0 110.823 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.421 HD22 ' H ' ' A' ' 150' ' ' ALA . 3.2 tm? -111.99 138.78 48.16 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.707 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.421 ' H ' HD22 ' A' ' 149' ' ' LEU . . . -135.92 125.37 25.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.462 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t -118.34 124.46 47.81 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 44.6 t -110.61 128.91 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.902 0.382 . . . . 0.0 110.868 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 57.6 m -142.75 143.16 32.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.373 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.4 p -89.15 157.34 18.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.885 0.374 . . . . 0.0 110.596 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -150.26 93.97 2.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.602 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 57.91 33.61 23.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.583 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 93.16 3.8 65.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -101.6 137.59 39.71 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.787 0.327 . . . . 0.0 110.164 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.95 119.03 32.3 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.296 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.428 HD13 HG23 ' A' ' 160' ' ' ILE . 76.1 mt -119.36 126.63 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.5 m -126.27 137.22 53.49 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.817 0.342 . . . . 0.0 110.571 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.32 98.01 7.01 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.794 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -96.37 113.74 25.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.856 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.8 mp -116.13 140.58 49.14 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.439 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.5 t -133.1 132.76 42.08 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.141 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 11.1 m -152.42 158.99 43.43 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.489 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.413 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -52.73 141.34 21.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.342 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -67.8 -39.48 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -61.5 -33.38 73.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.343 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -96.58 -17.27 20.56 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.17 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.523 ' O ' ' N ' ' A' ' 175' ' ' LYS . 52.2 t-105 -48.85 -40.08 28.13 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.931 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -61.22 -41.04 96.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.297 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 59.3 m -68.05 -38.92 83.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.629 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.5 m -111.44 21.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.378 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 171' ' ' TRP . 11.1 ptmm? -51.26 -50.41 59.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 29.8 m -65.07 -28.97 69.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.656 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.5 tp -56.14 -44.16 78.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.253 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.51 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 26.2 m-85 -63.35 -51.05 67.55 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.352 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.58 -41.15 98.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 184' ' ' SER . 44.1 m -66.6 -48.83 68.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.43 -43.55 98.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.432 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.55 -41.34 98.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.362 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 84.2 p -79.22 -25.65 42.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.874 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 180' ' ' THR . 41.4 t -62.75 -31.01 71.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.028 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -55.9 158.17 3.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.103 0.477 . . . . 0.0 110.576 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.523 ' CD2' ' N ' ' A' ' 187' ' ' VAL . 6.0 t-160 -136.97 145.5 44.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.368 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.523 ' N ' ' CD2' ' A' ' 186' ' ' HIS . 6.8 m -122.27 147.96 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.449 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 35.5 p90 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.722 -179.363 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.22 -22.21 73.79 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.724 2.283 . . . . 0.0 111.822 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.7 mt -59.89 -35.57 75.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.352 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.06 -169.24 47.94 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 t -148.45 18.38 1.05 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.845 0.355 . . . . 0.0 110.48 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.3 m -86.35 123.49 31.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.391 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.89 -179.93 39.74 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.45 3.57 78.02 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.12 135.87 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.803 0.335 . . . . 0.0 110.437 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.68 -174.11 43.74 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.409 HD13 ' H ' ' A' ' 29' ' ' ILE . 5.0 mp -86.21 80.22 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.01 166.44 6.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.9 m -107.98 154.54 21.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.865 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.58 152.42 47.66 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.029 0.442 . . . . 0.0 110.963 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 48' ' ' ASN . 2.1 mp0 -106.73 146.19 31.13 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.008 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -117.42 131.0 56.83 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.738 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -115.3 134.43 55.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.487 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 94.2 p -145.35 153.06 40.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.947 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 36' ' ' SER . 97.9 m-20 -143.04 119.43 10.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.27 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.1 p -69.16 -33.9 74.12 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.272 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.84 -48.45 78.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -84.25 -20.64 31.88 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.958 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.9 42.06 93.04 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -143.97 149.1 36.23 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.175 0.488 . . . . 0.0 110.467 179.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -153.66 145.39 23.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -151.28 158.52 43.96 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 tp -104.24 135.01 46.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.402 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 14.7 p90 -136.88 143.78 43.94 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.859 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.87 150.7 2.51 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.819 1.679 . . . . 0.0 112.149 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.419 ' CB ' ' NE2' ' A' ' 33' ' ' GLN . 51.1 p-10 -79.87 160.67 25.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.497 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.69 60.52 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.1 m0 -92.38 147.57 22.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.851 0.358 . . . . 0.0 110.201 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 51' ' ' ILE . 36.7 pt -116.5 144.44 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.415 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.33 133.49 11.4 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.22 133.67 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.331 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.16 124.64 32.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.227 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.93 59.47 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -77.15 135.19 38.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.063 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.79 3.69 73.65 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.46 -164.4 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.492 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -45.93 154.38 0.58 Allowed Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.412 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.31 130.77 23.26 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.36 2.04 . . . . 0.0 111.855 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' ILE . . . 96.47 -23.72 33.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.91 128.9 33.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.561 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -119.16 -57.88 1.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.502 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.2 t -143.49 141.66 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.884 0.373 . . . . 0.0 111.216 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.41 133.28 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.218 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -112.61 135.94 52.75 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.63 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -127.92 138.46 52.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.337 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -88.76 118.29 28.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.62 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.37 -37.03 84.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.684 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.62 -42.43 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.486 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.36 99.72 6.57 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.58 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -62.59 -37.43 86.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.39 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -58.77 -35.05 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.753 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -81.62 131.29 35.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -140.1 139.19 35.78 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.994 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -126.26 135.26 51.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.071 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 t -128.02 139.41 52.57 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.84 126.55 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.961 0.41 . . . . 0.0 110.231 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -124.11 119.24 56.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.274 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' GLY . 33.4 mm -116.07 131.92 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.289 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.512 ' O ' ' N ' ' A' ' 159' ' ' LEU . 49.2 m -145.96 166.48 25.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.35 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -104.8 137.98 41.77 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.3 pt -93.51 149.32 37.04 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.656 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -45.38 134.96 12.22 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.641 1.561 . . . . 0.0 111.496 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.1 t -65.1 -26.75 68.35 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.307 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -85.11 -20.81 29.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -129.79 158.24 39.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.209 0.528 . . . . 0.0 111.863 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.9 t -122.69 175.65 6.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.468 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.5 tp -52.07 -45.06 64.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.017 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 p -66.01 -46.02 79.44 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.164 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -66.79 -35.26 79.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.885 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.5 tp -55.83 -43.43 76.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.75 178.79 47.57 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.4 p -94.13 173.04 7.85 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.43 -41.56 76.61 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.15 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.3 m -72.53 -46.25 55.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.002 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -61.64 -50.89 70.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.431 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.32 -38.27 80.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.694 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.73 -44.03 96.04 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -67.24 -42.61 83.66 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.665 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -61.45 -38.45 87.25 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.664 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.39 -41.61 98.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.38 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.55 -43.2 93.59 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.187 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -64.89 -38.51 91.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.35 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.9 m -58.56 -47.62 83.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.883 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.45 -46.41 56.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.052 0.453 . . . . 0.0 110.503 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.4 m-20 -60.82 -30.41 70.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.285 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -43.59 -38.93 3.23 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.329 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.29 -39.68 9.52 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.624 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.505 ' C ' ' H ' ' A' ' 112' ' ' GLY . 8.9 p -86.13 -1.19 57.18 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.4 pt20 -58.39 -0.55 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.438 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -73.7 -64.37 2.49 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.134 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -118.42 -45.23 2.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.79 0.329 . . . . 0.0 111.46 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 110' ' ' SER . 69.9 mtm180 -85.24 144.81 27.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.481 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -123.98 143.85 50.16 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.796 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.85 132.38 45.23 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -114.11 128.81 56.54 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 39.0 tp -81.78 109.86 16.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.67 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.419 ' CG1' ' HE ' ' A' ' 137' ' ' ARG . 88.2 mt -74.09 -53.33 17.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.237 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.549 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 9.2 p30 -160.69 176.51 11.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.84 127.14 5.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.225 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 57.6 mp0 -141.43 159.35 42.41 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.701 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -140.29 147.77 40.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.941 0.4 . . . . 0.0 110.651 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -132.57 146.4 51.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.572 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -121.01 114.95 22.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.3 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -142.19 144.68 33.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.6 t0 51.25 34.44 11.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.533 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.45 -0.24 55.73 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -101.85 146.87 27.21 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.988 0.423 . . . . 0.0 110.188 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.3 t -114.47 128.86 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.214 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -118.09 122.64 43.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.54 132.05 51.24 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 52.8 m -112.55 132.25 55.2 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.053 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.32 110.34 12.72 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.065 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.549 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 69.9 tt0 -104.19 122.95 46.43 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -147.47 170.07 18.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.306 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.516 ' NH1' ' HE2' ' A' ' 147' ' ' HIS . 18.7 ptp180 -138.14 161.26 37.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.946 0.403 . . . . 0.0 110.926 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.0 t -108.16 133.46 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.092 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.5 pp -136.4 135.47 38.76 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.149 0.5 . . . . 0.0 111.622 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.37 128.1 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.65 -118.2 13.68 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -109.66 9.27 25.03 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.87 -0.194 . . . . 0.0 110.949 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -114.93 143.85 44.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.854 0.359 . . . . 0.0 111.492 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.29 130.13 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.465 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -83.28 -54.68 4.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.443 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.595 HH21 ' CA ' ' A' ' 166' ' ' THR . 15.2 ptm180 -170.3 173.29 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.123 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.516 ' HE2' ' NH1' ' A' ' 137' ' ' ARG . 50.7 m80 -105.49 142.81 34.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.128 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 13.5 t70 -139.88 150.75 44.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.767 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.6 tp -125.49 136.32 53.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.041 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.02 119.81 19.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.847 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.1 t -106.03 138.36 42.35 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.35 130.06 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.908 0.385 . . . . 0.0 111.007 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -148.44 150.94 34.36 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.413 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.1 p -118.95 152.34 36.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.523 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -159.54 118.07 2.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.637 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 59.45 27.88 17.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.33 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.93 9.8 83.88 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -100.46 127.17 46.88 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.51 121.46 31.75 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.135 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 160' ' ' ILE . 77.4 mt -119.45 127.64 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.304 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 46.1 m -129.66 135.28 48.33 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.663 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.0 103.84 11.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.895 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -100.12 110.0 22.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.573 0.225 . . . . 0.0 110.432 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.432 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 5.3 mp -115.0 136.05 53.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.408 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.5 t -127.47 134.1 49.85 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.885 0.374 . . . . 0.0 110.546 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.595 ' CA ' HH21 ' A' ' 146' ' ' ARG . 9.5 m -152.53 154.9 36.38 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.611 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.14 144.29 35.5 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.547 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.431 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 1.2 pp20? -70.32 -30.55 67.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.024 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.431 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 92.5 m-20 -59.86 -33.9 72.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.957 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -111.88 -5.3 14.38 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.501 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 52.4 t-105 -49.55 -39.17 33.74 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.786 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.42 -41.64 98.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.19 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.0 m -65.72 -39.87 91.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.699 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.6 m -108.86 21.64 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.278 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 171' ' ' TRP . 10.2 ptmm? -51.38 -50.0 60.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.392 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.1 t -64.92 -30.7 71.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.17 -44.16 74.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.303 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 27.9 m-85 -60.95 -49.83 75.84 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.308 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -64.59 -38.91 92.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.492 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 42.7 m -65.38 -49.01 70.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.476 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.29 -45.16 99.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.659 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -64.85 -42.18 95.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 110.371 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 21.2 t -73.87 -31.47 63.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.231 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 91.7 p -63.12 -24.13 67.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.308 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -57.34 156.11 8.13 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.498 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -136.0 156.75 48.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.522 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.82 151.42 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.831 0.348 . . . . 0.0 111.107 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.519 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 38.3 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.736 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 37.5 Cg_endo -64.55 147.21 90.23 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.919 2.413 . . . . 0.0 112.079 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.597 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -130.65 170.84 13.77 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.323 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.23 -178.09 51.47 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.9 p -141.6 156.13 45.7 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.834 0.349 . . . . 0.0 110.576 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.7 m -63.03 -36.35 83.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.733 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.46 -172.13 43.26 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.56 -123.73 0.89 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.13 142.89 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.722 0.296 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.09 -91.87 0.37 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.9 pt -128.71 168.39 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 111.143 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -114.54 -85.85 0.6 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.347 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.0 m -124.29 144.43 49.99 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.529 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.9 mt -101.28 144.12 30.52 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.377 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.501 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 20.5 mp0 -108.42 154.26 22.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.497 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -125.96 143.71 50.98 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.312 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -130.07 139.87 50.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.046 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.441 ' OG ' ' OH ' ' A' ' 188' ' ' TYR . 12.6 t -149.75 148.57 29.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 110.63 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -137.89 121.45 17.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.481 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.5 p -70.98 -33.22 70.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.504 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -61.93 -48.25 81.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -88.6 -20.47 24.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.784 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.84 42.02 93.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.73 150.72 42.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.153 0.477 . . . . 0.0 110.662 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -149.67 147.15 27.74 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.717 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -146.75 154.86 41.89 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.935 0.398 . . . . 0.0 110.983 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' N ' ' CD2' ' A' ' 45' ' ' LEU . 3.1 mm? -98.02 141.66 30.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.101 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -151.31 146.84 19.42 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.317 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.12 160.02 51.09 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.455 2.103 . . . . 0.0 112.347 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -69.83 160.81 31.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.709 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.18 0.28 57.14 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.528 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 32.6 m0 -91.22 141.3 28.95 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.68 128.37 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.999 0.428 . . . . 0.0 110.141 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.53 137.33 13.21 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.52 141.75 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.72 0.295 . . . . 0.0 110.57 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.17 122.61 31.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.05 0.452 . . . . 0.0 110.413 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 m -121.56 32.07 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.676 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -50.09 136.82 18.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.94 4.1 69.64 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.11 -164.33 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.636 0.255 . . . . 0.0 110.541 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 m -46.36 137.08 6.93 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.65 130.47 9.61 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.708 1.606 . . . . 0.0 112.717 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.0 -33.15 5.76 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.0 t -62.31 125.43 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.273 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -119.78 -57.22 1.98 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.68 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.7 t -136.32 142.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.082 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.01 132.97 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.419 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 76' ' ' LEU . 90.7 m-85 -112.78 133.19 54.91 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.263 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -124.82 140.93 52.48 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.443 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 81.9 m-20 -88.36 118.76 28.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.546 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 tp -67.35 -40.87 85.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.47 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.8 mt -61.62 -43.43 97.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.017 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -117.34 121.2 40.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.928 0.394 . . . . 0.0 110.371 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -80.95 -37.55 29.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.634 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 41.1 p-10 -62.57 -31.32 72.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.959 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 85.3 tt0 -85.89 131.3 34.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.939 0.399 . . . . 0.0 110.787 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -142.31 139.6 31.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.144 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PHE . 7.5 tt -123.78 134.81 53.58 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.7 t -128.74 138.91 52.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.334 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -113.18 123.82 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.4 mt -125.77 120.54 57.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.195 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.4 mt -121.1 132.64 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.172 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.4 m -136.15 164.7 27.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.47 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -103.73 135.36 45.43 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 9.6 pt -102.23 150.21 37.31 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.943 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -44.51 145.37 2.63 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.841 1.694 . . . . 0.0 111.222 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.6 p -80.08 -13.91 58.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.598 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -96.35 -20.93 18.12 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.765 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -124.06 157.14 35.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.099 0.476 . . . . 0.0 111.385 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.5 t -122.66 177.82 5.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.612 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 tp -51.66 -45.43 63.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.061 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.2 p -64.42 -44.55 90.87 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.098 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -65.76 -38.12 88.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.968 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.4 tp -56.23 -43.85 79.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.86 176.52 45.93 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 39.8 p -94.86 171.11 8.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.6 78.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.126 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.2 m -72.03 -44.93 62.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.747 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -61.84 -51.78 66.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.409 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.16 -38.01 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.668 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.33 -47.21 90.98 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.53 -41.63 84.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -62.35 -40.79 97.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.981 0.42 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -61.67 -41.3 97.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.857 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -58.99 -45.46 90.56 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.661 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -64.35 -43.01 95.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.873 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.1 m -60.85 -47.04 88.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.1 t -71.87 -46.11 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.602 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 111' ' ' GLN . 91.7 m-20 -61.43 -39.57 91.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.632 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -46.61 -36.25 6.74 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.533 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 -45.36 89.78 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.885 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 114' ' ' ARG . 8.6 m -123.7 22.18 9.08 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.6 tt0 -52.53 -28.48 20.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.673 0.273 . . . . 0.0 111.452 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.86 -62.1 2.75 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.138 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -117.74 -40.51 3.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.929 0.365 . . . . 0.0 111.681 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 110' ' ' SER . 52.6 ttp180 -92.09 146.2 23.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.046 0.451 . . . . 0.0 110.904 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.76 151.63 40.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.517 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.423 ' CB ' ' OD1' ' A' ' 107' ' ' ASN . . . -103.04 139.85 38.05 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.569 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -113.18 130.8 56.1 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.5 tt -81.21 106.01 12.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.082 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.7 mt -70.8 -51.06 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.378 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.549 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 7.5 p30 -160.66 173.91 14.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.953 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.1 122.92 4.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.189 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -142.09 159.56 41.99 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.689 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.42 147.83 43.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.524 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.7 141.55 47.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.705 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -110.61 112.81 24.96 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.393 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -137.59 144.33 41.94 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.97 0.414 . . . . 0.0 110.76 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.3 t0 50.98 33.28 8.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.35 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.84 0.97 61.08 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -104.05 146.94 27.99 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.978 0.418 . . . . 0.0 110.252 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.05 128.53 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.142 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 27.8 m-85 -118.06 124.47 48.18 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.853 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.62 128.13 50.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.0 m -109.02 122.25 46.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.201 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.8 mp -118.36 112.74 20.41 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.102 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.549 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 60.7 tt0 -106.46 123.96 48.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.426 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.94 169.66 20.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.499 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -135.85 156.3 49.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.76 0.314 . . . . 0.0 110.541 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.1 m -102.89 125.78 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.993 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.7 mt -107.75 123.35 48.41 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.5 t -117.31 130.36 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.66 -122.27 22.02 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 88.4 m-20 -116.33 21.95 13.21 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.982 -0.128 . . . . 0.0 111.217 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 78.2 m-20 -144.1 161.87 37.72 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.893 0.377 . . . . 0.0 111.17 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.49 120.46 30.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.6 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -69.98 -51.77 29.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.06 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -173.56 171.37 3.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.083 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -104.83 140.91 37.42 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.07 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.421 ' OD1' ' OG ' ' A' ' 165' ' ' SER . 18.0 t70 -133.61 150.86 51.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.144 0.497 . . . . 0.0 110.543 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 150' ' ' ALA . 3.2 tm? -125.97 138.58 53.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.578 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.413 ' H ' HD22 ' A' ' 149' ' ' LEU . . . -136.54 117.47 14.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.356 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t -104.1 126.22 51.05 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 26.5 t -112.45 129.02 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.7 m -145.02 148.03 33.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.244 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 p -109.64 143.48 39.32 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.922 0.391 . . . . 0.0 110.551 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -152.64 112.97 4.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 62.44 33.45 16.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.65 11.57 84.59 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.34 131.59 54.92 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.721 0.296 . . . . 0.0 110.597 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.75 120.36 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.8 124.86 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.6 m -127.25 132.31 50.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.792 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.83 99.71 7.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.56 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -98.03 111.69 23.91 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.654 0.264 . . . . 0.0 110.572 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.408 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 5.4 mp -116.91 136.9 52.59 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.28 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.421 ' OG ' ' OD1' ' A' ' 148' ' ' ASP . 50.2 m -126.56 136.19 52.23 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.858 0.361 . . . . 0.0 110.592 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.4 m -152.87 155.69 37.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.283 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.24 143.57 27.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.093 0.473 . . . . 0.0 111.197 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -71.19 -28.77 64.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.028 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.11 -34.28 71.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.232 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -114.62 -3.07 12.94 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.482 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 50.3 t-105 -49.79 -38.21 33.37 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.851 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -61.58 -41.83 97.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.263 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.6 m -66.84 -39.2 87.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.79 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.2 m -108.4 21.32 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.294 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 176' ' ' SER . 19.4 ptmt -52.03 -49.73 62.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.331 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.41 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 25.0 t -65.67 -29.41 69.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.358 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 tt -54.76 -45.69 74.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.036 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.482 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 25.7 m-85 -61.9 -49.78 74.84 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.53 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.03 -38.39 90.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.478 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 39.2 m -64.33 -47.95 77.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.353 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.07 -45.08 99.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.624 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.47 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.45 -44.42 94.55 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.208 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.5 t -71.31 -32.76 69.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.1 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 95.3 p -63.1 -24.82 68.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -56.4 156.96 5.39 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.332 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -134.76 153.3 52.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.47 148.79 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 111.115 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.441 ' OH ' ' OG ' ' A' ' 36' ' ' SER . 40.4 p90 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.676 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.77 150.31 88.53 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.795 2.33 . . . . 0.0 111.841 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.21 145.41 28.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.328 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.13 32.98 33.91 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -56.39 -33.06 65.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 110.645 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.9 p -150.61 19.01 0.82 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.24 -128.31 30.63 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.82 -102.5 0.16 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.4 p -129.78 143.32 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.859 0.362 . . . . 0.0 110.422 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.91 -169.56 41.54 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' ALA . 35.0 pt -76.4 141.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 110.66 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 29' ' ' ILE . . . -52.68 -107.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.942 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.6 m -122.8 146.92 47.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.31 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.4 mt -66.89 148.67 51.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.125 0.488 . . . . 0.0 110.798 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.482 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 1.7 pm0 -127.54 164.77 21.23 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.861 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -125.61 144.38 50.61 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.815 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -122.2 133.22 54.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.797 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.446 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 92.4 p -145.63 153.48 41.08 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.867 0.365 . . . . 0.0 110.795 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 36' ' ' SER . 99.9 m-20 -143.06 113.23 7.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.278 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.0 p -65.43 -32.96 74.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.886 0.374 . . . . 0.0 110.075 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -62.24 -45.19 94.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -89.36 -20.47 23.96 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.09 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.72 40.63 90.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -143.48 150.81 39.51 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.286 0.543 . . . . 0.0 110.443 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -156.73 146.35 20.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.113 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -155.57 158.27 38.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.127 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.03 154.14 17.31 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.684 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 46' ' ' TYR . 13.0 p90 -156.85 142.94 12.98 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.53 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.9 153.83 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.993 1.795 . . . . 0.0 112.462 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 49' ' ' GLY . 32.4 t-20 -81.44 157.15 25.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.426 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . 92.64 6.79 63.69 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.539 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 30.5 m0 -89.16 149.13 23.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.851 0.357 . . . . 0.0 110.262 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.26 145.69 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.16 128.75 9.01 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 t -113.9 132.99 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 110.462 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.59 134.26 35.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.288 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.31 55.2 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -73.33 136.02 44.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.229 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.15 69.26 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.79 -164.32 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.708 0.29 . . . . 0.0 110.484 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.63 158.15 0.88 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.181 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.33 128.8 20.08 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.442 2.095 . . . . 0.0 111.922 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 80' ' ' ILE . . . 97.14 -24.05 33.02 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t -63.49 130.63 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -119.19 -58.75 1.91 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.537 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.2 t -151.45 151.44 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.753 0.311 . . . . 0.0 111.143 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.26 144.27 33.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.264 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -112.77 134.64 54.19 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.448 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.31 141.04 52.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.413 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.539 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 45.8 m-20 -89.28 118.99 29.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.587 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.67 -40.02 91.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.577 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.6 mm -61.86 -46.97 95.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.682 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.8 103.81 8.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.973 0.416 . . . . 0.0 110.413 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.43 -38.38 83.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.263 0.554 . . . . 0.0 110.007 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.53 -36.37 73.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.901 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.83 125.9 31.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.932 0.396 . . . . 0.0 110.454 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -161.01 174.05 14.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 pp -159.98 158.76 31.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.187 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.1 t -127.68 139.36 52.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.22 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 t -111.15 123.71 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.86 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 51.4 mt -121.59 124.86 72.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.962 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 61' ' ' GLY . 76.3 mt -122.91 131.89 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.81 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 159' ' ' LEU . 51.1 m -146.06 166.97 24.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.086 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 2.0 pm0 -106.14 132.44 52.21 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 8.8 pt -88.75 148.93 42.77 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.506 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.71 136.68 43.07 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.629 1.553 . . . . 0.0 110.866 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -61.17 -27.15 68.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.947 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -67.8 -30.9 70.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.134 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -130.14 150.5 51.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.221 0.534 . . . . 0.0 111.576 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.414 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 81.4 p -112.6 174.87 5.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.713 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.6 tp -56.85 -41.2 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.01 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.3 p -69.82 -44.32 70.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.418 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HB3' ' H ' ' A' ' 88' ' ' THR . 44.4 t0 -64.28 -34.81 78.99 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.92 -52.14 63.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.214 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.56 179.04 47.6 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.68 ' HG1' ' H ' ' A' ' 97' ' ' ASP . 34.8 p -88.09 170.64 10.9 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.51 -41.88 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.836 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.3 m -72.14 -44.1 63.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.748 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.68 ' H ' ' HG1' ' A' ' 94' ' ' THR . 48.0 t0 -61.71 -52.88 62.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.35 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.1 -38.6 79.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.678 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.99 -43.98 94.75 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -67.14 -41.65 85.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.82 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -61.87 -38.95 90.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.665 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -62.29 -40.84 97.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.655 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -58.12 -45.68 86.86 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.499 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -65.29 -43.03 92.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.4 m -60.79 -45.67 93.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.945 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.56 -47.99 68.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.636 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.643 ' O ' ' N ' ' A' ' 111' ' ' GLN . 93.5 m-20 -62.6 -37.58 86.8 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.676 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -44.26 -37.0 2.98 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.309 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.38 -47.26 70.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.135 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.3 m -123.71 23.22 8.83 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.8 tt0 -50.32 -28.83 8.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.579 0.228 . . . . 0.0 111.328 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.67 -61.39 2.95 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.083 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -117.08 -35.94 3.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.929 0.364 . . . . 0.0 111.933 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -83.98 137.55 33.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.962 0.41 . . . . 0.0 111.266 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -129.13 139.9 51.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.959 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.54 135.15 44.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.333 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -114.51 125.18 53.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.182 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.8 tt -84.58 109.83 18.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.252 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.518 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.9 mt -74.6 -53.84 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.683 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 27.7 m120 -155.08 164.41 38.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.728 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.83 115.79 3.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.486 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -139.76 170.52 15.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.882 0.372 . . . . 0.0 110.69 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.401 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -141.28 150.52 42.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.645 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -132.45 139.07 47.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -108.46 114.19 27.83 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.452 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.94 142.98 34.31 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.96 0.41 . . . . 0.0 110.782 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 51.67 37.37 19.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.282 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.85 0.77 35.41 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -104.46 147.87 27.08 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.897 0.38 . . . . 0.0 110.115 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.71 128.56 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.108 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -117.16 126.83 53.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.822 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.3 m-85 -104.41 126.3 51.38 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.9 m -109.26 122.66 47.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 110.321 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.3 mp -116.78 122.22 43.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.826 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -116.77 119.45 35.49 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -148.97 167.32 26.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.589 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -135.53 152.93 51.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.927 0.394 . . . . 0.0 110.635 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 m -105.86 136.03 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.909 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.45 137.08 38.36 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.173 0.511 . . . . 0.0 111.2 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.25 133.35 60.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.393 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.42 -119.19 11.0 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -116.53 15.28 15.61 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.851 -0.205 . . . . 0.0 111.174 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -129.03 153.86 47.19 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.896 0.379 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.85 127.42 40.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.377 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -74.89 -52.22 11.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.631 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -174.55 173.9 2.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.087 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -109.2 137.31 47.28 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.163 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -130.87 142.65 50.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.884 0.373 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.2 tp -114.4 131.28 56.63 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.03 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -125.38 130.81 52.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.965 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.4 t -124.31 126.95 46.9 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.0 t -113.04 127.87 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 111.101 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.8 m -141.31 139.4 33.62 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.108 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.1 p -103.27 150.25 23.92 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.799 0.333 . . . . 0.0 110.342 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -149.14 106.07 3.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 57.04 30.89 18.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.814 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.06 5.22 68.12 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -95.61 123.56 39.22 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.06 118.0 28.47 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 160' ' ' ILE . 80.0 mt -120.76 126.68 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.863 0.364 . . . . 0.0 110.463 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.1 m -126.92 137.61 53.16 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.085 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.6 98.72 6.69 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.247 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -95.87 112.4 24.13 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.651 0.262 . . . . 0.0 110.58 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.6 mp -115.0 138.99 50.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.502 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 81.8 p -132.65 133.83 44.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.221 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 15.6 m -152.82 161.13 42.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.568 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.45 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -54.99 140.73 36.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.013 0.435 . . . . 0.0 111.181 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.66 -39.06 84.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 170' ' ' ARG . 37.8 p-10 -63.87 -32.58 74.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 15.1 tpt180 -94.65 -19.53 20.36 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.71 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.542 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 50.5 t-105 -47.95 -41.08 24.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.213 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.43 -42.09 98.2 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.172 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 46.9 m -66.68 -40.32 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.559 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.2 m -108.77 21.48 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.332 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 171' ' ' TRP . 11.1 ptmm? -50.43 -49.81 53.78 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.284 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 22.2 m -64.86 -29.72 70.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.661 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 tp -55.5 -44.49 76.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.368 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.542 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 25.3 m-85 -62.55 -50.29 71.91 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.308 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.22 -41.31 99.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.757 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 184' ' ' SER . 45.2 m -66.65 -49.04 67.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 68.7 t -62.7 -43.85 98.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.457 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -64.63 -39.65 94.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.424 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 t -80.2 -28.18 38.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.144 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 180' ' ' THR . 67.4 m -62.43 -30.97 71.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.385 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -55.22 156.8 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.468 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -139.25 160.65 39.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.621 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.41 150.21 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 111.035 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 39.5 p90 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.689 179.747 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.17 144.06 91.27 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.705 2.27 . . . . 0.0 111.833 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.537 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.7 mm? -63.8 -34.82 78.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.215 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.45 118.79 0.11 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.5 t -147.4 150.82 35.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.822 0.344 . . . . 0.0 110.433 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.1 m -80.0 108.44 13.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.384 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.58 63.85 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.79 -179.61 52.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -174.12 -20.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.372 . . . . 0.0 110.548 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.26 107.96 0.01 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.6 mt -59.76 -36.24 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.728 0.299 . . . . 0.0 110.708 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.79 66.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.761 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 m -136.98 21.52 3.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.491 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.445 ' O ' ' OE1' ' A' ' 33' ' ' GLN . 55.9 mt -112.8 137.14 51.57 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.804 0.335 . . . . 0.0 110.825 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.549 ' NE2' ' OD1' ' A' ' 48' ' ' ASN . 1.8 mp0 -110.16 156.64 20.34 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.77 140.56 51.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.384 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -125.03 135.36 52.68 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.037 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.429 ' OG ' ' OH ' ' A' ' 188' ' ' TYR . 21.2 t -146.02 147.89 32.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.903 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -138.37 118.35 13.37 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.9 p -70.99 -31.44 67.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.896 0.379 . . . . 0.0 110.247 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -62.29 -49.8 74.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.979 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -86.2 -20.61 28.29 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.37 40.24 80.26 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.83 149.91 39.21 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.219 0.509 . . . . 0.0 110.705 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -151.06 144.44 24.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.713 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -151.12 159.48 44.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.048 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.8 mt -100.2 151.28 21.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.394 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 11.2 p90 -150.91 146.74 19.62 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.535 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.24 161.36 44.73 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.441 2.094 . . . . 0.0 112.483 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.549 ' OD1' ' NE2' ' A' ' 33' ' ' GLN . 52.7 m-20 -73.5 159.29 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.553 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.9 -2.18 63.91 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -93.67 144.53 25.31 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 pt -118.47 141.78 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.309 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.84 133.67 11.48 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.8 t -111.68 133.19 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.924 0.392 . . . . 0.0 110.745 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -83.45 138.86 33.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.201 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.69 54.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.152 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -78.29 129.21 34.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.645 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.95 -4.52 75.1 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.21 -162.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.518 -0.341 . . . . 0.0 110.141 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.0 m -36.79 111.19 0.5 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -45.2 134.47 11.59 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.752 1.635 . . . . 0.0 112.101 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.91 -35.97 4.57 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.28 134.32 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -115.48 -58.43 2.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.236 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.6 t -143.46 143.38 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.798 0.333 . . . . 0.0 111.113 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.2 t -120.35 131.75 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.417 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -112.81 133.39 54.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.418 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 73.5 mtt85 -131.56 138.91 49.08 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.54 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -87.4 118.73 27.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.358 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -61.41 -38.97 89.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.534 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.62 -48.44 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.451 ' CD ' HH12 ' A' ' 170' ' ' ARG . 96.0 mt-10 -126.85 102.71 7.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.568 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -69.56 -25.49 64.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.976 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -57.85 -38.97 76.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.204 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -98.29 139.59 33.84 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.718 0.294 . . . . 0.0 110.381 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.87 147.65 18.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.001 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.1 tt -115.11 134.7 54.94 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.193 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.1 t -131.8 144.47 50.94 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.33 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.44 132.5 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.072 0.463 . . . . 0.0 110.493 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.0 mt -120.95 126.06 74.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.684 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.86 130.83 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.851 0.358 . . . . 0.0 110.486 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.9 m -139.63 161.96 36.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.953 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -105.44 132.54 51.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.738 0.304 . . . . 0.0 110.369 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -96.22 150.54 37.3 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.361 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.43 137.94 31.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.018 1.812 . . . . 0.0 111.045 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.7 t -63.28 -28.2 69.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.074 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.67 -31.14 70.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -129.97 158.41 39.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.139 0.495 . . . . 0.0 111.599 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.8 t -122.6 176.34 5.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.449 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.8 tp -52.36 -44.72 65.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.179 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.9 p -66.13 -45.59 80.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.92 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -67.56 -35.44 79.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.737 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.0 tp -55.88 -42.09 75.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.5 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.95 175.79 45.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.656 ' HG1' ' H ' ' A' ' 97' ' ' ASP . 38.0 p -93.93 171.19 9.02 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.09 -42.01 76.06 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.186 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.0 m -72.39 -44.93 61.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.029 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.656 ' H ' ' HG1' ' A' ' 94' ' ' THR . 46.3 t0 -62.1 -51.24 68.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.45 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.94 -38.76 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.558 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.5 -45.91 93.86 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -66.03 -41.21 91.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.642 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -62.29 -38.56 89.82 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.685 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -62.41 -41.46 98.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.1 mmt -58.81 -44.41 90.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.949 0.404 . . . . 0.0 110.34 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -64.97 -39.87 94.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.495 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.0 m -59.48 -47.26 86.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.857 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.6 t -71.59 -45.61 66.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.993 0.425 . . . . 0.0 110.331 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 111' ' ' GLN . 86.6 m-20 -62.06 -31.96 72.43 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.277 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -42.61 -36.15 1.3 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.219 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.82 -16.25 14.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.016 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -101.48 -3.33 28.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 107' ' ' ASN . 32.7 tt0 -67.12 13.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.961 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.54 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -84.99 -64.25 1.55 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.208 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.2 p-10 -118.59 -39.06 3.03 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.521 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 20.2 ptp180 -101.43 159.79 14.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.01 0.433 . . . . 0.0 111.24 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -130.0 150.24 51.37 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.518 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.25 138.28 40.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.15 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -123.44 130.32 52.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.1 tt -84.13 108.88 17.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.014 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 119' ' ' ILE . 96.6 mt -71.12 -54.95 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.783 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.55 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 11.4 p30 -156.65 176.78 12.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.976 0.417 . . . . 0.0 111.122 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.6 128.4 6.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.327 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -142.07 160.74 39.61 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.505 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.29 144.68 42.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.904 0.383 . . . . 0.0 110.47 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -131.94 152.46 51.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -124.91 116.34 22.04 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.562 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.87 144.5 33.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.013 0.435 . . . . 0.0 110.825 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.1 t0 52.29 28.99 6.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.58 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.96 -1.79 77.86 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -100.83 146.6 27.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.263 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.8 129.72 65.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.159 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -118.45 123.65 45.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.322 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.63 124.2 48.39 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.3 m -102.76 133.12 48.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.822 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.91 108.0 9.8 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.963 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.55 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 70.6 tt0 -100.12 126.17 46.32 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -148.22 168.74 21.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.159 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -137.77 160.0 40.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.479 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.51 133.73 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.461 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.423 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 3.0 pp -134.06 143.86 48.3 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.335 0.588 . . . . 0.0 111.1 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.5 p -108.54 133.29 54.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.248 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 51.75 -108.34 0.6 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -116.96 12.53 14.67 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -119.13 146.15 45.37 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.858 0.361 . . . . 0.0 111.704 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.6 128.28 37.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.816 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.423 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 70.5 tt0 -83.48 -53.51 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.406 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.5 ptm85 -172.64 171.99 4.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.424 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 63.7 m80 -108.89 137.44 46.8 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.256 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 84.4 m-20 -135.85 141.4 44.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.9 0.381 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 57.7 tp -116.49 136.71 52.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.986 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.87 132.82 39.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.938 0.399 . . . . 0.0 110.56 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.8 t -119.08 135.75 54.49 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.692 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.413 ' C ' ' HG1' ' A' ' 153' ' ' THR . 40.8 t -114.87 130.16 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.963 0.411 . . . . 0.0 110.542 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.413 ' HG1' ' C ' ' A' ' 152' ' ' VAL . 59.8 m -148.86 146.26 27.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.84 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.3 p -90.7 156.63 17.95 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.579 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 158' ' ' LYS . 9.1 t-20 -150.87 95.9 2.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.787 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 55.65 39.24 30.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.8 7.57 77.98 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 155' ' ' ASN . 68.9 mmtt -110.61 137.73 47.91 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 110.017 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.24 117.46 26.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.816 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.1 mm -107.92 119.97 58.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.1 m -120.49 132.22 55.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.814 0.34 . . . . 0.0 110.185 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.01 103.95 11.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.622 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -103.37 120.19 40.32 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.899 0.38 . . . . 0.0 111.562 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 mp -115.58 142.92 46.08 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.083 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 31.1 t -137.06 131.95 33.48 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.432 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.425 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 21.3 m -152.87 159.06 42.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.696 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.425 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -54.31 145.41 17.89 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.28 -36.68 71.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.8 -33.14 75.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.183 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.451 HH12 ' CD ' ' A' ' 71' ' ' GLU . 80.1 mtp180 -97.53 -16.69 19.98 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.515 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.604 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 48.4 t-105 -48.03 -41.73 26.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 110.691 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.38 -41.69 98.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.062 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.3 m -65.68 -40.39 92.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.382 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.9 m -107.2 21.51 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 171' ' ' TRP . 20.8 pttm -48.94 -45.38 41.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.412 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 86.7 p -67.89 -27.49 66.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.574 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.63 -44.61 85.7 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.917 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.604 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.4 m-85 -62.29 -50.01 73.4 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.388 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.24 -41.53 98.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.665 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.8 m -68.75 -49.62 57.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.4 -38.55 79.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.348 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.89 -40.55 97.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.294 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.2 p -80.96 -17.77 49.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.346 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -62.77 -37.76 87.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.193 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.481 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -54.29 146.09 16.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.771 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -135.91 154.95 50.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.6 m -127.22 151.56 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.903 0.382 . . . . 0.0 111.336 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.429 ' OH ' ' OG ' ' A' ' 36' ' ' SER . 43.5 p90 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.768 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.498 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 31.7 Cg_endo -62.65 147.02 95.33 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.761 2.308 . . . . 0.0 111.831 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.4 tp -93.68 128.5 39.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.235 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.89 11.58 0.17 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.3 m -64.25 154.77 34.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.4 p -150.56 -11.7 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.541 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.85 -128.25 28.88 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.43 -170.7 46.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.78 157.32 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.799 0.333 . . . . 0.0 110.47 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.05 -178.14 49.95 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 mm -77.73 51.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 110.024 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.28 157.17 41.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.202 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.67 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 25.7 t -84.76 136.32 33.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.582 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.7 mt -100.57 146.14 27.49 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.5 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.3 pm0 -138.51 165.51 26.67 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.062 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -119.09 139.89 51.01 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.086 0.469 . . . . 0.0 111.411 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -122.44 130.15 52.78 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.73 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.9 m -131.2 150.18 52.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.829 0.347 . . . . 0.0 110.821 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -139.1 122.08 16.7 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.448 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.1 p -75.36 -29.09 59.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.287 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.25 -48.35 81.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 49.6 t0 -93.12 -20.06 20.87 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.85 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.52 42.6 72.3 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.02 148.49 40.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.056 0.428 . . . . 0.0 110.199 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -146.51 142.07 27.68 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -154.03 158.17 40.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.075 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mp -100.96 144.63 29.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.153 0.501 . . . . 0.0 110.424 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -148.4 148.15 27.84 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.866 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.59 155.86 68.45 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.298 1.999 . . . . 0.0 112.159 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' ' 31' ' ' SER . 20.6 p30 -72.71 160.69 31.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.93 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.28 1.77 59.26 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.519 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 33.2 m0 -92.76 145.12 24.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.659 0.266 . . . . 0.0 110.296 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.4 pt -121.26 145.1 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.356 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.27 131.0 10.42 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.57 132.19 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.951 0.405 . . . . 0.0 110.521 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -81.84 135.73 35.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.196 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.59 56.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.412 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -74.94 132.9 41.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.112 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.8 2.62 71.91 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.06 -164.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.445 ' OG ' ' CG2' ' A' ' 62' ' ' VAL . 79.5 p -39.96 123.65 1.6 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.51 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -42.04 121.48 1.84 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.957 1.772 . . . . 0.0 112.823 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.69 -42.39 1.95 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.445 ' CG2' ' OG ' ' A' ' 59' ' ' SER . 56.1 t -63.88 122.04 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -120.0 -48.57 2.34 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.516 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.6 t -128.64 137.93 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 110.889 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.56 135.03 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.646 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.74 132.95 54.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.071 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' NH1' ' OD1' ' A' ' 75' ' ' ASN . 53.4 ttt85 -130.86 132.56 45.25 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.434 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.519 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 75.3 m-20 -92.27 118.86 31.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.58 -36.92 83.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.548 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.409 HG23 HD11 ' A' ' 70' ' ' ILE . 27.1 mm -62.84 -42.51 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.82 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -117.51 105.78 12.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.891 0.376 . . . . 0.0 110.693 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.72 -37.57 67.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.607 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 40.3 p-10 -62.59 -33.11 74.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.081 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 83.4 tt0 -87.16 130.42 34.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.888 0.375 . . . . 0.0 110.585 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.433 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 10.9 m-80 -140.85 139.18 34.42 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.089 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.9 tt -126.14 134.32 51.34 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.8 m -126.87 146.69 50.19 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.306 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.32 128.41 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.952 0.406 . . . . 0.0 110.278 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.5 mt -117.12 116.84 53.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.974 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.4 mm -116.01 123.97 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.922 0.392 . . . . 0.0 110.469 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 159' ' ' LEU . 75.3 m -146.67 160.59 42.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.05 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.9 pm0 -103.95 132.7 49.95 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.6 pt -88.54 148.33 41.79 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.661 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' LYS . 39.0 Cg_endo -66.7 138.02 47.78 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.716 1.611 . . . . 0.0 110.612 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.9 p -63.69 -26.11 68.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.994 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.08 -31.02 70.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.959 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 84' ' ' PRO . 97.4 mttt -130.62 155.63 46.24 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.046 0.45 . . . . 0.0 111.228 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.545 ' HG1' ' H ' ' A' ' 89' ' ' LEU . 14.8 t -122.82 174.97 6.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.346 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.545 ' H ' ' HG1' ' A' ' 88' ' ' THR . 49.3 tp -53.05 -43.53 66.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.125 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.6 p -67.39 -44.43 78.93 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.044 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -68.44 -34.81 76.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.979 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -55.57 -42.33 74.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.478 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.65 177.99 46.89 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.652 ' HG1' ' H ' ' A' ' 97' ' ' ASP . 35.0 p -92.69 172.22 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.39 76.0 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.222 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.5 m -72.68 -45.21 59.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.854 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.652 ' H ' ' HG1' ' A' ' 94' ' ' THR . 46.9 t0 -62.33 -51.62 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.68 -38.83 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.543 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -57.8 -53.26 46.74 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -62.24 -36.41 81.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.57 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -57.16 -38.37 73.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.599 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.37 -41.12 98.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.865 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.678 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -55.84 -54.06 49.18 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.396 0.617 . . . . 0.0 109.802 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -61.92 -38.42 88.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.802 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -59.42 -46.98 87.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.858 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.7 t -71.29 -46.23 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 0.0 110.384 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.0 m-20 -62.23 -31.02 71.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.053 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -43.99 -36.91 2.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.089 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.06 -11.1 14.98 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.234 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -121.32 18.11 11.44 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.506 -178.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.4 pt20 -75.64 2.13 12.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.563 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.67 -62.5 2.38 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.802 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.4 p-10 -117.25 -38.11 3.41 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.844 0.354 . . . . 0.0 111.477 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.517 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 40.4 ttm180 -79.2 141.28 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.28 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -129.5 132.48 46.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.959 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.77 134.11 46.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.895 0.378 . . . . 0.0 110.334 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.66 122.51 40.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.319 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 tp -81.29 111.11 17.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.327 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.525 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 97.0 mt -71.57 -42.75 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.891 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 4.0 m-80 177.76 174.47 0.52 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.297 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.81 144.15 22.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.161 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.411 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 57.5 mp0 -144.07 145.86 32.45 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.857 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.32 135.65 53.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.311 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -116.86 159.2 22.73 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -139.51 107.29 5.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.516 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.43 144.91 38.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.933 0.397 . . . . 0.0 111.052 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.1 t0 52.8 30.24 8.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.59 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.69 0.92 75.76 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -102.9 146.68 27.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.903 0.382 . . . . 0.0 110.154 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.34 129.23 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.344 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -117.63 127.97 54.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -105.88 122.44 46.12 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.1 m -105.55 123.33 47.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.234 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.38 125.01 53.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.93 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -120.36 117.99 29.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.362 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -146.48 162.5 38.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.27 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.485 ' HE ' ' CG1' ' A' ' 119' ' ' ILE . 19.8 ptp180 -124.54 149.05 47.37 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.015 0.436 . . . . 0.0 110.803 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.05 133.87 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.352 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -139.91 134.86 32.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.242 0.544 . . . . 0.0 110.923 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.442 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 32.0 t -116.57 135.64 56.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.387 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.27 -122.39 18.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -112.31 14.91 20.51 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 140' ' ' VAL . 21.7 p-10 -133.5 160.14 38.3 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 111.509 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.2 p -87.07 127.88 40.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.453 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -76.45 -55.2 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.756 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.475 ' NH1' ' O ' ' A' ' 73' ' ' ASP . 20.1 ptp180 -174.82 174.58 2.55 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.078 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 61.7 m170 -103.01 139.0 39.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.011 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -132.84 133.36 43.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.974 0.416 . . . . 0.0 111.161 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.5 tp -111.52 133.96 53.43 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.908 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.39 131.49 48.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.921 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.5 t -120.97 123.04 41.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.2 129.04 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.015 0.436 . . . . 0.0 111.186 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.5 m -143.69 146.19 33.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.29 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.5 p -111.15 152.02 27.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.751 0.31 . . . . 0.0 110.263 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -158.46 119.85 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 55.94 29.74 14.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.77 14.28 78.05 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -105.38 128.43 53.5 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -90.02 119.29 30.25 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 160' ' ' ILE . 75.8 mt -124.39 128.1 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.7 0.286 . . . . 0.0 110.738 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.8 m -131.18 139.44 49.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.394 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.75 103.99 11.76 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.224 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -99.31 110.27 22.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.627 0.251 . . . . 0.0 110.422 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.4 mp -116.2 134.63 54.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.58 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 55.7 m -125.91 136.63 53.26 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.058 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.6 m -152.86 157.33 40.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.46 142.28 49.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.375 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -69.09 -30.64 68.98 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.033 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.86 -34.12 71.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.053 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -113.24 -3.85 13.81 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.498 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.9 t-105 -49.78 -39.16 37.14 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.882 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.98 -42.18 99.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.091 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 56.9 m -64.78 -39.81 94.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.74 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 14.7 m -107.97 21.08 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.262 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -50.06 -49.48 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.285 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.3 t -64.63 -30.72 71.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.846 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -55.21 -44.06 75.03 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.217 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 24.3 m-85 -61.56 -50.33 73.07 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.348 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -64.47 -40.17 95.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.656 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 184' ' ' SER . 41.9 m -66.84 -47.11 72.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.501 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 63.9 t -62.7 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.664 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.47 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -67.01 -46.8 73.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.208 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.1 m -68.72 -33.14 73.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.382 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 180' ' ' THR . 17.8 t -62.2 -27.55 69.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.699 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -56.11 159.18 3.52 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.779 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -135.77 157.89 45.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.8 151.04 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.098 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.485 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 46.2 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.785 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.03 147.53 94.38 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.771 2.314 . . . . 0.0 111.796 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.463 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 7.2 mp -86.01 143.82 27.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.52 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 21' ' ' LEU . . . -57.31 -118.71 0.01 OUTLIER Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -115.08 148.63 38.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.811 0.338 . . . . 0.0 110.445 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.9 m -86.67 125.04 33.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.53 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.32 -177.04 51.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.71 155.06 46.19 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 28' ' ' GLY . 42.7 t -120.7 134.85 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 110.378 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 27' ' ' VAL . . . 57.39 113.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.79 -36.35 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.953 0.406 . . . . 0.0 110.616 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -155.95 84.64 1.02 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.272 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.549 ' OG ' ' O ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -162.03 46.13 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.605 0.717 . . . . 0.0 110.334 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' C ' ' NE2' ' A' ' 33' ' ' GLN . 19.2 mt -135.37 131.96 36.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.705 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.631 ' NE2' ' N ' ' A' ' 33' ' ' GLN . 1.0 OUTLIER -130.68 162.48 29.32 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.251 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -121.25 145.77 47.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.574 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -129.38 134.96 48.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.342 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.9 p -143.19 157.12 44.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.637 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -146.3 119.23 8.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.417 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.1 p -70.49 -32.82 70.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.586 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -62.65 -48.86 77.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.078 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -87.67 -20.75 25.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.869 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.03 39.83 88.8 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.31 151.45 45.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.299 0.549 . . . . 0.0 110.415 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -153.24 143.78 22.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.799 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -150.73 157.71 43.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 mt -98.5 150.96 21.13 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.558 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -152.17 146.11 18.19 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.003 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.48 153.62 69.96 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.397 2.065 . . . . 0.0 112.508 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -69.37 159.37 33.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.997 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.13 -2.51 63.65 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.533 ' CD1' ' OD1' ' A' ' 68' ' ' ASP . 35.8 m0 -94.91 147.13 23.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.772 0.32 . . . . 0.0 110.276 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.8 pt -120.4 149.88 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.324 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -114.98 141.8 17.25 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.7 144.9 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.756 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -84.38 134.87 34.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.379 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.91 55.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.491 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -70.89 135.01 47.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.82 2.34 69.58 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.44 -164.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.641 0.258 . . . . 0.0 110.485 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.76 154.36 1.24 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.215 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.18 131.24 24.6 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.277 1.985 . . . . 0.0 111.915 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 80' ' ' ILE . . . 95.47 -22.28 39.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.43 133.85 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.176 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -118.65 -58.3 1.98 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.639 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.2 t -145.16 148.99 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.928 0.394 . . . . 0.0 111.504 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.56 136.45 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.655 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -112.36 143.11 44.01 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.292 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -145.09 145.78 31.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.847 0.356 . . . . 0.0 110.682 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.533 ' OD1' ' CD1' ' A' ' 50' ' ' TRP . 62.8 m-20 -101.73 122.01 43.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.685 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.42 -39.92 95.78 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.231 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.6 -38.59 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.61 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -126.43 94.62 4.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.46 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -62.19 -38.44 89.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.15 0.5 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 42.1 p-10 -61.78 -32.48 72.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.198 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.525 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 14.0 tm-20 -86.21 125.94 33.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.946 0.403 . . . . 0.0 110.202 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.696 HD21 ' N ' ' A' ' 75' ' ' ASN . 0.0 OUTLIER -171.76 168.91 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.574 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.6 pp -157.23 157.12 33.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.509 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 m -131.16 147.86 52.65 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.67 128.19 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.188 0.518 . . . . 0.0 109.987 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.3 mt -117.08 124.37 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.805 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' GLY . 66.0 mt -118.25 128.8 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.473 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.3 m -138.38 163.38 32.02 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.93 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.77 134.72 47.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.688 0.28 . . . . 0.0 110.403 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.8 pt -103.23 149.21 36.72 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.679 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 87' ' ' LYS . 48.4 Cg_endo -68.24 137.57 40.67 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.105 1.87 . . . . 0.0 111.327 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.4 t -62.46 -27.66 69.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.15 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -67.48 -31.36 71.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.897 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 84' ' ' PRO . 67.9 mttm -128.73 151.96 48.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.077 0.465 . . . . 0.0 111.047 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 15.0 t -120.54 178.22 4.76 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.491 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.0 tp -50.12 -44.32 52.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.094 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.553 ' HG1' ' N ' ' A' ' 91' ' ' ASP . 44.0 p -65.33 -42.95 92.41 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.936 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.553 ' N ' ' HG1' ' A' ' 90' ' ' THR . 86.6 m-20 -65.45 -39.13 91.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.804 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.8 tp -56.4 -43.53 79.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.585 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.7 176.25 45.57 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.567 ' HG1' ' H ' ' A' ' 97' ' ' ASP . 33.5 p -93.2 172.58 8.21 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.74 79.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.1 m -72.26 -44.48 62.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.567 ' H ' ' HG1' ' A' ' 94' ' ' THR . 46.2 t0 -61.92 -50.98 69.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.303 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 82.1 t -60.49 -38.67 78.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.498 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.69 -44.02 94.21 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -69.33 -42.45 75.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.896 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -61.29 -39.05 89.01 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.961 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -62.03 -40.63 96.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.38 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.78 -44.26 94.01 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.404 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.28 -39.45 93.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.266 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.3 m -60.19 -47.63 85.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.811 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.52 -45.4 68.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.96 0.41 . . . . 0.0 110.496 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 111' ' ' GLN . 85.1 m-20 -62.41 -30.35 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.244 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -45.03 -39.91 6.09 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.972 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.48 -4.28 29.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.693 0.282 . . . . 0.0 110.8 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -121.44 14.65 11.17 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.052 -179.226 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 107' ' ' ASN . 6.5 tt0 -72.03 3.06 4.76 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.092 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.37 -64.6 1.44 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.67 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -117.71 -48.6 2.57 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.996 0.427 . . . . 0.0 111.379 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' SER . 84.4 mtt180 -70.12 149.02 48.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.508 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -134.43 129.83 35.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.849 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.76 128.21 46.89 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.76 0.314 . . . . 0.0 110.223 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -115.08 128.77 56.44 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.1 tp -81.98 108.99 15.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.081 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 119' ' ' ILE . 96.6 mt -70.39 -53.76 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.547 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.546 ' C ' HD21 ' A' ' 120' ' ' ASN . 0.3 OUTLIER -163.11 167.77 21.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.645 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.94 124.38 5.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.418 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -141.78 162.89 34.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.628 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.405 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.64 148.4 50.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.47 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -130.64 141.47 50.43 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.176 0.512 . . . . 0.0 111.258 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -107.65 112.69 25.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.275 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.25 141.47 35.86 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.945 0.403 . . . . 0.0 110.693 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.69 38.95 24.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.207 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.59 0.7 25.95 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -105.54 147.35 28.46 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.983 0.42 . . . . 0.0 110.189 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.19 128.38 72.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.011 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 21.2 m-85 -116.68 129.36 56.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.844 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.405 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.5 m-85 -104.11 128.23 51.75 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.3 m -110.93 123.89 51.04 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.248 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.6 mp -117.49 124.42 48.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.938 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.459 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 71.1 tt0 -118.07 120.2 37.06 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -147.05 170.02 18.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.075 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.726 HH21 ' HE2' ' A' ' 147' ' ' HIS . 11.6 ptm180 -138.18 155.56 48.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 110.8 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.62 133.52 47.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.374 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -142.71 136.37 28.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.197 0.522 . . . . 0.0 111.498 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.3 t -108.2 130.49 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.003 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.62 -119.52 18.98 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -110.02 10.52 24.14 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.816 -0.226 . . . . 0.0 111.228 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -117.74 147.35 43.05 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.761 0.315 . . . . 0.0 111.149 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 43.2 t -88.14 127.0 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.743 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -76.2 -54.03 7.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -173.7 174.36 3.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.181 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.726 ' HE2' HH21 ' A' ' 137' ' ' ARG . 29.9 m170 -104.87 139.86 38.99 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 83.9 m-20 -134.64 136.9 43.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -113.62 132.43 55.76 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.114 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -127.16 131.95 50.62 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.008 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.9 t -125.12 127.67 47.23 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.74 128.12 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.987 0.422 . . . . 0.0 110.939 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.8 m -139.72 141.84 36.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.035 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.7 p -104.76 152.6 22.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.909 0.385 . . . . 0.0 110.463 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -162.75 122.87 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 55.67 29.34 13.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.354 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.69 13.21 80.37 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -107.84 140.63 40.66 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.678 0.275 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.67 120.39 37.97 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.416 HD13 HG23 ' A' ' 160' ' ' ILE . 80.5 mt -118.46 124.48 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.049 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.2 m -125.93 136.18 52.74 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.314 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.07 99.85 7.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.061 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -97.2 111.63 23.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.668 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.07 138.25 51.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.831 0.348 . . . . 0.0 110.48 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.521 ' OG ' ' ND2' ' A' ' 75' ' ' ASN . 61.4 p -134.57 135.35 42.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.967 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 6.4 m -152.93 161.67 42.26 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.634 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.6 ' CB ' HH21 ' A' ' 170' ' ' ARG . . . -54.22 144.31 20.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.313 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -70.41 -36.34 73.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.055 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -62.76 -33.42 75.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.356 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.6 HH21 ' CB ' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -97.68 -19.89 17.96 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.896 -179.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.492 ' O ' ' N ' ' A' ' 175' ' ' LYS . 59.5 t-105 -45.58 -40.34 8.67 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.77 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.12 -42.61 99.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.199 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 55.0 m -66.96 -39.32 87.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.539 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.0 m -109.55 21.48 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 171' ' ' TRP . 16.9 pttm -51.69 -47.62 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.497 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 85.8 p -69.61 -24.09 63.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.467 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -59.07 -42.57 90.69 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.994 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.415 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 20.2 m-85 -66.9 -50.22 63.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.485 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.47 -41.22 98.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.579 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 184' ' ' SER . 47.8 m -67.91 -49.32 62.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 55.9 t -61.55 -42.99 96.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.462 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.61 -40.32 96.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.924 0.392 . . . . 0.0 110.287 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 39.1 m -79.63 -28.42 40.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.349 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.436 ' N ' ' O ' ' A' ' 180' ' ' THR . 87.8 p -63.19 -23.55 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.505 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -63.24 157.55 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.437 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -139.6 160.26 40.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.731 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.46 151.12 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 38.0 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.72 -179.812 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.04 147.94 93.91 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.827 2.351 . . . . 0.0 111.593 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 7.9 mp -58.63 -36.99 74.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.07 21.85 69.85 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.504 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 43.1 m -61.77 147.72 45.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.402 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.504 ' SG ' ' O ' ' A' ' 23' ' ' SER . 43.9 m -159.78 46.2 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.257 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.95 -105.57 1.3 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.41 32.57 27.76 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.8 m -60.26 137.14 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.726 0.298 . . . . 0.0 110.218 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.95 138.7 48.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -82.35 82.6 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.678 0.275 . . . . 0.0 110.38 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.93 -140.7 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.289 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.513 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 44.0 t -117.34 136.22 53.29 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.366 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.0 mt -112.49 146.07 39.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.252 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.553 HE22 ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -131.16 152.52 50.36 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.229 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -109.67 128.4 55.23 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.008 0.432 . . . . 0.0 110.958 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -114.31 119.04 35.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.544 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 50.0 m -126.98 149.07 50.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.934 0.397 . . . . 0.0 110.949 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 36' ' ' SER . 87.4 m-20 -138.18 111.4 7.94 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.245 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.9 p -64.41 -34.05 77.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.46 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 26.2 mtpp -60.9 -43.87 97.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.51 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -89.6 -20.41 23.76 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.092 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.34 37.56 90.68 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.1 151.12 45.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.095 0.448 . . . . 0.0 110.384 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -150.54 147.28 27.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 45' ' ' LEU . 43.3 t80 -160.77 147.57 15.33 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.067 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' O ' ' CE2' ' A' ' 44' ' ' PHE . 9.9 mp -93.77 143.3 26.46 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.943 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -149.51 130.63 7.2 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.991 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.97 157.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.221 1.947 . . . . 0.0 112.892 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.553 ' N ' HE22 ' A' ' 33' ' ' GLN . 66.9 m-80 -81.41 158.13 24.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.987 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.24 0.83 61.27 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -81.05 149.73 29.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.5 pt -113.4 142.25 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.376 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.34 133.47 11.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.4 t -108.85 133.33 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.853 0.359 . . . . 0.0 110.412 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.63 124.39 32.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.271 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.84 55.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.606 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -80.48 130.17 34.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.744 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.66 -3.57 78.47 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 59' ' ' SER . . . -80.25 -162.84 0.48 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.299 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 58' ' ' ALA . 28.2 m -36.43 109.24 0.41 Allowed Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.76 135.04 10.13 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.865 1.71 . . . . 0.0 111.997 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.19 -36.0 4.57 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.96 127.08 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.116 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -103.55 -59.11 1.77 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.693 0.283 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.4 t -150.56 141.21 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.17 130.95 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.76 133.91 55.53 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.521 ' NH2' ' OD1' ' A' ' 75' ' ' ASN . 76.2 mtp85 -124.55 140.89 52.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.719 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -88.48 118.31 28.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.391 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -62.42 -39.23 92.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.335 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 70' ' ' ILE . 26.6 mm -63.46 -42.3 95.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.792 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -112.86 107.04 15.49 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.816 0.341 . . . . 0.0 110.85 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -73.76 -45.9 48.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.309 0.576 . . . . 0.0 110.278 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.41 -37.24 74.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.206 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -84.08 129.53 34.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.382 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.521 ' OD1' ' NH2' ' A' ' 67' ' ' ARG . 7.4 m-80 -130.29 148.07 52.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.007 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.63 133.75 53.14 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 p -136.31 138.23 41.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.96 0.409 . . . . 0.0 110.158 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.9 t -122.08 130.62 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.931 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.0 mt -121.02 131.83 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.462 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 60.8 mt -122.54 133.05 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.621 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' LEU . 49.2 m -143.53 164.1 31.3 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.239 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -105.5 138.23 42.04 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.522 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.82 153.37 38.28 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.253 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 87' ' ' LYS . 72.4 Cg_endo -75.68 141.49 24.81 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.379 2.052 . . . . 0.0 110.892 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.8 p -68.44 -26.45 65.52 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.918 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -69.22 -32.0 70.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.972 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 84' ' ' PRO . 64.9 mttm -130.87 157.95 41.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.999 0.428 . . . . 0.0 111.302 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.7 t -123.12 175.47 6.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.834 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.5 tp -49.98 -45.31 51.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.07 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.1 p -65.61 -44.45 86.52 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.79 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.72 -36.26 83.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.99 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 tt -55.87 -47.7 76.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.429 . . . . 0.0 110.245 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.19 177.5 46.95 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.0 p -90.94 170.13 10.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.93 74.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.96 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.0 m -71.43 -45.07 63.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.5 -53.29 58.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.299 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 80.0 t -61.25 -39.73 83.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.705 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.09 -45.11 92.81 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -66.28 -41.62 89.58 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -62.21 -39.38 92.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -62.2 -40.54 96.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.703 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.8 mmt -58.16 -44.93 88.18 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.599 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.55 -44.49 90.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 110.066 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.7 m -60.2 -44.76 94.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.837 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.75 -46.21 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.461 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 111' ' ' GLN . 87.8 m-20 -64.36 -42.12 96.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.053 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -43.6 -20.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.37 . . . . 0.0 110.748 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 107' ' ' ASN . . . -91.1 -43.67 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.607 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.8 p -119.38 19.63 12.69 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.2 tt0 -56.38 -28.78 60.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.337 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -42.53 -62.64 2.12 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.23 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -117.63 -44.3 2.75 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.766 0.317 . . . . 0.0 111.336 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -80.47 144.95 32.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.469 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -131.53 142.55 49.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.162 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.16 135.41 44.86 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -116.73 129.64 56.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.9 tt -81.5 104.28 11.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.12 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.417 HG21 HD12 ' A' ' 119' ' ' ILE . 96.4 mt -70.35 -45.88 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.334 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 3.1 m-80 -169.65 166.71 9.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.363 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.14 126.3 5.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.413 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -142.9 163.5 32.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.748 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.17 149.69 46.08 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.506 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -131.65 144.89 51.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.143 0.497 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -111.53 114.53 27.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.557 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.91 138.57 33.97 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.504 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 129' ' ' GLN . 85.8 m-20 52.05 40.97 29.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.788 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.78 2.29 7.7 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 127' ' ' ASP . 66.3 tp60 -103.32 133.19 48.81 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.63 130.45 55.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.389 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -118.02 128.39 54.73 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -105.51 129.83 53.71 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.4 m -113.21 122.92 48.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.607 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.3 mp -115.39 126.1 53.99 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.739 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -118.81 122.12 41.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.768 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -150.44 171.3 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.29 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.715 HH21 ' HE2' ' A' ' 147' ' ' HIS . 9.6 ptm180 -136.5 156.58 48.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 110.494 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.2 t -106.39 135.01 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.025 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.79 136.25 30.48 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.163 0.506 . . . . 0.0 111.58 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.2 t -97.79 121.79 48.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.74 -110.89 3.08 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -113.31 10.56 18.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.565 0.222 . . . . 0.0 110.871 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -113.34 137.16 51.91 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.684 0.278 . . . . 0.0 111.317 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.73 126.63 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.637 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -81.05 -55.04 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.474 ' NH2' ' C ' ' A' ' 166' ' ' THR . 6.5 ptm85 -172.56 174.22 3.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.715 ' HE2' HH21 ' A' ' 137' ' ' ARG . 56.2 m170 -105.05 138.38 41.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.131 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 82.2 m-20 -135.36 130.93 35.71 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.725 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 tp -110.89 128.16 55.7 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.9 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.6 134.84 55.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.24 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.0 t -125.68 121.73 34.3 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.1 t -105.67 129.44 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.934 0.397 . . . . 0.0 110.874 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 59.8 m -142.79 144.42 32.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.0 p -86.93 156.82 19.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.871 0.367 . . . . 0.0 110.762 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -150.35 95.94 2.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.721 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 54.2 43.32 30.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.479 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.43 18.25 66.89 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.728 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 40.9 mtpt -121.71 137.26 54.83 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.952 0.376 . . . . 0.0 111.108 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 81' ' ' SER . 1.2 mt -91.81 119.28 31.47 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 160' ' ' ILE . 72.1 mt -123.29 122.14 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.2 m -115.72 133.24 56.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 110.245 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -105.2 110.23 22.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.612 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.82 122.14 43.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.951 0.405 . . . . 0.0 111.675 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mt -115.64 132.91 56.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.543 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.4 m -130.26 130.62 44.8 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.859 0.361 . . . . 0.0 110.31 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.474 ' C ' ' NH2' ' A' ' 146' ' ' ARG . 3.7 m -153.02 158.12 41.52 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.34 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -57.0 143.38 38.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.205 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -69.85 -29.64 66.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.166 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.19 -33.77 72.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.215 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -111.84 -6.48 14.27 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.557 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 53.7 t-105 -48.25 -39.52 21.67 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.811 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.85 -42.04 97.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 56.6 m -65.47 -39.99 92.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.569 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.5 m -107.71 21.44 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.255 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -49.21 -48.19 45.57 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.447 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.0 m -64.2 -32.08 73.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.649 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.9 tp -53.81 -44.94 70.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.045 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.557 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 18.9 m-85 -62.45 -49.04 77.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.477 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.92 -41.58 99.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 184' ' ' SER . 48.8 m -67.72 -47.62 68.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.81 -43.73 99.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.627 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -61.6 -38.45 87.64 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.7 t -85.14 -20.4 30.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 180' ' ' THR . 45.5 t -62.11 -33.58 74.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.059 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.2 OUTLIER -57.21 159.56 4.42 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.321 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -138.28 152.77 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 13.9 m -128.0 151.49 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.082 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.623 -179.734 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 28.2 Cg_endo -61.67 -23.61 76.57 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.721 2.281 . . . . 0.0 111.766 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 23' ' ' SER . 2.5 pp -59.9 -35.64 75.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.462 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.34 33.71 0.96 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 21' ' ' LEU . 54.0 p -65.18 160.32 21.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 110.605 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.2 m -93.82 130.71 39.74 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.48 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.82 -122.87 23.21 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.4 2.38 63.74 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 m -129.79 158.05 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.773 0.32 . . . . 0.0 110.142 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.98 3.35 0.11 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 30' ' ' ALA . 15.8 mm -100.36 154.5 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 29' ' ' ILE . . . -30.09 -69.09 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.578 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.7 ' HG ' HD21 ' A' ' 48' ' ' ASN . 87.8 p -149.68 152.48 35.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.754 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.3 mt -117.18 143.51 45.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.404 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.605 ' NE2' ' N ' ' A' ' 48' ' ' ASN . 2.1 pm0 -139.53 160.48 39.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.078 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -129.98 147.83 51.77 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.138 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.664 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -124.93 158.38 33.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.453 178.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -144.74 161.2 39.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.834 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 41' ' ' GLY . 45.0 t0 -145.52 109.06 4.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.646 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.6 m -59.64 -37.81 79.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.885 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 62.5 mttp -58.7 -47.06 85.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.25 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -89.75 -20.26 23.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.921 0.391 . . . . 0.0 110.507 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . 66.66 40.27 93.96 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.503 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.2 150.11 43.77 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.139 0.47 . . . . 0.0 110.608 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -153.42 147.31 25.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.376 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.482 ' CZ ' ' OH ' ' A' ' 35' ' ' TYR . 28.6 p90 -161.27 158.91 27.93 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.619 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 mt -81.06 153.49 27.34 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.412 0.625 . . . . 0.0 111.667 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.664 ' CD1' ' CZ ' ' A' ' 35' ' ' TYR . 16.8 p90 -162.41 141.79 7.18 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.457 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.27 156.52 58.88 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.276 1.984 . . . . 0.0 112.422 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.7 HD21 ' HG ' ' A' ' 31' ' ' SER . 44.6 p30 -74.25 160.7 30.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.216 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.43 -4.78 56.93 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.532 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 36.0 m0 -85.02 139.63 31.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.1 pt -113.61 134.39 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.158 0.504 . . . . 0.0 110.638 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.99 127.81 9.09 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.3 t -105.26 135.35 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.324 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 51.3 p30 -71.0 149.16 46.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.243 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -152.66 48.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.42 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -76.68 128.24 34.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.022 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.53 7.6 78.74 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.14 -164.68 0.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.637 0.256 . . . . 0.0 110.568 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.78 156.39 1.64 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.115 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.2 127.84 17.42 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.499 2.133 . . . . 0.0 112.253 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.456 ' O ' ' N ' ' A' ' 80' ' ' ILE . . . 97.51 -22.68 39.53 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.6 t -68.79 128.79 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -118.98 -57.5 2.02 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.8 t -142.21 142.54 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.86 0.362 . . . . 0.0 111.157 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.6 t -117.09 134.31 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.215 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -111.67 131.63 55.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.953 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -129.83 138.57 51.08 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.483 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 72.2 m-20 -89.26 118.77 29.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.625 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.8 tp -66.83 -39.3 87.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.981 0.42 . . . . 0.0 110.328 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 85.9 mt -62.11 -43.16 97.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.345 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -117.98 108.87 15.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.828 0.346 . . . . 0.0 110.817 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -65.43 -43.19 91.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.354 0.597 . . . . 0.0 110.379 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 91.4 m-20 -58.2 -37.42 74.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.338 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' OE2' ' OG1' ' A' ' 166' ' ' THR . 47.4 tp10 -74.85 132.38 41.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.32 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 19.7 m-80 -149.23 139.0 21.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.539 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -129.83 134.69 47.7 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.862 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.3 t -127.86 138.51 52.72 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.1 t -116.01 125.24 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.7 mt -124.5 122.04 62.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 61' ' ' GLY . 72.6 mt -120.88 135.33 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.703 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 159' ' ' LEU . 22.8 t -148.08 164.68 33.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.37 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -103.49 134.44 46.84 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.5 pt -92.8 148.77 36.63 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.455 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 87' ' ' LYS . 40.1 Cg_endo -66.51 136.51 43.19 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.541 1.494 . . . . 0.0 110.49 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.5 p -63.86 -26.09 68.46 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.854 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -68.57 -30.96 69.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.815 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 84' ' ' PRO . 28.5 mtmm -130.92 148.94 52.74 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.132 0.491 . . . . 0.0 111.544 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.421 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 71.6 p -109.35 179.06 4.26 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.652 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.69 -41.07 73.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.284 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.4 p -72.52 -44.66 61.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.014 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 88' ' ' THR . 44.4 t0 -64.68 -38.45 91.02 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.947 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.5 tp -55.9 -44.71 78.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 178.64 47.33 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.2 p -94.76 171.11 8.98 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.73 -38.23 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.044 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.3 m -72.03 -45.24 61.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.11 -50.84 64.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.353 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' CG2' HH21 ' A' ' 101' ' ' ARG . 72.0 t -59.4 -37.3 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.554 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -62.8 -63.6 4.49 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.557 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -46.96 -42.99 18.76 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.793 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.481 HH21 ' CG2' ' A' ' 98' ' ' VAL . 84.0 mtm180 -59.38 -43.34 92.93 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.533 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -59.45 -42.66 92.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.659 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -53.97 -54.86 33.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.301 0.572 . . . . 0.0 110.098 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -62.04 -39.22 91.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 m -58.43 -45.59 88.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.907 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.4 t -70.88 -46.73 66.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.619 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 111' ' ' GLN . 85.1 m-20 -60.59 -37.04 80.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.526 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 22.3 t70 -44.38 -17.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 107' ' ' ASN . . . -109.31 -27.2 9.65 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.383 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 114' ' ' ARG . 3.8 t -121.32 21.59 11.05 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.605 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -69.97 4.17 2.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.079 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -74.1 -63.07 2.76 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.206 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -117.24 -45.14 2.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.852 0.358 . . . . 0.0 111.419 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' SER . 93.4 mtm-85 -85.09 148.4 26.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.504 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -129.16 148.64 51.12 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.175 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.16 136.2 43.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.379 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -122.74 127.96 49.89 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.9 tt -82.66 108.74 16.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.854 0.359 . . . . 0.0 110.09 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.538 ' C ' HD21 ' A' ' 120' ' ' ASN . 96.1 mt -72.73 -58.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.836 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.538 HD21 ' C ' ' A' ' 119' ' ' ILE . 1.8 m-80 -146.29 164.0 33.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.132 0.491 . . . . 0.0 110.647 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.25 112.48 2.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.183 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -138.97 170.44 15.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -142.36 151.16 41.63 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.737 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.3 140.94 47.72 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.773 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 35.6 p30 -109.21 112.72 25.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -139.93 142.55 36.41 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.991 0.424 . . . . 0.0 110.738 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 52.35 37.73 23.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.316 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.17 1.77 36.26 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -106.28 147.86 28.65 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 110.092 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.33 128.19 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.003 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -116.52 127.77 54.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.72 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.41 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.09 126.22 51.03 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.2 m -107.12 124.45 49.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.247 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.3 123.61 45.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.839 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -119.25 122.46 41.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -149.15 168.57 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.299 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -138.64 160.03 40.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.752 0.311 . . . . 0.0 110.206 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 85.1 t -105.37 125.32 60.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.489 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 8.0 mt -104.85 137.73 42.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.168 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.63 136.39 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.92 -110.49 0.74 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -117.31 18.11 14.51 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -140.88 160.22 40.52 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.322 0.582 . . . . 0.0 112.432 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.7 p -72.37 122.51 25.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.39 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.526 ' OE1' ' NE ' ' A' ' 146' ' ' ARG . 2.0 tm-20 -75.11 -53.59 8.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 145' ' ' GLU . 15.0 ptp180 -172.46 169.64 5.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.127 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -109.04 136.07 49.16 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.04 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -135.17 135.89 41.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.888 0.375 . . . . 0.0 111.046 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.8 tp -111.11 133.94 53.09 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.004 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.37 131.14 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.503 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.7 m -119.31 136.71 54.12 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.36 127.69 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 111.288 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.5 m -144.83 144.21 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.08 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.0 p -107.48 145.59 32.88 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -146.73 111.45 5.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.138 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.452 ' CZ ' ' OXT' ' A' ' 188' ' ' TYR . 80.5 mtm180 55.74 31.86 18.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.81 8.71 75.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 31.7 mmtp -99.71 124.43 44.96 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -86.66 114.61 23.51 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.8 mm -109.76 128.6 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.5 m -130.42 134.46 47.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.729 0.299 . . . . 0.0 110.838 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.29 102.17 9.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.829 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -102.53 111.86 24.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.474 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.3 mp -117.16 137.51 52.28 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.653 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 54.4 m -126.85 134.35 50.53 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.031 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.425 ' OG1' ' OE2' ' A' ' 74' ' ' GLU . 17.2 m -153.11 156.31 38.43 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.65 143.79 19.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.257 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.21 -36.98 72.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.295 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.9 -33.29 73.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.516 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -100.88 -12.51 18.93 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.601 0.239 . . . . 0.0 111.29 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.529 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.7 t-105 -50.36 -39.79 47.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.757 0.313 . . . . 0.0 111.01 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -60.3 -42.05 94.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.152 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.1 m -66.18 -39.67 89.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.634 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.18 21.35 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.406 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 171' ' ' TRP . 47.2 pttt -51.37 -48.76 62.41 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.39 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.1 t -65.98 -29.03 69.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.686 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.1 tp -56.46 -44.25 80.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.191 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.529 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 28.3 m-85 -61.77 -50.95 70.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.122 0.486 . . . . 0.0 110.403 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -63.82 -40.91 97.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.562 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 184' ' ' SER . 41.6 m -66.26 -46.71 76.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.591 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 55.8 t -61.05 -46.16 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.097 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -65.96 -49.43 67.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.492 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.3 t -67.77 -34.04 76.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 180' ' ' THR . 16.5 t -62.61 -29.29 70.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.633 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -51.19 157.47 0.92 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.562 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -132.61 154.16 50.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.57 152.43 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 111.274 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.452 ' OXT' ' CZ ' ' A' ' 156' ' ' ARG . 38.2 p90 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.727 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.47 -22.41 74.0 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.695 2.264 . . . . 0.0 111.758 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.0 mt -89.84 143.99 26.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.288 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.2 19.9 59.95 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.5 t -109.94 141.53 42.57 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.819 0.343 . . . . 0.0 110.404 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 p -83.94 106.35 15.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.663 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.67 -177.29 49.42 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 44.83 77.54 0.09 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 m -60.68 135.4 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.334 . . . . 0.0 110.363 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.87 165.09 54.72 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mm -107.93 105.4 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.53 14.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.312 0.382 . . . . 0.0 110.455 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 48' ' ' ASN . 73.8 m -80.74 4.93 17.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.912 0.387 . . . . 0.0 110.753 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.4 mt -116.26 137.64 51.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.951 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -131.47 159.07 39.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.289 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -121.35 146.38 46.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.602 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -129.88 137.64 50.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.921 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.427 ' OG ' ' OH ' ' A' ' 188' ' ' TYR . 22.2 t -149.5 149.24 30.45 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.644 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -142.76 110.59 5.89 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.706 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.9 m -61.54 -37.31 83.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.568 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -58.68 -52.57 65.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 38.9 t0 -83.08 -21.07 33.82 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.762 0.315 . . . . 0.0 110.709 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.58 42.12 81.86 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.16 147.94 37.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.359 0.58 . . . . 0.0 110.129 179.082 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -153.1 141.38 20.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.803 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.91 156.66 40.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.75 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.7 mt -96.7 152.03 19.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.447 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -154.86 146.43 16.9 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.488 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.07 161.77 41.22 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.23 1.953 . . . . 0.0 112.101 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 31' ' ' SER . 43.0 p-10 -76.9 160.59 29.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.575 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.4 0.93 58.01 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.52 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 31.2 m0 -88.48 141.25 28.69 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.06 145.69 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.637 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.95 136.51 12.74 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.2 t -112.94 136.51 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.392 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -66.55 140.07 57.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.15 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.6 m -114.03 24.75 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.646 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -60.74 119.57 8.41 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.218 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.63 8.81 76.28 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.41 -164.58 0.65 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.14 157.77 67.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.503 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.45 128.32 16.13 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.382 2.054 . . . . 0.0 111.742 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.24 -17.79 58.05 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.08 123.99 25.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.641 -0.424 . . . . 0.0 109.891 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -100.87 -58.24 1.93 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.08 148.06 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 111.312 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.1 t -115.27 136.31 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.301 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -111.79 136.15 51.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.243 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -129.78 138.54 51.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.321 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 74.3 m-20 -82.46 118.58 23.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.79 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.04 -40.16 71.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.39 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.7 mm -61.4 -40.75 87.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.544 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' OE1' ' A' ' 74' ' ' GLU . 9.9 pt-20 -133.53 84.41 2.12 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.08 0.467 . . . . 0.0 110.284 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -52.16 -21.81 3.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.462 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -57.76 -37.82 74.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' OE1' ' OE2' ' A' ' 71' ' ' GLU . 97.7 mt-10 -84.33 141.35 30.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.991 0.424 . . . . 0.0 110.627 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -153.23 149.69 28.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.733 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 76' ' ' LEU . 1.7 pp -151.91 146.5 25.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.285 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.7 m -124.21 145.94 49.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.019 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.08 125.03 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.473 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mp -122.6 127.78 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.299 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.406 ' CD1' ' OD2' ' A' ' 40' ' ' ASP . 79.2 mt -122.65 132.08 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.664 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.3 m -145.82 167.25 23.65 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.115 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -106.05 137.21 44.36 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.9 pt -96.37 148.33 34.32 Favored Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.569 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 87' ' ' LYS . 36.9 Cg_endo -66.22 135.77 41.4 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.589 1.526 . . . . 0.0 110.759 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 t -62.1 -29.17 70.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.133 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -68.09 -31.3 70.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.037 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 84' ' ' PRO . 97.0 mttt -131.38 143.68 50.65 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.033 0.444 . . . . 0.0 111.008 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.405 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 13.9 t -110.46 -179.44 3.77 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.32 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 tp -51.05 -44.08 61.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.893 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.5 p -68.28 -43.35 77.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.433 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 88' ' ' THR . 89.0 m-20 -65.54 -40.45 92.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.41 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.2 mt -57.01 -41.29 78.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.639 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.87 178.18 47.2 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.394 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 32.9 p -93.37 173.83 7.51 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.7 -41.03 76.66 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.4 m -73.08 -46.0 54.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.034 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -63.14 -52.14 63.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.506 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.2 -37.93 71.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.72 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.539 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -60.15 -55.69 28.83 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -53.53 -39.77 64.96 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.875 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -58.58 -36.79 74.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.191 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -65.08 -41.98 94.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.721 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.654 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -54.22 -55.71 25.39 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.336 0.589 . . . . 0.0 109.826 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -62.1 -40.98 97.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.664 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.5 m -58.1 -47.09 84.28 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.929 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.2 t -72.19 -47.35 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.773 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 111' ' ' GLN . 95.8 m-20 -60.97 -39.51 89.86 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.792 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -44.41 -37.13 3.21 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.448 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.25 -45.06 74.22 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.9 p -123.37 22.09 9.36 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.633 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.8 tt0 -51.15 -28.88 12.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.5 0.19 . . . . 0.0 111.281 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -42.5 -61.74 2.39 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.287 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -117.2 -38.01 3.44 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.01 0.405 . . . . 0.0 111.74 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -88.39 138.33 31.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.019 0.437 . . . . 0.0 111.146 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -131.87 149.73 52.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.112 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -106.83 138.07 43.68 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.39 129.7 56.66 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.9 tp -82.61 111.99 19.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.909 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.494 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.5 mt -79.64 -50.29 18.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.569 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.9 m-80 -158.41 164.52 36.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.398 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.47 114.66 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.592 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.64 167.25 22.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.685 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.41 150.5 50.88 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.504 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -128.53 142.16 51.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.787 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -109.43 113.27 25.93 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.183 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -138.92 141.13 38.51 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.89 0.376 . . . . 0.0 110.755 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 50.52 38.9 19.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.366 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.42 0.34 29.93 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -105.21 147.41 28.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.916 0.389 . . . . 0.0 110.124 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -113.3 129.64 68.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.27 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 20.7 m-85 -117.06 130.49 56.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.755 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.4 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.13 124.48 49.16 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 54.2 m -103.29 130.26 50.5 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.59 106.37 8.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.234 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -101.14 124.5 46.95 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -152.71 172.77 16.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.408 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -141.2 158.78 43.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 110.448 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.16 137.32 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.501 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 141' ' ' GLY . 2.7 pp -135.04 131.69 37.34 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.049 0.452 . . . . 0.0 111.332 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.4 m -91.74 103.76 14.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 139' ' ' LEU . . . 74.02 -113.64 4.23 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -107.91 7.35 27.98 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.818 -0.225 . . . . 0.0 111.483 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -116.14 138.97 50.8 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.707 0.289 . . . . 0.0 111.249 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.72 122.21 33.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.344 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.13 -52.93 9.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.588 HH21 ' N ' ' A' ' 166' ' ' THR . 15.3 ptm180 -172.27 173.13 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.9 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -102.97 138.92 39.21 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -133.72 134.18 42.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.855 0.36 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.6 tp -111.32 131.21 55.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.079 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -127.65 125.72 40.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.029 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 27.8 t -118.74 132.57 56.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.678 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.07 127.56 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.99 0.424 . . . . 0.0 110.751 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.5 m -137.97 140.94 40.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.998 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.8 p -105.37 151.52 24.09 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.727 0.299 . . . . 0.0 110.364 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -161.53 119.07 2.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 55.17 32.1 17.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.67 14.31 80.06 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -105.26 128.8 53.62 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.42 119.06 31.58 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.3 mt -117.92 127.59 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.732 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 39.5 m -126.76 136.08 51.94 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.017 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.37 98.41 6.41 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -91.74 111.99 23.73 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.549 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.93 137.39 49.98 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.5 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 146' ' ' ARG . 32.3 t -136.27 129.45 31.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.365 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.588 ' N ' HH21 ' A' ' 146' ' ' ARG . 11.9 m -152.43 158.72 43.03 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.478 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -51.93 143.32 13.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -71.84 -36.78 70.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.043 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -63.32 -33.5 75.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.123 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.464 ' CD ' ' N ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER -96.95 -16.49 20.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.274 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.546 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 50.6 t-105 -48.56 -39.82 24.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.831 0.348 . . . . 0.0 110.769 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -61.69 -42.12 98.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 58.7 m -66.66 -40.0 88.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.657 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.2 m -109.55 21.17 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.149 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 171' ' ' TRP . 19.2 ptmt -50.59 -48.72 57.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.279 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.5 t -65.78 -29.75 70.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.773 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.8 tp -55.73 -44.45 77.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.374 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 26.3 m-85 -62.3 -50.47 71.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.088 0.47 . . . . 0.0 110.41 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.31 -41.41 98.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.605 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 184' ' ' SER . 50.7 m -66.07 -47.86 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.31 -43.63 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.523 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -62.94 -37.67 87.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.905 0.383 . . . . 0.0 110.306 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.2 t -83.62 -25.3 30.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 180' ' ' THR . 46.9 t -62.49 -30.03 70.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.17 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -59.76 157.58 11.86 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.463 -179.571 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -135.53 156.64 48.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.602 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.1 149.81 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.041 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.427 ' OH ' ' OG ' ' A' ' 36' ' ' SER . 38.9 p90 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.744 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 28.3 Cg_endo -61.43 -23.67 77.13 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.754 2.302 . . . . 0.0 111.811 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.479 ' CD2' ' H ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -66.0 -35.38 80.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.096 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 19' ' ' GLY . . . -177.53 -175.68 44.96 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.6 p -145.98 163.21 35.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.764 0.316 . . . . 0.0 110.459 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.4 t -129.37 139.81 51.57 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.432 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.1 -176.93 33.75 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.07 136.86 19.64 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.67 136.53 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.813 0.339 . . . . 0.0 110.393 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.01 23.16 59.83 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 pt -67.94 -16.28 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 110.812 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.14 159.7 42.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.506 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.2 t -65.58 137.36 57.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.506 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 mt -108.79 143.37 38.03 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.701 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.668 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.4 pm0 -137.98 163.9 30.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.857 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -117.69 133.94 55.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.727 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -112.48 135.13 53.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.846 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 93.8 p -146.79 153.89 40.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 110.855 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 36' ' ' SER . 99.2 m-20 -141.2 114.18 8.51 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.15 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.6 p -64.89 -33.95 77.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.434 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -62.49 -48.44 79.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -85.91 -20.48 28.95 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.101 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.51 40.54 90.98 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.211 -0.518 . . . . 0.0 111.83 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -141.97 151.56 42.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.332 0.566 . . . . 0.0 110.61 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -155.6 146.52 22.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -151.74 161.58 42.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.994 0.426 . . . . 0.0 111.18 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.569 ' N ' ' CD2' ' A' ' 45' ' ' LEU . 2.0 mm? -92.61 143.5 26.26 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.116 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -154.71 147.25 17.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.518 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.73 157.98 58.58 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.282 1.988 . . . . 0.0 112.24 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.668 ' N ' HE22 ' A' ' 33' ' ' GLN . 47.3 p-10 -71.35 160.42 32.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.563 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.99 6.45 57.94 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.406 ' HE1' ' CG ' ' A' ' 68' ' ' ASP . 27.2 m0 -93.6 142.79 26.94 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.301 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 pt -126.02 146.31 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.334 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.63 139.32 15.06 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.69 134.64 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.856 0.36 . . . . 0.0 110.526 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -79.08 137.74 37.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.683 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.86 55.7 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.065 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -72.81 135.07 45.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.072 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.41 4.76 70.42 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.64 -164.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.698 0.285 . . . . 0.0 110.72 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.12 153.74 3.09 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.562 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.27 133.08 27.44 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.264 1.976 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.01 -21.88 42.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.2 t -62.22 122.22 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.92 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -99.11 -58.55 1.91 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.76 168.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.492 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.0 135.79 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.058 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -112.18 128.54 56.26 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -122.91 135.56 54.55 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.802 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 71' ' ' GLU . 60.3 t0 -88.53 118.43 28.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.849 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.11 -38.65 91.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.387 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.404 HG23 HD11 ' A' ' 70' ' ' ILE . 89.3 mt -61.35 -42.15 92.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.78 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 68' ' ' ASP . 96.1 mt-10 -117.86 120.62 38.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.457 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -88.93 -40.26 13.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.32 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -58.47 -36.27 73.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.548 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -89.22 129.77 35.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.421 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -129.75 149.04 51.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.997 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.84 134.12 51.75 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 t -136.82 142.79 42.9 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 t -129.4 132.86 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.933 0.396 . . . . 0.0 110.674 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.4 mt -121.89 123.38 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.34 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.92 132.18 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.314 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 159' ' ' LEU . 4.1 m -151.68 166.75 30.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.406 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -105.71 135.82 46.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.0 pt -91.47 148.93 38.55 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.97 -179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -43.73 143.21 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.869 1.712 . . . . 0.0 111.382 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -73.1 -20.64 60.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.636 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 57.2 t0 -94.98 -17.18 22.18 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -129.94 156.26 44.71 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.933 0.397 . . . . 0.0 111.348 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.8 t -122.88 176.36 6.04 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.823 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.2 tp -49.92 -45.73 51.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.944 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.3 p -66.43 -44.13 83.76 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.988 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.71 -37.55 86.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.98 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.9 tp -55.85 -43.26 76.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.577 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.68 178.92 47.61 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.396 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.646 ' HG1' ' H ' ' A' ' 97' ' ' ASP . 43.4 p -92.29 170.44 9.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.54 74.96 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.91 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.8 m -72.02 -44.43 63.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.804 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.646 ' H ' ' HG1' ' A' ' 94' ' ' THR . 47.3 t0 -62.22 -52.68 62.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.431 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.8 t -60.12 -39.11 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.595 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.73 -43.3 94.57 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -67.78 -41.41 83.28 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.04 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -60.72 -38.6 85.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -62.98 -39.61 95.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.585 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.5 mmt -59.1 -45.37 91.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.863 0.363 . . . . 0.0 110.536 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -64.72 -41.82 95.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.872 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.8 m -60.86 -46.13 91.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.7 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.99 -47.5 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.102 0.477 . . . . 0.0 110.472 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 111' ' ' GLN . 89.6 m-20 -61.05 -34.29 74.65 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.39 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -47.59 -38.71 15.02 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.189 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.41 73.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.53 0.566 . . . . 0.0 112.53 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -123.03 22.15 9.62 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.641 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.3 pt20 -51.23 -15.55 0.38 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.27 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.01 -61.27 7.63 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.814 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 38.0 p-10 -117.46 -35.51 3.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.035 0.417 . . . . 0.0 111.74 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.528 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 58.9 ttm-85 -84.62 137.89 33.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 111.24 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -129.03 139.29 52.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.106 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.9 136.53 42.56 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -116.54 128.28 55.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.4 tt -82.99 106.31 14.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.926 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.28 -43.47 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.362 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -179.7 173.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.452 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.67 139.62 15.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.19 163.99 32.03 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.453 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.8 146.87 46.2 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -133.13 139.6 47.17 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.655 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -109.67 113.44 26.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.55 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.74 144.33 39.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.014 0.435 . . . . 0.0 110.956 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 60.6 t0 51.59 32.11 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.405 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.03 1.58 68.81 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -105.57 148.95 26.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.94 0.4 . . . . 0.0 110.114 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.2 t -114.37 128.54 71.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.009 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -118.05 126.81 53.0 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.54 125.88 50.35 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.2 m -105.17 125.41 50.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.332 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.2 mp -115.69 126.53 54.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.928 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -119.52 122.67 42.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.433 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -152.9 171.65 17.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.522 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -139.94 157.92 44.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.186 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.24 135.28 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.979 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -136.04 136.9 40.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.109 0.481 . . . . 0.0 111.107 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.42 134.48 57.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.223 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.43 -120.95 16.46 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -114.47 14.42 17.82 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.92 -0.165 . . . . 0.0 111.415 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -129.05 155.6 45.17 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.92 0.391 . . . . 0.0 111.143 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.7 p -86.66 126.93 40.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.324 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.539 ' OE1' ' NE ' ' A' ' 146' ' ' ARG . 2.1 tm-20 -76.01 -51.69 11.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.68 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.539 ' NE ' ' OE1' ' A' ' 145' ' ' GLU . 10.5 ptp180 -172.31 174.02 4.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.992 0.425 . . . . 0.0 111.192 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.404 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 73.8 m80 -107.21 139.44 41.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.013 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 78.3 m-20 -134.41 136.92 43.65 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.02 0.438 . . . . 0.0 111.477 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.3 tp -112.81 138.93 48.91 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.632 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.98 147.08 43.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.34 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.5 t -131.55 138.48 48.91 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.552 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 52.8 t -119.05 126.9 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.533 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.6 m -142.42 148.09 37.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.475 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.2 p -113.61 152.81 29.83 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.831 0.348 . . . . 0.0 110.641 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -151.12 107.44 3.47 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.274 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 59.35 32.16 21.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.791 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 87.1 6.21 79.21 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -97.27 123.26 41.02 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 81' ' ' SER . 1.0 OUTLIER -85.39 118.01 24.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.424 HD13 HG22 ' A' ' 160' ' ' ILE . 81.4 mt -121.94 120.55 61.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.8 m -123.87 133.99 53.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.011 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.91 125.02 50.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.866 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -112.3 114.99 28.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.897 0.38 . . . . 0.0 110.654 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.8 mt -111.33 130.17 55.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.1 m -133.59 129.82 37.51 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.475 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 8.0 m -153.41 152.66 31.29 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.441 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.15 147.95 46.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.588 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -70.27 -24.05 62.99 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.268 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -55.54 -34.11 64.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.173 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.79 0.09 8.03 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.519 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 44.9 t-105 -48.22 -39.11 20.14 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.852 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -63.43 -41.95 98.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 49.3 m -65.4 -39.94 92.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.627 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.22 21.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.176 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.36 -47.97 55.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.384 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.6 m -65.51 -31.9 73.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.652 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -54.52 -44.03 72.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.091 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.519 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 23.4 m-85 -61.07 -49.84 75.7 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.356 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -64.3 -40.38 95.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.591 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 184' ' ' SER . 50.1 m -67.65 -47.54 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.35 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.23 -43.46 98.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.614 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.77 -40.15 96.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 110.287 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 42.2 m -80.32 -27.72 38.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.249 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 180' ' ' THR . 40.1 t -62.26 -29.8 70.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.524 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -58.22 157.79 7.93 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.295 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -138.57 159.47 42.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.61 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.48 149.5 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.996 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 38.3 p90 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.682 179.83 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.506 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 29.7 Cg_endo -62.28 -23.39 75.25 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.725 2.283 . . . . 0.0 111.753 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.8 169.96 10.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.396 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -163.56 -173.35 32.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.1 t -56.67 -28.13 60.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.04 0.447 . . . . 0.0 110.402 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 94.1 m -49.11 -26.18 2.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.74 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.49 -178.92 52.6 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.99 22.94 62.51 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.1 m -65.39 137.63 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.89 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.42 144.79 10.77 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.2 mt -99.33 91.51 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.603 0.239 . . . . 0.0 110.399 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.64 147.4 1.4 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.214 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.485 ' N ' ' ND2' ' A' ' 48' ' ' ASN . 48.9 m -65.79 141.51 58.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 0.0 110.609 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.8 mt -114.92 142.57 46.41 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.195 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.485 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.6 pm0 -141.18 163.02 34.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.313 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -115.14 140.13 49.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.866 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -117.36 130.8 56.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.531 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.426 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 50.5 m -120.83 146.58 46.41 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.022 0.439 . . . . 0.0 111.022 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 36' ' ' SER . 98.8 m-20 -140.67 103.71 4.57 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.7 p -68.78 -15.1 63.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.52 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -57.25 -43.23 82.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.358 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -116.35 -13.33 11.03 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.058 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.79 50.04 6.19 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.64 148.76 30.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.033 0.444 . . . . 0.0 111.128 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -144.41 151.62 39.51 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.693 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -151.84 157.28 41.69 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mp -103.13 143.53 32.48 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.373 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.483 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 7.0 p90 -149.91 148.18 24.48 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.937 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.07 154.44 62.48 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.017 1.812 . . . . 0.0 111.849 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.485 ' N ' HE22 ' A' ' 33' ' ' GLN . 11.7 p30 -69.57 160.52 31.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.36 3.97 58.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.527 ' CD2' ' OD1' ' A' ' 68' ' ' ASP . 32.0 m0 -92.27 146.58 23.6 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.358 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.0 pt -117.92 139.93 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.301 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.29 139.87 14.79 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.8 t -113.6 134.76 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.895 0.378 . . . . 0.0 110.463 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -74.46 138.28 43.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.437 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 63' ' ' ASP . 26.8 m -132.84 46.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -76.75 124.38 27.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.055 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.3 11.83 82.91 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.65 -164.41 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.757 0.313 . . . . 0.0 110.658 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -54.13 153.54 9.17 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.173 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.92 128.56 17.99 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.384 2.056 . . . . 0.0 112.137 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 98.15 -25.1 29.04 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.13 131.39 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.985 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' O ' ' CG2' ' A' ' 55' ' ' VAL . 58.7 t0 -111.09 -58.01 2.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.0 t -147.81 145.26 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.868 0.366 . . . . 0.0 111.287 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.5 t -122.16 134.93 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.527 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.18 141.27 46.08 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.081 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' NH2' ' CD2' ' A' ' 69' ' ' LEU . 68.3 ttp85 -129.12 129.33 45.03 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.269 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.527 ' OD1' ' CD2' ' A' ' 50' ' ' TRP . 78.4 m-20 -92.23 118.89 31.32 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.7 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.572 ' CD2' ' NH2' ' A' ' 67' ' ' ARG . 70.2 mt -65.52 -37.45 86.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.256 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.4 mt -63.51 -38.07 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.754 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -128.56 88.84 2.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.461 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -61.17 -35.73 77.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.561 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 39.2 p-10 -62.38 -32.67 73.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 11.6 tm-20 -92.55 132.75 36.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.663 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -146.68 139.59 25.33 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.636 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 tt -114.26 133.51 55.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.086 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.0 m -133.07 149.01 52.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.37 129.7 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.176 0.513 . . . . 0.0 110.288 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.7 mt -120.5 124.14 71.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.361 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.4 mm -113.78 136.42 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.437 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.474 ' HG ' ' N ' ' A' ' 82' ' ' GLU . 32.2 t -139.86 161.03 38.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.233 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.474 ' N ' ' HG ' ' A' ' 81' ' ' SER . 22.9 pt-20 -104.73 134.31 48.1 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.421 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.7 pt -106.75 150.15 39.33 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.956 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.05 137.92 42.34 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.008 1.805 . . . . 0.0 111.337 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 t -63.42 -27.19 69.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.076 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -67.44 -31.31 71.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.927 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -128.8 152.0 48.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.154 0.502 . . . . 0.0 111.315 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.1 t -117.46 179.8 3.95 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.21 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.2 tp -50.92 -44.64 60.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.192 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 50.3 p -66.5 -44.83 81.49 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.147 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.404 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.2 m-20 -65.32 -38.41 90.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.9 tp -56.15 -43.43 78.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.646 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.69 177.99 46.93 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.9 p -93.6 172.33 8.33 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.31 -42.26 77.33 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.227 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.1 m -71.65 -44.91 63.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -62.3 -51.54 67.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.522 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.71 -39.99 83.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.22 -45.33 92.78 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.75 -41.78 87.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.994 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -61.62 -39.19 90.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.612 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -62.73 -40.27 96.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.74 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.1 mmt -58.14 -43.79 87.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.294 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -64.85 -45.28 86.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.302 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.4 m -59.91 -45.14 93.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.961 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.2 t -68.18 -47.52 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.644 ' O ' ' N ' ' A' ' 111' ' ' GLN . 96.0 m-20 -62.73 -36.52 83.27 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.233 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -43.61 -36.92 2.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.718 0.294 . . . . 0.0 111.004 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.54 -46.49 69.38 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.2 m -123.34 23.28 9.09 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.644 ' N ' ' O ' ' A' ' 107' ' ' ASN . 47.1 tt0 -51.96 -28.83 18.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.633 0.254 . . . . 0.0 111.357 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -41.55 -61.46 2.15 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.15 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -117.24 -38.97 3.26 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.93 0.365 . . . . 0.0 111.779 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -77.39 146.44 36.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.491 . . . . 0.0 111.793 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -135.01 133.47 39.46 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.927 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.14 134.29 43.29 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.52 ' OE1' ' NH2' ' A' ' 137' ' ' ARG . 75.8 tt0 -115.3 128.71 56.3 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.977 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.24 106.94 13.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.994 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.533 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 95.6 mt -71.03 -38.61 72.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.057 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.9 m-80 178.44 166.35 0.82 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.343 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.98 132.46 12.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -143.12 165.58 27.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.602 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.15 148.87 45.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.458 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -130.33 142.12 50.55 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 34.9 p30 -110.18 110.62 21.54 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.791 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -136.93 143.8 43.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.475 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 127' ' ' ASP . 22.6 t70 50.43 35.54 11.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.99 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.75 2.63 38.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.523 ' OE1' ' CE1' ' A' ' 131' ' ' TYR . 5.7 tm0? -106.43 136.54 46.0 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.458 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 44.7 t -106.69 129.41 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.852 0.358 . . . . 0.0 110.708 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.523 ' CE1' ' OE1' ' A' ' 129' ' ' GLN . 48.2 m-85 -117.24 131.11 56.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.57 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.13 130.14 51.85 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.8 m -110.42 124.33 51.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.181 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.73 125.32 52.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.982 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -117.58 122.34 43.37 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.537 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -150.82 172.74 15.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.562 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.52 ' NH2' ' OE1' ' A' ' 117' ' ' GLU . 38.3 ptt180 -140.4 158.09 44.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 110.729 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.37 132.84 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.122 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pp -140.52 135.7 32.15 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.05 0.452 . . . . 0.0 111.427 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.6 t -111.18 131.07 63.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.202 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.52 -120.6 21.21 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -109.38 11.17 25.29 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -124.1 152.68 42.45 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.024 0.44 . . . . 0.0 111.48 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.31 127.34 41.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.786 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -77.0 -53.64 7.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.544 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.538 HH21 ' CA ' ' A' ' 166' ' ' THR . 13.0 ptm180 -170.49 173.78 5.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.008 0.432 . . . . 0.0 111.384 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.418 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 52.2 m80 -108.02 137.7 45.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.055 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 79.1 m-20 -135.04 137.91 43.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.015 0.436 . . . . 0.0 111.018 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.5 tp -111.22 134.91 52.45 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.546 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -135.64 141.24 45.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.428 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.0 t -124.86 141.32 52.2 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.179 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.13 132.12 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.837 0.351 . . . . 0.0 110.438 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.0 m -146.21 153.49 40.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.555 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.6 p -116.84 145.19 43.72 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.858 0.361 . . . . 0.0 110.52 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.407 ' ND2' ' OXT' ' A' ' 188' ' ' TYR . 38.0 t30 -160.04 122.37 3.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.927 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 60.15 30.91 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.097 0.475 . . . . 0.0 110.276 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 77.47 11.8 85.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -109.89 135.26 51.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.52 114.74 26.31 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.9 mm -103.99 120.23 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 49.0 m -120.52 129.58 53.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.101 0.477 . . . . 0.0 110.561 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.28 117.32 32.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -120.1 122.96 42.2 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.978 0.418 . . . . 0.0 111.578 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.3 mp -119.93 140.57 50.69 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.382 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 63.1 m -130.87 135.65 47.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.365 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.538 ' CA ' HH21 ' A' ' 146' ' ' ARG . 16.6 m -153.06 153.93 33.85 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.57 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.27 145.71 42.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.358 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -69.98 -25.45 63.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.414 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 170' ' ' ARG . 55.4 p30 -60.56 -33.45 72.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.552 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 22.7 mmt85 -118.89 -1.12 11.07 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.576 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 46.9 t-105 -48.26 -40.62 25.32 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.693 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.98 -41.39 97.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.029 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 46.3 m -63.71 -39.41 94.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.438 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.9 m -105.85 21.17 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.964 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.412 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 19.1 ptmt -50.19 -45.19 53.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.823 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.435 ' O ' ' OG1' ' A' ' 180' ' ' THR . 24.2 t -63.13 -31.45 72.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.694 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.0 tp -59.43 -45.55 91.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.109 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 18.2 m-85 -60.89 -50.14 74.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.873 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 176' ' ' SER . 0.6 OUTLIER -69.27 -43.24 74.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.757 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 176' ' ' SER . 60.6 m -62.36 -48.36 80.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.704 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 80.5 t -71.57 -38.39 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.474 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.98 -38.98 93.33 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.353 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 81.4 p -80.18 -18.98 48.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.226 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.8 t -62.84 -39.04 93.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.699 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.493 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -54.77 149.03 11.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.08 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -133.88 159.02 41.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.3 m -126.57 150.45 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.67 0.272 . . . . 0.0 110.795 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.407 ' OXT' ' ND2' ' A' ' 155' ' ' ASN . 41.2 p90 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.882 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.466 ' N ' HH22 ' A' ' 124' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.41 142.56 85.72 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.722 2.281 . . . . 0.0 111.684 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.539 ' N ' ' CD2' ' A' ' 21' ' ' LEU . 2.6 mm? -63.41 -37.89 89.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.946 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.24 -8.01 80.55 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.0 p -156.35 168.18 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.822 0.344 . . . . 0.0 110.687 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.8 m -83.06 165.95 19.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.152 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.39 170.02 54.89 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.26 -175.05 48.91 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.8 m -128.78 157.25 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.743 0.306 . . . . 0.0 110.212 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.89 94.4 1.93 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.2 pt -76.56 -15.7 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.04 0.448 . . . . 0.0 110.619 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.63 163.34 40.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.123 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.1 m -56.39 140.36 45.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.485 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.4 mt -115.19 141.44 48.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.382 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 21.0 mp0 -103.58 148.45 25.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.908 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -119.3 136.49 54.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.184 0.516 . . . . 0.0 110.946 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -125.63 136.19 52.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.0 p -145.64 156.05 43.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.491 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -148.05 119.15 7.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.556 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.8 p -70.53 -32.61 70.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.879 0.371 . . . . 0.0 110.218 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 63.9 tttm -62.03 -49.94 74.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.799 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -86.87 -20.63 27.17 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.904 0.383 . . . . 0.0 110.567 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.28 43.34 93.1 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.16 147.61 36.91 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.225 0.513 . . . . 0.0 110.377 179.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -148.18 155.96 42.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.024 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.538 ' CZ ' ' O ' ' A' ' 45' ' ' LEU . 57.6 t80 -173.02 143.52 1.17 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.538 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . 9.9 mp -92.58 141.38 28.56 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -134.16 141.2 38.52 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.638 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.58 152.44 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.893 1.728 . . . . 0.0 112.484 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.2 p30 -81.41 158.75 24.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.234 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.29 8.84 74.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.437 ' NE1' ' OD1' ' A' ' 68' ' ' ASP . 27.7 m0 -94.1 149.03 21.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.451 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.2 pt -114.64 140.46 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.475 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.75 134.24 11.8 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.15 132.45 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.015 0.436 . . . . 0.0 110.569 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -83.88 137.96 33.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.339 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.83 52.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.371 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -72.81 134.06 44.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.357 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.64 4.72 82.58 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.81 -164.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.707 0.289 . . . . 0.0 110.694 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -45.1 152.1 0.62 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.556 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.78 132.98 26.19 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.23 1.953 . . . . 0.0 111.654 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.495 ' O ' ' N ' ' A' ' 80' ' ' ILE . . . 95.76 -27.63 15.4 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.55 133.9 26.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.085 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -115.78 -58.57 2.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.646 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.8 t -149.49 147.28 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.057 0.456 . . . . 0.0 111.522 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.18 134.87 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.158 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -112.13 138.16 49.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.406 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -128.95 133.63 47.9 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.531 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' OD1' ' NE1' ' A' ' 50' ' ' TRP . 60.1 t0 -88.15 119.07 28.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.444 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.9 mt -60.24 -37.82 81.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.737 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.406 HD11 ' H ' ' A' ' 70' ' ' ILE . 4.9 mp -67.13 -42.21 87.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.822 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 68' ' ' ASP . 90.6 mt-10 -121.24 124.24 44.17 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.009 0.433 . . . . 0.0 110.639 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -87.19 -39.58 15.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.549 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.45 -37.02 77.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.984 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' OE1' ' OE1' ' A' ' 71' ' ' GLU . 84.6 tt0 -85.12 132.68 34.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.409 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -155.58 138.78 15.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.945 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.2 tt -112.57 133.29 54.7 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.044 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.9 m -128.44 147.0 50.64 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.015 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.07 131.45 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.105 0.478 . . . . 0.0 110.616 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 51.0 mt -119.13 124.26 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.587 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 61' ' ' GLY . 63.1 mt -119.07 128.26 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 110.788 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 74.5 m -149.09 166.31 29.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.043 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -104.57 137.01 43.04 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 10.4 pt -92.44 149.55 38.46 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.394 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -45.42 136.71 11.54 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.649 1.566 . . . . 0.0 111.862 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -27.3 68.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.392 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -88.61 -16.23 33.03 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -131.22 157.23 43.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.043 0.449 . . . . 0.0 111.375 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.4 t -122.81 176.61 5.89 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.49 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.6 tp -51.83 -44.74 63.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.171 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.444 ' HG1' ' N ' ' A' ' 91' ' ' ASP . 44.5 p -65.51 -44.61 86.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.933 -179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.444 ' N ' ' HG1' ' A' ' 90' ' ' THR . 85.3 m-20 -67.16 -34.27 77.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.866 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.05 -50.01 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.893 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.37 179.18 47.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.3 p -90.91 171.69 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.26 -41.41 75.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.869 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.7 m -72.61 -45.17 60.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -61.57 -51.74 67.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.294 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.96 -38.77 81.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.514 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.02 -43.94 94.82 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -67.64 -42.36 82.38 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.945 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -62.33 -38.65 90.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.0 110.718 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.87 -40.77 96.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.541 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.6 mmt -58.9 -44.4 91.19 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.521 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 108' ' ' ASP . 43.9 tptt -65.46 -45.76 82.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.976 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.8 m -59.17 -46.12 89.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.015 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.29 -47.16 79.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 110.273 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.656 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.1 m-20 -63.39 -37.83 88.78 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.266 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 104' ' ' LYS . 88.8 m-20 -44.29 -38.31 3.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.729 0.299 . . . . 0.0 111.224 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.88 74.6 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.6 m -123.93 23.45 8.59 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.4 tt0 -48.5 -28.79 3.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.557 0.218 . . . . 0.0 111.544 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -44.05 -61.24 3.16 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.152 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -116.91 -36.01 3.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.956 0.378 . . . . 0.0 111.872 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -78.43 139.54 38.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 111.242 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -132.55 137.03 46.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.962 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.0 140.38 42.58 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.817 0.342 . . . . 0.0 110.458 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.418 ' OE1' ' NE ' ' A' ' 137' ' ' ARG . 83.4 mt-10 -124.8 123.4 39.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.734 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 tp -80.43 110.75 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.054 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.545 ' C ' HD21 ' A' ' 120' ' ' ASN . 96.9 mt -76.32 -55.71 10.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.846 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.545 HD21 ' C ' ' A' ' 119' ' ' ILE . 1.7 m-80 -145.23 163.22 35.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.083 0.468 . . . . 0.0 110.693 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.18 116.12 3.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.237 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.17 162.55 34.68 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.548 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.99 150.19 47.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 110.878 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.466 HH22 ' N ' ' A' ' 19' ' ' GLY . 65.4 mtp180 -129.5 160.35 33.45 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.385 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -134.83 114.22 12.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.721 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.84 142.5 38.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.608 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 127' ' ' ASP . 22.3 t70 50.49 36.57 13.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.02 2.66 48.24 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.525 ' OE1' ' CE2' ' A' ' 131' ' ' TYR . 4.4 tm0? -101.29 134.74 43.88 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.436 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 46.2 t -106.22 130.08 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 110.565 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.525 ' CE2' ' OE1' ' A' ' 129' ' ' GLN . 58.1 m-85 -119.41 128.24 53.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.045 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -106.61 129.93 54.45 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.7 m -112.37 122.8 48.76 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.522 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.37 125.05 51.52 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.048 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -117.09 123.81 47.71 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -151.75 164.04 37.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.945 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.418 ' NE ' ' OE1' ' A' ' 117' ' ' GLU . 39.5 ptt180 -126.62 156.97 40.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.083 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.09 130.71 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.3 mt -112.25 125.3 54.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.883 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 79.5 t -123.49 129.68 74.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.04 -121.64 16.77 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -116.44 22.35 12.87 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -148.35 161.5 41.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.955 0.407 . . . . 0.0 111.486 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.5 t -71.34 125.52 29.96 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.271 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' A' ' 146' ' ' ARG . 83.3 tt0 -73.9 -52.71 12.06 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.014 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' A' ' 145' ' ' GLU . 11.4 ptp85 -172.41 170.43 4.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.609 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.466 ' HD1' ' CB ' ' A' ' 168' ' ' GLU . 76.7 m80 -105.0 138.96 40.41 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.007 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 164' ' ' LEU . 13.4 t70 -135.52 147.58 48.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.146 0.498 . . . . 0.0 110.563 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 tp -123.17 124.96 44.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.556 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -123.81 134.74 53.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.234 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.5 t -122.84 134.27 54.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.35 129.93 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.157 0.503 . . . . 0.0 110.852 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.438 ' CG2' ' NE2' ' A' ' 129' ' ' GLN . 24.0 m -143.76 142.71 31.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.101 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.1 p -108.36 149.6 28.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 110.215 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.575 HD22 ' CA ' ' A' ' 188' ' ' TYR . 56.5 t30 -147.46 106.71 3.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.735 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 57.42 31.74 20.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 89.59 4.89 72.59 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 32.1 mmtp -96.05 123.85 39.82 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -89.36 114.38 25.79 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.89 127.41 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.103 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.7 m -123.67 135.91 54.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.037 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.07 105.51 15.56 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.886 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.19 120.06 38.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.876 0.37 . . . . 0.0 111.47 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.432 ' O ' ' OD2' ' A' ' 148' ' ' ASP . 19.2 mt -117.62 135.3 54.07 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.9 t -133.56 134.07 42.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.419 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 14.6 m -152.52 158.88 43.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.295 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -59.18 144.31 46.29 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.07 0.462 . . . . 0.0 111.422 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.466 ' CB ' ' HD1' ' A' ' 147' ' ' HIS . 22.9 pt-20 -74.44 -17.81 60.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.071 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -77.93 -9.77 59.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.902 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -133.61 -6.8 2.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.729 0.299 . . . . 0.0 110.742 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.617 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 45.3 t-105 -49.19 -39.02 27.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.624 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -63.48 -42.32 98.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.08 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.7 m -65.37 -40.74 93.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.526 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.3 m -105.33 21.21 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.848 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.77 -47.24 41.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.203 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 91.8 p -67.08 -28.61 68.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.81 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.8 tp -56.23 -43.18 78.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.627 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.617 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 19.4 m-85 -62.78 -49.49 74.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.451 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.4 -40.85 98.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.706 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.4 m -68.09 -51.49 45.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.401 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.463 ' O ' ' OG ' ' A' ' 184' ' ' SER . 4.0 p -69.96 -32.52 51.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.683 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.56 -40.29 96.59 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.101 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 76.0 p -85.11 -16.1 41.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.743 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 181' ' ' VAL . 88.4 p -64.72 -34.09 77.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.492 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.7 150.37 7.3 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.558 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -130.75 149.93 52.16 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.0 m -126.48 151.99 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 110.814 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.575 ' CA ' HD22 ' A' ' 155' ' ' ASN . 43.7 p90 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.622 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.46 146.23 92.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.73 2.286 . . . . 0.0 111.804 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.479 ' N ' ' CD1' ' A' ' 21' ' ' LEU . 7.2 mp -89.51 140.16 29.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.553 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.96 120.54 0.69 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 m -66.22 155.85 35.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.754 0.311 . . . . 0.0 110.621 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.9 t -129.2 133.82 47.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.273 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.26 -35.15 59.9 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.2 -143.05 32.53 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -132.01 141.18 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.883 0.373 . . . . 0.0 110.449 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.12 47.81 0.22 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.4 pt -68.27 -16.58 21.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.584 0.231 . . . . 0.0 111.216 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.3 56.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.972 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.7 p -149.98 11.31 0.73 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.885 0.374 . . . . 0.0 110.606 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.2 138.69 50.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.344 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -134.4 158.88 42.72 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.365 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.465 HH21 ' CD ' ' A' ' 43' ' ' GLU . 72.7 ttt180 -119.29 138.11 53.23 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.653 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -118.89 136.27 54.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.276 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 84.7 p -143.72 157.52 44.33 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.426 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.1 t0 -148.28 108.58 4.11 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.65 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.6 m -60.31 -36.76 78.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.694 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -58.66 -51.01 71.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.184 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -85.64 -20.17 29.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . 68.68 41.44 83.65 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 155.73 45.69 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.199 0.5 . . . . 0.0 110.727 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' CD ' HH21 ' A' ' 34' ' ' ARG . 3.0 pp20? -156.03 147.83 23.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.752 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -152.9 156.1 38.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt -94.4 158.96 15.33 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.397 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -170.57 144.88 2.03 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.689 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.01 158.73 56.12 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.349 2.033 . . . . 0.0 111.952 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -71.92 160.34 32.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.6 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.26 4.53 58.43 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.535 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 25.1 m0 -89.16 145.11 25.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.4 HD13 HG23 ' A' ' 51' ' ' ILE . 18.4 pt -115.11 138.29 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.503 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.73 121.98 7.43 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.53 134.75 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.942 0.401 . . . . 0.0 110.499 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 52.9 p30 -84.07 151.16 25.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.356 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.61 48.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.086 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -68.58 134.03 49.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.63 -0.63 83.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.3 -163.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 110.464 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.2 m -40.14 116.69 1.25 Allowed Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.586 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.04 132.89 8.6 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.703 1.602 . . . . 0.0 112.22 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.99 -40.48 2.41 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.2 135.18 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -118.55 -57.56 2.05 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.54 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -147.63 143.06 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.684 0.278 . . . . 0.0 111.048 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.47 137.93 54.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.928 0.395 . . . . 0.0 110.045 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.93 134.92 54.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.84 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -121.95 143.7 49.31 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.8 0.333 . . . . 0.0 110.758 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.535 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 11.2 m-20 -94.75 118.94 32.55 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.514 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.5 -38.7 90.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.559 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.41 HG21 HD11 ' A' ' 70' ' ' ILE . 26.5 mm -65.12 -41.77 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.748 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -124.42 95.16 4.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.753 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -64.4 -34.8 79.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.349 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.21 -37.37 74.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.81 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -89.44 128.9 36.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.604 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -141.08 139.05 33.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.297 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.93 132.91 52.35 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 p -120.12 138.84 53.34 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 t -125.45 124.21 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-O 120.883 0.373 . . . . 0.0 110.446 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.7 mt -125.1 117.75 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.802 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.2 mm -114.94 135.87 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.995 0.426 . . . . 0.0 110.643 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.9 m -145.36 166.03 26.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.935 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -107.93 141.47 39.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.652 0.263 . . . . 0.0 110.673 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.2 pt -107.72 149.63 39.19 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.697 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' LYS . 54.9 Cg_endo -69.19 139.96 43.58 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.101 1.867 . . . . 0.0 111.141 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.8 p -65.98 -24.96 66.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.979 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.29 -31.28 70.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.635 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 84' ' ' PRO . 29.5 mtmm -130.33 157.48 42.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.121 0.486 . . . . 0.0 111.263 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.7 t -122.48 178.1 5.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.366 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 tp -50.99 -44.65 60.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.16 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.3 p -64.9 -45.53 85.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.037 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -68.02 -36.15 79.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -56.13 -42.77 77.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.776 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.67 174.68 44.24 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.8 p -91.72 168.87 11.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.3 76.09 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.998 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.7 m -71.82 -43.95 64.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.823 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -61.57 -52.69 63.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.486 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.48 -38.51 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.738 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.02 -47.35 89.65 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -65.17 -42.86 93.26 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -62.74 -37.76 87.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -62.92 -41.12 99.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.611 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.9 mmt -59.88 -44.29 94.29 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.299 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.76 -41.71 95.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.213 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.6 m -59.23 -46.25 88.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.704 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.87 -47.12 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.048 0.451 . . . . 0.0 110.498 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 111' ' ' GLN . 92.9 m-20 -61.54 -35.41 77.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.36 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -45.71 -36.74 5.21 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.193 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.04 -45.86 76.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 112' ' ' GLY . 48.1 m -123.39 22.65 9.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.625 ' N ' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -52.43 -10.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.133 -179.015 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -59.97 -61.47 7.14 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.718 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -117.17 -40.53 3.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.794 0.331 . . . . 0.0 111.452 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -86.37 138.9 31.44 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.167 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -132.72 150.68 52.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.154 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.05 139.69 38.27 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' OE1' ' NE ' ' A' ' 137' ' ' ARG . 79.1 tt0 -113.23 130.9 56.09 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.9 tp -83.79 117.94 23.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.434 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.3 mt -85.48 -59.42 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.313 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.536 ' C ' HD21 ' A' ' 120' ' ' ASN . 0.4 OUTLIER -158.53 172.17 18.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.35 134.68 11.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.34 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.88 161.1 39.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.728 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -139.36 143.49 37.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.427 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -135.65 146.23 47.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.482 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -120.05 112.68 19.45 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.515 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -136.6 139.61 42.24 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 51.2 40.71 26.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.724 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.07 2.3 17.45 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.522 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 2.9 tm0? -101.79 134.67 44.6 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 43.6 t -106.37 129.6 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.944 0.402 . . . . 0.0 110.542 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.522 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 70.0 m-85 -118.95 123.53 44.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.904 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -104.94 118.88 37.64 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 56.7 m -93.66 132.57 37.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.2 107.0 8.31 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.269 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.442 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 74.7 tt0 -103.37 126.02 50.3 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -153.38 171.23 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.315 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.422 ' NE ' ' OE1' ' A' ' 117' ' ' GLU . 40.0 ptt180 -141.5 161.49 37.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.865 0.364 . . . . 0.0 110.262 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.78 139.99 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.006 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 pp -145.0 150.63 37.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.188 0.518 . . . . 0.0 111.087 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.92 134.86 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.558 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.68 -107.04 0.23 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 56.1 t0 -117.46 13.3 14.4 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.323 0.12 . . . . 0.0 111.323 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.84 142.67 47.05 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.738 0.304 . . . . 0.0 111.019 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.69 125.77 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.016 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -78.05 -53.74 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.703 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.534 ' NH1' ' OG ' ' A' ' 165' ' ' SER . 44.8 ptt85 -173.83 171.81 3.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.011 0.434 . . . . 0.0 111.403 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -108.07 141.52 39.65 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.526 ' OD2' ' NH1' ' A' ' 146' ' ' ARG . 74.5 m-20 -135.57 144.02 45.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.006 0.431 . . . . 0.0 111.11 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.5 tp -116.79 134.47 54.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.53 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.43 ' CB ' ' OD1' ' A' ' 163' ' ' ASP . . . -134.1 128.21 33.72 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.008 0.433 . . . . 0.0 110.925 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.7 t -115.2 127.76 55.73 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.12 131.72 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.941 0.401 . . . . 0.0 110.875 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.52 ' OG1' ' NE2' ' A' ' 129' ' ' GLN . 6.8 t -146.67 161.93 39.53 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.687 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -122.22 152.79 39.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.23 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -165.74 123.25 1.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.618 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 58.67 26.09 14.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.004 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.72 9.12 83.52 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -106.69 141.19 38.35 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.898 0.38 . . . . 0.0 110.385 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.43 117.81 31.04 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.401 HG23 HD12 ' A' ' 160' ' ' ILE . 71.0 mt -117.44 121.88 68.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.8 m -122.55 130.1 52.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.27 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.01 110.43 21.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 150' ' ' ALA . 90.2 m-20 -115.48 124.84 52.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.919 0.39 . . . . 0.0 110.951 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 mp -116.56 146.12 42.87 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.681 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.534 ' OG ' ' NH1' ' A' ' 146' ' ' ARG . 45.7 t -132.08 131.31 42.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.583 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.8 m -152.4 155.7 38.07 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.647 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.57 144.68 16.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.254 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -71.5 -34.38 70.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.154 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.91 -33.61 74.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.712 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -103.01 -12.68 17.27 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.564 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.3 t-105 -47.69 -40.37 19.92 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.379 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -64.07 -42.28 97.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 50.5 m -65.52 -40.96 93.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.465 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 m -106.42 21.45 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.12 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 171' ' ' TRP . 24.0 pttm -49.45 -45.63 46.84 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.222 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 84.8 p -67.45 -28.56 67.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.457 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -56.1 -45.14 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.564 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.1 m-85 -62.5 -48.07 81.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.221 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -62.57 -42.55 99.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.547 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 91.7 m -67.49 -49.02 65.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.02 -37.32 72.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.511 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.24 -38.58 91.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.374 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.4 p -84.72 -16.03 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.217 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.4 t -62.78 -37.9 88.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.421 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -59.66 155.49 15.57 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.066 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -137.86 161.18 37.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -128.4 151.06 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.956 0.408 . . . . 0.0 111.257 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.468 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 39.3 p90 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.624 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.4 145.4 36.61 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.731 2.287 . . . . 0.0 111.997 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 tp -57.14 -37.35 71.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.232 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -83.97 -177.86 51.58 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.5 p -136.08 156.4 48.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.532 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.7 m -87.79 0.4 55.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.81 -91.28 1.48 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.5 -159.92 35.54 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.69 135.4 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.797 0.332 . . . . 0.0 110.487 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.71 -122.21 2.0 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.0 pt -121.62 156.72 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.802 0.334 . . . . 0.0 110.634 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.86 140.81 49.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.724 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.9 t -171.34 6.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.325 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.8 mt -107.04 139.79 40.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.36 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 3.2 mp0 -116.89 154.49 30.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.547 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.55 138.53 50.96 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.34 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -126.73 131.07 51.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.944 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -141.12 152.36 44.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 110.769 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -143.58 118.69 10.1 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.388 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.4 p -71.31 -32.69 68.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.529 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.48 -47.58 83.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.025 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -88.36 -20.33 25.47 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.1 42.06 85.36 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -143.07 149.29 37.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.338 0.569 . . . . 0.0 110.356 179.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -151.66 144.19 24.21 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.77 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.71 158.09 41.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.52 150.01 22.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.093 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -158.17 145.99 13.74 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.359 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.19 156.4 66.43 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.309 2.006 . . . . 0.0 112.187 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.433 ' N ' HE22 ' A' ' 33' ' ' GLN . 39.2 p30 -71.78 160.36 32.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.57 2.13 58.8 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.53 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 33.9 m0 -91.81 144.5 25.43 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 110.436 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.6 pt -120.65 144.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.359 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.32 141.56 15.68 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -129.88 143.63 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -90.61 144.55 25.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.61 51.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.491 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -66.98 136.08 54.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.094 0.473 . . . . 0.0 110.337 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.36 1.62 71.66 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.86 -164.19 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.64 0.257 . . . . 0.0 110.53 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.1 m -41.54 124.29 2.33 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.337 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.03 132.32 6.0 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.785 1.657 . . . . 0.0 112.694 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.98 -33.69 5.76 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.9 t -62.42 122.84 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.114 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -120.22 -50.06 2.26 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.467 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.95 139.5 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.879 0.371 . . . . 0.0 110.91 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.82 138.35 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.49 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.66 135.01 52.83 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.859 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -121.64 134.77 54.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.26 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.53 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 66.1 m-20 -86.18 118.75 25.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.483 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -67.47 -39.36 85.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.593 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.411 ' H ' HD12 ' A' ' 70' ' ' ILE . 4.1 mp -61.11 -48.14 90.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.76 118.01 28.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.908 0.385 . . . . 0.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.42 -36.59 65.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.777 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 2.7 p30 -62.47 -34.62 77.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.864 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 84.3 tt0 -86.13 133.33 33.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.0 110.254 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.683 ' ND2' ' HG ' ' A' ' 165' ' ' SER . 1.7 p30 -154.25 139.66 17.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -114.54 134.62 54.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.932 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.7 m -120.13 145.1 47.25 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.17 127.63 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.002 0.429 . . . . 0.0 110.315 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 5.8 mt -114.82 122.57 69.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.699 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.403 HD12 HG23 ' A' ' 80' ' ' ILE . 82.1 mt -122.08 127.88 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.996 0.427 . . . . 0.0 110.796 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 159' ' ' LEU . 21.9 t -153.29 164.29 38.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.045 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -103.47 136.42 43.25 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.0 pt -92.89 148.42 35.85 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.347 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' LYS . 37.1 Cg_endo -65.28 136.17 46.24 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.64 1.56 . . . . 0.0 110.821 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.8 t -60.99 -29.12 69.5 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.038 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -67.57 -31.52 71.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.999 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 84' ' ' PRO . 68.0 mttm -130.61 144.84 51.7 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.046 0.451 . . . . 0.0 111.138 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.416 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.1 t -113.24 179.18 4.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.173 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 tp -52.75 -43.83 66.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.859 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 47.1 p -69.04 -45.03 71.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.447 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 88' ' ' THR . 82.4 m-20 -68.77 -34.92 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.106 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.6 tp -55.39 -44.35 76.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.394 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.17 178.06 46.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.9 p -92.85 169.8 10.18 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.46 72.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.966 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.4 m -72.36 -44.64 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.851 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -62.54 -50.97 69.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.425 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.418 ' CG2' HH21 ' A' ' 101' ' ' ARG . 79.4 t -62.65 -38.56 81.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.604 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.27 -47.05 92.74 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.37 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -62.8 -45.36 92.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.82 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.418 HH21 ' CG2' ' A' ' 98' ' ' VAL . 85.4 mtm180 -62.96 -43.86 97.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.041 0.448 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -57.0 -41.14 77.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.804 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.4 mmt -61.12 -43.46 98.85 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.143 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.93 -38.83 92.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.423 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.1 m -56.88 -45.71 82.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.599 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.28 -46.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.13 0.491 . . . . 0.0 110.449 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.657 ' O ' ' N ' ' A' ' 111' ' ' GLN . 1.4 m120 -62.43 -32.98 73.92 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.272 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -43.81 -37.64 2.87 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.675 0.274 . . . . 0.0 111.537 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.26 -47.27 71.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.6 m -123.53 24.17 8.66 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 107' ' ' ASN . 16.9 tt0 -46.55 -28.77 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.597 0.237 . . . . 0.0 111.536 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.71 -61.18 3.04 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.02 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 31.7 p-10 -117.02 -36.3 3.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.069 0.435 . . . . 0.0 111.711 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.566 HH11 ' CG1' ' A' ' 138' ' ' VAL . 59.7 ttm-85 -84.18 142.05 30.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 0.0 111.051 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -148.82 149.09 30.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.886 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.537 ' CB ' HD22 ' A' ' 107' ' ' ASN . . . -108.47 138.99 43.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.168 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -107.94 129.85 55.08 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.1 tt -81.54 108.09 14.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.953 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.4 mt -70.68 -56.32 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.112 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.539 ' C ' HD21 ' A' ' 120' ' ' ASN . 0.3 OUTLIER -156.29 169.9 23.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.901 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.7 119.85 4.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.336 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.34 163.18 33.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.73 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -139.12 149.45 44.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.473 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -131.72 144.49 51.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.1 0.476 . . . . 0.0 110.821 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -111.42 114.3 27.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.572 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -140.3 141.88 35.71 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.702 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 127' ' ' ASP . 22.6 t70 49.67 37.2 12.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.03 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.59 1.49 23.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 3.7 tm0? -103.18 133.48 48.21 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 46.6 t -105.59 130.43 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.855 0.359 . . . . 0.0 110.721 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 48.4 m-85 -119.04 129.59 55.19 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.823 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.4 127.47 53.0 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 55.6 m -105.03 129.66 53.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.69 107.12 9.42 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.12 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.467 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 79.4 tt0 -101.79 127.22 48.68 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -150.87 170.37 19.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.411 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.524 ' NH1' ' HE2' ' A' ' 147' ' ' HIS . 18.9 ptp180 -136.81 156.75 48.08 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.052 0.453 . . . . 0.0 110.37 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.566 ' CG1' HH11 ' A' ' 114' ' ' ARG . 58.3 t -104.7 135.17 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.443 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -145.2 135.02 23.59 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.189 0.518 . . . . 0.0 111.251 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.3 t -111.6 132.52 59.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.869 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.54 -122.05 25.56 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -110.73 11.83 22.58 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.854 -0.204 . . . . 0.0 111.139 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -120.02 149.97 41.31 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.829 0.347 . . . . 0.0 111.225 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.0 t -88.35 126.03 41.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.415 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -75.08 -53.85 8.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.416 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -173.94 173.6 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 111.26 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.524 ' HE2' ' NH1' ' A' ' 137' ' ' ARG . 53.4 m80 -105.21 143.58 33.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.133 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 164' ' ' LEU . 12.0 t70 -141.21 151.16 43.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.841 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.8 tp -124.1 135.0 53.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.034 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.51 132.51 39.28 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.895 0.378 . . . . 0.0 110.431 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 69.3 m -119.93 137.39 54.07 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.59 130.29 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.985 0.421 . . . . 0.0 110.683 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.5 m -146.97 144.85 29.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.322 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -110.9 150.36 29.3 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.192 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -151.14 106.7 3.37 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.264 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 61.83 34.84 16.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.066 0.46 . . . . 0.0 110.526 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.06 8.29 86.74 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -98.42 127.17 44.23 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.81 113.13 24.65 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.405 HD11 HG21 ' A' ' 160' ' ' ILE . 67.9 mt -122.25 124.29 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.328 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.0 m -124.62 134.27 52.98 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.14 111.04 23.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.65 119.97 40.48 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 111.428 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.426 ' O ' ' OD2' ' A' ' 148' ' ' ASP . 2.9 mp -115.47 142.64 46.44 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.136 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . 0.683 ' HG ' ' ND2' ' A' ' 75' ' ' ASN . 69.0 p -132.96 135.05 45.28 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.871 0.367 . . . . 0.0 110.547 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.0 m -152.88 157.02 40.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.248 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.29 143.69 55.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.04 0.448 . . . . 0.0 111.4 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.427 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 1.3 pp20? -69.82 -27.11 64.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.222 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.427 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 90.3 m-20 -59.36 -34.15 72.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.256 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -117.66 -1.59 11.59 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.554 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 44.5 t-105 -48.64 -39.34 23.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.554 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -63.26 -42.11 99.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.958 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 39.8 m -64.49 -40.47 95.73 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.8 m -105.11 20.87 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.902 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -49.33 -45.61 45.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.89 0.376 . . . . 0.0 110.952 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 85.1 p -68.07 -27.69 66.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.598 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.9 tp -56.84 -44.34 81.99 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.583 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.554 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.2 m-85 -63.59 -49.82 71.88 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.239 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -62.0 -42.28 98.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.579 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 65.0 m -67.6 -49.77 61.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.038 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.82 -37.92 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.38 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.46 -39.04 93.41 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.234 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.5 m -80.71 -19.54 44.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.273 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -62.53 -36.22 81.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.718 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -55.93 148.76 16.48 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.11 -179.555 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -136.85 155.53 49.67 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.22 150.61 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.183 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.489 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 40.9 p90 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.548 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.745 0.307 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.476 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 20.3 mp0 -115.41 155.06 28.11 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.014 0.435 . . . . 0.0 110.741 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -113.73 131.26 56.25 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.369 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -124.66 131.29 53.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.944 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -138.57 153.4 48.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.665 0.269 . . . . 0.0 110.757 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -144.2 109.61 5.16 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.787 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.0 m -61.74 -36.14 80.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.507 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -58.73 -51.41 70.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.938 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 38.4 t0 -85.86 -20.64 28.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.735 0.302 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.92 40.9 84.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.72 150.7 42.16 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.218 0.509 . . . . 0.0 110.17 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -151.12 143.07 23.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.598 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -151.74 160.06 43.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.176 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 mt -98.33 150.37 21.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.103 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -153.63 145.92 17.2 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.297 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.2 152.95 78.78 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.373 2.049 . . . . 0.0 112.151 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.1 p30 -73.15 160.26 32.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.576 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.84 58.22 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.475 ' NE1' ' CG ' ' A' ' 68' ' ' ASP . 30.1 m0 -92.95 145.57 24.27 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.4 pt -118.73 145.03 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.35 128.79 9.68 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.7 135.46 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.756 0.312 . . . . 0.0 110.297 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -76.57 129.29 36.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.431 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.14 36.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.766 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -59.37 135.94 57.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.43 . . . . 0.0 110.693 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.06 10.02 72.57 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.45 -164.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.683 0.278 . . . . 0.0 110.548 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.16 140.86 42.21 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.084 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -44.98 132.11 10.85 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.59 1.526 . . . . 0.0 112.463 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.481 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 94.97 -31.04 7.28 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.4 t -61.04 128.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -119.07 -57.33 2.03 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.209 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.4 t -143.95 148.51 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.867 0.365 . . . . 0.0 110.92 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.47 140.01 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.45 134.11 53.26 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.107 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -127.15 130.74 50.35 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.463 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' CG ' ' NE1' ' A' ' 50' ' ' TRP . 60.3 t0 -87.86 117.96 27.06 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.662 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.9 tp -65.22 -38.99 92.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.555 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.86 -39.54 82.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.044 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.54 96.19 4.6 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.809 0.338 . . . . 0.0 110.593 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -61.33 -37.0 81.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.374 0.607 . . . . 0.0 109.856 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.27 -36.83 73.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.971 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -82.66 130.65 35.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.436 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -140.32 139.09 35.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.363 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.62 136.23 53.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.686 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.0 t -126.16 140.37 52.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.739 0.304 . . . . 0.0 110.608 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.94 125.52 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.914 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.481 HG23 ' C ' ' A' ' 61' ' ' GLY . 30.9 mt -121.13 123.87 70.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.93 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.35 133.42 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.873 0.368 . . . . 0.0 110.682 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LEU . 22.7 t -151.11 162.56 40.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.313 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.565 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 2.0 pm0 -105.06 130.23 53.31 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.111 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 83' ' ' ILE . 6.4 pt -86.4 149.22 48.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.406 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 87' ' ' LYS . 36.2 Cg_endo -65.06 136.66 49.1 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.588 1.525 . . . . 0.0 110.753 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -60.96 -29.01 69.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.182 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -67.9 -31.44 71.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.898 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' PRO . 92.1 mttt -131.2 140.36 49.88 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.918 0.39 . . . . 0.0 111.169 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -105.96 -178.42 3.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.079 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.509 ' N ' ' OG1' ' A' ' 88' ' ' THR . 49.2 tp -52.18 -43.04 63.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.769 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.9 p -68.03 -43.76 78.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.093 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.52 -35.16 78.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 92' ' ' LEU . 4.4 tt -55.17 -49.05 72.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.129 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.74 176.67 45.95 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.409 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 36.2 p -90.38 171.26 9.58 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.12 -42.32 76.67 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.165 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.7 m -72.06 -43.91 64.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.809 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 94' ' ' THR . 47.4 t0 -61.94 -51.38 68.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.151 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.2 t -61.7 -38.53 80.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.568 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.63 -44.54 93.93 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -68.14 -39.77 82.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.821 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -61.61 -41.34 97.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -61.43 -41.16 96.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.63 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.9 mmt -58.62 -43.76 89.75 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.838 0.352 . . . . 0.0 110.365 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -64.57 -40.08 94.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.356 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -60.05 -47.33 86.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.892 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.3 t -71.7 -45.74 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.011 0.434 . . . . 0.0 110.497 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 111' ' ' GLN . 88.9 m-20 -60.43 -32.56 71.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.069 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -44.19 -37.65 3.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.215 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -105.72 -10.8 16.57 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 114' ' ' ARG . 1.3 t -121.39 16.1 11.33 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 107' ' ' ASN . 21.2 pt20 -79.83 6.98 9.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.086 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.35 -62.85 2.23 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.052 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -117.06 -41.23 3.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.634 0.254 . . . . 0.0 111.501 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' SER . 95.6 mtt180 -86.28 154.7 21.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.876 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -133.11 135.53 45.3 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.209 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.17 129.57 44.52 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.06 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -116.95 128.78 55.54 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.021 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.0 tp -83.66 110.85 18.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.024 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -55.25 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.104 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.53 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 24.5 p30 -161.4 168.57 23.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.921 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.68 122.44 4.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.232 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.96 162.9 34.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.583 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.414 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.48 148.28 50.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.571 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -130.67 150.14 52.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.775 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -120.45 116.36 25.3 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.847 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.45 142.27 39.47 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.456 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.3 t0 52.05 28.42 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.16 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.68 2.61 85.84 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 154' ' ' THR . 66.4 tp60 -104.02 135.99 44.5 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.02 129.89 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.964 0.411 . . . . 0.0 110.532 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.84 129.84 55.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.821 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.414 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.75 130.21 53.8 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.3 m -112.89 125.18 54.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.195 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.24 124.88 48.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.013 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.53 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 72.2 tt0 -119.72 124.2 45.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.86 169.75 20.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.38 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -138.88 160.31 40.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.394 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 63.4 t -104.42 126.35 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.008 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.1 mt -106.14 139.71 40.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.336 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.88 135.86 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.45 -112.63 1.41 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -118.23 22.88 11.92 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -142.63 157.1 45.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.219 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.3 123.86 32.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.102 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.445 ' CD ' ' NH1' ' A' ' 146' ' ' ARG . 85.3 tt0 -75.16 -53.28 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.111 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.445 ' NH1' ' CD ' ' A' ' 145' ' ' GLU . 33.6 ptt-85 -172.41 167.66 5.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -107.98 135.61 49.07 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.968 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -131.05 140.94 50.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.543 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.4 tp -111.2 132.23 54.49 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -129.2 132.48 47.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.387 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.4 m -121.79 139.78 53.18 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.36 131.51 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.972 0.415 . . . . 0.0 111.073 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.6 m -148.72 142.21 25.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.256 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.458 ' O ' ' NE2' ' A' ' 129' ' ' GLN . 13.0 p -106.41 149.56 26.9 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.343 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -150.39 106.68 3.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.077 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.413 ' NH2' ' OXT' ' A' ' 188' ' ' TYR . 17.0 ttm180 63.15 27.6 15.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.179 0.514 . . . . 0.0 110.579 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.13 3.08 73.38 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.804 -0.519 . . . . 0.0 111.804 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.49 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 11.5 mptt -94.95 126.11 40.06 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.417 -0.461 . . . . 0.0 109.81 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -88.54 118.62 28.31 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 78.2 mt -120.02 127.98 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.823 0.344 . . . . 0.0 110.663 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 89.0 m -129.12 136.86 50.78 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.725 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.68 103.28 11.07 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -102.27 108.68 20.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.81 0.338 . . . . 0.0 110.414 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 164' ' ' LEU . 5.3 mp -114.05 140.04 48.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.3 p -133.63 139.65 46.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.855 0.36 . . . . 0.0 110.306 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.9 m -152.99 157.2 40.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.5 145.93 37.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.555 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.415 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 2.0 pp20? -70.87 -21.06 62.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.971 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.415 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 93.6 m-20 -58.84 -34.58 71.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.22 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.517 ' O ' HG22 ' A' ' 174' ' ' VAL . 72.3 mtp85 -123.03 -1.34 8.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.576 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 59.9 t-105 -46.69 -40.25 12.91 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.812 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -64.56 -42.29 95.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.993 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.2 m -66.12 -39.67 90.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.728 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 170' ' ' ARG . 10.9 m -106.53 21.64 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.246 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 176' ' ' SER . 12.2 ptmm? -51.22 -50.93 58.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.194 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.409 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 24.9 t -64.94 -30.69 71.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.889 0.376 . . . . 0.0 111.088 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -52.55 -45.79 66.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.849 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 23.1 m-85 -62.0 -49.83 74.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.049 0.452 . . . . 0.0 110.467 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -63.24 -37.8 88.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.471 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 184' ' ' SER . 56.2 m -61.37 -47.4 86.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.296 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.49 -44.17 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.519 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -65.74 -42.93 90.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.556 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 85.2 p -74.79 -30.9 61.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 180' ' ' THR . 58.0 m -63.14 -29.67 70.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -52.74 156.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.137 0.494 . . . . 0.0 110.813 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -138.67 155.18 48.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.199 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.0 m -127.91 151.68 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.922 0.392 . . . . 0.0 111.244 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.413 ' OXT' ' NH2' ' A' ' 156' ' ' ARG . 41.2 p90 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.661 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 mt . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.516 ' OE1' ' ND2' ' A' ' 48' ' ' ASN . 2.9 tp60 -102.61 170.85 7.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.099 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -139.68 146.03 39.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.656 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.68 141.78 45.03 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.137 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.0 p -149.75 155.38 40.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 110.592 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -148.08 119.14 7.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.624 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.6 p -71.55 -29.75 65.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.172 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -61.54 -48.93 78.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.983 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 50.5 t0 -92.12 -20.39 21.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.738 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.75 44.87 60.97 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.853 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.455 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -142.65 149.05 38.39 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.232 0.516 . . . . 0.0 110.336 179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.73 143.48 22.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -152.47 158.85 43.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 111.059 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.6 mt -96.79 151.72 19.37 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.892 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 10.3 p90 -157.95 136.56 7.81 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.846 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -43.29 157.3 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.045 1.83 . . . . 0.0 112.559 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.516 ' ND2' ' OE1' ' A' ' 33' ' ' GLN . 2.1 m-20 -81.18 158.93 24.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.299 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.08 63.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 26.8 m0 -87.6 147.27 25.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.839 0.352 . . . . 0.0 110.175 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -114.7 132.31 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.043 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.89 133.2 11.61 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.33 134.24 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.964 0.412 . . . . 0.0 110.753 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 54' ' ' ASP . 37.0 p30 -91.36 121.29 32.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.518 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.25 60.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.464 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -78.73 132.91 37.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.163 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.0 3.62 73.11 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.39 -163.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 t -40.53 125.95 1.83 Allowed Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.449 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -41.5 127.16 3.2 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.97 1.78 . . . . 0.0 113.025 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.503 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 100.68 -36.18 4.34 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.533 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -63.63 127.02 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.174 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 61' ' ' GLY . 5.4 m-20 -119.57 -56.63 2.04 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.574 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.52 139.61 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.901 0.381 . . . . 0.0 111.098 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.3 t -123.08 132.63 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.127 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -112.28 134.27 53.92 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.41 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -124.76 143.36 50.83 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 73.8 m-20 -90.42 119.08 30.4 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.548 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.2 tp -65.4 -41.21 93.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.574 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.99 -45.03 99.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.048 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.67 120.67 37.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.863 0.363 . . . . 0.0 110.73 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -77.84 -40.38 40.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.56 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -58.7 -36.5 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.643 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.91 133.39 35.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -156.11 139.31 15.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.561 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.68 134.4 55.07 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.804 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.6 t -121.86 139.26 53.85 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.026 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.96 125.61 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.07 0.462 . . . . 0.0 110.279 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.503 HG23 ' C ' ' A' ' 61' ' ' GLY . 14.9 mt -117.35 123.52 71.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.7 mt -120.21 128.42 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.396 . . . . 0.0 110.952 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 61.3 m -149.03 166.0 29.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.3 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -105.64 138.41 41.88 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 159' ' ' LEU . 8.2 pt -93.09 149.4 37.46 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.653 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -44.51 140.19 6.37 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.651 1.568 . . . . 0.0 111.383 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -67.94 -25.38 65.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.403 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.4 p30 -93.03 -15.28 26.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -131.43 150.44 52.15 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.096 0.474 . . . . 0.0 111.486 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 46.8 p -112.86 -179.23 3.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.222 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.9 tp -56.36 -41.56 76.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.448 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.5 p -72.16 -45.07 61.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.968 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 88' ' ' THR . 45.7 t0 -64.7 -37.28 87.04 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.787 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.0 tp -55.8 -43.32 76.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.745 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.5 179.19 47.62 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.309 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 36.2 p -93.4 170.69 9.42 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.24 74.37 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.044 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 78.0 m -72.45 -45.67 58.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 94' ' ' THR . 45.6 t0 -61.25 -52.16 65.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.311 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.4 -38.62 82.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.713 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.71 -45.07 93.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -65.2 -41.45 94.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.541 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -63.11 -39.03 93.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.059 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.66 -41.49 98.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.699 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.8 mmt -58.38 -44.4 88.89 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.383 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -66.07 -42.48 89.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.359 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.5 m -59.24 -45.79 90.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.9 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.2 -47.48 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 0.0 110.478 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.646 ' O ' ' N ' ' A' ' 111' ' ' GLN . 93.4 m-20 -62.67 -34.65 77.53 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.451 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -46.61 -36.92 7.43 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.068 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.23 -47.11 71.78 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.41 ' C ' ' N ' ' A' ' 112' ' ' GLY . 74.8 m -123.26 22.25 9.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.646 ' N ' ' O ' ' A' ' 107' ' ' ASN . 10.3 pt20 -49.41 -13.38 0.08 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.403 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 110' ' ' SER . . . -58.08 -61.42 7.44 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.86 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 35.1 p-10 -117.46 -35.66 3.93 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.902 0.351 . . . . 0.0 111.685 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 58.2 ttp180 -85.13 135.77 33.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.914 0.388 . . . . 0.0 111.28 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -127.97 144.37 51.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.191 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -107.09 138.07 43.96 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -119.81 129.06 54.26 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.98 110.08 16.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.204 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.02 -55.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.557 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -145.75 159.35 43.31 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.553 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.37 112.81 2.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.463 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.1 168.98 18.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.657 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.63 147.18 42.6 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.763 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -130.35 143.86 51.03 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.921 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 125' ' ' ASP . 35.5 p30 -110.56 111.1 22.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.725 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -137.45 143.0 41.59 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.879 0.371 . . . . 0.0 110.839 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 51.38 37.97 20.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.317 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.24 2.61 41.78 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -107.67 149.47 28.07 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.964 0.411 . . . . 0.0 110.234 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.5 t -117.12 129.2 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.103 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 14.1 m-85 -119.31 128.15 53.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.067 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -100.62 120.04 39.46 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 63.2 m -95.17 127.46 41.24 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.94 110.76 11.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.53 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -107.28 126.58 52.61 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -150.79 170.45 19.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.349 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -136.97 156.8 47.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.041 0.448 . . . . 0.0 110.523 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.7 134.39 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.91 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.415 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.8 pp -135.77 136.26 40.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.161 0.505 . . . . 0.0 111.13 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.45 134.13 55.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.12 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.6 -121.06 19.05 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -113.91 14.17 18.47 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.926 -0.161 . . . . 0.0 111.275 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -127.15 153.6 45.84 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.901 0.382 . . . . 0.0 111.164 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 144' ' ' VAL . 14.7 p -85.67 126.93 40.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.237 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.415 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 83.9 tt0 -75.01 -52.75 10.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.773 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -175.21 173.97 2.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.028 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -109.84 136.78 48.61 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.16 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -132.88 141.57 48.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.892 0.377 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.9 tp -111.48 131.18 55.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.99 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.97 131.08 47.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.955 0.407 . . . . 0.0 110.486 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.0 m -120.69 138.15 54.1 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.6 t -119.85 129.16 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.033 0.444 . . . . 0.0 110.683 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.7 m -144.72 148.28 33.99 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.624 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -114.74 149.25 37.16 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.832 0.349 . . . . 0.0 110.303 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -149.82 107.04 3.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.032 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 65.07 26.26 12.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.12 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.4 1.44 71.78 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 2.4 mptp? -94.28 126.66 39.67 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -87.94 115.62 25.54 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 65.7 mt -121.45 123.52 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.005 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 72.7 m -122.45 132.11 54.19 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.52 113.12 26.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.817 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -115.04 124.85 52.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.905 0.383 . . . . 0.0 111.652 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.01 142.18 50.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.458 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 67.1 m -132.91 134.3 44.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.406 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 167' ' ' ALA . 22.9 m -153.18 159.2 42.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.87 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.453 ' N ' HG22 ' A' ' 166' ' ' THR . . . -56.36 141.56 41.44 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.365 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.81 -39.09 90.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.963 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.48 -33.07 74.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.194 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 174' ' ' VAL . 79.8 mtp180 -96.38 -17.56 20.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.35 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.59 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 47.9 t-105 -48.75 -41.73 33.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.713 0.292 . . . . 0.0 110.947 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.83 -41.69 97.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.136 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.7 m -65.56 -40.6 92.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.432 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.6 m -107.35 21.22 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.25 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 171' ' ' TRP . 19.0 ptmt -48.14 -47.4 34.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 111.111 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 27.0 t -64.83 -31.54 72.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.669 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.61 -45.64 73.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.044 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.59 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.2 m-85 -61.33 -50.11 74.26 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.263 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -63.28 -42.37 99.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.871 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.1 m -67.16 -49.01 66.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.777 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.9 t -70.01 -37.64 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.405 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.68 -37.03 84.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.317 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.0 t -84.62 -18.61 34.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.133 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 t -62.79 -35.87 81.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.629 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -55.89 147.23 19.85 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.931 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -134.44 157.72 45.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.37 151.19 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.767 0.317 . . . . 0.0 111.049 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.414 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 33.8 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.69 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.045 0.45 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 1.042 HE22 ' CB ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -135.91 158.94 43.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.915 179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -116.73 135.52 53.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.633 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -108.99 141.17 41.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.078 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.9 p -144.57 157.28 44.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.762 0.315 . . . . 0.0 110.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -146.96 112.32 5.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.766 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.7 m -62.0 -37.32 84.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.603 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -59.39 -52.33 66.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.227 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -84.49 -20.53 31.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.767 0.318 . . . . 0.0 110.77 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.65 43.17 86.17 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -142.37 151.88 42.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.235 0.517 . . . . 0.0 110.393 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -153.96 144.47 22.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.806 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -148.86 160.4 43.28 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.044 0.449 . . . . 0.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 tp -103.8 133.07 49.4 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.619 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -141.99 140.78 20.19 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.066 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -45.68 150.32 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.901 1.734 . . . . 0.0 112.217 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 1.042 ' CB ' HE22 ' A' ' 33' ' ' GLN . 37.2 p-10 -81.02 160.03 24.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.301 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.43 3.19 65.05 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 32.9 m0 -81.3 147.12 30.05 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.8 pt -111.43 134.25 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.327 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.85 138.59 14.0 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.45 134.05 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.771 0.32 . . . . 0.0 110.22 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 54' ' ' ASP . 48.7 p30 -84.45 145.57 28.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.72 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.1 m -151.66 51.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.353 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.45 133.5 46.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.048 0.451 . . . . 0.0 110.423 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.37 3.92 84.01 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.65 -164.24 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.8 m -40.49 117.88 1.43 Allowed Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.685 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.18 135.23 11.33 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.506 1.47 . . . . 0.0 111.895 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.462 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 99.84 -32.01 7.75 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.12 130.07 29.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -111.05 -57.79 2.19 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.708 0.289 . . . . 0.0 110.94 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -147.02 140.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.712 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.72 133.48 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.143 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.71 134.05 54.42 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.522 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -129.44 134.73 47.97 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.111 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 77.8 m-20 -86.61 119.1 26.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.836 0.35 . . . . 0.0 110.652 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.8 tt -65.11 -40.04 93.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.505 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 88.6 mt -61.37 -42.93 95.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.008 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -119.11 120.16 36.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.891 0.377 . . . . 0.0 110.659 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -82.82 -36.24 25.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.578 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 40.6 p-10 -62.37 -31.94 72.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.981 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 84.2 tt0 -87.13 130.47 34.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.62 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -139.57 139.5 36.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.297 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.39 134.76 52.03 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -129.53 138.91 51.61 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.13 128.3 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.405 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.462 HG23 ' C ' ' A' ' 61' ' ' GLY . 25.8 mt -123.68 123.97 68.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.326 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.3 mt -123.23 130.83 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.392 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.4 m -145.74 165.86 27.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.297 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -105.46 135.81 46.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 83' ' ' ILE . 8.1 pt -92.52 148.83 37.08 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.32 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' LYS . 37.3 Cg_endo -65.86 137.13 48.0 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.695 1.597 . . . . 0.0 110.69 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 t -60.88 -29.42 69.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.171 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -67.59 -31.34 71.32 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 84' ' ' PRO . 95.4 mttt -131.04 143.19 50.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.938 0.399 . . . . 0.0 111.007 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -111.87 179.82 3.9 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.086 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.484 ' N ' ' OG1' ' A' ' 88' ' ' THR . 45.8 tp -52.16 -45.16 64.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.079 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.3 p -68.51 -41.38 80.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.925 0.393 . . . . 0.0 110.882 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.452 ' H ' HG23 ' A' ' 88' ' ' THR . 50.0 t0 -66.41 -36.45 82.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.629 ' O ' HD23 ' A' ' 92' ' ' LEU . 4.8 tt -55.62 -47.54 76.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.241 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.09 178.52 47.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.5 p -90.71 172.96 8.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.15 76.43 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.113 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.1 m -72.14 -45.3 61.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.55 -51.12 69.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.246 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.55 -38.63 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.404 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.08 -45.55 93.75 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -69.52 -40.26 77.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.813 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -61.5 -41.18 96.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.043 0.449 . . . . 0.0 110.76 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -60.74 -40.66 93.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.633 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.7 mmt -59.26 -44.16 92.43 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.507 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -64.59 -39.63 94.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.154 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.8 m -59.26 -46.84 87.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.922 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.15 -46.04 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.048 0.451 . . . . 0.0 110.383 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 111' ' ' GLN . 86.3 m-20 -61.99 -31.29 71.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -44.12 -37.56 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -110.34 -7.71 14.78 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.808 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 114' ' ' ARG . 27.9 m -121.05 19.36 11.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.367 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 107' ' ' ASN . 21.1 pt20 -84.39 6.26 23.9 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.15 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.98 -63.22 2.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.831 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -117.3 -46.14 2.71 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.903 0.382 . . . . 0.0 110.934 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 110' ' ' SER . 93.2 mtm-85 -74.61 148.73 40.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.228 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -131.83 130.58 41.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.601 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.92 128.63 44.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 110.389 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -115.36 128.7 56.25 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.6 tp -82.71 111.6 18.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.929 0.395 . . . . 0.0 110.406 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.74 -57.68 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.362 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -146.35 161.3 40.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.647 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.41 112.93 2.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.388 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.37 167.37 22.27 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.896 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.418 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -136.93 149.7 47.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.754 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -132.52 143.04 49.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.778 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -111.82 115.03 28.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.428 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.12 144.76 36.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.983 0.42 . . . . 0.0 110.94 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.5 t0 54.74 22.1 3.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.41 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.54 -1.78 88.19 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -103.49 149.02 25.25 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.942 0.401 . . . . 0.0 110.077 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.67 128.42 67.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.995 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -117.49 127.73 54.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.873 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.31 124.78 49.78 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.7 m -105.78 122.76 46.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.299 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.3 mp -117.83 122.93 44.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.99 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -117.88 124.42 48.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.431 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -151.98 172.89 15.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.401 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -140.78 160.53 39.84 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.079 0.466 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.61 132.58 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.437 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pp -135.81 136.35 40.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 111.346 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.57 130.46 55.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.119 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.63 -116.95 10.08 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 56.7 t0 -114.73 12.44 17.08 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.468 0.175 . . . . 0.0 111.025 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -119.75 146.6 45.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.726 0.298 . . . . 0.0 110.951 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 144' ' ' VAL . 7.4 p -85.57 125.19 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.434 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -75.21 -52.66 10.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.717 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -173.23 172.49 3.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -104.84 141.18 36.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.028 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -134.49 136.74 43.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.991 0.424 . . . . 0.0 111.206 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.1 tp -111.55 135.63 51.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.724 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.53 134.97 42.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.252 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.0 m -121.49 141.36 51.11 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.097 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.7 128.88 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.853 0.359 . . . . 0.0 110.871 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.8 m -146.31 148.86 32.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.415 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -112.54 151.1 30.4 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.833 0.349 . . . . 0.0 110.357 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -150.37 103.95 3.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 62.52 31.38 17.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.977 0.417 . . . . 0.0 110.68 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 89.01 2.27 78.22 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.306 -0.473 . . . . 0.0 111.925 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 1.7 mptp? -95.1 125.17 39.57 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.7 OUTLIER -88.62 118.22 28.13 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.4 mt -120.49 128.16 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.759 0.314 . . . . 0.0 110.499 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.5 m -130.52 136.51 49.02 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.723 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.86 110.47 20.82 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.976 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -105.47 111.88 24.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.559 0.219 . . . . 0.0 110.509 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 164' ' ' LEU . 5.5 mp -119.09 135.59 54.57 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.744 0.307 . . . . 0.0 110.483 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -129.82 138.2 50.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.368 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.6 m -153.05 156.52 38.92 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.48 145.07 34.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.453 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.39 -29.07 65.61 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.325 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.33 -34.05 71.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.256 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.452 ' O ' HG22 ' A' ' 174' ' ' VAL . 60.7 mtp180 -113.79 -4.2 13.39 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.532 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 57.5 t-105 -49.54 -38.5 31.16 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.091 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.32 -43.11 99.59 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.183 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 77.9 m -65.58 -39.76 91.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.8 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 170' ' ' ARG . 11.3 m -108.45 21.11 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.521 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 176' ' ' SER . 17.4 pttp -51.75 -50.5 60.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.459 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 27.2 t -65.17 -29.67 70.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.734 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.6 tp -55.75 -43.6 76.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.233 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.532 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 28.5 m-85 -61.53 -49.58 76.14 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.385 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.64 -39.66 91.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.459 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.421 ' O ' ' OG ' ' A' ' 184' ' ' SER . 43.8 m -65.39 -47.35 76.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.277 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.34 -44.88 99.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.494 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.475 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -66.52 -45.36 79.78 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.283 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.0 t -69.96 -32.34 70.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.235 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 180' ' ' THR . 63.8 m -62.03 -30.08 70.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.306 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -49.9 157.08 0.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.522 -179.388 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -138.59 153.99 48.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.581 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.6 m -127.12 151.15 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.107 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 42.6 p90 . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.75 -179.875 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.6 mt . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 120.917 0.389 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.61 ' NE2' ' N ' ' A' ' 33' ' ' GLN . 2.8 mp0 -109.92 151.89 26.51 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.272 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -120.24 143.14 48.45 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.565 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -130.43 133.63 46.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.068 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -140.81 151.2 44.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.401 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -140.73 120.26 13.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.408 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.8 p -71.33 -32.59 68.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.574 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.22 -49.45 74.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.115 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -87.37 -20.63 26.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.825 0.345 . . . . 0.0 110.729 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.34 41.16 91.58 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -139.75 152.71 46.84 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.264 0.532 . . . . 0.0 110.418 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -151.39 148.58 28.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.461 ' C ' HD22 ' A' ' 45' ' ' LEU . 45.5 p90 -152.33 155.91 38.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.044 0.45 . . . . 0.0 111.53 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.663 HD22 ' N ' ' A' ' 45' ' ' LEU . 2.3 mm? -96.7 141.92 29.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.894 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -153.05 147.63 19.2 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.543 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.22 163.4 34.93 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.596 2.197 . . . . 0.0 112.968 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.596 ' ND2' ' NE2' ' A' ' 33' ' ' GLN . 68.6 m-80 -70.52 160.47 32.4 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.85 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.74 -6.19 57.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -97.08 141.84 29.73 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 51' ' ' ILE . 36.4 pt -123.13 147.28 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.42 137.39 13.23 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.19 136.19 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.895 0.379 . . . . 0.0 110.655 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -77.78 133.98 38.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.241 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 m -132.06 56.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.256 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -73.65 137.78 44.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.13 3.57 69.77 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.48 -164.22 0.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.798 0.332 . . . . 0.0 110.65 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.5 157.04 1.89 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.155 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.74 131.03 27.92 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.425 2.083 . . . . 0.0 111.722 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 94.3 -22.43 36.98 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.84 132.16 27.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.413 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -118.67 -58.4 1.97 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.033 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 m -146.87 165.81 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.178 0.514 . . . . 0.0 111.308 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.13 140.86 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.028 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -111.99 130.38 55.88 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -127.6 133.6 49.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.917 0.389 . . . . 0.0 111.132 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 71' ' ' GLU . 60.2 t0 -93.49 118.27 31.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.452 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt -63.62 -39.09 93.49 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.14 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.06 -40.86 90.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' A' ' 68' ' ' ASP . 79.1 mm-40 -117.99 118.11 31.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.621 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -85.91 -43.0 13.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.417 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -58.43 -39.69 80.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.993 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 33.9 mp0 -82.95 135.94 34.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.355 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.84 157.77 38.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.904 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 77' ' ' SER . 9.5 tp -132.09 133.87 44.83 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.047 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.44 ' N ' HD12 ' A' ' 76' ' ' LEU . 42.6 t -123.54 131.32 53.6 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.41 126.97 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.61 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.506 HG23 ' C ' ' A' ' 61' ' ' GLY . 49.4 mt -122.33 121.41 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.21 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.4 mm -116.77 129.92 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.01 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 159' ' ' LEU . 9.6 m -148.79 164.36 34.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.161 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -103.66 138.12 40.75 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 83' ' ' ILE . 10.6 pt -92.92 149.26 37.37 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.788 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -43.77 139.64 5.18 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.76 1.64 . . . . 0.0 111.487 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -69.01 -23.9 64.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.557 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 56.3 t0 -90.68 -18.38 25.17 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -128.73 157.32 41.73 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.104 0.478 . . . . 0.0 111.617 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.9 t -122.92 176.91 5.74 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.515 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 tp -51.0 -45.09 61.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.972 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.9 p -66.92 -44.99 79.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.089 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.36 -37.18 84.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.8 tp -55.91 -41.94 75.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.67 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.83 -179.41 48.35 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.425 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.2 p -96.05 171.9 8.33 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.73 73.57 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.133 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.3 m -73.05 -46.16 53.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.87 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.425 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.3 t0 -62.6 -50.97 69.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.164 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.36 -38.79 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -57.94 -56.12 26.87 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -59.52 -36.64 76.48 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.479 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -56.27 -40.26 73.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.099 0.476 . . . . 0.0 110.577 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -63.8 -41.58 97.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.127 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.674 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -54.98 -55.27 32.7 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.307 0.575 . . . . 0.0 110.096 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -61.29 -39.56 90.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.766 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.1 m -57.97 -45.63 86.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.7 t -71.7 -46.57 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.504 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 111' ' ' GLN . 12.8 m-20 -60.83 -33.9 73.75 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.879 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -45.63 -35.52 4.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.06 0.457 . . . . 0.0 110.439 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.47 -48.5 22.41 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 m -122.31 22.94 9.96 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 107' ' ' ASN . 16.1 pt20 -47.39 -18.59 0.12 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.632 0.253 . . . . 0.0 111.483 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.26 -61.44 7.38 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.167 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 38.1 p-10 -117.31 -30.84 5.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.072 0.436 . . . . 0.0 111.781 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.527 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 55.1 ttm-85 -80.19 136.92 36.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 111.026 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -133.17 135.86 45.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.37 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -107.87 136.62 47.29 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.951 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -118.64 127.76 53.9 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.9 tp -82.84 108.18 15.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.899 0.38 . . . . 0.0 110.209 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.546 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 97.0 mt -71.0 -38.3 71.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.942 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.3 m-80 -178.52 163.7 1.57 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.165 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.9 120.53 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.197 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -137.6 170.71 15.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.035 0.445 . . . . 0.0 110.919 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -141.78 150.74 42.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.506 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.83 136.77 46.45 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.152 0.501 . . . . 0.0 110.802 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -103.97 113.62 27.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -138.26 137.62 37.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.429 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 129' ' ' GLN . 87.2 m-20 51.24 42.3 28.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.627 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.13 1.59 5.67 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.524 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 2.8 tm0? -102.28 130.71 49.06 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.13 130.0 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.524 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 45.8 m-85 -118.87 131.4 56.06 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.724 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.435 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.07 128.44 53.34 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.464 ' C ' HD12 ' A' ' 134' ' ' LEU . 94.0 m -110.13 123.62 50.06 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.326 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.464 HD12 ' C ' ' A' ' 133' ' ' THR . 9.4 mp -115.45 127.51 55.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.992 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -123.43 120.49 33.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.297 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -150.31 169.68 20.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.471 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -133.73 152.92 52.01 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 110.554 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.415 ' CG1' HH11 ' A' ' 114' ' ' ARG . 74.2 t -105.01 133.57 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.375 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.411 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.7 pp -140.57 135.13 31.49 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.283 0.563 . . . . 0.0 111.087 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.6 t -115.02 134.27 58.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.131 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.54 -122.1 21.87 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -111.31 13.45 21.65 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -128.86 156.74 43.17 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.077 0.465 . . . . 0.0 111.475 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 144' ' ' VAL . 9.9 p -87.62 126.98 41.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.412 ' OE1' ' NH1' ' A' ' 114' ' ' ARG . 84.2 tt0 -74.77 -54.63 6.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.472 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -174.46 173.83 2.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.207 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.416 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 51.2 m170 -103.99 138.66 40.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.025 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 81.5 m-20 -135.38 137.92 42.81 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.011 0.434 . . . . 0.0 111.291 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 tp -114.15 130.52 56.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.845 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.79 137.85 54.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.82 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.1 t -126.82 126.02 42.66 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 52.4 t -114.83 129.94 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.12 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.9 m -143.83 144.34 31.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.0 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 p -110.99 150.34 29.4 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.209 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -156.66 117.16 3.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.964 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.523 ' HE ' ' H ' ' A' ' 156' ' ' ARG . 4.8 mmp_? 58.94 24.85 13.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.11 7.88 72.92 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.1 125.82 43.27 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -88.97 121.47 31.35 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.42 ' N ' HD23 ' A' ' 159' ' ' LEU . 76.5 mt -122.87 129.08 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.565 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 37.7 m -129.07 136.47 50.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.454 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.85 99.9 8.03 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -96.81 107.55 20.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.762 0.315 . . . . 0.0 110.616 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.54 133.42 54.6 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.801 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 89.0 p -128.46 135.8 49.97 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.788 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 5.9 m -152.97 154.82 35.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.549 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -54.89 141.0 35.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.239 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -67.77 -34.19 76.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.55 -33.78 68.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.994 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 174' ' ' VAL . 63.9 mtt85 -109.9 -7.18 15.02 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.499 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 52.2 t-105 -49.51 -38.26 29.83 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.832 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.53 -42.96 99.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 58.6 m -65.53 -39.82 92.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.722 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 170' ' ' ARG . 13.6 m -108.28 21.27 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.35 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 171' ' ' TRP . 50.8 pttt -52.22 -46.78 65.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 84.8 p -69.52 -25.83 64.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.602 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.99 -43.28 91.44 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.998 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.499 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 28.5 m-85 -61.7 -50.86 70.75 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.206 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.15 -41.05 99.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.558 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 184' ' ' SER . 41.8 m -67.22 -48.52 67.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.321 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.95 -45.1 99.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.731 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.514 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -66.48 -43.94 84.06 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.313 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.0 m -72.8 -31.13 64.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.342 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 180' ' ' THR . 40.3 m -61.82 -29.53 70.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.442 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -54.94 157.01 3.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.078 0.466 . . . . 0.0 110.944 -179.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -137.02 158.03 45.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.64 151.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.941 0.401 . . . . 0.0 111.008 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.524 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 38.1 p90 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.801 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 120.966 0.412 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.13 166.39 24.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.62 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.5 ptt-85 -115.84 144.68 43.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.708 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -124.13 132.44 53.64 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.189 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.9 m -139.15 151.18 46.43 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.544 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -141.61 118.48 11.15 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.32 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.6 p -72.31 -30.53 64.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.719 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -62.53 -47.61 83.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.722 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -90.21 -20.4 23.07 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.937 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.78 41.94 81.2 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -141.1 152.98 45.2 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.239 0.519 . . . . 0.0 110.22 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -153.26 148.17 26.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -157.22 157.57 34.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.162 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.6 mt -96.38 152.19 18.83 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -161.19 130.08 3.08 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.19 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -41.99 157.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.094 1.862 . . . . 0.0 112.507 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -80.8 160.31 24.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.869 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.84 12.53 63.91 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.532 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 28.2 m0 -91.24 151.68 20.82 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 110.479 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.0 pt -117.29 151.07 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.377 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.73 134.51 9.97 Favored Glycine 0 N--CA 1.466 0.651 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.62 141.19 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.62 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -87.03 144.72 26.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.181 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.69 49.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.308 0.575 . . . . 0.0 109.878 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -54.12 129.42 34.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.16 4.65 68.53 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.01 -164.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.12 157.89 2.78 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.249 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.8 130.62 25.13 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.341 2.027 . . . . 0.0 111.465 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 94.83 -22.47 37.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.423 ' N ' HG23 ' A' ' 79' ' ' ILE . 87.1 t -58.85 126.74 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.783 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -119.05 -57.98 1.98 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.596 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.5 t -145.68 146.04 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.83 0.348 . . . . 0.0 111.035 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.8 t -120.67 135.9 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.123 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -111.25 132.07 54.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.276 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -122.74 141.31 51.94 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.388 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 49.0 m-20 -93.37 118.97 31.95 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.566 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.0 mt -68.47 -38.16 80.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 110.623 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.16 -44.47 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.688 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -126.57 98.69 5.5 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.918 0.39 . . . . 0.0 110.621 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.765 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -61.77 -32.67 72.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.538 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.46 -36.25 73.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.575 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -86.76 131.5 34.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -146.66 138.86 24.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.445 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -118.89 134.56 55.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.688 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t -122.6 138.28 54.63 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.213 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.6 t -118.28 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 110.342 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.484 HG23 ' C ' ' A' ' 61' ' ' GLY . 54.6 mt -122.28 122.83 67.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.475 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' GLY . 72.2 mt -122.88 133.85 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.907 0.384 . . . . 0.0 111.059 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 15.9 t -148.46 167.77 24.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.097 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -105.58 136.63 44.81 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.762 0.315 . . . . 0.0 110.318 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 83' ' ' ILE . 10.1 pt -93.92 148.3 35.03 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.264 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 87' ' ' LYS . 38.8 Cg_endo -66.07 136.88 46.21 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.728 1.619 . . . . 0.0 110.968 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.3 t -61.44 -27.18 68.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.979 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -67.8 -30.86 70.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.023 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 84' ' ' PRO . 66.4 mttm -130.41 156.58 44.49 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.027 0.442 . . . . 0.0 111.119 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 91' ' ' ASP . 14.7 t -122.7 176.13 6.13 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.441 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.0 tp -52.65 -44.83 66.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.075 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.8 p -68.6 -46.51 69.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.424 ' H ' HG23 ' A' ' 88' ' ' THR . 21.9 t70 -66.24 -35.76 81.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.075 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -55.83 -43.07 76.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.505 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 175.05 44.48 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 38.0 p -92.82 170.69 9.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.61 77.99 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.118 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 74.7 m -72.03 -44.5 63.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.418 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.3 t0 -61.77 -51.26 69.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.405 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.22 -38.49 79.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.528 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.18 -46.78 92.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -67.24 -40.39 86.29 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.984 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -61.5 -41.4 97.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.028 0.442 . . . . 0.0 110.813 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -61.45 -40.33 94.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.755 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.7 mmt -58.64 -44.3 90.02 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.684 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -65.55 -45.51 83.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.005 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.9 m -59.2 -45.81 90.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.98 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.14 -47.12 79.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.995 0.426 . . . . 0.0 110.406 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 111' ' ' GLN . 91.7 m-20 -63.36 -38.43 91.14 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -43.77 -36.28 2.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.337 . . . . 0.0 111.006 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.98 -47.65 67.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.011 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.5 m -123.66 23.44 8.8 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 107' ' ' ASN . 16.2 tt0 -50.37 -28.72 8.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.596 0.236 . . . . 0.0 111.419 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.15 -61.72 2.62 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.098 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 34.3 p-10 -117.83 -35.27 3.95 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 117.046 0.423 . . . . 0.0 111.965 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.52 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 35.1 ttm180 -84.64 137.75 33.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 111.276 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -128.31 142.93 50.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.03 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.44 140.36 38.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.877 0.37 . . . . 0.0 110.421 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' CD ' ' CD2' ' A' ' 139' ' ' LEU . 93.3 mt-10 -121.32 123.54 42.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.459 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.7 tp -82.87 109.75 17.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.963 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.524 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.8 mt -72.44 -50.45 35.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.579 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 27.7 m120 -157.0 164.42 38.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.819 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.82 115.45 3.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.246 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -141.61 166.3 25.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.833 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.418 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -136.51 148.46 47.65 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -127.72 141.05 51.7 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.834 0.35 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -108.35 112.14 24.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.614 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 127' ' ' ASP . 79.4 mm-40 -138.28 144.07 40.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.432 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 126' ' ' GLU . 3.7 p-10 46.53 39.32 6.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.28 1.47 21.15 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 154' ' ' THR . 68.1 tp60 -105.95 132.36 52.14 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.43 130.44 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.987 0.422 . . . . 0.0 110.41 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -117.2 130.64 56.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.673 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -103.52 125.58 50.16 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.0 m -107.45 122.74 47.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.327 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.27 120.49 38.39 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.971 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -115.47 123.42 48.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -152.07 166.9 30.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.837 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -134.37 153.85 51.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.922 0.392 . . . . 0.0 110.486 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.01 136.42 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.755 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.402 ' CD2' ' CD ' ' A' ' 117' ' ' GLU . 2.7 pp -139.59 138.96 36.64 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.181 0.515 . . . . 0.0 111.225 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.6 m -110.5 134.01 54.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.243 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 62.04 -117.54 11.78 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 56.7 t0 -116.2 13.59 15.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.456 0.17 . . . . 0.0 110.963 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -121.98 148.0 45.34 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.753 0.311 . . . . 0.0 111.068 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 144' ' ' VAL . 13.8 p -85.48 126.84 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.467 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -75.81 -53.4 8.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.422 HH21 ' N ' ' A' ' 166' ' ' THR . 14.7 ptm180 -174.19 171.08 3.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.0 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.412 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 35.7 m170 -103.11 140.53 37.2 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.203 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 78.6 m-20 -134.84 136.19 42.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.924 0.393 . . . . 0.0 111.043 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.6 tp -111.23 134.41 52.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.631 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.78 136.17 42.39 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 110.553 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 52.8 m -123.66 140.47 52.96 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.6 t -121.68 129.56 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.871 0.367 . . . . 0.0 110.537 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.2 m -146.55 142.67 28.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.532 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.44 ' O ' ' NE2' ' A' ' 129' ' ' GLN . 16.7 p -106.0 151.8 24.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.805 0.335 . . . . 0.0 110.491 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -148.32 106.02 3.68 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.015 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 55.39 32.71 19.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.28 6.63 68.51 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -98.42 124.82 43.32 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.16 113.97 25.21 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 70.9 mt -120.02 126.5 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 89.6 m -122.68 132.26 54.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.295 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.56 111.15 22.19 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -114.6 133.98 55.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.962 0.411 . . . . 0.0 111.272 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 mp -129.87 144.33 51.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.426 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 82.5 p -134.98 134.04 40.11 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.298 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 167' ' ' ALA . 20.7 m -152.98 159.33 42.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.676 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.444 ' N ' HG22 ' A' ' 166' ' ' THR . . . -56.78 141.42 44.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.227 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -66.18 -38.61 88.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.878 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -62.08 -33.38 74.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.298 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.531 ' O ' HG22 ' A' ' 174' ' ' VAL . 75.1 mtm180 -96.38 -17.28 20.73 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.243 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.583 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 46.6 t-105 -48.53 -41.42 30.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.732 0.301 . . . . 0.0 110.784 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -63.0 -41.46 99.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.932 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.1 m -66.14 -40.61 90.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.7 m -108.08 21.41 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.266 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 171' ' ' TRP . 49.3 pttt -49.19 -45.9 44.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 111.38 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 83.8 p -67.91 -26.79 66.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.463 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.78 -45.35 86.11 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.926 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.583 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.1 m-85 -62.38 -49.73 74.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.244 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -62.35 -43.31 99.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.413 ' O ' ' OG ' ' A' ' 184' ' ' SER . 86.5 m -66.96 -50.62 61.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.824 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 76.1 t -67.49 -38.32 80.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.39 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.31 -36.67 82.86 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.055 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.7 t -85.02 -17.66 36.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.474 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 180' ' ' THR . 50.9 m -62.78 -36.13 82.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.388 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -58.66 148.82 27.8 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.39 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -138.71 160.18 40.28 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.4 m -128.18 151.66 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.952 0.406 . . . . 0.0 111.188 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 188' ' ' TYR . 35.9 p90 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.587 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.2 mt . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.623 ' NE2' ' ND2' ' A' ' 48' ' ' ASN . 5.4 mp0 -106.83 159.07 16.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.581 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -128.27 138.87 52.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.352 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -129.56 136.29 49.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.943 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.7 p -144.3 157.77 44.1 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -147.91 117.7 7.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.313 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.2 p -70.23 -31.96 69.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 110.448 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -62.13 -48.68 79.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.065 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -88.24 -20.53 25.37 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.97 42.8 76.35 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.81 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -143.97 151.79 40.22 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 117.308 0.554 . . . . 0.0 110.629 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -154.84 144.49 21.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.966 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -149.55 157.38 43.22 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.859 0.361 . . . . 0.0 110.822 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 33' ' ' GLN . 8.5 tp -101.63 134.72 44.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.369 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -139.7 148.53 56.14 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.5 165.49 27.21 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.652 2.235 . . . . 0.0 112.945 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.623 ' ND2' ' NE2' ' A' ' 33' ' ' GLN . 70.3 m-80 -73.22 159.7 33.05 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.602 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.41 -5.11 62.5 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.404 ' HE1' ' CG ' ' A' ' 68' ' ' ASP . 41.5 m0 -93.45 143.83 25.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.725 0.297 . . . . 0.0 110.26 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.7 pt -122.17 147.49 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.701 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.85 132.53 11.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.33 133.76 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.929 0.395 . . . . 0.0 110.641 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -80.02 140.67 36.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.37 51.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.47 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -75.02 132.85 41.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.031 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.25 -3.36 84.11 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.45 -163.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.544 -0.328 . . . . 0.0 110.279 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.0 m -39.24 108.84 0.5 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.68 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -45.51 136.55 11.96 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.569 1.512 . . . . 0.0 111.703 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.478 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 101.16 -31.91 8.1 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.51 129.22 28.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.125 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.433 ' OD2' HD12 ' A' ' 80' ' ' ILE . 55.7 t0 -100.24 -58.77 1.84 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.306 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.417 ' O ' HG22 ' A' ' 78' ' ' VAL . 65.1 t -150.13 149.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.152 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.71 135.72 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.4 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.08 138.69 48.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.298 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -131.01 129.83 42.56 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.302 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' CG ' ' HE1' ' A' ' 50' ' ' TRP . 60.4 t0 -87.58 118.26 26.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.559 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 mt -65.46 -37.79 87.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.58 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.5 mm -63.49 -43.96 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.46 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -124.74 97.8 5.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.459 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -60.47 -37.35 80.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.308 0.575 . . . . 0.0 109.769 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -58.48 -36.04 73.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -81.06 127.75 32.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.93 0.395 . . . . 0.0 110.311 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -156.01 165.15 37.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.528 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.3 pp -162.42 160.9 26.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.466 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.1 t -143.87 143.89 31.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.413 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.4 m -110.55 130.17 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.478 HG23 ' C ' ' A' ' 61' ' ' GLY . 25.5 mt -116.54 127.45 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.22 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.433 HD12 ' OD2' ' A' ' 63' ' ' ASP . 64.8 mt -118.23 127.95 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 110.425 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.1 m -143.3 164.76 29.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.772 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -106.23 131.52 53.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.707 0.289 . . . . 0.0 110.293 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -94.08 150.32 38.26 Favored Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 87' ' ' LYS . 55.8 Cg_endo -70.75 137.49 32.69 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.739 1.626 . . . . 0.0 110.878 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.6 t -63.54 -29.17 70.47 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.371 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 46.3 p30 -68.69 -29.29 67.71 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.599 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 99.1 mttt -132.03 144.89 51.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.025 0.44 . . . . 0.0 110.999 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -109.52 -179.8 3.92 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.31 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.6 tp -50.75 -44.63 58.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.82 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.2 p -66.27 -43.92 85.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.911 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -65.01 -38.92 92.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.2 tp -55.93 -43.15 77.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.504 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.75 173.86 43.58 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 36.1 p -91.72 171.61 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.08 -43.2 81.92 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.075 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.2 m -71.91 -44.21 64.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 94' ' ' THR . 45.8 t0 -61.43 -51.35 69.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.426 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.67 -38.53 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.573 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.78 -44.61 94.14 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -68.71 -43.08 76.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.101 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -61.37 -39.14 89.56 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.921 -0.311 . . . . 0.0 110.982 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -61.89 -40.65 96.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.526 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -59.22 -42.7 91.61 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.497 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 2.2 mptm? -67.99 -42.74 80.32 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.398 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.0 m -57.02 -44.52 82.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.71 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.55 -43.67 71.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.956 0.408 . . . . 0.0 110.142 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.97 -31.68 72.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.037 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 104' ' ' LYS . 94.9 m-20 -42.39 -32.28 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.915 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.28 -33.32 6.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.537 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 114' ' ' ARG . 5.7 p -88.55 -6.36 57.62 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -55.92 -28.59 57.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.531 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -41.97 -63.74 1.67 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.009 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.1 p-10 -119.36 -45.01 2.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.025 0.44 . . . . 0.0 111.47 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.494 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 83.5 mtm180 -81.69 148.77 28.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.96 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -129.83 142.01 50.74 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.729 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.96 136.75 45.05 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.657 0.265 . . . . 0.0 110.51 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -122.71 128.91 51.17 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.6 tp -82.69 108.15 15.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.906 0.384 . . . . 0.0 110.325 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.0 mt -74.21 -43.35 50.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.536 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.38 164.84 22.03 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.281 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.72 114.44 3.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.207 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -139.03 170.51 15.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -142.62 151.0 41.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -132.45 147.82 52.38 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.059 0.457 . . . . 0.0 111.016 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -114.51 114.63 26.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.561 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -138.22 142.53 39.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.7 t0 51.31 27.64 3.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.547 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.15 -2.37 84.51 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -100.37 146.95 26.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.055 0.455 . . . . 0.0 110.165 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.77 127.74 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.011 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 22.1 m-85 -116.88 126.77 53.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.841 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.4 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.69 126.4 51.73 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.7 m -108.43 122.15 46.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.214 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.76 113.8 22.37 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.134 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -108.94 123.19 48.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.572 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -150.03 169.13 21.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.599 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -132.58 156.59 46.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.049 0.452 . . . . 0.0 110.837 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.7 t -106.38 129.75 59.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.167 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.16 135.81 54.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.043 0.449 . . . . 0.0 111.501 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.21 87.65 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.95 -106.02 2.82 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -112.79 7.49 18.5 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -122.62 137.14 54.99 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.006 0.431 . . . . 0.0 111.585 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 144' ' ' VAL . 7.0 p -67.29 122.96 19.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.849 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -77.7 -56.17 4.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.343 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -169.57 169.58 8.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -103.49 134.87 46.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.075 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -129.71 137.76 50.76 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.042 0.448 . . . . 0.0 110.823 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.72 HD13 ' N ' ' A' ' 150' ' ' ALA . 3.2 tm? -111.99 138.78 48.16 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.707 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.72 ' N ' HD13 ' A' ' 149' ' ' LEU . . . -135.92 125.37 25.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.462 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t -118.34 124.46 47.81 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 44.6 t -110.61 128.91 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.902 0.382 . . . . 0.0 110.868 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 57.6 m -142.75 143.16 32.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.373 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.4 p -89.15 157.34 18.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.885 0.374 . . . . 0.0 110.596 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -150.26 93.97 2.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.602 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 57.91 33.61 23.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.583 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 93.16 3.8 65.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -101.6 137.59 39.71 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.787 0.327 . . . . 0.0 110.164 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.95 119.03 32.3 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.296 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.1 mt -119.36 126.63 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.5 m -126.27 137.22 53.49 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.817 0.342 . . . . 0.0 110.571 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.32 98.01 7.01 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.794 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -96.37 113.74 25.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.856 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.8 mp -116.13 140.58 49.14 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.439 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.5 t -133.1 132.76 42.08 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.141 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 11.1 m -152.42 158.99 43.43 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.489 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.413 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -52.73 141.34 21.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.342 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -67.8 -39.48 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -61.5 -33.38 73.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.343 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.444 ' O ' HG22 ' A' ' 174' ' ' VAL . 69.1 mtp180 -96.58 -17.27 20.56 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.17 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.523 ' O ' ' N ' ' A' ' 175' ' ' LYS . 52.2 t-105 -48.85 -40.08 28.13 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.931 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -61.22 -41.04 96.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.297 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 59.3 m -68.05 -38.92 83.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.629 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 170' ' ' ARG . 6.5 m -111.44 21.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.378 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 171' ' ' TRP . 11.1 ptmm? -51.26 -50.41 59.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 29.8 m -65.07 -28.97 69.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.656 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.5 tp -56.14 -44.16 78.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.253 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.51 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 26.2 m-85 -63.35 -51.05 67.55 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.352 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.58 -41.15 98.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 184' ' ' SER . 44.1 m -66.6 -48.83 68.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.43 -43.55 98.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.432 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.55 -41.34 98.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.362 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 84.2 p -79.22 -25.65 42.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.874 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 180' ' ' THR . 41.4 t -62.75 -31.01 71.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.028 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -55.9 158.17 3.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.103 0.477 . . . . 0.0 110.576 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.481 ' CE1' ' O ' ' A' ' 187' ' ' VAL . 3.7 t60 -136.97 145.5 44.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.368 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.481 ' O ' ' CE1' ' A' ' 186' ' ' HIS . 6.8 m -122.27 147.96 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.449 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 35.5 p90 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.722 -179.363 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.029 0.442 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 48' ' ' ASN . 2.1 mp0 -106.73 146.19 31.13 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.008 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -117.42 131.0 56.83 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.738 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -115.3 134.43 55.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.487 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 94.2 p -145.35 153.06 40.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.947 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 36' ' ' SER . 97.9 m-20 -143.04 119.43 10.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.27 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.1 p -69.16 -33.9 74.12 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.272 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.84 -48.45 78.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -84.25 -20.64 31.88 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.958 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.9 42.06 93.04 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -143.97 149.1 36.23 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.175 0.488 . . . . 0.0 110.467 179.343 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -153.66 145.39 23.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -151.28 158.52 43.96 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 tp -104.24 135.01 46.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.402 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 14.7 p90 -136.88 143.78 43.94 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.859 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.87 150.7 2.51 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.819 1.679 . . . . 0.0 112.149 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.419 ' CB ' ' NE2' ' A' ' 33' ' ' GLN . 51.1 p-10 -79.87 160.67 25.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.497 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.69 60.52 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.1 m0 -92.38 147.57 22.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.851 0.358 . . . . 0.0 110.201 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.7 pt -116.5 144.44 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.415 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.33 133.49 11.4 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.22 133.67 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.331 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.16 124.64 32.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.227 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.93 59.47 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -77.15 135.19 38.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.063 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.79 3.69 73.65 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.46 -164.4 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.492 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -45.93 154.38 0.58 Allowed Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.412 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.31 130.77 23.26 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.36 2.04 . . . . 0.0 111.855 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.482 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 96.47 -23.72 33.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.91 128.9 33.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.561 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -119.16 -57.88 1.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.502 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.2 t -143.49 141.66 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.884 0.373 . . . . 0.0 111.216 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.41 133.28 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.218 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -112.61 135.94 52.75 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.63 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -127.92 138.46 52.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.337 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -88.76 118.29 28.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.62 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.37 -37.03 84.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.684 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.62 -42.43 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.486 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.36 99.72 6.57 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.58 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -62.59 -37.43 86.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.39 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -58.77 -35.05 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.753 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -81.62 131.29 35.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -140.1 139.19 35.78 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.994 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -126.26 135.26 51.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.071 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 t -128.02 139.41 52.57 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.84 126.55 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.961 0.41 . . . . 0.0 110.231 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.482 HG23 ' C ' ' A' ' 61' ' ' GLY . 26.2 mt -124.11 119.24 56.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.274 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' GLY . 33.4 mm -116.07 131.92 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.289 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 159' ' ' LEU . 49.2 m -145.96 166.48 25.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.35 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -104.8 137.98 41.77 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.435 HG22 HD12 ' A' ' 159' ' ' LEU . 10.3 pt -93.51 149.32 37.04 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.656 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -45.38 134.96 12.22 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.641 1.561 . . . . 0.0 111.496 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.1 t -65.1 -26.75 68.35 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.307 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -85.11 -20.81 29.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -129.79 158.24 39.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.209 0.528 . . . . 0.0 111.863 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.426 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.9 t -122.69 175.65 6.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.468 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.5 tp -52.07 -45.06 64.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.017 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 p -66.01 -46.02 79.44 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.164 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 88' ' ' THR . 88.0 m-20 -66.79 -35.26 79.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.885 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.5 tp -55.83 -43.43 76.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.75 178.79 47.57 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 33.4 p -94.13 173.04 7.85 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.43 -41.56 76.61 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.15 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.3 m -72.53 -46.25 55.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.002 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' A' ' 94' ' ' THR . 44.4 t0 -61.64 -50.89 70.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.431 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.32 -38.27 80.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.694 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.73 -44.03 96.04 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -67.24 -42.61 83.66 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.665 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -61.45 -38.45 87.25 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.664 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.39 -41.61 98.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.38 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.55 -43.2 93.59 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.187 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -64.89 -38.51 91.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.35 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.9 m -58.56 -47.62 83.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.883 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.45 -46.41 56.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.052 0.453 . . . . 0.0 110.503 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.4 m-20 -60.82 -30.41 70.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.285 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -43.59 -38.93 3.23 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.329 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.29 -39.68 9.52 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.624 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 112' ' ' GLY . 8.9 p -86.13 -1.19 57.18 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.4 pt20 -58.39 -0.55 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.438 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -73.7 -64.37 2.49 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.134 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -118.42 -45.23 2.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.79 0.329 . . . . 0.0 111.46 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 110' ' ' SER . 69.9 mtm180 -85.24 144.81 27.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.481 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -123.98 143.85 50.16 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.796 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.85 132.38 45.23 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -114.11 128.81 56.54 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 39.0 tp -81.78 109.86 16.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.67 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.455 ' CG1' ' HE ' ' A' ' 137' ' ' ARG . 88.2 mt -74.09 -53.33 17.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.237 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.549 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 9.2 p30 -160.69 176.51 11.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.84 127.14 5.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.225 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.465 ' OE1' ' N ' ' A' ' 122' ' ' GLU . 57.6 mp0 -141.43 159.35 42.41 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.701 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -140.29 147.77 40.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.941 0.4 . . . . 0.0 110.651 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -132.57 146.4 51.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.572 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -121.01 114.95 22.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.3 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -142.19 144.68 33.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.6 t0 51.25 34.44 11.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.533 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.45 -0.24 55.73 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -101.85 146.87 27.21 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.988 0.423 . . . . 0.0 110.188 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.3 t -114.47 128.86 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.214 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -118.09 122.64 43.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.54 132.05 51.24 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 52.8 m -112.55 132.25 55.2 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.053 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.32 110.34 12.72 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.065 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.549 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 69.9 tt0 -104.19 122.95 46.43 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -147.47 170.07 18.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.306 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.455 ' HE ' ' CG1' ' A' ' 119' ' ' ILE . 18.7 ptp180 -138.14 161.26 37.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.946 0.403 . . . . 0.0 110.926 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.0 t -108.16 133.46 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.092 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.436 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.5 pp -136.4 135.47 38.76 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.149 0.5 . . . . 0.0 111.622 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.37 128.1 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.65 -118.2 13.68 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -109.66 9.27 25.03 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.87 -0.194 . . . . 0.0 110.949 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -114.93 143.85 44.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.854 0.359 . . . . 0.0 111.492 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.29 130.13 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.465 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.436 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 2.0 tm-20 -83.28 -54.68 4.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.443 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.614 HH21 ' CA ' ' A' ' 166' ' ' THR . 15.2 ptm180 -170.3 173.29 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.123 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.414 ' NE2' ' CZ ' ' A' ' 137' ' ' ARG . 50.7 m80 -105.49 142.81 34.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.128 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 13.5 t70 -139.88 150.75 44.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.767 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.6 tp -125.49 136.32 53.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.041 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.02 119.81 19.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.847 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.1 t -106.03 138.36 42.35 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.35 130.06 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.908 0.385 . . . . 0.0 111.007 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -148.44 150.94 34.36 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.413 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.1 p -118.95 152.34 36.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.523 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -159.54 118.07 2.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.637 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 59.45 27.88 17.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.33 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.93 9.8 83.88 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -100.46 127.17 46.88 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.51 121.46 31.75 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.135 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.402 ' N ' HD23 ' A' ' 159' ' ' LEU . 77.4 mt -119.45 127.64 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.304 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 46.1 m -129.66 135.28 48.33 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.663 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.0 103.84 11.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.895 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -100.12 110.0 22.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.573 0.225 . . . . 0.0 110.432 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.432 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 5.3 mp -115.0 136.05 53.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.408 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.5 t -127.47 134.1 49.85 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.885 0.374 . . . . 0.0 110.546 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.614 ' CA ' HH21 ' A' ' 146' ' ' ARG . 9.5 m -152.53 154.9 36.38 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.611 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.14 144.29 35.5 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.547 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.431 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 1.2 pp20? -70.32 -30.55 67.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.024 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.431 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 92.5 m-20 -59.86 -33.9 72.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.957 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 174' ' ' VAL . 1.1 mpt_? -111.88 -5.3 14.38 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.501 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 52.4 t-105 -49.55 -39.17 33.74 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.786 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.42 -41.64 98.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.19 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.0 m -65.72 -39.87 91.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.699 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 170' ' ' ARG . 11.6 m -108.86 21.64 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.278 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 171' ' ' TRP . 10.2 ptmm? -51.38 -50.0 60.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.392 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.1 t -64.92 -30.7 71.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.17 -44.16 74.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.303 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 27.9 m-85 -60.95 -49.83 75.84 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.308 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -64.59 -38.91 92.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.492 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 42.7 m -65.38 -49.01 70.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.476 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.29 -45.16 99.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.659 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -64.85 -42.18 95.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 110.371 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 21.2 t -73.87 -31.47 63.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.231 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 91.7 p -63.12 -24.13 67.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.308 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -57.34 156.11 8.13 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.498 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -136.0 156.75 48.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.522 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.82 151.42 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.831 0.348 . . . . 0.0 111.107 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.519 ' CG ' ' O ' ' A' ' 188' ' ' TYR . 38.3 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.736 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.9 mt . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 120.846 0.355 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.501 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 20.5 mp0 -108.42 154.26 22.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.497 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -125.96 143.71 50.98 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.312 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -130.07 139.87 50.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.046 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -149.75 148.57 29.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 110.63 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -137.89 121.45 17.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.481 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.5 p -70.98 -33.22 70.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.504 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -61.93 -48.25 81.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -88.6 -20.47 24.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.784 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.84 42.02 93.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.73 150.72 42.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.153 0.477 . . . . 0.0 110.662 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -149.67 147.15 27.74 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.717 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.462 ' C ' HD22 ' A' ' 45' ' ' LEU . 48.3 p90 -146.75 154.86 41.89 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.935 0.398 . . . . 0.0 110.983 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.651 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.1 mm? -98.02 141.66 30.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.101 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -151.31 146.84 19.42 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.317 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.12 160.02 51.09 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.455 2.103 . . . . 0.0 112.347 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -69.83 160.81 31.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.709 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.18 0.28 57.14 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.528 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 32.6 m0 -91.22 141.3 28.95 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.425 ' N ' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -115.68 128.37 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.999 0.428 . . . . 0.0 110.141 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.53 137.33 13.21 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.52 141.75 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.72 0.295 . . . . 0.0 110.57 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.17 122.61 31.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.05 0.452 . . . . 0.0 110.413 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 m -121.56 32.07 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.676 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -50.09 136.82 18.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.94 4.1 69.64 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.11 -164.33 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.636 0.255 . . . . 0.0 110.541 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 m -46.36 137.08 6.93 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.65 130.47 9.61 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.708 1.606 . . . . 0.0 112.717 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.465 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 96.0 -33.15 5.76 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.451 ' N ' HG23 ' A' ' 79' ' ' ILE . 92.0 t -62.31 125.43 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.273 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -119.78 -57.22 1.98 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.68 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.7 t -136.32 142.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.082 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.01 132.97 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.419 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 76' ' ' LEU . 90.7 m-85 -112.78 133.19 54.91 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.263 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -124.82 140.93 52.48 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.443 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 81.9 m-20 -88.36 118.76 28.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.546 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 tp -67.35 -40.87 85.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.47 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.8 mt -61.62 -43.43 97.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.017 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -117.34 121.2 40.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.928 0.394 . . . . 0.0 110.371 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -80.95 -37.55 29.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.634 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 41.1 p-10 -62.57 -31.32 72.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.959 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 85.3 tt0 -85.89 131.3 34.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.939 0.399 . . . . 0.0 110.787 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -142.31 139.6 31.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.144 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PHE . 7.5 tt -123.78 134.81 53.58 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.7 t -128.74 138.91 52.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.334 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -113.18 123.82 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.465 HG23 ' C ' ' A' ' 61' ' ' GLY . 12.4 mt -125.77 120.54 57.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.195 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.4 mt -121.1 132.64 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.172 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.4 m -136.15 164.7 27.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.47 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -103.73 135.36 45.43 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.504 ' CG2' HD12 ' A' ' 159' ' ' LEU . 9.6 pt -102.23 150.21 37.31 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.943 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -44.51 145.37 2.63 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.841 1.694 . . . . 0.0 111.222 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.6 p -80.08 -13.91 58.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.598 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -96.35 -20.93 18.12 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.765 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -124.06 157.14 35.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.099 0.476 . . . . 0.0 111.385 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.408 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.5 t -122.66 177.82 5.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.612 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 tp -51.66 -45.43 63.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.061 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.2 p -64.42 -44.55 90.87 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.098 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.2 m-20 -65.76 -38.12 88.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.4 tp -56.23 -43.85 79.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.86 176.52 45.93 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 39.8 p -94.86 171.11 8.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.6 78.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.126 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.2 m -72.03 -44.93 62.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.747 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.418 ' HB3' ' H ' ' A' ' 94' ' ' THR . 16.4 t70 -61.84 -51.78 66.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.409 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.16 -38.01 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.668 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.33 -47.21 90.98 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.53 -41.63 84.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -62.35 -40.79 97.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.981 0.42 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -61.67 -41.3 97.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.857 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -58.99 -45.46 90.56 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.661 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -64.35 -43.01 95.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.873 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.1 m -60.85 -47.04 88.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.1 t -71.87 -46.11 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.602 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 111' ' ' GLN . 91.7 m-20 -61.43 -39.57 91.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.632 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -46.61 -36.25 6.74 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.533 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 -45.36 89.78 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.885 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 114' ' ' ARG . 8.6 m -123.7 22.18 9.08 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.6 tt0 -52.53 -28.48 20.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.673 0.273 . . . . 0.0 111.452 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.86 -62.1 2.75 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.138 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -117.74 -40.51 3.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.929 0.365 . . . . 0.0 111.681 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 110' ' ' SER . 52.6 ttp180 -92.09 146.2 23.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.046 0.451 . . . . 0.0 110.904 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.76 151.63 40.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.517 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.463 ' HB3' ' OD1' ' A' ' 107' ' ' ASN . . . -103.04 139.85 38.05 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.569 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -113.18 130.8 56.1 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 118' ' ' LEU . 3.5 tt -81.21 106.01 12.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.082 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.7 mt -70.8 -51.06 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.378 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.549 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 7.5 p30 -160.66 173.91 14.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.953 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.1 122.92 4.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.189 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -142.09 159.56 41.99 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.689 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.42 147.83 43.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.524 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.7 141.55 47.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.705 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -110.61 112.81 24.96 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.393 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -137.59 144.33 41.94 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.97 0.414 . . . . 0.0 110.76 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.3 t0 50.98 33.28 8.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.35 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.84 0.97 61.08 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -104.05 146.94 27.99 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.978 0.418 . . . . 0.0 110.252 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.05 128.53 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.142 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 27.8 m-85 -118.06 124.47 48.18 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.853 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.62 128.13 50.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.0 m -109.02 122.25 46.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.201 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.8 mp -118.36 112.74 20.41 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.102 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.549 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 60.7 tt0 -106.46 123.96 48.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.426 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.94 169.66 20.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.499 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -135.85 156.3 49.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.76 0.314 . . . . 0.0 110.541 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.1 m -102.89 125.78 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.993 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 144' ' ' VAL . 6.7 mt -107.75 123.35 48.41 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.5 t -117.31 130.36 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.66 -122.27 22.02 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 88.4 m-20 -116.33 21.95 13.21 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.982 -0.128 . . . . 0.0 111.217 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 78.2 m-20 -144.1 161.87 37.72 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.893 0.377 . . . . 0.0 111.17 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 144' ' ' VAL . 7.8 p -79.49 120.46 30.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -69.98 -51.77 29.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.06 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -173.56 171.37 3.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.083 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -104.83 140.91 37.42 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.07 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 18.0 t70 -133.61 150.86 51.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.144 0.497 . . . . 0.0 110.543 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.73 HD13 ' N ' ' A' ' 150' ' ' ALA . 3.2 tm? -125.97 138.58 53.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.578 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.73 ' N ' HD13 ' A' ' 149' ' ' LEU . . . -136.54 117.47 14.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.356 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t -104.1 126.22 51.05 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 26.5 t -112.45 129.02 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.7 m -145.02 148.03 33.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.244 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 p -109.64 143.48 39.32 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.922 0.391 . . . . 0.0 110.551 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -152.64 112.97 4.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 62.44 33.45 16.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.65 11.57 84.59 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.34 131.59 54.92 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.721 0.296 . . . . 0.0 110.597 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.504 HD12 ' CG2' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -87.75 120.36 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.8 124.86 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.6 m -127.25 132.31 50.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.792 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.83 99.71 7.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.56 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -98.03 111.69 23.91 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.654 0.264 . . . . 0.0 110.572 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 164' ' ' LEU . 5.4 mp -116.91 136.9 52.59 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.28 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -126.56 136.19 52.23 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.858 0.361 . . . . 0.0 110.592 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.4 m -152.87 155.69 37.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.283 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.24 143.57 27.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.093 0.473 . . . . 0.0 111.197 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -71.19 -28.77 64.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.028 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.11 -34.28 71.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.232 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.416 ' O ' HG22 ' A' ' 174' ' ' VAL . 89.6 mtt-85 -114.62 -3.07 12.94 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.482 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 50.3 t-105 -49.79 -38.21 33.37 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.851 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -61.58 -41.83 97.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.263 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.6 m -66.84 -39.2 87.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.79 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 170' ' ' ARG . 8.2 m -108.4 21.32 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.294 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 176' ' ' SER . 19.4 ptmt -52.03 -49.73 62.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.331 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.41 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 25.0 t -65.67 -29.41 69.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.358 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 tt -54.76 -45.69 74.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.036 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.482 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 25.7 m-85 -61.9 -49.78 74.84 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.53 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.03 -38.39 90.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.478 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 39.2 m -64.33 -47.95 77.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.353 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.07 -45.08 99.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.624 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.47 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.45 -44.42 94.55 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.208 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.5 t -71.31 -32.76 69.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.1 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 95.3 p -63.1 -24.82 68.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -56.4 156.96 5.39 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.332 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -134.76 153.3 52.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.47 148.79 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 111.115 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.676 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 121.125 0.488 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.482 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 1.7 pm0 -127.54 164.77 21.23 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.861 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -125.61 144.38 50.61 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.815 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -122.2 133.22 54.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.797 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.446 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 92.4 p -145.63 153.48 41.08 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.867 0.365 . . . . 0.0 110.795 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 36' ' ' SER . 99.9 m-20 -143.06 113.23 7.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.278 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.0 p -65.43 -32.96 74.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.886 0.374 . . . . 0.0 110.075 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -62.24 -45.19 94.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -89.36 -20.47 23.96 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.09 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.72 40.63 90.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -143.48 150.81 39.51 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.286 0.543 . . . . 0.0 110.443 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -156.73 146.35 20.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.113 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -155.57 158.27 38.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.127 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.03 154.14 17.31 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.684 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 13.0 p90 -156.85 142.94 12.98 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.53 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.9 153.83 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.993 1.795 . . . . 0.0 112.462 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 49' ' ' GLY . 32.4 t-20 -81.44 157.15 25.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.426 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . 92.64 6.79 63.69 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.539 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 30.5 m0 -89.16 149.13 23.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.851 0.357 . . . . 0.0 110.262 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.26 145.69 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.16 128.75 9.01 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 t -113.9 132.99 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 110.462 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.59 134.26 35.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.288 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.31 55.2 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -73.33 136.02 44.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.229 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.15 69.26 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.79 -164.32 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.708 0.29 . . . . 0.0 110.484 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.63 158.15 0.88 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.181 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.33 128.8 20.08 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.442 2.095 . . . . 0.0 111.922 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.52 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 97.14 -24.05 33.02 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t -63.49 130.63 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -119.19 -58.75 1.91 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.537 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.2 t -151.45 151.44 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.753 0.311 . . . . 0.0 111.143 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.26 144.27 33.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.264 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.454 ' HB2' HD11 ' A' ' 76' ' ' LEU . 84.8 m-85 -112.77 134.64 54.19 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.448 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.31 141.04 52.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.413 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.539 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 45.8 m-20 -89.28 118.99 29.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.587 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.67 -40.02 91.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.577 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.6 mm -61.86 -46.97 95.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.682 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.8 103.81 8.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.973 0.416 . . . . 0.0 110.413 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.43 -38.38 83.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.263 0.554 . . . . 0.0 110.007 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.53 -36.37 73.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.901 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.83 125.9 31.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.932 0.396 . . . . 0.0 110.454 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -161.01 174.05 14.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.601 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.3 pp -159.98 158.76 31.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.1 t -127.68 139.36 52.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.22 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 t -111.15 123.71 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.86 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.52 HG23 ' C ' ' A' ' 61' ' ' GLY . 51.4 mt -121.59 124.86 72.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.962 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 61' ' ' GLY . 76.3 mt -122.91 131.89 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.81 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 159' ' ' LEU . 51.1 m -146.06 166.97 24.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.086 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 2.0 pm0 -106.14 132.44 52.21 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 83' ' ' ILE . 8.8 pt -88.75 148.93 42.77 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.506 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.71 136.68 43.07 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.629 1.553 . . . . 0.0 110.866 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -61.17 -27.15 68.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.947 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -67.8 -30.9 70.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.134 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -130.14 150.5 51.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.221 0.534 . . . . 0.0 111.576 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.476 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 81.4 p -112.6 174.87 5.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.713 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.6 tp -56.85 -41.2 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.01 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.3 p -69.82 -44.32 70.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.418 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 88' ' ' THR . 44.4 t0 -64.28 -34.81 78.99 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -54.92 -52.14 63.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.214 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.56 179.04 47.6 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.8 p -88.09 170.64 10.9 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.51 -41.88 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.836 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.3 m -72.14 -44.1 63.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.748 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -61.71 -52.88 62.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.35 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.1 -38.6 79.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.678 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.99 -43.98 94.75 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -67.14 -41.65 85.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.82 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -61.87 -38.95 90.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.665 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -62.29 -40.84 97.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.655 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -58.12 -45.68 86.86 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.499 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -65.29 -43.03 92.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.4 m -60.79 -45.67 93.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.945 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.56 -47.99 68.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.636 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.643 ' O ' ' N ' ' A' ' 111' ' ' GLN . 93.5 m-20 -62.6 -37.58 86.8 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.676 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -44.26 -37.0 2.98 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.309 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.38 -47.26 70.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.135 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.3 m -123.71 23.22 8.83 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.8 tt0 -50.32 -28.83 8.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.579 0.228 . . . . 0.0 111.328 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.67 -61.39 2.95 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.083 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -117.08 -35.94 3.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.929 0.364 . . . . 0.0 111.933 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -83.98 137.55 33.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.962 0.41 . . . . 0.0 111.266 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -129.13 139.9 51.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.959 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.54 135.15 44.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.333 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -114.51 125.18 53.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.182 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.535 ' C ' HD23 ' A' ' 118' ' ' LEU . 3.8 tt -84.58 109.83 18.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.252 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.455 ' N ' HD23 ' A' ' 118' ' ' LEU . 96.9 mt -74.6 -53.84 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.683 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -155.08 164.41 38.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.728 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.83 115.79 3.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.486 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -139.76 170.52 15.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.882 0.372 . . . . 0.0 110.69 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.401 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -141.28 150.52 42.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.645 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -132.45 139.07 47.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -108.46 114.19 27.83 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.452 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.94 142.98 34.31 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.96 0.41 . . . . 0.0 110.782 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 51.67 37.37 19.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.282 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.85 0.77 35.41 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -104.46 147.87 27.08 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.897 0.38 . . . . 0.0 110.115 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.71 128.56 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.108 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -117.16 126.83 53.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.822 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.3 m-85 -104.41 126.3 51.38 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.408 ' C ' HD12 ' A' ' 134' ' ' LEU . 89.9 m -109.26 122.66 47.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 110.321 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 133' ' ' THR . 8.3 mp -116.78 122.22 43.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.826 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -116.77 119.45 35.49 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -148.97 167.32 26.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.589 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -135.53 152.93 51.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.927 0.394 . . . . 0.0 110.635 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 m -105.86 136.03 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.909 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.45 137.08 38.36 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.173 0.511 . . . . 0.0 111.2 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.25 133.35 60.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.393 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.42 -119.19 11.0 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -116.53 15.28 15.61 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.851 -0.205 . . . . 0.0 111.174 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -129.03 153.86 47.19 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.896 0.379 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 144' ' ' VAL . 14.9 p -86.85 127.42 40.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.377 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -74.89 -52.22 11.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.631 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -174.55 173.9 2.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.087 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -109.2 137.31 47.28 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.163 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -130.87 142.65 50.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.884 0.373 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.2 tp -114.4 131.28 56.63 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.03 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -125.38 130.81 52.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.965 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.4 t -124.31 126.95 46.9 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.0 t -113.04 127.87 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 111.101 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.8 m -141.31 139.4 33.62 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.108 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.1 p -103.27 150.25 23.92 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.799 0.333 . . . . 0.0 110.342 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -149.14 106.07 3.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 57.04 30.89 18.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.814 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.06 5.22 68.12 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -95.61 123.56 39.22 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.06 118.0 28.47 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.76 126.68 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.863 0.364 . . . . 0.0 110.463 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.1 m -126.92 137.61 53.16 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.085 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.6 98.72 6.69 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.247 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -95.87 112.4 24.13 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.651 0.262 . . . . 0.0 110.58 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.6 mp -115.0 138.99 50.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.502 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 81.8 p -132.65 133.83 44.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.221 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 15.6 m -152.82 161.13 42.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.568 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.45 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -54.99 140.73 36.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.013 0.435 . . . . 0.0 111.181 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.66 -39.06 84.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 170' ' ' ARG . 37.8 p-10 -63.87 -32.58 74.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 15.1 tpt180 -94.65 -19.53 20.36 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.71 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.542 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 50.5 t-105 -47.95 -41.08 24.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.213 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.43 -42.09 98.2 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.172 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 46.9 m -66.68 -40.32 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.559 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 170' ' ' ARG . 11.2 m -108.77 21.48 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.332 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 171' ' ' TRP . 11.1 ptmm? -50.43 -49.81 53.78 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.284 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 22.2 m -64.86 -29.72 70.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.661 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 tp -55.5 -44.49 76.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.368 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.542 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 25.3 m-85 -62.55 -50.29 71.91 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.308 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.22 -41.31 99.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.757 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 184' ' ' SER . 45.2 m -66.65 -49.04 67.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 68.7 t -62.7 -43.85 98.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.457 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -64.63 -39.65 94.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.424 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 t -80.2 -28.18 38.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.144 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 180' ' ' THR . 67.4 m -62.43 -30.97 71.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.385 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -55.22 156.8 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.468 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -139.25 160.65 39.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.621 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.41 150.21 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 111.035 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 39.5 p90 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.689 179.747 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.595 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 55.9 mt . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.804 0.335 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.595 ' NE2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -110.16 156.64 20.34 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.416 ' H ' ' HD2' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -120.77 140.56 51.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.384 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -125.03 135.36 52.68 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.037 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 t -146.02 147.89 32.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.903 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -138.37 118.35 13.37 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.9 p -70.99 -31.44 67.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.896 0.379 . . . . 0.0 110.247 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -62.29 -49.8 74.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.979 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -86.2 -20.61 28.29 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.37 40.24 80.26 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.83 149.91 39.21 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.219 0.509 . . . . 0.0 110.705 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -151.06 144.44 24.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.713 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -151.12 159.48 44.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.048 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.8 mt -100.2 151.28 21.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.394 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 11.2 p90 -150.91 146.74 19.62 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.535 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.24 161.36 44.73 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.441 2.094 . . . . 0.0 112.483 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -73.5 159.29 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.553 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.9 -2.18 63.91 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -93.67 144.53 25.31 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 pt -118.47 141.78 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.309 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.84 133.67 11.48 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.532 HG21 ' NH1' ' A' ' 67' ' ' ARG . 22.8 t -111.68 133.19 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.924 0.392 . . . . 0.0 110.745 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -83.45 138.86 33.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.201 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.69 54.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.152 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -78.29 129.21 34.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.645 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.95 -4.52 75.1 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.21 -162.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.518 -0.341 . . . . 0.0 110.141 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.0 m -36.79 111.19 0.5 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -45.2 134.47 11.59 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.752 1.635 . . . . 0.0 112.101 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.489 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 101.91 -35.97 4.57 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.28 134.32 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -115.48 -58.43 2.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.236 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.6 t -143.46 143.38 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.798 0.333 . . . . 0.0 111.113 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.487 HG11 ' NH2' ' A' ' 67' ' ' ARG . 44.2 t -120.35 131.75 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.417 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -112.81 133.39 54.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.418 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.532 ' NH1' HG21 ' A' ' 53' ' ' VAL . 73.5 mtt85 -131.56 138.91 49.08 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.54 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -87.4 118.73 27.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.358 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -61.41 -38.97 89.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.534 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.62 -48.44 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.467 ' CD ' HH12 ' A' ' 170' ' ' ARG . 96.0 mt-10 -126.85 102.71 7.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.568 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -69.56 -25.49 64.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.976 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -57.85 -38.97 76.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.204 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -98.29 139.59 33.84 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.718 0.294 . . . . 0.0 110.381 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -158.87 147.65 18.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.001 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.1 tt -115.11 134.7 54.94 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.193 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.1 t -131.8 144.47 50.94 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.33 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.44 132.5 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.072 0.463 . . . . 0.0 110.493 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.489 HG23 ' C ' ' A' ' 61' ' ' GLY . 28.0 mt -120.95 126.06 74.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.684 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.86 130.83 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.851 0.358 . . . . 0.0 110.486 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.9 m -139.63 161.96 36.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.953 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -105.44 132.54 51.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.738 0.304 . . . . 0.0 110.369 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -96.22 150.54 37.3 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.361 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.43 137.94 31.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.018 1.812 . . . . 0.0 111.045 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.7 t -63.28 -28.2 69.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.074 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.67 -31.14 70.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -129.97 158.41 39.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.139 0.495 . . . . 0.0 111.599 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.449 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.8 t -122.6 176.34 5.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.449 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.8 tp -52.36 -44.72 65.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.179 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.9 p -66.13 -45.59 80.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.92 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 88' ' ' THR . 86.4 m-20 -67.56 -35.44 79.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.737 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.0 tp -55.88 -42.09 75.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.5 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.95 175.79 45.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.415 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 38.0 p -93.93 171.19 9.02 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.09 -42.01 76.06 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.186 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.0 m -72.39 -44.93 61.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.029 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.3 t0 -62.1 -51.24 68.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.45 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.94 -38.76 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.558 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.5 -45.91 93.86 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -66.03 -41.21 91.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.642 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -62.29 -38.56 89.82 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.685 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -62.41 -41.46 98.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.1 mmt -58.81 -44.41 90.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.949 0.404 . . . . 0.0 110.34 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -64.97 -39.87 94.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.495 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.0 m -59.48 -47.26 86.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.857 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.6 t -71.59 -45.61 66.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.993 0.425 . . . . 0.0 110.331 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 111' ' ' GLN . 86.6 m-20 -62.06 -31.96 72.43 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.277 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -42.61 -36.15 1.3 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.219 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.82 -16.25 14.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.016 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.503 ' C ' ' H ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -101.48 -3.33 28.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 107' ' ' ASN . 32.7 tt0 -67.12 13.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.961 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -84.99 -64.25 1.55 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.208 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.2 p-10 -118.59 -39.06 3.03 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.53 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 20.2 ptp180 -101.43 159.79 14.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.01 0.433 . . . . 0.0 111.24 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -130.0 150.24 51.37 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.518 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.411 ' HB3' ' OD1' ' A' ' 107' ' ' ASN . . . -104.25 138.28 40.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.15 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -123.44 130.32 52.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.536 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.1 tt -84.13 108.88 17.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.014 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.417 ' N ' HD23 ' A' ' 118' ' ' LEU . 96.6 mt -71.12 -54.95 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.783 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.55 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 11.4 p30 -156.65 176.78 12.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.976 0.417 . . . . 0.0 111.122 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.6 128.4 6.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.327 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -142.07 160.74 39.61 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.505 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.29 144.68 42.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.904 0.383 . . . . 0.0 110.47 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -131.94 152.46 51.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -124.91 116.34 22.04 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.562 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.87 144.5 33.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.013 0.435 . . . . 0.0 110.825 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.1 t0 52.29 28.99 6.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.58 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.96 -1.79 77.86 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -100.83 146.6 27.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.263 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.8 129.72 65.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.159 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -118.45 123.65 45.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.322 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.63 124.2 48.39 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.3 m -102.76 133.12 48.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.822 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.91 108.0 9.8 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.963 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.55 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 70.6 tt0 -100.12 126.17 46.32 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -148.22 168.74 21.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.159 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -137.77 160.0 40.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.479 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.51 133.73 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.461 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 3.0 pp -134.06 143.86 48.3 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.335 0.588 . . . . 0.0 111.1 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 140' ' ' VAL . 14.5 p -108.54 133.29 54.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.248 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 51.75 -108.34 0.6 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -116.96 12.53 14.67 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -119.13 146.15 45.37 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.858 0.361 . . . . 0.0 111.704 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.6 128.28 37.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.816 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 70.5 tt0 -83.48 -53.51 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.406 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.474 ' HE ' ' HG ' ' A' ' 165' ' ' SER . 6.5 ptm85 -172.64 171.99 4.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.424 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 63.7 m80 -108.89 137.44 46.8 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.256 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 84.4 m-20 -135.85 141.4 44.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.9 0.381 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 57.7 tp -116.49 136.71 52.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.986 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.87 132.82 39.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.938 0.399 . . . . 0.0 110.56 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.8 t -119.08 135.75 54.49 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.692 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.87 130.16 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.963 0.411 . . . . 0.0 110.542 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 59.8 m -148.86 146.26 27.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.84 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.3 p -90.7 156.63 17.95 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.579 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 158' ' ' LYS . 9.1 t-20 -150.87 95.9 2.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.787 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 55.65 39.24 30.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.8 7.57 77.98 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 155' ' ' ASN . 68.9 mmtt -110.61 137.73 47.91 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 110.017 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.24 117.46 26.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.816 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.1 mm -107.92 119.97 58.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.1 m -120.49 132.22 55.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.814 0.34 . . . . 0.0 110.185 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.01 103.95 11.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.622 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -103.37 120.19 40.32 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.899 0.38 . . . . 0.0 111.562 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 mp -115.58 142.92 46.08 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.083 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.474 ' HG ' ' HE ' ' A' ' 146' ' ' ARG . 31.1 t -137.06 131.95 33.48 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.432 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 167' ' ' ALA . 21.3 m -152.87 159.06 42.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.696 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.447 ' N ' HG22 ' A' ' 166' ' ' THR . . . -54.31 145.41 17.89 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.28 -36.68 71.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.8 -33.14 75.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.183 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 174' ' ' VAL . 80.1 mtp180 -97.53 -16.69 19.98 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.515 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.604 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 48.4 t-105 -48.03 -41.73 26.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 110.691 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.38 -41.69 98.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.062 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.3 m -65.68 -40.39 92.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.382 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 170' ' ' ARG . 7.9 m -107.2 21.51 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 171' ' ' TRP . 20.8 pttm -48.94 -45.38 41.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.412 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 86.7 p -67.89 -27.49 66.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.574 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.63 -44.61 85.7 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.917 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.604 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.4 m-85 -62.29 -50.01 73.4 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.388 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.24 -41.53 98.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.665 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.8 m -68.75 -49.62 57.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.4 -38.55 79.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.348 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.89 -40.55 97.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.294 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.2 p -80.96 -17.77 49.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.346 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -62.77 -37.76 87.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.193 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -54.29 146.09 16.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.771 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -135.91 154.95 50.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.6 m -127.22 151.56 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.903 0.382 . . . . 0.0 111.336 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 43.5 p90 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.768 -179.731 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.932 0.396 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.522 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.3 pm0 -138.51 165.51 26.67 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.062 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -119.09 139.89 51.01 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.086 0.469 . . . . 0.0 111.411 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -122.44 130.15 52.78 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.73 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.9 m -131.2 150.18 52.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.829 0.347 . . . . 0.0 110.821 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -139.1 122.08 16.7 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.448 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.1 p -75.36 -29.09 59.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.287 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.25 -48.35 81.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.56 ' OD2' HD12 ' A' ' 80' ' ' ILE . 49.6 t0 -93.12 -20.06 20.87 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.85 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.52 42.6 72.3 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.02 148.49 40.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.056 0.428 . . . . 0.0 110.199 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -146.51 142.07 27.68 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -154.03 158.17 40.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.075 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 45' ' ' LEU . 11.1 mp -100.96 144.63 29.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.153 0.501 . . . . 0.0 110.424 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -148.4 148.15 27.84 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.866 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.59 155.86 68.45 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.298 1.999 . . . . 0.0 112.159 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.522 ' N ' HE22 ' A' ' 33' ' ' GLN . 20.6 p30 -72.71 160.69 31.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.93 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.28 1.77 59.26 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.519 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 33.2 m0 -92.76 145.12 24.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.659 0.266 . . . . 0.0 110.296 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.4 pt -121.26 145.1 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.356 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.27 131.0 10.42 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.57 132.19 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.951 0.405 . . . . 0.0 110.521 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -81.84 135.73 35.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.196 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.59 56.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.412 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -74.94 132.9 41.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.112 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.8 2.62 71.91 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.06 -164.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.445 ' OG ' ' CG2' ' A' ' 62' ' ' VAL . 79.5 p -39.96 123.65 1.6 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.51 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -42.04 121.48 1.84 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.957 1.772 . . . . 0.0 112.823 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 107.69 -42.39 1.95 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.445 ' CG2' ' OG ' ' A' ' 59' ' ' SER . 56.1 t -63.88 122.04 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -120.0 -48.57 2.34 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.516 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.6 t -128.64 137.93 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 110.889 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.56 135.03 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.646 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.74 132.95 54.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.071 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' NH1' ' OD1' ' A' ' 75' ' ' ASN . 53.4 ttt85 -130.86 132.56 45.25 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.434 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.519 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 75.3 m-20 -92.27 118.86 31.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.58 -36.92 83.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.548 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.84 -42.51 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.82 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -117.51 105.78 12.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.891 0.376 . . . . 0.0 110.693 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.72 -37.57 67.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.607 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 40.3 p-10 -62.59 -33.11 74.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.081 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 83.4 tt0 -87.16 130.42 34.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.888 0.375 . . . . 0.0 110.585 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.433 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 10.9 m-80 -140.85 139.18 34.42 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.089 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.9 tt -126.14 134.32 51.34 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.8 m -126.87 146.69 50.19 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.306 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.32 128.41 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.952 0.406 . . . . 0.0 110.278 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.467 HG23 ' C ' ' A' ' 61' ' ' GLY . 5.5 mt -117.12 116.84 53.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.974 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.56 HD12 ' OD2' ' A' ' 40' ' ' ASP . 33.4 mm -116.01 123.97 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.922 0.392 . . . . 0.0 110.469 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 159' ' ' LEU . 75.3 m -146.67 160.59 42.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.05 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.575 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.9 pm0 -103.95 132.7 49.95 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.6 pt -88.54 148.33 41.79 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.661 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' LYS . 39.0 Cg_endo -66.7 138.02 47.78 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.716 1.611 . . . . 0.0 110.612 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.9 p -63.69 -26.11 68.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.994 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.08 -31.02 70.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.959 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 84' ' ' PRO . 97.4 mttt -130.62 155.63 46.24 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.046 0.45 . . . . 0.0 111.228 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.8 t -122.82 174.97 6.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.346 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 tp -53.05 -43.53 66.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.6 p -67.39 -44.43 78.93 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.044 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 88' ' ' THR . 89.9 m-20 -68.44 -34.81 76.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.979 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -55.57 -42.33 74.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.478 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.65 177.99 46.89 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.0 p -92.69 172.22 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.39 76.0 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.222 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.5 m -72.68 -45.21 59.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.854 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.9 t0 -62.33 -51.62 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.68 -38.83 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.543 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -57.8 -53.26 46.74 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -62.24 -36.41 81.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.57 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -57.16 -38.37 73.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.599 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.37 -41.12 98.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.865 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.678 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -55.84 -54.06 49.18 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.396 0.617 . . . . 0.0 109.802 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -61.92 -38.42 88.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.802 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -59.42 -46.98 87.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.858 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.7 t -71.29 -46.23 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 0.0 110.384 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.0 m-20 -62.23 -31.02 71.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.053 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -43.99 -36.91 2.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.089 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.06 -11.1 14.98 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.234 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -121.32 18.11 11.44 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.506 -178.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 107' ' ' ASN . 20.2 pt20 -75.64 2.13 12.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.563 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.67 -62.5 2.38 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.802 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.4 p-10 -117.25 -38.11 3.41 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.844 0.354 . . . . 0.0 111.477 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.531 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 40.4 ttm180 -79.2 141.28 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.28 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -129.5 132.48 46.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.959 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.77 134.11 46.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.895 0.378 . . . . 0.0 110.334 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.66 122.51 40.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.319 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 tp -81.29 111.11 17.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.327 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.521 ' CG1' ' HE ' ' A' ' 137' ' ' ARG . 97.0 mt -71.57 -42.75 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.891 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 177.76 174.47 0.52 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.297 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.81 144.15 22.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.161 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 122' ' ' GLU . 57.5 mp0 -144.07 145.86 32.45 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.857 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.32 135.65 53.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.311 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -116.86 159.2 22.73 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -139.51 107.29 5.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.516 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.43 144.91 38.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.933 0.397 . . . . 0.0 111.052 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.1 t0 52.8 30.24 8.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.59 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.69 0.92 75.76 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -102.9 146.68 27.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.903 0.382 . . . . 0.0 110.154 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.34 129.23 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.344 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -117.63 127.97 54.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -105.88 122.44 46.12 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.427 ' C ' HD12 ' A' ' 134' ' ' LEU . 87.1 m -105.55 123.33 47.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.234 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.427 HD12 ' C ' ' A' ' 133' ' ' THR . 9.5 mp -114.38 125.01 53.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.93 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -120.36 117.99 29.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.362 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -146.48 162.5 38.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.27 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.521 ' HE ' ' CG1' ' A' ' 119' ' ' ILE . 19.8 ptp180 -124.54 149.05 47.37 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.015 0.436 . . . . 0.0 110.803 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.05 133.87 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.352 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -139.91 134.86 32.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.242 0.544 . . . . 0.0 110.923 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.442 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 32.0 t -116.57 135.64 56.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.387 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.27 -122.39 18.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -112.31 14.91 20.51 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 140' ' ' VAL . 21.7 p-10 -133.5 160.14 38.3 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 111.509 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 144' ' ' VAL . 13.2 p -87.07 127.88 40.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.453 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.411 ' HG2' ' HE ' ' A' ' 146' ' ' ARG . 82.7 tt0 -76.45 -55.2 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.756 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.475 ' NH1' ' O ' ' A' ' 73' ' ' ASP . 20.1 ptp180 -174.82 174.58 2.55 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.078 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 61.7 m170 -103.01 139.0 39.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.011 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -132.84 133.36 43.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.974 0.416 . . . . 0.0 111.161 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.5 tp -111.52 133.96 53.43 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.908 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.39 131.49 48.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.921 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.5 t -120.97 123.04 41.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.2 129.04 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.015 0.436 . . . . 0.0 111.186 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.5 m -143.69 146.19 33.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.29 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.5 p -111.15 152.02 27.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.751 0.31 . . . . 0.0 110.263 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -158.46 119.85 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 55.94 29.74 14.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.77 14.28 78.05 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -105.38 128.43 53.5 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -90.02 119.29 30.25 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.39 128.1 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.7 0.286 . . . . 0.0 110.738 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.8 m -131.18 139.44 49.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.394 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.75 103.99 11.76 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.224 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -99.31 110.27 22.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.627 0.251 . . . . 0.0 110.422 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.4 mp -116.2 134.63 54.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.58 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 55.7 m -125.91 136.63 53.26 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.058 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.6 m -152.86 157.33 40.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.46 142.28 49.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.375 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -69.09 -30.64 68.98 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.033 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.86 -34.12 71.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.053 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.45 ' O ' HG22 ' A' ' 174' ' ' VAL . 71.0 mtp85 -113.24 -3.85 13.81 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.498 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.9 t-105 -49.78 -39.16 37.14 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.882 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.98 -42.18 99.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.091 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 56.9 m -64.78 -39.81 94.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.74 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.466 HG23 ' CZ ' ' A' ' 178' ' ' PHE . 14.7 m -107.97 21.08 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.262 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -50.06 -49.48 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.285 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.3 t -64.63 -30.72 71.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.846 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -55.21 -44.06 75.03 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.217 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 24.3 m-85 -61.56 -50.33 73.07 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.348 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -64.47 -40.17 95.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.656 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 184' ' ' SER . 41.9 m -66.84 -47.11 72.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.501 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 63.9 t -62.7 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.664 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.47 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -67.01 -46.8 73.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.208 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.1 m -68.72 -33.14 73.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.382 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 180' ' ' THR . 17.8 t -62.2 -27.55 69.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.699 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -56.11 159.18 3.52 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.779 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -135.77 157.89 45.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.8 151.04 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.098 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.485 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 46.2 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.785 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 120.825 0.345 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.481 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 20.9 mp0 -130.68 162.48 29.32 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.251 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -121.25 145.77 47.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.574 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -129.38 134.96 48.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.342 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.9 p -143.19 157.12 44.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.637 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -146.3 119.23 8.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.417 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.1 p -70.49 -32.82 70.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.586 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -62.65 -48.86 77.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.078 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -87.67 -20.75 25.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.869 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.03 39.83 88.8 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.31 151.45 45.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.299 0.549 . . . . 0.0 110.415 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -153.24 143.78 22.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.799 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -150.73 157.71 43.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 mt -98.5 150.96 21.13 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.558 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -152.17 146.11 18.19 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.003 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.48 153.62 69.96 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.397 2.065 . . . . 0.0 112.508 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -69.37 159.37 33.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.997 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.13 -2.51 63.65 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.533 ' CD1' ' OD1' ' A' ' 68' ' ' ASP . 35.8 m0 -94.91 147.13 23.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.772 0.32 . . . . 0.0 110.276 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.8 pt -120.4 149.88 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.324 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -114.98 141.8 17.25 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.7 144.9 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.756 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -84.38 134.87 34.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.379 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.91 55.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.491 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -70.89 135.01 47.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.82 2.34 69.58 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.44 -164.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.641 0.258 . . . . 0.0 110.485 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.76 154.36 1.24 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.215 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.18 131.24 24.6 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.277 1.985 . . . . 0.0 111.915 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.516 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 95.47 -22.28 39.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.43 133.85 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.176 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -118.65 -58.3 1.98 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.639 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 78' ' ' VAL . 44.2 t -145.16 148.99 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.928 0.394 . . . . 0.0 111.504 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.56 136.45 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.655 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -112.36 143.11 44.01 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.292 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -145.09 145.78 31.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.847 0.356 . . . . 0.0 110.682 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.533 ' OD1' ' CD1' ' A' ' 50' ' ' TRP . 62.8 m-20 -101.73 122.01 43.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.685 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.42 -39.92 95.78 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.231 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.6 -38.59 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.61 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -126.43 94.62 4.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.46 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -62.19 -38.44 89.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.15 0.5 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 42.1 p-10 -61.78 -32.48 72.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.198 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.525 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 14.0 tm-20 -86.21 125.94 33.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.946 0.403 . . . . 0.0 110.202 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -171.76 168.91 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.574 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.6 pp -157.23 157.12 33.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.509 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 m -131.16 147.86 52.65 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 m -115.67 128.19 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.188 0.518 . . . . 0.0 109.987 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.516 HG23 ' C ' ' A' ' 61' ' ' GLY . 56.3 mt -117.08 124.37 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.805 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' GLY . 66.0 mt -118.25 128.8 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.473 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.3 m -138.38 163.38 32.02 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.93 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.77 134.72 47.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.688 0.28 . . . . 0.0 110.403 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.447 ' CG2' HD12 ' A' ' 159' ' ' LEU . 10.8 pt -103.23 149.21 36.72 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.679 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 87' ' ' LYS . 48.4 Cg_endo -68.24 137.57 40.67 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.105 1.87 . . . . 0.0 111.327 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.4 t -62.46 -27.66 69.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.15 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -67.48 -31.36 71.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.897 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 84' ' ' PRO . 67.9 mttm -128.73 151.96 48.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.077 0.465 . . . . 0.0 111.047 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.414 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.0 t -120.54 178.22 4.76 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.491 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.404 HD21 ' CG ' ' A' ' 132' ' ' TYR . 47.0 tp -50.12 -44.32 52.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.094 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.0 p -65.33 -42.95 92.41 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.936 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 88' ' ' THR . 86.6 m-20 -65.45 -39.13 91.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.804 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.8 tp -56.4 -43.53 79.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.585 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.7 176.25 45.57 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.412 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 33.5 p -93.2 172.58 8.21 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.74 79.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.1 m -72.26 -44.48 62.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.2 t0 -61.92 -50.98 69.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.303 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 82.1 t -60.49 -38.67 78.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.498 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.69 -44.02 94.21 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -69.33 -42.45 75.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.896 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -61.29 -39.05 89.01 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.961 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -62.03 -40.63 96.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.38 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.78 -44.26 94.01 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.404 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.28 -39.45 93.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.266 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.3 m -60.19 -47.63 85.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.811 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.52 -45.4 68.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.96 0.41 . . . . 0.0 110.496 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 111' ' ' GLN . 85.1 m-20 -62.41 -30.35 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.244 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -45.03 -39.91 6.09 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.972 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.48 -4.28 29.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.693 0.282 . . . . 0.0 110.8 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -121.44 14.65 11.17 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.052 -179.226 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 107' ' ' ASN . 6.5 tt0 -72.03 3.06 4.76 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.092 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.37 -64.6 1.44 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.67 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -117.71 -48.6 2.57 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.996 0.427 . . . . 0.0 111.379 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' SER . 84.4 mtt180 -70.12 149.02 48.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.508 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -134.43 129.83 35.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.849 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.76 128.21 46.89 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.76 0.314 . . . . 0.0 110.223 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -115.08 128.77 56.44 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.1 tp -81.98 108.99 15.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.081 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.39 -53.76 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.547 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.518 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 24.3 p30 -163.11 167.77 21.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.645 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.94 124.38 5.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.418 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -141.78 162.89 34.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.628 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.405 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.64 148.4 50.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.47 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -130.64 141.47 50.43 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.176 0.512 . . . . 0.0 111.258 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -107.65 112.69 25.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.275 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.25 141.47 35.86 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.945 0.403 . . . . 0.0 110.693 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.69 38.95 24.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.207 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.59 0.7 25.95 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -105.54 147.35 28.46 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.983 0.42 . . . . 0.0 110.189 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.19 128.38 72.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.011 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 21.2 m-85 -116.68 129.36 56.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.844 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.405 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.5 m-85 -104.11 128.23 51.75 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.3 m -110.93 123.89 51.04 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.248 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.6 mp -117.49 124.42 48.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.938 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.518 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 71.1 tt0 -118.07 120.2 37.06 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -147.05 170.02 18.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.075 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.551 ' NH2' ' NE2' ' A' ' 147' ' ' HIS . 11.6 ptm180 -138.18 155.56 48.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 110.8 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.62 133.52 47.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.374 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -142.71 136.37 28.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.197 0.522 . . . . 0.0 111.498 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.3 t -108.2 130.49 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.003 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.62 -119.52 18.98 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -110.02 10.52 24.14 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.816 -0.226 . . . . 0.0 111.228 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -117.74 147.35 43.05 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.761 0.315 . . . . 0.0 111.149 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.468 HG11 HH21 ' A' ' 137' ' ' ARG . 43.2 t -88.14 127.0 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.743 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -76.2 -54.03 7.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -173.7 174.36 3.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.181 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.551 ' NE2' ' NH2' ' A' ' 137' ' ' ARG . 29.9 m170 -104.87 139.86 38.99 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 83.9 m-20 -134.64 136.9 43.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -113.62 132.43 55.76 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.114 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -127.16 131.95 50.62 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.008 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.9 t -125.12 127.67 47.23 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.74 128.12 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.987 0.422 . . . . 0.0 110.939 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.8 m -139.72 141.84 36.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.035 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.7 p -104.76 152.6 22.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.909 0.385 . . . . 0.0 110.463 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -162.75 122.87 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 55.67 29.34 13.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.354 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.69 13.21 80.37 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -107.84 140.63 40.66 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.678 0.275 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.447 HD12 ' CG2' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -97.67 120.39 37.97 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 80.5 mt -118.46 124.48 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.049 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.2 m -125.93 136.18 52.74 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.314 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.07 99.85 7.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.061 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -97.2 111.63 23.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.668 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.07 138.25 51.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.831 0.348 . . . . 0.0 110.48 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 61.4 p -134.57 135.35 42.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.967 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 6.4 m -152.93 161.67 42.26 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.634 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.619 ' CB ' HH21 ' A' ' 170' ' ' ARG . . . -54.22 144.31 20.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.313 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -70.41 -36.34 73.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.055 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -62.76 -33.42 75.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.356 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.619 HH21 ' CB ' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -97.68 -19.89 17.96 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.896 -179.341 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.492 ' O ' ' N ' ' A' ' 175' ' ' LYS . 59.5 t-105 -45.58 -40.34 8.67 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.77 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.12 -42.61 99.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.199 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 55.0 m -66.96 -39.32 87.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.539 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 170' ' ' ARG . 6.0 m -109.55 21.48 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 171' ' ' TRP . 16.9 pttm -51.69 -47.62 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.497 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 85.8 p -69.61 -24.09 63.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.467 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 181' ' ' VAL . 11.3 tp -59.07 -42.57 90.69 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.994 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.415 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 20.2 m-85 -66.9 -50.22 63.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.485 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.47 -41.22 98.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.579 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 184' ' ' SER . 47.8 m -67.91 -49.32 62.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 177' ' ' LEU . 55.9 t -61.55 -42.99 96.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.462 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.61 -40.32 96.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.924 0.392 . . . . 0.0 110.287 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 39.1 m -79.63 -28.42 40.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.349 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 180' ' ' THR . 87.8 p -63.19 -23.55 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.505 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -63.24 157.55 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.437 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -139.6 160.26 40.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.731 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.46 151.12 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 38.0 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.72 -179.812 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 120.723 0.297 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.658 HE22 ' HA ' ' A' ' 48' ' ' ASN . 5.2 pm0 -131.16 152.52 50.36 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.229 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -109.67 128.4 55.23 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.008 0.432 . . . . 0.0 110.958 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -114.31 119.04 35.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.544 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 50.0 m -126.98 149.07 50.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.934 0.397 . . . . 0.0 110.949 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 36' ' ' SER . 87.4 m-20 -138.18 111.4 7.94 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.245 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.9 p -64.41 -34.05 77.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.46 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 26.2 mtpp -60.9 -43.87 97.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.51 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -89.6 -20.41 23.76 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.092 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.34 37.56 90.68 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.1 151.12 45.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.095 0.448 . . . . 0.0 110.384 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -150.54 147.28 27.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 45' ' ' LEU . 43.3 t80 -160.77 147.57 15.33 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.067 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.531 ' O ' ' CE2' ' A' ' 44' ' ' PHE . 9.9 mp -93.77 143.3 26.46 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.943 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -149.51 130.63 7.2 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.991 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.97 157.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.221 1.947 . . . . 0.0 112.892 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.658 ' HA ' HE22 ' A' ' 33' ' ' GLN . 66.9 m-80 -81.41 158.13 24.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.987 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.24 0.83 61.27 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -81.05 149.73 29.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.5 pt -113.4 142.25 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.376 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.34 133.47 11.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.4 t -108.85 133.33 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.853 0.359 . . . . 0.0 110.412 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.63 124.39 32.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.271 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.84 55.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.606 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -80.48 130.17 34.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.744 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.66 -3.57 78.47 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 59' ' ' SER . . . -80.25 -162.84 0.48 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.299 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 58' ' ' ALA . 28.2 m -36.43 109.24 0.41 Allowed Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.76 135.04 10.13 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.865 1.71 . . . . 0.0 111.997 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 102.19 -36.0 4.57 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.96 127.08 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.116 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.44 ' OD2' HD12 ' A' ' 80' ' ' ILE . 31.3 t0 -103.55 -59.11 1.77 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.693 0.283 . . . . 0.0 110.927 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.4 t -150.56 141.21 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.17 130.95 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.76 133.91 55.53 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.521 ' NH2' ' OD1' ' A' ' 75' ' ' ASN . 76.2 mtp85 -124.55 140.89 52.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.719 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -88.48 118.31 28.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.391 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -62.42 -39.23 92.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.335 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.6 mm -63.46 -42.3 95.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.792 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -112.86 107.04 15.49 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.816 0.341 . . . . 0.0 110.85 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -73.76 -45.9 48.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.309 0.576 . . . . 0.0 110.278 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.41 -37.24 74.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.206 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -84.08 129.53 34.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.382 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.521 ' OD1' ' NH2' ' A' ' 67' ' ' ARG . 7.4 m-80 -130.29 148.07 52.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.007 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.661 HD13 ' N ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -124.63 133.75 53.14 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.661 ' N ' HD13 ' A' ' 76' ' ' LEU . 1.9 p -136.31 138.23 41.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.96 0.409 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.9 t -122.08 130.62 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.931 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.45 HG23 ' C ' ' A' ' 61' ' ' GLY . 28.0 mt -121.02 131.83 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.462 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.44 HD12 ' OD2' ' A' ' 63' ' ' ASP . 60.8 mt -122.54 133.05 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.621 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' LEU . 49.2 m -143.53 164.1 31.3 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.239 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -105.5 138.23 42.04 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.522 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.82 153.37 38.28 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.253 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 87' ' ' LYS . 72.4 Cg_endo -75.68 141.49 24.81 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.379 2.052 . . . . 0.0 110.892 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.8 p -68.44 -26.45 65.52 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.918 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -69.22 -32.0 70.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.972 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 84' ' ' PRO . 64.9 mttm -130.87 157.95 41.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.999 0.428 . . . . 0.0 111.302 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.7 t -123.12 175.47 6.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.834 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.5 tp -49.98 -45.31 51.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.07 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.1 p -65.61 -44.45 86.52 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.79 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.72 -36.26 83.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.99 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.63 ' O ' HD23 ' A' ' 92' ' ' LEU . 4.9 tt -55.87 -47.7 76.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.429 . . . . 0.0 110.245 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.19 177.5 46.95 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.0 p -90.94 170.13 10.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.93 74.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.96 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.0 m -71.43 -45.07 63.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.5 -53.29 58.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.299 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 80.0 t -61.25 -39.73 83.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.705 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.09 -45.11 92.81 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -66.28 -41.62 89.58 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -62.21 -39.38 92.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -62.2 -40.54 96.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.703 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.8 mmt -58.16 -44.93 88.18 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.599 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.55 -44.49 90.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 110.066 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.7 m -60.2 -44.76 94.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.837 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.75 -46.21 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.461 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 111' ' ' GLN . 87.8 m-20 -64.36 -42.12 96.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.053 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -43.6 -20.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.37 . . . . 0.0 110.748 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 107' ' ' ASN . . . -91.1 -43.67 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.607 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.8 p -119.38 19.63 12.69 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.2 tt0 -56.38 -28.78 60.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.337 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -42.53 -62.64 2.12 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.23 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -117.63 -44.3 2.75 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.766 0.317 . . . . 0.0 111.336 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -80.47 144.95 32.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.469 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -131.53 142.55 49.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.162 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.16 135.41 44.86 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -116.73 129.64 56.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.9 tt -81.5 104.28 11.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.12 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.35 -45.88 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.334 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -169.65 166.71 9.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.363 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.14 126.3 5.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.413 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -142.9 163.5 32.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.748 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.17 149.69 46.08 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.506 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -131.65 144.89 51.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.143 0.497 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -111.53 114.53 27.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.557 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.91 138.57 33.97 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.504 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 52.05 40.97 29.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.788 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.78 2.29 7.7 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -103.32 133.19 48.81 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.63 130.45 55.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.389 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -118.02 128.39 54.73 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -105.51 129.83 53.71 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.436 ' C ' HD12 ' A' ' 134' ' ' LEU . 87.4 m -113.21 122.92 48.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.436 HD12 ' C ' ' A' ' 133' ' ' THR . 9.3 mp -115.39 126.1 53.99 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.739 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -118.81 122.12 41.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.768 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -150.44 171.3 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.29 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -136.5 156.58 48.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 110.494 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.2 t -106.39 135.01 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.025 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.79 136.25 30.48 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.163 0.506 . . . . 0.0 111.58 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.2 t -97.79 121.79 48.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.74 -110.89 3.08 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -113.31 10.56 18.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.565 0.222 . . . . 0.0 110.871 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -113.34 137.16 51.91 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.684 0.278 . . . . 0.0 111.317 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 144' ' ' VAL . 7.2 p -78.73 126.63 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.637 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -81.05 -55.04 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.474 ' NH2' ' C ' ' A' ' 166' ' ' THR . 6.5 ptm85 -172.56 174.22 3.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 56.2 m170 -105.05 138.38 41.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.131 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 82.2 m-20 -135.36 130.93 35.71 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.725 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 tp -110.89 128.16 55.7 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.9 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.6 134.84 55.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.24 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.0 t -125.68 121.73 34.3 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.1 t -105.67 129.44 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.934 0.397 . . . . 0.0 110.874 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 59.8 m -142.79 144.42 32.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.0 p -86.93 156.82 19.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.871 0.367 . . . . 0.0 110.762 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -150.35 95.94 2.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.721 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 54.2 43.32 30.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.479 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.43 18.25 66.89 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.728 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 40.9 mtpt -121.71 137.26 54.83 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.952 0.376 . . . . 0.0 111.108 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 81' ' ' SER . 1.2 mt -91.81 119.28 31.47 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.29 122.14 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.2 m -115.72 133.24 56.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 110.245 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -105.2 110.23 22.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.612 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.82 122.14 43.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.951 0.405 . . . . 0.0 111.675 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mt -115.64 132.91 56.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.543 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.4 m -130.26 130.62 44.8 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.859 0.361 . . . . 0.0 110.31 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.474 ' C ' ' NH2' ' A' ' 146' ' ' ARG . 3.7 m -153.02 158.12 41.52 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.34 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -57.0 143.38 38.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.205 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -69.85 -29.64 66.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.166 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.19 -33.77 72.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.215 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.491 ' O ' HG22 ' A' ' 174' ' ' VAL . 86.8 mtt180 -111.84 -6.48 14.27 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.557 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 53.7 t-105 -48.25 -39.52 21.67 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.811 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.85 -42.04 97.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 56.6 m -65.47 -39.99 92.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.569 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 170' ' ' ARG . 8.5 m -107.71 21.44 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.255 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -49.21 -48.19 45.57 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.447 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.0 m -64.2 -32.08 73.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.649 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.9 tp -53.81 -44.94 70.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.045 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.557 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 18.9 m-85 -62.45 -49.04 77.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.477 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.92 -41.58 99.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 184' ' ' SER . 48.8 m -67.72 -47.62 68.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.438 HG13 ' CZ ' ' A' ' 44' ' ' PHE . 56.0 t -62.81 -43.73 99.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.627 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -61.6 -38.45 87.64 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.7 t -85.14 -20.4 30.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 180' ' ' THR . 45.5 t -62.11 -33.58 74.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.059 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.2 OUTLIER -57.21 159.56 4.42 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.321 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -138.28 152.77 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 13.9 m -128.0 151.49 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.082 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.623 -179.734 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 120.92 0.391 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.486 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 0.4 OUTLIER -139.53 160.48 39.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.078 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -129.98 147.83 51.77 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.138 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.664 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -124.93 158.38 33.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.453 178.683 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -144.74 161.2 39.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.834 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 41' ' ' GLY . 45.0 t0 -145.52 109.06 4.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.646 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.6 m -59.64 -37.81 79.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.885 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 62.5 mttp -58.7 -47.06 85.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.25 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.48 ' OD2' HD13 ' A' ' 80' ' ' ILE . 47.2 t0 -89.75 -20.26 23.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.921 0.391 . . . . 0.0 110.507 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . 66.66 40.27 93.96 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.503 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.2 150.11 43.77 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.139 0.47 . . . . 0.0 110.608 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -153.42 147.31 25.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.376 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.419 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 28.6 p90 -161.27 158.91 27.93 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.619 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 mt -81.06 153.49 27.34 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.412 0.625 . . . . 0.0 111.667 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.664 ' CD1' ' CZ ' ' A' ' 35' ' ' TYR . 16.8 p90 -162.41 141.79 7.18 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.457 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.27 156.52 58.88 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.276 1.984 . . . . 0.0 112.422 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.454 ' N ' ' OE1' ' A' ' 33' ' ' GLN . 44.6 p30 -74.25 160.7 30.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.216 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.43 -4.78 56.93 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.532 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 36.0 m0 -85.02 139.63 31.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.1 pt -113.61 134.39 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.158 0.504 . . . . 0.0 110.638 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.99 127.81 9.09 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.3 t -105.26 135.35 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.324 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 54' ' ' ASP . 51.3 p30 -71.0 149.16 46.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.243 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -152.66 48.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.42 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -76.68 128.24 34.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.022 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.53 7.6 78.74 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.14 -164.68 0.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.637 0.256 . . . . 0.0 110.568 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.78 156.39 1.64 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.115 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.2 127.84 17.42 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.499 2.133 . . . . 0.0 112.253 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 97.51 -22.68 39.53 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.6 t -68.79 128.79 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -118.98 -57.5 2.02 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.8 t -142.21 142.54 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.86 0.362 . . . . 0.0 111.157 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.6 t -117.09 134.31 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.215 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -111.67 131.63 55.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.953 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -129.83 138.57 51.08 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.483 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 72.2 m-20 -89.26 118.77 29.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.625 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.8 tp -66.83 -39.3 87.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.981 0.42 . . . . 0.0 110.328 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 85.9 mt -62.11 -43.16 97.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.345 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -117.98 108.87 15.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.828 0.346 . . . . 0.0 110.817 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -65.43 -43.19 91.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.354 0.597 . . . . 0.0 110.379 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.2 -37.42 74.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.338 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.455 ' CD ' ' HG1' ' A' ' 166' ' ' THR . 47.4 tp10 -74.85 132.38 41.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.32 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -149.23 139.0 21.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.539 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -129.83 134.69 47.7 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.862 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.3 t -127.86 138.51 52.72 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.1 t -116.01 125.24 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.507 HG23 ' C ' ' A' ' 61' ' ' GLY . 54.7 mt -124.5 122.04 62.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.48 HD13 ' OD2' ' A' ' 40' ' ' ASP . 72.6 mt -120.88 135.33 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.703 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -148.08 164.68 33.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.37 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -103.49 134.44 46.84 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 83' ' ' ILE . 12.5 pt -92.8 148.77 36.63 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.455 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 87' ' ' LYS . 40.1 Cg_endo -66.51 136.51 43.19 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.541 1.494 . . . . 0.0 110.49 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.5 p -63.86 -26.09 68.46 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.854 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -68.57 -30.96 69.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.815 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 84' ' ' PRO . 28.5 mtmm -130.92 148.94 52.74 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.132 0.491 . . . . 0.0 111.544 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.472 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 71.6 p -109.35 179.06 4.26 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.652 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.69 -41.07 73.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.284 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.4 p -72.52 -44.66 61.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.014 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 88' ' ' THR . 44.4 t0 -64.68 -38.45 91.02 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.947 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.5 tp -55.9 -44.71 78.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 178.64 47.33 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.2 p -94.76 171.11 8.98 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.73 -38.23 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.044 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.3 m -72.03 -45.24 61.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.11 -50.84 64.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.353 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.568 HG22 ' NH2' ' A' ' 101' ' ' ARG . 72.0 t -59.4 -37.3 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.554 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -62.8 -63.6 4.49 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.557 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -46.96 -42.99 18.76 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.793 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.568 ' NH2' HG22 ' A' ' 98' ' ' VAL . 84.0 mtm180 -59.38 -43.34 92.93 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.533 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -59.45 -42.66 92.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.659 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -53.97 -54.86 33.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.301 0.572 . . . . 0.0 110.098 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -62.04 -39.22 91.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 m -58.43 -45.59 88.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.907 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.4 t -70.88 -46.73 66.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.619 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 111' ' ' GLN . 85.1 m-20 -60.59 -37.04 80.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.526 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 22.3 t70 -44.38 -17.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 107' ' ' ASN . . . -109.31 -27.2 9.65 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.383 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 114' ' ' ARG . 3.8 t -121.32 21.59 11.05 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.605 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.543 ' CD ' ' H ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -69.97 4.17 2.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.079 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.1 -63.07 2.76 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.206 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -117.24 -45.14 2.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.852 0.358 . . . . 0.0 111.419 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' SER . 93.4 mtm-85 -85.09 148.4 26.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.504 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -129.16 148.64 51.12 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.175 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.16 136.2 43.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.379 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -122.74 127.96 49.89 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.9 tt -82.66 108.74 16.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.854 0.359 . . . . 0.0 110.09 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.1 mt -72.73 -58.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.836 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -146.29 164.0 33.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.132 0.491 . . . . 0.0 110.647 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.25 112.48 2.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.183 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -138.97 170.44 15.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -142.36 151.16 41.63 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.737 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.3 140.94 47.72 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.773 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 125' ' ' ASP . 35.6 p30 -109.21 112.72 25.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -139.93 142.55 36.41 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.991 0.424 . . . . 0.0 110.738 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 52.35 37.73 23.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.316 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.17 1.77 36.26 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -106.28 147.86 28.65 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 110.092 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.33 128.19 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.003 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -116.52 127.77 54.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.72 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.41 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.09 126.22 51.03 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.2 m -107.12 124.45 49.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.247 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.446 HD21 ' HA2' ' A' ' 99' ' ' GLY . 5.9 mp -118.3 123.61 45.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.839 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -119.25 122.46 41.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -149.15 168.57 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.299 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -138.64 160.03 40.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.752 0.311 . . . . 0.0 110.206 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 85.1 t -105.37 125.32 60.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.489 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 144' ' ' VAL . 8.0 mt -104.85 137.73 42.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.168 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.63 136.39 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.92 -110.49 0.74 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -117.31 18.11 14.51 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -140.88 160.22 40.52 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.322 0.582 . . . . 0.0 112.432 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 144' ' ' VAL . 12.7 p -72.37 122.51 25.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.39 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.526 ' OE1' ' NE ' ' A' ' 146' ' ' ARG . 2.0 tm-20 -75.11 -53.59 8.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 145' ' ' GLU . 15.0 ptp180 -172.46 169.64 5.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.127 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -109.04 136.07 49.16 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.04 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -135.17 135.89 41.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.888 0.375 . . . . 0.0 111.046 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.8 tp -111.11 133.94 53.09 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.004 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.37 131.14 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.503 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.7 m -119.31 136.71 54.12 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.36 127.69 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 111.288 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.5 m -144.83 144.21 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.08 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.0 p -107.48 145.59 32.88 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -146.73 111.45 5.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.138 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.452 ' CZ ' ' OXT' ' A' ' 188' ' ' TYR . 80.5 mtm180 55.74 31.86 18.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.81 8.71 75.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.471 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 31.7 mmtp -99.71 124.43 44.96 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.66 114.61 23.51 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.8 mm -109.76 128.6 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.5 m -130.42 134.46 47.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.729 0.299 . . . . 0.0 110.838 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.29 102.17 9.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.829 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -102.53 111.86 24.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.474 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 164' ' ' LEU . 5.3 mp -117.16 137.51 52.28 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.653 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 54.4 m -126.85 134.35 50.53 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.031 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.455 ' HG1' ' CD ' ' A' ' 74' ' ' GLU . 17.2 m -153.11 156.31 38.43 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.65 143.79 19.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.257 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.21 -36.98 72.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.295 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.9 -33.29 73.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.516 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.423 ' O ' HG22 ' A' ' 174' ' ' VAL . 56.4 ttt-85 -100.88 -12.51 18.93 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.601 0.239 . . . . 0.0 111.29 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.529 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.7 t-105 -50.36 -39.79 47.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.757 0.313 . . . . 0.0 111.01 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -60.3 -42.05 94.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.152 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.1 m -66.18 -39.67 89.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.634 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 170' ' ' ARG . 12.3 m -110.18 21.35 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.406 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 171' ' ' TRP . 47.2 pttt -51.37 -48.76 62.41 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.39 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.1 t -65.98 -29.03 69.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.686 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 181' ' ' VAL . 11.1 tp -56.46 -44.25 80.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.191 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.529 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 28.3 m-85 -61.77 -50.95 70.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.122 0.486 . . . . 0.0 110.403 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -63.82 -40.91 97.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.562 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 184' ' ' SER . 41.6 m -66.26 -46.71 76.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.591 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 177' ' ' LEU . 55.8 t -61.05 -46.16 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.097 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -65.96 -49.43 67.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.492 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.3 t -67.77 -34.04 76.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 180' ' ' THR . 16.5 t -62.61 -29.29 70.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.633 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -51.19 157.47 0.92 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.562 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -132.61 154.16 50.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.57 152.43 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 111.274 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.452 ' OXT' ' CZ ' ' A' ' 156' ' ' ARG . 38.2 p90 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.727 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.4 mt . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -131.47 159.07 39.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.289 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -121.35 146.38 46.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.602 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -129.88 137.64 50.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.921 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.427 ' OG ' ' OH ' ' A' ' 188' ' ' TYR . 22.2 t -149.5 149.24 30.45 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.644 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -142.76 110.59 5.89 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.706 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.9 m -61.54 -37.31 83.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.568 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -58.68 -52.57 65.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.48 ' OD2' HD13 ' A' ' 80' ' ' ILE . 38.9 t0 -83.08 -21.07 33.82 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.762 0.315 . . . . 0.0 110.709 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.58 42.12 81.86 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.16 147.94 37.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.359 0.58 . . . . 0.0 110.129 179.082 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -153.1 141.38 20.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.803 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.91 156.66 40.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.75 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.7 mt -96.7 152.03 19.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.447 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -154.86 146.43 16.9 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.488 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.07 161.77 41.22 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.23 1.953 . . . . 0.0 112.101 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -76.9 160.59 29.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.575 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.4 0.93 58.01 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.52 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 31.2 m0 -88.48 141.25 28.69 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.06 145.69 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.637 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.95 136.51 12.74 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.2 t -112.94 136.51 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.392 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -66.55 140.07 57.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.15 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.6 m -114.03 24.75 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.646 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -60.74 119.57 8.41 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.218 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.63 8.81 76.28 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.41 -164.58 0.65 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.14 157.77 67.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.503 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.45 128.32 16.13 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.382 2.054 . . . . 0.0 111.742 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 98.24 -17.79 58.05 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.08 123.99 25.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.641 -0.424 . . . . 0.0 109.891 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -100.87 -58.24 1.93 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.08 148.06 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 111.312 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.1 t -115.27 136.31 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.301 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -111.79 136.15 51.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.243 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -129.78 138.54 51.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.321 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 74.3 m-20 -82.46 118.58 23.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.79 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.04 -40.16 71.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.39 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.7 mm -61.4 -40.75 87.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.544 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' OE1' ' A' ' 74' ' ' GLU . 9.9 pt-20 -133.53 84.41 2.12 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.08 0.467 . . . . 0.0 110.284 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -52.16 -21.81 3.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.462 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -57.76 -37.82 74.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' OE1' ' OE2' ' A' ' 71' ' ' GLU . 97.7 mt-10 -84.33 141.35 30.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.991 0.424 . . . . 0.0 110.627 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -153.23 149.69 28.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.733 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.687 ' C ' HD12 ' A' ' 76' ' ' LEU . 1.7 pp -151.91 146.5 25.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.285 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.7 m -124.21 145.94 49.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.019 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.08 125.03 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.473 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.5 mp -122.6 127.78 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.299 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.48 HD13 ' OD2' ' A' ' 40' ' ' ASP . 79.2 mt -122.65 132.08 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.664 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.3 m -145.82 167.25 23.65 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.115 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -106.05 137.21 44.36 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.9 pt -96.37 148.33 34.32 Favored Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.569 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 87' ' ' LYS . 36.9 Cg_endo -66.22 135.77 41.4 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.589 1.526 . . . . 0.0 110.759 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 t -62.1 -29.17 70.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.133 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -68.09 -31.3 70.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.037 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 84' ' ' PRO . 97.0 mttt -131.38 143.68 50.65 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.033 0.444 . . . . 0.0 111.008 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 13.9 t -110.46 -179.44 3.77 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.32 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.451 HD21 ' CG ' ' A' ' 132' ' ' TYR . 45.9 tp -51.05 -44.08 61.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.893 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.5 p -68.28 -43.35 77.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.433 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 88' ' ' THR . 89.0 m-20 -65.54 -40.45 92.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.41 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.2 mt -57.01 -41.29 78.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.639 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.87 178.18 47.2 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.394 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 32.9 p -93.37 173.83 7.51 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.7 -41.03 76.66 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.4 m -73.08 -46.0 54.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.034 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 94' ' ' THR . 44.6 t0 -63.14 -52.14 63.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.506 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.2 -37.93 71.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.72 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.539 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -60.15 -55.69 28.83 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -53.53 -39.77 64.96 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.875 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -58.58 -36.79 74.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.191 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -65.08 -41.98 94.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.721 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.654 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -54.22 -55.71 25.39 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.336 0.589 . . . . 0.0 109.826 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -62.1 -40.98 97.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.664 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.5 m -58.1 -47.09 84.28 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.929 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.2 t -72.19 -47.35 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.773 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 111' ' ' GLN . 95.8 m-20 -60.97 -39.51 89.86 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.792 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -44.41 -37.13 3.21 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.448 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.25 -45.06 74.22 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.9 p -123.37 22.09 9.36 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.633 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.8 tt0 -51.15 -28.88 12.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.5 0.19 . . . . 0.0 111.281 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -42.5 -61.74 2.39 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.287 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -117.2 -38.01 3.44 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.01 0.405 . . . . 0.0 111.74 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -88.39 138.33 31.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.019 0.437 . . . . 0.0 111.146 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -131.87 149.73 52.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.112 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.424 ' H ' ' ND2' ' A' ' 107' ' ' ASN . . . -106.83 138.07 43.68 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.39 129.7 56.66 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.9 tp -82.61 111.99 19.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.909 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.5 mt -79.64 -50.29 18.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.569 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -158.41 164.52 36.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.398 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.47 114.66 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.592 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.64 167.25 22.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.685 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.41 150.5 50.88 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.504 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -128.53 142.16 51.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.787 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -109.43 113.27 25.93 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.183 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -138.92 141.13 38.51 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.89 0.376 . . . . 0.0 110.755 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 50.52 38.9 19.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.366 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.42 0.34 29.93 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -105.21 147.41 28.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.916 0.389 . . . . 0.0 110.124 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -113.3 129.64 68.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.27 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 20.7 m-85 -117.06 130.49 56.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.755 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.451 ' CG ' HD21 ' A' ' 89' ' ' LEU . 2.4 m-85 -104.13 124.48 49.16 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 54.2 m -103.29 130.26 50.5 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.59 106.37 8.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.234 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -101.14 124.5 46.95 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -152.71 172.77 16.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.408 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -141.2 158.78 43.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 110.448 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.16 137.32 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.501 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 141' ' ' GLY . 2.7 pp -135.04 131.69 37.34 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.049 0.452 . . . . 0.0 111.332 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 140' ' ' VAL . 1.4 m -91.74 103.76 14.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 139' ' ' LEU . . . 74.02 -113.64 4.23 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -107.91 7.35 27.98 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.818 -0.225 . . . . 0.0 111.483 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -116.14 138.97 50.8 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.707 0.289 . . . . 0.0 111.249 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 144' ' ' VAL . 7.3 p -78.72 122.21 33.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.344 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.13 -52.93 9.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.607 HH21 ' N ' ' A' ' 166' ' ' THR . 15.3 ptm180 -172.27 173.13 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.9 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -102.97 138.92 39.21 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -133.72 134.18 42.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.855 0.36 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.6 tp -111.32 131.21 55.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.079 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -127.65 125.72 40.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.029 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 27.8 t -118.74 132.57 56.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.678 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.07 127.56 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.99 0.424 . . . . 0.0 110.751 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.5 m -137.97 140.94 40.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.998 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.8 p -105.37 151.52 24.09 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.727 0.299 . . . . 0.0 110.364 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -161.53 119.07 2.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 55.17 32.1 17.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.67 14.31 80.06 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -105.26 128.8 53.62 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.42 119.06 31.58 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.3 mt -117.92 127.59 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.732 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 39.5 m -126.76 136.08 51.94 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.017 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.37 98.41 6.41 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -91.74 111.99 23.73 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.549 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.93 137.39 49.98 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.5 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 146' ' ' ARG . 32.3 t -136.27 129.45 31.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.365 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.607 ' N ' HH21 ' A' ' 146' ' ' ARG . 11.9 m -152.43 158.72 43.03 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.478 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -51.93 143.32 13.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -71.84 -36.78 70.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.043 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -63.32 -33.5 75.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.123 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.464 ' CD ' ' N ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER -96.95 -16.49 20.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.274 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.546 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 50.6 t-105 -48.56 -39.82 24.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.831 0.348 . . . . 0.0 110.769 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -61.69 -42.12 98.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 58.7 m -66.66 -40.0 88.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.657 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.2 m -109.55 21.17 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.149 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 171' ' ' TRP . 19.2 ptmt -50.59 -48.72 57.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.279 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.5 t -65.78 -29.75 70.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.773 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.8 tp -55.73 -44.45 77.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.374 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 26.3 m-85 -62.3 -50.47 71.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.088 0.47 . . . . 0.0 110.41 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.31 -41.41 98.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.605 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 184' ' ' SER . 50.7 m -66.07 -47.86 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.31 -43.63 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.523 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -62.94 -37.67 87.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.905 0.383 . . . . 0.0 110.306 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.2 t -83.62 -25.3 30.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 180' ' ' THR . 46.9 t -62.49 -30.03 70.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.17 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -59.76 157.58 11.86 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.463 -179.571 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -135.53 156.64 48.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.602 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.1 149.81 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.041 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.427 ' OH ' ' OG ' ' A' ' 36' ' ' SER . 38.9 p90 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.744 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 mt . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 120.979 0.419 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.693 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.4 pm0 -137.98 163.9 30.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.857 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -117.69 133.94 55.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.727 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -112.48 135.13 53.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.846 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 93.8 p -146.79 153.89 40.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 110.855 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 36' ' ' SER . 99.2 m-20 -141.2 114.18 8.51 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.15 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.6 p -64.89 -33.95 77.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.434 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -62.49 -48.44 79.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -85.91 -20.48 28.95 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.101 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.51 40.54 90.98 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.211 -0.518 . . . . 0.0 111.83 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -141.97 151.56 42.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.332 0.566 . . . . 0.0 110.61 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -155.6 146.52 22.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -151.74 161.58 42.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.994 0.426 . . . . 0.0 111.18 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.651 HD22 ' N ' ' A' ' 45' ' ' LEU . 2.0 mm? -92.61 143.5 26.26 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.116 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -154.71 147.25 17.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.518 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.73 157.98 58.58 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.282 1.988 . . . . 0.0 112.24 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.693 ' N ' HE22 ' A' ' 33' ' ' GLN . 47.3 p-10 -71.35 160.42 32.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.563 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.99 6.45 57.94 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.435 ' HE1' ' CG ' ' A' ' 68' ' ' ASP . 27.2 m0 -93.6 142.79 26.94 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.301 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 pt -126.02 146.31 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.334 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.63 139.32 15.06 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.69 134.64 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.856 0.36 . . . . 0.0 110.526 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -79.08 137.74 37.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.683 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.86 55.7 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.065 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -72.81 135.07 45.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.072 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.41 4.76 70.42 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.64 -164.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.698 0.285 . . . . 0.0 110.72 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.12 153.74 3.09 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.562 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.27 133.08 27.44 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.264 1.976 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 96.01 -21.88 42.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.2 t -62.22 122.22 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.92 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -99.11 -58.55 1.91 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.76 168.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.492 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.0 135.79 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.058 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -112.18 128.54 56.26 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -122.91 135.56 54.55 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.802 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' CG ' ' HE1' ' A' ' 50' ' ' TRP . 60.3 t0 -88.53 118.43 28.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.849 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.11 -38.65 91.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.387 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.35 -42.15 92.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.78 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 68' ' ' ASP . 96.1 mt-10 -117.86 120.62 38.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.457 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -88.93 -40.26 13.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.32 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -58.47 -36.27 73.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.548 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -89.22 129.77 35.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.421 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -129.75 149.04 51.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.997 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 77' ' ' SER . 0.3 OUTLIER -125.84 134.12 51.75 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.722 ' N ' HD13 ' A' ' 76' ' ' LEU . 13.3 t -136.82 142.79 42.9 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 t -129.4 132.86 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.933 0.396 . . . . 0.0 110.674 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.504 HG23 ' C ' ' A' ' 61' ' ' GLY . 50.4 mt -121.89 123.38 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.34 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.92 132.18 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.314 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 159' ' ' LEU . 4.1 m -151.68 166.75 30.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.406 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -105.71 135.82 46.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 83' ' ' ILE . 10.0 pt -91.47 148.93 38.55 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.97 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -43.73 143.21 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.869 1.712 . . . . 0.0 111.382 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -73.1 -20.64 60.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.636 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 57.2 t0 -94.98 -17.18 22.18 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -129.94 156.26 44.71 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.933 0.397 . . . . 0.0 111.348 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 13.8 t -122.88 176.36 6.04 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.823 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.2 tp -49.92 -45.73 51.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.944 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.3 p -66.43 -44.13 83.76 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.988 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 88' ' ' THR . 57.8 t0 -65.71 -37.55 86.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.98 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.9 tp -55.85 -43.26 76.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.577 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.68 178.92 47.61 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.396 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.406 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 43.4 p -92.29 170.44 9.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.54 74.96 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.91 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.8 m -72.02 -44.43 63.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.804 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 94' ' ' THR . 47.3 t0 -62.22 -52.68 62.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.431 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.8 t -60.12 -39.11 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.595 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.73 -43.3 94.57 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -67.78 -41.41 83.28 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.04 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -60.72 -38.6 85.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -62.98 -39.61 95.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.585 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.5 mmt -59.1 -45.37 91.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.863 0.363 . . . . 0.0 110.536 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -64.72 -41.82 95.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.872 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.8 m -60.86 -46.13 91.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.7 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.99 -47.5 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.102 0.477 . . . . 0.0 110.472 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 111' ' ' GLN . 89.6 m-20 -61.05 -34.29 74.65 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.39 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -47.59 -38.71 15.02 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.189 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.41 73.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.53 0.566 . . . . 0.0 112.53 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -123.03 22.15 9.62 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.641 ' N ' ' O ' ' A' ' 107' ' ' ASN . 17.3 pt20 -51.23 -15.55 0.38 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.27 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.01 -61.27 7.63 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.814 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 38.0 p-10 -117.46 -35.51 3.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.035 0.417 . . . . 0.0 111.74 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.528 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 58.9 ttm-85 -84.62 137.89 33.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 111.24 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -129.03 139.29 52.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.106 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.9 136.53 42.56 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -116.54 128.28 55.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.477 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.4 tt -82.99 106.31 14.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.926 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.405 ' N ' HD23 ' A' ' 118' ' ' LEU . 96.5 mt -70.28 -43.47 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.362 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.402 ' N ' HD23 ' A' ' 118' ' ' LEU . 14.9 m-20 -179.7 173.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.452 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.67 139.62 15.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.19 163.99 32.03 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.453 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.8 146.87 46.2 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -133.13 139.6 47.17 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.655 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -109.67 113.44 26.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.55 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.74 144.33 39.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.014 0.435 . . . . 0.0 110.956 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 60.6 t0 51.59 32.11 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.405 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.03 1.58 68.81 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -105.57 148.95 26.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.94 0.4 . . . . 0.0 110.114 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.2 t -114.37 128.54 71.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.009 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -118.05 126.81 53.0 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.54 125.88 50.35 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.2 m -105.17 125.41 50.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.332 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.2 mp -115.69 126.53 54.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.928 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -119.52 122.67 42.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.433 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -152.9 171.65 17.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.522 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -139.94 157.92 44.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.186 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.24 135.28 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.979 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -136.04 136.9 40.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.109 0.481 . . . . 0.0 111.107 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.42 134.48 57.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.223 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.43 -120.95 16.46 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -114.47 14.42 17.82 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.92 -0.165 . . . . 0.0 111.415 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -129.05 155.6 45.17 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.92 0.391 . . . . 0.0 111.143 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 144' ' ' VAL . 14.7 p -86.66 126.93 40.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.324 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.539 ' OE1' ' NE ' ' A' ' 146' ' ' ARG . 2.1 tm-20 -76.01 -51.69 11.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.68 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.539 ' NE ' ' OE1' ' A' ' 145' ' ' GLU . 10.5 ptp180 -172.31 174.02 4.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.992 0.425 . . . . 0.0 111.192 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.404 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 73.8 m80 -107.21 139.44 41.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.013 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 78.3 m-20 -134.41 136.92 43.65 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.02 0.438 . . . . 0.0 111.477 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.3 tp -112.81 138.93 48.91 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.632 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.98 147.08 43.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.34 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.5 t -131.55 138.48 48.91 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.552 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 52.8 t -119.05 126.9 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.533 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.6 m -142.42 148.09 37.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.475 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.2 p -113.61 152.81 29.83 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.831 0.348 . . . . 0.0 110.641 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -151.12 107.44 3.47 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.274 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 59.35 32.16 21.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.791 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 87.1 6.21 79.21 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -97.27 123.26 41.02 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 81' ' ' SER . 1.0 OUTLIER -85.39 118.01 24.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.416 ' N ' HD23 ' A' ' 159' ' ' LEU . 81.4 mt -121.94 120.55 61.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.8 m -123.87 133.99 53.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.011 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.91 125.02 50.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.866 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -112.3 114.99 28.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.897 0.38 . . . . 0.0 110.654 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.434 HD23 ' CD2' ' A' ' 76' ' ' LEU . 11.8 mt -111.33 130.17 55.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.1 m -133.59 129.82 37.51 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.475 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 8.0 m -153.41 152.66 31.29 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.441 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.15 147.95 46.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.588 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -70.27 -24.05 62.99 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.268 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -55.54 -34.11 64.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.173 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.455 ' O ' HG22 ' A' ' 174' ' ' VAL . 96.6 mtt180 -124.79 0.09 8.03 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.519 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 44.9 t-105 -48.22 -39.11 20.14 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.852 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -63.43 -41.95 98.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 49.3 m -65.4 -39.94 92.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.627 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' A' ' 178' ' ' PHE . 12.8 m -105.22 21.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.176 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.36 -47.97 55.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.384 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.6 m -65.51 -31.9 73.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.652 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -54.52 -44.03 72.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.091 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.519 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 23.4 m-85 -61.07 -49.84 75.7 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.356 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -64.3 -40.38 95.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.591 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 184' ' ' SER . 50.1 m -67.65 -47.54 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.35 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.23 -43.46 98.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.614 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.77 -40.15 96.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 110.287 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 42.2 m -80.32 -27.72 38.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.249 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 180' ' ' THR . 40.1 t -62.26 -29.8 70.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.524 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -58.22 157.79 7.93 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.295 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -138.57 159.47 42.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.61 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.48 149.5 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.996 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 38.3 p90 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.682 179.83 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.8 mt . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.843 0.354 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.512 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.6 pm0 -141.18 163.02 34.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.313 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -115.14 140.13 49.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.866 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -117.36 130.8 56.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.531 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.426 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 50.5 m -120.83 146.58 46.41 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.022 0.439 . . . . 0.0 111.022 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 36' ' ' SER . 98.8 m-20 -140.67 103.71 4.57 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.7 p -68.78 -15.1 63.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.52 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -57.25 -43.23 82.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.358 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -116.35 -13.33 11.03 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.058 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.79 50.04 6.19 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.64 148.76 30.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.033 0.444 . . . . 0.0 111.128 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -144.41 151.62 39.51 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.693 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -151.84 157.28 41.69 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.7 mp -103.13 143.53 32.48 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.373 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.483 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 7.0 p90 -149.91 148.18 24.48 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.937 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.07 154.44 62.48 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.017 1.812 . . . . 0.0 111.849 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.512 ' N ' HE22 ' A' ' 33' ' ' GLN . 11.7 p30 -69.57 160.52 31.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.36 3.97 58.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.527 ' CD2' ' OD1' ' A' ' 68' ' ' ASP . 32.0 m0 -92.27 146.58 23.6 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.358 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.0 pt -117.92 139.93 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.301 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.29 139.87 14.79 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.8 t -113.6 134.76 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.895 0.378 . . . . 0.0 110.463 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -74.46 138.28 43.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.437 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 63' ' ' ASP . 26.8 m -132.84 46.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -76.75 124.38 27.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.055 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.3 11.83 82.91 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.65 -164.41 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.757 0.313 . . . . 0.0 110.658 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -54.13 153.54 9.17 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.173 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.92 128.56 17.99 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.384 2.056 . . . . 0.0 112.137 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 98.15 -25.1 29.04 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.13 131.39 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.985 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' O ' ' CG2' ' A' ' 55' ' ' VAL . 58.7 t0 -111.09 -58.01 2.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.0 t -147.81 145.26 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.868 0.366 . . . . 0.0 111.287 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.448 HG23 HG11 ' A' ' 55' ' ' VAL . 86.5 t -122.16 134.93 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.527 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.18 141.27 46.08 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.081 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' NH2' ' CD2' ' A' ' 69' ' ' LEU . 68.3 ttp85 -129.12 129.33 45.03 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.269 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.527 ' OD1' ' CD2' ' A' ' 50' ' ' TRP . 78.4 m-20 -92.23 118.89 31.32 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.7 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.572 ' CD2' ' NH2' ' A' ' 67' ' ' ARG . 70.2 mt -65.52 -37.45 86.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.256 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.4 mt -63.51 -38.07 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.754 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -128.56 88.84 2.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.461 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -61.17 -35.73 77.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.561 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 39.2 p-10 -62.38 -32.67 73.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 11.6 tm-20 -92.55 132.75 36.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.663 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -146.68 139.59 25.33 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.636 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 tt -114.26 133.51 55.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.086 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.0 m -133.07 149.01 52.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.37 129.7 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.176 0.513 . . . . 0.0 110.288 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.511 HG23 ' C ' ' A' ' 61' ' ' GLY . 55.7 mt -120.5 124.14 71.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.361 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.4 mm -113.78 136.42 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.437 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.2 t -139.86 161.03 38.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.233 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.73 134.31 48.1 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.421 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.515 ' CG2' HD12 ' A' ' 159' ' ' LEU . 11.7 pt -106.75 150.15 39.33 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.956 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.05 137.92 42.34 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.008 1.805 . . . . 0.0 111.337 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 t -63.42 -27.19 69.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.076 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -67.44 -31.31 71.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.927 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -128.8 152.0 48.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.154 0.502 . . . . 0.0 111.315 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.1 t -117.46 179.8 3.95 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.21 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.2 tp -50.92 -44.64 60.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.192 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 50.3 p -66.5 -44.83 81.49 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.147 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.2 m-20 -65.32 -38.41 90.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.9 tp -56.15 -43.43 78.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.646 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.69 177.99 46.93 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.403 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.9 p -93.6 172.33 8.33 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.31 -42.26 77.33 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.227 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.1 m -71.65 -44.91 63.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 94' ' ' THR . 44.6 t0 -62.3 -51.54 67.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.522 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.71 -39.99 83.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.22 -45.33 92.78 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.75 -41.78 87.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.994 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -61.62 -39.19 90.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.612 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -62.73 -40.27 96.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.74 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.1 mmt -58.14 -43.79 87.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.294 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -64.85 -45.28 86.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.302 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.4 m -59.91 -45.14 93.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.961 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.2 t -68.18 -47.52 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.644 ' O ' ' N ' ' A' ' 111' ' ' GLN . 96.0 m-20 -62.73 -36.52 83.27 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.233 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -43.61 -36.92 2.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.718 0.294 . . . . 0.0 111.004 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.54 -46.49 69.38 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.2 m -123.34 23.28 9.09 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.644 ' N ' ' O ' ' A' ' 107' ' ' ASN . 47.1 tt0 -51.96 -28.83 18.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.633 0.254 . . . . 0.0 111.357 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -41.55 -61.46 2.15 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.15 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -117.24 -38.97 3.26 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.93 0.365 . . . . 0.0 111.779 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -77.39 146.44 36.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.491 . . . . 0.0 111.793 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -135.01 133.47 39.46 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.927 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.14 134.29 43.29 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.52 ' OE1' ' NH2' ' A' ' 137' ' ' ARG . 75.8 tt0 -115.3 128.71 56.3 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.977 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.24 106.94 13.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.994 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.533 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 95.6 mt -71.03 -38.61 72.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.057 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.9 m-80 178.44 166.35 0.82 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.343 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.98 132.46 12.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -143.12 165.58 27.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.602 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.15 148.87 45.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.458 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -130.33 142.12 50.55 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 125' ' ' ASP . 34.9 p30 -110.18 110.62 21.54 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.791 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -136.93 143.8 43.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.475 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.426 ' O ' ' OD2' ' A' ' 127' ' ' ASP . 22.6 t70 50.43 35.54 11.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.99 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.75 2.63 38.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.523 ' OE1' ' CE1' ' A' ' 131' ' ' TYR . 5.7 tm0? -106.43 136.54 46.0 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.458 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 44.7 t -106.69 129.41 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.852 0.358 . . . . 0.0 110.708 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.523 ' CE1' ' OE1' ' A' ' 129' ' ' GLN . 48.2 m-85 -117.24 131.11 56.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.57 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.13 130.14 51.85 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.8 m -110.42 124.33 51.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.181 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.73 125.32 52.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.982 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -117.58 122.34 43.37 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.537 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -150.82 172.74 15.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.562 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.52 ' NH2' ' OE1' ' A' ' 117' ' ' GLU . 38.3 ptt180 -140.4 158.09 44.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 110.729 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.37 132.84 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.122 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pp -140.52 135.7 32.15 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.05 0.452 . . . . 0.0 111.427 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.6 t -111.18 131.07 63.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.202 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.52 -120.6 21.21 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -109.38 11.17 25.29 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -124.1 152.68 42.45 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.024 0.44 . . . . 0.0 111.48 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 144' ' ' VAL . 9.9 p -88.31 127.34 41.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.786 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -77.0 -53.64 7.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.544 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.556 HH21 ' CA ' ' A' ' 166' ' ' THR . 13.0 ptm180 -170.49 173.78 5.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.008 0.432 . . . . 0.0 111.384 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' HIS . . . . . 0.418 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 52.2 m80 -108.02 137.7 45.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.055 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 79.1 m-20 -135.04 137.91 43.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.015 0.436 . . . . 0.0 111.018 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.5 tp -111.22 134.91 52.45 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.546 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -135.64 141.24 45.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.428 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.0 t -124.86 141.32 52.2 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.179 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.13 132.12 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.837 0.351 . . . . 0.0 110.438 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.0 m -146.21 153.49 40.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.555 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.6 p -116.84 145.19 43.72 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.858 0.361 . . . . 0.0 110.52 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -160.04 122.37 3.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.927 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 60.15 30.91 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.097 0.475 . . . . 0.0 110.276 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 77.47 11.8 85.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -109.89 135.26 51.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -89.52 114.74 26.31 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.9 mm -103.99 120.23 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 49.0 m -120.52 129.58 53.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.101 0.477 . . . . 0.0 110.561 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.28 117.32 32.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -120.1 122.96 42.2 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.978 0.418 . . . . 0.0 111.578 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.3 mp -119.93 140.57 50.69 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.382 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 63.1 m -130.87 135.65 47.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.365 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.556 ' CA ' HH21 ' A' ' 146' ' ' ARG . 16.6 m -153.06 153.93 33.85 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.57 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.27 145.71 42.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.358 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -69.98 -25.45 63.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.414 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 170' ' ' ARG . 55.4 p30 -60.56 -33.45 72.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.552 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 22.7 mmt85 -118.89 -1.12 11.07 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.576 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 46.9 t-105 -48.26 -40.62 25.32 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.693 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.98 -41.39 97.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.029 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 46.3 m -63.71 -39.41 94.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.438 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 170' ' ' ARG . 6.9 m -105.85 21.17 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.964 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.412 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 19.1 ptmt -50.19 -45.19 53.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.823 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 24.2 t -63.13 -31.45 72.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.694 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.0 tp -59.43 -45.55 91.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.109 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 18.2 m-85 -60.89 -50.14 74.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.873 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 176' ' ' SER . 0.6 OUTLIER -69.27 -43.24 74.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.757 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 60.6 m -62.36 -48.36 80.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.704 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 80.5 t -71.57 -38.39 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.474 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.98 -38.98 93.33 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.353 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 81.4 p -80.18 -18.98 48.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.226 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.8 t -62.84 -39.04 93.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.699 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -54.77 149.03 11.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.08 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -133.88 159.02 41.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.3 m -126.57 150.45 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.67 0.272 . . . . 0.0 110.795 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.2 p90 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.882 -179.505 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.4 mt . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 120.791 0.329 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 21.0 mp0 -103.58 148.45 25.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.908 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -119.3 136.49 54.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.184 0.516 . . . . 0.0 110.946 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -125.63 136.19 52.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.0 p -145.64 156.05 43.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.491 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -148.05 119.15 7.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.556 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.8 p -70.53 -32.61 70.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.879 0.371 . . . . 0.0 110.218 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 63.9 tttm -62.03 -49.94 74.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.799 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -86.87 -20.63 27.17 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.904 0.383 . . . . 0.0 110.567 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.28 43.34 93.1 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.16 147.61 36.91 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.225 0.513 . . . . 0.0 110.377 179.403 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -148.18 155.96 42.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.024 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.538 ' CZ ' ' O ' ' A' ' 45' ' ' LEU . 57.6 t80 -173.02 143.52 1.17 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.538 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . 9.9 mp -92.58 141.38 28.56 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -134.16 141.2 38.52 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.638 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.58 152.44 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.893 1.728 . . . . 0.0 112.484 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.415 ' HB3' HE22 ' A' ' 33' ' ' GLN . 54.2 p30 -81.41 158.75 24.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.234 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.29 8.84 74.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.437 ' NE1' ' OD1' ' A' ' 68' ' ' ASP . 27.7 m0 -94.1 149.03 21.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.451 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.2 pt -114.64 140.46 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.475 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.75 134.24 11.8 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.15 132.45 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.015 0.436 . . . . 0.0 110.569 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -83.88 137.96 33.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.339 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.83 52.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.371 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -72.81 134.06 44.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.357 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.64 4.72 82.58 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.81 -164.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.707 0.289 . . . . 0.0 110.694 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -45.1 152.1 0.62 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.556 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.78 132.98 26.19 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.23 1.953 . . . . 0.0 111.654 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.543 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 95.76 -27.63 15.4 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.55 133.9 26.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.085 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' OD2' HD12 ' A' ' 80' ' ' ILE . 53.4 t0 -115.78 -58.57 2.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.646 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 78' ' ' VAL . 65.8 t -149.49 147.28 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.057 0.456 . . . . 0.0 111.522 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.18 134.87 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.158 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -112.13 138.16 49.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.406 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -128.95 133.63 47.9 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.531 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' OD1' ' NE1' ' A' ' 50' ' ' TRP . 60.1 t0 -88.15 119.07 28.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.444 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.9 mt -60.24 -37.82 81.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.737 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.647 ' H ' HD12 ' A' ' 70' ' ' ILE . 4.9 mp -67.13 -42.21 87.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.822 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 68' ' ' ASP . 90.6 mt-10 -121.24 124.24 44.17 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.009 0.433 . . . . 0.0 110.639 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -87.19 -39.58 15.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.549 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.45 -37.02 77.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.984 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' OE1' ' OE1' ' A' ' 71' ' ' GLU . 84.6 tt0 -85.12 132.68 34.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.409 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -155.58 138.78 15.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.945 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 76' ' ' LEU . 10.2 tt -112.57 133.29 54.7 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.044 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.9 m -128.44 147.0 50.64 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.015 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.7 m -124.07 131.45 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.105 0.478 . . . . 0.0 110.616 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.543 HG23 ' C ' ' A' ' 61' ' ' GLY . 51.0 mt -119.13 124.26 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.587 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 61' ' ' GLY . 63.1 mt -119.07 128.26 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 110.788 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 74.5 m -149.09 166.31 29.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.043 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -104.57 137.01 43.04 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.44 HG22 HD12 ' A' ' 159' ' ' LEU . 10.4 pt -92.44 149.55 38.46 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.394 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -45.42 136.71 11.54 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.649 1.566 . . . . 0.0 111.862 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -27.3 68.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.392 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -88.61 -16.23 33.03 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -131.22 157.23 43.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.043 0.449 . . . . 0.0 111.375 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.417 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.4 t -122.81 176.61 5.89 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.49 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.6 tp -51.83 -44.74 63.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.171 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.5 p -65.51 -44.61 86.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.933 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.3 m-20 -67.16 -34.27 77.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.866 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -55.05 -50.01 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.893 -179.444 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.37 179.18 47.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.421 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.3 p -90.91 171.69 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.26 -41.41 75.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.869 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.7 m -72.61 -45.17 60.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.7 t0 -61.57 -51.74 67.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.294 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.96 -38.77 81.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.514 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.02 -43.94 94.82 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -67.64 -42.36 82.38 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.945 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -62.33 -38.65 90.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.0 110.718 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.87 -40.77 96.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.541 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.6 mmt -58.9 -44.4 91.19 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.521 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 108' ' ' ASP . 43.9 tptt -65.46 -45.76 82.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.976 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.8 m -59.17 -46.12 89.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.015 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.29 -47.16 79.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 110.273 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.656 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.1 m-20 -63.39 -37.83 88.78 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.266 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 104' ' ' LYS . 88.8 m-20 -44.29 -38.31 3.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.729 0.299 . . . . 0.0 111.224 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.88 74.6 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.6 m -123.93 23.45 8.59 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.4 tt0 -48.5 -28.79 3.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.557 0.218 . . . . 0.0 111.544 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -44.05 -61.24 3.16 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.152 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -116.91 -36.01 3.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.956 0.378 . . . . 0.0 111.872 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -78.43 139.54 38.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 111.242 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -132.55 137.03 46.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.962 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.0 140.38 42.58 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.817 0.342 . . . . 0.0 110.458 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.418 ' OE1' ' NE ' ' A' ' 137' ' ' ARG . 83.4 mt-10 -124.8 123.4 39.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.734 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 tp -80.43 110.75 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.054 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.32 -55.71 10.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.846 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -145.23 163.22 35.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.083 0.468 . . . . 0.0 110.693 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.18 116.12 3.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.237 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.17 162.55 34.68 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.548 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.99 150.19 47.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 110.878 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -129.5 160.35 33.45 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.385 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -134.83 114.22 12.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.721 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.84 142.5 38.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.608 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.426 ' O ' ' OD2' ' A' ' 127' ' ' ASP . 22.3 t70 50.49 36.57 13.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.02 2.66 48.24 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.525 ' OE1' ' CE2' ' A' ' 131' ' ' TYR . 4.4 tm0? -101.29 134.74 43.88 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.436 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 46.2 t -106.22 130.08 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 110.565 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.525 ' CE2' ' OE1' ' A' ' 129' ' ' GLN . 58.1 m-85 -119.41 128.24 53.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.045 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -106.61 129.93 54.45 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.7 m -112.37 122.8 48.76 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.522 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.37 125.05 51.52 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.048 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -117.09 123.81 47.71 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -151.75 164.04 37.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.945 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.418 ' NE ' ' OE1' ' A' ' 117' ' ' GLU . 39.5 ptt180 -126.62 156.97 40.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.083 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.09 130.71 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.3 mt -112.25 125.3 54.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.883 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 79.5 t -123.49 129.68 74.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.04 -121.64 16.77 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -116.44 22.35 12.87 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -148.35 161.5 41.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.955 0.407 . . . . 0.0 111.486 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.5 t -71.34 125.52 29.96 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.271 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' A' ' 146' ' ' ARG . 83.3 tt0 -73.9 -52.71 12.06 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.014 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' A' ' 145' ' ' GLU . 11.4 ptp85 -172.41 170.43 4.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.609 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -105.0 138.96 40.41 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.007 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 164' ' ' LEU . 13.4 t70 -135.52 147.58 48.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.146 0.498 . . . . 0.0 110.563 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 tp -123.17 124.96 44.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.556 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -123.81 134.74 53.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.234 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.5 t -122.84 134.27 54.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.35 129.93 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.157 0.503 . . . . 0.0 110.852 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.438 ' CG2' ' NE2' ' A' ' 129' ' ' GLN . 24.0 m -143.76 142.71 31.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.101 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.1 p -108.36 149.6 28.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 110.215 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -147.46 106.71 3.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.735 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 57.42 31.74 20.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 89.59 4.89 72.59 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 32.1 mmtp -96.05 123.85 39.82 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -89.36 114.38 25.79 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.89 127.41 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.103 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.7 m -123.67 135.91 54.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.037 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.07 105.51 15.56 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.886 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.19 120.06 38.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.876 0.37 . . . . 0.0 111.47 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.432 ' O ' ' OD2' ' A' ' 148' ' ' ASP . 19.2 mt -117.62 135.3 54.07 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.9 t -133.56 134.07 42.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.419 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 14.6 m -152.52 158.88 43.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.295 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -59.18 144.31 46.29 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.07 0.462 . . . . 0.0 111.422 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -74.44 -17.81 60.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.071 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -77.93 -9.77 59.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.902 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.498 ' O ' HG22 ' A' ' 174' ' ' VAL . 77.3 mtp180 -133.61 -6.8 2.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.729 0.299 . . . . 0.0 110.742 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.617 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 45.3 t-105 -49.19 -39.02 27.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.624 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -63.48 -42.32 98.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.08 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.7 m -65.37 -40.74 93.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.526 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.3 m -105.33 21.21 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.848 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.77 -47.24 41.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.203 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 91.8 p -67.08 -28.61 68.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.81 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.8 tp -56.23 -43.18 78.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.627 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.617 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 19.4 m-85 -62.78 -49.49 74.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.451 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.4 -40.85 98.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.706 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.4 m -68.09 -51.49 45.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.401 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' A' ' 184' ' ' SER . 4.0 p -69.96 -32.52 51.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.683 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.56 -40.29 96.59 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.101 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 76.0 p -85.11 -16.1 41.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.743 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 181' ' ' VAL . 88.4 p -64.72 -34.09 77.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.492 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.7 150.37 7.3 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.558 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -130.75 149.93 52.16 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.0 m -126.48 151.99 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 110.814 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.505 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 43.7 p90 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.622 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.828 0.347 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -134.4 158.88 42.72 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.365 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.483 HH21 ' CD ' ' A' ' 43' ' ' GLU . 72.7 ttt180 -119.29 138.11 53.23 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.653 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -118.89 136.27 54.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.276 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 84.7 p -143.72 157.52 44.33 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.426 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.1 t0 -148.28 108.58 4.11 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.65 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.6 m -60.31 -36.76 78.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.694 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -58.66 -51.01 71.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.184 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -85.64 -20.17 29.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . 68.68 41.44 83.65 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 155.73 45.69 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.199 0.5 . . . . 0.0 110.727 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' CD ' HH21 ' A' ' 34' ' ' ARG . 3.0 pp20? -156.03 147.83 23.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.752 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -152.9 156.1 38.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt -94.4 158.96 15.33 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.397 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -170.57 144.88 2.03 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.689 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.01 158.73 56.12 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.349 2.033 . . . . 0.0 111.952 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -71.92 160.34 32.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.6 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.26 4.53 58.43 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.535 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 25.1 m0 -89.16 145.11 25.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 pt -115.11 138.29 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.503 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.73 121.98 7.43 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.53 134.75 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.942 0.401 . . . . 0.0 110.499 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 54' ' ' ASP . 52.9 p30 -84.07 151.16 25.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.356 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.61 48.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.086 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -68.58 134.03 49.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.63 -0.63 83.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.3 -163.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 110.464 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.2 m -40.14 116.69 1.25 Allowed Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.586 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.04 132.89 8.6 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.703 1.602 . . . . 0.0 112.22 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 101.99 -40.48 2.41 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.2 135.18 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -118.55 -57.56 2.05 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.54 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -147.63 143.06 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.684 0.278 . . . . 0.0 111.048 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.47 137.93 54.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.928 0.395 . . . . 0.0 110.045 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.93 134.92 54.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.84 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -121.95 143.7 49.31 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.8 0.333 . . . . 0.0 110.758 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.535 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 11.2 m-20 -94.75 118.94 32.55 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.514 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.5 -38.7 90.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.559 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.5 mm -65.12 -41.77 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.748 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -124.42 95.16 4.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.753 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -64.4 -34.8 79.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.349 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.21 -37.37 74.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.81 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -89.44 128.9 36.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.604 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -141.08 139.05 33.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.297 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -106.93 132.91 52.35 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.593 ' N ' HD13 ' A' ' 76' ' ' LEU . 4.9 p -120.12 138.84 53.34 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 t -125.45 124.21 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-O 120.883 0.373 . . . . 0.0 110.446 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.494 HG23 ' C ' ' A' ' 61' ' ' GLY . 15.7 mt -125.1 117.75 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.802 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.2 mm -114.94 135.87 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.995 0.426 . . . . 0.0 110.643 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.9 m -145.36 166.03 26.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.935 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -107.93 141.47 39.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.652 0.263 . . . . 0.0 110.673 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.2 pt -107.72 149.63 39.19 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.697 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' LYS . 54.9 Cg_endo -69.19 139.96 43.58 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.101 1.867 . . . . 0.0 111.141 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.8 p -65.98 -24.96 66.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.979 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.29 -31.28 70.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.635 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 84' ' ' PRO . 29.5 mtmm -130.33 157.48 42.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.121 0.486 . . . . 0.0 111.263 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.407 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.7 t -122.48 178.1 5.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.366 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 tp -50.99 -44.65 60.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.16 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.3 p -64.9 -45.53 85.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.037 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 88' ' ' THR . 84.6 m-20 -68.02 -36.15 79.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -56.13 -42.77 77.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.776 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.67 174.68 44.24 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 41.8 p -91.72 168.87 11.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.3 76.09 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.998 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.7 m -71.82 -43.95 64.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.823 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 94' ' ' THR . 47.7 t0 -61.57 -52.69 63.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.486 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.48 -38.51 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.738 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.02 -47.35 89.65 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -65.17 -42.86 93.26 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -62.74 -37.76 87.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -62.92 -41.12 99.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.611 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.9 mmt -59.88 -44.29 94.29 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.299 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.76 -41.71 95.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.213 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.6 m -59.23 -46.25 88.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.704 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.87 -47.12 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.048 0.451 . . . . 0.0 110.498 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 111' ' ' GLN . 92.9 m-20 -61.54 -35.41 77.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.36 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -45.71 -36.74 5.21 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.193 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.04 -45.86 76.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 112' ' ' GLY . 48.1 m -123.39 22.65 9.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.625 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.1 pp0? -52.43 -10.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.133 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -59.97 -61.47 7.14 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.718 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -117.17 -40.53 3.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.794 0.331 . . . . 0.0 111.452 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -86.37 138.9 31.44 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.167 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -132.72 150.68 52.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.154 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.05 139.69 38.27 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.422 ' OE1' ' NE ' ' A' ' 137' ' ' ARG . 79.1 tt0 -113.23 130.9 56.09 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.9 tp -83.79 117.94 23.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.434 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.3 mt -85.48 -59.42 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.313 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.486 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 23.9 p30 -158.53 172.17 18.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.35 134.68 11.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.34 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.88 161.1 39.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.728 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.401 ' HB1' ' CE1' ' A' ' 132' ' ' TYR . . . -139.36 143.49 37.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.427 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -135.65 146.23 47.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.482 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -120.05 112.68 19.45 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.515 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -136.6 139.61 42.24 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 51.2 40.71 26.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.724 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.07 2.3 17.45 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.522 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 2.9 tm0? -101.79 134.67 44.6 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 43.6 t -106.37 129.6 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.944 0.402 . . . . 0.0 110.542 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.522 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 70.0 m-85 -118.95 123.53 44.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.904 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 2.5 m-30 -104.94 118.88 37.64 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 56.7 m -93.66 132.57 37.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.2 107.0 8.31 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.269 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.486 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 74.7 tt0 -103.37 126.02 50.3 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -153.38 171.23 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.315 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.422 ' NE ' ' OE1' ' A' ' 117' ' ' GLU . 40.0 ptt180 -141.5 161.49 37.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.865 0.364 . . . . 0.0 110.262 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.78 139.99 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.006 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 pp -145.0 150.63 37.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.188 0.518 . . . . 0.0 111.087 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.92 134.86 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.558 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.68 -107.04 0.23 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 56.1 t0 -117.46 13.3 14.4 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.323 0.12 . . . . 0.0 111.323 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.84 142.67 47.05 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.738 0.304 . . . . 0.0 111.019 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.69 125.77 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.016 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -78.05 -53.74 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.703 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.534 ' NH1' ' OG ' ' A' ' 165' ' ' SER . 44.8 ptt85 -173.83 171.81 3.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.011 0.434 . . . . 0.0 111.403 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -108.07 141.52 39.65 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.526 ' OD2' ' NH1' ' A' ' 146' ' ' ARG . 74.5 m-20 -135.57 144.02 45.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.006 0.431 . . . . 0.0 111.11 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.5 tp -116.79 134.47 54.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.53 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.43 ' CB ' ' OD1' ' A' ' 163' ' ' ASP . . . -134.1 128.21 33.72 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.008 0.433 . . . . 0.0 110.925 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.7 t -115.2 127.76 55.73 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.12 131.72 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.941 0.401 . . . . 0.0 110.875 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.52 ' OG1' ' NE2' ' A' ' 129' ' ' GLN . 6.8 t -146.67 161.93 39.53 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.687 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -122.22 152.79 39.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.23 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -165.74 123.25 1.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.618 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 58.67 26.09 14.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.004 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.72 9.12 83.52 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -106.69 141.19 38.35 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.898 0.38 . . . . 0.0 110.385 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.43 117.81 31.04 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 71.0 mt -117.44 121.88 68.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.8 m -122.55 130.1 52.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.27 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.01 110.43 21.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 150' ' ' ALA . 90.2 m-20 -115.48 124.84 52.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.919 0.39 . . . . 0.0 110.951 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 mp -116.56 146.12 42.87 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.681 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.534 ' OG ' ' NH1' ' A' ' 146' ' ' ARG . 45.7 t -132.08 131.31 42.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.583 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.8 m -152.4 155.7 38.07 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.647 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.57 144.68 16.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.254 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -71.5 -34.38 70.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.154 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.91 -33.61 74.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.712 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.519 ' O ' HG22 ' A' ' 174' ' ' VAL . 78.9 mtm180 -103.01 -12.68 17.27 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.564 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.3 t-105 -47.69 -40.37 19.92 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.379 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -64.07 -42.28 97.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 50.5 m -65.52 -40.96 93.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.465 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 170' ' ' ARG . 10.5 m -106.42 21.45 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.12 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 171' ' ' TRP . 24.0 pttm -49.45 -45.63 46.84 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.222 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 84.8 p -67.45 -28.56 67.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.457 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -56.1 -45.14 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.564 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.1 m-85 -62.5 -48.07 81.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.221 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -62.57 -42.55 99.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.547 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 91.7 m -67.49 -49.02 65.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.02 -37.32 72.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.511 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.24 -38.58 91.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.374 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.4 p -84.72 -16.03 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.217 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.4 t -62.78 -37.9 88.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -59.66 155.49 15.57 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.066 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -137.86 161.18 37.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -128.4 151.06 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.956 0.408 . . . . 0.0 111.257 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.468 ' CG ' ' O ' ' A' ' 188' ' ' TYR . 39.3 p90 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.624 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.479 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 24.3 mp0 -116.89 154.49 30.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.547 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.55 138.53 50.96 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.34 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -126.73 131.07 51.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.944 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -141.12 152.36 44.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 110.769 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -143.58 118.69 10.1 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.388 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.4 p -71.31 -32.69 68.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.529 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.48 -47.58 83.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.025 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -88.36 -20.33 25.47 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.1 42.06 85.36 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -143.07 149.29 37.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.338 0.569 . . . . 0.0 110.356 179.406 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -151.66 144.19 24.21 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.77 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.71 158.09 41.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.52 150.01 22.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.093 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -158.17 145.99 13.74 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.359 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.19 156.4 66.43 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.309 2.006 . . . . 0.0 112.187 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -71.78 160.36 32.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.57 2.13 58.8 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.53 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 33.9 m0 -91.81 144.5 25.43 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 110.436 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.6 pt -120.65 144.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.359 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.32 141.56 15.68 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -129.88 143.63 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -90.61 144.55 25.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.61 51.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.491 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -66.98 136.08 54.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.094 0.473 . . . . 0.0 110.337 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.36 1.62 71.66 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.86 -164.19 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.64 0.257 . . . . 0.0 110.53 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.1 m -41.54 124.29 2.33 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.337 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.03 132.32 6.0 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.785 1.657 . . . . 0.0 112.694 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.448 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 97.98 -33.69 5.76 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.9 t -62.42 122.84 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.114 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -120.22 -50.06 2.26 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.467 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.95 139.5 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.879 0.371 . . . . 0.0 110.91 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.82 138.35 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.49 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.66 135.01 52.83 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.859 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -121.64 134.77 54.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.26 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.53 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 66.1 m-20 -86.18 118.75 25.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.483 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -67.47 -39.36 85.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.593 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.577 ' H ' HD12 ' A' ' 70' ' ' ILE . 4.1 mp -61.11 -48.14 90.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.76 118.01 28.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.908 0.385 . . . . 0.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.42 -36.59 65.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.777 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 2.7 p30 -62.47 -34.62 77.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.864 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.516 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 84.3 tt0 -86.13 133.33 33.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.0 110.254 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -154.25 139.66 17.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -114.54 134.62 54.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.932 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.7 m -120.13 145.1 47.25 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.17 127.63 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.002 0.429 . . . . 0.0 110.315 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.448 HG23 ' C ' ' A' ' 61' ' ' GLY . 5.8 mt -114.82 122.57 69.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.699 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 82.1 mt -122.08 127.88 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.996 0.427 . . . . 0.0 110.796 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 159' ' ' LEU . 21.9 t -153.29 164.29 38.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.045 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -103.47 136.42 43.25 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.0 pt -92.89 148.42 35.85 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.347 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' LYS . 37.1 Cg_endo -65.28 136.17 46.24 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.64 1.56 . . . . 0.0 110.821 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.8 t -60.99 -29.12 69.5 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.038 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -67.57 -31.52 71.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.999 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 84' ' ' PRO . 68.0 mttm -130.61 144.84 51.7 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.046 0.451 . . . . 0.0 111.138 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.451 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.1 t -113.24 179.18 4.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.173 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 tp -52.75 -43.83 66.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.859 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 47.1 p -69.04 -45.03 71.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.447 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.451 ' HB2' ' H ' ' A' ' 88' ' ' THR . 82.4 m-20 -68.77 -34.92 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.106 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.6 tp -55.39 -44.35 76.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.394 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.17 178.06 46.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.412 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 43.9 p -92.85 169.8 10.18 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.46 72.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.966 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.4 m -72.36 -44.64 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.851 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 94' ' ' THR . 45.7 t0 -62.54 -50.97 69.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.425 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.629 HG22 HH21 ' A' ' 101' ' ' ARG . 79.4 t -62.65 -38.56 81.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.604 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.27 -47.05 92.74 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.37 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -62.8 -45.36 92.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.82 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.629 HH21 HG22 ' A' ' 98' ' ' VAL . 85.4 mtm180 -62.96 -43.86 97.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.041 0.448 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -57.0 -41.14 77.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.804 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.4 mmt -61.12 -43.46 98.85 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.143 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.93 -38.83 92.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.423 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.1 m -56.88 -45.71 82.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.599 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.28 -46.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.13 0.491 . . . . 0.0 110.449 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.878 HD22 ' H ' ' A' ' 116' ' ' ALA . 10.8 m-20 -62.43 -32.98 73.92 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.272 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -43.81 -37.64 2.87 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.675 0.274 . . . . 0.0 111.537 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.26 -47.27 71.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.6 m -123.53 24.17 8.66 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 107' ' ' ASN . 16.9 tt0 -46.55 -28.77 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.597 0.237 . . . . 0.0 111.536 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.71 -61.18 3.04 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.02 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 31.7 p-10 -117.02 -36.3 3.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.069 0.435 . . . . 0.0 111.711 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.578 HH11 ' CG1' ' A' ' 138' ' ' VAL . 59.7 ttm-85 -84.18 142.05 30.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 0.0 111.051 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -148.82 149.09 30.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.886 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.878 ' H ' HD22 ' A' ' 107' ' ' ASN . . . -108.47 138.99 43.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.168 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -107.94 129.85 55.08 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.1 tt -81.54 108.09 14.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.953 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.426 HD12 ' HG2' ' A' ' 135' ' ' GLU . 97.4 mt -70.68 -56.32 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.112 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.603 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 25.2 p30 -156.29 169.9 23.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.901 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.7 119.85 4.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.336 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.34 163.18 33.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.73 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.402 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -139.12 149.45 44.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.473 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -131.72 144.49 51.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.1 0.476 . . . . 0.0 110.821 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -111.42 114.3 27.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.572 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -140.3 141.88 35.71 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.702 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.423 ' O ' ' OD2' ' A' ' 127' ' ' ASP . 22.6 t70 49.67 37.2 12.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.03 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.59 1.49 23.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 3.7 tm0? -103.18 133.48 48.21 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 46.6 t -105.59 130.43 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.855 0.359 . . . . 0.0 110.721 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 48.4 m-85 -119.04 129.59 55.19 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.823 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.4 127.47 53.0 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 55.6 m -105.03 129.66 53.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.69 107.12 9.42 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.12 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.603 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 79.4 tt0 -101.79 127.22 48.68 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -150.87 170.37 19.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.411 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -136.81 156.75 48.08 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.052 0.453 . . . . 0.0 110.37 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.578 ' CG1' HH11 ' A' ' 114' ' ' ARG . 58.3 t -104.7 135.17 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.443 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.407 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.7 pp -145.2 135.02 23.59 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.189 0.518 . . . . 0.0 111.251 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.3 t -111.6 132.52 59.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.869 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.54 -122.05 25.56 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -110.73 11.83 22.58 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.854 -0.204 . . . . 0.0 111.139 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -120.02 149.97 41.31 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.829 0.347 . . . . 0.0 111.225 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.0 t -88.35 126.03 41.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.415 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.407 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 47.4 tp10 -75.08 -53.85 8.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.416 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -173.94 173.6 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 111.26 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -105.21 143.58 33.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.133 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 164' ' ' LEU . 12.0 t70 -141.21 151.16 43.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.841 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.8 tp -124.1 135.0 53.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.034 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.51 132.51 39.28 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.895 0.378 . . . . 0.0 110.431 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 69.3 m -119.93 137.39 54.07 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.59 130.29 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.985 0.421 . . . . 0.0 110.683 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.415 HG23 HE22 ' A' ' 129' ' ' GLN . 24.5 m -146.97 144.85 29.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -110.9 150.36 29.3 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.192 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -151.14 106.7 3.37 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.264 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 61.83 34.84 16.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.066 0.46 . . . . 0.0 110.526 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.06 8.29 86.74 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -98.42 127.17 44.23 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.81 113.13 24.65 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 67.9 mt -122.25 124.29 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.328 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.0 m -124.62 134.27 52.98 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.14 111.04 23.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.65 119.97 40.48 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 111.428 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.426 ' O ' ' OD2' ' A' ' 148' ' ' ASP . 2.9 mp -115.47 142.64 46.44 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.136 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.0 p -132.96 135.05 45.28 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.871 0.367 . . . . 0.0 110.547 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.0 m -152.88 157.02 40.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.248 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.29 143.69 55.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.04 0.448 . . . . 0.0 111.4 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.427 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 1.3 pp20? -69.82 -27.11 64.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.222 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.427 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 90.3 m-20 -59.36 -34.15 72.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.256 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.448 ' O ' HG22 ' A' ' 174' ' ' VAL . 73.8 mtm180 -117.66 -1.59 11.59 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.554 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 44.5 t-105 -48.64 -39.34 23.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.554 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -63.26 -42.11 99.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.958 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 39.8 m -64.49 -40.47 95.73 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.458 HG23 ' CZ ' ' A' ' 178' ' ' PHE . 12.8 m -105.11 20.87 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.902 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -49.33 -45.61 45.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.89 0.376 . . . . 0.0 110.952 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 85.1 p -68.07 -27.69 66.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.598 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.9 tp -56.84 -44.34 81.99 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.583 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.554 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.2 m-85 -63.59 -49.82 71.88 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.239 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -62.0 -42.28 98.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.579 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 65.0 m -67.6 -49.77 61.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.038 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.82 -37.92 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.38 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.46 -39.04 93.41 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.234 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.5 m -80.71 -19.54 44.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.273 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -62.53 -36.22 81.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.718 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -55.93 148.76 16.48 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.11 -179.555 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -136.85 155.53 49.67 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.22 150.61 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.183 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' TYR . . . . . 0.489 ' CG ' ' O ' ' A' ' 188' ' ' TYR . 40.9 p90 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.548 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.404 ' N ' HD23 ' A' ' 21' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.54 31.75 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.919 2.413 . . . . 0.0 112.478 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 21' ' ' LEU . 2.9 mm? -61.02 -35.89 78.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.062 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.55 -173.64 51.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.9 t -149.55 149.12 30.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.808 0.337 . . . . 0.0 110.442 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.8 m -87.1 115.85 24.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.266 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 27' ' ' VAL . . . -176.94 -172.65 41.76 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.28 39.34 0.45 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' A' ' 25' ' ' GLY . 8.5 p -54.66 -34.65 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 0.0 110.76 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.42 125.42 17.57 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 31' ' ' SER . 27.2 pt -126.39 161.97 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 110.554 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.95 75.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.48 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.666 ' C ' HE22 ' A' ' 33' ' ' GLN . 10.2 t -164.0 -133.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.359 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.1 mt -85.3 142.71 29.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.214 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.666 HE22 ' C ' ' A' ' 31' ' ' SER . 20.3 mp0 -115.41 155.06 28.11 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.014 0.435 . . . . 0.0 110.741 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -113.73 131.26 56.25 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.369 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -124.66 131.29 53.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.944 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -138.57 153.4 48.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.665 0.269 . . . . 0.0 110.757 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -144.2 109.61 5.16 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.787 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.0 m -61.74 -36.14 80.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.507 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -58.73 -51.41 70.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.938 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 38.4 t0 -85.86 -20.64 28.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.735 0.302 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.92 40.9 84.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.72 150.7 42.16 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.218 0.509 . . . . 0.0 110.17 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -151.12 143.07 23.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.598 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -151.74 160.06 43.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.176 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 mt -98.33 150.37 21.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.103 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -153.63 145.92 17.2 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.297 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.2 152.95 78.78 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.373 2.049 . . . . 0.0 112.151 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.1 p30 -73.15 160.26 32.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.576 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.84 58.22 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.475 ' NE1' ' CG ' ' A' ' 68' ' ' ASP . 30.1 m0 -92.95 145.57 24.27 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.4 pt -118.73 145.03 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.35 128.79 9.68 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.7 135.46 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.756 0.312 . . . . 0.0 110.297 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -76.57 129.29 36.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.431 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.14 36.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.766 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -59.37 135.94 57.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.43 . . . . 0.0 110.693 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.06 10.02 72.57 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.45 -164.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.683 0.278 . . . . 0.0 110.548 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.16 140.86 42.21 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.084 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -44.98 132.11 10.85 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.59 1.526 . . . . 0.0 112.463 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.481 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 94.97 -31.04 7.28 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.4 t -61.04 128.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -119.07 -57.33 2.03 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.209 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.4 t -143.95 148.51 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.867 0.365 . . . . 0.0 110.92 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.47 140.01 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.45 134.11 53.26 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.107 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -127.15 130.74 50.35 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.463 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' CG ' ' NE1' ' A' ' 50' ' ' TRP . 60.3 t0 -87.86 117.96 27.06 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.662 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.9 tp -65.22 -38.99 92.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.555 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.86 -39.54 82.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.044 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.54 96.19 4.6 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.809 0.338 . . . . 0.0 110.593 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -61.33 -37.0 81.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.374 0.607 . . . . 0.0 109.856 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.27 -36.83 73.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.971 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -82.66 130.65 35.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.436 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -140.32 139.09 35.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.363 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.62 136.23 53.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.686 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.0 t -126.16 140.37 52.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.739 0.304 . . . . 0.0 110.608 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.94 125.52 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.914 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.481 HG23 ' C ' ' A' ' 61' ' ' GLY . 30.9 mt -121.13 123.87 70.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.93 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.35 133.42 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.873 0.368 . . . . 0.0 110.682 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LEU . 22.7 t -151.11 162.56 40.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.313 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.565 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 2.0 pm0 -105.06 130.23 53.31 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.111 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 83' ' ' ILE . 6.4 pt -86.4 149.22 48.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.406 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 87' ' ' LYS . 36.2 Cg_endo -65.06 136.66 49.1 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.588 1.525 . . . . 0.0 110.753 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -60.96 -29.01 69.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.182 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -67.9 -31.44 71.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.898 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' PRO . 92.1 mttt -131.2 140.36 49.88 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.918 0.39 . . . . 0.0 111.169 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -105.96 -178.42 3.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.079 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.509 ' N ' ' OG1' ' A' ' 88' ' ' THR . 49.2 tp -52.18 -43.04 63.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.769 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.9 p -68.03 -43.76 78.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.093 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.52 -35.16 78.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.602 ' O ' HD23 ' A' ' 92' ' ' LEU . 4.4 tt -55.17 -49.05 72.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.129 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.74 176.67 45.95 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.409 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 36.2 p -90.38 171.26 9.58 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.12 -42.32 76.67 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.165 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.7 m -72.06 -43.91 64.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.809 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 94' ' ' THR . 47.4 t0 -61.94 -51.38 68.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.151 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.2 t -61.7 -38.53 80.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.568 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.63 -44.54 93.93 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -68.14 -39.77 82.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.821 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -61.61 -41.34 97.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -61.43 -41.16 96.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.63 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.9 mmt -58.62 -43.76 89.75 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.838 0.352 . . . . 0.0 110.365 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -64.57 -40.08 94.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.356 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -60.05 -47.33 86.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.892 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.3 t -71.7 -45.74 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.011 0.434 . . . . 0.0 110.497 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 111' ' ' GLN . 88.9 m-20 -60.43 -32.56 71.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.069 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -44.19 -37.65 3.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.215 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -105.72 -10.8 16.57 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 114' ' ' ARG . 1.3 t -121.39 16.1 11.33 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 107' ' ' ASN . 21.2 pt20 -79.83 6.98 9.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.086 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.35 -62.85 2.23 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.052 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -117.06 -41.23 3.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.634 0.254 . . . . 0.0 111.501 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' SER . 95.6 mtt180 -86.28 154.7 21.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.876 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -133.11 135.53 45.3 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.209 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.17 129.57 44.52 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.06 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -116.95 128.78 55.54 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.021 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.0 tp -83.66 110.85 18.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.024 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -55.25 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.104 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.53 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 24.5 p30 -161.4 168.57 23.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.921 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.68 122.44 4.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.232 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.96 162.9 34.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.583 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.414 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.48 148.28 50.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.571 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -130.67 150.14 52.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.775 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -120.45 116.36 25.3 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.847 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.45 142.27 39.47 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.456 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.3 t0 52.05 28.42 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.16 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.68 2.61 85.84 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 154' ' ' THR . 66.4 tp60 -104.02 135.99 44.5 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.02 129.89 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.964 0.411 . . . . 0.0 110.532 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.84 129.84 55.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.821 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.414 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.75 130.21 53.8 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.3 m -112.89 125.18 54.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.195 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.24 124.88 48.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.013 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.53 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 72.2 tt0 -119.72 124.2 45.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.86 169.75 20.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.38 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -138.88 160.31 40.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.394 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 63.4 t -104.42 126.35 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.008 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.1 mt -106.14 139.71 40.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.336 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.88 135.86 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.45 -112.63 1.41 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -118.23 22.88 11.92 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -142.63 157.1 45.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.219 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.3 123.86 32.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.102 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.445 ' CD ' ' NH1' ' A' ' 146' ' ' ARG . 85.3 tt0 -75.16 -53.28 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.111 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.445 ' NH1' ' CD ' ' A' ' 145' ' ' GLU . 33.6 ptt-85 -172.41 167.66 5.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -107.98 135.61 49.07 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.968 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -131.05 140.94 50.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.543 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.4 tp -111.2 132.23 54.49 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -129.2 132.48 47.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.387 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.4 m -121.79 139.78 53.18 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.36 131.51 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.972 0.415 . . . . 0.0 111.073 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.6 m -148.72 142.21 25.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.256 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.458 ' O ' ' NE2' ' A' ' 129' ' ' GLN . 13.0 p -106.41 149.56 26.9 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.343 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -150.39 106.68 3.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.077 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.413 ' NH2' ' OXT' ' A' ' 188' ' ' TYR . 17.0 ttm180 63.15 27.6 15.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.179 0.514 . . . . 0.0 110.579 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.13 3.08 73.38 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.804 -0.519 . . . . 0.0 111.804 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.49 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 11.5 mptt -94.95 126.11 40.06 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.417 -0.461 . . . . 0.0 109.81 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -88.54 118.62 28.31 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 78.2 mt -120.02 127.98 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.823 0.344 . . . . 0.0 110.663 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 89.0 m -129.12 136.86 50.78 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.725 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.68 103.28 11.07 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -102.27 108.68 20.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.81 0.338 . . . . 0.0 110.414 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 164' ' ' LEU . 5.3 mp -114.05 140.04 48.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.3 p -133.63 139.65 46.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.855 0.36 . . . . 0.0 110.306 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.9 m -152.99 157.2 40.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.5 145.93 37.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.555 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.415 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 2.0 pp20? -70.87 -21.06 62.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.971 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.415 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 93.6 m-20 -58.84 -34.58 71.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.22 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.517 ' O ' HG22 ' A' ' 174' ' ' VAL . 72.3 mtp85 -123.03 -1.34 8.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.576 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 59.9 t-105 -46.69 -40.25 12.91 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.812 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -64.56 -42.29 95.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.993 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.2 m -66.12 -39.67 90.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.728 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 170' ' ' ARG . 10.9 m -106.53 21.64 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.246 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 176' ' ' SER . 12.2 ptmm? -51.22 -50.93 58.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.194 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.409 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 24.9 t -64.94 -30.69 71.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.889 0.376 . . . . 0.0 111.088 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -52.55 -45.79 66.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.849 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 23.1 m-85 -62.0 -49.83 74.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.049 0.452 . . . . 0.0 110.467 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -63.24 -37.8 88.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.471 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 184' ' ' SER . 56.2 m -61.37 -47.4 86.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.296 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.49 -44.17 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.519 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -65.74 -42.93 90.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.556 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 85.2 p -74.79 -30.9 61.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 180' ' ' THR . 58.0 m -63.14 -29.67 70.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -52.74 156.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.137 0.494 . . . . 0.0 110.813 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -138.67 155.18 48.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.199 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.0 m -127.91 151.68 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.922 0.392 . . . . 0.0 111.244 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.413 ' OXT' ' NH2' ' A' ' 156' ' ' ARG . 41.2 p90 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.661 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.499 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 30.9 Cg_endo -62.69 145.86 95.12 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.73 2.287 . . . . 0.0 111.781 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.5 mt -89.9 142.77 27.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.231 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -83.73 176.29 52.22 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.418 ' H ' ' H ' ' A' ' 24' ' ' CYS . 5.7 t 179.59 5.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.733 0.301 . . . . 0.0 110.555 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.418 ' H ' ' H ' ' A' ' 23' ' ' SER . 5.8 p -80.88 108.39 14.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.02 -42.23 2.83 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.47 21.5 64.29 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 m -60.75 146.06 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.78 0.324 . . . . 0.0 110.646 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.67 -175.54 38.15 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.6 pt -82.95 -177.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.232 0.539 . . . . 0.0 111.314 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.66 -117.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.685 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.9 t -127.53 113.74 16.53 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.759 0.314 . . . . 0.0 110.164 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.1 mt -115.36 142.76 46.26 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.889 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.516 ' OE1' ' ND2' ' A' ' 48' ' ' ASN . 2.9 tp60 -102.61 170.85 7.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.099 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -139.68 146.03 39.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.656 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.68 141.78 45.03 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.137 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.0 p -149.75 155.38 40.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 110.592 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -148.08 119.14 7.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.624 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.6 p -71.55 -29.75 65.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.172 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -61.54 -48.93 78.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.983 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 50.5 t0 -92.12 -20.39 21.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.738 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.75 44.87 60.97 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.853 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.455 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -142.65 149.05 38.39 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.232 0.516 . . . . 0.0 110.336 179.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.73 143.48 22.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -152.47 158.85 43.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 111.059 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.6 mt -96.79 151.72 19.37 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.892 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 10.3 p90 -157.95 136.56 7.81 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.846 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -43.29 157.3 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.045 1.83 . . . . 0.0 112.559 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.516 ' ND2' ' OE1' ' A' ' 33' ' ' GLN . 2.1 m-20 -81.18 158.93 24.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.299 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.08 63.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 26.8 m0 -87.6 147.27 25.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.839 0.352 . . . . 0.0 110.175 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -114.7 132.31 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.043 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.89 133.2 11.61 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.33 134.24 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.964 0.412 . . . . 0.0 110.753 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 54' ' ' ASP . 37.0 p30 -91.36 121.29 32.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.518 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.25 60.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.464 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -78.73 132.91 37.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.163 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.0 3.62 73.11 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.39 -163.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 t -40.53 125.95 1.83 Allowed Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.449 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -41.5 127.16 3.2 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.97 1.78 . . . . 0.0 113.025 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.503 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 100.68 -36.18 4.34 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.533 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -63.63 127.02 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.174 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 61' ' ' GLY . 5.4 m-20 -119.57 -56.63 2.04 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.574 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.52 139.61 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.901 0.381 . . . . 0.0 111.098 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.3 t -123.08 132.63 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.127 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -112.28 134.27 53.92 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.41 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -124.76 143.36 50.83 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 73.8 m-20 -90.42 119.08 30.4 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.548 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.2 tp -65.4 -41.21 93.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.574 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.99 -45.03 99.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.048 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.67 120.67 37.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.863 0.363 . . . . 0.0 110.73 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -77.84 -40.38 40.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.56 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -58.7 -36.5 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.643 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.91 133.39 35.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -156.11 139.31 15.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.561 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.68 134.4 55.07 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.804 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.6 t -121.86 139.26 53.85 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.026 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.96 125.61 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.07 0.462 . . . . 0.0 110.279 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.503 HG23 ' C ' ' A' ' 61' ' ' GLY . 14.9 mt -117.35 123.52 71.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.7 mt -120.21 128.42 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.396 . . . . 0.0 110.952 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 61.3 m -149.03 166.0 29.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.3 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -105.64 138.41 41.88 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 159' ' ' LEU . 8.2 pt -93.09 149.4 37.46 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.653 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -44.51 140.19 6.37 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.651 1.568 . . . . 0.0 111.383 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -67.94 -25.38 65.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.403 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.4 p30 -93.03 -15.28 26.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -131.43 150.44 52.15 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.096 0.474 . . . . 0.0 111.486 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 46.8 p -112.86 -179.23 3.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.222 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.9 tp -56.36 -41.56 76.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.448 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.5 p -72.16 -45.07 61.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.968 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 88' ' ' THR . 45.7 t0 -64.7 -37.28 87.04 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.787 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.0 tp -55.8 -43.32 76.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.745 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.5 179.19 47.62 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.309 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 36.2 p -93.4 170.69 9.42 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.24 74.37 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.044 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 78.0 m -72.45 -45.67 58.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 94' ' ' THR . 45.6 t0 -61.25 -52.16 65.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.311 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.4 -38.62 82.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.713 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.71 -45.07 93.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -65.2 -41.45 94.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.541 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -63.11 -39.03 93.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.059 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.66 -41.49 98.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.699 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.8 mmt -58.38 -44.4 88.89 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.383 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -66.07 -42.48 89.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.359 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.5 m -59.24 -45.79 90.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.9 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.2 -47.48 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 0.0 110.478 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.646 ' O ' ' N ' ' A' ' 111' ' ' GLN . 93.4 m-20 -62.67 -34.65 77.53 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.451 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -46.61 -36.92 7.43 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.068 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.23 -47.11 71.78 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.41 ' C ' ' N ' ' A' ' 112' ' ' GLY . 74.8 m -123.26 22.25 9.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.646 ' N ' ' O ' ' A' ' 107' ' ' ASN . 10.3 pt20 -49.41 -13.38 0.08 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.403 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 110' ' ' SER . . . -58.08 -61.42 7.44 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.86 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 35.1 p-10 -117.46 -35.66 3.93 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.902 0.351 . . . . 0.0 111.685 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 58.2 ttp180 -85.13 135.77 33.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.914 0.388 . . . . 0.0 111.28 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -127.97 144.37 51.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.191 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -107.09 138.07 43.96 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -119.81 129.06 54.26 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.98 110.08 16.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.204 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.7 mt -77.02 -55.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.557 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -145.75 159.35 43.31 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.553 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.37 112.81 2.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.463 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.1 168.98 18.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.657 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.63 147.18 42.6 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.763 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -130.35 143.86 51.03 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.921 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 125' ' ' ASP . 35.5 p30 -110.56 111.1 22.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.725 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -137.45 143.0 41.59 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.879 0.371 . . . . 0.0 110.839 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 51.38 37.97 20.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.317 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.24 2.61 41.78 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -107.67 149.47 28.07 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.964 0.411 . . . . 0.0 110.234 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.5 t -117.12 129.2 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.103 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 14.1 m-85 -119.31 128.15 53.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.067 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -100.62 120.04 39.46 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 63.2 m -95.17 127.46 41.24 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.94 110.76 11.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.53 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -107.28 126.58 52.61 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -150.79 170.45 19.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.349 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -136.97 156.8 47.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.041 0.448 . . . . 0.0 110.523 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.7 134.39 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.91 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.415 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.8 pp -135.77 136.26 40.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.161 0.505 . . . . 0.0 111.13 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.45 134.13 55.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.12 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.6 -121.06 19.05 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -113.91 14.17 18.47 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.926 -0.161 . . . . 0.0 111.275 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -127.15 153.6 45.84 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.901 0.382 . . . . 0.0 111.164 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 144' ' ' VAL . 14.7 p -85.67 126.93 40.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.237 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.415 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 83.9 tt0 -75.01 -52.75 10.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.773 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -175.21 173.97 2.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.028 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -109.84 136.78 48.61 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.16 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -132.88 141.57 48.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.892 0.377 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.9 tp -111.48 131.18 55.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.99 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.97 131.08 47.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.955 0.407 . . . . 0.0 110.486 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.0 m -120.69 138.15 54.1 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.6 t -119.85 129.16 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.033 0.444 . . . . 0.0 110.683 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.7 m -144.72 148.28 33.99 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.624 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -114.74 149.25 37.16 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.832 0.349 . . . . 0.0 110.303 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -149.82 107.04 3.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.032 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 65.07 26.26 12.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.12 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.4 1.44 71.78 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 2.4 mptp? -94.28 126.66 39.67 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -87.94 115.62 25.54 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 65.7 mt -121.45 123.52 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.005 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 72.7 m -122.45 132.11 54.19 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.52 113.12 26.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.817 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -115.04 124.85 52.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.905 0.383 . . . . 0.0 111.652 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.01 142.18 50.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.458 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 67.1 m -132.91 134.3 44.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.406 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 167' ' ' ALA . 22.9 m -153.18 159.2 42.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.87 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.453 ' N ' HG22 ' A' ' 166' ' ' THR . . . -56.36 141.56 41.44 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.365 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.81 -39.09 90.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.963 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.48 -33.07 74.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.194 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 174' ' ' VAL . 79.8 mtp180 -96.38 -17.56 20.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.35 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.59 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 47.9 t-105 -48.75 -41.73 33.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.713 0.292 . . . . 0.0 110.947 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.83 -41.69 97.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.136 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.7 m -65.56 -40.6 92.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.432 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.6 m -107.35 21.22 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.25 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 171' ' ' TRP . 19.0 ptmt -48.14 -47.4 34.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 111.111 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 27.0 t -64.83 -31.54 72.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.669 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.61 -45.64 73.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.044 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.59 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.2 m-85 -61.33 -50.11 74.26 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.263 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -63.28 -42.37 99.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.871 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.1 m -67.16 -49.01 66.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.777 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.9 t -70.01 -37.64 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.405 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.68 -37.03 84.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.317 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.0 t -84.62 -18.61 34.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.133 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 t -62.79 -35.87 81.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.629 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.433 ' CD1' ' O ' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -55.89 147.23 19.85 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.931 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -134.44 157.72 45.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.37 151.19 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.767 0.317 . . . . 0.0 111.049 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.414 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 33.8 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.69 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.78 -21.17 72.8 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.686 2.257 . . . . 0.0 111.77 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.9 mt -88.05 144.3 26.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.306 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.94 23.76 0.02 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.1 t -114.77 137.5 51.86 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.808 0.337 . . . . 0.0 110.487 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 93.0 m -65.15 -28.4 69.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.754 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.38 -105.0 2.32 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.62 -174.42 48.12 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.9 p -130.28 143.41 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.88 77.02 0.05 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 29' ' ' ILE . 31.6 pt -126.38 167.85 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.187 0.518 . . . . 0.0 111.239 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.6 170.9 8.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.242 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.5 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 60.9 p -61.64 164.48 5.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.109 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.1 156.7 44.78 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.045 0.45 . . . . 0.0 111.224 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 1.042 HE22 ' CB ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -135.91 158.94 43.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.915 179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -116.73 135.52 53.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.633 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -108.99 141.17 41.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.078 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.9 p -144.57 157.28 44.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.762 0.315 . . . . 0.0 110.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -146.96 112.32 5.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.766 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.7 m -62.0 -37.32 84.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.603 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -59.39 -52.33 66.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.227 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -84.49 -20.53 31.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.767 0.318 . . . . 0.0 110.77 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.65 43.17 86.17 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -142.37 151.88 42.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.235 0.517 . . . . 0.0 110.393 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -153.96 144.47 22.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.806 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -148.86 160.4 43.28 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.044 0.449 . . . . 0.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 tp -103.8 133.07 49.4 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.619 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -141.99 140.78 20.19 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.066 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -45.68 150.32 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.901 1.734 . . . . 0.0 112.217 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 1.042 ' CB ' HE22 ' A' ' 33' ' ' GLN . 37.2 p-10 -81.02 160.03 24.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.301 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.43 3.19 65.05 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 32.9 m0 -81.3 147.12 30.05 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.8 pt -111.43 134.25 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.327 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.85 138.59 14.0 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.45 134.05 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.771 0.32 . . . . 0.0 110.22 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 54' ' ' ASP . 48.7 p30 -84.45 145.57 28.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.72 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.1 m -151.66 51.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.353 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.45 133.5 46.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.048 0.451 . . . . 0.0 110.423 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.37 3.92 84.01 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.65 -164.24 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.8 m -40.49 117.88 1.43 Allowed Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.685 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.18 135.23 11.33 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.506 1.47 . . . . 0.0 111.895 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.462 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 99.84 -32.01 7.75 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.12 130.07 29.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -111.05 -57.79 2.19 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.708 0.289 . . . . 0.0 110.94 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -147.02 140.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.712 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.72 133.48 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.143 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.71 134.05 54.42 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.522 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -129.44 134.73 47.97 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.111 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 77.8 m-20 -86.61 119.1 26.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.836 0.35 . . . . 0.0 110.652 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.8 tt -65.11 -40.04 93.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.505 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 88.6 mt -61.37 -42.93 95.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.008 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -119.11 120.16 36.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.891 0.377 . . . . 0.0 110.659 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -82.82 -36.24 25.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.578 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 40.6 p-10 -62.37 -31.94 72.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.981 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 84.2 tt0 -87.13 130.47 34.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.62 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -139.57 139.5 36.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.297 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.39 134.76 52.03 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -129.53 138.91 51.61 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.13 128.3 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.405 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.462 HG23 ' C ' ' A' ' 61' ' ' GLY . 25.8 mt -123.68 123.97 68.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.326 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.3 mt -123.23 130.83 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.392 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.4 m -145.74 165.86 27.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.297 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -105.46 135.81 46.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 83' ' ' ILE . 8.1 pt -92.52 148.83 37.08 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.32 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' LYS . 37.3 Cg_endo -65.86 137.13 48.0 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.695 1.597 . . . . 0.0 110.69 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 t -60.88 -29.42 69.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.171 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -67.59 -31.34 71.32 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 84' ' ' PRO . 95.4 mttt -131.04 143.19 50.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.938 0.399 . . . . 0.0 111.007 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -111.87 179.82 3.9 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.086 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.484 ' N ' ' OG1' ' A' ' 88' ' ' THR . 45.8 tp -52.16 -45.16 64.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.079 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.3 p -68.51 -41.38 80.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.925 0.393 . . . . 0.0 110.882 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.452 ' H ' HG23 ' A' ' 88' ' ' THR . 50.0 t0 -66.41 -36.45 82.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.629 ' O ' HD23 ' A' ' 92' ' ' LEU . 4.8 tt -55.62 -47.54 76.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.241 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.09 178.52 47.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.5 p -90.71 172.96 8.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.15 76.43 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.113 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.1 m -72.14 -45.3 61.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.55 -51.12 69.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.246 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.55 -38.63 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.404 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.08 -45.55 93.75 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -69.52 -40.26 77.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.813 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -61.5 -41.18 96.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.043 0.449 . . . . 0.0 110.76 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -60.74 -40.66 93.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.633 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.7 mmt -59.26 -44.16 92.43 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.507 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -64.59 -39.63 94.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.154 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.8 m -59.26 -46.84 87.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.922 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.15 -46.04 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.048 0.451 . . . . 0.0 110.383 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 111' ' ' GLN . 86.3 m-20 -61.99 -31.29 71.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -44.12 -37.56 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -110.34 -7.71 14.78 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.808 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 114' ' ' ARG . 27.9 m -121.05 19.36 11.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.367 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 107' ' ' ASN . 21.1 pt20 -84.39 6.26 23.9 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.15 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.98 -63.22 2.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.831 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -117.3 -46.14 2.71 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.903 0.382 . . . . 0.0 110.934 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 110' ' ' SER . 93.2 mtm-85 -74.61 148.73 40.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.228 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -131.83 130.58 41.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.601 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.92 128.63 44.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 110.389 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -115.36 128.7 56.25 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.6 tp -82.71 111.6 18.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.929 0.395 . . . . 0.0 110.406 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.74 -57.68 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.362 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -146.35 161.3 40.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.647 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.41 112.93 2.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.388 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.37 167.37 22.27 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.896 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.418 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -136.93 149.7 47.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.754 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -132.52 143.04 49.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.778 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -111.82 115.03 28.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.428 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.12 144.76 36.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.983 0.42 . . . . 0.0 110.94 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.5 t0 54.74 22.1 3.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.41 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.54 -1.78 88.19 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -103.49 149.02 25.25 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.942 0.401 . . . . 0.0 110.077 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.67 128.42 67.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.995 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -117.49 127.73 54.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.873 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.31 124.78 49.78 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.7 m -105.78 122.76 46.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.299 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.3 mp -117.83 122.93 44.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.99 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -117.88 124.42 48.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.431 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -151.98 172.89 15.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.401 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -140.78 160.53 39.84 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.079 0.466 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.61 132.58 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.437 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pp -135.81 136.35 40.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 111.346 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.57 130.46 55.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.119 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.63 -116.95 10.08 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 56.7 t0 -114.73 12.44 17.08 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.468 0.175 . . . . 0.0 111.025 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -119.75 146.6 45.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.726 0.298 . . . . 0.0 110.951 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 144' ' ' VAL . 7.4 p -85.57 125.19 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.434 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -75.21 -52.66 10.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.717 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -173.23 172.49 3.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -104.84 141.18 36.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.028 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -134.49 136.74 43.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.991 0.424 . . . . 0.0 111.206 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.1 tp -111.55 135.63 51.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.724 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.53 134.97 42.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.252 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.0 m -121.49 141.36 51.11 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.097 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.7 128.88 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.853 0.359 . . . . 0.0 110.871 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.8 m -146.31 148.86 32.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.415 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -112.54 151.1 30.4 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.833 0.349 . . . . 0.0 110.357 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -150.37 103.95 3.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 62.52 31.38 17.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.977 0.417 . . . . 0.0 110.68 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 89.01 2.27 78.22 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.306 -0.473 . . . . 0.0 111.925 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 1.7 mptp? -95.1 125.17 39.57 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.7 OUTLIER -88.62 118.22 28.13 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.4 mt -120.49 128.16 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.759 0.314 . . . . 0.0 110.499 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.5 m -130.52 136.51 49.02 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.723 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.86 110.47 20.82 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.976 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -105.47 111.88 24.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.559 0.219 . . . . 0.0 110.509 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 164' ' ' LEU . 5.5 mp -119.09 135.59 54.57 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.744 0.307 . . . . 0.0 110.483 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -129.82 138.2 50.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.368 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.6 m -153.05 156.52 38.92 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.48 145.07 34.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.453 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.39 -29.07 65.61 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.325 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.33 -34.05 71.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.256 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.452 ' O ' HG22 ' A' ' 174' ' ' VAL . 60.7 mtp180 -113.79 -4.2 13.39 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.532 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 57.5 t-105 -49.54 -38.5 31.16 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.091 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.32 -43.11 99.59 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.183 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 77.9 m -65.58 -39.76 91.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.8 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 170' ' ' ARG . 11.3 m -108.45 21.11 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.521 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 176' ' ' SER . 17.4 pttp -51.75 -50.5 60.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.459 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 27.2 t -65.17 -29.67 70.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.734 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.6 tp -55.75 -43.6 76.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.233 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.532 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 28.5 m-85 -61.53 -49.58 76.14 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.385 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.64 -39.66 91.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.459 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.421 ' O ' ' OG ' ' A' ' 184' ' ' SER . 43.8 m -65.39 -47.35 76.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.277 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.34 -44.88 99.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.494 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.475 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -66.52 -45.36 79.78 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.283 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.0 t -69.96 -32.34 70.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.235 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 180' ' ' THR . 63.8 m -62.03 -30.08 70.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.306 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -49.9 157.08 0.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.522 -179.388 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -138.59 153.99 48.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.581 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.6 m -127.12 151.15 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.107 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 42.6 p90 . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.75 -179.875 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.55 -20.8 71.74 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.667 2.245 . . . . 0.0 111.819 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 mt -91.36 137.72 32.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.434 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.93 -179.68 39.42 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.9 t -143.45 141.75 30.94 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.451 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.6 p -177.64 102.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.75 44.81 37.34 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.13 -37.97 55.34 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 m -131.66 151.25 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.843 0.354 . . . . 0.0 110.477 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.38 -179.96 42.26 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.3 mm -84.97 36.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.323 0.582 . . . . 0.0 109.731 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.86 159.06 44.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.233 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.8 p -67.08 153.86 42.64 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.401 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.6 mt -113.61 145.3 41.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.533 ' CD ' ' ND2' ' A' ' 48' ' ' ASN . 13.8 mp0 -109.92 151.89 26.51 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.272 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -120.24 143.14 48.45 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.565 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -130.43 133.63 46.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.068 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -140.81 151.2 44.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.401 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -140.73 120.26 13.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.408 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.8 p -71.33 -32.59 68.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.574 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.22 -49.45 74.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.115 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -87.37 -20.63 26.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.825 0.345 . . . . 0.0 110.729 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.34 41.16 91.58 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -139.75 152.71 46.84 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.264 0.532 . . . . 0.0 110.418 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -151.39 148.58 28.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.461 ' C ' HD22 ' A' ' 45' ' ' LEU . 45.5 p90 -152.33 155.91 38.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.044 0.45 . . . . 0.0 111.53 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.663 HD22 ' N ' ' A' ' 45' ' ' LEU . 2.3 mm? -96.7 141.92 29.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.894 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -153.05 147.63 19.2 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.543 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.22 163.4 34.93 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.596 2.197 . . . . 0.0 112.968 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.533 ' ND2' ' CD ' ' A' ' 33' ' ' GLN . 27.9 m120 -70.52 160.47 32.4 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.85 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.74 -6.19 57.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -97.08 141.84 29.73 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 51' ' ' ILE . 36.4 pt -123.13 147.28 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.42 137.39 13.23 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.19 136.19 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.895 0.379 . . . . 0.0 110.655 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -77.78 133.98 38.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.241 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 m -132.06 56.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.256 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -73.65 137.78 44.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.13 3.57 69.77 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.48 -164.22 0.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.798 0.332 . . . . 0.0 110.65 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.5 157.04 1.89 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.155 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.74 131.03 27.92 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.425 2.083 . . . . 0.0 111.722 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 94.3 -22.43 36.98 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.84 132.16 27.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.413 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -118.67 -58.4 1.97 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.033 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 m -146.87 165.81 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.178 0.514 . . . . 0.0 111.308 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.13 140.86 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.028 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -111.99 130.38 55.88 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -127.6 133.6 49.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.917 0.389 . . . . 0.0 111.132 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 71' ' ' GLU . 60.2 t0 -93.49 118.27 31.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.452 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt -63.62 -39.09 93.49 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.14 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.06 -40.86 90.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' A' ' 68' ' ' ASP . 79.1 mm-40 -117.99 118.11 31.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.621 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -85.91 -43.0 13.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.417 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -58.43 -39.69 80.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.993 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 33.9 mp0 -82.95 135.94 34.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.355 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.84 157.77 38.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.904 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 77' ' ' SER . 9.5 tp -132.09 133.87 44.83 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.047 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.44 ' N ' HD12 ' A' ' 76' ' ' LEU . 42.6 t -123.54 131.32 53.6 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.41 126.97 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.61 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.506 HG23 ' C ' ' A' ' 61' ' ' GLY . 49.4 mt -122.33 121.41 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.21 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.4 mm -116.77 129.92 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.01 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 159' ' ' LEU . 9.6 m -148.79 164.36 34.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.161 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -103.66 138.12 40.75 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 83' ' ' ILE . 10.6 pt -92.92 149.26 37.37 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.788 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -43.77 139.64 5.18 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.76 1.64 . . . . 0.0 111.487 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -69.01 -23.9 64.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.557 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 56.3 t0 -90.68 -18.38 25.17 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -128.73 157.32 41.73 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.104 0.478 . . . . 0.0 111.617 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.9 t -122.92 176.91 5.74 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.515 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 tp -51.0 -45.09 61.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.972 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.9 p -66.92 -44.99 79.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.089 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.36 -37.18 84.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.8 tp -55.91 -41.94 75.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.67 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.83 -179.41 48.35 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.425 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.2 p -96.05 171.9 8.33 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.73 73.57 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.133 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.3 m -73.05 -46.16 53.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.87 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.425 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.3 t0 -62.6 -50.97 69.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.164 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.36 -38.79 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -57.94 -56.12 26.87 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -59.52 -36.64 76.48 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.479 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -56.27 -40.26 73.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.099 0.476 . . . . 0.0 110.577 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -63.8 -41.58 97.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.127 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.674 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -54.98 -55.27 32.7 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.307 0.575 . . . . 0.0 110.096 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -61.29 -39.56 90.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.766 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.1 m -57.97 -45.63 86.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.7 t -71.7 -46.57 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.504 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 111' ' ' GLN . 12.8 m-20 -60.83 -33.9 73.75 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.879 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -45.63 -35.52 4.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.06 0.457 . . . . 0.0 110.439 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.47 -48.5 22.41 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 m -122.31 22.94 9.96 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 107' ' ' ASN . 16.1 pt20 -47.39 -18.59 0.12 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.632 0.253 . . . . 0.0 111.483 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.26 -61.44 7.38 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.167 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 38.1 p-10 -117.31 -30.84 5.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.072 0.436 . . . . 0.0 111.781 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.527 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 55.1 ttm-85 -80.19 136.92 36.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 111.026 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -133.17 135.86 45.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.37 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -107.87 136.62 47.29 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.951 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -118.64 127.76 53.9 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.9 tp -82.84 108.18 15.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.899 0.38 . . . . 0.0 110.209 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.546 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 97.0 mt -71.0 -38.3 71.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.942 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.3 m-80 -178.52 163.7 1.57 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.165 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.9 120.53 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.197 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -137.6 170.71 15.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.035 0.445 . . . . 0.0 110.919 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -141.78 150.74 42.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.506 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.83 136.77 46.45 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.152 0.501 . . . . 0.0 110.802 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -103.97 113.62 27.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -138.26 137.62 37.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.429 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 129' ' ' GLN . 87.2 m-20 51.24 42.3 28.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.627 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.13 1.59 5.67 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.524 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 2.8 tm0? -102.28 130.71 49.06 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.13 130.0 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.524 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 45.8 m-85 -118.87 131.4 56.06 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.724 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.435 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.07 128.44 53.34 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.464 ' C ' HD12 ' A' ' 134' ' ' LEU . 94.0 m -110.13 123.62 50.06 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.326 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.464 HD12 ' C ' ' A' ' 133' ' ' THR . 9.4 mp -115.45 127.51 55.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.992 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -123.43 120.49 33.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.297 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -150.31 169.68 20.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.471 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -133.73 152.92 52.01 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 110.554 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.415 ' CG1' HH11 ' A' ' 114' ' ' ARG . 74.2 t -105.01 133.57 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.375 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.411 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.7 pp -140.57 135.13 31.49 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.283 0.563 . . . . 0.0 111.087 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.6 t -115.02 134.27 58.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.131 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.54 -122.1 21.87 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -111.31 13.45 21.65 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -128.86 156.74 43.17 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.077 0.465 . . . . 0.0 111.475 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 144' ' ' VAL . 9.9 p -87.62 126.98 41.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.412 ' OE1' ' NH1' ' A' ' 114' ' ' ARG . 84.2 tt0 -74.77 -54.63 6.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.472 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -174.46 173.83 2.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.207 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.416 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 51.2 m170 -103.99 138.66 40.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.025 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 81.5 m-20 -135.38 137.92 42.81 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.011 0.434 . . . . 0.0 111.291 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 tp -114.15 130.52 56.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.845 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.79 137.85 54.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.82 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.1 t -126.82 126.02 42.66 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 52.4 t -114.83 129.94 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.12 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.9 m -143.83 144.34 31.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.0 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 p -110.99 150.34 29.4 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.209 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -156.66 117.16 3.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.964 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.523 ' HE ' ' H ' ' A' ' 156' ' ' ARG . 4.8 mmp_? 58.94 24.85 13.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.11 7.88 72.92 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.1 125.82 43.27 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -88.97 121.47 31.35 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.42 ' N ' HD23 ' A' ' 159' ' ' LEU . 76.5 mt -122.87 129.08 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.565 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 37.7 m -129.07 136.47 50.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.454 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.85 99.9 8.03 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -96.81 107.55 20.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.762 0.315 . . . . 0.0 110.616 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.54 133.42 54.6 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.801 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 89.0 p -128.46 135.8 49.97 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.788 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 5.9 m -152.97 154.82 35.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.549 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -54.89 141.0 35.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.239 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -67.77 -34.19 76.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.55 -33.78 68.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.994 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 174' ' ' VAL . 63.9 mtt85 -109.9 -7.18 15.02 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.499 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 52.2 t-105 -49.51 -38.26 29.83 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.832 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.53 -42.96 99.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 58.6 m -65.53 -39.82 92.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.722 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 170' ' ' ARG . 13.6 m -108.28 21.27 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.35 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 171' ' ' TRP . 50.8 pttt -52.22 -46.78 65.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 84.8 p -69.52 -25.83 64.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.602 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.99 -43.28 91.44 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.998 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.499 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 28.5 m-85 -61.7 -50.86 70.75 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.206 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.15 -41.05 99.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.558 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 184' ' ' SER . 41.8 m -67.22 -48.52 67.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.321 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.95 -45.1 99.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.731 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.514 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -66.48 -43.94 84.06 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.313 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.0 m -72.8 -31.13 64.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.342 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 180' ' ' THR . 40.3 m -61.82 -29.53 70.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.442 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -54.94 157.01 3.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.078 0.466 . . . . 0.0 110.944 -179.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -137.02 158.03 45.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.64 151.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.941 0.401 . . . . 0.0 111.008 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.524 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 38.1 p90 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.801 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.98 144.85 35.1 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.703 2.268 . . . . 0.0 111.905 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.6 mt -90.18 140.42 29.69 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.454 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.14 4.77 74.06 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 p -77.22 156.93 31.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.0 t -138.52 127.6 24.07 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.344 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.42 176.58 48.36 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.63 135.96 13.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -122.3 133.97 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.308 . . . . 0.0 110.416 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.87 143.36 26.47 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.4 mm -59.57 -45.08 94.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.93 0.395 . . . . 0.0 110.133 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.76 150.13 15.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.445 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.8 t -148.48 155.5 41.26 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.234 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.72 160.49 37.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.966 0.412 . . . . 0.0 110.909 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.13 166.39 24.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.62 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.5 ptt-85 -115.84 144.68 43.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.708 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -124.13 132.44 53.64 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.189 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.9 m -139.15 151.18 46.43 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.544 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -141.61 118.48 11.15 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.32 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.6 p -72.31 -30.53 64.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.719 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -62.53 -47.61 83.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.722 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -90.21 -20.4 23.07 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.937 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.78 41.94 81.2 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -141.1 152.98 45.2 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.239 0.519 . . . . 0.0 110.22 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -153.26 148.17 26.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -157.22 157.57 34.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.162 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.6 mt -96.38 152.19 18.83 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -161.19 130.08 3.08 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.19 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -41.99 157.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.094 1.862 . . . . 0.0 112.507 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.575 ' C ' HD21 ' A' ' 48' ' ' ASN . 0.1 OUTLIER -80.8 160.31 24.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.869 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.84 12.53 63.91 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.532 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 28.2 m0 -91.24 151.68 20.82 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 110.479 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.0 pt -117.29 151.07 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.377 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.73 134.51 9.97 Favored Glycine 0 N--CA 1.466 0.651 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.62 141.19 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.62 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -87.03 144.72 26.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.181 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.69 49.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.308 0.575 . . . . 0.0 109.878 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -54.12 129.42 34.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.16 4.65 68.53 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.01 -164.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.12 157.89 2.78 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.249 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.8 130.62 25.13 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.341 2.027 . . . . 0.0 111.465 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 94.83 -22.47 37.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.423 ' N ' HG23 ' A' ' 79' ' ' ILE . 87.1 t -58.85 126.74 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.783 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -119.05 -57.98 1.98 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.596 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.5 t -145.68 146.04 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.83 0.348 . . . . 0.0 111.035 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.8 t -120.67 135.9 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.123 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -111.25 132.07 54.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.276 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -122.74 141.31 51.94 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.388 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 49.0 m-20 -93.37 118.97 31.95 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.566 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.0 mt -68.47 -38.16 80.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 110.623 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.16 -44.47 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.688 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -126.57 98.69 5.5 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.918 0.39 . . . . 0.0 110.621 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.765 ' H ' ' NE ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -61.77 -32.67 72.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.538 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.46 -36.25 73.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.575 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -86.76 131.5 34.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -146.66 138.86 24.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.445 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -118.89 134.56 55.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.688 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t -122.6 138.28 54.63 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.213 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.6 t -118.28 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 110.342 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.484 HG23 ' C ' ' A' ' 61' ' ' GLY . 54.6 mt -122.28 122.83 67.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.475 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' GLY . 72.2 mt -122.88 133.85 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.907 0.384 . . . . 0.0 111.059 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 15.9 t -148.46 167.77 24.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.097 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -105.58 136.63 44.81 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.762 0.315 . . . . 0.0 110.318 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 83' ' ' ILE . 10.1 pt -93.92 148.3 35.03 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.264 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 87' ' ' LYS . 38.8 Cg_endo -66.07 136.88 46.21 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.728 1.619 . . . . 0.0 110.968 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.3 t -61.44 -27.18 68.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.979 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -67.8 -30.86 70.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.023 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 84' ' ' PRO . 66.4 mttm -130.41 156.58 44.49 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.027 0.442 . . . . 0.0 111.119 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 91' ' ' ASP . 14.7 t -122.7 176.13 6.13 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.441 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.0 tp -52.65 -44.83 66.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.075 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.8 p -68.6 -46.51 69.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.424 ' H ' HG23 ' A' ' 88' ' ' THR . 21.9 t70 -66.24 -35.76 81.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.075 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -55.83 -43.07 76.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.505 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 175.05 44.48 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 38.0 p -92.82 170.69 9.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.61 77.99 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.118 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 74.7 m -72.03 -44.5 63.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.418 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.3 t0 -61.77 -51.26 69.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.405 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.22 -38.49 79.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.528 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.18 -46.78 92.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -67.24 -40.39 86.29 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.984 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -61.5 -41.4 97.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.028 0.442 . . . . 0.0 110.813 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -61.45 -40.33 94.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.755 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.7 mmt -58.64 -44.3 90.02 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.684 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -65.55 -45.51 83.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.005 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.9 m -59.2 -45.81 90.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.98 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.14 -47.12 79.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.995 0.426 . . . . 0.0 110.406 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 111' ' ' GLN . 91.7 m-20 -63.36 -38.43 91.14 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -43.77 -36.28 2.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.337 . . . . 0.0 111.006 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.98 -47.65 67.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.011 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.5 m -123.66 23.44 8.8 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 107' ' ' ASN . 16.2 tt0 -50.37 -28.72 8.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.596 0.236 . . . . 0.0 111.419 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.15 -61.72 2.62 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.098 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 34.3 p-10 -117.83 -35.27 3.95 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 117.046 0.423 . . . . 0.0 111.965 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.52 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 35.1 ttm180 -84.64 137.75 33.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 111.276 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -128.31 142.93 50.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.03 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.44 140.36 38.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.877 0.37 . . . . 0.0 110.421 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' CD ' ' CD2' ' A' ' 139' ' ' LEU . 93.3 mt-10 -121.32 123.54 42.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.459 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.7 tp -82.87 109.75 17.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.963 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.524 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.8 mt -72.44 -50.45 35.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.579 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 27.7 m120 -157.0 164.42 38.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.819 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.82 115.45 3.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.246 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -141.61 166.3 25.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.833 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.418 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -136.51 148.46 47.65 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -127.72 141.05 51.7 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.834 0.35 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -108.35 112.14 24.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.614 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 127' ' ' ASP . 79.4 mm-40 -138.28 144.07 40.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.432 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 126' ' ' GLU . 3.7 p-10 46.53 39.32 6.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.28 1.47 21.15 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 154' ' ' THR . 68.1 tp60 -105.95 132.36 52.14 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.43 130.44 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.987 0.422 . . . . 0.0 110.41 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -117.2 130.64 56.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.673 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -103.52 125.58 50.16 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.0 m -107.45 122.74 47.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.327 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.27 120.49 38.39 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.971 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -115.47 123.42 48.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -152.07 166.9 30.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.837 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -134.37 153.85 51.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.922 0.392 . . . . 0.0 110.486 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.01 136.42 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.755 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.402 ' CD2' ' CD ' ' A' ' 117' ' ' GLU . 2.7 pp -139.59 138.96 36.64 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.181 0.515 . . . . 0.0 111.225 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.6 m -110.5 134.01 54.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.243 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 62.04 -117.54 11.78 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 56.7 t0 -116.2 13.59 15.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.456 0.17 . . . . 0.0 110.963 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -121.98 148.0 45.34 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.753 0.311 . . . . 0.0 111.068 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.459 HG13 ' O ' ' A' ' 144' ' ' VAL . 13.8 p -85.48 126.84 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.467 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -75.81 -53.4 8.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.422 HH21 ' N ' ' A' ' 166' ' ' THR . 14.7 ptm180 -174.19 171.08 3.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.0 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.412 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 35.7 m170 -103.11 140.53 37.2 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.203 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 78.6 m-20 -134.84 136.19 42.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.924 0.393 . . . . 0.0 111.043 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.6 tp -111.23 134.41 52.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.631 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.78 136.17 42.39 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 110.553 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 52.8 m -123.66 140.47 52.96 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.6 t -121.68 129.56 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.871 0.367 . . . . 0.0 110.537 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.2 m -146.55 142.67 28.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.532 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.44 ' O ' ' NE2' ' A' ' 129' ' ' GLN . 16.7 p -106.0 151.8 24.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.805 0.335 . . . . 0.0 110.491 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -148.32 106.02 3.68 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.015 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 55.39 32.71 19.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.28 6.63 68.51 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -98.42 124.82 43.32 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.16 113.97 25.21 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 70.9 mt -120.02 126.5 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 89.6 m -122.68 132.26 54.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.295 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.56 111.15 22.19 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -114.6 133.98 55.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.962 0.411 . . . . 0.0 111.272 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 mp -129.87 144.33 51.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.426 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 82.5 p -134.98 134.04 40.11 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.298 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 167' ' ' ALA . 20.7 m -152.98 159.33 42.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.676 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.444 ' N ' HG22 ' A' ' 166' ' ' THR . . . -56.78 141.42 44.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.227 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -66.18 -38.61 88.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.878 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -62.08 -33.38 74.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.298 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.531 ' O ' HG22 ' A' ' 174' ' ' VAL . 75.1 mtm180 -96.38 -17.28 20.73 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.243 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.583 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 46.6 t-105 -48.53 -41.42 30.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.732 0.301 . . . . 0.0 110.784 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -63.0 -41.46 99.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.932 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.1 m -66.14 -40.61 90.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.7 m -108.08 21.41 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.266 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 171' ' ' TRP . 49.3 pttt -49.19 -45.9 44.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 111.38 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 83.8 p -67.91 -26.79 66.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.463 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.78 -45.35 86.11 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.926 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.583 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.1 m-85 -62.38 -49.73 74.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.244 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -62.35 -43.31 99.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.413 ' O ' ' OG ' ' A' ' 184' ' ' SER . 86.5 m -66.96 -50.62 61.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.824 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 76.1 t -67.49 -38.32 80.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.39 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.31 -36.67 82.86 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.055 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.7 t -85.02 -17.66 36.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.474 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 180' ' ' THR . 50.9 m -62.78 -36.13 82.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.388 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.451 ' CD1' ' O ' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -58.66 148.82 27.8 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.39 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -138.71 160.18 40.28 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.4 m -128.18 151.66 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.952 0.406 . . . . 0.0 111.188 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.47 ' CG ' ' O ' ' A' ' 188' ' ' TYR . 35.9 p90 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.587 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 47.2 Cg_exo -54.35 -17.3 11.85 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.766 2.311 . . . . 0.0 111.951 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.672 HD12 ' N ' ' A' ' 21' ' ' LEU . 7.3 mp -82.48 139.19 34.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.355 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.29 -169.87 48.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.0 t -142.67 143.99 32.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.751 0.31 . . . . 0.0 110.543 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.1 m -90.04 115.38 27.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.229 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.75 -123.38 26.68 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 27.63 52.05 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -55.9 -36.09 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.555 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.93 144.7 0.11 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.56 ' N ' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -67.45 -9.15 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.724 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.42 161.79 42.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.34 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.7 p -61.14 154.86 22.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 110.562 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.2 mt -108.23 144.81 35.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.57 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.557 ' O ' HD12 ' A' ' 45' ' ' LEU . 5.4 mp0 -106.83 159.07 16.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.581 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -128.27 138.87 52.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.352 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -129.56 136.29 49.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.943 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.7 p -144.3 157.77 44.1 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -147.91 117.7 7.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.313 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.2 p -70.23 -31.96 69.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 110.448 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -62.13 -48.68 79.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.065 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -88.24 -20.53 25.37 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.97 42.8 76.35 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.81 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -143.97 151.79 40.22 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 117.308 0.554 . . . . 0.0 110.629 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -154.84 144.49 21.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.966 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -149.55 157.38 43.22 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.859 0.361 . . . . 0.0 110.822 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 33' ' ' GLN . 8.5 tp -101.63 134.72 44.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.369 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -139.7 148.53 56.14 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.5 165.49 27.21 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.652 2.235 . . . . 0.0 112.945 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.539 ' ND2' ' CD ' ' A' ' 33' ' ' GLN . 27.1 m120 -73.22 159.7 33.05 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.602 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.41 -5.11 62.5 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.404 ' HE1' ' CG ' ' A' ' 68' ' ' ASP . 41.5 m0 -93.45 143.83 25.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.725 0.297 . . . . 0.0 110.26 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.7 pt -122.17 147.49 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.701 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.85 132.53 11.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.33 133.76 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.929 0.395 . . . . 0.0 110.641 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -80.02 140.67 36.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.37 51.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.47 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -75.02 132.85 41.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.031 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.25 -3.36 84.11 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.45 -163.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.544 -0.328 . . . . 0.0 110.279 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.0 m -39.24 108.84 0.5 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.68 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -45.51 136.55 11.96 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.569 1.512 . . . . 0.0 111.703 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.478 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 101.16 -31.91 8.1 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.51 129.22 28.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.125 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' OD2' HD12 ' A' ' 80' ' ' ILE . 55.7 t0 -100.24 -58.77 1.84 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.306 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.417 ' O ' HG22 ' A' ' 78' ' ' VAL . 65.1 t -150.13 149.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.152 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.71 135.72 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.4 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.08 138.69 48.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.298 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -131.01 129.83 42.56 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.302 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' CG ' ' HE1' ' A' ' 50' ' ' TRP . 60.4 t0 -87.58 118.26 26.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.559 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 mt -65.46 -37.79 87.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.58 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.5 mm -63.49 -43.96 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.46 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -124.74 97.8 5.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.459 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -60.47 -37.35 80.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.308 0.575 . . . . 0.0 109.769 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -58.48 -36.04 73.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -81.06 127.75 32.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.93 0.395 . . . . 0.0 110.311 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -156.01 165.15 37.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.528 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.3 pp -162.42 160.9 26.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.466 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.1 t -143.87 143.89 31.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.413 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.4 m -110.55 130.17 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.478 HG23 ' C ' ' A' ' 61' ' ' GLY . 25.5 mt -116.54 127.45 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.22 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.433 HD12 ' OD2' ' A' ' 63' ' ' ASP . 64.8 mt -118.23 127.95 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 110.425 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.1 m -143.3 164.76 29.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.772 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -106.23 131.52 53.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.707 0.289 . . . . 0.0 110.293 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -94.08 150.32 38.26 Favored Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 87' ' ' LYS . 55.8 Cg_endo -70.75 137.49 32.69 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.739 1.626 . . . . 0.0 110.878 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.6 t -63.54 -29.17 70.47 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.371 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 46.3 p30 -68.69 -29.29 67.71 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.599 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 99.1 mttt -132.03 144.89 51.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.025 0.44 . . . . 0.0 110.999 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -109.52 -179.8 3.92 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.31 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.6 tp -50.75 -44.63 58.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.82 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.2 p -66.27 -43.92 85.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.911 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -65.01 -38.92 92.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.2 tp -55.93 -43.15 77.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.504 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.75 173.86 43.58 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 36.1 p -91.72 171.61 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.08 -43.2 81.92 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.075 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.2 m -71.91 -44.21 64.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 94' ' ' THR . 45.8 t0 -61.43 -51.35 69.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.426 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.67 -38.53 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.573 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.78 -44.61 94.14 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -68.71 -43.08 76.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.101 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -61.37 -39.14 89.56 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.921 -0.311 . . . . 0.0 110.982 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -61.89 -40.65 96.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.526 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -59.22 -42.7 91.61 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.497 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 2.2 mptm? -67.99 -42.74 80.32 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.398 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.0 m -57.02 -44.52 82.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.71 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.55 -43.67 71.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.956 0.408 . . . . 0.0 110.142 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.97 -31.68 72.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.037 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 104' ' ' LYS . 94.9 m-20 -42.39 -32.28 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.915 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.28 -33.32 6.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.537 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 114' ' ' ARG . 5.7 p -88.55 -6.36 57.62 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -55.92 -28.59 57.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.531 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -41.97 -63.74 1.67 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.009 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.1 p-10 -119.36 -45.01 2.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.025 0.44 . . . . 0.0 111.47 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.494 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 83.5 mtm180 -81.69 148.77 28.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.96 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -129.83 142.01 50.74 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.729 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.96 136.75 45.05 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.657 0.265 . . . . 0.0 110.51 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -122.71 128.91 51.17 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.6 tp -82.69 108.15 15.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.906 0.384 . . . . 0.0 110.325 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.0 mt -74.21 -43.35 50.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.536 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.38 164.84 22.03 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.281 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.72 114.44 3.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.207 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -139.03 170.51 15.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -142.62 151.0 41.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -132.45 147.82 52.38 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.059 0.457 . . . . 0.0 111.016 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -114.51 114.63 26.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.561 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -138.22 142.53 39.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.7 t0 51.31 27.64 3.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.547 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.15 -2.37 84.51 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -100.37 146.95 26.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.055 0.455 . . . . 0.0 110.165 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.77 127.74 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.011 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 22.1 m-85 -116.88 126.77 53.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.841 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.4 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.69 126.4 51.73 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.7 m -108.43 122.15 46.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.214 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.76 113.8 22.37 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.134 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -108.94 123.19 48.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.572 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -150.03 169.13 21.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.599 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -132.58 156.59 46.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.049 0.452 . . . . 0.0 110.837 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.7 t -106.38 129.75 59.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.167 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.16 135.81 54.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.043 0.449 . . . . 0.0 111.501 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.21 87.65 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.95 -106.02 2.82 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -112.79 7.49 18.5 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -122.62 137.14 54.99 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.006 0.431 . . . . 0.0 111.585 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 144' ' ' VAL . 7.0 p -67.29 122.96 19.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.849 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -77.7 -56.17 4.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.343 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -169.57 169.58 8.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -103.49 134.87 46.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.075 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -129.71 137.76 50.76 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.042 0.448 . . . . 0.0 110.823 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.72 HD13 ' N ' ' A' ' 150' ' ' ALA . 3.2 tm? -111.99 138.78 48.16 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.707 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.72 ' N ' HD13 ' A' ' 149' ' ' LEU . . . -135.92 125.37 25.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.462 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t -118.34 124.46 47.81 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 44.6 t -110.61 128.91 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.902 0.382 . . . . 0.0 110.868 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 57.6 m -142.75 143.16 32.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.373 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.4 p -89.15 157.34 18.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.885 0.374 . . . . 0.0 110.596 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -150.26 93.97 2.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.602 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 57.91 33.61 23.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.583 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 93.16 3.8 65.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -101.6 137.59 39.71 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.787 0.327 . . . . 0.0 110.164 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.95 119.03 32.3 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.296 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.1 mt -119.36 126.63 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.5 m -126.27 137.22 53.49 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.817 0.342 . . . . 0.0 110.571 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.32 98.01 7.01 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.794 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -96.37 113.74 25.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.856 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.8 mp -116.13 140.58 49.14 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.439 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.5 t -133.1 132.76 42.08 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.141 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 11.1 m -152.42 158.99 43.43 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.489 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.413 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -52.73 141.34 21.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.342 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -67.8 -39.48 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -61.5 -33.38 73.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.343 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.444 ' O ' HG22 ' A' ' 174' ' ' VAL . 69.1 mtp180 -96.58 -17.27 20.56 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.17 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.523 ' O ' ' N ' ' A' ' 175' ' ' LYS . 52.2 t-105 -48.85 -40.08 28.13 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.931 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -61.22 -41.04 96.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.297 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 59.3 m -68.05 -38.92 83.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.629 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 170' ' ' ARG . 6.5 m -111.44 21.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.378 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 171' ' ' TRP . 11.1 ptmm? -51.26 -50.41 59.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 29.8 m -65.07 -28.97 69.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.656 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.5 tp -56.14 -44.16 78.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.253 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.51 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 26.2 m-85 -63.35 -51.05 67.55 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.352 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.58 -41.15 98.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 184' ' ' SER . 44.1 m -66.6 -48.83 68.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.43 -43.55 98.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.432 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.55 -41.34 98.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.362 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 84.2 p -79.22 -25.65 42.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.874 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 180' ' ' THR . 41.4 t -62.75 -31.01 71.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.028 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -55.9 158.17 3.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.103 0.477 . . . . 0.0 110.576 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.481 ' CE1' ' O ' ' A' ' 187' ' ' VAL . 3.7 t60 -136.97 145.5 44.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.368 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.481 ' O ' ' CE1' ' A' ' 186' ' ' HIS . 6.8 m -122.27 147.96 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.449 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 35.5 p90 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.722 -179.363 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.22 -22.21 73.79 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.724 2.283 . . . . 0.0 111.822 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.7 mt -59.89 -35.57 75.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.352 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.06 -169.24 47.94 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 t -148.45 18.38 1.05 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.845 0.355 . . . . 0.0 110.48 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.3 m -86.35 123.49 31.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.391 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.89 -179.93 39.74 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.45 3.57 78.02 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.12 135.87 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.803 0.335 . . . . 0.0 110.437 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.68 -174.11 43.74 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 29' ' ' ILE . 5.0 mp -86.21 80.22 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.01 166.44 6.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.9 m -107.98 154.54 21.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.865 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.58 152.42 47.66 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.029 0.442 . . . . 0.0 110.963 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 48' ' ' ASN . 2.1 mp0 -106.73 146.19 31.13 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.008 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -117.42 131.0 56.83 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.738 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -115.3 134.43 55.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.487 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 94.2 p -145.35 153.06 40.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.947 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 36' ' ' SER . 97.9 m-20 -143.04 119.43 10.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.27 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.1 p -69.16 -33.9 74.12 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.272 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.84 -48.45 78.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -84.25 -20.64 31.88 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.958 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.9 42.06 93.04 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -143.97 149.1 36.23 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.175 0.488 . . . . 0.0 110.467 179.343 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -153.66 145.39 23.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -151.28 158.52 43.96 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 tp -104.24 135.01 46.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.402 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 14.7 p90 -136.88 143.78 43.94 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.859 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.87 150.7 2.51 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.819 1.679 . . . . 0.0 112.149 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.419 ' CB ' ' NE2' ' A' ' 33' ' ' GLN . 51.1 p-10 -79.87 160.67 25.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.497 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.69 60.52 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.1 m0 -92.38 147.57 22.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.851 0.358 . . . . 0.0 110.201 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.7 pt -116.5 144.44 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.415 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.33 133.49 11.4 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.22 133.67 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.331 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.16 124.64 32.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.227 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.93 59.47 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -77.15 135.19 38.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.063 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.79 3.69 73.65 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.46 -164.4 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.492 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -45.93 154.38 0.58 Allowed Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.412 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.31 130.77 23.26 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.36 2.04 . . . . 0.0 111.855 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.482 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 96.47 -23.72 33.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.91 128.9 33.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.561 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -119.16 -57.88 1.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.502 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.2 t -143.49 141.66 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.884 0.373 . . . . 0.0 111.216 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.41 133.28 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.218 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -112.61 135.94 52.75 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.63 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -127.92 138.46 52.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.337 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -88.76 118.29 28.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.62 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.37 -37.03 84.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.684 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.62 -42.43 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.486 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.36 99.72 6.57 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.58 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -62.59 -37.43 86.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.39 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -58.77 -35.05 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.753 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -81.62 131.29 35.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -140.1 139.19 35.78 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.994 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -126.26 135.26 51.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.071 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 t -128.02 139.41 52.57 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.84 126.55 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.961 0.41 . . . . 0.0 110.231 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG23 ' C ' ' A' ' 61' ' ' GLY . 26.2 mt -124.11 119.24 56.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.274 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' GLY . 33.4 mm -116.07 131.92 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.289 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 159' ' ' LEU . 49.2 m -145.96 166.48 25.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.35 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -104.8 137.98 41.77 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.435 HG22 HD12 ' A' ' 159' ' ' LEU . 10.3 pt -93.51 149.32 37.04 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.656 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -45.38 134.96 12.22 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.641 1.561 . . . . 0.0 111.496 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.1 t -65.1 -26.75 68.35 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.307 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -85.11 -20.81 29.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -129.79 158.24 39.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.209 0.528 . . . . 0.0 111.863 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.426 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.9 t -122.69 175.65 6.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.468 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.5 tp -52.07 -45.06 64.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.017 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 p -66.01 -46.02 79.44 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.164 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 88' ' ' THR . 88.0 m-20 -66.79 -35.26 79.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.885 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.5 tp -55.83 -43.43 76.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.75 178.79 47.57 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 33.4 p -94.13 173.04 7.85 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.43 -41.56 76.61 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.15 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.3 m -72.53 -46.25 55.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.002 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' A' ' 94' ' ' THR . 44.4 t0 -61.64 -50.89 70.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.431 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.32 -38.27 80.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.694 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.73 -44.03 96.04 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -67.24 -42.61 83.66 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.665 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -61.45 -38.45 87.25 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.664 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.39 -41.61 98.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.38 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.55 -43.2 93.59 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.187 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -64.89 -38.51 91.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.35 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.9 m -58.56 -47.62 83.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.883 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.45 -46.41 56.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.052 0.453 . . . . 0.0 110.503 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.4 m-20 -60.82 -30.41 70.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.285 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -43.59 -38.93 3.23 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.329 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.29 -39.68 9.52 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.624 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 112' ' ' GLY . 8.9 p -86.13 -1.19 57.18 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.4 pt20 -58.39 -0.55 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.438 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -73.7 -64.37 2.49 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.134 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -118.42 -45.23 2.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.79 0.329 . . . . 0.0 111.46 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 110' ' ' SER . 69.9 mtm180 -85.24 144.81 27.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.481 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -123.98 143.85 50.16 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.796 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.85 132.38 45.23 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -114.11 128.81 56.54 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 39.0 tp -81.78 109.86 16.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.67 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.455 ' CG1' ' HE ' ' A' ' 137' ' ' ARG . 88.2 mt -74.09 -53.33 17.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.237 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.549 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 9.2 p30 -160.69 176.51 11.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.84 127.14 5.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.225 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.465 ' OE1' ' N ' ' A' ' 122' ' ' GLU . 57.6 mp0 -141.43 159.35 42.41 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.701 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -140.29 147.77 40.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.941 0.4 . . . . 0.0 110.651 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -132.57 146.4 51.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.572 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -121.01 114.95 22.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.3 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -142.19 144.68 33.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.6 t0 51.25 34.44 11.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.533 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.45 -0.24 55.73 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -101.85 146.87 27.21 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.988 0.423 . . . . 0.0 110.188 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.3 t -114.47 128.86 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.214 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -118.09 122.64 43.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.54 132.05 51.24 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 52.8 m -112.55 132.25 55.2 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.053 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.32 110.34 12.72 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.065 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.549 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 69.9 tt0 -104.19 122.95 46.43 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -147.47 170.07 18.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.306 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.455 ' HE ' ' CG1' ' A' ' 119' ' ' ILE . 18.7 ptp180 -138.14 161.26 37.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.946 0.403 . . . . 0.0 110.926 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.0 t -108.16 133.46 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.092 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.436 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.5 pp -136.4 135.47 38.76 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.149 0.5 . . . . 0.0 111.622 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.37 128.1 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.65 -118.2 13.68 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -109.66 9.27 25.03 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.87 -0.194 . . . . 0.0 110.949 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -114.93 143.85 44.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.854 0.359 . . . . 0.0 111.492 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.29 130.13 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.465 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.436 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 2.0 tm-20 -83.28 -54.68 4.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.443 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.614 HH21 ' CA ' ' A' ' 166' ' ' THR . 15.2 ptm180 -170.3 173.29 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.123 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.414 ' NE2' ' CZ ' ' A' ' 137' ' ' ARG . 50.7 m80 -105.49 142.81 34.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.128 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 13.5 t70 -139.88 150.75 44.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.767 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.6 tp -125.49 136.32 53.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.041 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.02 119.81 19.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.847 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.1 t -106.03 138.36 42.35 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.35 130.06 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.908 0.385 . . . . 0.0 111.007 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -148.44 150.94 34.36 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.413 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.1 p -118.95 152.34 36.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.523 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -159.54 118.07 2.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.637 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 59.45 27.88 17.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.33 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.93 9.8 83.88 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -100.46 127.17 46.88 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.51 121.46 31.75 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.135 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.402 ' N ' HD23 ' A' ' 159' ' ' LEU . 77.4 mt -119.45 127.64 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.304 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 46.1 m -129.66 135.28 48.33 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.663 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.0 103.84 11.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.895 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -100.12 110.0 22.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.573 0.225 . . . . 0.0 110.432 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.432 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 5.3 mp -115.0 136.05 53.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.408 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.5 t -127.47 134.1 49.85 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.885 0.374 . . . . 0.0 110.546 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.614 ' CA ' HH21 ' A' ' 146' ' ' ARG . 9.5 m -152.53 154.9 36.38 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.611 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.14 144.29 35.5 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.547 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.431 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 1.2 pp20? -70.32 -30.55 67.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.024 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.431 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 92.5 m-20 -59.86 -33.9 72.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.957 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 174' ' ' VAL . 1.1 mpt_? -111.88 -5.3 14.38 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.501 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 52.4 t-105 -49.55 -39.17 33.74 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.786 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.42 -41.64 98.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.19 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.0 m -65.72 -39.87 91.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.699 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 170' ' ' ARG . 11.6 m -108.86 21.64 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.278 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 171' ' ' TRP . 10.2 ptmm? -51.38 -50.0 60.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.392 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.1 t -64.92 -30.7 71.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.17 -44.16 74.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.303 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 27.9 m-85 -60.95 -49.83 75.84 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.308 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -64.59 -38.91 92.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.492 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 42.7 m -65.38 -49.01 70.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.476 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.29 -45.16 99.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.659 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -64.85 -42.18 95.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 110.371 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 21.2 t -73.87 -31.47 63.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.231 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 91.7 p -63.12 -24.13 67.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.308 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -57.34 156.11 8.13 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.498 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -136.0 156.75 48.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.522 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.82 151.42 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.831 0.348 . . . . 0.0 111.107 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.519 ' CG ' ' O ' ' A' ' 188' ' ' TYR . 38.3 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.736 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 37.5 Cg_endo -64.55 147.21 90.23 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.919 2.413 . . . . 0.0 112.079 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.861 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -130.65 170.84 13.77 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.323 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.23 -178.09 51.47 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.9 p -141.6 156.13 45.7 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.834 0.349 . . . . 0.0 110.576 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.7 m -63.03 -36.35 83.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.733 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.46 -172.13 43.26 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.56 -123.73 0.89 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.13 142.89 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.722 0.296 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.09 -91.87 0.37 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.9 pt -128.71 168.39 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 111.143 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' HB3' HD21 ' A' ' 48' ' ' ASN . . . -114.54 -85.85 0.6 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.347 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.0 m -124.29 144.43 49.99 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.529 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.9 mt -101.28 144.12 30.52 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.377 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.501 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 20.5 mp0 -108.42 154.26 22.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.497 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -125.96 143.71 50.98 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.312 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -130.07 139.87 50.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.046 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -149.75 148.57 29.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 110.63 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -137.89 121.45 17.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.481 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.5 p -70.98 -33.22 70.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.504 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -61.93 -48.25 81.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -88.6 -20.47 24.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.784 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.84 42.02 93.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.73 150.72 42.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.153 0.477 . . . . 0.0 110.662 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -149.67 147.15 27.74 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.717 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.462 ' C ' HD22 ' A' ' 45' ' ' LEU . 48.3 p90 -146.75 154.86 41.89 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.935 0.398 . . . . 0.0 110.983 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.651 HD22 ' N ' ' A' ' 45' ' ' LEU . 3.1 mm? -98.02 141.66 30.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.101 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -151.31 146.84 19.42 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.317 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.12 160.02 51.09 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.455 2.103 . . . . 0.0 112.347 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.405 HD21 ' HB3' ' A' ' 30' ' ' ALA . 27.1 p30 -69.83 160.81 31.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.18 0.28 57.14 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.528 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 32.6 m0 -91.22 141.3 28.95 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.425 ' N ' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -115.68 128.37 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.999 0.428 . . . . 0.0 110.141 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.53 137.33 13.21 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.52 141.75 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.72 0.295 . . . . 0.0 110.57 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.17 122.61 31.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.05 0.452 . . . . 0.0 110.413 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 m -121.56 32.07 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.676 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -50.09 136.82 18.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.94 4.1 69.64 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.11 -164.33 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.636 0.255 . . . . 0.0 110.541 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 m -46.36 137.08 6.93 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.65 130.47 9.61 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.708 1.606 . . . . 0.0 112.717 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 96.0 -33.15 5.76 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.451 ' N ' HG23 ' A' ' 79' ' ' ILE . 92.0 t -62.31 125.43 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.273 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -119.78 -57.22 1.98 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.68 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.7 t -136.32 142.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.082 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.01 132.97 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.419 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 76' ' ' LEU . 90.7 m-85 -112.78 133.19 54.91 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.263 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -124.82 140.93 52.48 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.443 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 81.9 m-20 -88.36 118.76 28.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.546 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 tp -67.35 -40.87 85.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.47 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.8 mt -61.62 -43.43 97.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.017 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -117.34 121.2 40.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.928 0.394 . . . . 0.0 110.371 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -80.95 -37.55 29.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.634 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 41.1 p-10 -62.57 -31.32 72.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.959 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 85.3 tt0 -85.89 131.3 34.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.939 0.399 . . . . 0.0 110.787 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -142.31 139.6 31.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.144 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PHE . 7.5 tt -123.78 134.81 53.58 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.7 t -128.74 138.91 52.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.334 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -113.18 123.82 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.465 HG23 ' C ' ' A' ' 61' ' ' GLY . 12.4 mt -125.77 120.54 57.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.195 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.4 mt -121.1 132.64 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.172 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.4 m -136.15 164.7 27.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.47 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -103.73 135.36 45.43 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.504 ' CG2' HD12 ' A' ' 159' ' ' LEU . 9.6 pt -102.23 150.21 37.31 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.943 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -44.51 145.37 2.63 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.841 1.694 . . . . 0.0 111.222 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.6 p -80.08 -13.91 58.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.598 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -96.35 -20.93 18.12 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.765 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -124.06 157.14 35.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.099 0.476 . . . . 0.0 111.385 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.408 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.5 t -122.66 177.82 5.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.612 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 tp -51.66 -45.43 63.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.061 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.2 p -64.42 -44.55 90.87 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.098 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.2 m-20 -65.76 -38.12 88.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.4 tp -56.23 -43.85 79.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.86 176.52 45.93 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 39.8 p -94.86 171.11 8.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.6 78.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.126 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.2 m -72.03 -44.93 62.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.747 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.418 ' HB3' ' H ' ' A' ' 94' ' ' THR . 16.4 t70 -61.84 -51.78 66.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.409 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.16 -38.01 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.668 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.33 -47.21 90.98 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.53 -41.63 84.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -62.35 -40.79 97.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.981 0.42 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -61.67 -41.3 97.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.857 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -58.99 -45.46 90.56 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.661 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -64.35 -43.01 95.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.873 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.1 m -60.85 -47.04 88.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.1 t -71.87 -46.11 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.602 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 111' ' ' GLN . 91.7 m-20 -61.43 -39.57 91.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.632 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -46.61 -36.25 6.74 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.533 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 -45.36 89.78 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.885 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 114' ' ' ARG . 8.6 m -123.7 22.18 9.08 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.6 tt0 -52.53 -28.48 20.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.673 0.273 . . . . 0.0 111.452 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.86 -62.1 2.75 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.138 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -117.74 -40.51 3.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.929 0.365 . . . . 0.0 111.681 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 110' ' ' SER . 52.6 ttp180 -92.09 146.2 23.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.046 0.451 . . . . 0.0 110.904 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.76 151.63 40.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.517 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.463 ' HB3' ' OD1' ' A' ' 107' ' ' ASN . . . -103.04 139.85 38.05 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.569 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -113.18 130.8 56.1 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 118' ' ' LEU . 3.5 tt -81.21 106.01 12.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.082 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.7 mt -70.8 -51.06 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.378 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.549 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 7.5 p30 -160.66 173.91 14.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.953 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.1 122.92 4.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.189 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -142.09 159.56 41.99 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.689 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.42 147.83 43.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.524 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.7 141.55 47.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.705 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -110.61 112.81 24.96 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.393 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -137.59 144.33 41.94 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.97 0.414 . . . . 0.0 110.76 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.3 t0 50.98 33.28 8.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.35 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.84 0.97 61.08 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -104.05 146.94 27.99 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.978 0.418 . . . . 0.0 110.252 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.05 128.53 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.142 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 27.8 m-85 -118.06 124.47 48.18 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.853 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.62 128.13 50.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.0 m -109.02 122.25 46.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.201 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.8 mp -118.36 112.74 20.41 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.102 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.549 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 60.7 tt0 -106.46 123.96 48.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.426 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.94 169.66 20.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.499 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -135.85 156.3 49.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.76 0.314 . . . . 0.0 110.541 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.1 m -102.89 125.78 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.993 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 144' ' ' VAL . 6.7 mt -107.75 123.35 48.41 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.5 t -117.31 130.36 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.66 -122.27 22.02 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 88.4 m-20 -116.33 21.95 13.21 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.982 -0.128 . . . . 0.0 111.217 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 78.2 m-20 -144.1 161.87 37.72 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.893 0.377 . . . . 0.0 111.17 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 144' ' ' VAL . 7.8 p -79.49 120.46 30.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -69.98 -51.77 29.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.06 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -173.56 171.37 3.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.083 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -104.83 140.91 37.42 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.07 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 18.0 t70 -133.61 150.86 51.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.144 0.497 . . . . 0.0 110.543 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.73 HD13 ' N ' ' A' ' 150' ' ' ALA . 3.2 tm? -125.97 138.58 53.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.578 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.73 ' N ' HD13 ' A' ' 149' ' ' LEU . . . -136.54 117.47 14.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.356 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t -104.1 126.22 51.05 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 26.5 t -112.45 129.02 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.7 m -145.02 148.03 33.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.244 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 p -109.64 143.48 39.32 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.922 0.391 . . . . 0.0 110.551 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -152.64 112.97 4.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 62.44 33.45 16.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.65 11.57 84.59 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.34 131.59 54.92 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.721 0.296 . . . . 0.0 110.597 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.504 HD12 ' CG2' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -87.75 120.36 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.8 124.86 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.6 m -127.25 132.31 50.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.792 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.83 99.71 7.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.56 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -98.03 111.69 23.91 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.654 0.264 . . . . 0.0 110.572 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 164' ' ' LEU . 5.4 mp -116.91 136.9 52.59 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.28 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -126.56 136.19 52.23 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.858 0.361 . . . . 0.0 110.592 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.4 m -152.87 155.69 37.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.283 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.24 143.57 27.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.093 0.473 . . . . 0.0 111.197 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -71.19 -28.77 64.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.028 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.11 -34.28 71.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.232 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.416 ' O ' HG22 ' A' ' 174' ' ' VAL . 89.6 mtt-85 -114.62 -3.07 12.94 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.482 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 50.3 t-105 -49.79 -38.21 33.37 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.851 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -61.58 -41.83 97.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.263 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.6 m -66.84 -39.2 87.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.79 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 170' ' ' ARG . 8.2 m -108.4 21.32 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.294 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 176' ' ' SER . 19.4 ptmt -52.03 -49.73 62.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.331 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.41 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 25.0 t -65.67 -29.41 69.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.358 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 tt -54.76 -45.69 74.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.036 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.482 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 25.7 m-85 -61.9 -49.78 74.84 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.53 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.03 -38.39 90.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.478 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 39.2 m -64.33 -47.95 77.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.353 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.07 -45.08 99.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.624 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.47 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.45 -44.42 94.55 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.208 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.5 t -71.31 -32.76 69.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.1 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 95.3 p -63.1 -24.82 68.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -56.4 156.96 5.39 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.332 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -134.76 153.3 52.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.47 148.79 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 111.115 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.676 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.77 150.31 88.53 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.795 2.33 . . . . 0.0 111.841 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.21 145.41 28.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.328 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.13 32.98 33.91 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -56.39 -33.06 65.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 110.645 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.9 p -150.61 19.01 0.82 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.24 -128.31 30.63 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.82 -102.5 0.16 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.4 p -129.78 143.32 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.859 0.362 . . . . 0.0 110.422 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.91 -169.56 41.54 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' ALA . 35.0 pt -76.4 141.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 110.66 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 29' ' ' ILE . . . -52.68 -107.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.942 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.6 m -122.8 146.92 47.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.31 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.4 mt -66.89 148.67 51.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.125 0.488 . . . . 0.0 110.798 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.482 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 1.7 pm0 -127.54 164.77 21.23 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.861 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -125.61 144.38 50.61 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.815 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -122.2 133.22 54.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.797 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.446 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 92.4 p -145.63 153.48 41.08 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.867 0.365 . . . . 0.0 110.795 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 36' ' ' SER . 99.9 m-20 -143.06 113.23 7.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.278 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.0 p -65.43 -32.96 74.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.886 0.374 . . . . 0.0 110.075 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -62.24 -45.19 94.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -89.36 -20.47 23.96 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.09 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.72 40.63 90.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -143.48 150.81 39.51 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.286 0.543 . . . . 0.0 110.443 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -156.73 146.35 20.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.113 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -155.57 158.27 38.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.127 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.03 154.14 17.31 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.684 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.46 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 13.0 p90 -156.85 142.94 12.98 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.53 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.9 153.83 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.993 1.795 . . . . 0.0 112.462 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 49' ' ' GLY . 32.4 t-20 -81.44 157.15 25.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.426 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . 92.64 6.79 63.69 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.539 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 30.5 m0 -89.16 149.13 23.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.851 0.357 . . . . 0.0 110.262 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.26 145.69 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.16 128.75 9.01 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 t -113.9 132.99 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 110.462 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.59 134.26 35.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.288 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.31 55.2 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -73.33 136.02 44.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.229 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.15 69.26 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.79 -164.32 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.708 0.29 . . . . 0.0 110.484 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.63 158.15 0.88 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.181 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.33 128.8 20.08 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.442 2.095 . . . . 0.0 111.922 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.52 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 97.14 -24.05 33.02 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t -63.49 130.63 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -119.19 -58.75 1.91 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.537 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.2 t -151.45 151.44 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.753 0.311 . . . . 0.0 111.143 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.26 144.27 33.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.264 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.454 ' HB2' HD11 ' A' ' 76' ' ' LEU . 84.8 m-85 -112.77 134.64 54.19 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.448 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.31 141.04 52.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.413 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.539 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 45.8 m-20 -89.28 118.99 29.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.587 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.67 -40.02 91.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.577 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.6 mm -61.86 -46.97 95.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.682 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.8 103.81 8.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.973 0.416 . . . . 0.0 110.413 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.43 -38.38 83.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.263 0.554 . . . . 0.0 110.007 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.53 -36.37 73.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.901 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.83 125.9 31.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.932 0.396 . . . . 0.0 110.454 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -161.01 174.05 14.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.601 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.3 pp -159.98 158.76 31.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.1 t -127.68 139.36 52.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.22 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 t -111.15 123.71 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.86 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.52 HG23 ' C ' ' A' ' 61' ' ' GLY . 51.4 mt -121.59 124.86 72.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.962 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 61' ' ' GLY . 76.3 mt -122.91 131.89 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.81 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 159' ' ' LEU . 51.1 m -146.06 166.97 24.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.086 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 2.0 pm0 -106.14 132.44 52.21 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 83' ' ' ILE . 8.8 pt -88.75 148.93 42.77 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.506 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.71 136.68 43.07 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.629 1.553 . . . . 0.0 110.866 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -61.17 -27.15 68.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.947 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -67.8 -30.9 70.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.134 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -130.14 150.5 51.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.221 0.534 . . . . 0.0 111.576 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.476 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 81.4 p -112.6 174.87 5.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.713 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.6 tp -56.85 -41.2 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.01 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.3 p -69.82 -44.32 70.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.418 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 88' ' ' THR . 44.4 t0 -64.28 -34.81 78.99 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -54.92 -52.14 63.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.214 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.56 179.04 47.6 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.8 p -88.09 170.64 10.9 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.51 -41.88 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.836 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.3 m -72.14 -44.1 63.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.748 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -61.71 -52.88 62.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.35 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.1 -38.6 79.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.678 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.99 -43.98 94.75 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -67.14 -41.65 85.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.82 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -61.87 -38.95 90.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.665 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -62.29 -40.84 97.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.655 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -58.12 -45.68 86.86 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.499 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -65.29 -43.03 92.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.4 m -60.79 -45.67 93.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.945 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.56 -47.99 68.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.636 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.643 ' O ' ' N ' ' A' ' 111' ' ' GLN . 93.5 m-20 -62.6 -37.58 86.8 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.676 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -44.26 -37.0 2.98 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.309 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.38 -47.26 70.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.135 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.3 m -123.71 23.22 8.83 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.8 tt0 -50.32 -28.83 8.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.579 0.228 . . . . 0.0 111.328 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.67 -61.39 2.95 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.083 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -117.08 -35.94 3.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.929 0.364 . . . . 0.0 111.933 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -83.98 137.55 33.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.962 0.41 . . . . 0.0 111.266 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -129.13 139.9 51.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.959 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.54 135.15 44.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.333 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -114.51 125.18 53.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.182 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.535 ' C ' HD23 ' A' ' 118' ' ' LEU . 3.8 tt -84.58 109.83 18.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.252 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.455 ' N ' HD23 ' A' ' 118' ' ' LEU . 96.9 mt -74.6 -53.84 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.683 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -155.08 164.41 38.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.728 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.83 115.79 3.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.486 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -139.76 170.52 15.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.882 0.372 . . . . 0.0 110.69 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.401 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -141.28 150.52 42.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.645 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -132.45 139.07 47.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -108.46 114.19 27.83 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.452 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.94 142.98 34.31 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.96 0.41 . . . . 0.0 110.782 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 51.67 37.37 19.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.282 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.85 0.77 35.41 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -104.46 147.87 27.08 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.897 0.38 . . . . 0.0 110.115 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.71 128.56 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.108 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -117.16 126.83 53.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.822 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.3 m-85 -104.41 126.3 51.38 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.408 ' C ' HD12 ' A' ' 134' ' ' LEU . 89.9 m -109.26 122.66 47.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 110.321 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 133' ' ' THR . 8.3 mp -116.78 122.22 43.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.826 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -116.77 119.45 35.49 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -148.97 167.32 26.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.589 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -135.53 152.93 51.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.927 0.394 . . . . 0.0 110.635 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 m -105.86 136.03 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.909 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.45 137.08 38.36 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.173 0.511 . . . . 0.0 111.2 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.25 133.35 60.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.393 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.42 -119.19 11.0 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -116.53 15.28 15.61 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.851 -0.205 . . . . 0.0 111.174 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -129.03 153.86 47.19 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.896 0.379 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 144' ' ' VAL . 14.9 p -86.85 127.42 40.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.377 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -74.89 -52.22 11.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.631 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -174.55 173.9 2.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.087 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -109.2 137.31 47.28 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.163 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -130.87 142.65 50.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.884 0.373 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.2 tp -114.4 131.28 56.63 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.03 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -125.38 130.81 52.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.965 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.4 t -124.31 126.95 46.9 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.0 t -113.04 127.87 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 111.101 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.8 m -141.31 139.4 33.62 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.108 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.1 p -103.27 150.25 23.92 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.799 0.333 . . . . 0.0 110.342 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -149.14 106.07 3.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 57.04 30.89 18.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.814 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.06 5.22 68.12 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -95.61 123.56 39.22 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.06 118.0 28.47 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.76 126.68 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.863 0.364 . . . . 0.0 110.463 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.1 m -126.92 137.61 53.16 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.085 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.6 98.72 6.69 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.247 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -95.87 112.4 24.13 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.651 0.262 . . . . 0.0 110.58 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.6 mp -115.0 138.99 50.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.502 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 81.8 p -132.65 133.83 44.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.221 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 15.6 m -152.82 161.13 42.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.568 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.45 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -54.99 140.73 36.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.013 0.435 . . . . 0.0 111.181 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.66 -39.06 84.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 170' ' ' ARG . 37.8 p-10 -63.87 -32.58 74.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 15.1 tpt180 -94.65 -19.53 20.36 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.71 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.542 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 50.5 t-105 -47.95 -41.08 24.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.213 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.43 -42.09 98.2 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.172 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 46.9 m -66.68 -40.32 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.559 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 170' ' ' ARG . 11.2 m -108.77 21.48 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.332 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 171' ' ' TRP . 11.1 ptmm? -50.43 -49.81 53.78 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.284 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 22.2 m -64.86 -29.72 70.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.661 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 tp -55.5 -44.49 76.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.368 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.542 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 25.3 m-85 -62.55 -50.29 71.91 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.308 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.22 -41.31 99.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.757 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 184' ' ' SER . 45.2 m -66.65 -49.04 67.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 68.7 t -62.7 -43.85 98.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.457 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -64.63 -39.65 94.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.424 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 t -80.2 -28.18 38.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.144 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 180' ' ' THR . 67.4 m -62.43 -30.97 71.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.385 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -55.22 156.8 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.468 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -139.25 160.65 39.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.621 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.41 150.21 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 111.035 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 39.5 p90 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.689 179.747 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.17 144.06 91.27 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.705 2.27 . . . . 0.0 111.833 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 21' ' ' LEU . 2.7 mm? -63.8 -34.82 78.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.215 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.45 118.79 0.11 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.5 t -147.4 150.82 35.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.822 0.344 . . . . 0.0 110.433 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.1 m -80.0 108.44 13.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.384 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.58 63.85 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.79 -179.61 52.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -174.12 -20.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.372 . . . . 0.0 110.548 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.26 107.96 0.01 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.6 mt -59.76 -36.24 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.728 0.299 . . . . 0.0 110.708 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.79 66.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.761 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 m -136.98 21.52 3.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.491 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.595 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 55.9 mt -112.8 137.14 51.57 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.804 0.335 . . . . 0.0 110.825 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.595 ' NE2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -110.16 156.64 20.34 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.416 ' H ' ' HD2' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -120.77 140.56 51.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.384 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -125.03 135.36 52.68 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.037 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 t -146.02 147.89 32.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.903 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -138.37 118.35 13.37 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.9 p -70.99 -31.44 67.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.896 0.379 . . . . 0.0 110.247 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -62.29 -49.8 74.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.979 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -86.2 -20.61 28.29 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.37 40.24 80.26 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.83 149.91 39.21 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.219 0.509 . . . . 0.0 110.705 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -151.06 144.44 24.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.713 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -151.12 159.48 44.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.048 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.8 mt -100.2 151.28 21.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.394 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 11.2 p90 -150.91 146.74 19.62 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.535 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.24 161.36 44.73 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.441 2.094 . . . . 0.0 112.483 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -73.5 159.29 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.553 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.9 -2.18 63.91 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -93.67 144.53 25.31 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 pt -118.47 141.78 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.309 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.84 133.67 11.48 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.532 HG21 ' NH1' ' A' ' 67' ' ' ARG . 22.8 t -111.68 133.19 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.924 0.392 . . . . 0.0 110.745 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -83.45 138.86 33.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.201 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.69 54.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.152 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -78.29 129.21 34.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.645 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.95 -4.52 75.1 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.21 -162.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.518 -0.341 . . . . 0.0 110.141 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.0 m -36.79 111.19 0.5 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -45.2 134.47 11.59 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.752 1.635 . . . . 0.0 112.101 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.489 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 101.91 -35.97 4.57 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.28 134.32 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -115.48 -58.43 2.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.236 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.6 t -143.46 143.38 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.798 0.333 . . . . 0.0 111.113 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.487 HG11 ' NH2' ' A' ' 67' ' ' ARG . 44.2 t -120.35 131.75 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.417 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -112.81 133.39 54.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.418 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.532 ' NH1' HG21 ' A' ' 53' ' ' VAL . 73.5 mtt85 -131.56 138.91 49.08 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.54 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -87.4 118.73 27.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.358 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -61.41 -38.97 89.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.534 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.62 -48.44 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.467 ' CD ' HH12 ' A' ' 170' ' ' ARG . 96.0 mt-10 -126.85 102.71 7.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.568 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -69.56 -25.49 64.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.976 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -57.85 -38.97 76.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.204 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -98.29 139.59 33.84 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.718 0.294 . . . . 0.0 110.381 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -158.87 147.65 18.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.001 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.1 tt -115.11 134.7 54.94 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.193 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.1 t -131.8 144.47 50.94 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.33 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.44 132.5 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.072 0.463 . . . . 0.0 110.493 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.489 HG23 ' C ' ' A' ' 61' ' ' GLY . 28.0 mt -120.95 126.06 74.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.684 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.86 130.83 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.851 0.358 . . . . 0.0 110.486 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.9 m -139.63 161.96 36.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.953 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -105.44 132.54 51.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.738 0.304 . . . . 0.0 110.369 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -96.22 150.54 37.3 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.361 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.43 137.94 31.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.018 1.812 . . . . 0.0 111.045 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.7 t -63.28 -28.2 69.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.074 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.67 -31.14 70.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -129.97 158.41 39.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.139 0.495 . . . . 0.0 111.599 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.449 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.8 t -122.6 176.34 5.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.449 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.8 tp -52.36 -44.72 65.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.179 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.9 p -66.13 -45.59 80.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.92 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 88' ' ' THR . 86.4 m-20 -67.56 -35.44 79.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.737 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.0 tp -55.88 -42.09 75.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.5 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.95 175.79 45.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.415 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 38.0 p -93.93 171.19 9.02 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.09 -42.01 76.06 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.186 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.0 m -72.39 -44.93 61.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.029 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.3 t0 -62.1 -51.24 68.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.45 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.94 -38.76 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.558 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.5 -45.91 93.86 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -66.03 -41.21 91.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.642 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -62.29 -38.56 89.82 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.685 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -62.41 -41.46 98.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.1 mmt -58.81 -44.41 90.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.949 0.404 . . . . 0.0 110.34 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -64.97 -39.87 94.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.495 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.0 m -59.48 -47.26 86.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.857 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.6 t -71.59 -45.61 66.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.993 0.425 . . . . 0.0 110.331 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 111' ' ' GLN . 86.6 m-20 -62.06 -31.96 72.43 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.277 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -42.61 -36.15 1.3 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.219 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.82 -16.25 14.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.016 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.503 ' C ' ' H ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -101.48 -3.33 28.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 107' ' ' ASN . 32.7 tt0 -67.12 13.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.961 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -84.99 -64.25 1.55 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.208 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.2 p-10 -118.59 -39.06 3.03 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.53 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 20.2 ptp180 -101.43 159.79 14.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.01 0.433 . . . . 0.0 111.24 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -130.0 150.24 51.37 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.518 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.411 ' HB3' ' OD1' ' A' ' 107' ' ' ASN . . . -104.25 138.28 40.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.15 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -123.44 130.32 52.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.536 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.1 tt -84.13 108.88 17.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.014 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.417 ' N ' HD23 ' A' ' 118' ' ' LEU . 96.6 mt -71.12 -54.95 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.783 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.55 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 11.4 p30 -156.65 176.78 12.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.976 0.417 . . . . 0.0 111.122 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.6 128.4 6.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.327 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -142.07 160.74 39.61 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.505 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.29 144.68 42.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.904 0.383 . . . . 0.0 110.47 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -131.94 152.46 51.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -124.91 116.34 22.04 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.562 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.87 144.5 33.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.013 0.435 . . . . 0.0 110.825 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.1 t0 52.29 28.99 6.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.58 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.96 -1.79 77.86 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -100.83 146.6 27.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.263 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.8 129.72 65.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.159 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -118.45 123.65 45.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.322 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.63 124.2 48.39 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.3 m -102.76 133.12 48.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.822 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.91 108.0 9.8 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.963 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.55 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 70.6 tt0 -100.12 126.17 46.32 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -148.22 168.74 21.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.159 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -137.77 160.0 40.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.479 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.51 133.73 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.461 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 3.0 pp -134.06 143.86 48.3 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.335 0.588 . . . . 0.0 111.1 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 140' ' ' VAL . 14.5 p -108.54 133.29 54.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.248 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 51.75 -108.34 0.6 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -116.96 12.53 14.67 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -119.13 146.15 45.37 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.858 0.361 . . . . 0.0 111.704 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.6 128.28 37.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.816 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 70.5 tt0 -83.48 -53.51 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.406 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.474 ' HE ' ' HG ' ' A' ' 165' ' ' SER . 6.5 ptm85 -172.64 171.99 4.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.424 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 63.7 m80 -108.89 137.44 46.8 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.256 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 84.4 m-20 -135.85 141.4 44.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.9 0.381 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 57.7 tp -116.49 136.71 52.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.986 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.87 132.82 39.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.938 0.399 . . . . 0.0 110.56 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.8 t -119.08 135.75 54.49 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.692 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.87 130.16 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.963 0.411 . . . . 0.0 110.542 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 59.8 m -148.86 146.26 27.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.84 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.3 p -90.7 156.63 17.95 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.579 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 158' ' ' LYS . 9.1 t-20 -150.87 95.9 2.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.787 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 55.65 39.24 30.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.8 7.57 77.98 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 155' ' ' ASN . 68.9 mmtt -110.61 137.73 47.91 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 110.017 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.24 117.46 26.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.816 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.1 mm -107.92 119.97 58.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.1 m -120.49 132.22 55.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.814 0.34 . . . . 0.0 110.185 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.01 103.95 11.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.622 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -103.37 120.19 40.32 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.899 0.38 . . . . 0.0 111.562 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 mp -115.58 142.92 46.08 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.083 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.474 ' HG ' ' HE ' ' A' ' 146' ' ' ARG . 31.1 t -137.06 131.95 33.48 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.432 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 167' ' ' ALA . 21.3 m -152.87 159.06 42.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.696 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.447 ' N ' HG22 ' A' ' 166' ' ' THR . . . -54.31 145.41 17.89 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.28 -36.68 71.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.8 -33.14 75.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.183 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 174' ' ' VAL . 80.1 mtp180 -97.53 -16.69 19.98 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.515 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.604 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 48.4 t-105 -48.03 -41.73 26.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 110.691 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.38 -41.69 98.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.062 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.3 m -65.68 -40.39 92.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.382 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 170' ' ' ARG . 7.9 m -107.2 21.51 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 171' ' ' TRP . 20.8 pttm -48.94 -45.38 41.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.412 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 86.7 p -67.89 -27.49 66.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.574 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.63 -44.61 85.7 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.917 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.604 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.4 m-85 -62.29 -50.01 73.4 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.388 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.24 -41.53 98.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.665 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.8 m -68.75 -49.62 57.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.4 -38.55 79.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.348 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.89 -40.55 97.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.294 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.2 p -80.96 -17.77 49.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.346 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -62.77 -37.76 87.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.193 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -54.29 146.09 16.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.771 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -135.91 154.95 50.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.6 m -127.22 151.56 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.903 0.382 . . . . 0.0 111.336 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 43.5 p90 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.768 -179.731 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.498 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 31.7 Cg_endo -62.65 147.02 95.33 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.761 2.308 . . . . 0.0 111.831 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.4 tp -93.68 128.5 39.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.235 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.89 11.58 0.17 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.3 m -64.25 154.77 34.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.4 p -150.56 -11.7 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.541 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.85 -128.25 28.88 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.43 -170.7 46.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.78 157.32 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.799 0.333 . . . . 0.0 110.47 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.05 -178.14 49.95 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 mm -77.73 51.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 110.024 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.28 157.17 41.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.202 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.7 t -84.76 136.32 33.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.582 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.7 mt -100.57 146.14 27.49 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.522 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.3 pm0 -138.51 165.51 26.67 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.062 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -119.09 139.89 51.01 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.086 0.469 . . . . 0.0 111.411 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -122.44 130.15 52.78 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.73 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.9 m -131.2 150.18 52.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.829 0.347 . . . . 0.0 110.821 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -139.1 122.08 16.7 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.448 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.1 p -75.36 -29.09 59.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.287 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.25 -48.35 81.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.56 ' OD2' HD12 ' A' ' 80' ' ' ILE . 49.6 t0 -93.12 -20.06 20.87 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.85 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.52 42.6 72.3 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.02 148.49 40.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.056 0.428 . . . . 0.0 110.199 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -146.51 142.07 27.68 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -154.03 158.17 40.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.075 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 45' ' ' LEU . 11.1 mp -100.96 144.63 29.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.153 0.501 . . . . 0.0 110.424 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -148.4 148.15 27.84 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.866 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.59 155.86 68.45 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.298 1.999 . . . . 0.0 112.159 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.765 ' C ' HD21 ' A' ' 48' ' ' ASN . 0.2 OUTLIER -72.71 160.69 31.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.93 -179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.28 1.77 59.26 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.519 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 33.2 m0 -92.76 145.12 24.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.659 0.266 . . . . 0.0 110.296 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.4 pt -121.26 145.1 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.356 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.27 131.0 10.42 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.57 132.19 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.951 0.405 . . . . 0.0 110.521 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -81.84 135.73 35.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.196 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.59 56.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.412 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -74.94 132.9 41.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.112 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.8 2.62 71.91 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.06 -164.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.445 ' OG ' ' CG2' ' A' ' 62' ' ' VAL . 79.5 p -39.96 123.65 1.6 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.51 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -42.04 121.48 1.84 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.957 1.772 . . . . 0.0 112.823 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 107.69 -42.39 1.95 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.445 ' CG2' ' OG ' ' A' ' 59' ' ' SER . 56.1 t -63.88 122.04 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -120.0 -48.57 2.34 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.516 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.6 t -128.64 137.93 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 110.889 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.56 135.03 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.646 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.74 132.95 54.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.071 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' NH1' ' OD1' ' A' ' 75' ' ' ASN . 53.4 ttt85 -130.86 132.56 45.25 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.434 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.519 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 75.3 m-20 -92.27 118.86 31.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.58 -36.92 83.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.548 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.84 -42.51 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.82 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -117.51 105.78 12.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.891 0.376 . . . . 0.0 110.693 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.72 -37.57 67.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.607 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 40.3 p-10 -62.59 -33.11 74.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.081 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 83.4 tt0 -87.16 130.42 34.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.888 0.375 . . . . 0.0 110.585 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.433 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 10.9 m-80 -140.85 139.18 34.42 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.089 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.9 tt -126.14 134.32 51.34 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.8 m -126.87 146.69 50.19 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.306 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.32 128.41 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.952 0.406 . . . . 0.0 110.278 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.467 HG23 ' C ' ' A' ' 61' ' ' GLY . 5.5 mt -117.12 116.84 53.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.974 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.56 HD12 ' OD2' ' A' ' 40' ' ' ASP . 33.4 mm -116.01 123.97 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.922 0.392 . . . . 0.0 110.469 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 159' ' ' LEU . 75.3 m -146.67 160.59 42.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.05 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.575 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 1.9 pm0 -103.95 132.7 49.95 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.6 pt -88.54 148.33 41.79 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.661 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' LYS . 39.0 Cg_endo -66.7 138.02 47.78 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.716 1.611 . . . . 0.0 110.612 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.9 p -63.69 -26.11 68.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.994 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.08 -31.02 70.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.959 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 84' ' ' PRO . 97.4 mttt -130.62 155.63 46.24 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.046 0.45 . . . . 0.0 111.228 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.8 t -122.82 174.97 6.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.346 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 tp -53.05 -43.53 66.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.6 p -67.39 -44.43 78.93 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.044 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 88' ' ' THR . 89.9 m-20 -68.44 -34.81 76.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.979 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -55.57 -42.33 74.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.478 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.65 177.99 46.89 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.0 p -92.69 172.22 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.39 76.0 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.222 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.5 m -72.68 -45.21 59.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.854 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.9 t0 -62.33 -51.62 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.68 -38.83 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.543 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -57.8 -53.26 46.74 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -62.24 -36.41 81.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.57 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -57.16 -38.37 73.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.599 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.37 -41.12 98.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.865 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.678 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -55.84 -54.06 49.18 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.396 0.617 . . . . 0.0 109.802 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -61.92 -38.42 88.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.802 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -59.42 -46.98 87.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.858 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.7 t -71.29 -46.23 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 0.0 110.384 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.0 m-20 -62.23 -31.02 71.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.053 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -43.99 -36.91 2.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.089 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.06 -11.1 14.98 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.234 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -121.32 18.11 11.44 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.506 -178.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 107' ' ' ASN . 20.2 pt20 -75.64 2.13 12.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.563 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.67 -62.5 2.38 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.802 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.4 p-10 -117.25 -38.11 3.41 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.844 0.354 . . . . 0.0 111.477 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.531 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 40.4 ttm180 -79.2 141.28 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.28 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -129.5 132.48 46.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.959 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.77 134.11 46.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.895 0.378 . . . . 0.0 110.334 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.66 122.51 40.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.319 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 tp -81.29 111.11 17.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.327 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.521 ' CG1' ' HE ' ' A' ' 137' ' ' ARG . 97.0 mt -71.57 -42.75 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.891 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 177.76 174.47 0.52 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.297 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.81 144.15 22.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.161 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.411 ' OE1' ' N ' ' A' ' 122' ' ' GLU . 57.5 mp0 -144.07 145.86 32.45 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.857 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.32 135.65 53.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.311 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -116.86 159.2 22.73 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -139.51 107.29 5.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.516 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.43 144.91 38.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.933 0.397 . . . . 0.0 111.052 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.1 t0 52.8 30.24 8.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.59 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.69 0.92 75.76 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -102.9 146.68 27.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.903 0.382 . . . . 0.0 110.154 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.34 129.23 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.344 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -117.63 127.97 54.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -105.88 122.44 46.12 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.427 ' C ' HD12 ' A' ' 134' ' ' LEU . 87.1 m -105.55 123.33 47.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.234 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.427 HD12 ' C ' ' A' ' 133' ' ' THR . 9.5 mp -114.38 125.01 53.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.93 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -120.36 117.99 29.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.362 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -146.48 162.5 38.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.27 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.521 ' HE ' ' CG1' ' A' ' 119' ' ' ILE . 19.8 ptp180 -124.54 149.05 47.37 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.015 0.436 . . . . 0.0 110.803 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.05 133.87 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.352 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -139.91 134.86 32.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.242 0.544 . . . . 0.0 110.923 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.442 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 32.0 t -116.57 135.64 56.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.387 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.27 -122.39 18.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -112.31 14.91 20.51 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 140' ' ' VAL . 21.7 p-10 -133.5 160.14 38.3 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 111.509 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 144' ' ' VAL . 13.2 p -87.07 127.88 40.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.453 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.411 ' HG2' ' HE ' ' A' ' 146' ' ' ARG . 82.7 tt0 -76.45 -55.2 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.756 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.475 ' NH1' ' O ' ' A' ' 73' ' ' ASP . 20.1 ptp180 -174.82 174.58 2.55 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.078 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 61.7 m170 -103.01 139.0 39.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.011 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -132.84 133.36 43.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.974 0.416 . . . . 0.0 111.161 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.5 tp -111.52 133.96 53.43 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.908 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.39 131.49 48.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.921 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.5 t -120.97 123.04 41.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.2 129.04 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.015 0.436 . . . . 0.0 111.186 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.5 m -143.69 146.19 33.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.29 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.5 p -111.15 152.02 27.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.751 0.31 . . . . 0.0 110.263 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -158.46 119.85 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 55.94 29.74 14.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.77 14.28 78.05 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -105.38 128.43 53.5 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -90.02 119.29 30.25 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.39 128.1 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.7 0.286 . . . . 0.0 110.738 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.8 m -131.18 139.44 49.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.394 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.75 103.99 11.76 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.224 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -99.31 110.27 22.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.627 0.251 . . . . 0.0 110.422 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.4 mp -116.2 134.63 54.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.58 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 55.7 m -125.91 136.63 53.26 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.058 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.6 m -152.86 157.33 40.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.46 142.28 49.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.375 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -69.09 -30.64 68.98 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.033 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.86 -34.12 71.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.053 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.45 ' O ' HG22 ' A' ' 174' ' ' VAL . 71.0 mtp85 -113.24 -3.85 13.81 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.498 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.9 t-105 -49.78 -39.16 37.14 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.882 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.98 -42.18 99.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.091 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 56.9 m -64.78 -39.81 94.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.74 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.466 HG23 ' CZ ' ' A' ' 178' ' ' PHE . 14.7 m -107.97 21.08 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.262 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -50.06 -49.48 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.285 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.3 t -64.63 -30.72 71.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.846 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -55.21 -44.06 75.03 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.217 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 24.3 m-85 -61.56 -50.33 73.07 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.348 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -64.47 -40.17 95.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.656 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 184' ' ' SER . 41.9 m -66.84 -47.11 72.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.501 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 63.9 t -62.7 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.664 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.47 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -67.01 -46.8 73.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.208 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.1 m -68.72 -33.14 73.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.382 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 180' ' ' THR . 17.8 t -62.2 -27.55 69.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.699 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -56.11 159.18 3.52 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.779 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -135.77 157.89 45.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.8 151.04 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.098 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.485 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 46.2 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.785 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.03 147.53 94.38 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.771 2.314 . . . . 0.0 111.796 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 21' ' ' LEU . 7.2 mp -86.01 143.82 27.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.52 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 21' ' ' LEU . . . -57.31 -118.71 0.01 OUTLIER Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -115.08 148.63 38.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.811 0.338 . . . . 0.0 110.445 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.9 m -86.67 125.04 33.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.53 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.32 -177.04 51.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.71 155.06 46.19 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 28' ' ' GLY . 42.7 t -120.7 134.85 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 110.378 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 27' ' ' VAL . . . 57.39 113.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.79 -36.35 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.953 0.406 . . . . 0.0 110.616 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -155.95 84.64 1.02 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.272 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.549 ' O ' ' OG ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -162.03 46.13 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.605 0.717 . . . . 0.0 110.334 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.2 mt -135.37 131.96 36.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.705 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.481 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 20.9 mp0 -130.68 162.48 29.32 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.251 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -121.25 145.77 47.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.574 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -129.38 134.96 48.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.342 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.9 p -143.19 157.12 44.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.637 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -146.3 119.23 8.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.417 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.1 p -70.49 -32.82 70.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.586 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -62.65 -48.86 77.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.078 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -87.67 -20.75 25.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.869 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.03 39.83 88.8 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.31 151.45 45.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.299 0.549 . . . . 0.0 110.415 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -153.24 143.78 22.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.799 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -150.73 157.71 43.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 mt -98.5 150.96 21.13 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.558 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -152.17 146.11 18.19 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.003 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.48 153.62 69.96 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.397 2.065 . . . . 0.0 112.508 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -69.37 159.37 33.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.997 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.13 -2.51 63.65 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.533 ' CD1' ' OD1' ' A' ' 68' ' ' ASP . 35.8 m0 -94.91 147.13 23.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.772 0.32 . . . . 0.0 110.276 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.8 pt -120.4 149.88 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.324 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -114.98 141.8 17.25 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.7 144.9 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.756 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -84.38 134.87 34.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.379 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.91 55.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.491 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -70.89 135.01 47.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.82 2.34 69.58 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.44 -164.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.641 0.258 . . . . 0.0 110.485 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.76 154.36 1.24 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.215 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.18 131.24 24.6 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.277 1.985 . . . . 0.0 111.915 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.516 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 95.47 -22.28 39.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.43 133.85 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.176 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -118.65 -58.3 1.98 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.639 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 78' ' ' VAL . 44.2 t -145.16 148.99 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.928 0.394 . . . . 0.0 111.504 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.56 136.45 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.655 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -112.36 143.11 44.01 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.292 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -145.09 145.78 31.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.847 0.356 . . . . 0.0 110.682 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.533 ' OD1' ' CD1' ' A' ' 50' ' ' TRP . 62.8 m-20 -101.73 122.01 43.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.685 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.42 -39.92 95.78 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.231 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.6 -38.59 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.61 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -126.43 94.62 4.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.46 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -62.19 -38.44 89.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.15 0.5 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 42.1 p-10 -61.78 -32.48 72.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.198 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.525 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 14.0 tm-20 -86.21 125.94 33.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.946 0.403 . . . . 0.0 110.202 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -171.76 168.91 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.574 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.6 pp -157.23 157.12 33.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.509 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 m -131.16 147.86 52.65 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 m -115.67 128.19 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.188 0.518 . . . . 0.0 109.987 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.516 HG23 ' C ' ' A' ' 61' ' ' GLY . 56.3 mt -117.08 124.37 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.805 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' GLY . 66.0 mt -118.25 128.8 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.473 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.3 m -138.38 163.38 32.02 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.93 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.77 134.72 47.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.688 0.28 . . . . 0.0 110.403 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.447 ' CG2' HD12 ' A' ' 159' ' ' LEU . 10.8 pt -103.23 149.21 36.72 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.679 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 87' ' ' LYS . 48.4 Cg_endo -68.24 137.57 40.67 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.105 1.87 . . . . 0.0 111.327 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.4 t -62.46 -27.66 69.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.15 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -67.48 -31.36 71.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.897 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 84' ' ' PRO . 67.9 mttm -128.73 151.96 48.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.077 0.465 . . . . 0.0 111.047 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.414 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.0 t -120.54 178.22 4.76 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.491 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.404 HD21 ' CG ' ' A' ' 132' ' ' TYR . 47.0 tp -50.12 -44.32 52.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.094 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.0 p -65.33 -42.95 92.41 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.936 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 88' ' ' THR . 86.6 m-20 -65.45 -39.13 91.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.804 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.8 tp -56.4 -43.53 79.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.585 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.7 176.25 45.57 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.412 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 33.5 p -93.2 172.58 8.21 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.74 79.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.1 m -72.26 -44.48 62.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.2 t0 -61.92 -50.98 69.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.303 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 82.1 t -60.49 -38.67 78.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.498 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.69 -44.02 94.21 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -69.33 -42.45 75.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.896 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -61.29 -39.05 89.01 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.961 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -62.03 -40.63 96.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.38 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.78 -44.26 94.01 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.404 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.28 -39.45 93.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.266 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.3 m -60.19 -47.63 85.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.811 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.52 -45.4 68.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.96 0.41 . . . . 0.0 110.496 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 111' ' ' GLN . 85.1 m-20 -62.41 -30.35 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.244 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -45.03 -39.91 6.09 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.972 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.48 -4.28 29.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.693 0.282 . . . . 0.0 110.8 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -121.44 14.65 11.17 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.052 -179.226 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 107' ' ' ASN . 6.5 tt0 -72.03 3.06 4.76 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.092 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.37 -64.6 1.44 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.67 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -117.71 -48.6 2.57 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.996 0.427 . . . . 0.0 111.379 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' SER . 84.4 mtt180 -70.12 149.02 48.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.508 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -134.43 129.83 35.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.849 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.76 128.21 46.89 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.76 0.314 . . . . 0.0 110.223 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -115.08 128.77 56.44 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.1 tp -81.98 108.99 15.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.081 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.39 -53.76 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.547 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.518 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 24.3 p30 -163.11 167.77 21.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.645 179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.94 124.38 5.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.418 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -141.78 162.89 34.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.628 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.405 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.64 148.4 50.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.47 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -130.64 141.47 50.43 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.176 0.512 . . . . 0.0 111.258 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -107.65 112.69 25.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.275 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.25 141.47 35.86 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.945 0.403 . . . . 0.0 110.693 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.69 38.95 24.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.207 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.59 0.7 25.95 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -105.54 147.35 28.46 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.983 0.42 . . . . 0.0 110.189 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.19 128.38 72.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.011 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 21.2 m-85 -116.68 129.36 56.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.844 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.405 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.5 m-85 -104.11 128.23 51.75 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.3 m -110.93 123.89 51.04 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.248 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.6 mp -117.49 124.42 48.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.938 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.518 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 71.1 tt0 -118.07 120.2 37.06 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -147.05 170.02 18.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.075 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.551 ' NH2' ' NE2' ' A' ' 147' ' ' HIS . 11.6 ptm180 -138.18 155.56 48.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 110.8 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.62 133.52 47.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.374 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -142.71 136.37 28.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.197 0.522 . . . . 0.0 111.498 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.3 t -108.2 130.49 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.003 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.62 -119.52 18.98 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -110.02 10.52 24.14 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.816 -0.226 . . . . 0.0 111.228 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -117.74 147.35 43.05 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.761 0.315 . . . . 0.0 111.149 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.468 HG11 HH21 ' A' ' 137' ' ' ARG . 43.2 t -88.14 127.0 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.743 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -76.2 -54.03 7.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -173.7 174.36 3.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.181 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.551 ' NE2' ' NH2' ' A' ' 137' ' ' ARG . 29.9 m170 -104.87 139.86 38.99 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 83.9 m-20 -134.64 136.9 43.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -113.62 132.43 55.76 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.114 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -127.16 131.95 50.62 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.008 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.9 t -125.12 127.67 47.23 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.74 128.12 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.987 0.422 . . . . 0.0 110.939 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.8 m -139.72 141.84 36.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.035 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.7 p -104.76 152.6 22.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.909 0.385 . . . . 0.0 110.463 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -162.75 122.87 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 55.67 29.34 13.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.354 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.69 13.21 80.37 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -107.84 140.63 40.66 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.678 0.275 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.447 HD12 ' CG2' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -97.67 120.39 37.97 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 80.5 mt -118.46 124.48 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.049 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.2 m -125.93 136.18 52.74 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.314 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.07 99.85 7.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.061 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -97.2 111.63 23.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.668 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.07 138.25 51.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.831 0.348 . . . . 0.0 110.48 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 61.4 p -134.57 135.35 42.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.967 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 6.4 m -152.93 161.67 42.26 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.634 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.619 ' CB ' HH21 ' A' ' 170' ' ' ARG . . . -54.22 144.31 20.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.313 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -70.41 -36.34 73.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.055 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -62.76 -33.42 75.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.356 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.619 HH21 ' CB ' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -97.68 -19.89 17.96 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.896 -179.341 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.492 ' O ' ' N ' ' A' ' 175' ' ' LYS . 59.5 t-105 -45.58 -40.34 8.67 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.77 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.12 -42.61 99.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.199 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 55.0 m -66.96 -39.32 87.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.539 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 170' ' ' ARG . 6.0 m -109.55 21.48 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 171' ' ' TRP . 16.9 pttm -51.69 -47.62 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.497 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 85.8 p -69.61 -24.09 63.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.467 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 181' ' ' VAL . 11.3 tp -59.07 -42.57 90.69 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.994 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.415 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 20.2 m-85 -66.9 -50.22 63.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.485 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.47 -41.22 98.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.579 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 184' ' ' SER . 47.8 m -67.91 -49.32 62.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 177' ' ' LEU . 55.9 t -61.55 -42.99 96.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.462 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.61 -40.32 96.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.924 0.392 . . . . 0.0 110.287 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 39.1 m -79.63 -28.42 40.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.349 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 180' ' ' THR . 87.8 p -63.19 -23.55 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.505 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -63.24 157.55 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.437 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -139.6 160.26 40.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.731 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.46 151.12 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 38.0 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.72 -179.812 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.04 147.94 93.91 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.827 2.351 . . . . 0.0 111.593 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 21' ' ' LEU . 7.9 mp -58.63 -36.99 74.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.07 21.85 69.85 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.467 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 43.1 m -61.77 147.72 45.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.402 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 23' ' ' SER . 43.9 m -159.78 46.2 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.257 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.95 -105.57 1.3 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.41 32.57 27.76 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.8 m -60.26 137.14 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.726 0.298 . . . . 0.0 110.218 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.95 138.7 48.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -82.35 82.6 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.678 0.275 . . . . 0.0 110.38 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.93 -140.7 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.289 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.513 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 44.0 t -117.34 136.22 53.29 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.366 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.0 mt -112.49 146.07 39.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.252 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.658 HE22 ' HA ' ' A' ' 48' ' ' ASN . 5.2 pm0 -131.16 152.52 50.36 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.229 179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -109.67 128.4 55.23 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.008 0.432 . . . . 0.0 110.958 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -114.31 119.04 35.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.544 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 50.0 m -126.98 149.07 50.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.934 0.397 . . . . 0.0 110.949 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 36' ' ' SER . 87.4 m-20 -138.18 111.4 7.94 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.245 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.9 p -64.41 -34.05 77.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.46 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 26.2 mtpp -60.9 -43.87 97.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.51 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -89.6 -20.41 23.76 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.092 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.34 37.56 90.68 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.1 151.12 45.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.095 0.448 . . . . 0.0 110.384 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -150.54 147.28 27.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 45' ' ' LEU . 43.3 t80 -160.77 147.57 15.33 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.067 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' O ' ' CE2' ' A' ' 44' ' ' PHE . 9.9 mp -93.77 143.3 26.46 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.943 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -149.51 130.63 7.2 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.991 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.97 157.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.221 1.947 . . . . 0.0 112.892 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.658 ' HA ' HE22 ' A' ' 33' ' ' GLN . 66.9 m-80 -81.41 158.13 24.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.987 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.24 0.83 61.27 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -81.05 149.73 29.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.5 pt -113.4 142.25 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.376 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.34 133.47 11.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.4 t -108.85 133.33 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.853 0.359 . . . . 0.0 110.412 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.63 124.39 32.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.271 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.84 55.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.606 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -80.48 130.17 34.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.744 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.66 -3.57 78.47 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 59' ' ' SER . . . -80.25 -162.84 0.48 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.299 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 58' ' ' ALA . 28.2 m -36.43 109.24 0.41 Allowed Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.76 135.04 10.13 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.865 1.71 . . . . 0.0 111.997 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 102.19 -36.0 4.57 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.96 127.08 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.116 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.44 ' OD2' HD12 ' A' ' 80' ' ' ILE . 31.3 t0 -103.55 -59.11 1.77 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.693 0.283 . . . . 0.0 110.927 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.4 t -150.56 141.21 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.17 130.95 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.76 133.91 55.53 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.521 ' NH2' ' OD1' ' A' ' 75' ' ' ASN . 76.2 mtp85 -124.55 140.89 52.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.719 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -88.48 118.31 28.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.391 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -62.42 -39.23 92.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.335 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.6 mm -63.46 -42.3 95.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.792 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -112.86 107.04 15.49 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.816 0.341 . . . . 0.0 110.85 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -73.76 -45.9 48.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.309 0.576 . . . . 0.0 110.278 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.41 -37.24 74.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.206 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -84.08 129.53 34.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.382 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.521 ' OD1' ' NH2' ' A' ' 67' ' ' ARG . 7.4 m-80 -130.29 148.07 52.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.007 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.661 HD13 ' N ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -124.63 133.75 53.14 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.661 ' N ' HD13 ' A' ' 76' ' ' LEU . 1.9 p -136.31 138.23 41.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.96 0.409 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.9 t -122.08 130.62 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.931 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.45 HG23 ' C ' ' A' ' 61' ' ' GLY . 28.0 mt -121.02 131.83 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.462 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.44 HD12 ' OD2' ' A' ' 63' ' ' ASP . 60.8 mt -122.54 133.05 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.621 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' LEU . 49.2 m -143.53 164.1 31.3 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.239 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -105.5 138.23 42.04 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.522 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.82 153.37 38.28 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.253 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 87' ' ' LYS . 72.4 Cg_endo -75.68 141.49 24.81 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.379 2.052 . . . . 0.0 110.892 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.8 p -68.44 -26.45 65.52 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.918 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -69.22 -32.0 70.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.972 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 84' ' ' PRO . 64.9 mttm -130.87 157.95 41.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.999 0.428 . . . . 0.0 111.302 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.7 t -123.12 175.47 6.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.834 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.5 tp -49.98 -45.31 51.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.07 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.1 p -65.61 -44.45 86.52 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.79 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.72 -36.26 83.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.99 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.63 ' O ' HD23 ' A' ' 92' ' ' LEU . 4.9 tt -55.87 -47.7 76.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.429 . . . . 0.0 110.245 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.19 177.5 46.95 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.0 p -90.94 170.13 10.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.93 74.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.96 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.0 m -71.43 -45.07 63.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.5 -53.29 58.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.299 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 80.0 t -61.25 -39.73 83.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.705 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.09 -45.11 92.81 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -66.28 -41.62 89.58 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -62.21 -39.38 92.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -62.2 -40.54 96.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.703 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.8 mmt -58.16 -44.93 88.18 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.599 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.55 -44.49 90.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 110.066 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.7 m -60.2 -44.76 94.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.837 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.75 -46.21 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.461 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 111' ' ' GLN . 87.8 m-20 -64.36 -42.12 96.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.053 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -43.6 -20.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.37 . . . . 0.0 110.748 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 107' ' ' ASN . . . -91.1 -43.67 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.607 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.8 p -119.38 19.63 12.69 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.2 tt0 -56.38 -28.78 60.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.337 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -42.53 -62.64 2.12 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.23 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -117.63 -44.3 2.75 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.766 0.317 . . . . 0.0 111.336 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -80.47 144.95 32.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.469 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -131.53 142.55 49.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.162 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.16 135.41 44.86 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -116.73 129.64 56.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.9 tt -81.5 104.28 11.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.12 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.4 mt -70.35 -45.88 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.334 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -169.65 166.71 9.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.363 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.14 126.3 5.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.413 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -142.9 163.5 32.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.748 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.17 149.69 46.08 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.506 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -131.65 144.89 51.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.143 0.497 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -111.53 114.53 27.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.557 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.91 138.57 33.97 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.504 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 52.05 40.97 29.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.788 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.78 2.29 7.7 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -103.32 133.19 48.81 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.63 130.45 55.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.389 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -118.02 128.39 54.73 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -105.51 129.83 53.71 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.436 ' C ' HD12 ' A' ' 134' ' ' LEU . 87.4 m -113.21 122.92 48.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.436 HD12 ' C ' ' A' ' 133' ' ' THR . 9.3 mp -115.39 126.1 53.99 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.739 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -118.81 122.12 41.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.768 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -150.44 171.3 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.29 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -136.5 156.58 48.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 110.494 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.2 t -106.39 135.01 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.025 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.79 136.25 30.48 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.163 0.506 . . . . 0.0 111.58 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.2 t -97.79 121.79 48.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.74 -110.89 3.08 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -113.31 10.56 18.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.565 0.222 . . . . 0.0 110.871 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -113.34 137.16 51.91 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.684 0.278 . . . . 0.0 111.317 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 144' ' ' VAL . 7.2 p -78.73 126.63 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.637 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -81.05 -55.04 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.474 ' NH2' ' C ' ' A' ' 166' ' ' THR . 6.5 ptm85 -172.56 174.22 3.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 56.2 m170 -105.05 138.38 41.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.131 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 82.2 m-20 -135.36 130.93 35.71 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.725 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 tp -110.89 128.16 55.7 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.9 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.6 134.84 55.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.24 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.0 t -125.68 121.73 34.3 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.1 t -105.67 129.44 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.934 0.397 . . . . 0.0 110.874 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 59.8 m -142.79 144.42 32.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.0 p -86.93 156.82 19.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.871 0.367 . . . . 0.0 110.762 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -150.35 95.94 2.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.721 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 54.2 43.32 30.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.479 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.43 18.25 66.89 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.728 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 40.9 mtpt -121.71 137.26 54.83 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.952 0.376 . . . . 0.0 111.108 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 81' ' ' SER . 1.2 mt -91.81 119.28 31.47 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.29 122.14 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.2 m -115.72 133.24 56.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 110.245 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -105.2 110.23 22.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.612 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.82 122.14 43.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.951 0.405 . . . . 0.0 111.675 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mt -115.64 132.91 56.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.543 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.4 m -130.26 130.62 44.8 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.859 0.361 . . . . 0.0 110.31 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.474 ' C ' ' NH2' ' A' ' 146' ' ' ARG . 3.7 m -153.02 158.12 41.52 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.34 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -57.0 143.38 38.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.205 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -69.85 -29.64 66.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.166 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.19 -33.77 72.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.215 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.491 ' O ' HG22 ' A' ' 174' ' ' VAL . 86.8 mtt180 -111.84 -6.48 14.27 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.557 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 53.7 t-105 -48.25 -39.52 21.67 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.811 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.85 -42.04 97.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 56.6 m -65.47 -39.99 92.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.569 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 170' ' ' ARG . 8.5 m -107.71 21.44 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.255 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -49.21 -48.19 45.57 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.447 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.0 m -64.2 -32.08 73.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.649 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.9 tp -53.81 -44.94 70.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.045 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.557 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 18.9 m-85 -62.45 -49.04 77.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.477 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.92 -41.58 99.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 184' ' ' SER . 48.8 m -67.72 -47.62 68.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.438 HG13 ' CZ ' ' A' ' 44' ' ' PHE . 56.0 t -62.81 -43.73 99.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.627 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -61.6 -38.45 87.64 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.7 t -85.14 -20.4 30.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 180' ' ' THR . 45.5 t -62.11 -33.58 74.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.059 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.2 OUTLIER -57.21 159.56 4.42 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.321 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -138.28 152.77 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 13.9 m -128.0 151.49 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.082 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.623 -179.734 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 28.2 Cg_endo -61.67 -23.61 76.57 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.721 2.281 . . . . 0.0 111.766 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 23' ' ' SER . 2.5 pp -59.9 -35.64 75.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.462 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.34 33.71 0.96 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 21' ' ' LEU . 54.0 p -65.18 160.32 21.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 110.605 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.2 m -93.82 130.71 39.74 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.48 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.82 -122.87 23.21 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.4 2.38 63.74 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 m -129.79 158.05 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.773 0.32 . . . . 0.0 110.142 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.98 3.35 0.11 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 30' ' ' ALA . 15.8 mm -100.36 154.5 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 29' ' ' ILE . . . -30.09 -69.09 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.578 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.8 p -149.68 152.48 35.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.754 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.3 mt -117.18 143.51 45.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.404 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.486 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 0.4 OUTLIER -139.53 160.48 39.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.078 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -129.98 147.83 51.77 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.138 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.664 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -124.93 158.38 33.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.453 178.683 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -144.74 161.2 39.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.834 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 41' ' ' GLY . 45.0 t0 -145.52 109.06 4.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.646 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.6 m -59.64 -37.81 79.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.885 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 62.5 mttp -58.7 -47.06 85.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.25 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.48 ' OD2' HD13 ' A' ' 80' ' ' ILE . 47.2 t0 -89.75 -20.26 23.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.921 0.391 . . . . 0.0 110.507 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . 66.66 40.27 93.96 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.503 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.2 150.11 43.77 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.139 0.47 . . . . 0.0 110.608 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -153.42 147.31 25.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.376 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.419 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 28.6 p90 -161.27 158.91 27.93 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.619 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 mt -81.06 153.49 27.34 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.412 0.625 . . . . 0.0 111.667 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.664 ' CD1' ' CZ ' ' A' ' 35' ' ' TYR . 16.8 p90 -162.41 141.79 7.18 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.457 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.27 156.52 58.88 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.276 1.984 . . . . 0.0 112.422 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.813 ' C ' HD21 ' A' ' 48' ' ' ASN . 0.2 OUTLIER -74.25 160.7 30.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.216 179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.43 -4.78 56.93 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.532 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 36.0 m0 -85.02 139.63 31.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.1 pt -113.61 134.39 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.158 0.504 . . . . 0.0 110.638 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.99 127.81 9.09 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.3 t -105.26 135.35 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.324 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 54' ' ' ASP . 51.3 p30 -71.0 149.16 46.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.243 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -152.66 48.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.42 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -76.68 128.24 34.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.022 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.53 7.6 78.74 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.14 -164.68 0.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.637 0.256 . . . . 0.0 110.568 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.78 156.39 1.64 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.115 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.2 127.84 17.42 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.499 2.133 . . . . 0.0 112.253 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 97.51 -22.68 39.53 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.6 t -68.79 128.79 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -118.98 -57.5 2.02 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.8 t -142.21 142.54 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.86 0.362 . . . . 0.0 111.157 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.6 t -117.09 134.31 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.215 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -111.67 131.63 55.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.953 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -129.83 138.57 51.08 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.483 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 72.2 m-20 -89.26 118.77 29.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.625 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.8 tp -66.83 -39.3 87.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.981 0.42 . . . . 0.0 110.328 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 85.9 mt -62.11 -43.16 97.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.345 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -117.98 108.87 15.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.828 0.346 . . . . 0.0 110.817 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -65.43 -43.19 91.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.354 0.597 . . . . 0.0 110.379 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.2 -37.42 74.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.338 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.455 ' CD ' ' HG1' ' A' ' 166' ' ' THR . 47.4 tp10 -74.85 132.38 41.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.32 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -149.23 139.0 21.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.539 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -129.83 134.69 47.7 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.862 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.3 t -127.86 138.51 52.72 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.1 t -116.01 125.24 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.507 HG23 ' C ' ' A' ' 61' ' ' GLY . 54.7 mt -124.5 122.04 62.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.48 HD13 ' OD2' ' A' ' 40' ' ' ASP . 72.6 mt -120.88 135.33 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.703 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -148.08 164.68 33.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.37 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -103.49 134.44 46.84 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 83' ' ' ILE . 12.5 pt -92.8 148.77 36.63 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.455 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 87' ' ' LYS . 40.1 Cg_endo -66.51 136.51 43.19 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.541 1.494 . . . . 0.0 110.49 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.5 p -63.86 -26.09 68.46 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.854 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -68.57 -30.96 69.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.815 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 84' ' ' PRO . 28.5 mtmm -130.92 148.94 52.74 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.132 0.491 . . . . 0.0 111.544 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.472 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 71.6 p -109.35 179.06 4.26 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.652 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.69 -41.07 73.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.284 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.4 p -72.52 -44.66 61.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.014 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 88' ' ' THR . 44.4 t0 -64.68 -38.45 91.02 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.947 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.5 tp -55.9 -44.71 78.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 178.64 47.33 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.2 p -94.76 171.11 8.98 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.73 -38.23 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.044 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.3 m -72.03 -45.24 61.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.11 -50.84 64.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.353 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.568 HG22 ' NH2' ' A' ' 101' ' ' ARG . 72.0 t -59.4 -37.3 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.554 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -62.8 -63.6 4.49 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.557 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -46.96 -42.99 18.76 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.793 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.568 ' NH2' HG22 ' A' ' 98' ' ' VAL . 84.0 mtm180 -59.38 -43.34 92.93 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.533 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -59.45 -42.66 92.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.659 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -53.97 -54.86 33.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.301 0.572 . . . . 0.0 110.098 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -62.04 -39.22 91.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 m -58.43 -45.59 88.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.907 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.4 t -70.88 -46.73 66.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.619 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 111' ' ' GLN . 85.1 m-20 -60.59 -37.04 80.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.526 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 22.3 t70 -44.38 -17.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 107' ' ' ASN . . . -109.31 -27.2 9.65 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.383 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 114' ' ' ARG . 3.8 t -121.32 21.59 11.05 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.605 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.543 ' CD ' ' H ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -69.97 4.17 2.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.079 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.1 -63.07 2.76 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.206 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -117.24 -45.14 2.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.852 0.358 . . . . 0.0 111.419 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' SER . 93.4 mtm-85 -85.09 148.4 26.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.504 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -129.16 148.64 51.12 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.175 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.16 136.2 43.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.379 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -122.74 127.96 49.89 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.9 tt -82.66 108.74 16.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.854 0.359 . . . . 0.0 110.09 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.1 mt -72.73 -58.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.836 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -146.29 164.0 33.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.132 0.491 . . . . 0.0 110.647 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.25 112.48 2.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.183 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -138.97 170.44 15.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -142.36 151.16 41.63 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.737 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.3 140.94 47.72 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.773 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 125' ' ' ASP . 35.6 p30 -109.21 112.72 25.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -139.93 142.55 36.41 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.991 0.424 . . . . 0.0 110.738 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 52.35 37.73 23.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.316 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.17 1.77 36.26 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -106.28 147.86 28.65 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 110.092 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.33 128.19 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.003 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -116.52 127.77 54.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.72 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.41 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.09 126.22 51.03 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.2 m -107.12 124.45 49.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.247 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.446 HD21 ' HA2' ' A' ' 99' ' ' GLY . 5.9 mp -118.3 123.61 45.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.839 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -119.25 122.46 41.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -149.15 168.57 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.299 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -138.64 160.03 40.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.752 0.311 . . . . 0.0 110.206 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 85.1 t -105.37 125.32 60.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.489 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 144' ' ' VAL . 8.0 mt -104.85 137.73 42.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.168 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.63 136.39 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.92 -110.49 0.74 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -117.31 18.11 14.51 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -140.88 160.22 40.52 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.322 0.582 . . . . 0.0 112.432 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 144' ' ' VAL . 12.7 p -72.37 122.51 25.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.39 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.526 ' OE1' ' NE ' ' A' ' 146' ' ' ARG . 2.0 tm-20 -75.11 -53.59 8.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 145' ' ' GLU . 15.0 ptp180 -172.46 169.64 5.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.127 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -109.04 136.07 49.16 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.04 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -135.17 135.89 41.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.888 0.375 . . . . 0.0 111.046 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.8 tp -111.11 133.94 53.09 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.004 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.37 131.14 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.503 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.7 m -119.31 136.71 54.12 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.36 127.69 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 111.288 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.5 m -144.83 144.21 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.08 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.0 p -107.48 145.59 32.88 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -146.73 111.45 5.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.138 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.452 ' CZ ' ' OXT' ' A' ' 188' ' ' TYR . 80.5 mtm180 55.74 31.86 18.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.81 8.71 75.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.471 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 31.7 mmtp -99.71 124.43 44.96 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.66 114.61 23.51 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.8 mm -109.76 128.6 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.5 m -130.42 134.46 47.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.729 0.299 . . . . 0.0 110.838 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.29 102.17 9.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.829 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -102.53 111.86 24.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.474 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 164' ' ' LEU . 5.3 mp -117.16 137.51 52.28 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.653 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 54.4 m -126.85 134.35 50.53 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.031 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.455 ' HG1' ' CD ' ' A' ' 74' ' ' GLU . 17.2 m -153.11 156.31 38.43 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.65 143.79 19.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.257 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.21 -36.98 72.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.295 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.9 -33.29 73.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.516 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.423 ' O ' HG22 ' A' ' 174' ' ' VAL . 56.4 ttt-85 -100.88 -12.51 18.93 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.601 0.239 . . . . 0.0 111.29 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.529 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.7 t-105 -50.36 -39.79 47.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.757 0.313 . . . . 0.0 111.01 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -60.3 -42.05 94.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.152 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.1 m -66.18 -39.67 89.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.634 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 170' ' ' ARG . 12.3 m -110.18 21.35 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.406 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 171' ' ' TRP . 47.2 pttt -51.37 -48.76 62.41 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.39 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.1 t -65.98 -29.03 69.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.686 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 181' ' ' VAL . 11.1 tp -56.46 -44.25 80.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.191 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.529 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 28.3 m-85 -61.77 -50.95 70.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.122 0.486 . . . . 0.0 110.403 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -63.82 -40.91 97.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.562 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 184' ' ' SER . 41.6 m -66.26 -46.71 76.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.591 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 177' ' ' LEU . 55.8 t -61.05 -46.16 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.097 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -65.96 -49.43 67.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.492 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.3 t -67.77 -34.04 76.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 180' ' ' THR . 16.5 t -62.61 -29.29 70.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.633 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -51.19 157.47 0.92 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.562 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -132.61 154.16 50.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.57 152.43 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 111.274 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.452 ' OXT' ' CZ ' ' A' ' 156' ' ' ARG . 38.2 p90 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.727 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.47 -22.41 74.0 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.695 2.264 . . . . 0.0 111.758 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.0 mt -89.84 143.99 26.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.288 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.2 19.9 59.95 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.5 t -109.94 141.53 42.57 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.819 0.343 . . . . 0.0 110.404 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 p -83.94 106.35 15.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.663 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.67 -177.29 49.42 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 44.83 77.54 0.09 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 m -60.68 135.4 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.334 . . . . 0.0 110.363 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.87 165.09 54.72 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mm -107.93 105.4 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.53 14.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.312 0.382 . . . . 0.0 110.455 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 48' ' ' ASN . 73.8 m -80.74 4.93 17.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.912 0.387 . . . . 0.0 110.753 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.4 mt -116.26 137.64 51.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.951 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -131.47 159.07 39.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.289 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -121.35 146.38 46.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.602 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -129.88 137.64 50.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.921 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.427 ' OG ' ' OH ' ' A' ' 188' ' ' TYR . 22.2 t -149.5 149.24 30.45 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.644 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -142.76 110.59 5.89 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.706 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.9 m -61.54 -37.31 83.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.568 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -58.68 -52.57 65.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.48 ' OD2' HD13 ' A' ' 80' ' ' ILE . 38.9 t0 -83.08 -21.07 33.82 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.762 0.315 . . . . 0.0 110.709 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.58 42.12 81.86 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.16 147.94 37.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.359 0.58 . . . . 0.0 110.129 179.082 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -153.1 141.38 20.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.803 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.91 156.66 40.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.75 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.7 mt -96.7 152.03 19.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.447 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -154.86 146.43 16.9 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.488 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.07 161.77 41.22 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.23 1.953 . . . . 0.0 112.101 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 31' ' ' SER . 43.0 p-10 -76.9 160.59 29.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.575 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.4 0.93 58.01 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.52 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 31.2 m0 -88.48 141.25 28.69 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.06 145.69 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.637 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.95 136.51 12.74 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.2 t -112.94 136.51 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.392 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -66.55 140.07 57.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.15 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.6 m -114.03 24.75 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.646 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -60.74 119.57 8.41 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.218 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.63 8.81 76.28 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.41 -164.58 0.65 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.14 157.77 67.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.503 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.45 128.32 16.13 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.382 2.054 . . . . 0.0 111.742 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 98.24 -17.79 58.05 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.08 123.99 25.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.641 -0.424 . . . . 0.0 109.891 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -100.87 -58.24 1.93 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.08 148.06 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 111.312 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.1 t -115.27 136.31 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.301 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -111.79 136.15 51.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.243 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -129.78 138.54 51.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.321 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 74.3 m-20 -82.46 118.58 23.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.79 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.04 -40.16 71.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.39 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.7 mm -61.4 -40.75 87.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.544 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' OE1' ' A' ' 74' ' ' GLU . 9.9 pt-20 -133.53 84.41 2.12 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.08 0.467 . . . . 0.0 110.284 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -52.16 -21.81 3.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.462 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -57.76 -37.82 74.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' OE1' ' OE2' ' A' ' 71' ' ' GLU . 97.7 mt-10 -84.33 141.35 30.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.991 0.424 . . . . 0.0 110.627 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -153.23 149.69 28.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.733 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.687 ' C ' HD12 ' A' ' 76' ' ' LEU . 1.7 pp -151.91 146.5 25.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.285 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.7 m -124.21 145.94 49.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.019 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.08 125.03 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.473 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.5 mp -122.6 127.78 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.299 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.48 HD13 ' OD2' ' A' ' 40' ' ' ASP . 79.2 mt -122.65 132.08 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.664 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.3 m -145.82 167.25 23.65 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.115 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -106.05 137.21 44.36 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.9 pt -96.37 148.33 34.32 Favored Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.569 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 87' ' ' LYS . 36.9 Cg_endo -66.22 135.77 41.4 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.589 1.526 . . . . 0.0 110.759 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 t -62.1 -29.17 70.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.133 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -68.09 -31.3 70.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.037 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 84' ' ' PRO . 97.0 mttt -131.38 143.68 50.65 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.033 0.444 . . . . 0.0 111.008 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 13.9 t -110.46 -179.44 3.77 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.32 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.451 HD21 ' CG ' ' A' ' 132' ' ' TYR . 45.9 tp -51.05 -44.08 61.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.893 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.5 p -68.28 -43.35 77.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.433 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 88' ' ' THR . 89.0 m-20 -65.54 -40.45 92.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.41 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.2 mt -57.01 -41.29 78.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.639 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.87 178.18 47.2 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.394 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 32.9 p -93.37 173.83 7.51 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.7 -41.03 76.66 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.4 m -73.08 -46.0 54.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.034 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 94' ' ' THR . 44.6 t0 -63.14 -52.14 63.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.506 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.2 -37.93 71.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.72 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.539 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -60.15 -55.69 28.83 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -53.53 -39.77 64.96 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.875 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -58.58 -36.79 74.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.191 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -65.08 -41.98 94.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.721 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.654 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -54.22 -55.71 25.39 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.336 0.589 . . . . 0.0 109.826 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -62.1 -40.98 97.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.664 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.5 m -58.1 -47.09 84.28 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.929 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.2 t -72.19 -47.35 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.773 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 111' ' ' GLN . 95.8 m-20 -60.97 -39.51 89.86 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.792 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -44.41 -37.13 3.21 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.448 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.25 -45.06 74.22 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.9 p -123.37 22.09 9.36 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.633 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.8 tt0 -51.15 -28.88 12.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.5 0.19 . . . . 0.0 111.281 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -42.5 -61.74 2.39 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.287 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -117.2 -38.01 3.44 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.01 0.405 . . . . 0.0 111.74 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -88.39 138.33 31.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.019 0.437 . . . . 0.0 111.146 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -131.87 149.73 52.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.112 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.424 ' H ' ' ND2' ' A' ' 107' ' ' ASN . . . -106.83 138.07 43.68 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.39 129.7 56.66 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.9 tp -82.61 111.99 19.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.909 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.5 mt -79.64 -50.29 18.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.569 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -158.41 164.52 36.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.398 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.47 114.66 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.592 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.64 167.25 22.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.685 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.41 150.5 50.88 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.504 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -128.53 142.16 51.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.787 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -109.43 113.27 25.93 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.183 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -138.92 141.13 38.51 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.89 0.376 . . . . 0.0 110.755 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 50.52 38.9 19.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.366 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.42 0.34 29.93 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -105.21 147.41 28.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.916 0.389 . . . . 0.0 110.124 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -113.3 129.64 68.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.27 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 20.7 m-85 -117.06 130.49 56.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.755 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.451 ' CG ' HD21 ' A' ' 89' ' ' LEU . 2.4 m-85 -104.13 124.48 49.16 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 54.2 m -103.29 130.26 50.5 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.59 106.37 8.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.234 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -101.14 124.5 46.95 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -152.71 172.77 16.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.408 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -141.2 158.78 43.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 110.448 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.16 137.32 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.501 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 141' ' ' GLY . 2.7 pp -135.04 131.69 37.34 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.049 0.452 . . . . 0.0 111.332 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 140' ' ' VAL . 1.4 m -91.74 103.76 14.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 139' ' ' LEU . . . 74.02 -113.64 4.23 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -107.91 7.35 27.98 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.818 -0.225 . . . . 0.0 111.483 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -116.14 138.97 50.8 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.707 0.289 . . . . 0.0 111.249 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 144' ' ' VAL . 7.3 p -78.72 122.21 33.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.344 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.13 -52.93 9.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.607 HH21 ' N ' ' A' ' 166' ' ' THR . 15.3 ptm180 -172.27 173.13 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.9 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -102.97 138.92 39.21 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -133.72 134.18 42.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.855 0.36 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.6 tp -111.32 131.21 55.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.079 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -127.65 125.72 40.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.029 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 27.8 t -118.74 132.57 56.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.678 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.07 127.56 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.99 0.424 . . . . 0.0 110.751 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.5 m -137.97 140.94 40.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.998 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.8 p -105.37 151.52 24.09 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.727 0.299 . . . . 0.0 110.364 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -161.53 119.07 2.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 55.17 32.1 17.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.67 14.31 80.06 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -105.26 128.8 53.62 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.42 119.06 31.58 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.3 mt -117.92 127.59 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.732 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 39.5 m -126.76 136.08 51.94 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.017 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.37 98.41 6.41 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -91.74 111.99 23.73 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.549 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.93 137.39 49.98 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.5 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 146' ' ' ARG . 32.3 t -136.27 129.45 31.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.365 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.607 ' N ' HH21 ' A' ' 146' ' ' ARG . 11.9 m -152.43 158.72 43.03 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.478 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -51.93 143.32 13.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -71.84 -36.78 70.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.043 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -63.32 -33.5 75.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.123 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.464 ' CD ' ' N ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER -96.95 -16.49 20.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.274 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.546 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 50.6 t-105 -48.56 -39.82 24.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.831 0.348 . . . . 0.0 110.769 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -61.69 -42.12 98.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 58.7 m -66.66 -40.0 88.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.657 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.2 m -109.55 21.17 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.149 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 171' ' ' TRP . 19.2 ptmt -50.59 -48.72 57.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.279 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.5 t -65.78 -29.75 70.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.773 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.8 tp -55.73 -44.45 77.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.374 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 26.3 m-85 -62.3 -50.47 71.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.088 0.47 . . . . 0.0 110.41 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.31 -41.41 98.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.605 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 184' ' ' SER . 50.7 m -66.07 -47.86 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.31 -43.63 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.523 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -62.94 -37.67 87.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.905 0.383 . . . . 0.0 110.306 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.2 t -83.62 -25.3 30.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 180' ' ' THR . 46.9 t -62.49 -30.03 70.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.17 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -59.76 157.58 11.86 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.463 -179.571 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -135.53 156.64 48.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.602 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.1 149.81 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.041 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.427 ' OH ' ' OG ' ' A' ' 36' ' ' SER . 38.9 p90 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.744 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 28.3 Cg_endo -61.43 -23.67 77.13 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.754 2.302 . . . . 0.0 111.811 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 21' ' ' LEU . 0.1 OUTLIER -66.0 -35.38 80.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.096 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 19' ' ' GLY . . . -177.53 -175.68 44.96 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.6 p -145.98 163.21 35.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.764 0.316 . . . . 0.0 110.459 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.4 t -129.37 139.81 51.57 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.432 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.1 -176.93 33.75 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.07 136.86 19.64 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.67 136.53 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.813 0.339 . . . . 0.0 110.393 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.01 23.16 59.83 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 pt -67.94 -16.28 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 110.812 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.14 159.7 42.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.506 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.2 t -65.58 137.36 57.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.506 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 mt -108.79 143.37 38.03 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.701 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.693 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.4 pm0 -137.98 163.9 30.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.857 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -117.69 133.94 55.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.727 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -112.48 135.13 53.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.846 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 93.8 p -146.79 153.89 40.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 110.855 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 36' ' ' SER . 99.2 m-20 -141.2 114.18 8.51 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.15 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.6 p -64.89 -33.95 77.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.434 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -62.49 -48.44 79.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -85.91 -20.48 28.95 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.101 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.51 40.54 90.98 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.211 -0.518 . . . . 0.0 111.83 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -141.97 151.56 42.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.332 0.566 . . . . 0.0 110.61 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -155.6 146.52 22.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -151.74 161.58 42.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.994 0.426 . . . . 0.0 111.18 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.651 HD22 ' N ' ' A' ' 45' ' ' LEU . 2.0 mm? -92.61 143.5 26.26 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.116 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -154.71 147.25 17.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.518 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.73 157.98 58.58 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.282 1.988 . . . . 0.0 112.24 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.693 ' N ' HE22 ' A' ' 33' ' ' GLN . 47.3 p-10 -71.35 160.42 32.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.563 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.99 6.45 57.94 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.435 ' HE1' ' CG ' ' A' ' 68' ' ' ASP . 27.2 m0 -93.6 142.79 26.94 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.301 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 pt -126.02 146.31 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.334 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.63 139.32 15.06 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.69 134.64 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.856 0.36 . . . . 0.0 110.526 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -79.08 137.74 37.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.683 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.86 55.7 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.065 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -72.81 135.07 45.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.072 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.41 4.76 70.42 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.64 -164.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.698 0.285 . . . . 0.0 110.72 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.12 153.74 3.09 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.562 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.27 133.08 27.44 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.264 1.976 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 96.01 -21.88 42.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.2 t -62.22 122.22 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.92 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -99.11 -58.55 1.91 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.76 168.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.492 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.0 135.79 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.058 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -112.18 128.54 56.26 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -122.91 135.56 54.55 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.802 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' CG ' ' HE1' ' A' ' 50' ' ' TRP . 60.3 t0 -88.53 118.43 28.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.849 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.11 -38.65 91.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.387 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.35 -42.15 92.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.78 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 68' ' ' ASP . 96.1 mt-10 -117.86 120.62 38.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.457 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -88.93 -40.26 13.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.32 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -58.47 -36.27 73.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.548 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -89.22 129.77 35.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.421 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -129.75 149.04 51.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.997 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 77' ' ' SER . 0.3 OUTLIER -125.84 134.12 51.75 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.722 ' N ' HD13 ' A' ' 76' ' ' LEU . 13.3 t -136.82 142.79 42.9 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 t -129.4 132.86 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.933 0.396 . . . . 0.0 110.674 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.504 HG23 ' C ' ' A' ' 61' ' ' GLY . 50.4 mt -121.89 123.38 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.34 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.92 132.18 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.314 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 159' ' ' LEU . 4.1 m -151.68 166.75 30.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.406 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -105.71 135.82 46.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 83' ' ' ILE . 10.0 pt -91.47 148.93 38.55 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.97 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -43.73 143.21 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.869 1.712 . . . . 0.0 111.382 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -73.1 -20.64 60.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.636 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 57.2 t0 -94.98 -17.18 22.18 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -129.94 156.26 44.71 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.933 0.397 . . . . 0.0 111.348 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 13.8 t -122.88 176.36 6.04 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.823 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.2 tp -49.92 -45.73 51.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.944 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.3 p -66.43 -44.13 83.76 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.988 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 88' ' ' THR . 57.8 t0 -65.71 -37.55 86.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.98 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.9 tp -55.85 -43.26 76.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.577 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.68 178.92 47.61 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.396 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.406 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 43.4 p -92.29 170.44 9.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.54 74.96 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.91 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.8 m -72.02 -44.43 63.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.804 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 94' ' ' THR . 47.3 t0 -62.22 -52.68 62.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.431 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.8 t -60.12 -39.11 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.595 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.73 -43.3 94.57 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -67.78 -41.41 83.28 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.04 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -60.72 -38.6 85.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -62.98 -39.61 95.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.585 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.5 mmt -59.1 -45.37 91.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.863 0.363 . . . . 0.0 110.536 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -64.72 -41.82 95.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.872 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.8 m -60.86 -46.13 91.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.7 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.99 -47.5 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.102 0.477 . . . . 0.0 110.472 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 111' ' ' GLN . 89.6 m-20 -61.05 -34.29 74.65 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.39 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -47.59 -38.71 15.02 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.189 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.41 73.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.53 0.566 . . . . 0.0 112.53 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -123.03 22.15 9.62 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.641 ' N ' ' O ' ' A' ' 107' ' ' ASN . 17.3 pt20 -51.23 -15.55 0.38 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.27 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.01 -61.27 7.63 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.814 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 38.0 p-10 -117.46 -35.51 3.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.035 0.417 . . . . 0.0 111.74 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.528 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 58.9 ttm-85 -84.62 137.89 33.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 111.24 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -129.03 139.29 52.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.106 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.9 136.53 42.56 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -116.54 128.28 55.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.477 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.4 tt -82.99 106.31 14.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.926 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.405 ' N ' HD23 ' A' ' 118' ' ' LEU . 96.5 mt -70.28 -43.47 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.362 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.402 ' N ' HD23 ' A' ' 118' ' ' LEU . 14.9 m-20 -179.7 173.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.452 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.67 139.62 15.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.19 163.99 32.03 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.453 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.8 146.87 46.2 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -133.13 139.6 47.17 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.655 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -109.67 113.44 26.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.55 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.74 144.33 39.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.014 0.435 . . . . 0.0 110.956 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 60.6 t0 51.59 32.11 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.405 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.03 1.58 68.81 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -105.57 148.95 26.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.94 0.4 . . . . 0.0 110.114 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.2 t -114.37 128.54 71.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.009 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -118.05 126.81 53.0 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.54 125.88 50.35 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.2 m -105.17 125.41 50.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.332 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.2 mp -115.69 126.53 54.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.928 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -119.52 122.67 42.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.433 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -152.9 171.65 17.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.522 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -139.94 157.92 44.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.186 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.24 135.28 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.979 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -136.04 136.9 40.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.109 0.481 . . . . 0.0 111.107 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.42 134.48 57.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.223 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.43 -120.95 16.46 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -114.47 14.42 17.82 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.92 -0.165 . . . . 0.0 111.415 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -129.05 155.6 45.17 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.92 0.391 . . . . 0.0 111.143 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 144' ' ' VAL . 14.7 p -86.66 126.93 40.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.324 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.539 ' OE1' ' NE ' ' A' ' 146' ' ' ARG . 2.1 tm-20 -76.01 -51.69 11.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.68 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.539 ' NE ' ' OE1' ' A' ' 145' ' ' GLU . 10.5 ptp180 -172.31 174.02 4.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.992 0.425 . . . . 0.0 111.192 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.404 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 73.8 m80 -107.21 139.44 41.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.013 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 78.3 m-20 -134.41 136.92 43.65 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.02 0.438 . . . . 0.0 111.477 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.3 tp -112.81 138.93 48.91 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.632 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.98 147.08 43.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.34 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.5 t -131.55 138.48 48.91 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.552 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 52.8 t -119.05 126.9 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.533 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.6 m -142.42 148.09 37.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.475 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.2 p -113.61 152.81 29.83 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.831 0.348 . . . . 0.0 110.641 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -151.12 107.44 3.47 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.274 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 59.35 32.16 21.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.791 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 87.1 6.21 79.21 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -97.27 123.26 41.02 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 81' ' ' SER . 1.0 OUTLIER -85.39 118.01 24.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.416 ' N ' HD23 ' A' ' 159' ' ' LEU . 81.4 mt -121.94 120.55 61.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.8 m -123.87 133.99 53.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.011 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.91 125.02 50.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.866 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -112.3 114.99 28.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.897 0.38 . . . . 0.0 110.654 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.434 HD23 ' CD2' ' A' ' 76' ' ' LEU . 11.8 mt -111.33 130.17 55.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.1 m -133.59 129.82 37.51 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.475 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 8.0 m -153.41 152.66 31.29 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.441 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.15 147.95 46.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.588 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -70.27 -24.05 62.99 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.268 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -55.54 -34.11 64.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.173 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.455 ' O ' HG22 ' A' ' 174' ' ' VAL . 96.6 mtt180 -124.79 0.09 8.03 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.519 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 44.9 t-105 -48.22 -39.11 20.14 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.852 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -63.43 -41.95 98.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 49.3 m -65.4 -39.94 92.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.627 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' A' ' 178' ' ' PHE . 12.8 m -105.22 21.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.176 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.36 -47.97 55.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.384 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.6 m -65.51 -31.9 73.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.652 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -54.52 -44.03 72.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.091 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.519 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 23.4 m-85 -61.07 -49.84 75.7 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.356 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -64.3 -40.38 95.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.591 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 184' ' ' SER . 50.1 m -67.65 -47.54 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.35 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.23 -43.46 98.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.614 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.77 -40.15 96.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 110.287 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 42.2 m -80.32 -27.72 38.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.249 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 180' ' ' THR . 40.1 t -62.26 -29.8 70.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.524 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -58.22 157.79 7.93 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.295 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -138.57 159.47 42.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.61 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.48 149.5 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.996 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 38.3 p90 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.682 179.83 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.506 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 29.7 Cg_endo -62.28 -23.39 75.25 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.725 2.283 . . . . 0.0 111.753 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -91.8 169.96 10.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.396 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -163.56 -173.35 32.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.1 t -56.67 -28.13 60.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.04 0.447 . . . . 0.0 110.402 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 94.1 m -49.11 -26.18 2.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.74 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.49 -178.92 52.6 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.99 22.94 62.51 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.1 m -65.39 137.63 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.89 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.42 144.79 10.77 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.2 mt -99.33 91.51 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.603 0.239 . . . . 0.0 110.399 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.64 147.4 1.4 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.214 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.9 m -65.79 141.51 58.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 0.0 110.609 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.8 mt -114.92 142.57 46.41 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.195 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.512 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.6 pm0 -141.18 163.02 34.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.313 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -115.14 140.13 49.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.866 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -117.36 130.8 56.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.531 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.426 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 50.5 m -120.83 146.58 46.41 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.022 0.439 . . . . 0.0 111.022 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 36' ' ' SER . 98.8 m-20 -140.67 103.71 4.57 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.7 p -68.78 -15.1 63.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.52 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -57.25 -43.23 82.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.358 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -116.35 -13.33 11.03 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.058 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.79 50.04 6.19 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.64 148.76 30.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.033 0.444 . . . . 0.0 111.128 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -144.41 151.62 39.51 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.693 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -151.84 157.28 41.69 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.7 mp -103.13 143.53 32.48 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.373 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.483 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 7.0 p90 -149.91 148.18 24.48 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.937 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.07 154.44 62.48 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.017 1.812 . . . . 0.0 111.849 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.512 ' N ' HE22 ' A' ' 33' ' ' GLN . 2.0 p-10 -69.57 160.52 31.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.36 3.97 58.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.527 ' CD2' ' OD1' ' A' ' 68' ' ' ASP . 32.0 m0 -92.27 146.58 23.6 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.358 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.0 pt -117.92 139.93 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.301 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.29 139.87 14.79 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.8 t -113.6 134.76 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.895 0.378 . . . . 0.0 110.463 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -74.46 138.28 43.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.437 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 63' ' ' ASP . 26.8 m -132.84 46.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -76.75 124.38 27.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.055 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.3 11.83 82.91 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.65 -164.41 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.757 0.313 . . . . 0.0 110.658 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -54.13 153.54 9.17 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.173 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.92 128.56 17.99 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.384 2.056 . . . . 0.0 112.137 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 98.15 -25.1 29.04 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.13 131.39 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.985 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' O ' ' CG2' ' A' ' 55' ' ' VAL . 58.7 t0 -111.09 -58.01 2.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.0 t -147.81 145.26 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.868 0.366 . . . . 0.0 111.287 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.448 HG23 HG11 ' A' ' 55' ' ' VAL . 86.5 t -122.16 134.93 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.527 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.18 141.27 46.08 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.081 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' NH2' ' CD2' ' A' ' 69' ' ' LEU . 68.3 ttp85 -129.12 129.33 45.03 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.269 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.527 ' OD1' ' CD2' ' A' ' 50' ' ' TRP . 78.4 m-20 -92.23 118.89 31.32 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.7 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.572 ' CD2' ' NH2' ' A' ' 67' ' ' ARG . 70.2 mt -65.52 -37.45 86.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.256 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.4 mt -63.51 -38.07 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.754 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -128.56 88.84 2.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.461 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -61.17 -35.73 77.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.561 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 39.2 p-10 -62.38 -32.67 73.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 11.6 tm-20 -92.55 132.75 36.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.663 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -146.68 139.59 25.33 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.636 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 tt -114.26 133.51 55.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.086 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.0 m -133.07 149.01 52.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.37 129.7 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.176 0.513 . . . . 0.0 110.288 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.511 HG23 ' C ' ' A' ' 61' ' ' GLY . 55.7 mt -120.5 124.14 71.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.361 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.4 mm -113.78 136.42 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.437 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.2 t -139.86 161.03 38.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.233 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.73 134.31 48.1 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.421 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.515 ' CG2' HD12 ' A' ' 159' ' ' LEU . 11.7 pt -106.75 150.15 39.33 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.956 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.05 137.92 42.34 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.008 1.805 . . . . 0.0 111.337 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 t -63.42 -27.19 69.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.076 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -67.44 -31.31 71.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.927 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -128.8 152.0 48.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.154 0.502 . . . . 0.0 111.315 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.1 t -117.46 179.8 3.95 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.21 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.2 tp -50.92 -44.64 60.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.192 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 50.3 p -66.5 -44.83 81.49 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.147 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.2 m-20 -65.32 -38.41 90.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.9 tp -56.15 -43.43 78.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.646 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.69 177.99 46.93 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.403 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.9 p -93.6 172.33 8.33 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.31 -42.26 77.33 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.227 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.1 m -71.65 -44.91 63.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 94' ' ' THR . 44.6 t0 -62.3 -51.54 67.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.522 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.71 -39.99 83.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.22 -45.33 92.78 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.75 -41.78 87.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.994 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -61.62 -39.19 90.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.612 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -62.73 -40.27 96.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.74 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.1 mmt -58.14 -43.79 87.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.294 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -64.85 -45.28 86.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.302 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.4 m -59.91 -45.14 93.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.961 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.2 t -68.18 -47.52 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.644 ' O ' ' N ' ' A' ' 111' ' ' GLN . 96.0 m-20 -62.73 -36.52 83.27 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.233 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -43.61 -36.92 2.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.718 0.294 . . . . 0.0 111.004 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.54 -46.49 69.38 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.2 m -123.34 23.28 9.09 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.644 ' N ' ' O ' ' A' ' 107' ' ' ASN . 47.1 tt0 -51.96 -28.83 18.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.633 0.254 . . . . 0.0 111.357 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -41.55 -61.46 2.15 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.15 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -117.24 -38.97 3.26 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.93 0.365 . . . . 0.0 111.779 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -77.39 146.44 36.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.491 . . . . 0.0 111.793 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -135.01 133.47 39.46 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.927 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.14 134.29 43.29 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.52 ' OE1' ' NH2' ' A' ' 137' ' ' ARG . 75.8 tt0 -115.3 128.71 56.3 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.977 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.24 106.94 13.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.994 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.533 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 95.6 mt -71.03 -38.61 72.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.057 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.9 m-80 178.44 166.35 0.82 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.343 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.98 132.46 12.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -143.12 165.58 27.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.602 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.15 148.87 45.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.458 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -130.33 142.12 50.55 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 125' ' ' ASP . 34.9 p30 -110.18 110.62 21.54 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.791 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -136.93 143.8 43.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.475 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.426 ' O ' ' OD2' ' A' ' 127' ' ' ASP . 22.6 t70 50.43 35.54 11.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.99 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.75 2.63 38.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.523 ' OE1' ' CE1' ' A' ' 131' ' ' TYR . 5.7 tm0? -106.43 136.54 46.0 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.458 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 44.7 t -106.69 129.41 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.852 0.358 . . . . 0.0 110.708 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.523 ' CE1' ' OE1' ' A' ' 129' ' ' GLN . 48.2 m-85 -117.24 131.11 56.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.57 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.13 130.14 51.85 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.8 m -110.42 124.33 51.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.181 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.73 125.32 52.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.982 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -117.58 122.34 43.37 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.537 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -150.82 172.74 15.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.562 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.52 ' NH2' ' OE1' ' A' ' 117' ' ' GLU . 38.3 ptt180 -140.4 158.09 44.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 110.729 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.37 132.84 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.122 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pp -140.52 135.7 32.15 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.05 0.452 . . . . 0.0 111.427 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.6 t -111.18 131.07 63.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.202 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.52 -120.6 21.21 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -109.38 11.17 25.29 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -124.1 152.68 42.45 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.024 0.44 . . . . 0.0 111.48 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 144' ' ' VAL . 9.9 p -88.31 127.34 41.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.786 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -77.0 -53.64 7.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.544 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.556 HH21 ' CA ' ' A' ' 166' ' ' THR . 13.0 ptm180 -170.49 173.78 5.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.008 0.432 . . . . 0.0 111.384 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.418 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 52.2 m80 -108.02 137.7 45.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.055 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 79.1 m-20 -135.04 137.91 43.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.015 0.436 . . . . 0.0 111.018 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.5 tp -111.22 134.91 52.45 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.546 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -135.64 141.24 45.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.428 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.0 t -124.86 141.32 52.2 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.179 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.13 132.12 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.837 0.351 . . . . 0.0 110.438 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.0 m -146.21 153.49 40.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.555 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.6 p -116.84 145.19 43.72 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.858 0.361 . . . . 0.0 110.52 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -160.04 122.37 3.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.927 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 60.15 30.91 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.097 0.475 . . . . 0.0 110.276 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 77.47 11.8 85.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -109.89 135.26 51.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -89.52 114.74 26.31 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.9 mm -103.99 120.23 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 49.0 m -120.52 129.58 53.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.101 0.477 . . . . 0.0 110.561 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.28 117.32 32.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -120.1 122.96 42.2 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.978 0.418 . . . . 0.0 111.578 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.3 mp -119.93 140.57 50.69 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.382 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 63.1 m -130.87 135.65 47.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.365 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.556 ' CA ' HH21 ' A' ' 146' ' ' ARG . 16.6 m -153.06 153.93 33.85 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.57 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.27 145.71 42.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.358 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -69.98 -25.45 63.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.414 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 170' ' ' ARG . 55.4 p30 -60.56 -33.45 72.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.552 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 22.7 mmt85 -118.89 -1.12 11.07 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.576 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 46.9 t-105 -48.26 -40.62 25.32 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.693 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.98 -41.39 97.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.029 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 46.3 m -63.71 -39.41 94.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.438 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 170' ' ' ARG . 6.9 m -105.85 21.17 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.964 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.412 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 19.1 ptmt -50.19 -45.19 53.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.823 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 24.2 t -63.13 -31.45 72.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.694 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.0 tp -59.43 -45.55 91.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.109 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 18.2 m-85 -60.89 -50.14 74.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.873 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 176' ' ' SER . 0.6 OUTLIER -69.27 -43.24 74.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.757 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 60.6 m -62.36 -48.36 80.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.704 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 80.5 t -71.57 -38.39 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.474 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.98 -38.98 93.33 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.353 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 81.4 p -80.18 -18.98 48.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.226 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.8 t -62.84 -39.04 93.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.699 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -54.77 149.03 11.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.08 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 -133.88 159.02 41.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.3 m -126.57 150.45 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.67 0.272 . . . . 0.0 110.795 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 41.2 p90 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.882 -179.505 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.478 ' N ' HH22 ' A' ' 124' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.41 142.56 85.72 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.722 2.281 . . . . 0.0 111.684 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 21' ' ' LEU . 2.6 mm? -63.41 -37.89 89.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.946 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.24 -8.01 80.55 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.0 p -156.35 168.18 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.822 0.344 . . . . 0.0 110.687 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.8 m -83.06 165.95 19.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.152 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.39 170.02 54.89 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.26 -175.05 48.91 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.8 m -128.78 157.25 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.743 0.306 . . . . 0.0 110.212 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.89 94.4 1.93 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.2 pt -76.56 -15.7 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.04 0.448 . . . . 0.0 110.619 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.63 163.34 40.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.123 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.1 m -56.39 140.36 45.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.485 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.4 mt -115.19 141.44 48.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.382 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 21.0 mp0 -103.58 148.45 25.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.908 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -119.3 136.49 54.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.184 0.516 . . . . 0.0 110.946 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -125.63 136.19 52.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.0 p -145.64 156.05 43.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.491 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -148.05 119.15 7.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.556 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.8 p -70.53 -32.61 70.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.879 0.371 . . . . 0.0 110.218 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 63.9 tttm -62.03 -49.94 74.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.799 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -86.87 -20.63 27.17 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.904 0.383 . . . . 0.0 110.567 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.28 43.34 93.1 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.16 147.61 36.91 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.225 0.513 . . . . 0.0 110.377 179.403 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -148.18 155.96 42.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.024 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.538 ' CZ ' ' O ' ' A' ' 45' ' ' LEU . 57.6 t80 -173.02 143.52 1.17 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.538 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . 9.9 mp -92.58 141.38 28.56 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -134.16 141.2 38.52 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.638 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.58 152.44 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.893 1.728 . . . . 0.0 112.484 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.415 ' HB3' HE22 ' A' ' 33' ' ' GLN . 54.2 p30 -81.41 158.75 24.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.234 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.29 8.84 74.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.437 ' NE1' ' OD1' ' A' ' 68' ' ' ASP . 27.7 m0 -94.1 149.03 21.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.451 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.2 pt -114.64 140.46 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.475 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.75 134.24 11.8 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.15 132.45 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.015 0.436 . . . . 0.0 110.569 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -83.88 137.96 33.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.339 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.83 52.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.371 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -72.81 134.06 44.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.357 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.64 4.72 82.58 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.81 -164.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.707 0.289 . . . . 0.0 110.694 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -45.1 152.1 0.62 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.556 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.78 132.98 26.19 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.23 1.953 . . . . 0.0 111.654 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.543 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 95.76 -27.63 15.4 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.55 133.9 26.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.085 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' OD2' HD12 ' A' ' 80' ' ' ILE . 53.4 t0 -115.78 -58.57 2.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.646 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 78' ' ' VAL . 65.8 t -149.49 147.28 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.057 0.456 . . . . 0.0 111.522 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.18 134.87 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.158 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -112.13 138.16 49.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.406 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -128.95 133.63 47.9 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.531 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' OD1' ' NE1' ' A' ' 50' ' ' TRP . 60.1 t0 -88.15 119.07 28.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.444 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.9 mt -60.24 -37.82 81.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.737 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.647 ' H ' HD12 ' A' ' 70' ' ' ILE . 4.9 mp -67.13 -42.21 87.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.822 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 68' ' ' ASP . 90.6 mt-10 -121.24 124.24 44.17 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.009 0.433 . . . . 0.0 110.639 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -87.19 -39.58 15.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.549 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.45 -37.02 77.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.984 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' OE1' ' OE1' ' A' ' 71' ' ' GLU . 84.6 tt0 -85.12 132.68 34.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.409 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -155.58 138.78 15.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.945 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 76' ' ' LEU . 10.2 tt -112.57 133.29 54.7 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.044 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.9 m -128.44 147.0 50.64 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.015 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.7 m -124.07 131.45 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.105 0.478 . . . . 0.0 110.616 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.543 HG23 ' C ' ' A' ' 61' ' ' GLY . 51.0 mt -119.13 124.26 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.587 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 61' ' ' GLY . 63.1 mt -119.07 128.26 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 110.788 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 74.5 m -149.09 166.31 29.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.043 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -104.57 137.01 43.04 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.44 HG22 HD12 ' A' ' 159' ' ' LEU . 10.4 pt -92.44 149.55 38.46 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.394 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -45.42 136.71 11.54 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.649 1.566 . . . . 0.0 111.862 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -27.3 68.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.392 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -88.61 -16.23 33.03 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -131.22 157.23 43.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.043 0.449 . . . . 0.0 111.375 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.417 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.4 t -122.81 176.61 5.89 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.49 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.6 tp -51.83 -44.74 63.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.171 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.5 p -65.51 -44.61 86.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.933 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.3 m-20 -67.16 -34.27 77.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.866 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -55.05 -50.01 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.893 -179.444 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.37 179.18 47.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.421 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.3 p -90.91 171.69 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.26 -41.41 75.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.869 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.7 m -72.61 -45.17 60.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.7 t0 -61.57 -51.74 67.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.294 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.96 -38.77 81.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.514 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.02 -43.94 94.82 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -67.64 -42.36 82.38 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.945 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -62.33 -38.65 90.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.0 110.718 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.87 -40.77 96.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.541 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.6 mmt -58.9 -44.4 91.19 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.521 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 108' ' ' ASP . 43.9 tptt -65.46 -45.76 82.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.976 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.8 m -59.17 -46.12 89.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.015 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.29 -47.16 79.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 110.273 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.656 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.1 m-20 -63.39 -37.83 88.78 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.266 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 104' ' ' LYS . 88.8 m-20 -44.29 -38.31 3.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.729 0.299 . . . . 0.0 111.224 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.88 74.6 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.6 m -123.93 23.45 8.59 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.4 tt0 -48.5 -28.79 3.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.557 0.218 . . . . 0.0 111.544 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -44.05 -61.24 3.16 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.152 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -116.91 -36.01 3.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.956 0.378 . . . . 0.0 111.872 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -78.43 139.54 38.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 111.242 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -132.55 137.03 46.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.962 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.0 140.38 42.58 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.817 0.342 . . . . 0.0 110.458 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.418 ' OE1' ' NE ' ' A' ' 137' ' ' ARG . 83.4 mt-10 -124.8 123.4 39.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.734 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 tp -80.43 110.75 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.054 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.32 -55.71 10.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.846 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -145.23 163.22 35.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.083 0.468 . . . . 0.0 110.693 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.18 116.12 3.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.237 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.17 162.55 34.68 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.548 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.99 150.19 47.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 110.878 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.478 HH22 ' N ' ' A' ' 19' ' ' GLY . 65.4 mtp180 -129.5 160.35 33.45 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.385 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -134.83 114.22 12.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.721 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.84 142.5 38.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.608 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.426 ' O ' ' OD2' ' A' ' 127' ' ' ASP . 22.3 t70 50.49 36.57 13.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.02 2.66 48.24 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.525 ' OE1' ' CE2' ' A' ' 131' ' ' TYR . 4.4 tm0? -101.29 134.74 43.88 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.436 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 46.2 t -106.22 130.08 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 110.565 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.525 ' CE2' ' OE1' ' A' ' 129' ' ' GLN . 58.1 m-85 -119.41 128.24 53.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.045 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -106.61 129.93 54.45 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.7 m -112.37 122.8 48.76 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.522 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.37 125.05 51.52 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.048 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -117.09 123.81 47.71 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -151.75 164.04 37.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.945 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.418 ' NE ' ' OE1' ' A' ' 117' ' ' GLU . 39.5 ptt180 -126.62 156.97 40.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.083 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.09 130.71 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.3 mt -112.25 125.3 54.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.883 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 79.5 t -123.49 129.68 74.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.04 -121.64 16.77 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -116.44 22.35 12.87 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -148.35 161.5 41.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.955 0.407 . . . . 0.0 111.486 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.5 t -71.34 125.52 29.96 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.271 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' A' ' 146' ' ' ARG . 83.3 tt0 -73.9 -52.71 12.06 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.014 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' A' ' 145' ' ' GLU . 11.4 ptp85 -172.41 170.43 4.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.609 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -105.0 138.96 40.41 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.007 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 164' ' ' LEU . 13.4 t70 -135.52 147.58 48.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.146 0.498 . . . . 0.0 110.563 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 tp -123.17 124.96 44.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.556 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -123.81 134.74 53.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.234 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.5 t -122.84 134.27 54.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.35 129.93 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.157 0.503 . . . . 0.0 110.852 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.438 ' CG2' ' NE2' ' A' ' 129' ' ' GLN . 24.0 m -143.76 142.71 31.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.101 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.1 p -108.36 149.6 28.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 110.215 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -147.46 106.71 3.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.735 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 57.42 31.74 20.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 89.59 4.89 72.59 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 32.1 mmtp -96.05 123.85 39.82 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -89.36 114.38 25.79 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.89 127.41 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.103 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.7 m -123.67 135.91 54.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.037 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.07 105.51 15.56 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.886 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.19 120.06 38.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.876 0.37 . . . . 0.0 111.47 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.432 ' O ' ' OD2' ' A' ' 148' ' ' ASP . 19.2 mt -117.62 135.3 54.07 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.9 t -133.56 134.07 42.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.419 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 14.6 m -152.52 158.88 43.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.295 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -59.18 144.31 46.29 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.07 0.462 . . . . 0.0 111.422 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -74.44 -17.81 60.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.071 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -77.93 -9.77 59.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.902 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.498 ' O ' HG22 ' A' ' 174' ' ' VAL . 77.3 mtp180 -133.61 -6.8 2.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.729 0.299 . . . . 0.0 110.742 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.617 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 45.3 t-105 -49.19 -39.02 27.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.624 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -63.48 -42.32 98.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.08 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.7 m -65.37 -40.74 93.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.526 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.3 m -105.33 21.21 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.848 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.77 -47.24 41.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.203 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 91.8 p -67.08 -28.61 68.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.81 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.8 tp -56.23 -43.18 78.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.627 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.617 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 19.4 m-85 -62.78 -49.49 74.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.451 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.4 -40.85 98.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.706 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.4 m -68.09 -51.49 45.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.401 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' A' ' 184' ' ' SER . 4.0 p -69.96 -32.52 51.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.683 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.56 -40.29 96.59 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.101 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 76.0 p -85.11 -16.1 41.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.743 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 181' ' ' VAL . 88.4 p -64.72 -34.09 77.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.492 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.7 150.37 7.3 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.558 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -130.75 149.93 52.16 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.0 m -126.48 151.99 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 110.814 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.505 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 43.7 p90 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.622 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.46 146.23 92.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.73 2.286 . . . . 0.0 111.804 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.668 HD12 ' N ' ' A' ' 21' ' ' LEU . 7.2 mp -89.51 140.16 29.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.553 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.96 120.54 0.69 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 m -66.22 155.85 35.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.754 0.311 . . . . 0.0 110.621 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.9 t -129.2 133.82 47.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.273 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.26 -35.15 59.9 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.2 -143.05 32.53 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -132.01 141.18 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.883 0.373 . . . . 0.0 110.449 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.12 47.81 0.22 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 29' ' ' ILE . 23.4 pt -68.27 -16.58 21.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.584 0.231 . . . . 0.0 111.216 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.3 56.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.972 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.7 p -149.98 11.31 0.73 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.885 0.374 . . . . 0.0 110.606 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.2 138.69 50.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.344 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -134.4 158.88 42.72 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.365 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.483 HH21 ' CD ' ' A' ' 43' ' ' GLU . 72.7 ttt180 -119.29 138.11 53.23 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.653 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -118.89 136.27 54.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.276 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 84.7 p -143.72 157.52 44.33 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.426 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.1 t0 -148.28 108.58 4.11 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.65 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.6 m -60.31 -36.76 78.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.694 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -58.66 -51.01 71.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.184 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -85.64 -20.17 29.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . 68.68 41.44 83.65 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 155.73 45.69 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.199 0.5 . . . . 0.0 110.727 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' CD ' HH21 ' A' ' 34' ' ' ARG . 3.0 pp20? -156.03 147.83 23.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.752 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -152.9 156.1 38.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt -94.4 158.96 15.33 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.397 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -170.57 144.88 2.03 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.689 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.01 158.73 56.12 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.349 2.033 . . . . 0.0 111.952 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -71.92 160.34 32.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.6 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.26 4.53 58.43 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.535 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 25.1 m0 -89.16 145.11 25.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 pt -115.11 138.29 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.503 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.73 121.98 7.43 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.53 134.75 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.942 0.401 . . . . 0.0 110.499 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 54' ' ' ASP . 52.9 p30 -84.07 151.16 25.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.356 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.61 48.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.086 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -68.58 134.03 49.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.63 -0.63 83.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.3 -163.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 110.464 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.2 m -40.14 116.69 1.25 Allowed Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.586 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.04 132.89 8.6 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.703 1.602 . . . . 0.0 112.22 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 101.99 -40.48 2.41 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.2 135.18 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -118.55 -57.56 2.05 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.54 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -147.63 143.06 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.684 0.278 . . . . 0.0 111.048 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.47 137.93 54.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.928 0.395 . . . . 0.0 110.045 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.93 134.92 54.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.84 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -121.95 143.7 49.31 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.8 0.333 . . . . 0.0 110.758 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.535 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 11.2 m-20 -94.75 118.94 32.55 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.514 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.5 -38.7 90.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.559 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.5 mm -65.12 -41.77 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.748 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -124.42 95.16 4.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.753 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -64.4 -34.8 79.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.349 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.21 -37.37 74.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.81 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -89.44 128.9 36.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.604 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -141.08 139.05 33.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.297 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -106.93 132.91 52.35 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.593 ' N ' HD13 ' A' ' 76' ' ' LEU . 4.9 p -120.12 138.84 53.34 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 t -125.45 124.21 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-O 120.883 0.373 . . . . 0.0 110.446 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.494 HG23 ' C ' ' A' ' 61' ' ' GLY . 15.7 mt -125.1 117.75 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.802 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.2 mm -114.94 135.87 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.995 0.426 . . . . 0.0 110.643 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.9 m -145.36 166.03 26.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.935 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -107.93 141.47 39.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.652 0.263 . . . . 0.0 110.673 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.2 pt -107.72 149.63 39.19 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.697 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' LYS . 54.9 Cg_endo -69.19 139.96 43.58 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.101 1.867 . . . . 0.0 111.141 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.8 p -65.98 -24.96 66.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.979 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.29 -31.28 70.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.635 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 84' ' ' PRO . 29.5 mtmm -130.33 157.48 42.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.121 0.486 . . . . 0.0 111.263 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.407 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.7 t -122.48 178.1 5.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.366 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 tp -50.99 -44.65 60.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.16 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.3 p -64.9 -45.53 85.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.037 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 88' ' ' THR . 84.6 m-20 -68.02 -36.15 79.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -56.13 -42.77 77.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.776 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.67 174.68 44.24 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 41.8 p -91.72 168.87 11.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.3 76.09 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.998 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.7 m -71.82 -43.95 64.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.823 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 94' ' ' THR . 47.7 t0 -61.57 -52.69 63.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.486 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.48 -38.51 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.738 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.02 -47.35 89.65 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -65.17 -42.86 93.26 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -62.74 -37.76 87.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -62.92 -41.12 99.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.611 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.9 mmt -59.88 -44.29 94.29 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.299 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.76 -41.71 95.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.213 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.6 m -59.23 -46.25 88.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.704 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.87 -47.12 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.048 0.451 . . . . 0.0 110.498 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 111' ' ' GLN . 92.9 m-20 -61.54 -35.41 77.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.36 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -45.71 -36.74 5.21 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.193 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.04 -45.86 76.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 112' ' ' GLY . 48.1 m -123.39 22.65 9.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.625 ' N ' ' O ' ' A' ' 107' ' ' ASN . 5.1 pp0? -52.43 -10.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.133 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -59.97 -61.47 7.14 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.718 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -117.17 -40.53 3.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.794 0.331 . . . . 0.0 111.452 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -86.37 138.9 31.44 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.167 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -132.72 150.68 52.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.154 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.05 139.69 38.27 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' OE1' ' NE ' ' A' ' 137' ' ' ARG . 79.1 tt0 -113.23 130.9 56.09 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.9 tp -83.79 117.94 23.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.434 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.3 mt -85.48 -59.42 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.313 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.486 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 23.9 p30 -158.53 172.17 18.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.35 134.68 11.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.34 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.88 161.1 39.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.728 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.401 ' HB1' ' CE1' ' A' ' 132' ' ' TYR . . . -139.36 143.49 37.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.427 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -135.65 146.23 47.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.482 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -120.05 112.68 19.45 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.515 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -136.6 139.61 42.24 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 51.2 40.71 26.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.724 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.07 2.3 17.45 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.522 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 2.9 tm0? -101.79 134.67 44.6 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 43.6 t -106.37 129.6 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.944 0.402 . . . . 0.0 110.542 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.522 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 70.0 m-85 -118.95 123.53 44.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.904 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 2.5 m-30 -104.94 118.88 37.64 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 56.7 m -93.66 132.57 37.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.2 107.0 8.31 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.269 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.486 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 74.7 tt0 -103.37 126.02 50.3 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -153.38 171.23 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.315 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.422 ' NE ' ' OE1' ' A' ' 117' ' ' GLU . 40.0 ptt180 -141.5 161.49 37.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.865 0.364 . . . . 0.0 110.262 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.78 139.99 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.006 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 pp -145.0 150.63 37.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.188 0.518 . . . . 0.0 111.087 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.92 134.86 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.558 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.68 -107.04 0.23 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 56.1 t0 -117.46 13.3 14.4 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.323 0.12 . . . . 0.0 111.323 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.84 142.67 47.05 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.738 0.304 . . . . 0.0 111.019 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.69 125.77 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.016 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -78.05 -53.74 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.703 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.534 ' NH1' ' OG ' ' A' ' 165' ' ' SER . 44.8 ptt85 -173.83 171.81 3.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.011 0.434 . . . . 0.0 111.403 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -108.07 141.52 39.65 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.526 ' OD2' ' NH1' ' A' ' 146' ' ' ARG . 74.5 m-20 -135.57 144.02 45.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.006 0.431 . . . . 0.0 111.11 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.5 tp -116.79 134.47 54.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.53 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.43 ' CB ' ' OD1' ' A' ' 163' ' ' ASP . . . -134.1 128.21 33.72 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.008 0.433 . . . . 0.0 110.925 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.7 t -115.2 127.76 55.73 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.12 131.72 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.941 0.401 . . . . 0.0 110.875 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.52 ' OG1' ' NE2' ' A' ' 129' ' ' GLN . 6.8 t -146.67 161.93 39.53 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.687 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -122.22 152.79 39.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.23 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -165.74 123.25 1.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.618 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 58.67 26.09 14.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.004 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.72 9.12 83.52 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -106.69 141.19 38.35 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.898 0.38 . . . . 0.0 110.385 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.43 117.81 31.04 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 71.0 mt -117.44 121.88 68.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.8 m -122.55 130.1 52.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.27 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.01 110.43 21.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 150' ' ' ALA . 90.2 m-20 -115.48 124.84 52.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.919 0.39 . . . . 0.0 110.951 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 mp -116.56 146.12 42.87 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.681 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.534 ' OG ' ' NH1' ' A' ' 146' ' ' ARG . 45.7 t -132.08 131.31 42.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.583 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.8 m -152.4 155.7 38.07 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.647 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.57 144.68 16.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.254 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -71.5 -34.38 70.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.154 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.91 -33.61 74.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.712 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.519 ' O ' HG22 ' A' ' 174' ' ' VAL . 78.9 mtm180 -103.01 -12.68 17.27 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.564 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.3 t-105 -47.69 -40.37 19.92 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.379 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -64.07 -42.28 97.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 50.5 m -65.52 -40.96 93.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.465 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 170' ' ' ARG . 10.5 m -106.42 21.45 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.12 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 171' ' ' TRP . 24.0 pttm -49.45 -45.63 46.84 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.222 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 84.8 p -67.45 -28.56 67.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.457 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -56.1 -45.14 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.564 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.1 m-85 -62.5 -48.07 81.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.221 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -62.57 -42.55 99.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.547 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 91.7 m -67.49 -49.02 65.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.02 -37.32 72.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.511 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.24 -38.58 91.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.374 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.4 p -84.72 -16.03 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.217 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.4 t -62.78 -37.9 88.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -59.66 155.49 15.57 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.066 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -137.86 161.18 37.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -128.4 151.06 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.956 0.408 . . . . 0.0 111.257 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.468 ' CG ' ' O ' ' A' ' 188' ' ' TYR . 39.3 p90 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.624 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.4 145.4 36.61 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.731 2.287 . . . . 0.0 111.997 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 tp -57.14 -37.35 71.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.232 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -83.97 -177.86 51.58 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.5 p -136.08 156.4 48.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.532 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.7 m -87.79 0.4 55.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.81 -91.28 1.48 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.5 -159.92 35.54 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.69 135.4 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.797 0.332 . . . . 0.0 110.487 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.71 -122.21 2.0 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.0 pt -121.62 156.72 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.802 0.334 . . . . 0.0 110.634 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.86 140.81 49.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.724 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 32' ' ' LEU . 14.9 t -171.34 6.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.325 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.406 ' H ' ' H ' ' A' ' 31' ' ' SER . 40.8 mt -107.04 139.79 40.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.36 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 24.3 mp0 -116.89 154.49 30.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.547 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.55 138.53 50.96 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.34 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -126.73 131.07 51.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.944 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -141.12 152.36 44.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 110.769 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -143.58 118.69 10.1 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.388 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.4 p -71.31 -32.69 68.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.529 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.48 -47.58 83.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.025 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -88.36 -20.33 25.47 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.1 42.06 85.36 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -143.07 149.29 37.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.338 0.569 . . . . 0.0 110.356 179.406 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -151.66 144.19 24.21 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.77 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.71 158.09 41.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.52 150.01 22.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.093 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -158.17 145.99 13.74 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.359 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.19 156.4 66.43 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.309 2.006 . . . . 0.0 112.187 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.2 p30 -71.78 160.36 32.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.57 2.13 58.8 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.53 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 33.9 m0 -91.81 144.5 25.43 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 110.436 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.6 pt -120.65 144.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.359 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.32 141.56 15.68 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -129.88 143.63 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -90.61 144.55 25.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.61 51.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.491 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -66.98 136.08 54.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.094 0.473 . . . . 0.0 110.337 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.36 1.62 71.66 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.86 -164.19 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.64 0.257 . . . . 0.0 110.53 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.1 m -41.54 124.29 2.33 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.337 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.03 132.32 6.0 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.785 1.657 . . . . 0.0 112.694 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.448 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 97.98 -33.69 5.76 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.9 t -62.42 122.84 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.114 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -120.22 -50.06 2.26 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.467 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.95 139.5 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.879 0.371 . . . . 0.0 110.91 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.82 138.35 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.49 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.66 135.01 52.83 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.859 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -121.64 134.77 54.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.26 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.53 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 66.1 m-20 -86.18 118.75 25.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.483 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -67.47 -39.36 85.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.593 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.577 ' H ' HD12 ' A' ' 70' ' ' ILE . 4.1 mp -61.11 -48.14 90.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.76 118.01 28.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.908 0.385 . . . . 0.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.42 -36.59 65.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.777 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 2.7 p30 -62.47 -34.62 77.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.864 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 84.3 tt0 -86.13 133.33 33.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.0 110.254 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -154.25 139.66 17.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -114.54 134.62 54.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.932 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.7 m -120.13 145.1 47.25 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.17 127.63 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.002 0.429 . . . . 0.0 110.315 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.448 HG23 ' C ' ' A' ' 61' ' ' GLY . 5.8 mt -114.82 122.57 69.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.699 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 82.1 mt -122.08 127.88 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.996 0.427 . . . . 0.0 110.796 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 159' ' ' LEU . 21.9 t -153.29 164.29 38.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.045 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -103.47 136.42 43.25 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.0 pt -92.89 148.42 35.85 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.347 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' LYS . 37.1 Cg_endo -65.28 136.17 46.24 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.64 1.56 . . . . 0.0 110.821 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.8 t -60.99 -29.12 69.5 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.038 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -67.57 -31.52 71.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.999 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 84' ' ' PRO . 68.0 mttm -130.61 144.84 51.7 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.046 0.451 . . . . 0.0 111.138 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.451 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.1 t -113.24 179.18 4.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.173 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 tp -52.75 -43.83 66.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.859 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 47.1 p -69.04 -45.03 71.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.447 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.451 ' HB2' ' H ' ' A' ' 88' ' ' THR . 82.4 m-20 -68.77 -34.92 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.106 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.6 tp -55.39 -44.35 76.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.394 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.17 178.06 46.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.412 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 43.9 p -92.85 169.8 10.18 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.46 72.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.966 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.4 m -72.36 -44.64 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.851 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 94' ' ' THR . 45.7 t0 -62.54 -50.97 69.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.425 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.629 HG22 HH21 ' A' ' 101' ' ' ARG . 79.4 t -62.65 -38.56 81.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.604 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.27 -47.05 92.74 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.37 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -62.8 -45.36 92.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.82 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.629 HH21 HG22 ' A' ' 98' ' ' VAL . 85.4 mtm180 -62.96 -43.86 97.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.041 0.448 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -57.0 -41.14 77.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.804 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.4 mmt -61.12 -43.46 98.85 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.143 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.93 -38.83 92.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.423 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.1 m -56.88 -45.71 82.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.599 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.28 -46.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.13 0.491 . . . . 0.0 110.449 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.878 HD22 ' H ' ' A' ' 116' ' ' ALA . 10.8 m-20 -62.43 -32.98 73.92 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.272 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -43.81 -37.64 2.87 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.675 0.274 . . . . 0.0 111.537 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.26 -47.27 71.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.6 m -123.53 24.17 8.66 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 107' ' ' ASN . 16.9 tt0 -46.55 -28.77 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.597 0.237 . . . . 0.0 111.536 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.71 -61.18 3.04 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.02 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 31.7 p-10 -117.02 -36.3 3.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.069 0.435 . . . . 0.0 111.711 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.578 HH11 ' CG1' ' A' ' 138' ' ' VAL . 59.7 ttm-85 -84.18 142.05 30.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 0.0 111.051 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -148.82 149.09 30.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.886 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.878 ' H ' HD22 ' A' ' 107' ' ' ASN . . . -108.47 138.99 43.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.168 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -107.94 129.85 55.08 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.1 tt -81.54 108.09 14.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.953 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.426 HD12 ' HG2' ' A' ' 135' ' ' GLU . 97.4 mt -70.68 -56.32 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.112 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.603 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 25.2 p30 -156.29 169.9 23.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.901 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.7 119.85 4.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.336 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.34 163.18 33.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.73 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -139.12 149.45 44.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.473 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -131.72 144.49 51.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.1 0.476 . . . . 0.0 110.821 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -111.42 114.3 27.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.572 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -140.3 141.88 35.71 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.702 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.423 ' O ' ' OD2' ' A' ' 127' ' ' ASP . 22.6 t70 49.67 37.2 12.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.03 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.59 1.49 23.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 3.7 tm0? -103.18 133.48 48.21 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 46.6 t -105.59 130.43 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.855 0.359 . . . . 0.0 110.721 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 48.4 m-85 -119.04 129.59 55.19 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.823 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.4 127.47 53.0 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 55.6 m -105.03 129.66 53.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.69 107.12 9.42 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.12 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.603 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 79.4 tt0 -101.79 127.22 48.68 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -150.87 170.37 19.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.411 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -136.81 156.75 48.08 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.052 0.453 . . . . 0.0 110.37 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.578 ' CG1' HH11 ' A' ' 114' ' ' ARG . 58.3 t -104.7 135.17 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.443 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.407 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.7 pp -145.2 135.02 23.59 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.189 0.518 . . . . 0.0 111.251 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.3 t -111.6 132.52 59.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.869 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.54 -122.05 25.56 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -110.73 11.83 22.58 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.854 -0.204 . . . . 0.0 111.139 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -120.02 149.97 41.31 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.829 0.347 . . . . 0.0 111.225 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.0 t -88.35 126.03 41.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.415 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.407 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 47.4 tp10 -75.08 -53.85 8.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.416 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -173.94 173.6 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 111.26 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -105.21 143.58 33.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.133 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 164' ' ' LEU . 12.0 t70 -141.21 151.16 43.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.841 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.8 tp -124.1 135.0 53.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.034 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.51 132.51 39.28 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.895 0.378 . . . . 0.0 110.431 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 69.3 m -119.93 137.39 54.07 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.59 130.29 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.985 0.421 . . . . 0.0 110.683 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.415 HG23 HE22 ' A' ' 129' ' ' GLN . 24.5 m -146.97 144.85 29.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -110.9 150.36 29.3 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.192 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -151.14 106.7 3.37 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.264 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 61.83 34.84 16.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.066 0.46 . . . . 0.0 110.526 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.06 8.29 86.74 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -98.42 127.17 44.23 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.81 113.13 24.65 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 67.9 mt -122.25 124.29 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.328 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.0 m -124.62 134.27 52.98 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.14 111.04 23.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.65 119.97 40.48 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 111.428 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.426 ' O ' ' OD2' ' A' ' 148' ' ' ASP . 2.9 mp -115.47 142.64 46.44 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.136 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.0 p -132.96 135.05 45.28 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.871 0.367 . . . . 0.0 110.547 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.0 m -152.88 157.02 40.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.248 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.29 143.69 55.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.04 0.448 . . . . 0.0 111.4 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.427 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 1.3 pp20? -69.82 -27.11 64.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.222 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.427 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 90.3 m-20 -59.36 -34.15 72.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.256 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.448 ' O ' HG22 ' A' ' 174' ' ' VAL . 73.8 mtm180 -117.66 -1.59 11.59 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.554 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 44.5 t-105 -48.64 -39.34 23.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.554 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -63.26 -42.11 99.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.958 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 39.8 m -64.49 -40.47 95.73 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.458 HG23 ' CZ ' ' A' ' 178' ' ' PHE . 12.8 m -105.11 20.87 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.902 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -49.33 -45.61 45.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.89 0.376 . . . . 0.0 110.952 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 85.1 p -68.07 -27.69 66.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.598 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.9 tp -56.84 -44.34 81.99 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.583 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.554 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.2 m-85 -63.59 -49.82 71.88 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.239 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -62.0 -42.28 98.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.579 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 65.0 m -67.6 -49.77 61.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.038 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.82 -37.92 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.38 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.46 -39.04 93.41 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.234 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.5 m -80.71 -19.54 44.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.273 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -62.53 -36.22 81.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.718 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -55.93 148.76 16.48 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.11 -179.555 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -136.85 155.53 49.67 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.22 150.61 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.183 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.489 ' CG ' ' O ' ' A' ' 188' ' ' TYR . 40.9 p90 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.548 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.745 0.307 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.557 HE22 ' N ' ' A' ' 48' ' ' ASN . 4.2 mp0 -115.41 155.06 28.11 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.014 0.435 . . . . 0.0 110.741 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -113.73 131.26 56.25 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.369 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -124.66 131.29 53.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.944 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -138.57 153.4 48.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.665 0.269 . . . . 0.0 110.757 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -144.2 109.61 5.16 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.787 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.0 m -61.74 -36.14 80.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.507 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -58.73 -51.41 70.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.938 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 38.4 t0 -85.86 -20.64 28.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.735 0.302 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.92 40.9 84.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.72 150.7 42.16 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.218 0.509 . . . . 0.0 110.17 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -151.12 143.07 23.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.598 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -151.74 160.06 43.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.176 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 mt -98.33 150.37 21.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.103 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -153.63 145.92 17.2 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.297 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.2 152.95 78.78 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.373 2.049 . . . . 0.0 112.151 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.557 ' N ' HE22 ' A' ' 33' ' ' GLN . 54.1 p30 -73.15 160.26 32.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.576 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.84 58.22 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.475 ' NE1' ' CG ' ' A' ' 68' ' ' ASP . 30.1 m0 -92.95 145.57 24.27 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.4 pt -118.73 145.03 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.35 128.79 9.68 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.7 135.46 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.756 0.312 . . . . 0.0 110.297 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -76.57 129.29 36.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.431 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.14 36.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.766 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -59.37 135.94 57.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.43 . . . . 0.0 110.693 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.06 10.02 72.57 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.45 -164.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.683 0.278 . . . . 0.0 110.548 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.16 140.86 42.21 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.084 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -44.98 132.11 10.85 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.59 1.526 . . . . 0.0 112.463 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.481 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 94.97 -31.04 7.28 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.4 t -61.04 128.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -119.07 -57.33 2.03 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.209 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.4 t -143.95 148.51 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.867 0.365 . . . . 0.0 110.92 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.47 140.01 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.45 134.11 53.26 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.107 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -127.15 130.74 50.35 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.463 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' CG ' ' NE1' ' A' ' 50' ' ' TRP . 60.3 t0 -87.86 117.96 27.06 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.662 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.9 tp -65.22 -38.99 92.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.555 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.86 -39.54 82.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.044 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.54 96.19 4.6 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.809 0.338 . . . . 0.0 110.593 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -61.33 -37.0 81.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.374 0.607 . . . . 0.0 109.856 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.27 -36.83 73.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.971 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -82.66 130.65 35.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.436 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -140.32 139.09 35.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.363 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.62 136.23 53.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.686 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.0 t -126.16 140.37 52.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.739 0.304 . . . . 0.0 110.608 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.94 125.52 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.914 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.481 HG23 ' C ' ' A' ' 61' ' ' GLY . 30.9 mt -121.13 123.87 70.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.93 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.35 133.42 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.873 0.368 . . . . 0.0 110.682 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LEU . 22.7 t -151.11 162.56 40.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.313 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 2.0 pm0 -105.06 130.23 53.31 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.111 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 83' ' ' ILE . 6.4 pt -86.4 149.22 48.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.406 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 87' ' ' LYS . 36.2 Cg_endo -65.06 136.66 49.1 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.588 1.525 . . . . 0.0 110.753 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -60.96 -29.01 69.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.182 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -67.9 -31.44 71.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.898 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' PRO . 92.1 mttt -131.2 140.36 49.88 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.918 0.39 . . . . 0.0 111.169 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -105.96 -178.42 3.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.079 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.509 ' N ' ' OG1' ' A' ' 88' ' ' THR . 49.2 tp -52.18 -43.04 63.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.769 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.9 p -68.03 -43.76 78.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.093 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.52 -35.16 78.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 92' ' ' LEU . 4.4 tt -55.17 -49.05 72.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.129 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.74 176.67 45.95 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.409 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 36.2 p -90.38 171.26 9.58 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.12 -42.32 76.67 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.165 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.7 m -72.06 -43.91 64.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.809 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 94' ' ' THR . 47.4 t0 -61.94 -51.38 68.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.151 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.2 t -61.7 -38.53 80.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.568 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.63 -44.54 93.93 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -68.14 -39.77 82.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.821 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -61.61 -41.34 97.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -61.43 -41.16 96.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.63 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.9 mmt -58.62 -43.76 89.75 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.838 0.352 . . . . 0.0 110.365 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -64.57 -40.08 94.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.356 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -60.05 -47.33 86.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.892 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.3 t -71.7 -45.74 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.011 0.434 . . . . 0.0 110.497 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 111' ' ' GLN . 88.9 m-20 -60.43 -32.56 71.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.069 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -44.19 -37.65 3.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.215 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -105.72 -10.8 16.57 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 114' ' ' ARG . 1.3 t -121.39 16.1 11.33 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.5 pt20 -79.83 6.98 9.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.086 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.35 -62.85 2.23 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.052 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -117.06 -41.23 3.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.634 0.254 . . . . 0.0 111.501 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' SER . 95.6 mtt180 -86.28 154.7 21.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.876 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -133.11 135.53 45.3 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.209 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.17 129.57 44.52 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.06 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -116.95 128.78 55.54 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.021 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.0 tp -83.66 110.85 18.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.024 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -55.25 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.104 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.57 ' C ' HD22 ' A' ' 120' ' ' ASN . 0.3 OUTLIER -161.4 168.57 23.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.921 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.68 122.44 4.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.232 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.96 162.9 34.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.583 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.414 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.48 148.28 50.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.571 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -130.67 150.14 52.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.775 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -120.45 116.36 25.3 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.847 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.45 142.27 39.47 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.456 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.3 t0 52.05 28.42 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.16 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.68 2.61 85.84 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 154' ' ' THR . 66.4 tp60 -104.02 135.99 44.5 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.02 129.89 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.964 0.411 . . . . 0.0 110.532 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.84 129.84 55.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.821 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.414 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.75 130.21 53.8 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.3 m -112.89 125.18 54.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.195 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.24 124.88 48.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.013 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.451 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 72.2 tt0 -119.72 124.2 45.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.86 169.75 20.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.38 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -138.88 160.31 40.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.394 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 63.4 t -104.42 126.35 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.008 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.1 mt -106.14 139.71 40.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.336 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.88 135.86 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.45 -112.63 1.41 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -118.23 22.88 11.92 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -142.63 157.1 45.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.219 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.3 123.86 32.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.102 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.445 ' CD ' ' NH1' ' A' ' 146' ' ' ARG . 85.3 tt0 -75.16 -53.28 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.111 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.445 ' NH1' ' CD ' ' A' ' 145' ' ' GLU . 33.6 ptt-85 -172.41 167.66 5.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -107.98 135.61 49.07 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.968 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -131.05 140.94 50.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.543 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.4 tp -111.2 132.23 54.49 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -129.2 132.48 47.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.387 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.4 m -121.79 139.78 53.18 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.36 131.51 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.972 0.415 . . . . 0.0 111.073 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.6 m -148.72 142.21 25.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.256 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.458 ' O ' ' NE2' ' A' ' 129' ' ' GLN . 13.0 p -106.41 149.56 26.9 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.343 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -150.39 106.68 3.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.077 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.413 ' NH2' ' OXT' ' A' ' 188' ' ' TYR . 17.0 ttm180 63.15 27.6 15.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.179 0.514 . . . . 0.0 110.579 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.13 3.08 73.38 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.804 -0.519 . . . . 0.0 111.804 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.49 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 11.5 mptt -94.95 126.11 40.06 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.417 -0.461 . . . . 0.0 109.81 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -88.54 118.62 28.31 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 78.2 mt -120.02 127.98 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.823 0.344 . . . . 0.0 110.663 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 89.0 m -129.12 136.86 50.78 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.725 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.68 103.28 11.07 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -102.27 108.68 20.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.81 0.338 . . . . 0.0 110.414 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 164' ' ' LEU . 5.3 mp -114.05 140.04 48.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.3 p -133.63 139.65 46.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.855 0.36 . . . . 0.0 110.306 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.9 m -152.99 157.2 40.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.5 145.93 37.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.555 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.415 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 2.0 pp20? -70.87 -21.06 62.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.971 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.415 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 93.6 m-20 -58.84 -34.58 71.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.22 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.517 ' O ' HG22 ' A' ' 174' ' ' VAL . 72.3 mtp85 -123.03 -1.34 8.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.576 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 59.9 t-105 -46.69 -40.25 12.91 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.812 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -64.56 -42.29 95.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.993 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.2 m -66.12 -39.67 90.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.728 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 170' ' ' ARG . 10.9 m -106.53 21.64 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.246 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 176' ' ' SER . 12.2 ptmm? -51.22 -50.93 58.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.194 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.409 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 24.9 t -64.94 -30.69 71.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.889 0.376 . . . . 0.0 111.088 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -52.55 -45.79 66.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.849 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 23.1 m-85 -62.0 -49.83 74.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.049 0.452 . . . . 0.0 110.467 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -63.24 -37.8 88.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.471 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 184' ' ' SER . 56.2 m -61.37 -47.4 86.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.296 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.49 -44.17 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.519 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -65.74 -42.93 90.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.556 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 85.2 p -74.79 -30.9 61.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 180' ' ' THR . 58.0 m -63.14 -29.67 70.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -52.74 156.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.137 0.494 . . . . 0.0 110.813 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -138.67 155.18 48.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.199 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.0 m -127.91 151.68 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.922 0.392 . . . . 0.0 111.244 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.413 ' OXT' ' NH2' ' A' ' 156' ' ' ARG . 41.2 p90 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.661 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.58 ' C ' HD21 ' A' ' 48' ' ' ASN . 42.1 mt . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.519 ' NE2' ' OD1' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -102.61 170.85 7.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.099 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -139.68 146.03 39.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.656 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.68 141.78 45.03 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.137 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.0 p -149.75 155.38 40.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 110.592 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -148.08 119.14 7.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.624 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.6 p -71.55 -29.75 65.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.172 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -61.54 -48.93 78.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.983 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 50.5 t0 -92.12 -20.39 21.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.738 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.75 44.87 60.97 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.853 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.455 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -142.65 149.05 38.39 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.232 0.516 . . . . 0.0 110.336 179.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.73 143.48 22.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -152.47 158.85 43.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 111.059 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.6 mt -96.79 151.72 19.37 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.892 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' N ' ' CD1' ' A' ' 46' ' ' TYR . 10.3 p90 -157.95 136.56 7.81 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.846 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -43.29 157.3 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.045 1.83 . . . . 0.0 112.559 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.696 HD22 ' N ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -81.18 158.93 24.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.299 179.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.08 63.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 26.8 m0 -87.6 147.27 25.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.839 0.352 . . . . 0.0 110.175 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -114.7 132.31 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.043 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.89 133.2 11.61 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.33 134.24 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.964 0.412 . . . . 0.0 110.753 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 37.0 p30 -91.36 121.29 32.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.518 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.25 60.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.464 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -78.73 132.91 37.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.163 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.0 3.62 73.11 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.39 -163.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 t -40.53 125.95 1.83 Allowed Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.449 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -41.5 127.16 3.2 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.97 1.78 . . . . 0.0 113.025 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.503 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 100.68 -36.18 4.34 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.533 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -63.63 127.02 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.174 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 61' ' ' GLY . 5.4 m-20 -119.57 -56.63 2.04 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.574 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.52 139.61 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.901 0.381 . . . . 0.0 111.098 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.3 t -123.08 132.63 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.127 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -112.28 134.27 53.92 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.41 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -124.76 143.36 50.83 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 73.8 m-20 -90.42 119.08 30.4 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.548 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.2 tp -65.4 -41.21 93.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.574 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.99 -45.03 99.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.048 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.67 120.67 37.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.863 0.363 . . . . 0.0 110.73 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -77.84 -40.38 40.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.56 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -58.7 -36.5 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.643 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.91 133.39 35.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -156.11 139.31 15.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.561 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.68 134.4 55.07 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.804 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.6 t -121.86 139.26 53.85 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.026 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.96 125.61 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.07 0.462 . . . . 0.0 110.279 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.503 HG23 ' C ' ' A' ' 61' ' ' GLY . 14.9 mt -117.35 123.52 71.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.7 mt -120.21 128.42 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.396 . . . . 0.0 110.952 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 61.3 m -149.03 166.0 29.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.3 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -105.64 138.41 41.88 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 159' ' ' LEU . 8.2 pt -93.09 149.4 37.46 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.653 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -44.51 140.19 6.37 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.651 1.568 . . . . 0.0 111.383 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -67.94 -25.38 65.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.403 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.4 p30 -93.03 -15.28 26.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -131.43 150.44 52.15 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.096 0.474 . . . . 0.0 111.486 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 46.8 p -112.86 -179.23 3.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.222 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.9 tp -56.36 -41.56 76.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.448 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.5 p -72.16 -45.07 61.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.968 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 88' ' ' THR . 45.7 t0 -64.7 -37.28 87.04 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.787 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.0 tp -55.8 -43.32 76.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.745 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.5 179.19 47.62 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.309 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 36.2 p -93.4 170.69 9.42 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.24 74.37 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.044 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 78.0 m -72.45 -45.67 58.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 94' ' ' THR . 45.6 t0 -61.25 -52.16 65.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.311 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.4 -38.62 82.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.713 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.71 -45.07 93.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -65.2 -41.45 94.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.541 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -63.11 -39.03 93.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.059 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.66 -41.49 98.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.699 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.8 mmt -58.38 -44.4 88.89 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.383 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -66.07 -42.48 89.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.359 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.5 m -59.24 -45.79 90.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.9 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.2 -47.48 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 0.0 110.478 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.646 ' O ' ' N ' ' A' ' 111' ' ' GLN . 93.4 m-20 -62.67 -34.65 77.53 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.451 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -46.61 -36.92 7.43 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.068 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.23 -47.11 71.78 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.41 ' C ' ' N ' ' A' ' 112' ' ' GLY . 74.8 m -123.26 22.25 9.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.646 ' N ' ' O ' ' A' ' 107' ' ' ASN . 10.3 pt20 -49.41 -13.38 0.08 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.403 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 110' ' ' SER . . . -58.08 -61.42 7.44 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.86 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 35.1 p-10 -117.46 -35.66 3.93 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.902 0.351 . . . . 0.0 111.685 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 58.2 ttp180 -85.13 135.77 33.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.914 0.388 . . . . 0.0 111.28 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -127.97 144.37 51.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.191 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -107.09 138.07 43.96 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -119.81 129.06 54.26 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.98 110.08 16.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.204 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.574 ' C ' HD22 ' A' ' 120' ' ' ASN . 96.7 mt -77.02 -55.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.557 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.574 HD22 ' C ' ' A' ' 119' ' ' ILE . 1.7 m-80 -145.75 159.35 43.31 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.37 112.81 2.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.463 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.1 168.98 18.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.657 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.63 147.18 42.6 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.763 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -130.35 143.86 51.03 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.921 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 35.5 p30 -110.56 111.1 22.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.725 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -137.45 143.0 41.59 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.879 0.371 . . . . 0.0 110.839 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 51.38 37.97 20.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.317 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.24 2.61 41.78 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -107.67 149.47 28.07 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.964 0.411 . . . . 0.0 110.234 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.5 t -117.12 129.2 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.103 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 14.1 m-85 -119.31 128.15 53.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.067 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -100.62 120.04 39.46 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 63.2 m -95.17 127.46 41.24 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.94 110.76 11.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.53 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -107.28 126.58 52.61 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -150.79 170.45 19.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.349 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -136.97 156.8 47.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.041 0.448 . . . . 0.0 110.523 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.7 134.39 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.91 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.415 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.8 pp -135.77 136.26 40.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.161 0.505 . . . . 0.0 111.13 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.45 134.13 55.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.12 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.6 -121.06 19.05 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -113.91 14.17 18.47 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.926 -0.161 . . . . 0.0 111.275 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -127.15 153.6 45.84 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.901 0.382 . . . . 0.0 111.164 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 144' ' ' VAL . 14.7 p -85.67 126.93 40.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.237 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.415 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 83.9 tt0 -75.01 -52.75 10.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.773 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -175.21 173.97 2.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.028 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -109.84 136.78 48.61 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.16 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -132.88 141.57 48.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.892 0.377 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.9 tp -111.48 131.18 55.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.99 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.97 131.08 47.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.955 0.407 . . . . 0.0 110.486 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.0 m -120.69 138.15 54.1 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.6 t -119.85 129.16 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.033 0.444 . . . . 0.0 110.683 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.7 m -144.72 148.28 33.99 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.624 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -114.74 149.25 37.16 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.832 0.349 . . . . 0.0 110.303 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -149.82 107.04 3.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.032 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 65.07 26.26 12.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.12 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.4 1.44 71.78 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 2.4 mptp? -94.28 126.66 39.67 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -87.94 115.62 25.54 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 65.7 mt -121.45 123.52 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.005 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 72.7 m -122.45 132.11 54.19 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.52 113.12 26.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.817 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -115.04 124.85 52.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.905 0.383 . . . . 0.0 111.652 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.01 142.18 50.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.458 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 67.1 m -132.91 134.3 44.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.406 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 167' ' ' ALA . 22.9 m -153.18 159.2 42.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.87 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.453 ' N ' HG22 ' A' ' 166' ' ' THR . . . -56.36 141.56 41.44 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.365 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.81 -39.09 90.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.963 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.48 -33.07 74.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.194 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 174' ' ' VAL . 79.8 mtp180 -96.38 -17.56 20.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.35 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.59 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 47.9 t-105 -48.75 -41.73 33.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.713 0.292 . . . . 0.0 110.947 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.83 -41.69 97.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.136 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.7 m -65.56 -40.6 92.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.432 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.6 m -107.35 21.22 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.25 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 171' ' ' TRP . 19.0 ptmt -48.14 -47.4 34.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 111.111 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 27.0 t -64.83 -31.54 72.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.669 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.61 -45.64 73.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.044 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.59 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.2 m-85 -61.33 -50.11 74.26 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.263 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -63.28 -42.37 99.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.871 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.1 m -67.16 -49.01 66.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.777 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.9 t -70.01 -37.64 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.405 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.68 -37.03 84.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.317 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.0 t -84.62 -18.61 34.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.133 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 t -62.79 -35.87 81.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.629 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.433 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -55.89 147.23 19.85 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.931 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -134.44 157.72 45.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.37 151.19 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.767 0.317 . . . . 0.0 111.049 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.414 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 33.8 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.69 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.045 0.45 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.678 ' NE2' ' H ' ' A' ' 33' ' ' GLN . 1.3 pm0 -135.91 158.94 43.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.915 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -116.73 135.52 53.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.633 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -108.99 141.17 41.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.078 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.9 p -144.57 157.28 44.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.762 0.315 . . . . 0.0 110.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -146.96 112.32 5.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.766 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.7 m -62.0 -37.32 84.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.603 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -59.39 -52.33 66.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.227 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -84.49 -20.53 31.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.767 0.318 . . . . 0.0 110.77 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.65 43.17 86.17 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -142.37 151.88 42.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.235 0.517 . . . . 0.0 110.393 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -153.96 144.47 22.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.806 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -148.86 160.4 43.28 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.044 0.449 . . . . 0.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 tp -103.8 133.07 49.4 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.619 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -141.99 140.78 20.19 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.066 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -45.68 150.32 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.901 1.734 . . . . 0.0 112.217 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.665 ' N ' HE22 ' A' ' 33' ' ' GLN . 37.2 p-10 -81.02 160.03 24.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.301 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.43 3.19 65.05 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 32.9 m0 -81.3 147.12 30.05 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.8 pt -111.43 134.25 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.327 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.85 138.59 14.0 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.45 134.05 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.771 0.32 . . . . 0.0 110.22 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 48.7 p30 -84.45 145.57 28.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.72 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.1 m -151.66 51.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.353 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.45 133.5 46.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.048 0.451 . . . . 0.0 110.423 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.37 3.92 84.01 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.65 -164.24 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.8 m -40.49 117.88 1.43 Allowed Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.685 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.18 135.23 11.33 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.506 1.47 . . . . 0.0 111.895 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.462 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 99.84 -32.01 7.75 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.12 130.07 29.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -111.05 -57.79 2.19 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.708 0.289 . . . . 0.0 110.94 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -147.02 140.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.712 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.72 133.48 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.143 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.71 134.05 54.42 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.522 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -129.44 134.73 47.97 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.111 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 77.8 m-20 -86.61 119.1 26.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.836 0.35 . . . . 0.0 110.652 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.8 tt -65.11 -40.04 93.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.505 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 88.6 mt -61.37 -42.93 95.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.008 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -119.11 120.16 36.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.891 0.377 . . . . 0.0 110.659 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -82.82 -36.24 25.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.578 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 40.6 p-10 -62.37 -31.94 72.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.981 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 84.2 tt0 -87.13 130.47 34.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.62 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -139.57 139.5 36.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.297 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.39 134.76 52.03 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -129.53 138.91 51.61 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.13 128.3 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.405 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.462 HG23 ' C ' ' A' ' 61' ' ' GLY . 25.8 mt -123.68 123.97 68.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.326 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.3 mt -123.23 130.83 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.392 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.4 m -145.74 165.86 27.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.297 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -105.46 135.81 46.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 83' ' ' ILE . 8.1 pt -92.52 148.83 37.08 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.32 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' LYS . 37.3 Cg_endo -65.86 137.13 48.0 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.695 1.597 . . . . 0.0 110.69 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 t -60.88 -29.42 69.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.171 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -67.59 -31.34 71.32 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 84' ' ' PRO . 95.4 mttt -131.04 143.19 50.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.938 0.399 . . . . 0.0 111.007 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -111.87 179.82 3.9 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.086 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.484 ' N ' ' OG1' ' A' ' 88' ' ' THR . 45.8 tp -52.16 -45.16 64.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.079 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.3 p -68.51 -41.38 80.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.925 0.393 . . . . 0.0 110.882 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.452 ' H ' HG23 ' A' ' 88' ' ' THR . 50.0 t0 -66.41 -36.45 82.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 92' ' ' LEU . 4.8 tt -55.62 -47.54 76.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.241 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.09 178.52 47.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.5 p -90.71 172.96 8.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.15 76.43 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.113 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.1 m -72.14 -45.3 61.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.55 -51.12 69.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.246 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.55 -38.63 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.404 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.08 -45.55 93.75 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -69.52 -40.26 77.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.813 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -61.5 -41.18 96.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.043 0.449 . . . . 0.0 110.76 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -60.74 -40.66 93.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.633 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.7 mmt -59.26 -44.16 92.43 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.507 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -64.59 -39.63 94.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.154 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.8 m -59.26 -46.84 87.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.922 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.15 -46.04 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.048 0.451 . . . . 0.0 110.383 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 111' ' ' GLN . 86.3 m-20 -61.99 -31.29 71.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -44.12 -37.56 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -110.34 -7.71 14.78 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.808 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 114' ' ' ARG . 27.9 m -121.05 19.36 11.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.367 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.5 pt20 -84.39 6.26 23.9 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.15 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.98 -63.22 2.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.831 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -117.3 -46.14 2.71 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.903 0.382 . . . . 0.0 110.934 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 110' ' ' SER . 93.2 mtm-85 -74.61 148.73 40.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.228 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -131.83 130.58 41.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.601 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.92 128.63 44.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 110.389 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -115.36 128.7 56.25 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.6 tp -82.71 111.6 18.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.929 0.395 . . . . 0.0 110.406 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.574 ' C ' HD22 ' A' ' 120' ' ' ASN . 96.2 mt -77.74 -57.68 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.362 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.574 HD22 ' C ' ' A' ' 119' ' ' ILE . 1.8 m-80 -146.35 161.3 40.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.647 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.41 112.93 2.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.388 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.37 167.37 22.27 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.896 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.418 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -136.93 149.7 47.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.754 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -132.52 143.04 49.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.778 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -111.82 115.03 28.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.428 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.12 144.76 36.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.983 0.42 . . . . 0.0 110.94 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.5 t0 54.74 22.1 3.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.41 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.54 -1.78 88.19 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -103.49 149.02 25.25 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.942 0.401 . . . . 0.0 110.077 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.67 128.42 67.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.995 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -117.49 127.73 54.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.873 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.31 124.78 49.78 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.7 m -105.78 122.76 46.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.299 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.3 mp -117.83 122.93 44.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.99 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -117.88 124.42 48.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.431 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -151.98 172.89 15.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.401 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -140.78 160.53 39.84 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.079 0.466 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.61 132.58 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.437 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pp -135.81 136.35 40.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 111.346 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.57 130.46 55.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.119 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.63 -116.95 10.08 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.552 ' C ' HD22 ' A' ' 143' ' ' ASN . 56.7 t0 -114.73 12.44 17.08 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.468 0.175 . . . . 0.0 111.025 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.552 HD22 ' C ' ' A' ' 142' ' ' ASP . 3.6 m120 -119.75 146.6 45.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.726 0.298 . . . . 0.0 110.951 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 144' ' ' VAL . 7.4 p -85.57 125.19 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.434 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -75.21 -52.66 10.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.717 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -173.23 172.49 3.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -104.84 141.18 36.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.028 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -134.49 136.74 43.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.991 0.424 . . . . 0.0 111.206 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.1 tp -111.55 135.63 51.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.724 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.53 134.97 42.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.252 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.0 m -121.49 141.36 51.11 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.097 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.7 128.88 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.853 0.359 . . . . 0.0 110.871 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.8 m -146.31 148.86 32.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.415 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -112.54 151.1 30.4 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.833 0.349 . . . . 0.0 110.357 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -150.37 103.95 3.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 62.52 31.38 17.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.977 0.417 . . . . 0.0 110.68 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 89.01 2.27 78.22 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.306 -0.473 . . . . 0.0 111.925 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 1.7 mptp? -95.1 125.17 39.57 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.7 OUTLIER -88.62 118.22 28.13 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.4 mt -120.49 128.16 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.759 0.314 . . . . 0.0 110.499 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.5 m -130.52 136.51 49.02 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.723 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.86 110.47 20.82 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.976 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -105.47 111.88 24.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.559 0.219 . . . . 0.0 110.509 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 164' ' ' LEU . 5.5 mp -119.09 135.59 54.57 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.744 0.307 . . . . 0.0 110.483 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -129.82 138.2 50.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.368 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.6 m -153.05 156.52 38.92 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.48 145.07 34.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.453 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.39 -29.07 65.61 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.325 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.33 -34.05 71.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.256 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.452 ' O ' HG22 ' A' ' 174' ' ' VAL . 60.7 mtp180 -113.79 -4.2 13.39 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.532 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 57.5 t-105 -49.54 -38.5 31.16 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.091 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.32 -43.11 99.59 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.183 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 77.9 m -65.58 -39.76 91.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.8 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 170' ' ' ARG . 11.3 m -108.45 21.11 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.521 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 176' ' ' SER . 17.4 pttp -51.75 -50.5 60.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.459 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 27.2 t -65.17 -29.67 70.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.734 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.6 tp -55.75 -43.6 76.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.233 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.532 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 28.5 m-85 -61.53 -49.58 76.14 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.385 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.64 -39.66 91.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.459 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.421 ' O ' ' OG ' ' A' ' 184' ' ' SER . 43.8 m -65.39 -47.35 76.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.277 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.34 -44.88 99.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.494 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.475 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -66.52 -45.36 79.78 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.283 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.0 t -69.96 -32.34 70.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.235 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 180' ' ' THR . 63.8 m -62.03 -30.08 70.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.306 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -49.9 157.08 0.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.522 -179.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -138.59 153.99 48.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.581 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.6 m -127.12 151.15 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.107 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 42.6 p90 . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.75 -179.875 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.6 mt . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 120.917 0.389 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.61 ' NE2' ' N ' ' A' ' 33' ' ' GLN . 2.8 mp0 -109.92 151.89 26.51 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.272 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -120.24 143.14 48.45 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.565 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -130.43 133.63 46.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.068 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -140.81 151.2 44.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.401 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -140.73 120.26 13.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.408 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.8 p -71.33 -32.59 68.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.574 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.22 -49.45 74.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.115 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -87.37 -20.63 26.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.825 0.345 . . . . 0.0 110.729 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.34 41.16 91.58 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -139.75 152.71 46.84 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.264 0.532 . . . . 0.0 110.418 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -151.39 148.58 28.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.461 ' C ' HD22 ' A' ' 45' ' ' LEU . 45.5 p90 -152.33 155.91 38.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.044 0.45 . . . . 0.0 111.53 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.663 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.3 mm? -96.7 141.92 29.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.894 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -153.05 147.63 19.2 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.543 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.22 163.4 34.93 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.596 2.197 . . . . 0.0 112.968 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.596 ' ND2' ' NE2' ' A' ' 33' ' ' GLN . 68.6 m-80 -70.52 160.47 32.4 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.85 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.74 -6.19 57.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -97.08 141.84 29.73 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 51' ' ' ILE . 36.4 pt -123.13 147.28 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.42 137.39 13.23 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.19 136.19 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.895 0.379 . . . . 0.0 110.655 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -77.78 133.98 38.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.241 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 m -132.06 56.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.256 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -73.65 137.78 44.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.13 3.57 69.77 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.48 -164.22 0.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.798 0.332 . . . . 0.0 110.65 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.5 157.04 1.89 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.155 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.74 131.03 27.92 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.425 2.083 . . . . 0.0 111.722 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 94.3 -22.43 36.98 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.84 132.16 27.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.413 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -118.67 -58.4 1.97 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.033 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 m -146.87 165.81 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.178 0.514 . . . . 0.0 111.308 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.13 140.86 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.028 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -111.99 130.38 55.88 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -127.6 133.6 49.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.917 0.389 . . . . 0.0 111.132 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 71' ' ' GLU . 60.2 t0 -93.49 118.27 31.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.452 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt -63.62 -39.09 93.49 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.14 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.06 -40.86 90.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' A' ' 68' ' ' ASP . 79.1 mm-40 -117.99 118.11 31.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.621 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -85.91 -43.0 13.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.417 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -58.43 -39.69 80.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.993 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 33.9 mp0 -82.95 135.94 34.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.355 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.84 157.77 38.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.904 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 77' ' ' SER . 9.5 tp -132.09 133.87 44.83 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.047 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.44 ' N ' HD12 ' A' ' 76' ' ' LEU . 42.6 t -123.54 131.32 53.6 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.41 126.97 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.61 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.506 HG23 ' C ' ' A' ' 61' ' ' GLY . 49.4 mt -122.33 121.41 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.21 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.4 mm -116.77 129.92 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.01 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 159' ' ' LEU . 9.6 m -148.79 164.36 34.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.161 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -103.66 138.12 40.75 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 83' ' ' ILE . 10.6 pt -92.92 149.26 37.37 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.788 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -43.77 139.64 5.18 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.76 1.64 . . . . 0.0 111.487 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -69.01 -23.9 64.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.557 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 56.3 t0 -90.68 -18.38 25.17 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -128.73 157.32 41.73 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.104 0.478 . . . . 0.0 111.617 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.9 t -122.92 176.91 5.74 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.515 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 tp -51.0 -45.09 61.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.972 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.9 p -66.92 -44.99 79.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.089 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.36 -37.18 84.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.8 tp -55.91 -41.94 75.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.67 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.83 -179.41 48.35 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.425 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.2 p -96.05 171.9 8.33 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.73 73.57 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.133 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.3 m -73.05 -46.16 53.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.87 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.425 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.3 t0 -62.6 -50.97 69.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.164 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.36 -38.79 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -57.94 -56.12 26.87 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -59.52 -36.64 76.48 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.479 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -56.27 -40.26 73.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.099 0.476 . . . . 0.0 110.577 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -63.8 -41.58 97.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.127 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.674 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -54.98 -55.27 32.7 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.307 0.575 . . . . 0.0 110.096 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -61.29 -39.56 90.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.766 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.1 m -57.97 -45.63 86.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.7 t -71.7 -46.57 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.504 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 111' ' ' GLN . 1.6 m120 -60.83 -33.9 73.75 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.879 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -45.63 -35.52 4.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.06 0.457 . . . . 0.0 110.439 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.47 -48.5 22.41 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 m -122.31 22.94 9.96 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.3 pt20 -47.39 -18.59 0.12 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.632 0.253 . . . . 0.0 111.483 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.26 -61.44 7.38 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.167 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 38.1 p-10 -117.31 -30.84 5.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.072 0.436 . . . . 0.0 111.781 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.527 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 55.1 ttm-85 -80.19 136.92 36.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 111.026 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -133.17 135.86 45.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.37 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.523 ' CB ' HD21 ' A' ' 107' ' ' ASN . . . -107.87 136.62 47.29 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.951 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -118.64 127.76 53.9 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.9 tp -82.84 108.18 15.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.899 0.38 . . . . 0.0 110.209 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.546 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 97.0 mt -71.0 -38.3 71.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.942 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.3 m-80 -178.52 163.7 1.57 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.165 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.9 120.53 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.197 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -137.6 170.71 15.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.035 0.445 . . . . 0.0 110.919 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -141.78 150.74 42.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.506 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.83 136.77 46.45 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.152 0.501 . . . . 0.0 110.802 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -103.97 113.62 27.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -138.26 137.62 37.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.429 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 129' ' ' GLN . 87.2 m-20 51.24 42.3 28.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.627 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.13 1.59 5.67 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.524 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 2.8 tm0? -102.28 130.71 49.06 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.13 130.0 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.524 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 45.8 m-85 -118.87 131.4 56.06 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.724 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.435 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.07 128.44 53.34 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.464 ' C ' HD12 ' A' ' 134' ' ' LEU . 94.0 m -110.13 123.62 50.06 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.326 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.464 HD12 ' C ' ' A' ' 133' ' ' THR . 9.4 mp -115.45 127.51 55.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.992 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -123.43 120.49 33.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.297 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -150.31 169.68 20.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.471 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -133.73 152.92 52.01 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 110.554 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.415 ' CG1' HH11 ' A' ' 114' ' ' ARG . 74.2 t -105.01 133.57 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.375 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.411 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.7 pp -140.57 135.13 31.49 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.283 0.563 . . . . 0.0 111.087 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.6 t -115.02 134.27 58.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.131 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.54 -122.1 21.87 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -111.31 13.45 21.65 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -128.86 156.74 43.17 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.077 0.465 . . . . 0.0 111.475 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 144' ' ' VAL . 9.9 p -87.62 126.98 41.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.412 ' OE1' ' NH1' ' A' ' 114' ' ' ARG . 84.2 tt0 -74.77 -54.63 6.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.472 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -174.46 173.83 2.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.207 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.416 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 51.2 m170 -103.99 138.66 40.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.025 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 81.5 m-20 -135.38 137.92 42.81 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.011 0.434 . . . . 0.0 111.291 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 tp -114.15 130.52 56.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.845 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.79 137.85 54.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.82 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.1 t -126.82 126.02 42.66 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 52.4 t -114.83 129.94 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.12 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.9 m -143.83 144.34 31.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.0 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 p -110.99 150.34 29.4 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.209 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -156.66 117.16 3.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.964 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.523 ' HE ' ' H ' ' A' ' 156' ' ' ARG . 4.8 mmp_? 58.94 24.85 13.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.11 7.88 72.92 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.1 125.82 43.27 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -88.97 121.47 31.35 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.42 ' N ' HD23 ' A' ' 159' ' ' LEU . 76.5 mt -122.87 129.08 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.565 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 37.7 m -129.07 136.47 50.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.454 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.85 99.9 8.03 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -96.81 107.55 20.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.762 0.315 . . . . 0.0 110.616 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.54 133.42 54.6 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.801 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 89.0 p -128.46 135.8 49.97 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.788 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 5.9 m -152.97 154.82 35.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.549 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -54.89 141.0 35.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.239 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -67.77 -34.19 76.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.55 -33.78 68.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.994 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 174' ' ' VAL . 63.9 mtt85 -109.9 -7.18 15.02 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.499 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 52.2 t-105 -49.51 -38.26 29.83 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.832 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.53 -42.96 99.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 58.6 m -65.53 -39.82 92.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.722 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 170' ' ' ARG . 13.6 m -108.28 21.27 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.35 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 171' ' ' TRP . 50.8 pttt -52.22 -46.78 65.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 84.8 p -69.52 -25.83 64.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.602 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.99 -43.28 91.44 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.998 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.499 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 28.5 m-85 -61.7 -50.86 70.75 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.206 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.15 -41.05 99.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.558 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 184' ' ' SER . 41.8 m -67.22 -48.52 67.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.321 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.95 -45.1 99.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.731 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.514 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -66.48 -43.94 84.06 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.313 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.0 m -72.8 -31.13 64.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.342 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 180' ' ' THR . 40.3 m -61.82 -29.53 70.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.442 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -54.94 157.01 3.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.078 0.466 . . . . 0.0 110.944 -179.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -137.02 158.03 45.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.64 151.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.941 0.401 . . . . 0.0 111.008 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.524 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 38.1 p90 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.801 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.463 0.214 0 CA-C-O 120.966 0.412 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.13 166.39 24.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.62 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.5 ptt-85 -115.84 144.68 43.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.708 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -124.13 132.44 53.64 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.189 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.9 m -139.15 151.18 46.43 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.544 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -141.61 118.48 11.15 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.32 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.6 p -72.31 -30.53 64.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.719 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -62.53 -47.61 83.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.722 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -90.21 -20.4 23.07 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.937 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.78 41.94 81.2 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -141.1 152.98 45.2 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.239 0.519 . . . . 0.0 110.22 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -153.26 148.17 26.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -157.22 157.57 34.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.162 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.6 mt -96.38 152.19 18.83 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -161.19 130.08 3.08 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.19 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -41.99 157.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.094 1.862 . . . . 0.0 112.507 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -80.8 160.31 24.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.869 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.84 12.53 63.91 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.532 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 28.2 m0 -91.24 151.68 20.82 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 110.479 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.0 pt -117.29 151.07 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.377 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.73 134.51 9.97 Favored Glycine 0 N--CA 1.466 0.651 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.62 141.19 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.62 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -87.03 144.72 26.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.181 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.69 49.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.308 0.575 . . . . 0.0 109.878 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -54.12 129.42 34.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.16 4.65 68.53 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.01 -164.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.12 157.89 2.78 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.249 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.8 130.62 25.13 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.341 2.027 . . . . 0.0 111.465 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 94.83 -22.47 37.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.423 ' N ' HG23 ' A' ' 79' ' ' ILE . 87.1 t -58.85 126.74 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.783 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -119.05 -57.98 1.98 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.596 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.5 t -145.68 146.04 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.83 0.348 . . . . 0.0 111.035 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.8 t -120.67 135.9 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.123 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -111.25 132.07 54.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.276 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -122.74 141.31 51.94 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.388 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 49.0 m-20 -93.37 118.97 31.95 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.566 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.0 mt -68.47 -38.16 80.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 110.623 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.16 -44.47 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.688 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -126.57 98.69 5.5 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.918 0.39 . . . . 0.0 110.621 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.765 ' NE ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -61.77 -32.67 72.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.538 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.46 -36.25 73.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.575 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -86.76 131.5 34.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -146.66 138.86 24.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.445 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -118.89 134.56 55.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.688 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t -122.6 138.28 54.63 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.213 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.6 t -118.28 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 110.342 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.484 HG23 ' C ' ' A' ' 61' ' ' GLY . 54.6 mt -122.28 122.83 67.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.475 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' GLY . 72.2 mt -122.88 133.85 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.907 0.384 . . . . 0.0 111.059 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 15.9 t -148.46 167.77 24.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.097 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -105.58 136.63 44.81 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.762 0.315 . . . . 0.0 110.318 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 83' ' ' ILE . 10.1 pt -93.92 148.3 35.03 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.264 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 87' ' ' LYS . 38.8 Cg_endo -66.07 136.88 46.21 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.728 1.619 . . . . 0.0 110.968 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.3 t -61.44 -27.18 68.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.979 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -67.8 -30.86 70.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.023 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 84' ' ' PRO . 66.4 mttm -130.41 156.58 44.49 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.027 0.442 . . . . 0.0 111.119 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 91' ' ' ASP . 14.7 t -122.7 176.13 6.13 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.441 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.0 tp -52.65 -44.83 66.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.075 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.8 p -68.6 -46.51 69.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.424 ' H ' HG23 ' A' ' 88' ' ' THR . 21.9 t70 -66.24 -35.76 81.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.075 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -55.83 -43.07 76.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.505 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 175.05 44.48 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 38.0 p -92.82 170.69 9.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.61 77.99 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.118 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 74.7 m -72.03 -44.5 63.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.418 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.3 t0 -61.77 -51.26 69.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.405 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.22 -38.49 79.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.528 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.18 -46.78 92.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -67.24 -40.39 86.29 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.984 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -61.5 -41.4 97.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.028 0.442 . . . . 0.0 110.813 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -61.45 -40.33 94.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.755 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.7 mmt -58.64 -44.3 90.02 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.684 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -65.55 -45.51 83.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.005 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.9 m -59.2 -45.81 90.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.98 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.14 -47.12 79.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.995 0.426 . . . . 0.0 110.406 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 111' ' ' GLN . 91.7 m-20 -63.36 -38.43 91.14 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -43.77 -36.28 2.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.337 . . . . 0.0 111.006 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.98 -47.65 67.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.011 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.5 m -123.66 23.44 8.8 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.6 tt0 -50.37 -28.72 8.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.596 0.236 . . . . 0.0 111.419 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.15 -61.72 2.62 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.098 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 34.3 p-10 -117.83 -35.27 3.95 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 117.046 0.423 . . . . 0.0 111.965 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.52 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 35.1 ttm180 -84.64 137.75 33.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 111.276 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -128.31 142.93 50.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.03 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.44 140.36 38.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.877 0.37 . . . . 0.0 110.421 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' CD ' ' CD2' ' A' ' 139' ' ' LEU . 93.3 mt-10 -121.32 123.54 42.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.459 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.7 tp -82.87 109.75 17.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.963 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.524 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.8 mt -72.44 -50.45 35.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.579 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 27.7 m120 -157.0 164.42 38.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.819 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.82 115.45 3.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.246 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -141.61 166.3 25.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.833 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.418 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -136.51 148.46 47.65 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -127.72 141.05 51.7 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.834 0.35 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -108.35 112.14 24.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.614 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 127' ' ' ASP . 79.4 mm-40 -138.28 144.07 40.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.432 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 126' ' ' GLU . 3.7 p-10 46.53 39.32 6.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.28 1.47 21.15 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 154' ' ' THR . 68.1 tp60 -105.95 132.36 52.14 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.43 130.44 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.987 0.422 . . . . 0.0 110.41 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -117.2 130.64 56.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.673 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -103.52 125.58 50.16 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.0 m -107.45 122.74 47.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.327 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.27 120.49 38.39 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.971 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -115.47 123.42 48.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -152.07 166.9 30.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.837 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -134.37 153.85 51.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.922 0.392 . . . . 0.0 110.486 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.01 136.42 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.755 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.402 ' CD2' ' CD ' ' A' ' 117' ' ' GLU . 2.7 pp -139.59 138.96 36.64 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.181 0.515 . . . . 0.0 111.225 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.6 m -110.5 134.01 54.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.243 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 62.04 -117.54 11.78 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 56.7 t0 -116.2 13.59 15.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.456 0.17 . . . . 0.0 110.963 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -121.98 148.0 45.34 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.753 0.311 . . . . 0.0 111.068 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 144' ' ' VAL . 13.8 p -85.48 126.84 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.467 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -75.81 -53.4 8.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.422 HH21 ' N ' ' A' ' 166' ' ' THR . 14.7 ptm180 -174.19 171.08 3.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.0 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.412 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 35.7 m170 -103.11 140.53 37.2 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.203 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 78.6 m-20 -134.84 136.19 42.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.924 0.393 . . . . 0.0 111.043 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.6 tp -111.23 134.41 52.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.631 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.78 136.17 42.39 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 110.553 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 52.8 m -123.66 140.47 52.96 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.6 t -121.68 129.56 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.871 0.367 . . . . 0.0 110.537 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.2 m -146.55 142.67 28.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.532 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.44 ' O ' ' NE2' ' A' ' 129' ' ' GLN . 16.7 p -106.0 151.8 24.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.805 0.335 . . . . 0.0 110.491 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -148.32 106.02 3.68 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.015 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 55.39 32.71 19.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.28 6.63 68.51 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -98.42 124.82 43.32 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.16 113.97 25.21 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 70.9 mt -120.02 126.5 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 89.6 m -122.68 132.26 54.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.295 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.56 111.15 22.19 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -114.6 133.98 55.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.962 0.411 . . . . 0.0 111.272 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 mp -129.87 144.33 51.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.426 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 82.5 p -134.98 134.04 40.11 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.298 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 167' ' ' ALA . 20.7 m -152.98 159.33 42.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.676 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.444 ' N ' HG22 ' A' ' 166' ' ' THR . . . -56.78 141.42 44.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.227 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -66.18 -38.61 88.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.878 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -62.08 -33.38 74.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.298 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.531 ' O ' HG22 ' A' ' 174' ' ' VAL . 75.1 mtm180 -96.38 -17.28 20.73 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.243 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.583 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 46.6 t-105 -48.53 -41.42 30.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.732 0.301 . . . . 0.0 110.784 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -63.0 -41.46 99.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.932 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.1 m -66.14 -40.61 90.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.7 m -108.08 21.41 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.266 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 171' ' ' TRP . 49.3 pttt -49.19 -45.9 44.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 111.38 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 83.8 p -67.91 -26.79 66.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.463 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.78 -45.35 86.11 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.926 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.583 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.1 m-85 -62.38 -49.73 74.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.244 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -62.35 -43.31 99.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.413 ' O ' ' OG ' ' A' ' 184' ' ' SER . 86.5 m -66.96 -50.62 61.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.824 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 76.1 t -67.49 -38.32 80.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.39 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.31 -36.67 82.86 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.055 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.7 t -85.02 -17.66 36.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.474 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 180' ' ' THR . 50.9 m -62.78 -36.13 82.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.388 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.451 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -58.66 148.82 27.8 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.39 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -138.71 160.18 40.28 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.4 m -128.18 151.66 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.952 0.406 . . . . 0.0 111.188 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.47 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 35.9 p90 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.587 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.2 mt . . . . . 0 N--CA 1.465 0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.623 ' NE2' ' ND2' ' A' ' 48' ' ' ASN . 5.4 mp0 -106.83 159.07 16.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.581 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -128.27 138.87 52.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.352 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -129.56 136.29 49.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.943 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.7 p -144.3 157.77 44.1 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -147.91 117.7 7.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.313 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.2 p -70.23 -31.96 69.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 110.448 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -62.13 -48.68 79.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.065 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -88.24 -20.53 25.37 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.97 42.8 76.35 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.81 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -143.97 151.79 40.22 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 117.308 0.554 . . . . 0.0 110.629 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -154.84 144.49 21.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.966 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -149.55 157.38 43.22 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.859 0.361 . . . . 0.0 110.822 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 33' ' ' GLN . 8.5 tp -101.63 134.72 44.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.369 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -139.7 148.53 56.14 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.5 165.49 27.21 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.652 2.235 . . . . 0.0 112.945 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.623 ' ND2' ' NE2' ' A' ' 33' ' ' GLN . 70.3 m-80 -73.22 159.7 33.05 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.602 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.41 -5.11 62.5 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.404 ' HE1' ' CG ' ' A' ' 68' ' ' ASP . 41.5 m0 -93.45 143.83 25.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.725 0.297 . . . . 0.0 110.26 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.7 pt -122.17 147.49 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.701 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.85 132.53 11.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.33 133.76 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.929 0.395 . . . . 0.0 110.641 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -80.02 140.67 36.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.37 51.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.47 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -75.02 132.85 41.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.031 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.25 -3.36 84.11 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.45 -163.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.544 -0.328 . . . . 0.0 110.279 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.0 m -39.24 108.84 0.5 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.68 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -45.51 136.55 11.96 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.569 1.512 . . . . 0.0 111.703 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.478 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 101.16 -31.91 8.1 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.51 129.22 28.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.125 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.433 ' OD2' HD12 ' A' ' 80' ' ' ILE . 55.7 t0 -100.24 -58.77 1.84 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.306 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.417 ' O ' HG22 ' A' ' 78' ' ' VAL . 65.1 t -150.13 149.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.152 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.71 135.72 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.4 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.08 138.69 48.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.298 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -131.01 129.83 42.56 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.302 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' CG ' ' HE1' ' A' ' 50' ' ' TRP . 60.4 t0 -87.58 118.26 26.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.559 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 mt -65.46 -37.79 87.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.58 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.5 mm -63.49 -43.96 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.46 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -124.74 97.8 5.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.459 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -60.47 -37.35 80.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.308 0.575 . . . . 0.0 109.769 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -58.48 -36.04 73.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -81.06 127.75 32.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.93 0.395 . . . . 0.0 110.311 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -156.01 165.15 37.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.528 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.3 pp -162.42 160.9 26.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.466 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.1 t -143.87 143.89 31.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.413 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.4 m -110.55 130.17 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.478 HG23 ' C ' ' A' ' 61' ' ' GLY . 25.5 mt -116.54 127.45 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.22 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.433 HD12 ' OD2' ' A' ' 63' ' ' ASP . 64.8 mt -118.23 127.95 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 110.425 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.1 m -143.3 164.76 29.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.772 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -106.23 131.52 53.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.707 0.289 . . . . 0.0 110.293 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -94.08 150.32 38.26 Favored Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 87' ' ' LYS . 55.8 Cg_endo -70.75 137.49 32.69 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.739 1.626 . . . . 0.0 110.878 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.6 t -63.54 -29.17 70.47 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.371 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 46.3 p30 -68.69 -29.29 67.71 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.599 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 99.1 mttt -132.03 144.89 51.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.025 0.44 . . . . 0.0 110.999 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -109.52 -179.8 3.92 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.31 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.6 tp -50.75 -44.63 58.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.82 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.2 p -66.27 -43.92 85.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.911 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -65.01 -38.92 92.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.2 tp -55.93 -43.15 77.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.504 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.75 173.86 43.58 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 36.1 p -91.72 171.61 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.08 -43.2 81.92 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.075 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.2 m -71.91 -44.21 64.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 94' ' ' THR . 45.8 t0 -61.43 -51.35 69.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.426 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.67 -38.53 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.573 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.78 -44.61 94.14 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -68.71 -43.08 76.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.101 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -61.37 -39.14 89.56 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.921 -0.311 . . . . 0.0 110.982 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -61.89 -40.65 96.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.526 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -59.22 -42.7 91.61 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.497 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 2.2 mptm? -67.99 -42.74 80.32 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.398 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.0 m -57.02 -44.52 82.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.71 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.55 -43.67 71.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.956 0.408 . . . . 0.0 110.142 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.97 -31.68 72.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.037 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 104' ' ' LYS . 94.9 m-20 -42.39 -32.28 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.915 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.28 -33.32 6.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.537 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 114' ' ' ARG . 5.7 p -88.55 -6.36 57.62 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -55.92 -28.59 57.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.531 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -41.97 -63.74 1.67 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.009 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.1 p-10 -119.36 -45.01 2.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.025 0.44 . . . . 0.0 111.47 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.494 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 83.5 mtm180 -81.69 148.77 28.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.96 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -129.83 142.01 50.74 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.729 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.96 136.75 45.05 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.657 0.265 . . . . 0.0 110.51 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -122.71 128.91 51.17 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.6 tp -82.69 108.15 15.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.906 0.384 . . . . 0.0 110.325 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.0 mt -74.21 -43.35 50.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.536 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.38 164.84 22.03 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.281 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.72 114.44 3.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.207 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -139.03 170.51 15.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -142.62 151.0 41.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -132.45 147.82 52.38 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.059 0.457 . . . . 0.0 111.016 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -114.51 114.63 26.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.561 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -138.22 142.53 39.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.7 t0 51.31 27.64 3.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.547 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.15 -2.37 84.51 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -100.37 146.95 26.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.055 0.455 . . . . 0.0 110.165 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.77 127.74 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.011 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 22.1 m-85 -116.88 126.77 53.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.841 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.4 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.69 126.4 51.73 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.7 m -108.43 122.15 46.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.214 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.76 113.8 22.37 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.134 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -108.94 123.19 48.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.572 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -150.03 169.13 21.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.599 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -132.58 156.59 46.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.049 0.452 . . . . 0.0 110.837 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.7 t -106.38 129.75 59.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.167 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.16 135.81 54.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.043 0.449 . . . . 0.0 111.501 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.21 87.65 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.95 -106.02 2.82 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -112.79 7.49 18.5 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -122.62 137.14 54.99 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.006 0.431 . . . . 0.0 111.585 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 144' ' ' VAL . 7.0 p -67.29 122.96 19.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.849 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -77.7 -56.17 4.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.343 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -169.57 169.58 8.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -103.49 134.87 46.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.075 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -129.71 137.76 50.76 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.042 0.448 . . . . 0.0 110.823 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.72 HD13 ' N ' ' A' ' 150' ' ' ALA . 3.2 tm? -111.99 138.78 48.16 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.707 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.72 ' N ' HD13 ' A' ' 149' ' ' LEU . . . -135.92 125.37 25.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.462 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t -118.34 124.46 47.81 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 44.6 t -110.61 128.91 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.902 0.382 . . . . 0.0 110.868 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 57.6 m -142.75 143.16 32.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.373 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.4 p -89.15 157.34 18.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.885 0.374 . . . . 0.0 110.596 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -150.26 93.97 2.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.602 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 57.91 33.61 23.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.583 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 93.16 3.8 65.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -101.6 137.59 39.71 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.787 0.327 . . . . 0.0 110.164 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.95 119.03 32.3 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.296 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.1 mt -119.36 126.63 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.5 m -126.27 137.22 53.49 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.817 0.342 . . . . 0.0 110.571 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.32 98.01 7.01 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.794 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -96.37 113.74 25.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.856 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.8 mp -116.13 140.58 49.14 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.439 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.5 t -133.1 132.76 42.08 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.141 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 11.1 m -152.42 158.99 43.43 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.489 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.413 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -52.73 141.34 21.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.342 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -67.8 -39.48 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -61.5 -33.38 73.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.343 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.444 ' O ' HG22 ' A' ' 174' ' ' VAL . 69.1 mtp180 -96.58 -17.27 20.56 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.17 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.523 ' O ' ' N ' ' A' ' 175' ' ' LYS . 52.2 t-105 -48.85 -40.08 28.13 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.931 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -61.22 -41.04 96.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.297 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 59.3 m -68.05 -38.92 83.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.629 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 170' ' ' ARG . 6.5 m -111.44 21.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.378 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 171' ' ' TRP . 11.1 ptmm? -51.26 -50.41 59.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 29.8 m -65.07 -28.97 69.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.656 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.5 tp -56.14 -44.16 78.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.253 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.51 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 26.2 m-85 -63.35 -51.05 67.55 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.352 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.58 -41.15 98.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 184' ' ' SER . 44.1 m -66.6 -48.83 68.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.43 -43.55 98.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.432 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.55 -41.34 98.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.362 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 84.2 p -79.22 -25.65 42.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.874 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 180' ' ' THR . 41.4 t -62.75 -31.01 71.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.028 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -55.9 158.17 3.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.103 0.477 . . . . 0.0 110.576 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.523 ' CD2' ' N ' ' A' ' 187' ' ' VAL . 6.0 t-160 -136.97 145.5 44.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.368 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.523 ' N ' ' CD2' ' A' ' 186' ' ' HIS . 6.8 m -122.27 147.96 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.449 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 35.5 p90 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.722 -179.363 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.029 0.442 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 48' ' ' ASN . 2.1 mp0 -106.73 146.19 31.13 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.008 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -117.42 131.0 56.83 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.738 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -115.3 134.43 55.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.487 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 94.2 p -145.35 153.06 40.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.947 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 36' ' ' SER . 97.9 m-20 -143.04 119.43 10.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.27 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.1 p -69.16 -33.9 74.12 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.272 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.84 -48.45 78.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -84.25 -20.64 31.88 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.958 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.9 42.06 93.04 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -143.97 149.1 36.23 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.175 0.488 . . . . 0.0 110.467 179.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -153.66 145.39 23.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -151.28 158.52 43.96 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 tp -104.24 135.01 46.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.402 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 14.7 p90 -136.88 143.78 43.94 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.859 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.87 150.7 2.51 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.819 1.679 . . . . 0.0 112.149 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.419 ' CB ' ' NE2' ' A' ' 33' ' ' GLN . 51.1 p-10 -79.87 160.67 25.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.497 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.69 60.52 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.1 m0 -92.38 147.57 22.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.851 0.358 . . . . 0.0 110.201 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.7 pt -116.5 144.44 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.415 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.33 133.49 11.4 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.22 133.67 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.331 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.16 124.64 32.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.227 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.93 59.47 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -77.15 135.19 38.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.063 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.79 3.69 73.65 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.46 -164.4 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.492 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -45.93 154.38 0.58 Allowed Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.412 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.31 130.77 23.26 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.36 2.04 . . . . 0.0 111.855 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.482 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 96.47 -23.72 33.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.91 128.9 33.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.561 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -119.16 -57.88 1.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.502 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.2 t -143.49 141.66 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.884 0.373 . . . . 0.0 111.216 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.41 133.28 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.218 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -112.61 135.94 52.75 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.63 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -127.92 138.46 52.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.337 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -88.76 118.29 28.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.62 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.37 -37.03 84.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.684 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.62 -42.43 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.486 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.36 99.72 6.57 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.58 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -62.59 -37.43 86.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.39 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -58.77 -35.05 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.753 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -81.62 131.29 35.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -140.1 139.19 35.78 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.994 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -126.26 135.26 51.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.071 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 t -128.02 139.41 52.57 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.84 126.55 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.961 0.41 . . . . 0.0 110.231 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.482 HG23 ' C ' ' A' ' 61' ' ' GLY . 26.2 mt -124.11 119.24 56.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.274 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' GLY . 33.4 mm -116.07 131.92 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.289 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 159' ' ' LEU . 49.2 m -145.96 166.48 25.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.35 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -104.8 137.98 41.77 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.435 HG22 HD12 ' A' ' 159' ' ' LEU . 10.3 pt -93.51 149.32 37.04 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.656 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -45.38 134.96 12.22 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.641 1.561 . . . . 0.0 111.496 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.1 t -65.1 -26.75 68.35 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.307 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -85.11 -20.81 29.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -129.79 158.24 39.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.209 0.528 . . . . 0.0 111.863 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.426 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.9 t -122.69 175.65 6.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.468 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.5 tp -52.07 -45.06 64.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.017 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 p -66.01 -46.02 79.44 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.164 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 88' ' ' THR . 88.0 m-20 -66.79 -35.26 79.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.885 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.5 tp -55.83 -43.43 76.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.75 178.79 47.57 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 33.4 p -94.13 173.04 7.85 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.43 -41.56 76.61 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.15 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.3 m -72.53 -46.25 55.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.002 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' A' ' 94' ' ' THR . 44.4 t0 -61.64 -50.89 70.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.431 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.32 -38.27 80.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.694 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.73 -44.03 96.04 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -67.24 -42.61 83.66 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.665 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -61.45 -38.45 87.25 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.664 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.39 -41.61 98.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.38 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.55 -43.2 93.59 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.187 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -64.89 -38.51 91.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.35 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.9 m -58.56 -47.62 83.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.883 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.45 -46.41 56.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.052 0.453 . . . . 0.0 110.503 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.4 m-20 -60.82 -30.41 70.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.285 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -43.59 -38.93 3.23 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.329 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.29 -39.68 9.52 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.624 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 112' ' ' GLY . 8.9 p -86.13 -1.19 57.18 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.4 pt20 -58.39 -0.55 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.438 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -73.7 -64.37 2.49 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.134 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -118.42 -45.23 2.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.79 0.329 . . . . 0.0 111.46 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 110' ' ' SER . 69.9 mtm180 -85.24 144.81 27.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.481 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -123.98 143.85 50.16 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.796 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.85 132.38 45.23 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -114.11 128.81 56.54 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 39.0 tp -81.78 109.86 16.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.67 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.455 ' CG1' ' HE ' ' A' ' 137' ' ' ARG . 88.2 mt -74.09 -53.33 17.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.237 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.549 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 9.2 p30 -160.69 176.51 11.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.84 127.14 5.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.225 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 57.6 mp0 -141.43 159.35 42.41 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.701 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -140.29 147.77 40.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.941 0.4 . . . . 0.0 110.651 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -132.57 146.4 51.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.572 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -121.01 114.95 22.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.3 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -142.19 144.68 33.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.6 t0 51.25 34.44 11.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.533 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.45 -0.24 55.73 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -101.85 146.87 27.21 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.988 0.423 . . . . 0.0 110.188 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.3 t -114.47 128.86 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.214 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -118.09 122.64 43.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.54 132.05 51.24 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 52.8 m -112.55 132.25 55.2 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.053 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.32 110.34 12.72 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.065 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.549 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 69.9 tt0 -104.19 122.95 46.43 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -147.47 170.07 18.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.306 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.455 ' HE ' ' CG1' ' A' ' 119' ' ' ILE . 18.7 ptp180 -138.14 161.26 37.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.946 0.403 . . . . 0.0 110.926 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.0 t -108.16 133.46 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.092 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.436 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.5 pp -136.4 135.47 38.76 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.149 0.5 . . . . 0.0 111.622 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.37 128.1 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.65 -118.2 13.68 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -109.66 9.27 25.03 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.87 -0.194 . . . . 0.0 110.949 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -114.93 143.85 44.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.854 0.359 . . . . 0.0 111.492 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.29 130.13 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.465 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.436 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 2.0 tm-20 -83.28 -54.68 4.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.443 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.614 HH21 ' CA ' ' A' ' 166' ' ' THR . 15.2 ptm180 -170.3 173.29 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.123 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.414 ' NE2' ' CZ ' ' A' ' 137' ' ' ARG . 50.7 m80 -105.49 142.81 34.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.128 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 13.5 t70 -139.88 150.75 44.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.767 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.6 tp -125.49 136.32 53.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.041 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.02 119.81 19.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.847 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.1 t -106.03 138.36 42.35 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.35 130.06 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.908 0.385 . . . . 0.0 111.007 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -148.44 150.94 34.36 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.413 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.1 p -118.95 152.34 36.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.523 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -159.54 118.07 2.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.637 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 59.45 27.88 17.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.33 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.93 9.8 83.88 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -100.46 127.17 46.88 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.51 121.46 31.75 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.135 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.402 ' N ' HD23 ' A' ' 159' ' ' LEU . 77.4 mt -119.45 127.64 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.304 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 46.1 m -129.66 135.28 48.33 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.663 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.0 103.84 11.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.895 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -100.12 110.0 22.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.573 0.225 . . . . 0.0 110.432 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.432 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 5.3 mp -115.0 136.05 53.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.408 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.5 t -127.47 134.1 49.85 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.885 0.374 . . . . 0.0 110.546 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.614 ' CA ' HH21 ' A' ' 146' ' ' ARG . 9.5 m -152.53 154.9 36.38 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.611 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.14 144.29 35.5 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.547 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.431 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 1.2 pp20? -70.32 -30.55 67.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.024 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.431 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 92.5 m-20 -59.86 -33.9 72.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.957 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 174' ' ' VAL . 1.1 mpt_? -111.88 -5.3 14.38 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.501 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 52.4 t-105 -49.55 -39.17 33.74 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.786 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.42 -41.64 98.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.19 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.0 m -65.72 -39.87 91.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.699 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 170' ' ' ARG . 11.6 m -108.86 21.64 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.278 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 171' ' ' TRP . 10.2 ptmm? -51.38 -50.0 60.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.392 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.1 t -64.92 -30.7 71.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.17 -44.16 74.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.303 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 27.9 m-85 -60.95 -49.83 75.84 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.308 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -64.59 -38.91 92.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.492 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 42.7 m -65.38 -49.01 70.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.476 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.29 -45.16 99.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.659 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -64.85 -42.18 95.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 110.371 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 21.2 t -73.87 -31.47 63.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.231 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 91.7 p -63.12 -24.13 67.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.308 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -57.34 156.11 8.13 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.498 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -136.0 156.75 48.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.522 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.82 151.42 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.831 0.348 . . . . 0.0 111.107 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.519 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 38.3 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.736 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.9 mt . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 120.846 0.355 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.501 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 20.5 mp0 -108.42 154.26 22.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.497 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -125.96 143.71 50.98 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.312 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -130.07 139.87 50.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.046 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -149.75 148.57 29.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 110.63 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -137.89 121.45 17.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.481 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.5 p -70.98 -33.22 70.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.504 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -61.93 -48.25 81.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -88.6 -20.47 24.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.784 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.84 42.02 93.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.73 150.72 42.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.153 0.477 . . . . 0.0 110.662 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -149.67 147.15 27.74 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.717 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.462 ' C ' HD22 ' A' ' 45' ' ' LEU . 48.3 p90 -146.75 154.86 41.89 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.935 0.398 . . . . 0.0 110.983 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.651 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.1 mm? -98.02 141.66 30.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.101 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -151.31 146.84 19.42 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.317 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.12 160.02 51.09 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.455 2.103 . . . . 0.0 112.347 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -69.83 160.81 31.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.709 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.18 0.28 57.14 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.528 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 32.6 m0 -91.22 141.3 28.95 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.425 HD13 ' N ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -115.68 128.37 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.999 0.428 . . . . 0.0 110.141 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.53 137.33 13.21 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.52 141.75 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.72 0.295 . . . . 0.0 110.57 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.17 122.61 31.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.05 0.452 . . . . 0.0 110.413 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 m -121.56 32.07 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.676 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -50.09 136.82 18.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.94 4.1 69.64 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.11 -164.33 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.636 0.255 . . . . 0.0 110.541 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 m -46.36 137.08 6.93 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.65 130.47 9.61 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.708 1.606 . . . . 0.0 112.717 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.465 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 96.0 -33.15 5.76 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.451 ' N ' HG23 ' A' ' 79' ' ' ILE . 92.0 t -62.31 125.43 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.273 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -119.78 -57.22 1.98 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.68 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.7 t -136.32 142.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.082 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.01 132.97 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.419 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 76' ' ' LEU . 90.7 m-85 -112.78 133.19 54.91 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.263 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -124.82 140.93 52.48 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.443 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 81.9 m-20 -88.36 118.76 28.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.546 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 tp -67.35 -40.87 85.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.47 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.8 mt -61.62 -43.43 97.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.017 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -117.34 121.2 40.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.928 0.394 . . . . 0.0 110.371 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -80.95 -37.55 29.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.634 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 41.1 p-10 -62.57 -31.32 72.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.959 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 85.3 tt0 -85.89 131.3 34.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.939 0.399 . . . . 0.0 110.787 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -142.31 139.6 31.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.144 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PHE . 7.5 tt -123.78 134.81 53.58 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.7 t -128.74 138.91 52.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.334 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -113.18 123.82 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.465 HG23 ' C ' ' A' ' 61' ' ' GLY . 12.4 mt -125.77 120.54 57.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.195 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.4 mt -121.1 132.64 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.172 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.4 m -136.15 164.7 27.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.47 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -103.73 135.36 45.43 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.504 ' CG2' HD12 ' A' ' 159' ' ' LEU . 9.6 pt -102.23 150.21 37.31 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.943 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -44.51 145.37 2.63 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.841 1.694 . . . . 0.0 111.222 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.6 p -80.08 -13.91 58.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.598 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -96.35 -20.93 18.12 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.765 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -124.06 157.14 35.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.099 0.476 . . . . 0.0 111.385 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.408 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.5 t -122.66 177.82 5.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.612 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 tp -51.66 -45.43 63.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.061 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.2 p -64.42 -44.55 90.87 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.098 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.2 m-20 -65.76 -38.12 88.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.4 tp -56.23 -43.85 79.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.86 176.52 45.93 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 39.8 p -94.86 171.11 8.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.6 78.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.126 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.2 m -72.03 -44.93 62.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.747 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.418 ' HB3' ' H ' ' A' ' 94' ' ' THR . 16.4 t70 -61.84 -51.78 66.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.409 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.16 -38.01 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.668 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.33 -47.21 90.98 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.53 -41.63 84.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -62.35 -40.79 97.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.981 0.42 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -61.67 -41.3 97.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.857 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -58.99 -45.46 90.56 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.661 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -64.35 -43.01 95.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.873 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.1 m -60.85 -47.04 88.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.1 t -71.87 -46.11 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.602 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 111' ' ' GLN . 91.7 m-20 -61.43 -39.57 91.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.632 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -46.61 -36.25 6.74 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.533 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 -45.36 89.78 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.885 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 114' ' ' ARG . 8.6 m -123.7 22.18 9.08 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.6 tt0 -52.53 -28.48 20.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.673 0.273 . . . . 0.0 111.452 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.86 -62.1 2.75 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.138 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -117.74 -40.51 3.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.929 0.365 . . . . 0.0 111.681 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 110' ' ' SER . 52.6 ttp180 -92.09 146.2 23.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.046 0.451 . . . . 0.0 110.904 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.76 151.63 40.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.517 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.463 ' HB3' ' OD1' ' A' ' 107' ' ' ASN . . . -103.04 139.85 38.05 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.569 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -113.18 130.8 56.1 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 118' ' ' LEU . 3.5 tt -81.21 106.01 12.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.082 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.7 mt -70.8 -51.06 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.378 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.549 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 7.5 p30 -160.66 173.91 14.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.953 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.1 122.92 4.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.189 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -142.09 159.56 41.99 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.689 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.42 147.83 43.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.524 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.7 141.55 47.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.705 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -110.61 112.81 24.96 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.393 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -137.59 144.33 41.94 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.97 0.414 . . . . 0.0 110.76 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.3 t0 50.98 33.28 8.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.35 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.84 0.97 61.08 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -104.05 146.94 27.99 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.978 0.418 . . . . 0.0 110.252 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.05 128.53 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.142 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 27.8 m-85 -118.06 124.47 48.18 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.853 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.62 128.13 50.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.0 m -109.02 122.25 46.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.201 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.8 mp -118.36 112.74 20.41 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.102 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.549 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 60.7 tt0 -106.46 123.96 48.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.426 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.94 169.66 20.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.499 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -135.85 156.3 49.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.76 0.314 . . . . 0.0 110.541 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.1 m -102.89 125.78 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.993 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 144' ' ' VAL . 6.7 mt -107.75 123.35 48.41 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.5 t -117.31 130.36 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.66 -122.27 22.02 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 88.4 m-20 -116.33 21.95 13.21 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.982 -0.128 . . . . 0.0 111.217 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 78.2 m-20 -144.1 161.87 37.72 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.893 0.377 . . . . 0.0 111.17 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 144' ' ' VAL . 7.8 p -79.49 120.46 30.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -69.98 -51.77 29.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.06 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -173.56 171.37 3.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.083 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -104.83 140.91 37.42 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.07 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 18.0 t70 -133.61 150.86 51.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.144 0.497 . . . . 0.0 110.543 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.73 HD13 ' N ' ' A' ' 150' ' ' ALA . 3.2 tm? -125.97 138.58 53.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.578 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.73 ' N ' HD13 ' A' ' 149' ' ' LEU . . . -136.54 117.47 14.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.356 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t -104.1 126.22 51.05 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 26.5 t -112.45 129.02 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.7 m -145.02 148.03 33.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.244 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 p -109.64 143.48 39.32 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.922 0.391 . . . . 0.0 110.551 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -152.64 112.97 4.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 62.44 33.45 16.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.65 11.57 84.59 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.34 131.59 54.92 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.721 0.296 . . . . 0.0 110.597 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.504 HD12 ' CG2' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -87.75 120.36 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.8 124.86 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.6 m -127.25 132.31 50.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.792 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.83 99.71 7.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.56 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -98.03 111.69 23.91 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.654 0.264 . . . . 0.0 110.572 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 164' ' ' LEU . 5.4 mp -116.91 136.9 52.59 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.28 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -126.56 136.19 52.23 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.858 0.361 . . . . 0.0 110.592 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.4 m -152.87 155.69 37.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.283 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.24 143.57 27.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.093 0.473 . . . . 0.0 111.197 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -71.19 -28.77 64.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.028 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.11 -34.28 71.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.232 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.416 ' O ' HG22 ' A' ' 174' ' ' VAL . 89.6 mtt-85 -114.62 -3.07 12.94 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.482 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 50.3 t-105 -49.79 -38.21 33.37 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.851 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -61.58 -41.83 97.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.263 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.6 m -66.84 -39.2 87.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.79 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 170' ' ' ARG . 8.2 m -108.4 21.32 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.294 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 176' ' ' SER . 19.4 ptmt -52.03 -49.73 62.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.331 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.41 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 25.0 t -65.67 -29.41 69.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.358 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 tt -54.76 -45.69 74.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.036 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.482 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 25.7 m-85 -61.9 -49.78 74.84 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.53 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.03 -38.39 90.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.478 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 39.2 m -64.33 -47.95 77.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.353 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.07 -45.08 99.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.624 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.47 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.45 -44.42 94.55 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.208 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.5 t -71.31 -32.76 69.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.1 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 95.3 p -63.1 -24.82 68.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -56.4 156.96 5.39 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.332 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -134.76 153.3 52.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.47 148.79 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 111.115 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.676 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 121.125 0.488 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.482 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 1.7 pm0 -127.54 164.77 21.23 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.861 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -125.61 144.38 50.61 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.815 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -122.2 133.22 54.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.797 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.446 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 92.4 p -145.63 153.48 41.08 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.867 0.365 . . . . 0.0 110.795 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 36' ' ' SER . 99.9 m-20 -143.06 113.23 7.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.278 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.0 p -65.43 -32.96 74.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.886 0.374 . . . . 0.0 110.075 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -62.24 -45.19 94.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -89.36 -20.47 23.96 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.09 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.72 40.63 90.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -143.48 150.81 39.51 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.286 0.543 . . . . 0.0 110.443 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -156.73 146.35 20.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.113 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -155.57 158.27 38.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.127 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.03 154.14 17.31 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.684 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 46' ' ' TYR . 13.0 p90 -156.85 142.94 12.98 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.53 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.9 153.83 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.993 1.795 . . . . 0.0 112.462 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 49' ' ' GLY . 32.4 t-20 -81.44 157.15 25.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.426 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . 92.64 6.79 63.69 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.539 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 30.5 m0 -89.16 149.13 23.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.851 0.357 . . . . 0.0 110.262 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.26 145.69 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.16 128.75 9.01 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 t -113.9 132.99 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 110.462 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.59 134.26 35.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.288 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.31 55.2 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -73.33 136.02 44.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.229 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.15 69.26 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.79 -164.32 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.708 0.29 . . . . 0.0 110.484 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.63 158.15 0.88 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.181 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.33 128.8 20.08 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.442 2.095 . . . . 0.0 111.922 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.52 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 97.14 -24.05 33.02 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t -63.49 130.63 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -119.19 -58.75 1.91 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.537 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.2 t -151.45 151.44 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.753 0.311 . . . . 0.0 111.143 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.26 144.27 33.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.264 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.454 ' HB2' HD11 ' A' ' 76' ' ' LEU . 84.8 m-85 -112.77 134.64 54.19 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.448 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.31 141.04 52.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.413 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.539 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 45.8 m-20 -89.28 118.99 29.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.587 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.67 -40.02 91.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.577 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.6 mm -61.86 -46.97 95.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.682 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.8 103.81 8.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.973 0.416 . . . . 0.0 110.413 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.43 -38.38 83.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.263 0.554 . . . . 0.0 110.007 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.53 -36.37 73.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.901 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.83 125.9 31.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.932 0.396 . . . . 0.0 110.454 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -161.01 174.05 14.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.601 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.3 pp -159.98 158.76 31.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.1 t -127.68 139.36 52.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.22 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 t -111.15 123.71 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.86 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.52 HG23 ' C ' ' A' ' 61' ' ' GLY . 51.4 mt -121.59 124.86 72.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.962 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 61' ' ' GLY . 76.3 mt -122.91 131.89 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.81 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 159' ' ' LEU . 51.1 m -146.06 166.97 24.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.086 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 2.0 pm0 -106.14 132.44 52.21 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 83' ' ' ILE . 8.8 pt -88.75 148.93 42.77 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.506 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.71 136.68 43.07 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.629 1.553 . . . . 0.0 110.866 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -61.17 -27.15 68.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.947 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -67.8 -30.9 70.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.134 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -130.14 150.5 51.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.221 0.534 . . . . 0.0 111.576 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.476 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 81.4 p -112.6 174.87 5.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.713 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.6 tp -56.85 -41.2 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.01 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.3 p -69.82 -44.32 70.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.418 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 88' ' ' THR . 44.4 t0 -64.28 -34.81 78.99 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -54.92 -52.14 63.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.214 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.56 179.04 47.6 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.8 p -88.09 170.64 10.9 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.51 -41.88 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.836 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.3 m -72.14 -44.1 63.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.748 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -61.71 -52.88 62.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.35 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.1 -38.6 79.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.678 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.99 -43.98 94.75 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -67.14 -41.65 85.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.82 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -61.87 -38.95 90.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.665 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -62.29 -40.84 97.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.655 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -58.12 -45.68 86.86 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.499 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -65.29 -43.03 92.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.4 m -60.79 -45.67 93.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.945 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.56 -47.99 68.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.636 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.643 ' O ' ' N ' ' A' ' 111' ' ' GLN . 93.5 m-20 -62.6 -37.58 86.8 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.676 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -44.26 -37.0 2.98 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.309 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.38 -47.26 70.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.135 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.3 m -123.71 23.22 8.83 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.8 tt0 -50.32 -28.83 8.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.579 0.228 . . . . 0.0 111.328 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.67 -61.39 2.95 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.083 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -117.08 -35.94 3.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.929 0.364 . . . . 0.0 111.933 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -83.98 137.55 33.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.962 0.41 . . . . 0.0 111.266 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -129.13 139.9 51.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.959 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.54 135.15 44.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.333 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -114.51 125.18 53.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.182 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.535 ' C ' HD23 ' A' ' 118' ' ' LEU . 3.8 tt -84.58 109.83 18.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.252 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.518 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.9 mt -74.6 -53.84 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.683 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 27.7 m120 -155.08 164.41 38.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.728 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.83 115.79 3.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.486 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -139.76 170.52 15.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.882 0.372 . . . . 0.0 110.69 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.401 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -141.28 150.52 42.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.645 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -132.45 139.07 47.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -108.46 114.19 27.83 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.452 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.94 142.98 34.31 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.96 0.41 . . . . 0.0 110.782 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 51.67 37.37 19.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.282 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.85 0.77 35.41 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -104.46 147.87 27.08 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.897 0.38 . . . . 0.0 110.115 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.71 128.56 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.108 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -117.16 126.83 53.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.822 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.3 m-85 -104.41 126.3 51.38 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.408 ' C ' HD12 ' A' ' 134' ' ' LEU . 89.9 m -109.26 122.66 47.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 110.321 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 133' ' ' THR . 8.3 mp -116.78 122.22 43.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.826 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -116.77 119.45 35.49 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -148.97 167.32 26.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.589 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -135.53 152.93 51.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.927 0.394 . . . . 0.0 110.635 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 m -105.86 136.03 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.909 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.45 137.08 38.36 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.173 0.511 . . . . 0.0 111.2 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.25 133.35 60.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.393 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.42 -119.19 11.0 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -116.53 15.28 15.61 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.851 -0.205 . . . . 0.0 111.174 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -129.03 153.86 47.19 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.896 0.379 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 144' ' ' VAL . 14.9 p -86.85 127.42 40.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.377 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -74.89 -52.22 11.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.631 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -174.55 173.9 2.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.087 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -109.2 137.31 47.28 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.163 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -130.87 142.65 50.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.884 0.373 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.2 tp -114.4 131.28 56.63 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.03 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -125.38 130.81 52.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.965 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.4 t -124.31 126.95 46.9 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.0 t -113.04 127.87 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 111.101 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.8 m -141.31 139.4 33.62 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.108 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.1 p -103.27 150.25 23.92 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.799 0.333 . . . . 0.0 110.342 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -149.14 106.07 3.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 57.04 30.89 18.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.814 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.06 5.22 68.12 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -95.61 123.56 39.22 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.06 118.0 28.47 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.76 126.68 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.863 0.364 . . . . 0.0 110.463 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.1 m -126.92 137.61 53.16 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.085 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.6 98.72 6.69 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.247 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -95.87 112.4 24.13 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.651 0.262 . . . . 0.0 110.58 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.6 mp -115.0 138.99 50.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.502 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 81.8 p -132.65 133.83 44.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.221 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 15.6 m -152.82 161.13 42.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.568 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.45 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -54.99 140.73 36.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.013 0.435 . . . . 0.0 111.181 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.66 -39.06 84.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 170' ' ' ARG . 37.8 p-10 -63.87 -32.58 74.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 15.1 tpt180 -94.65 -19.53 20.36 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.71 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.542 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 50.5 t-105 -47.95 -41.08 24.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.213 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.43 -42.09 98.2 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.172 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 46.9 m -66.68 -40.32 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.559 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 170' ' ' ARG . 11.2 m -108.77 21.48 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.332 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 171' ' ' TRP . 11.1 ptmm? -50.43 -49.81 53.78 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.284 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 22.2 m -64.86 -29.72 70.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.661 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 tp -55.5 -44.49 76.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.368 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.542 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 25.3 m-85 -62.55 -50.29 71.91 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.308 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.22 -41.31 99.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.757 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 184' ' ' SER . 45.2 m -66.65 -49.04 67.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 68.7 t -62.7 -43.85 98.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.457 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -64.63 -39.65 94.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.424 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 t -80.2 -28.18 38.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.144 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 180' ' ' THR . 67.4 m -62.43 -30.97 71.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.385 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -55.22 156.8 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.468 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -139.25 160.65 39.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.621 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.41 150.21 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 111.035 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 39.5 p90 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.689 179.747 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.445 ' O ' ' OE1' ' A' ' 33' ' ' GLN . 55.9 mt . . . . . 0 N--CA 1.467 0.392 0 CA-C-O 120.804 0.335 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.549 ' NE2' ' OD1' ' A' ' 48' ' ' ASN . 1.8 mp0 -110.16 156.64 20.34 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.416 ' H ' ' HD2' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -120.77 140.56 51.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.384 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -125.03 135.36 52.68 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.037 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 t -146.02 147.89 32.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.903 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -138.37 118.35 13.37 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.9 p -70.99 -31.44 67.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.896 0.379 . . . . 0.0 110.247 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -62.29 -49.8 74.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.979 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -86.2 -20.61 28.29 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.37 40.24 80.26 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.83 149.91 39.21 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.219 0.509 . . . . 0.0 110.705 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -151.06 144.44 24.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.713 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -151.12 159.48 44.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.048 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.8 mt -100.2 151.28 21.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.394 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 11.2 p90 -150.91 146.74 19.62 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.535 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.24 161.36 44.73 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.441 2.094 . . . . 0.0 112.483 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.549 ' OD1' ' NE2' ' A' ' 33' ' ' GLN . 52.7 m-20 -73.5 159.29 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.553 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.9 -2.18 63.91 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -93.67 144.53 25.31 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 pt -118.47 141.78 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.309 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.84 133.67 11.48 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.532 HG21 ' NH1' ' A' ' 67' ' ' ARG . 22.8 t -111.68 133.19 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.924 0.392 . . . . 0.0 110.745 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -83.45 138.86 33.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.201 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.69 54.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.152 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -78.29 129.21 34.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.645 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.95 -4.52 75.1 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.21 -162.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.518 -0.341 . . . . 0.0 110.141 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.0 m -36.79 111.19 0.5 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -45.2 134.47 11.59 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.752 1.635 . . . . 0.0 112.101 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.489 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 101.91 -35.97 4.57 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.28 134.32 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -115.48 -58.43 2.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.236 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.6 t -143.46 143.38 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.798 0.333 . . . . 0.0 111.113 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.487 HG11 ' NH2' ' A' ' 67' ' ' ARG . 44.2 t -120.35 131.75 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.417 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -112.81 133.39 54.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.418 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.532 ' NH1' HG21 ' A' ' 53' ' ' VAL . 73.5 mtt85 -131.56 138.91 49.08 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.54 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -87.4 118.73 27.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.358 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -61.41 -38.97 89.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.534 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.62 -48.44 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.467 ' CD ' HH12 ' A' ' 170' ' ' ARG . 96.0 mt-10 -126.85 102.71 7.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.568 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -69.56 -25.49 64.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.976 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -57.85 -38.97 76.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.204 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -98.29 139.59 33.84 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.718 0.294 . . . . 0.0 110.381 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.87 147.65 18.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.001 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.1 tt -115.11 134.7 54.94 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.193 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.1 t -131.8 144.47 50.94 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.33 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.44 132.5 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.072 0.463 . . . . 0.0 110.493 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.489 HG23 ' C ' ' A' ' 61' ' ' GLY . 28.0 mt -120.95 126.06 74.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.684 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.86 130.83 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.851 0.358 . . . . 0.0 110.486 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.9 m -139.63 161.96 36.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.953 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -105.44 132.54 51.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.738 0.304 . . . . 0.0 110.369 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -96.22 150.54 37.3 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.361 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.43 137.94 31.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.018 1.812 . . . . 0.0 111.045 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.7 t -63.28 -28.2 69.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.074 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.67 -31.14 70.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -129.97 158.41 39.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.139 0.495 . . . . 0.0 111.599 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.449 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.8 t -122.6 176.34 5.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.449 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.8 tp -52.36 -44.72 65.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.179 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.9 p -66.13 -45.59 80.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.92 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 88' ' ' THR . 86.4 m-20 -67.56 -35.44 79.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.737 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.0 tp -55.88 -42.09 75.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.5 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.95 175.79 45.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.415 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 38.0 p -93.93 171.19 9.02 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.09 -42.01 76.06 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.186 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.0 m -72.39 -44.93 61.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.029 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.3 t0 -62.1 -51.24 68.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.45 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.94 -38.76 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.558 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.5 -45.91 93.86 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -66.03 -41.21 91.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.642 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -62.29 -38.56 89.82 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.685 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -62.41 -41.46 98.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.1 mmt -58.81 -44.41 90.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.949 0.404 . . . . 0.0 110.34 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -64.97 -39.87 94.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.495 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.0 m -59.48 -47.26 86.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.857 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.6 t -71.59 -45.61 66.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.993 0.425 . . . . 0.0 110.331 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 111' ' ' GLN . 86.6 m-20 -62.06 -31.96 72.43 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.277 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -42.61 -36.15 1.3 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.219 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.82 -16.25 14.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.016 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.503 ' C ' ' H ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -101.48 -3.33 28.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 107' ' ' ASN . 32.7 tt0 -67.12 13.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.961 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -84.99 -64.25 1.55 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.208 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.2 p-10 -118.59 -39.06 3.03 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.53 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 20.2 ptp180 -101.43 159.79 14.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.01 0.433 . . . . 0.0 111.24 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -130.0 150.24 51.37 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.518 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.411 ' HB3' ' OD1' ' A' ' 107' ' ' ASN . . . -104.25 138.28 40.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.15 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -123.44 130.32 52.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.536 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.1 tt -84.13 108.88 17.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.014 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.417 ' N ' HD23 ' A' ' 118' ' ' LEU . 96.6 mt -71.12 -54.95 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.783 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.55 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 11.4 p30 -156.65 176.78 12.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.976 0.417 . . . . 0.0 111.122 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.6 128.4 6.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.327 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -142.07 160.74 39.61 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.505 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.29 144.68 42.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.904 0.383 . . . . 0.0 110.47 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -131.94 152.46 51.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -124.91 116.34 22.04 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.562 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.87 144.5 33.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.013 0.435 . . . . 0.0 110.825 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.1 t0 52.29 28.99 6.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.58 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.96 -1.79 77.86 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -100.83 146.6 27.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.263 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.8 129.72 65.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.159 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -118.45 123.65 45.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.322 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.63 124.2 48.39 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.3 m -102.76 133.12 48.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.822 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.91 108.0 9.8 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.963 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.55 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 70.6 tt0 -100.12 126.17 46.32 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -148.22 168.74 21.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.159 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -137.77 160.0 40.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.479 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.51 133.73 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.461 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 3.0 pp -134.06 143.86 48.3 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.335 0.588 . . . . 0.0 111.1 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 140' ' ' VAL . 14.5 p -108.54 133.29 54.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.248 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 51.75 -108.34 0.6 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -116.96 12.53 14.67 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -119.13 146.15 45.37 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.858 0.361 . . . . 0.0 111.704 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.6 128.28 37.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.816 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 70.5 tt0 -83.48 -53.51 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.406 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.474 ' HE ' ' HG ' ' A' ' 165' ' ' SER . 6.5 ptm85 -172.64 171.99 4.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.424 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 63.7 m80 -108.89 137.44 46.8 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.256 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 84.4 m-20 -135.85 141.4 44.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.9 0.381 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 57.7 tp -116.49 136.71 52.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.986 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.87 132.82 39.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.938 0.399 . . . . 0.0 110.56 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.8 t -119.08 135.75 54.49 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.692 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.87 130.16 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.963 0.411 . . . . 0.0 110.542 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 59.8 m -148.86 146.26 27.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.84 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.3 p -90.7 156.63 17.95 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.579 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 158' ' ' LYS . 9.1 t-20 -150.87 95.9 2.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.787 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 55.65 39.24 30.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.8 7.57 77.98 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 155' ' ' ASN . 68.9 mmtt -110.61 137.73 47.91 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 110.017 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.24 117.46 26.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.816 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.1 mm -107.92 119.97 58.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.1 m -120.49 132.22 55.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.814 0.34 . . . . 0.0 110.185 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.01 103.95 11.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.622 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -103.37 120.19 40.32 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.899 0.38 . . . . 0.0 111.562 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 mp -115.58 142.92 46.08 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.083 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.474 ' HG ' ' HE ' ' A' ' 146' ' ' ARG . 31.1 t -137.06 131.95 33.48 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.432 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 167' ' ' ALA . 21.3 m -152.87 159.06 42.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.696 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.447 ' N ' HG22 ' A' ' 166' ' ' THR . . . -54.31 145.41 17.89 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.28 -36.68 71.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.8 -33.14 75.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.183 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 174' ' ' VAL . 80.1 mtp180 -97.53 -16.69 19.98 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.515 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.604 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 48.4 t-105 -48.03 -41.73 26.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 110.691 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.38 -41.69 98.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.062 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.3 m -65.68 -40.39 92.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.382 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 170' ' ' ARG . 7.9 m -107.2 21.51 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 171' ' ' TRP . 20.8 pttm -48.94 -45.38 41.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.412 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 86.7 p -67.89 -27.49 66.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.574 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.63 -44.61 85.7 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.917 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.604 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.4 m-85 -62.29 -50.01 73.4 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.388 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.24 -41.53 98.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.665 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.8 m -68.75 -49.62 57.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.4 -38.55 79.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.348 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.89 -40.55 97.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.294 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.2 p -80.96 -17.77 49.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.346 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -62.77 -37.76 87.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.193 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.481 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -54.29 146.09 16.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.771 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -135.91 154.95 50.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.6 m -127.22 151.56 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.903 0.382 . . . . 0.0 111.336 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 43.5 p90 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.768 -179.731 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 N--CA 1.464 0.241 0 CA-C-O 120.932 0.396 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.522 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.3 pm0 -138.51 165.51 26.67 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.062 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -119.09 139.89 51.01 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.086 0.469 . . . . 0.0 111.411 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -122.44 130.15 52.78 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.73 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.9 m -131.2 150.18 52.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.829 0.347 . . . . 0.0 110.821 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -139.1 122.08 16.7 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.448 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.1 p -75.36 -29.09 59.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.287 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.25 -48.35 81.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.56 ' OD2' HD12 ' A' ' 80' ' ' ILE . 49.6 t0 -93.12 -20.06 20.87 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.85 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.52 42.6 72.3 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.02 148.49 40.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.056 0.428 . . . . 0.0 110.199 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -146.51 142.07 27.68 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -154.03 158.17 40.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.075 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 45' ' ' LEU . 11.1 mp -100.96 144.63 29.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.153 0.501 . . . . 0.0 110.424 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -148.4 148.15 27.84 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.866 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.59 155.86 68.45 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.298 1.999 . . . . 0.0 112.159 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.522 ' N ' HE22 ' A' ' 33' ' ' GLN . 20.6 p30 -72.71 160.69 31.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.93 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.28 1.77 59.26 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.519 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 33.2 m0 -92.76 145.12 24.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.659 0.266 . . . . 0.0 110.296 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.4 pt -121.26 145.1 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.356 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.27 131.0 10.42 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.57 132.19 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.951 0.405 . . . . 0.0 110.521 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -81.84 135.73 35.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.196 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.59 56.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.412 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -74.94 132.9 41.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.112 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.8 2.62 71.91 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.06 -164.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.445 ' OG ' ' CG2' ' A' ' 62' ' ' VAL . 79.5 p -39.96 123.65 1.6 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.51 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -42.04 121.48 1.84 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.957 1.772 . . . . 0.0 112.823 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 107.69 -42.39 1.95 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.445 ' CG2' ' OG ' ' A' ' 59' ' ' SER . 56.1 t -63.88 122.04 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -120.0 -48.57 2.34 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.516 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.6 t -128.64 137.93 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 110.889 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.56 135.03 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.646 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.74 132.95 54.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.071 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' NH1' ' OD1' ' A' ' 75' ' ' ASN . 53.4 ttt85 -130.86 132.56 45.25 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.434 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.519 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 75.3 m-20 -92.27 118.86 31.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.58 -36.92 83.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.548 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.84 -42.51 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.82 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -117.51 105.78 12.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.891 0.376 . . . . 0.0 110.693 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.72 -37.57 67.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.607 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 40.3 p-10 -62.59 -33.11 74.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.081 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 83.4 tt0 -87.16 130.42 34.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.888 0.375 . . . . 0.0 110.585 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.433 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 10.9 m-80 -140.85 139.18 34.42 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.089 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.9 tt -126.14 134.32 51.34 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.8 m -126.87 146.69 50.19 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.306 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.32 128.41 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.952 0.406 . . . . 0.0 110.278 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.467 HG23 ' C ' ' A' ' 61' ' ' GLY . 5.5 mt -117.12 116.84 53.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.974 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.56 HD12 ' OD2' ' A' ' 40' ' ' ASP . 33.4 mm -116.01 123.97 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.922 0.392 . . . . 0.0 110.469 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 159' ' ' LEU . 75.3 m -146.67 160.59 42.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.05 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.575 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.9 pm0 -103.95 132.7 49.95 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.6 pt -88.54 148.33 41.79 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.661 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' LYS . 39.0 Cg_endo -66.7 138.02 47.78 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.716 1.611 . . . . 0.0 110.612 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.9 p -63.69 -26.11 68.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.994 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.08 -31.02 70.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.959 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 84' ' ' PRO . 97.4 mttt -130.62 155.63 46.24 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.046 0.45 . . . . 0.0 111.228 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.8 t -122.82 174.97 6.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.346 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 tp -53.05 -43.53 66.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.6 p -67.39 -44.43 78.93 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.044 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 88' ' ' THR . 89.9 m-20 -68.44 -34.81 76.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.979 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -55.57 -42.33 74.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.478 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.65 177.99 46.89 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.0 p -92.69 172.22 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.39 76.0 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.222 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.5 m -72.68 -45.21 59.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.854 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.9 t0 -62.33 -51.62 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.68 -38.83 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.543 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -57.8 -53.26 46.74 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -62.24 -36.41 81.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.57 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -57.16 -38.37 73.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.599 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.37 -41.12 98.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.865 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.678 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -55.84 -54.06 49.18 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.396 0.617 . . . . 0.0 109.802 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -61.92 -38.42 88.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.802 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -59.42 -46.98 87.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.858 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.7 t -71.29 -46.23 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 0.0 110.384 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.0 m-20 -62.23 -31.02 71.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.053 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -43.99 -36.91 2.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.089 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.06 -11.1 14.98 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.234 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -121.32 18.11 11.44 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.506 -178.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.4 pt20 -75.64 2.13 12.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.563 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.67 -62.5 2.38 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.802 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.4 p-10 -117.25 -38.11 3.41 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.844 0.354 . . . . 0.0 111.477 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.531 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 40.4 ttm180 -79.2 141.28 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.28 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -129.5 132.48 46.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.959 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.77 134.11 46.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.895 0.378 . . . . 0.0 110.334 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.66 122.51 40.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.319 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 tp -81.29 111.11 17.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.327 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.525 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 97.0 mt -71.57 -42.75 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.891 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 4.0 m-80 177.76 174.47 0.52 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.297 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.81 144.15 22.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.161 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.411 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 57.5 mp0 -144.07 145.86 32.45 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.857 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.32 135.65 53.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.311 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -116.86 159.2 22.73 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -139.51 107.29 5.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.516 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.43 144.91 38.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.933 0.397 . . . . 0.0 111.052 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.1 t0 52.8 30.24 8.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.59 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.69 0.92 75.76 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -102.9 146.68 27.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.903 0.382 . . . . 0.0 110.154 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.34 129.23 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.344 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -117.63 127.97 54.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -105.88 122.44 46.12 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.427 ' C ' HD12 ' A' ' 134' ' ' LEU . 87.1 m -105.55 123.33 47.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.234 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.427 HD12 ' C ' ' A' ' 133' ' ' THR . 9.5 mp -114.38 125.01 53.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.93 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -120.36 117.99 29.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.362 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -146.48 162.5 38.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.27 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.521 ' HE ' ' CG1' ' A' ' 119' ' ' ILE . 19.8 ptp180 -124.54 149.05 47.37 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.015 0.436 . . . . 0.0 110.803 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.05 133.87 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.352 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -139.91 134.86 32.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.242 0.544 . . . . 0.0 110.923 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.442 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 32.0 t -116.57 135.64 56.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.387 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.27 -122.39 18.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -112.31 14.91 20.51 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 140' ' ' VAL . 21.7 p-10 -133.5 160.14 38.3 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 111.509 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 144' ' ' VAL . 13.2 p -87.07 127.88 40.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.453 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.411 ' HG2' ' HE ' ' A' ' 146' ' ' ARG . 82.7 tt0 -76.45 -55.2 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.756 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.475 ' NH1' ' O ' ' A' ' 73' ' ' ASP . 20.1 ptp180 -174.82 174.58 2.55 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.078 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 61.7 m170 -103.01 139.0 39.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.011 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -132.84 133.36 43.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.974 0.416 . . . . 0.0 111.161 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.5 tp -111.52 133.96 53.43 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.908 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.39 131.49 48.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.921 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.5 t -120.97 123.04 41.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.2 129.04 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.015 0.436 . . . . 0.0 111.186 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.5 m -143.69 146.19 33.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.29 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.5 p -111.15 152.02 27.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.751 0.31 . . . . 0.0 110.263 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -158.46 119.85 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 55.94 29.74 14.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.77 14.28 78.05 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -105.38 128.43 53.5 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -90.02 119.29 30.25 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.39 128.1 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.7 0.286 . . . . 0.0 110.738 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.8 m -131.18 139.44 49.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.394 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.75 103.99 11.76 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.224 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -99.31 110.27 22.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.627 0.251 . . . . 0.0 110.422 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.4 mp -116.2 134.63 54.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.58 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 55.7 m -125.91 136.63 53.26 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.058 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.6 m -152.86 157.33 40.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.46 142.28 49.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.375 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -69.09 -30.64 68.98 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.033 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.86 -34.12 71.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.053 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.45 ' O ' HG22 ' A' ' 174' ' ' VAL . 71.0 mtp85 -113.24 -3.85 13.81 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.498 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.9 t-105 -49.78 -39.16 37.14 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.882 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.98 -42.18 99.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.091 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 56.9 m -64.78 -39.81 94.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.74 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.466 HG23 ' CZ ' ' A' ' 178' ' ' PHE . 14.7 m -107.97 21.08 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.262 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -50.06 -49.48 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.285 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.3 t -64.63 -30.72 71.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.846 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -55.21 -44.06 75.03 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.217 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 24.3 m-85 -61.56 -50.33 73.07 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.348 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -64.47 -40.17 95.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.656 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 184' ' ' SER . 41.9 m -66.84 -47.11 72.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.501 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 63.9 t -62.7 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.664 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.47 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -67.01 -46.8 73.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.208 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.1 m -68.72 -33.14 73.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.382 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 180' ' ' THR . 17.8 t -62.2 -27.55 69.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.699 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -56.11 159.18 3.52 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.779 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -135.77 157.89 45.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.8 151.04 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.098 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.485 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 46.2 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.785 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' C ' ' NE2' ' A' ' 33' ' ' GLN . 19.2 mt . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 120.825 0.345 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.631 ' NE2' ' N ' ' A' ' 33' ' ' GLN . 1.0 OUTLIER -130.68 162.48 29.32 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.251 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -121.25 145.77 47.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.574 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -129.38 134.96 48.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.342 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.9 p -143.19 157.12 44.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.637 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -146.3 119.23 8.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.417 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.1 p -70.49 -32.82 70.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.586 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -62.65 -48.86 77.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.078 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -87.67 -20.75 25.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.869 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.03 39.83 88.8 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.31 151.45 45.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.299 0.549 . . . . 0.0 110.415 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -153.24 143.78 22.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.799 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -150.73 157.71 43.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 mt -98.5 150.96 21.13 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.558 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -152.17 146.11 18.19 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.003 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.48 153.62 69.96 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.397 2.065 . . . . 0.0 112.508 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -69.37 159.37 33.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.997 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.13 -2.51 63.65 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.533 ' CD1' ' OD1' ' A' ' 68' ' ' ASP . 35.8 m0 -94.91 147.13 23.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.772 0.32 . . . . 0.0 110.276 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.8 pt -120.4 149.88 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.324 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -114.98 141.8 17.25 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.7 144.9 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.756 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -84.38 134.87 34.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.379 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.91 55.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.491 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -70.89 135.01 47.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.82 2.34 69.58 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.44 -164.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.641 0.258 . . . . 0.0 110.485 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.76 154.36 1.24 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.215 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.18 131.24 24.6 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.277 1.985 . . . . 0.0 111.915 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.516 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 95.47 -22.28 39.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.43 133.85 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.176 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -118.65 -58.3 1.98 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.639 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 78' ' ' VAL . 44.2 t -145.16 148.99 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.928 0.394 . . . . 0.0 111.504 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.56 136.45 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.655 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -112.36 143.11 44.01 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.292 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -145.09 145.78 31.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.847 0.356 . . . . 0.0 110.682 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.533 ' OD1' ' CD1' ' A' ' 50' ' ' TRP . 62.8 m-20 -101.73 122.01 43.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.685 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.42 -39.92 95.78 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.231 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.6 -38.59 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.61 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -126.43 94.62 4.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.46 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -62.19 -38.44 89.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.15 0.5 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 42.1 p-10 -61.78 -32.48 72.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.198 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.525 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 14.0 tm-20 -86.21 125.94 33.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.946 0.403 . . . . 0.0 110.202 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.718 ' N ' HD22 ' A' ' 75' ' ' ASN . 0.0 OUTLIER -171.76 168.91 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.574 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.6 pp -157.23 157.12 33.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.509 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 m -131.16 147.86 52.65 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 m -115.67 128.19 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.188 0.518 . . . . 0.0 109.987 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.516 HG23 ' C ' ' A' ' 61' ' ' GLY . 56.3 mt -117.08 124.37 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.805 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' GLY . 66.0 mt -118.25 128.8 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.473 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.3 m -138.38 163.38 32.02 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.93 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.77 134.72 47.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.688 0.28 . . . . 0.0 110.403 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.447 ' CG2' HD12 ' A' ' 159' ' ' LEU . 10.8 pt -103.23 149.21 36.72 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.679 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 87' ' ' LYS . 48.4 Cg_endo -68.24 137.57 40.67 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.105 1.87 . . . . 0.0 111.327 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.4 t -62.46 -27.66 69.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.15 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -67.48 -31.36 71.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.897 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 84' ' ' PRO . 67.9 mttm -128.73 151.96 48.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.077 0.465 . . . . 0.0 111.047 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.414 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.0 t -120.54 178.22 4.76 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.491 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.404 HD21 ' CG ' ' A' ' 132' ' ' TYR . 47.0 tp -50.12 -44.32 52.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.094 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.0 p -65.33 -42.95 92.41 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.936 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 88' ' ' THR . 86.6 m-20 -65.45 -39.13 91.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.804 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.8 tp -56.4 -43.53 79.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.585 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.7 176.25 45.57 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.412 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 33.5 p -93.2 172.58 8.21 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.74 79.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.1 m -72.26 -44.48 62.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.2 t0 -61.92 -50.98 69.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.303 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 82.1 t -60.49 -38.67 78.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.498 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.69 -44.02 94.21 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -69.33 -42.45 75.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.896 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -61.29 -39.05 89.01 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.961 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -62.03 -40.63 96.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.38 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.78 -44.26 94.01 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.404 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.28 -39.45 93.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.266 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.3 m -60.19 -47.63 85.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.811 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.52 -45.4 68.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.96 0.41 . . . . 0.0 110.496 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 111' ' ' GLN . 85.1 m-20 -62.41 -30.35 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.244 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -45.03 -39.91 6.09 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.972 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.48 -4.28 29.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.693 0.282 . . . . 0.0 110.8 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -121.44 14.65 11.17 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.052 -179.226 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 107' ' ' ASN . 6.5 tt0 -72.03 3.06 4.76 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.092 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.37 -64.6 1.44 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.67 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -117.71 -48.6 2.57 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.996 0.427 . . . . 0.0 111.379 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' SER . 84.4 mtt180 -70.12 149.02 48.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.508 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -134.43 129.83 35.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.849 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.76 128.21 46.89 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.76 0.314 . . . . 0.0 110.223 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -115.08 128.77 56.44 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.1 tp -81.98 108.99 15.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.081 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.39 -53.76 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.547 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.572 ' C ' HD22 ' A' ' 120' ' ' ASN . 0.3 OUTLIER -163.11 167.77 21.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.645 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.94 124.38 5.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.418 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -141.78 162.89 34.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.628 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.405 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.64 148.4 50.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.47 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -130.64 141.47 50.43 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.176 0.512 . . . . 0.0 111.258 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -107.65 112.69 25.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.275 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.25 141.47 35.86 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.945 0.403 . . . . 0.0 110.693 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.69 38.95 24.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.207 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.59 0.7 25.95 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -105.54 147.35 28.46 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.983 0.42 . . . . 0.0 110.189 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.19 128.38 72.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.011 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 21.2 m-85 -116.68 129.36 56.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.844 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.405 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.5 m-85 -104.11 128.23 51.75 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.3 m -110.93 123.89 51.04 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.248 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.6 mp -117.49 124.42 48.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.938 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.459 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 71.1 tt0 -118.07 120.2 37.06 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -147.05 170.02 18.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.075 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.551 ' NH2' ' NE2' ' A' ' 147' ' ' HIS . 11.6 ptm180 -138.18 155.56 48.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 110.8 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.62 133.52 47.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.374 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -142.71 136.37 28.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.197 0.522 . . . . 0.0 111.498 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.3 t -108.2 130.49 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.003 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.62 -119.52 18.98 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -110.02 10.52 24.14 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.816 -0.226 . . . . 0.0 111.228 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -117.74 147.35 43.05 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.761 0.315 . . . . 0.0 111.149 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.468 HG11 HH21 ' A' ' 137' ' ' ARG . 43.2 t -88.14 127.0 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.743 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -76.2 -54.03 7.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -173.7 174.36 3.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.181 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.551 ' NE2' ' NH2' ' A' ' 137' ' ' ARG . 29.9 m170 -104.87 139.86 38.99 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 83.9 m-20 -134.64 136.9 43.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -113.62 132.43 55.76 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.114 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -127.16 131.95 50.62 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.008 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.9 t -125.12 127.67 47.23 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.74 128.12 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.987 0.422 . . . . 0.0 110.939 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.8 m -139.72 141.84 36.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.035 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.7 p -104.76 152.6 22.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.909 0.385 . . . . 0.0 110.463 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -162.75 122.87 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 55.67 29.34 13.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.354 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.69 13.21 80.37 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -107.84 140.63 40.66 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.678 0.275 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.447 HD12 ' CG2' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -97.67 120.39 37.97 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 80.5 mt -118.46 124.48 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.049 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.2 m -125.93 136.18 52.74 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.314 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.07 99.85 7.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.061 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -97.2 111.63 23.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.668 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.07 138.25 51.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.831 0.348 . . . . 0.0 110.48 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.521 ' OG ' ' ND2' ' A' ' 75' ' ' ASN . 61.4 p -134.57 135.35 42.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.967 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 6.4 m -152.93 161.67 42.26 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.634 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.619 ' CB ' HH21 ' A' ' 170' ' ' ARG . . . -54.22 144.31 20.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.313 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -70.41 -36.34 73.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.055 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -62.76 -33.42 75.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.356 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.619 HH21 ' CB ' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -97.68 -19.89 17.96 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.896 -179.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.492 ' O ' ' N ' ' A' ' 175' ' ' LYS . 59.5 t-105 -45.58 -40.34 8.67 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.77 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.12 -42.61 99.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.199 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 55.0 m -66.96 -39.32 87.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.539 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 170' ' ' ARG . 6.0 m -109.55 21.48 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 171' ' ' TRP . 16.9 pttm -51.69 -47.62 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.497 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 85.8 p -69.61 -24.09 63.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.467 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 181' ' ' VAL . 11.3 tp -59.07 -42.57 90.69 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.994 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.415 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 20.2 m-85 -66.9 -50.22 63.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.485 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.47 -41.22 98.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.579 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 184' ' ' SER . 47.8 m -67.91 -49.32 62.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 177' ' ' LEU . 55.9 t -61.55 -42.99 96.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.462 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.61 -40.32 96.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.924 0.392 . . . . 0.0 110.287 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 39.1 m -79.63 -28.42 40.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.349 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 180' ' ' THR . 87.8 p -63.19 -23.55 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.505 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -63.24 157.55 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.437 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -139.6 160.26 40.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.731 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.46 151.12 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 38.0 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.72 -179.812 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 120.723 0.297 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.586 HE22 ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -131.16 152.52 50.36 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.229 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -109.67 128.4 55.23 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.008 0.432 . . . . 0.0 110.958 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -114.31 119.04 35.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.544 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 50.0 m -126.98 149.07 50.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.934 0.397 . . . . 0.0 110.949 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 36' ' ' SER . 87.4 m-20 -138.18 111.4 7.94 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.245 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.9 p -64.41 -34.05 77.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.46 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 26.2 mtpp -60.9 -43.87 97.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.51 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -89.6 -20.41 23.76 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.092 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.34 37.56 90.68 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.1 151.12 45.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.095 0.448 . . . . 0.0 110.384 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -150.54 147.28 27.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 45' ' ' LEU . 43.3 t80 -160.77 147.57 15.33 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.067 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.531 ' O ' ' CE2' ' A' ' 44' ' ' PHE . 9.9 mp -93.77 143.3 26.46 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.943 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -149.51 130.63 7.2 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.991 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.97 157.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.221 1.947 . . . . 0.0 112.892 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.586 ' N ' HE22 ' A' ' 33' ' ' GLN . 66.9 m-80 -81.41 158.13 24.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.987 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.24 0.83 61.27 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -81.05 149.73 29.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.5 pt -113.4 142.25 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.376 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.34 133.47 11.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.4 t -108.85 133.33 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.853 0.359 . . . . 0.0 110.412 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.63 124.39 32.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.271 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.84 55.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.606 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -80.48 130.17 34.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.744 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.66 -3.57 78.47 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 59' ' ' SER . . . -80.25 -162.84 0.48 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.299 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 58' ' ' ALA . 28.2 m -36.43 109.24 0.41 Allowed Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.76 135.04 10.13 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.865 1.71 . . . . 0.0 111.997 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 102.19 -36.0 4.57 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.96 127.08 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.116 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.44 ' OD2' HD12 ' A' ' 80' ' ' ILE . 31.3 t0 -103.55 -59.11 1.77 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.693 0.283 . . . . 0.0 110.927 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.4 t -150.56 141.21 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.17 130.95 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.76 133.91 55.53 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.521 ' NH2' ' OD1' ' A' ' 75' ' ' ASN . 76.2 mtp85 -124.55 140.89 52.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.719 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -88.48 118.31 28.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.391 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -62.42 -39.23 92.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.335 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.6 mm -63.46 -42.3 95.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.792 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -112.86 107.04 15.49 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.816 0.341 . . . . 0.0 110.85 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -73.76 -45.9 48.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.309 0.576 . . . . 0.0 110.278 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.41 -37.24 74.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.206 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -84.08 129.53 34.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.382 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.521 ' OD1' ' NH2' ' A' ' 67' ' ' ARG . 7.4 m-80 -130.29 148.07 52.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.007 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.661 HD13 ' N ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -124.63 133.75 53.14 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.661 ' N ' HD13 ' A' ' 76' ' ' LEU . 1.9 p -136.31 138.23 41.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.96 0.409 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.9 t -122.08 130.62 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.931 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.45 HG23 ' C ' ' A' ' 61' ' ' GLY . 28.0 mt -121.02 131.83 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.462 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.44 HD12 ' OD2' ' A' ' 63' ' ' ASP . 60.8 mt -122.54 133.05 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.621 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' LEU . 49.2 m -143.53 164.1 31.3 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.239 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -105.5 138.23 42.04 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.522 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.82 153.37 38.28 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.253 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 87' ' ' LYS . 72.4 Cg_endo -75.68 141.49 24.81 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.379 2.052 . . . . 0.0 110.892 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.8 p -68.44 -26.45 65.52 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.918 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -69.22 -32.0 70.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.972 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 84' ' ' PRO . 64.9 mttm -130.87 157.95 41.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.999 0.428 . . . . 0.0 111.302 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.7 t -123.12 175.47 6.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.834 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.5 tp -49.98 -45.31 51.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.07 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.1 p -65.61 -44.45 86.52 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.79 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.72 -36.26 83.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.99 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 92' ' ' LEU . 4.9 tt -55.87 -47.7 76.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.429 . . . . 0.0 110.245 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.19 177.5 46.95 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.0 p -90.94 170.13 10.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.93 74.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.96 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.0 m -71.43 -45.07 63.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.5 -53.29 58.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.299 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 80.0 t -61.25 -39.73 83.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.705 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.09 -45.11 92.81 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -66.28 -41.62 89.58 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -62.21 -39.38 92.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -62.2 -40.54 96.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.703 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.8 mmt -58.16 -44.93 88.18 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.599 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.55 -44.49 90.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 110.066 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.7 m -60.2 -44.76 94.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.837 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.75 -46.21 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.461 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 111' ' ' GLN . 87.8 m-20 -64.36 -42.12 96.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.053 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -43.6 -20.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.37 . . . . 0.0 110.748 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 107' ' ' ASN . . . -91.1 -43.67 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.607 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.8 p -119.38 19.63 12.69 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.2 tt0 -56.38 -28.78 60.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.337 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -42.53 -62.64 2.12 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.23 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -117.63 -44.3 2.75 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.766 0.317 . . . . 0.0 111.336 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -80.47 144.95 32.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.469 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -131.53 142.55 49.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.162 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.16 135.41 44.86 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -116.73 129.64 56.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.9 tt -81.5 104.28 11.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.12 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.4 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.4 mt -70.35 -45.88 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.334 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 3.1 m-80 -169.65 166.71 9.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.363 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.14 126.3 5.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.413 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -142.9 163.5 32.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.748 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.17 149.69 46.08 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.506 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -131.65 144.89 51.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.143 0.497 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -111.53 114.53 27.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.557 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.91 138.57 33.97 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.504 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 52.05 40.97 29.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.788 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.78 2.29 7.7 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -103.32 133.19 48.81 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.63 130.45 55.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.389 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -118.02 128.39 54.73 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -105.51 129.83 53.71 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.436 ' C ' HD12 ' A' ' 134' ' ' LEU . 87.4 m -113.21 122.92 48.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.436 HD12 ' C ' ' A' ' 133' ' ' THR . 9.3 mp -115.39 126.1 53.99 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.739 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -118.81 122.12 41.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.768 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -150.44 171.3 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.29 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -136.5 156.58 48.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 110.494 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.2 t -106.39 135.01 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.025 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.79 136.25 30.48 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.163 0.506 . . . . 0.0 111.58 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.2 t -97.79 121.79 48.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.74 -110.89 3.08 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -113.31 10.56 18.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.565 0.222 . . . . 0.0 110.871 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -113.34 137.16 51.91 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.684 0.278 . . . . 0.0 111.317 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 144' ' ' VAL . 7.2 p -78.73 126.63 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.637 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -81.05 -55.04 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.474 ' NH2' ' C ' ' A' ' 166' ' ' THR . 6.5 ptm85 -172.56 174.22 3.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 56.2 m170 -105.05 138.38 41.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.131 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 82.2 m-20 -135.36 130.93 35.71 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.725 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 tp -110.89 128.16 55.7 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.9 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.6 134.84 55.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.24 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.0 t -125.68 121.73 34.3 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.1 t -105.67 129.44 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.934 0.397 . . . . 0.0 110.874 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 59.8 m -142.79 144.42 32.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.0 p -86.93 156.82 19.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.871 0.367 . . . . 0.0 110.762 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -150.35 95.94 2.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.721 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 54.2 43.32 30.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.479 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.43 18.25 66.89 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.728 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 40.9 mtpt -121.71 137.26 54.83 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.952 0.376 . . . . 0.0 111.108 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 81' ' ' SER . 1.2 mt -91.81 119.28 31.47 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.29 122.14 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.2 m -115.72 133.24 56.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 110.245 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -105.2 110.23 22.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.612 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.82 122.14 43.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.951 0.405 . . . . 0.0 111.675 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mt -115.64 132.91 56.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.543 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.4 m -130.26 130.62 44.8 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.859 0.361 . . . . 0.0 110.31 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.474 ' C ' ' NH2' ' A' ' 146' ' ' ARG . 3.7 m -153.02 158.12 41.52 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.34 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -57.0 143.38 38.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.205 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -69.85 -29.64 66.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.166 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.19 -33.77 72.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.215 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.491 ' O ' HG22 ' A' ' 174' ' ' VAL . 86.8 mtt180 -111.84 -6.48 14.27 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.557 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 53.7 t-105 -48.25 -39.52 21.67 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.811 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.85 -42.04 97.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 56.6 m -65.47 -39.99 92.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.569 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 170' ' ' ARG . 8.5 m -107.71 21.44 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.255 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -49.21 -48.19 45.57 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.447 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.0 m -64.2 -32.08 73.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.649 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.9 tp -53.81 -44.94 70.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.045 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.557 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 18.9 m-85 -62.45 -49.04 77.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.477 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.92 -41.58 99.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 184' ' ' SER . 48.8 m -67.72 -47.62 68.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.438 HG13 ' CZ ' ' A' ' 44' ' ' PHE . 56.0 t -62.81 -43.73 99.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.627 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -61.6 -38.45 87.64 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.7 t -85.14 -20.4 30.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 180' ' ' THR . 45.5 t -62.11 -33.58 74.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.059 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.2 OUTLIER -57.21 159.56 4.42 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.321 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -138.28 152.77 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 13.9 m -128.0 151.49 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.082 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.623 -179.734 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 N--CA 1.466 0.347 0 CA-C-O 120.92 0.391 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.605 ' NE2' ' N ' ' A' ' 48' ' ' ASN . 2.1 pm0 -139.53 160.48 39.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.078 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -129.98 147.83 51.77 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.138 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.664 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -124.93 158.38 33.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.453 178.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -144.74 161.2 39.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.834 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 41' ' ' GLY . 45.0 t0 -145.52 109.06 4.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.646 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.6 m -59.64 -37.81 79.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.885 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 62.5 mttp -58.7 -47.06 85.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.25 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.48 ' OD2' HD13 ' A' ' 80' ' ' ILE . 47.2 t0 -89.75 -20.26 23.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.921 0.391 . . . . 0.0 110.507 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . 66.66 40.27 93.96 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.503 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.2 150.11 43.77 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.139 0.47 . . . . 0.0 110.608 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -153.42 147.31 25.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.376 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.419 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 28.6 p90 -161.27 158.91 27.93 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.619 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 mt -81.06 153.49 27.34 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.412 0.625 . . . . 0.0 111.667 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.664 ' CD1' ' CZ ' ' A' ' 35' ' ' TYR . 16.8 p90 -162.41 141.79 7.18 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.457 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.27 156.52 58.88 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.276 1.984 . . . . 0.0 112.422 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.605 ' N ' ' NE2' ' A' ' 33' ' ' GLN . 44.6 p30 -74.25 160.7 30.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.216 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.43 -4.78 56.93 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.532 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 36.0 m0 -85.02 139.63 31.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.1 pt -113.61 134.39 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.158 0.504 . . . . 0.0 110.638 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.99 127.81 9.09 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.3 t -105.26 135.35 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.324 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 51.3 p30 -71.0 149.16 46.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.243 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -152.66 48.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.42 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -76.68 128.24 34.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.022 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.53 7.6 78.74 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.14 -164.68 0.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.637 0.256 . . . . 0.0 110.568 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.78 156.39 1.64 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.115 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.2 127.84 17.42 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.499 2.133 . . . . 0.0 112.253 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 97.51 -22.68 39.53 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.6 t -68.79 128.79 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -118.98 -57.5 2.02 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.8 t -142.21 142.54 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.86 0.362 . . . . 0.0 111.157 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.6 t -117.09 134.31 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.215 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -111.67 131.63 55.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.953 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -129.83 138.57 51.08 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.483 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 72.2 m-20 -89.26 118.77 29.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.625 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.8 tp -66.83 -39.3 87.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.981 0.42 . . . . 0.0 110.328 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 85.9 mt -62.11 -43.16 97.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.345 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -117.98 108.87 15.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.828 0.346 . . . . 0.0 110.817 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -65.43 -43.19 91.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.354 0.597 . . . . 0.0 110.379 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 91.4 m-20 -58.2 -37.42 74.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.338 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.455 ' CD ' ' HG1' ' A' ' 166' ' ' THR . 47.4 tp10 -74.85 132.38 41.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.32 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 19.7 m-80 -149.23 139.0 21.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.539 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -129.83 134.69 47.7 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.862 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.3 t -127.86 138.51 52.72 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.1 t -116.01 125.24 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.507 HG23 ' C ' ' A' ' 61' ' ' GLY . 54.7 mt -124.5 122.04 62.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.48 HD13 ' OD2' ' A' ' 40' ' ' ASP . 72.6 mt -120.88 135.33 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.703 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -148.08 164.68 33.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.37 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -103.49 134.44 46.84 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 83' ' ' ILE . 12.5 pt -92.8 148.77 36.63 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.455 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 87' ' ' LYS . 40.1 Cg_endo -66.51 136.51 43.19 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.541 1.494 . . . . 0.0 110.49 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.5 p -63.86 -26.09 68.46 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.854 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -68.57 -30.96 69.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.815 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 84' ' ' PRO . 28.5 mtmm -130.92 148.94 52.74 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.132 0.491 . . . . 0.0 111.544 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.472 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 71.6 p -109.35 179.06 4.26 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.652 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.69 -41.07 73.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.284 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.4 p -72.52 -44.66 61.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.014 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 88' ' ' THR . 44.4 t0 -64.68 -38.45 91.02 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.947 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.5 tp -55.9 -44.71 78.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 178.64 47.33 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.2 p -94.76 171.11 8.98 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.73 -38.23 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.044 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.3 m -72.03 -45.24 61.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.11 -50.84 64.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.353 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.568 HG22 ' NH2' ' A' ' 101' ' ' ARG . 72.0 t -59.4 -37.3 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.554 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -62.8 -63.6 4.49 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.557 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -46.96 -42.99 18.76 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.793 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.568 ' NH2' HG22 ' A' ' 98' ' ' VAL . 84.0 mtm180 -59.38 -43.34 92.93 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.533 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -59.45 -42.66 92.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.659 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -53.97 -54.86 33.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.301 0.572 . . . . 0.0 110.098 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -62.04 -39.22 91.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 m -58.43 -45.59 88.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.907 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.4 t -70.88 -46.73 66.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.619 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 111' ' ' GLN . 85.1 m-20 -60.59 -37.04 80.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.526 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 22.3 t70 -44.38 -17.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 107' ' ' ASN . . . -109.31 -27.2 9.65 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.383 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 114' ' ' ARG . 3.8 t -121.32 21.59 11.05 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.605 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.543 ' H ' ' CD ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -69.97 4.17 2.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.079 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.1 -63.07 2.76 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.206 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -117.24 -45.14 2.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.852 0.358 . . . . 0.0 111.419 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' SER . 93.4 mtm-85 -85.09 148.4 26.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.504 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -129.16 148.64 51.12 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.175 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.16 136.2 43.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.379 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -122.74 127.96 49.89 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.9 tt -82.66 108.74 16.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.854 0.359 . . . . 0.0 110.09 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.573 ' C ' HD22 ' A' ' 120' ' ' ASN . 96.1 mt -72.73 -58.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.836 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.573 HD22 ' C ' ' A' ' 119' ' ' ILE . 1.8 m-80 -146.29 164.0 33.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.132 0.491 . . . . 0.0 110.647 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.25 112.48 2.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.183 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -138.97 170.44 15.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -142.36 151.16 41.63 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.737 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.3 140.94 47.72 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.773 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 35.6 p30 -109.21 112.72 25.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -139.93 142.55 36.41 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.991 0.424 . . . . 0.0 110.738 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 52.35 37.73 23.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.316 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.17 1.77 36.26 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -106.28 147.86 28.65 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 110.092 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.33 128.19 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.003 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -116.52 127.77 54.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.72 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.41 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.09 126.22 51.03 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.2 m -107.12 124.45 49.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.247 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.446 HD21 ' HA2' ' A' ' 99' ' ' GLY . 5.9 mp -118.3 123.61 45.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.839 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -119.25 122.46 41.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -149.15 168.57 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.299 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -138.64 160.03 40.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.752 0.311 . . . . 0.0 110.206 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 85.1 t -105.37 125.32 60.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.489 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 144' ' ' VAL . 8.0 mt -104.85 137.73 42.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.168 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.63 136.39 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.92 -110.49 0.74 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -117.31 18.11 14.51 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -140.88 160.22 40.52 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.322 0.582 . . . . 0.0 112.432 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 144' ' ' VAL . 12.7 p -72.37 122.51 25.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.39 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.526 ' OE1' ' NE ' ' A' ' 146' ' ' ARG . 2.0 tm-20 -75.11 -53.59 8.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 145' ' ' GLU . 15.0 ptp180 -172.46 169.64 5.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.127 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -109.04 136.07 49.16 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.04 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -135.17 135.89 41.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.888 0.375 . . . . 0.0 111.046 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.8 tp -111.11 133.94 53.09 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.004 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.37 131.14 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.503 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.7 m -119.31 136.71 54.12 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.36 127.69 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 111.288 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.5 m -144.83 144.21 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.08 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.0 p -107.48 145.59 32.88 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -146.73 111.45 5.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.138 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.452 ' CZ ' ' OXT' ' A' ' 188' ' ' TYR . 80.5 mtm180 55.74 31.86 18.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.81 8.71 75.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.471 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 31.7 mmtp -99.71 124.43 44.96 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.66 114.61 23.51 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.8 mm -109.76 128.6 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.5 m -130.42 134.46 47.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.729 0.299 . . . . 0.0 110.838 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.29 102.17 9.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.829 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -102.53 111.86 24.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.474 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 164' ' ' LEU . 5.3 mp -117.16 137.51 52.28 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.653 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 54.4 m -126.85 134.35 50.53 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.031 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.455 ' HG1' ' CD ' ' A' ' 74' ' ' GLU . 17.2 m -153.11 156.31 38.43 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.65 143.79 19.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.257 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.21 -36.98 72.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.295 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.9 -33.29 73.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.516 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.423 ' O ' HG22 ' A' ' 174' ' ' VAL . 56.4 ttt-85 -100.88 -12.51 18.93 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.601 0.239 . . . . 0.0 111.29 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.529 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.7 t-105 -50.36 -39.79 47.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.757 0.313 . . . . 0.0 111.01 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -60.3 -42.05 94.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.152 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.1 m -66.18 -39.67 89.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.634 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 170' ' ' ARG . 12.3 m -110.18 21.35 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.406 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 171' ' ' TRP . 47.2 pttt -51.37 -48.76 62.41 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.39 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.1 t -65.98 -29.03 69.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.686 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 181' ' ' VAL . 11.1 tp -56.46 -44.25 80.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.191 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.529 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 28.3 m-85 -61.77 -50.95 70.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.122 0.486 . . . . 0.0 110.403 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -63.82 -40.91 97.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.562 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 184' ' ' SER . 41.6 m -66.26 -46.71 76.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.591 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 177' ' ' LEU . 55.8 t -61.05 -46.16 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.097 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -65.96 -49.43 67.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.492 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.3 t -67.77 -34.04 76.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 180' ' ' THR . 16.5 t -62.61 -29.29 70.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.633 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -51.19 157.47 0.92 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.562 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -132.61 154.16 50.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.57 152.43 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 111.274 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.452 ' OXT' ' CZ ' ' A' ' 156' ' ' ARG . 38.2 p90 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.727 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.4 mt . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.954 0.407 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -131.47 159.07 39.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.289 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -121.35 146.38 46.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.602 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -129.88 137.64 50.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.921 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.427 ' OG ' ' OH ' ' A' ' 188' ' ' TYR . 22.2 t -149.5 149.24 30.45 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.644 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -142.76 110.59 5.89 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.706 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.9 m -61.54 -37.31 83.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.568 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -58.68 -52.57 65.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.48 ' OD2' HD13 ' A' ' 80' ' ' ILE . 38.9 t0 -83.08 -21.07 33.82 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.762 0.315 . . . . 0.0 110.709 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.58 42.12 81.86 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.16 147.94 37.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.359 0.58 . . . . 0.0 110.129 179.082 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -153.1 141.38 20.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.803 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.91 156.66 40.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.75 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.7 mt -96.7 152.03 19.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.447 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -154.86 146.43 16.9 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.488 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.07 161.77 41.22 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.23 1.953 . . . . 0.0 112.101 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.0 p-10 -76.9 160.59 29.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.575 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.4 0.93 58.01 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.52 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 31.2 m0 -88.48 141.25 28.69 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.06 145.69 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.637 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.95 136.51 12.74 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.2 t -112.94 136.51 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.392 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -66.55 140.07 57.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.15 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.6 m -114.03 24.75 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.646 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -60.74 119.57 8.41 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.218 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.63 8.81 76.28 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.41 -164.58 0.65 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.14 157.77 67.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.503 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.45 128.32 16.13 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.382 2.054 . . . . 0.0 111.742 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.424 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 98.24 -17.79 58.05 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.08 123.99 25.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.641 -0.424 . . . . 0.0 109.891 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -100.87 -58.24 1.93 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.08 148.06 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 111.312 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.1 t -115.27 136.31 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.301 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -111.79 136.15 51.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.243 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -129.78 138.54 51.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.321 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 74.3 m-20 -82.46 118.58 23.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.79 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.04 -40.16 71.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.39 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.7 mm -61.4 -40.75 87.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.544 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' OE1' ' A' ' 74' ' ' GLU . 9.9 pt-20 -133.53 84.41 2.12 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.08 0.467 . . . . 0.0 110.284 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -52.16 -21.81 3.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.462 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -57.76 -37.82 74.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' OE1' ' OE2' ' A' ' 71' ' ' GLU . 97.7 mt-10 -84.33 141.35 30.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.991 0.424 . . . . 0.0 110.627 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -153.23 149.69 28.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.733 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.687 ' C ' HD12 ' A' ' 76' ' ' LEU . 1.7 pp -151.91 146.5 25.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.285 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.7 m -124.21 145.94 49.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.019 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.08 125.03 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.473 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.5 mp -122.6 127.78 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.299 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.48 HD13 ' OD2' ' A' ' 40' ' ' ASP . 79.2 mt -122.65 132.08 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.664 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.3 m -145.82 167.25 23.65 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.115 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -106.05 137.21 44.36 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.9 pt -96.37 148.33 34.32 Favored Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.569 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 87' ' ' LYS . 36.9 Cg_endo -66.22 135.77 41.4 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.589 1.526 . . . . 0.0 110.759 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 t -62.1 -29.17 70.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.133 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -68.09 -31.3 70.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.037 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 84' ' ' PRO . 97.0 mttt -131.38 143.68 50.65 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.033 0.444 . . . . 0.0 111.008 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 13.9 t -110.46 -179.44 3.77 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.32 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.451 HD21 ' CG ' ' A' ' 132' ' ' TYR . 45.9 tp -51.05 -44.08 61.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.893 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.5 p -68.28 -43.35 77.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.433 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 88' ' ' THR . 89.0 m-20 -65.54 -40.45 92.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.41 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.2 mt -57.01 -41.29 78.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.639 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.87 178.18 47.2 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.394 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 32.9 p -93.37 173.83 7.51 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.7 -41.03 76.66 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.4 m -73.08 -46.0 54.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.034 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 94' ' ' THR . 44.6 t0 -63.14 -52.14 63.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.506 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.2 -37.93 71.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.72 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.539 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -60.15 -55.69 28.83 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -53.53 -39.77 64.96 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.875 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -58.58 -36.79 74.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.191 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -65.08 -41.98 94.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.721 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.654 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -54.22 -55.71 25.39 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.336 0.589 . . . . 0.0 109.826 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -62.1 -40.98 97.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.664 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.5 m -58.1 -47.09 84.28 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.929 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.2 t -72.19 -47.35 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.773 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 111' ' ' GLN . 95.8 m-20 -60.97 -39.51 89.86 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.792 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -44.41 -37.13 3.21 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.448 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.25 -45.06 74.22 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.9 p -123.37 22.09 9.36 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.633 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.8 tt0 -51.15 -28.88 12.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.5 0.19 . . . . 0.0 111.281 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -42.5 -61.74 2.39 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.287 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -117.2 -38.01 3.44 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.01 0.405 . . . . 0.0 111.74 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -88.39 138.33 31.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.019 0.437 . . . . 0.0 111.146 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -131.87 149.73 52.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.112 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.424 ' H ' ' ND2' ' A' ' 107' ' ' ASN . . . -106.83 138.07 43.68 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.39 129.7 56.66 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.9 tp -82.61 111.99 19.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.909 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.494 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.5 mt -79.64 -50.29 18.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.569 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.9 m-80 -158.41 164.52 36.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.398 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.47 114.66 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.592 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.64 167.25 22.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.685 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.41 150.5 50.88 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.504 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -128.53 142.16 51.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.787 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -109.43 113.27 25.93 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.183 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -138.92 141.13 38.51 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.89 0.376 . . . . 0.0 110.755 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 50.52 38.9 19.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.366 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.42 0.34 29.93 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -105.21 147.41 28.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.916 0.389 . . . . 0.0 110.124 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -113.3 129.64 68.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.27 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 20.7 m-85 -117.06 130.49 56.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.755 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.451 ' CG ' HD21 ' A' ' 89' ' ' LEU . 2.4 m-85 -104.13 124.48 49.16 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 54.2 m -103.29 130.26 50.5 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.59 106.37 8.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.234 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -101.14 124.5 46.95 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -152.71 172.77 16.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.408 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -141.2 158.78 43.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 110.448 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.16 137.32 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.501 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 141' ' ' GLY . 2.7 pp -135.04 131.69 37.34 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.049 0.452 . . . . 0.0 111.332 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 140' ' ' VAL . 1.4 m -91.74 103.76 14.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 139' ' ' LEU . . . 74.02 -113.64 4.23 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -107.91 7.35 27.98 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.818 -0.225 . . . . 0.0 111.483 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -116.14 138.97 50.8 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.707 0.289 . . . . 0.0 111.249 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 144' ' ' VAL . 7.3 p -78.72 122.21 33.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.344 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.13 -52.93 9.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.607 HH21 ' N ' ' A' ' 166' ' ' THR . 15.3 ptm180 -172.27 173.13 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.9 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -102.97 138.92 39.21 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -133.72 134.18 42.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.855 0.36 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.6 tp -111.32 131.21 55.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.079 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -127.65 125.72 40.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.029 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 27.8 t -118.74 132.57 56.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.678 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.07 127.56 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.99 0.424 . . . . 0.0 110.751 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.5 m -137.97 140.94 40.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.998 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.8 p -105.37 151.52 24.09 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.727 0.299 . . . . 0.0 110.364 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -161.53 119.07 2.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 55.17 32.1 17.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.67 14.31 80.06 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -105.26 128.8 53.62 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.42 119.06 31.58 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.3 mt -117.92 127.59 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.732 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 39.5 m -126.76 136.08 51.94 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.017 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.37 98.41 6.41 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -91.74 111.99 23.73 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.549 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.93 137.39 49.98 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.5 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 146' ' ' ARG . 32.3 t -136.27 129.45 31.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.365 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.607 ' N ' HH21 ' A' ' 146' ' ' ARG . 11.9 m -152.43 158.72 43.03 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.478 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -51.93 143.32 13.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -71.84 -36.78 70.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.043 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -63.32 -33.5 75.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.123 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.464 ' CD ' ' N ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER -96.95 -16.49 20.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.274 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.546 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 50.6 t-105 -48.56 -39.82 24.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.831 0.348 . . . . 0.0 110.769 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -61.69 -42.12 98.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 58.7 m -66.66 -40.0 88.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.657 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.2 m -109.55 21.17 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.149 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 171' ' ' TRP . 19.2 ptmt -50.59 -48.72 57.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.279 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.5 t -65.78 -29.75 70.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.773 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.8 tp -55.73 -44.45 77.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.374 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 26.3 m-85 -62.3 -50.47 71.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.088 0.47 . . . . 0.0 110.41 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.31 -41.41 98.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.605 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 184' ' ' SER . 50.7 m -66.07 -47.86 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.31 -43.63 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.523 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -62.94 -37.67 87.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.905 0.383 . . . . 0.0 110.306 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.2 t -83.62 -25.3 30.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 180' ' ' THR . 46.9 t -62.49 -30.03 70.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.17 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -59.76 157.58 11.86 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.463 -179.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -135.53 156.64 48.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.602 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.1 149.81 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.041 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.427 ' OH ' ' OG ' ' A' ' 36' ' ' SER . 38.9 p90 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.744 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 mt . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 120.979 0.419 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.693 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.4 pm0 -137.98 163.9 30.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.857 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -117.69 133.94 55.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.727 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -112.48 135.13 53.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.846 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 93.8 p -146.79 153.89 40.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 110.855 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 36' ' ' SER . 99.2 m-20 -141.2 114.18 8.51 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.15 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.6 p -64.89 -33.95 77.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.434 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -62.49 -48.44 79.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -85.91 -20.48 28.95 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.101 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.51 40.54 90.98 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.211 -0.518 . . . . 0.0 111.83 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -141.97 151.56 42.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.332 0.566 . . . . 0.0 110.61 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -155.6 146.52 22.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -151.74 161.58 42.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.994 0.426 . . . . 0.0 111.18 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.651 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.0 mm? -92.61 143.5 26.26 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.116 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -154.71 147.25 17.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.518 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.73 157.98 58.58 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.282 1.988 . . . . 0.0 112.24 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.693 ' N ' HE22 ' A' ' 33' ' ' GLN . 47.3 p-10 -71.35 160.42 32.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.563 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.99 6.45 57.94 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.435 ' HE1' ' CG ' ' A' ' 68' ' ' ASP . 27.2 m0 -93.6 142.79 26.94 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.301 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 pt -126.02 146.31 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.334 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.63 139.32 15.06 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.69 134.64 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.856 0.36 . . . . 0.0 110.526 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -79.08 137.74 37.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.683 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.86 55.7 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.065 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -72.81 135.07 45.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.072 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.41 4.76 70.42 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.64 -164.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.698 0.285 . . . . 0.0 110.72 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.12 153.74 3.09 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.562 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.27 133.08 27.44 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.264 1.976 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 96.01 -21.88 42.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.2 t -62.22 122.22 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.92 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -99.11 -58.55 1.91 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.76 168.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.492 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.0 135.79 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.058 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -112.18 128.54 56.26 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -122.91 135.56 54.55 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.802 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' CG ' ' HE1' ' A' ' 50' ' ' TRP . 60.3 t0 -88.53 118.43 28.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.849 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.11 -38.65 91.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.387 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.35 -42.15 92.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.78 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 68' ' ' ASP . 96.1 mt-10 -117.86 120.62 38.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.457 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -88.93 -40.26 13.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.32 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -58.47 -36.27 73.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.548 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -89.22 129.77 35.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.421 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -129.75 149.04 51.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.997 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 77' ' ' SER . 0.3 OUTLIER -125.84 134.12 51.75 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.722 ' N ' HD13 ' A' ' 76' ' ' LEU . 13.3 t -136.82 142.79 42.9 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 t -129.4 132.86 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.933 0.396 . . . . 0.0 110.674 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.504 HG23 ' C ' ' A' ' 61' ' ' GLY . 50.4 mt -121.89 123.38 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.34 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.92 132.18 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.314 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 159' ' ' LEU . 4.1 m -151.68 166.75 30.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.406 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -105.71 135.82 46.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 83' ' ' ILE . 10.0 pt -91.47 148.93 38.55 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.97 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -43.73 143.21 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.869 1.712 . . . . 0.0 111.382 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -73.1 -20.64 60.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.636 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 57.2 t0 -94.98 -17.18 22.18 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -129.94 156.26 44.71 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.933 0.397 . . . . 0.0 111.348 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 13.8 t -122.88 176.36 6.04 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.823 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.2 tp -49.92 -45.73 51.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.944 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.3 p -66.43 -44.13 83.76 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.988 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 88' ' ' THR . 57.8 t0 -65.71 -37.55 86.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.98 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.9 tp -55.85 -43.26 76.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.577 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.68 178.92 47.61 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.396 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.406 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 43.4 p -92.29 170.44 9.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.54 74.96 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.91 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.8 m -72.02 -44.43 63.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.804 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 94' ' ' THR . 47.3 t0 -62.22 -52.68 62.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.431 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.8 t -60.12 -39.11 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.595 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.73 -43.3 94.57 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -67.78 -41.41 83.28 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.04 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -60.72 -38.6 85.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -62.98 -39.61 95.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.585 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.5 mmt -59.1 -45.37 91.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.863 0.363 . . . . 0.0 110.536 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -64.72 -41.82 95.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.872 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.8 m -60.86 -46.13 91.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.7 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.99 -47.5 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.102 0.477 . . . . 0.0 110.472 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 111' ' ' GLN . 89.6 m-20 -61.05 -34.29 74.65 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.39 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -47.59 -38.71 15.02 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.189 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.41 73.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.53 0.566 . . . . 0.0 112.53 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -123.03 22.15 9.62 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.641 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.3 pt20 -51.23 -15.55 0.38 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.27 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.01 -61.27 7.63 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.814 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 38.0 p-10 -117.46 -35.51 3.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.035 0.417 . . . . 0.0 111.74 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.528 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 58.9 ttm-85 -84.62 137.89 33.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 111.24 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -129.03 139.29 52.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.106 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.9 136.53 42.56 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -116.54 128.28 55.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.477 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.4 tt -82.99 106.31 14.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.926 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.405 ' N ' HD23 ' A' ' 118' ' ' LEU . 96.5 mt -70.28 -43.47 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.362 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.402 ' N ' HD23 ' A' ' 118' ' ' LEU . 14.9 m-20 -179.7 173.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.452 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.67 139.62 15.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.19 163.99 32.03 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.453 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.8 146.87 46.2 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -133.13 139.6 47.17 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.655 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -109.67 113.44 26.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.55 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.74 144.33 39.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.014 0.435 . . . . 0.0 110.956 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 60.6 t0 51.59 32.11 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.405 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.03 1.58 68.81 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -105.57 148.95 26.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.94 0.4 . . . . 0.0 110.114 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.2 t -114.37 128.54 71.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.009 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -118.05 126.81 53.0 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.54 125.88 50.35 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.2 m -105.17 125.41 50.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.332 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.2 mp -115.69 126.53 54.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.928 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -119.52 122.67 42.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.433 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -152.9 171.65 17.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.522 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -139.94 157.92 44.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.186 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.24 135.28 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.979 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -136.04 136.9 40.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.109 0.481 . . . . 0.0 111.107 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.42 134.48 57.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.223 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.43 -120.95 16.46 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -114.47 14.42 17.82 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.92 -0.165 . . . . 0.0 111.415 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -129.05 155.6 45.17 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.92 0.391 . . . . 0.0 111.143 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 144' ' ' VAL . 14.7 p -86.66 126.93 40.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.324 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.539 ' OE1' ' NE ' ' A' ' 146' ' ' ARG . 2.1 tm-20 -76.01 -51.69 11.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.68 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.539 ' NE ' ' OE1' ' A' ' 145' ' ' GLU . 10.5 ptp180 -172.31 174.02 4.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.992 0.425 . . . . 0.0 111.192 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.404 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 73.8 m80 -107.21 139.44 41.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.013 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 78.3 m-20 -134.41 136.92 43.65 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.02 0.438 . . . . 0.0 111.477 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.3 tp -112.81 138.93 48.91 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.632 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.98 147.08 43.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.34 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.5 t -131.55 138.48 48.91 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.552 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 52.8 t -119.05 126.9 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.533 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.6 m -142.42 148.09 37.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.475 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.2 p -113.61 152.81 29.83 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.831 0.348 . . . . 0.0 110.641 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -151.12 107.44 3.47 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.274 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 59.35 32.16 21.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.791 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 87.1 6.21 79.21 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -97.27 123.26 41.02 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 81' ' ' SER . 1.0 OUTLIER -85.39 118.01 24.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.416 ' N ' HD23 ' A' ' 159' ' ' LEU . 81.4 mt -121.94 120.55 61.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.8 m -123.87 133.99 53.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.011 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.91 125.02 50.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.866 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -112.3 114.99 28.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.897 0.38 . . . . 0.0 110.654 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.434 HD23 ' CD2' ' A' ' 76' ' ' LEU . 11.8 mt -111.33 130.17 55.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.1 m -133.59 129.82 37.51 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.475 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 8.0 m -153.41 152.66 31.29 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.441 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.15 147.95 46.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.588 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -70.27 -24.05 62.99 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.268 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -55.54 -34.11 64.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.173 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.455 ' O ' HG22 ' A' ' 174' ' ' VAL . 96.6 mtt180 -124.79 0.09 8.03 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.519 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 44.9 t-105 -48.22 -39.11 20.14 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.852 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -63.43 -41.95 98.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 49.3 m -65.4 -39.94 92.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.627 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' A' ' 178' ' ' PHE . 12.8 m -105.22 21.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.176 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.36 -47.97 55.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.384 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.6 m -65.51 -31.9 73.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.652 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -54.52 -44.03 72.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.091 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.519 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 23.4 m-85 -61.07 -49.84 75.7 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.356 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -64.3 -40.38 95.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.591 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 184' ' ' SER . 50.1 m -67.65 -47.54 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.35 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.23 -43.46 98.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.614 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.77 -40.15 96.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 110.287 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 42.2 m -80.32 -27.72 38.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.249 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 180' ' ' THR . 40.1 t -62.26 -29.8 70.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.524 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -58.22 157.79 7.93 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.295 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -138.57 159.47 42.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.61 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.48 149.5 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.996 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 38.3 p90 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.682 179.83 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.8 mt . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.843 0.354 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.512 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.6 pm0 -141.18 163.02 34.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.313 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -115.14 140.13 49.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.866 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -117.36 130.8 56.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.531 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.426 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 50.5 m -120.83 146.58 46.41 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.022 0.439 . . . . 0.0 111.022 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 36' ' ' SER . 98.8 m-20 -140.67 103.71 4.57 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.7 p -68.78 -15.1 63.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.52 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -57.25 -43.23 82.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.358 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -116.35 -13.33 11.03 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.058 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.79 50.04 6.19 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.64 148.76 30.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.033 0.444 . . . . 0.0 111.128 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -144.41 151.62 39.51 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.693 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -151.84 157.28 41.69 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.7 mp -103.13 143.53 32.48 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.373 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.483 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 7.0 p90 -149.91 148.18 24.48 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.937 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.07 154.44 62.48 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.017 1.812 . . . . 0.0 111.849 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.512 ' N ' HE22 ' A' ' 33' ' ' GLN . 11.7 p30 -69.57 160.52 31.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.36 3.97 58.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.527 ' CD2' ' OD1' ' A' ' 68' ' ' ASP . 32.0 m0 -92.27 146.58 23.6 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.358 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.0 pt -117.92 139.93 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.301 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.29 139.87 14.79 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.8 t -113.6 134.76 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.895 0.378 . . . . 0.0 110.463 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -74.46 138.28 43.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.437 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 63' ' ' ASP . 26.8 m -132.84 46.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -76.75 124.38 27.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.055 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.3 11.83 82.91 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.65 -164.41 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.757 0.313 . . . . 0.0 110.658 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -54.13 153.54 9.17 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.173 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.92 128.56 17.99 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.384 2.056 . . . . 0.0 112.137 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 98.15 -25.1 29.04 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.13 131.39 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.985 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' O ' ' CG2' ' A' ' 55' ' ' VAL . 58.7 t0 -111.09 -58.01 2.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.0 t -147.81 145.26 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.868 0.366 . . . . 0.0 111.287 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.448 HG23 HG11 ' A' ' 55' ' ' VAL . 86.5 t -122.16 134.93 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.527 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.18 141.27 46.08 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.081 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' NH2' ' CD2' ' A' ' 69' ' ' LEU . 68.3 ttp85 -129.12 129.33 45.03 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.269 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.527 ' OD1' ' CD2' ' A' ' 50' ' ' TRP . 78.4 m-20 -92.23 118.89 31.32 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.7 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.572 ' CD2' ' NH2' ' A' ' 67' ' ' ARG . 70.2 mt -65.52 -37.45 86.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.256 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.4 mt -63.51 -38.07 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.754 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -128.56 88.84 2.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.461 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -61.17 -35.73 77.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.561 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 39.2 p-10 -62.38 -32.67 73.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 11.6 tm-20 -92.55 132.75 36.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.663 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -146.68 139.59 25.33 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.636 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 tt -114.26 133.51 55.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.086 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.0 m -133.07 149.01 52.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.37 129.7 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.176 0.513 . . . . 0.0 110.288 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.511 HG23 ' C ' ' A' ' 61' ' ' GLY . 55.7 mt -120.5 124.14 71.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.361 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.4 mm -113.78 136.42 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.437 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.2 t -139.86 161.03 38.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.233 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.73 134.31 48.1 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.421 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.515 ' CG2' HD12 ' A' ' 159' ' ' LEU . 11.7 pt -106.75 150.15 39.33 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.956 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.05 137.92 42.34 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.008 1.805 . . . . 0.0 111.337 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 t -63.42 -27.19 69.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.076 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -67.44 -31.31 71.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.927 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -128.8 152.0 48.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.154 0.502 . . . . 0.0 111.315 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.1 t -117.46 179.8 3.95 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.21 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.2 tp -50.92 -44.64 60.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.192 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 50.3 p -66.5 -44.83 81.49 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.147 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.2 m-20 -65.32 -38.41 90.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.9 tp -56.15 -43.43 78.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.646 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.69 177.99 46.93 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.403 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.9 p -93.6 172.33 8.33 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.31 -42.26 77.33 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.227 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.1 m -71.65 -44.91 63.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 94' ' ' THR . 44.6 t0 -62.3 -51.54 67.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.522 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.71 -39.99 83.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.22 -45.33 92.78 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.75 -41.78 87.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.994 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -61.62 -39.19 90.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.612 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -62.73 -40.27 96.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.74 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.1 mmt -58.14 -43.79 87.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.294 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -64.85 -45.28 86.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.302 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.4 m -59.91 -45.14 93.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.961 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.2 t -68.18 -47.52 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.644 ' O ' ' N ' ' A' ' 111' ' ' GLN . 96.0 m-20 -62.73 -36.52 83.27 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.233 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -43.61 -36.92 2.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.718 0.294 . . . . 0.0 111.004 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.54 -46.49 69.38 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.2 m -123.34 23.28 9.09 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.644 ' N ' ' O ' ' A' ' 107' ' ' ASN . 47.1 tt0 -51.96 -28.83 18.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.633 0.254 . . . . 0.0 111.357 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -41.55 -61.46 2.15 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.15 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -117.24 -38.97 3.26 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.93 0.365 . . . . 0.0 111.779 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -77.39 146.44 36.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.491 . . . . 0.0 111.793 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -135.01 133.47 39.46 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.927 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.14 134.29 43.29 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.52 ' OE1' ' NH2' ' A' ' 137' ' ' ARG . 75.8 tt0 -115.3 128.71 56.3 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.977 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.24 106.94 13.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.994 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.533 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 95.6 mt -71.03 -38.61 72.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.057 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.9 m-80 178.44 166.35 0.82 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.343 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.98 132.46 12.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -143.12 165.58 27.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.602 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.15 148.87 45.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.458 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -130.33 142.12 50.55 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 34.9 p30 -110.18 110.62 21.54 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.791 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -136.93 143.8 43.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.475 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 127' ' ' ASP . 22.6 t70 50.43 35.54 11.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.99 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.75 2.63 38.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.523 ' OE1' ' CE1' ' A' ' 131' ' ' TYR . 5.7 tm0? -106.43 136.54 46.0 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.458 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 44.7 t -106.69 129.41 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.852 0.358 . . . . 0.0 110.708 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.523 ' CE1' ' OE1' ' A' ' 129' ' ' GLN . 48.2 m-85 -117.24 131.11 56.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.57 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.13 130.14 51.85 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.8 m -110.42 124.33 51.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.181 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.73 125.32 52.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.982 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -117.58 122.34 43.37 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.537 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -150.82 172.74 15.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.562 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.52 ' NH2' ' OE1' ' A' ' 117' ' ' GLU . 38.3 ptt180 -140.4 158.09 44.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 110.729 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.37 132.84 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.122 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pp -140.52 135.7 32.15 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.05 0.452 . . . . 0.0 111.427 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.6 t -111.18 131.07 63.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.202 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.52 -120.6 21.21 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -109.38 11.17 25.29 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -124.1 152.68 42.45 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.024 0.44 . . . . 0.0 111.48 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 144' ' ' VAL . 9.9 p -88.31 127.34 41.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.786 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -77.0 -53.64 7.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.544 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.556 HH21 ' CA ' ' A' ' 166' ' ' THR . 13.0 ptm180 -170.49 173.78 5.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.008 0.432 . . . . 0.0 111.384 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . 0.418 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 52.2 m80 -108.02 137.7 45.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.055 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 79.1 m-20 -135.04 137.91 43.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.015 0.436 . . . . 0.0 111.018 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.5 tp -111.22 134.91 52.45 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.546 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -135.64 141.24 45.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.428 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.0 t -124.86 141.32 52.2 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.179 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.13 132.12 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.837 0.351 . . . . 0.0 110.438 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.0 m -146.21 153.49 40.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.555 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.6 p -116.84 145.19 43.72 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.858 0.361 . . . . 0.0 110.52 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.407 ' ND2' ' OXT' ' A' ' 188' ' ' TYR . 38.0 t30 -160.04 122.37 3.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.927 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 60.15 30.91 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.097 0.475 . . . . 0.0 110.276 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 77.47 11.8 85.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -109.89 135.26 51.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -89.52 114.74 26.31 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.9 mm -103.99 120.23 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 49.0 m -120.52 129.58 53.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.101 0.477 . . . . 0.0 110.561 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.28 117.32 32.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -120.1 122.96 42.2 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.978 0.418 . . . . 0.0 111.578 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.3 mp -119.93 140.57 50.69 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.382 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 63.1 m -130.87 135.65 47.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.365 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.556 ' CA ' HH21 ' A' ' 146' ' ' ARG . 16.6 m -153.06 153.93 33.85 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.57 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.27 145.71 42.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.358 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -69.98 -25.45 63.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.414 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 170' ' ' ARG . 55.4 p30 -60.56 -33.45 72.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.552 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 22.7 mmt85 -118.89 -1.12 11.07 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.576 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 46.9 t-105 -48.26 -40.62 25.32 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.693 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.98 -41.39 97.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.029 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 46.3 m -63.71 -39.41 94.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.438 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 170' ' ' ARG . 6.9 m -105.85 21.17 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.964 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.412 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 19.1 ptmt -50.19 -45.19 53.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.823 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 24.2 t -63.13 -31.45 72.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.694 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.0 tp -59.43 -45.55 91.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.109 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 18.2 m-85 -60.89 -50.14 74.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.873 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 176' ' ' SER . 0.6 OUTLIER -69.27 -43.24 74.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.757 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 60.6 m -62.36 -48.36 80.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.704 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 80.5 t -71.57 -38.39 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.474 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.98 -38.98 93.33 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.353 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 81.4 p -80.18 -18.98 48.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.226 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.8 t -62.84 -39.04 93.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.699 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.493 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -54.77 149.03 11.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.08 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -133.88 159.02 41.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.3 m -126.57 150.45 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.67 0.272 . . . . 0.0 110.795 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.407 ' OXT' ' ND2' ' A' ' 155' ' ' ASN . 41.2 p90 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.882 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.4 mt . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 120.791 0.329 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 21.0 mp0 -103.58 148.45 25.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.908 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -119.3 136.49 54.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.184 0.516 . . . . 0.0 110.946 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -125.63 136.19 52.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.0 p -145.64 156.05 43.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.491 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -148.05 119.15 7.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.556 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.8 p -70.53 -32.61 70.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.879 0.371 . . . . 0.0 110.218 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 63.9 tttm -62.03 -49.94 74.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.799 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -86.87 -20.63 27.17 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.904 0.383 . . . . 0.0 110.567 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.28 43.34 93.1 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.16 147.61 36.91 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.225 0.513 . . . . 0.0 110.377 179.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -148.18 155.96 42.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.024 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.538 ' CZ ' ' O ' ' A' ' 45' ' ' LEU . 57.6 t80 -173.02 143.52 1.17 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.538 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . 9.9 mp -92.58 141.38 28.56 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -134.16 141.2 38.52 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.638 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.58 152.44 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.893 1.728 . . . . 0.0 112.484 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.415 ' HB3' HE22 ' A' ' 33' ' ' GLN . 54.2 p30 -81.41 158.75 24.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.234 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.29 8.84 74.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.437 ' NE1' ' OD1' ' A' ' 68' ' ' ASP . 27.7 m0 -94.1 149.03 21.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.451 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.2 pt -114.64 140.46 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.475 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.75 134.24 11.8 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.15 132.45 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.015 0.436 . . . . 0.0 110.569 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -83.88 137.96 33.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.339 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.83 52.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.371 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -72.81 134.06 44.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.357 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.64 4.72 82.58 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.81 -164.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.707 0.289 . . . . 0.0 110.694 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -45.1 152.1 0.62 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.556 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.78 132.98 26.19 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.23 1.953 . . . . 0.0 111.654 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.543 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 95.76 -27.63 15.4 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.55 133.9 26.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.085 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' OD2' HD12 ' A' ' 80' ' ' ILE . 53.4 t0 -115.78 -58.57 2.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.646 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 78' ' ' VAL . 65.8 t -149.49 147.28 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.057 0.456 . . . . 0.0 111.522 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.18 134.87 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.158 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -112.13 138.16 49.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.406 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -128.95 133.63 47.9 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.531 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.437 ' OD1' ' NE1' ' A' ' 50' ' ' TRP . 60.1 t0 -88.15 119.07 28.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.444 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.9 mt -60.24 -37.82 81.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.737 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.647 ' H ' HD12 ' A' ' 70' ' ' ILE . 4.9 mp -67.13 -42.21 87.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.822 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 68' ' ' ASP . 90.6 mt-10 -121.24 124.24 44.17 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.009 0.433 . . . . 0.0 110.639 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -87.19 -39.58 15.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.549 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.45 -37.02 77.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.984 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' OE1' ' OE1' ' A' ' 71' ' ' GLU . 84.6 tt0 -85.12 132.68 34.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.409 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -155.58 138.78 15.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.945 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 76' ' ' LEU . 10.2 tt -112.57 133.29 54.7 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.044 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.9 m -128.44 147.0 50.64 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.015 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.7 m -124.07 131.45 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.105 0.478 . . . . 0.0 110.616 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.543 HG23 ' C ' ' A' ' 61' ' ' GLY . 51.0 mt -119.13 124.26 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.587 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 61' ' ' GLY . 63.1 mt -119.07 128.26 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 110.788 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 74.5 m -149.09 166.31 29.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.043 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -104.57 137.01 43.04 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.44 HG22 HD12 ' A' ' 159' ' ' LEU . 10.4 pt -92.44 149.55 38.46 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.394 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -45.42 136.71 11.54 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.649 1.566 . . . . 0.0 111.862 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -27.3 68.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.392 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -88.61 -16.23 33.03 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -131.22 157.23 43.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.043 0.449 . . . . 0.0 111.375 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.417 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.4 t -122.81 176.61 5.89 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.49 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.6 tp -51.83 -44.74 63.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.171 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.5 p -65.51 -44.61 86.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.933 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.3 m-20 -67.16 -34.27 77.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.866 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.473 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -55.05 -50.01 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.893 -179.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.37 179.18 47.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.421 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.3 p -90.91 171.69 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.26 -41.41 75.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.869 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.7 m -72.61 -45.17 60.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.7 t0 -61.57 -51.74 67.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.294 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.96 -38.77 81.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.514 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.02 -43.94 94.82 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -67.64 -42.36 82.38 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.945 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -62.33 -38.65 90.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.0 110.718 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.87 -40.77 96.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.541 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.6 mmt -58.9 -44.4 91.19 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.521 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 108' ' ' ASP . 43.9 tptt -65.46 -45.76 82.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.976 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.8 m -59.17 -46.12 89.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.015 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.29 -47.16 79.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 110.273 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.656 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.1 m-20 -63.39 -37.83 88.78 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.266 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 104' ' ' LYS . 88.8 m-20 -44.29 -38.31 3.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.729 0.299 . . . . 0.0 111.224 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.88 74.6 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.6 m -123.93 23.45 8.59 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.4 tt0 -48.5 -28.79 3.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.557 0.218 . . . . 0.0 111.544 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -44.05 -61.24 3.16 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.152 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -116.91 -36.01 3.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.956 0.378 . . . . 0.0 111.872 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -78.43 139.54 38.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 111.242 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -132.55 137.03 46.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.962 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.0 140.38 42.58 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.817 0.342 . . . . 0.0 110.458 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.418 ' OE1' ' NE ' ' A' ' 137' ' ' ARG . 83.4 mt-10 -124.8 123.4 39.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.734 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 tp -80.43 110.75 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.054 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.582 ' C ' HD22 ' A' ' 120' ' ' ASN . 96.9 mt -76.32 -55.71 10.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.846 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.582 HD22 ' C ' ' A' ' 119' ' ' ILE . 1.7 m-80 -145.23 163.22 35.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.083 0.468 . . . . 0.0 110.693 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.18 116.12 3.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.237 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.17 162.55 34.68 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.548 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.99 150.19 47.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 110.878 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -129.5 160.35 33.45 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.385 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -134.83 114.22 12.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.721 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.84 142.5 38.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.608 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 127' ' ' ASP . 22.3 t70 50.49 36.57 13.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.02 2.66 48.24 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.525 ' OE1' ' CE2' ' A' ' 131' ' ' TYR . 4.4 tm0? -101.29 134.74 43.88 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.436 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 46.2 t -106.22 130.08 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 110.565 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.525 ' CE2' ' OE1' ' A' ' 129' ' ' GLN . 58.1 m-85 -119.41 128.24 53.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.045 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -106.61 129.93 54.45 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.7 m -112.37 122.8 48.76 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.522 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.37 125.05 51.52 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.048 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -117.09 123.81 47.71 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -151.75 164.04 37.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.945 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.418 ' NE ' ' OE1' ' A' ' 117' ' ' GLU . 39.5 ptt180 -126.62 156.97 40.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.083 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.09 130.71 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.3 mt -112.25 125.3 54.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.883 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 79.5 t -123.49 129.68 74.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.04 -121.64 16.77 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -116.44 22.35 12.87 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -148.35 161.5 41.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.955 0.407 . . . . 0.0 111.486 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.5 t -71.34 125.52 29.96 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.271 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' A' ' 146' ' ' ARG . 83.3 tt0 -73.9 -52.71 12.06 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.014 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' A' ' 145' ' ' GLU . 11.4 ptp85 -172.41 170.43 4.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.609 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -105.0 138.96 40.41 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.007 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 164' ' ' LEU . 13.4 t70 -135.52 147.58 48.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.146 0.498 . . . . 0.0 110.563 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 tp -123.17 124.96 44.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.556 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -123.81 134.74 53.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.234 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.5 t -122.84 134.27 54.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.35 129.93 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.157 0.503 . . . . 0.0 110.852 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.438 ' CG2' ' NE2' ' A' ' 129' ' ' GLN . 24.0 m -143.76 142.71 31.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.101 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.1 p -108.36 149.6 28.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 110.215 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.606 HD21 ' CA ' ' A' ' 188' ' ' TYR . 56.5 t30 -147.46 106.71 3.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.735 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 57.42 31.74 20.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 89.59 4.89 72.59 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 32.1 mmtp -96.05 123.85 39.82 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -89.36 114.38 25.79 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.89 127.41 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.103 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.7 m -123.67 135.91 54.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.037 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.07 105.51 15.56 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.886 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.19 120.06 38.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.876 0.37 . . . . 0.0 111.47 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.432 ' O ' ' OD2' ' A' ' 148' ' ' ASP . 19.2 mt -117.62 135.3 54.07 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.9 t -133.56 134.07 42.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.419 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 14.6 m -152.52 158.88 43.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.295 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -59.18 144.31 46.29 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.07 0.462 . . . . 0.0 111.422 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -74.44 -17.81 60.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.071 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -77.93 -9.77 59.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.902 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.498 ' O ' HG22 ' A' ' 174' ' ' VAL . 77.3 mtp180 -133.61 -6.8 2.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.729 0.299 . . . . 0.0 110.742 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.617 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 45.3 t-105 -49.19 -39.02 27.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.624 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -63.48 -42.32 98.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.08 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.7 m -65.37 -40.74 93.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.526 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.3 m -105.33 21.21 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.848 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.77 -47.24 41.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.203 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 91.8 p -67.08 -28.61 68.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.81 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.8 tp -56.23 -43.18 78.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.627 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.617 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 19.4 m-85 -62.78 -49.49 74.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.451 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.4 -40.85 98.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.706 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.4 m -68.09 -51.49 45.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.401 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' A' ' 184' ' ' SER . 4.0 p -69.96 -32.52 51.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.683 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.56 -40.29 96.59 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.101 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 76.0 p -85.11 -16.1 41.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.743 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 181' ' ' VAL . 88.4 p -64.72 -34.09 77.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.492 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.7 150.37 7.3 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.558 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -130.75 149.93 52.16 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.0 m -126.48 151.99 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 110.814 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.606 ' CA ' HD21 ' A' ' 155' ' ' ASN . 43.7 p90 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.622 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.5 mt . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.828 0.347 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -134.4 158.88 42.72 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.365 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.483 HH21 ' CD ' ' A' ' 43' ' ' GLU . 72.7 ttt180 -119.29 138.11 53.23 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.653 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -118.89 136.27 54.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.276 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 84.7 p -143.72 157.52 44.33 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.426 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.1 t0 -148.28 108.58 4.11 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.65 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.6 m -60.31 -36.76 78.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.694 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -58.66 -51.01 71.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.184 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -85.64 -20.17 29.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . 68.68 41.44 83.65 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 155.73 45.69 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.199 0.5 . . . . 0.0 110.727 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' CD ' HH21 ' A' ' 34' ' ' ARG . 3.0 pp20? -156.03 147.83 23.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.752 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -152.9 156.1 38.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt -94.4 158.96 15.33 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.397 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -170.57 144.88 2.03 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.689 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.01 158.73 56.12 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.349 2.033 . . . . 0.0 111.952 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -71.92 160.34 32.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.6 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.26 4.53 58.43 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.535 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 25.1 m0 -89.16 145.11 25.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 pt -115.11 138.29 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.503 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.73 121.98 7.43 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.53 134.75 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.942 0.401 . . . . 0.0 110.499 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 52.9 p30 -84.07 151.16 25.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.356 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.61 48.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.086 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -68.58 134.03 49.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.63 -0.63 83.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.3 -163.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 110.464 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.2 m -40.14 116.69 1.25 Allowed Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.586 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.04 132.89 8.6 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.703 1.602 . . . . 0.0 112.22 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 101.99 -40.48 2.41 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.2 135.18 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -118.55 -57.56 2.05 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.54 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -147.63 143.06 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.684 0.278 . . . . 0.0 111.048 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.47 137.93 54.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.928 0.395 . . . . 0.0 110.045 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.93 134.92 54.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.84 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -121.95 143.7 49.31 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.8 0.333 . . . . 0.0 110.758 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.535 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 11.2 m-20 -94.75 118.94 32.55 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.514 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.5 -38.7 90.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.559 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.5 mm -65.12 -41.77 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.748 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -124.42 95.16 4.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.753 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -64.4 -34.8 79.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.349 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.21 -37.37 74.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.81 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -89.44 128.9 36.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.604 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -141.08 139.05 33.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.297 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -106.93 132.91 52.35 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.593 ' N ' HD13 ' A' ' 76' ' ' LEU . 4.9 p -120.12 138.84 53.34 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 t -125.45 124.21 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-O 120.883 0.373 . . . . 0.0 110.446 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.494 HG23 ' C ' ' A' ' 61' ' ' GLY . 15.7 mt -125.1 117.75 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.802 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.2 mm -114.94 135.87 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.995 0.426 . . . . 0.0 110.643 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.9 m -145.36 166.03 26.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.935 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -107.93 141.47 39.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.652 0.263 . . . . 0.0 110.673 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.2 pt -107.72 149.63 39.19 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.697 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' LYS . 54.9 Cg_endo -69.19 139.96 43.58 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.101 1.867 . . . . 0.0 111.141 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.8 p -65.98 -24.96 66.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.979 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.29 -31.28 70.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.635 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 84' ' ' PRO . 29.5 mtmm -130.33 157.48 42.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.121 0.486 . . . . 0.0 111.263 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.407 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.7 t -122.48 178.1 5.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.366 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 tp -50.99 -44.65 60.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.16 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.3 p -64.9 -45.53 85.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.037 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 88' ' ' THR . 84.6 m-20 -68.02 -36.15 79.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -56.13 -42.77 77.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.776 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.67 174.68 44.24 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 41.8 p -91.72 168.87 11.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.3 76.09 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.998 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.7 m -71.82 -43.95 64.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.823 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 94' ' ' THR . 47.7 t0 -61.57 -52.69 63.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.486 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.48 -38.51 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.738 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.02 -47.35 89.65 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -65.17 -42.86 93.26 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -62.74 -37.76 87.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -62.92 -41.12 99.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.611 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.9 mmt -59.88 -44.29 94.29 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.299 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.76 -41.71 95.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.213 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.6 m -59.23 -46.25 88.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.704 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.87 -47.12 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.048 0.451 . . . . 0.0 110.498 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 111' ' ' GLN . 92.9 m-20 -61.54 -35.41 77.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.36 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -45.71 -36.74 5.21 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.193 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.04 -45.86 76.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 112' ' ' GLY . 48.1 m -123.39 22.65 9.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.625 ' N ' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -52.43 -10.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.133 -179.015 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -59.97 -61.47 7.14 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.718 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -117.17 -40.53 3.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.794 0.331 . . . . 0.0 111.452 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -86.37 138.9 31.44 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.167 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -132.72 150.68 52.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.154 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.05 139.69 38.27 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.422 ' OE1' ' NE ' ' A' ' 137' ' ' ARG . 79.1 tt0 -113.23 130.9 56.09 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.9 tp -83.79 117.94 23.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.434 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.3 mt -85.48 -59.42 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.313 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.56 ' C ' HD22 ' A' ' 120' ' ' ASN . 0.4 OUTLIER -158.53 172.17 18.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.35 134.68 11.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.34 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.88 161.1 39.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.728 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.401 ' HB1' ' CE1' ' A' ' 132' ' ' TYR . . . -139.36 143.49 37.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.427 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -135.65 146.23 47.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.482 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -120.05 112.68 19.45 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.515 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -136.6 139.61 42.24 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 51.2 40.71 26.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.724 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.07 2.3 17.45 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.522 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 2.9 tm0? -101.79 134.67 44.6 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 43.6 t -106.37 129.6 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.944 0.402 . . . . 0.0 110.542 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.522 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 70.0 m-85 -118.95 123.53 44.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.904 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 2.5 m-30 -104.94 118.88 37.64 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 56.7 m -93.66 132.57 37.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.2 107.0 8.31 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.269 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.442 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 74.7 tt0 -103.37 126.02 50.3 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -153.38 171.23 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.315 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.422 ' NE ' ' OE1' ' A' ' 117' ' ' GLU . 40.0 ptt180 -141.5 161.49 37.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.865 0.364 . . . . 0.0 110.262 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.78 139.99 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.006 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 pp -145.0 150.63 37.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.188 0.518 . . . . 0.0 111.087 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.92 134.86 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.558 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.68 -107.04 0.23 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 56.1 t0 -117.46 13.3 14.4 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.323 0.12 . . . . 0.0 111.323 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.84 142.67 47.05 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.738 0.304 . . . . 0.0 111.019 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.69 125.77 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.016 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -78.05 -53.74 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.703 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.534 ' NH1' ' OG ' ' A' ' 165' ' ' SER . 44.8 ptt85 -173.83 171.81 3.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.011 0.434 . . . . 0.0 111.403 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -108.07 141.52 39.65 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.526 ' OD2' ' NH1' ' A' ' 146' ' ' ARG . 74.5 m-20 -135.57 144.02 45.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.006 0.431 . . . . 0.0 111.11 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.5 tp -116.79 134.47 54.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.53 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.43 ' CB ' ' OD1' ' A' ' 163' ' ' ASP . . . -134.1 128.21 33.72 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.008 0.433 . . . . 0.0 110.925 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.7 t -115.2 127.76 55.73 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.12 131.72 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.941 0.401 . . . . 0.0 110.875 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.52 ' OG1' ' NE2' ' A' ' 129' ' ' GLN . 6.8 t -146.67 161.93 39.53 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.687 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -122.22 152.79 39.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.23 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -165.74 123.25 1.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.618 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 58.67 26.09 14.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.004 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.72 9.12 83.52 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -106.69 141.19 38.35 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.898 0.38 . . . . 0.0 110.385 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.43 117.81 31.04 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 71.0 mt -117.44 121.88 68.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.8 m -122.55 130.1 52.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.27 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.01 110.43 21.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 150' ' ' ALA . 90.2 m-20 -115.48 124.84 52.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.919 0.39 . . . . 0.0 110.951 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 mp -116.56 146.12 42.87 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.681 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.534 ' OG ' ' NH1' ' A' ' 146' ' ' ARG . 45.7 t -132.08 131.31 42.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.583 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.8 m -152.4 155.7 38.07 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.647 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.57 144.68 16.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.254 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -71.5 -34.38 70.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.154 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.91 -33.61 74.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.712 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.519 ' O ' HG22 ' A' ' 174' ' ' VAL . 78.9 mtm180 -103.01 -12.68 17.27 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.564 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.3 t-105 -47.69 -40.37 19.92 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.379 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -64.07 -42.28 97.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 50.5 m -65.52 -40.96 93.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.465 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 170' ' ' ARG . 10.5 m -106.42 21.45 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.12 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 171' ' ' TRP . 24.0 pttm -49.45 -45.63 46.84 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.222 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 84.8 p -67.45 -28.56 67.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.457 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -56.1 -45.14 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.564 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.1 m-85 -62.5 -48.07 81.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.221 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -62.57 -42.55 99.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.547 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 91.7 m -67.49 -49.02 65.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.02 -37.32 72.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.511 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.24 -38.58 91.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.374 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.4 p -84.72 -16.03 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.217 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.4 t -62.78 -37.9 88.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.421 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -59.66 155.49 15.57 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.066 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -137.86 161.18 37.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -128.4 151.06 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.956 0.408 . . . . 0.0 111.257 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.468 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 39.3 p90 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.624 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.8 mt . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 120.825 0.345 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.479 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 3.2 mp0 -116.89 154.49 30.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.547 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.55 138.53 50.96 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.34 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -126.73 131.07 51.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.944 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -141.12 152.36 44.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 110.769 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -143.58 118.69 10.1 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.388 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.4 p -71.31 -32.69 68.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.529 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.48 -47.58 83.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.025 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -88.36 -20.33 25.47 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.1 42.06 85.36 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -143.07 149.29 37.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.338 0.569 . . . . 0.0 110.356 179.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -151.66 144.19 24.21 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.77 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.71 158.09 41.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.52 150.01 22.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.093 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -158.17 145.99 13.74 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.359 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.19 156.4 66.43 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.309 2.006 . . . . 0.0 112.187 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.453 ' N ' HE22 ' A' ' 33' ' ' GLN . 39.2 p30 -71.78 160.36 32.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.57 2.13 58.8 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.53 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 33.9 m0 -91.81 144.5 25.43 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 110.436 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.6 pt -120.65 144.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.359 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.32 141.56 15.68 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -129.88 143.63 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -90.61 144.55 25.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.61 51.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.491 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -66.98 136.08 54.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.094 0.473 . . . . 0.0 110.337 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.36 1.62 71.66 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.86 -164.19 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.64 0.257 . . . . 0.0 110.53 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.1 m -41.54 124.29 2.33 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.337 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.03 132.32 6.0 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.785 1.657 . . . . 0.0 112.694 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.448 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 97.98 -33.69 5.76 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.9 t -62.42 122.84 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.114 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -120.22 -50.06 2.26 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.467 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.95 139.5 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.879 0.371 . . . . 0.0 110.91 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.82 138.35 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.49 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.66 135.01 52.83 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.859 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -121.64 134.77 54.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.26 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.53 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 66.1 m-20 -86.18 118.75 25.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.483 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -67.47 -39.36 85.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.593 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.577 ' H ' HD12 ' A' ' 70' ' ' ILE . 4.1 mp -61.11 -48.14 90.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.76 118.01 28.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.908 0.385 . . . . 0.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.42 -36.59 65.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.777 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 2.7 p30 -62.47 -34.62 77.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.864 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.516 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 84.3 tt0 -86.13 133.33 33.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.0 110.254 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -154.25 139.66 17.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -114.54 134.62 54.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.932 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.7 m -120.13 145.1 47.25 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.17 127.63 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.002 0.429 . . . . 0.0 110.315 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.448 HG23 ' C ' ' A' ' 61' ' ' GLY . 5.8 mt -114.82 122.57 69.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.699 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 82.1 mt -122.08 127.88 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.996 0.427 . . . . 0.0 110.796 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 159' ' ' LEU . 21.9 t -153.29 164.29 38.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.045 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -103.47 136.42 43.25 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.0 pt -92.89 148.42 35.85 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.347 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' LYS . 37.1 Cg_endo -65.28 136.17 46.24 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.64 1.56 . . . . 0.0 110.821 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.8 t -60.99 -29.12 69.5 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.038 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -67.57 -31.52 71.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.999 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 84' ' ' PRO . 68.0 mttm -130.61 144.84 51.7 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.046 0.451 . . . . 0.0 111.138 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.451 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.1 t -113.24 179.18 4.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.173 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 tp -52.75 -43.83 66.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.859 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 47.1 p -69.04 -45.03 71.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.447 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.451 ' HB2' ' H ' ' A' ' 88' ' ' THR . 82.4 m-20 -68.77 -34.92 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.106 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.6 tp -55.39 -44.35 76.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.394 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.17 178.06 46.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.412 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 43.9 p -92.85 169.8 10.18 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.46 72.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.966 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.4 m -72.36 -44.64 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.851 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 94' ' ' THR . 45.7 t0 -62.54 -50.97 69.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.425 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.629 HG22 HH21 ' A' ' 101' ' ' ARG . 79.4 t -62.65 -38.56 81.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.604 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.27 -47.05 92.74 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.37 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -62.8 -45.36 92.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.82 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.629 HH21 HG22 ' A' ' 98' ' ' VAL . 85.4 mtm180 -62.96 -43.86 97.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.041 0.448 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -57.0 -41.14 77.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.804 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.4 mmt -61.12 -43.46 98.85 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.143 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.93 -38.83 92.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.423 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.1 m -56.88 -45.71 82.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.599 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.28 -46.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.13 0.491 . . . . 0.0 110.449 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.657 ' O ' ' N ' ' A' ' 111' ' ' GLN . 1.4 m120 -62.43 -32.98 73.92 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.272 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -43.81 -37.64 2.87 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.675 0.274 . . . . 0.0 111.537 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.26 -47.27 71.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.6 m -123.53 24.17 8.66 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 107' ' ' ASN . 16.9 tt0 -46.55 -28.77 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.597 0.237 . . . . 0.0 111.536 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.71 -61.18 3.04 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.02 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 31.7 p-10 -117.02 -36.3 3.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.069 0.435 . . . . 0.0 111.711 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.578 HH11 ' CG1' ' A' ' 138' ' ' VAL . 59.7 ttm-85 -84.18 142.05 30.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 0.0 111.051 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -148.82 149.09 30.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.886 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.578 ' CB ' HD21 ' A' ' 107' ' ' ASN . . . -108.47 138.99 43.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.168 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -107.94 129.85 55.08 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.1 tt -81.54 108.09 14.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.953 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.426 HD12 ' HG2' ' A' ' 135' ' ' GLU . 97.4 mt -70.68 -56.32 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.112 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.567 ' C ' HD22 ' A' ' 120' ' ' ASN . 0.3 OUTLIER -156.29 169.9 23.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.901 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.7 119.85 4.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.336 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.34 163.18 33.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.73 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.402 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -139.12 149.45 44.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.473 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -131.72 144.49 51.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.1 0.476 . . . . 0.0 110.821 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -111.42 114.3 27.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.572 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -140.3 141.88 35.71 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.702 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 127' ' ' ASP . 22.6 t70 49.67 37.2 12.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.03 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.59 1.49 23.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 3.7 tm0? -103.18 133.48 48.21 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 46.6 t -105.59 130.43 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.855 0.359 . . . . 0.0 110.721 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 48.4 m-85 -119.04 129.59 55.19 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.823 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.4 127.47 53.0 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 55.6 m -105.03 129.66 53.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.69 107.12 9.42 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.12 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.467 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 79.4 tt0 -101.79 127.22 48.68 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -150.87 170.37 19.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.411 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -136.81 156.75 48.08 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.052 0.453 . . . . 0.0 110.37 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.578 ' CG1' HH11 ' A' ' 114' ' ' ARG . 58.3 t -104.7 135.17 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.443 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.407 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.7 pp -145.2 135.02 23.59 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.189 0.518 . . . . 0.0 111.251 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.3 t -111.6 132.52 59.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.869 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.54 -122.05 25.56 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -110.73 11.83 22.58 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.854 -0.204 . . . . 0.0 111.139 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -120.02 149.97 41.31 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.829 0.347 . . . . 0.0 111.225 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.0 t -88.35 126.03 41.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.415 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.407 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 47.4 tp10 -75.08 -53.85 8.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.416 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -173.94 173.6 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 111.26 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -105.21 143.58 33.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.133 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 164' ' ' LEU . 12.0 t70 -141.21 151.16 43.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.841 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.8 tp -124.1 135.0 53.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.034 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.51 132.51 39.28 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.895 0.378 . . . . 0.0 110.431 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 69.3 m -119.93 137.39 54.07 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.59 130.29 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.985 0.421 . . . . 0.0 110.683 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.415 HG23 HE22 ' A' ' 129' ' ' GLN . 24.5 m -146.97 144.85 29.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -110.9 150.36 29.3 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.192 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -151.14 106.7 3.37 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.264 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 61.83 34.84 16.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.066 0.46 . . . . 0.0 110.526 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.06 8.29 86.74 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -98.42 127.17 44.23 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.81 113.13 24.65 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 67.9 mt -122.25 124.29 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.328 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.0 m -124.62 134.27 52.98 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.14 111.04 23.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.65 119.97 40.48 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 111.428 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.426 ' O ' ' OD2' ' A' ' 148' ' ' ASP . 2.9 mp -115.47 142.64 46.44 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.136 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.0 p -132.96 135.05 45.28 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.871 0.367 . . . . 0.0 110.547 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.0 m -152.88 157.02 40.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.248 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.29 143.69 55.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.04 0.448 . . . . 0.0 111.4 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.427 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 1.3 pp20? -69.82 -27.11 64.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.222 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.427 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 90.3 m-20 -59.36 -34.15 72.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.256 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.448 ' O ' HG22 ' A' ' 174' ' ' VAL . 73.8 mtm180 -117.66 -1.59 11.59 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.554 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 44.5 t-105 -48.64 -39.34 23.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.554 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -63.26 -42.11 99.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.958 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 39.8 m -64.49 -40.47 95.73 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.458 HG23 ' CZ ' ' A' ' 178' ' ' PHE . 12.8 m -105.11 20.87 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.902 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -49.33 -45.61 45.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.89 0.376 . . . . 0.0 110.952 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 85.1 p -68.07 -27.69 66.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.598 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.9 tp -56.84 -44.34 81.99 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.583 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.554 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.2 m-85 -63.59 -49.82 71.88 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.239 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -62.0 -42.28 98.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.579 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 65.0 m -67.6 -49.77 61.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.038 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.82 -37.92 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.38 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.46 -39.04 93.41 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.234 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.5 m -80.71 -19.54 44.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.273 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -62.53 -36.22 81.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.718 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -55.93 148.76 16.48 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.11 -179.555 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -136.85 155.53 49.67 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.22 150.61 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.183 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' TYR . . . . . 0.489 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 40.9 p90 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.548 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.404 ' N ' HD23 ' A' ' 21' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.54 31.75 0.35 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.919 2.413 . . . . 0.0 112.478 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.9 mm? -61.02 -35.89 78.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.88 0.371 . . . . 0.0 110.062 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.55 -173.64 51.41 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.9 t -149.55 149.12 30.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.808 0.337 . . . . 0.0 110.442 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.8 m -87.1 115.85 24.76 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.266 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 27' ' ' VAL . . . -176.94 -172.65 41.76 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.28 39.34 0.45 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.474 ' H ' ' C ' ' A' ' 25' ' ' GLY . 8.5 p -54.66 -34.65 30.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.738 0.304 . . . . 0.0 110.76 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.42 125.42 17.57 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 31' ' ' SER . 27.2 pt -126.39 161.97 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.758 0.313 . . . . 0.0 110.554 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.95 75.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.48 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 29' ' ' ILE . 10.2 t -164.0 -133.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.359 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.1 mt -85.3 142.71 29.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.214 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.557 HE22 ' N ' ' A' ' 48' ' ' ASN . 4.2 mp0 -115.41 155.06 28.11 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.014 0.435 . . . . 0.0 110.741 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -113.73 131.26 56.25 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.369 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -124.66 131.29 53.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.944 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -138.57 153.4 48.69 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.665 0.269 . . . . 0.0 110.757 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -144.2 109.61 5.16 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.787 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.0 m -61.74 -36.14 80.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.507 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -58.73 -51.41 70.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.938 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 38.4 t0 -85.86 -20.64 28.8 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.735 0.302 . . . . 0.0 110.937 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.92 40.9 84.17 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.495 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.72 150.7 42.16 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 117.218 0.509 . . . . 0.0 110.17 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -151.12 143.07 23.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.598 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -151.74 160.06 43.73 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.176 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.7 mt -98.33 150.37 21.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.103 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -153.63 145.92 17.2 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.297 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.2 152.95 78.78 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.373 2.049 . . . . 0.0 112.151 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.557 ' N ' HE22 ' A' ' 33' ' ' GLN . 54.1 p30 -73.15 160.26 32.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.576 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.59 -0.84 58.22 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.475 ' NE1' ' CG ' ' A' ' 68' ' ' ASP . 30.1 m0 -92.95 145.57 24.27 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.4 pt -118.73 145.03 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.469 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.35 128.79 9.68 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -111.7 135.46 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-O 120.756 0.312 . . . . 0.0 110.297 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -76.57 129.29 36.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.431 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.9 m -128.14 36.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.766 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -59.37 135.94 57.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.43 . . . . 0.0 110.693 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.06 10.02 72.57 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.45 -164.67 0.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.683 0.278 . . . . 0.0 110.548 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.16 140.86 42.21 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.084 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -44.98 132.11 10.85 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 121.59 1.526 . . . . 0.0 112.463 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.481 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 94.97 -31.04 7.28 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 97.4 t -61.04 128.93 23.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -119.07 -57.33 2.03 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.209 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.4 t -143.95 148.51 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.867 0.365 . . . . 0.0 110.92 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.2 p -123.47 140.01 48.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -111.45 134.11 53.26 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.107 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -127.15 130.74 50.35 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.463 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' CG ' ' NE1' ' A' ' 50' ' ' TRP . 60.3 t0 -87.86 117.96 27.06 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.662 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.9 tp -65.22 -38.99 92.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.555 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.86 -39.54 82.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.044 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -126.54 96.19 4.6 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.809 0.338 . . . . 0.0 110.593 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -61.33 -37.0 81.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.374 0.607 . . . . 0.0 109.856 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.27 -36.83 73.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.971 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -82.66 130.65 35.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.436 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -140.32 139.09 35.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.363 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.62 136.23 53.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.686 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.0 t -126.16 140.37 52.61 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.739 0.304 . . . . 0.0 110.608 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.1 t -117.94 125.52 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.914 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.481 HG23 ' C ' ' A' ' 61' ' ' GLY . 30.9 mt -121.13 123.87 70.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.93 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.9 mt -120.35 133.42 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.873 0.368 . . . . 0.0 110.682 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 159' ' ' LEU . 22.7 t -151.11 162.56 40.64 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.313 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 2.0 pm0 -105.06 130.23 53.31 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.111 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 83' ' ' ILE . 6.4 pt -86.4 149.22 48.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.406 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 87' ' ' LYS . 36.2 Cg_endo -65.06 136.66 49.1 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.588 1.525 . . . . 0.0 110.753 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 t -60.96 -29.01 69.4 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.182 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -67.9 -31.44 71.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.898 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 84' ' ' PRO . 92.1 mttt -131.2 140.36 49.88 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.918 0.39 . . . . 0.0 111.169 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -105.96 -178.42 3.65 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.079 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.509 ' N ' ' OG1' ' A' ' 88' ' ' THR . 49.2 tp -52.18 -43.04 63.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.769 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.9 p -68.03 -43.76 78.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.093 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.52 -35.16 78.56 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 92' ' ' LEU . 4.4 tt -55.17 -49.05 72.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.129 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.74 176.67 45.95 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.409 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 36.2 p -90.38 171.26 9.58 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.12 -42.32 76.67 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.165 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.7 m -72.06 -43.91 64.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.809 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.409 ' HB3' ' H ' ' A' ' 94' ' ' THR . 47.4 t0 -61.94 -51.38 68.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.151 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.2 t -61.7 -38.53 80.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.568 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.63 -44.54 93.93 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -68.14 -39.77 82.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.821 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -61.61 -41.34 97.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.981 0.419 . . . . 0.0 110.833 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -61.43 -41.16 96.74 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.63 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.9 mmt -58.62 -43.76 89.75 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.838 0.352 . . . . 0.0 110.365 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -64.57 -40.08 94.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.356 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -60.05 -47.33 86.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.892 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.3 t -71.7 -45.74 65.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.011 0.434 . . . . 0.0 110.497 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.542 ' O ' ' N ' ' A' ' 111' ' ' GLN . 88.9 m-20 -60.43 -32.56 71.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.069 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -44.19 -37.65 3.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.215 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -105.72 -10.8 16.57 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 114' ' ' ARG . 1.3 t -121.39 16.1 11.33 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.542 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.5 pt20 -79.83 6.98 9.61 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.086 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -78.35 -62.85 2.23 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.052 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -117.06 -41.23 3.03 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.634 0.254 . . . . 0.0 111.501 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 110' ' ' SER . 95.6 mtt180 -86.28 154.7 21.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 110.876 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -133.11 135.53 45.3 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.209 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.17 129.57 44.52 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.06 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -116.95 128.78 55.54 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.021 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.0 tp -83.66 110.85 18.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.024 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -55.25 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.104 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.57 ' C ' HD22 ' A' ' 120' ' ' ASN . 0.3 OUTLIER -161.4 168.57 23.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.921 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.68 122.44 4.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.232 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.96 162.9 34.38 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.583 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.414 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.48 148.28 50.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.571 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -130.67 150.14 52.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.775 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -120.45 116.36 25.3 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.847 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.45 142.27 39.47 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.456 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 58.3 t0 52.05 28.42 5.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.16 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 78.68 2.61 85.84 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 154' ' ' THR . 66.4 tp60 -104.02 135.99 44.5 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.02 129.89 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.964 0.411 . . . . 0.0 110.532 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -118.84 129.84 55.43 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.821 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.414 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.75 130.21 53.8 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 79.3 m -112.89 125.18 54.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.195 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.3 mp -118.24 124.88 48.96 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.013 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.451 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 72.2 tt0 -119.72 124.2 45.64 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.86 169.75 20.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.38 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -138.88 160.31 40.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.394 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 63.4 t -104.42 126.35 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.008 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 6.1 mt -106.14 139.71 40.23 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.336 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.88 135.86 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 49.45 -112.63 1.41 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -118.23 22.88 11.92 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -142.63 157.1 45.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.289 -0.564 . . . . 0.0 112.219 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.3 123.86 32.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.102 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.445 ' CD ' ' NH1' ' A' ' 146' ' ' ARG . 85.3 tt0 -75.16 -53.28 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.111 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.445 ' NH1' ' CD ' ' A' ' 145' ' ' GLU . 33.6 ptt-85 -172.41 167.66 5.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.837 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -107.98 135.61 49.07 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.968 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -131.05 140.94 50.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.543 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.4 tp -111.2 132.23 54.49 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -129.2 132.48 47.28 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.387 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 43.4 m -121.79 139.78 53.18 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.0 t -123.36 131.51 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.972 0.415 . . . . 0.0 111.073 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 43.6 m -148.72 142.21 25.33 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.256 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.458 ' O ' ' NE2' ' A' ' 129' ' ' GLN . 13.0 p -106.41 149.56 26.9 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.795 0.331 . . . . 0.0 110.343 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -150.39 106.68 3.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.077 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.413 ' NH2' ' OXT' ' A' ' 188' ' ' TYR . 17.0 ttm180 63.15 27.6 15.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.179 0.514 . . . . 0.0 110.579 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.13 3.08 73.38 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.804 -0.519 . . . . 0.0 111.804 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.49 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 11.5 mptt -94.95 126.11 40.06 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 122.417 -0.461 . . . . 0.0 109.81 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -88.54 118.62 28.31 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 78.2 mt -120.02 127.98 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.823 0.344 . . . . 0.0 110.663 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 89.0 m -129.12 136.86 50.78 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.725 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.68 103.28 11.07 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -102.27 108.68 20.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.81 0.338 . . . . 0.0 110.414 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 164' ' ' LEU . 5.3 mp -114.05 140.04 48.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.561 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 87.3 p -133.63 139.65 46.62 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.855 0.36 . . . . 0.0 110.306 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.9 m -152.99 157.2 40.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.201 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.5 145.93 37.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.555 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.415 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 2.0 pp20? -70.87 -21.06 62.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.971 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.415 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 93.6 m-20 -58.84 -34.58 71.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.22 -178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.517 ' O ' HG22 ' A' ' 174' ' ' VAL . 72.3 mtp85 -123.03 -1.34 8.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.576 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 59.9 t-105 -46.69 -40.25 12.91 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.812 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -64.56 -42.29 95.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.993 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.2 m -66.12 -39.67 90.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.728 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.517 HG22 ' O ' ' A' ' 170' ' ' ARG . 10.9 m -106.53 21.64 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.246 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.409 ' CG ' ' N ' ' A' ' 176' ' ' SER . 12.2 ptmm? -51.22 -50.93 58.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.194 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.409 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 24.9 t -64.94 -30.69 71.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.889 0.376 . . . . 0.0 111.088 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.529 ' O ' HD23 ' A' ' 177' ' ' LEU . 1.0 OUTLIER -52.55 -45.79 66.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.849 -178.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 23.1 m-85 -62.0 -49.83 74.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.049 0.452 . . . . 0.0 110.467 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -63.24 -37.8 88.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.471 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 184' ' ' SER . 56.2 m -61.37 -47.4 86.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.296 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.49 -44.17 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.519 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.502 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -65.74 -42.93 90.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.556 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 85.2 p -74.79 -30.9 61.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 180' ' ' THR . 58.0 m -63.14 -29.67 70.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.502 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -52.74 156.73 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.137 0.494 . . . . 0.0 110.813 -179.204 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -138.67 155.18 48.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.199 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.0 m -127.91 151.68 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.922 0.392 . . . . 0.0 111.244 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.413 ' OXT' ' NH2' ' A' ' 156' ' ' ARG . 41.2 p90 . . . . . 0 C--O 1.219 -0.511 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.661 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.499 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 30.9 Cg_endo -62.69 145.86 95.12 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.73 2.287 . . . . 0.0 111.781 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 43.5 mt -89.9 142.77 27.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.231 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -83.73 176.29 52.22 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.418 ' H ' ' H ' ' A' ' 24' ' ' CYS . 5.7 t 179.59 5.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.733 0.301 . . . . 0.0 110.555 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.418 ' H ' ' H ' ' A' ' 23' ' ' SER . 5.8 p -80.88 108.39 14.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.855 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.02 -42.23 2.83 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.47 21.5 64.29 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.3 m -60.75 146.06 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.78 0.324 . . . . 0.0 110.646 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -75.67 -175.54 38.15 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.6 pt -82.95 -177.68 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.232 0.539 . . . . 0.0 111.314 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.66 -117.04 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.685 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.415 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 31.9 t -127.53 113.74 16.53 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.759 0.314 . . . . 0.0 110.164 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.58 ' C ' HD21 ' A' ' 48' ' ' ASN . 42.1 mt -115.36 142.76 46.26 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.889 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.519 ' NE2' ' OD1' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -102.61 170.85 7.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.099 -179.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -139.68 146.03 39.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.656 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -135.68 141.78 45.03 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.137 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.0 p -149.75 155.38 40.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 110.592 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -148.08 119.14 7.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.624 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.6 p -71.55 -29.75 65.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.172 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -61.54 -48.93 78.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.983 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.414 ' O ' ' OD1' ' A' ' 40' ' ' ASP . 50.5 t0 -92.12 -20.39 21.31 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.738 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.75 44.87 60.97 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.234 -0.508 . . . . 0.0 111.853 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.455 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -142.65 149.05 38.39 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.232 0.516 . . . . 0.0 110.336 179.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -152.73 143.48 22.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -152.47 158.85 43.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 111.059 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.6 mt -96.79 151.72 19.37 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.892 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' N ' ' CD1' ' A' ' 46' ' ' TYR . 10.3 p90 -157.95 136.56 7.81 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.846 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -43.29 157.3 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.045 1.83 . . . . 0.0 112.559 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.696 HD22 ' N ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -81.18 158.93 24.74 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.299 179.514 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.08 63.07 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.399 -0.681 . . . . 0.0 111.399 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 26.8 m0 -87.6 147.27 25.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.839 0.352 . . . . 0.0 110.175 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -114.7 132.31 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.043 179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.89 133.2 11.61 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.1 t -109.33 134.24 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-O 120.964 0.412 . . . . 0.0 110.753 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 37.0 p30 -91.36 121.29 32.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.518 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 m -133.25 60.77 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.464 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -78.73 132.91 37.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.163 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.0 3.62 73.11 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.39 -163.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 t -40.53 125.95 1.83 Allowed Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.449 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_exo -41.5 127.16 3.2 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.97 1.78 . . . . 0.0 113.025 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.503 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 100.68 -36.18 4.34 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.533 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.7 t -63.63 127.02 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.174 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 61' ' ' GLY . 5.4 m-20 -119.57 -56.63 2.04 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.574 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.52 139.61 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.901 0.381 . . . . 0.0 111.098 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.3 t -123.08 132.63 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.127 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -112.28 134.27 53.92 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.41 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -124.76 143.36 50.83 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.797 0.332 . . . . 0.0 110.457 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 73.8 m-20 -90.42 119.08 30.4 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.548 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.2 tp -65.4 -41.21 93.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.574 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.99 -45.03 99.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.048 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -119.67 120.67 37.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.863 0.363 . . . . 0.0 110.73 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -77.84 -40.38 40.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.56 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -58.7 -36.5 74.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.643 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -82.91 133.39 35.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.295 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -156.11 139.31 15.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.561 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.68 134.4 55.07 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.804 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.6 t -121.86 139.26 53.85 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.026 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -117.96 125.61 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.07 0.462 . . . . 0.0 110.279 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.503 HG23 ' C ' ' A' ' 61' ' ' GLY . 14.9 mt -117.35 123.52 71.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.627 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.7 mt -120.21 128.42 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 CA-C-O 120.933 0.396 . . . . 0.0 110.952 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.477 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 61.3 m -149.03 166.0 29.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.3 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.3 mp0 -105.64 138.41 41.88 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 159' ' ' LEU . 8.2 pt -93.09 149.4 37.46 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.653 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -44.51 140.19 6.37 Favored 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.651 1.568 . . . . 0.0 111.383 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -67.94 -25.38 65.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.403 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.4 p30 -93.03 -15.28 26.34 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -131.43 150.44 52.15 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.096 0.474 . . . . 0.0 111.486 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 46.8 p -112.86 -179.23 3.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.222 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.9 tp -56.36 -41.56 76.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.448 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 57.5 p -72.16 -45.07 61.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.968 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 88' ' ' THR . 45.7 t0 -64.7 -37.28 87.04 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.787 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 45.0 tp -55.8 -43.32 76.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.745 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.5 179.19 47.62 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.309 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 36.2 p -93.4 170.69 9.42 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.24 74.37 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.044 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 78.0 m -72.45 -45.67 58.48 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 94' ' ' THR . 45.6 t0 -61.25 -52.16 65.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.311 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.4 -38.62 82.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.713 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.71 -45.07 93.79 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -65.2 -41.45 94.49 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.541 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -63.11 -39.03 93.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.059 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -63.66 -41.49 98.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.699 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.8 mmt -58.38 -44.4 88.89 Favored 'General case' 0 N--CA 1.461 0.117 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.383 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -66.07 -42.48 89.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.359 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.5 m -59.24 -45.79 90.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.9 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.2 -47.48 73.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.986 0.422 . . . . 0.0 110.478 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.646 ' O ' ' N ' ' A' ' 111' ' ' GLN . 93.4 m-20 -62.67 -34.65 77.53 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.451 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -46.61 -36.92 7.43 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.068 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.23 -47.11 71.78 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.41 ' C ' ' N ' ' A' ' 112' ' ' GLY . 74.8 m -123.26 22.25 9.41 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.646 ' N ' ' O ' ' A' ' 107' ' ' ASN . 10.3 pt20 -49.41 -13.38 0.08 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.403 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.41 ' N ' ' C ' ' A' ' 110' ' ' SER . . . -58.08 -61.42 7.44 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.86 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 35.1 p-10 -117.46 -35.66 3.93 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.902 0.351 . . . . 0.0 111.685 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.532 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 58.2 ttp180 -85.13 135.77 33.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.914 0.388 . . . . 0.0 111.28 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -127.97 144.37 51.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.191 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -107.09 138.07 43.96 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.757 0.313 . . . . 0.0 110.252 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -119.81 129.06 54.26 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 tp -81.98 110.08 16.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.204 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.574 ' C ' HD22 ' A' ' 120' ' ' ASN . 96.7 mt -77.02 -55.6 10.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.557 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.574 HD22 ' C ' ' A' ' 119' ' ' ILE . 1.7 m-80 -145.75 159.35 43.31 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.37 112.81 2.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.463 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.1 168.98 18.46 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.657 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.63 147.18 42.6 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.763 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -130.35 143.86 51.03 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.921 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 35.5 p30 -110.56 111.1 22.1 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.725 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -137.45 143.0 41.59 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.879 0.371 . . . . 0.0 110.839 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 51.38 37.97 20.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.317 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.24 2.61 41.78 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -107.67 149.47 28.07 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 120.964 0.411 . . . . 0.0 110.234 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.5 t -117.12 129.2 74.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.103 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 14.1 m-85 -119.31 128.15 53.86 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.067 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -100.62 120.04 39.46 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 63.2 m -95.17 127.46 41.24 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.94 110.76 11.93 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.53 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -107.28 126.58 52.61 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -150.79 170.45 19.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.349 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -136.97 156.8 47.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.041 0.448 . . . . 0.0 110.523 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.7 134.39 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.91 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.415 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.8 pp -135.77 136.26 40.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.161 0.505 . . . . 0.0 111.13 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.6 t -112.45 134.13 55.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.12 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.6 -121.06 19.05 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -113.91 14.17 18.47 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 122.926 -0.161 . . . . 0.0 111.275 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -127.15 153.6 45.84 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.901 0.382 . . . . 0.0 111.164 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 144' ' ' VAL . 14.7 p -85.67 126.93 40.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.237 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.415 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 83.9 tt0 -75.01 -52.75 10.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.773 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.6 ptp180 -175.21 173.97 2.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.028 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -109.84 136.78 48.61 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.16 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -132.88 141.57 48.48 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.892 0.377 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.9 tp -111.48 131.18 55.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.99 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.97 131.08 47.43 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.955 0.407 . . . . 0.0 110.486 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.0 m -120.69 138.15 54.1 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.6 t -119.85 129.16 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.033 0.444 . . . . 0.0 110.683 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 47.7 m -144.72 148.28 33.99 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.624 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -114.74 149.25 37.16 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.832 0.349 . . . . 0.0 110.303 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -149.82 107.04 3.59 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.032 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 65.07 26.26 12.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.12 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.4 1.44 71.78 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 2.4 mptp? -94.28 126.66 39.67 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -87.94 115.62 25.54 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 65.7 mt -121.45 123.52 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.005 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 72.7 m -122.45 132.11 54.19 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.52 113.12 26.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.817 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -115.04 124.85 52.67 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.905 0.383 . . . . 0.0 111.652 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.01 142.18 50.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.458 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 67.1 m -132.91 134.3 44.38 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.406 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 167' ' ' ALA . 22.9 m -153.18 159.2 42.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.87 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.453 ' N ' HG22 ' A' ' 166' ' ' THR . . . -56.36 141.56 41.44 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.365 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -65.81 -39.09 90.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.963 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -62.48 -33.07 74.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.194 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.575 ' O ' HG22 ' A' ' 174' ' ' VAL . 79.8 mtp180 -96.38 -17.56 20.55 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.35 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.59 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 47.9 t-105 -48.75 -41.73 33.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.713 0.292 . . . . 0.0 110.947 -179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.83 -41.69 97.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.136 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.7 m -65.56 -40.6 92.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.432 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.6 m -107.35 21.22 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.25 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 171' ' ' TRP . 19.0 ptmt -48.14 -47.4 34.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 111.111 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 27.0 t -64.83 -31.54 72.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.669 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.6 tp -54.61 -45.64 73.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.044 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.59 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.2 m-85 -61.33 -50.11 74.26 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.263 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -63.28 -42.37 99.1 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.871 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.1 m -67.16 -49.01 66.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.777 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.9 t -70.01 -37.64 73.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.405 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.68 -37.03 84.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.317 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.0 t -84.62 -18.61 34.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.133 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.8 t -62.79 -35.87 81.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.629 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.433 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -55.89 147.23 19.85 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.931 -179.567 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -134.44 157.72 45.72 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.37 151.19 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.767 0.317 . . . . 0.0 111.049 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.414 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 33.8 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.69 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.78 -21.17 72.8 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.686 2.257 . . . . 0.0 111.77 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.9 mt -88.05 144.3 26.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.306 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.94 23.76 0.02 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.1 t -114.77 137.5 51.86 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.808 0.337 . . . . 0.0 110.487 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 93.0 m -65.15 -28.4 69.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.754 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 80.38 -105.0 2.32 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.62 -174.42 48.12 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.9 p -130.28 143.41 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-O 120.86 0.362 . . . . 0.0 110.494 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 175.88 77.02 0.05 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 29' ' ' ILE . 31.6 pt -126.38 167.85 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.187 0.518 . . . . 0.0 111.239 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -120.6 170.9 8.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.242 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.5 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 60.9 p -61.64 164.48 5.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.109 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.1 156.7 44.78 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.045 0.45 . . . . 0.0 111.224 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.678 ' NE2' ' H ' ' A' ' 33' ' ' GLN . 1.3 pm0 -135.91 158.94 43.17 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.915 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -116.73 135.52 53.7 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.633 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -108.99 141.17 41.49 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.078 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 81.9 p -144.57 157.28 44.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.762 0.315 . . . . 0.0 110.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -146.96 112.32 5.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.766 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.7 m -62.0 -37.32 84.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.603 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.7 ttmm -59.39 -52.33 66.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.227 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -84.49 -20.53 31.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.767 0.318 . . . . 0.0 110.77 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.65 43.17 86.17 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.829 -0.508 . . . . 0.0 111.829 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -142.37 151.88 42.32 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 117.235 0.517 . . . . 0.0 110.393 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -153.96 144.47 22.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.806 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -148.86 160.4 43.28 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.044 0.449 . . . . 0.0 111.155 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 tp -103.8 133.07 49.4 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.619 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -141.99 140.78 20.19 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.066 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -45.68 150.32 1.59 Allowed 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.901 1.734 . . . . 0.0 112.217 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.665 ' N ' HE22 ' A' ' 33' ' ' GLN . 37.2 p-10 -81.02 160.03 24.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.301 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.43 3.19 65.05 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 32.9 m0 -81.3 147.12 30.05 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.8 pt -111.43 134.25 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.327 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.85 138.59 14.0 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.45 134.05 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.771 0.32 . . . . 0.0 110.22 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 48.7 p30 -84.45 145.57 28.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.72 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.1 m -151.66 51.03 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.353 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.45 133.5 46.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.048 0.451 . . . . 0.0 110.423 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.37 3.92 84.01 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.65 -164.24 0.69 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.797 0.332 . . . . 0.0 110.73 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.8 m -40.49 117.88 1.43 Allowed Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.685 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -45.18 135.23 11.33 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 121.506 1.47 . . . . 0.0 111.895 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.462 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 99.84 -32.01 7.75 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 81.0 t -65.12 130.07 29.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -111.05 -57.79 2.19 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.708 0.289 . . . . 0.0 110.94 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.1 t -147.02 140.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.712 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -109.72 133.48 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.143 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -112.71 134.05 54.42 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.522 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -129.44 134.73 47.97 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.111 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 77.8 m-20 -86.61 119.1 26.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.836 0.35 . . . . 0.0 110.652 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.8 tt -65.11 -40.04 93.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.505 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 88.6 mt -61.37 -42.93 95.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.008 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -119.11 120.16 36.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.891 0.377 . . . . 0.0 110.659 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -82.82 -36.24 25.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.578 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 40.6 p-10 -62.37 -31.94 72.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.981 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.529 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 84.2 tt0 -87.13 130.47 34.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.62 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 m-80 -139.57 139.5 36.84 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.297 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.8 tt -125.39 134.76 52.03 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.8 t -129.53 138.91 51.61 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -115.13 128.3 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.405 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.462 HG23 ' C ' ' A' ' 61' ' ' GLY . 25.8 mt -123.68 123.97 68.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.326 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 73.3 mt -123.23 130.83 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.392 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.4 m -145.74 165.86 27.55 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.297 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -105.46 135.81 46.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 83' ' ' ILE . 8.1 pt -92.52 148.83 37.08 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.32 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' LYS . 37.3 Cg_endo -65.86 137.13 48.0 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.695 1.597 . . . . 0.0 110.69 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 t -60.88 -29.42 69.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.171 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -67.59 -31.34 71.32 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 84' ' ' PRO . 95.4 mttt -131.04 143.19 50.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.938 0.399 . . . . 0.0 111.007 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.484 ' OG1' ' N ' ' A' ' 89' ' ' LEU . 0.9 OUTLIER -111.87 179.82 3.9 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.086 179.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.484 ' N ' ' OG1' ' A' ' 88' ' ' THR . 45.8 tp -52.16 -45.16 64.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.079 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 56.3 p -68.51 -41.38 80.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.925 0.393 . . . . 0.0 110.882 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.452 ' H ' HG23 ' A' ' 88' ' ' THR . 50.0 t0 -66.41 -36.45 82.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.943 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 92' ' ' LEU . 4.8 tt -55.62 -47.54 76.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.241 -179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.09 178.52 47.61 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.5 p -90.71 172.96 8.29 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.15 76.43 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.113 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.1 m -72.14 -45.3 61.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.729 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.55 -51.12 69.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.246 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.55 -38.63 78.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.404 179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.08 -45.55 93.75 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -69.52 -40.26 77.05 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.813 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 19.0 mmm180 -61.5 -41.18 96.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.043 0.449 . . . . 0.0 110.76 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -60.74 -40.66 93.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.633 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.7 mmt -59.26 -44.16 92.43 Favored 'General case' 0 N--CA 1.461 0.103 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.507 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -64.59 -39.63 94.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.154 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 44.8 m -59.26 -46.84 87.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.922 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.15 -46.04 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.048 0.451 . . . . 0.0 110.383 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' A' ' 111' ' ' GLN . 86.3 m-20 -61.99 -31.29 71.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.051 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -44.12 -37.56 3.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.87 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -110.34 -7.71 14.78 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.808 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 114' ' ' ARG . 27.9 m -121.05 19.36 11.62 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.367 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.534 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.5 pt20 -84.39 6.26 23.9 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.15 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.98 -63.22 2.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 120.573 -0.823 . . . . 0.0 111.831 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -117.3 -46.14 2.71 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.903 0.382 . . . . 0.0 110.934 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.454 ' O ' ' O ' ' A' ' 110' ' ' SER . 93.2 mtm-85 -74.61 148.73 40.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.228 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -131.83 130.58 41.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.601 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -97.92 128.63 44.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.848 0.356 . . . . 0.0 110.389 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.7 tp10 -115.36 128.7 56.25 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.6 tp -82.71 111.6 18.8 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.929 0.395 . . . . 0.0 110.406 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.574 ' C ' HD22 ' A' ' 120' ' ' ASN . 96.2 mt -77.74 -57.68 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.362 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.574 HD22 ' C ' ' A' ' 119' ' ' ILE . 1.8 m-80 -146.35 161.3 40.65 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.647 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.41 112.93 2.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.388 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.37 167.37 22.27 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.896 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.418 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -136.93 149.7 47.74 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.754 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.8 mtt85 -132.52 143.04 49.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.778 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -111.82 115.03 28.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.428 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -140.12 144.76 36.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.983 0.42 . . . . 0.0 110.94 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 56.5 t0 54.74 22.1 3.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.41 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.54 -1.78 88.19 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -103.49 149.02 25.25 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 120.942 0.401 . . . . 0.0 110.077 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.67 128.42 67.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.995 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -117.49 127.73 54.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.873 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.31 124.78 49.78 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.7 m -105.78 122.76 46.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.299 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.3 mp -117.83 122.93 44.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.99 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -117.88 124.42 48.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.431 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -151.98 172.89 15.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.401 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -140.78 160.53 39.84 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.079 0.466 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.61 132.58 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.437 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pp -135.81 136.35 40.6 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.2 0.524 . . . . 0.0 111.346 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.7 t -104.57 130.46 55.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.119 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 61.63 -116.95 10.08 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.552 ' C ' HD22 ' A' ' 143' ' ' ASN . 56.7 t0 -114.73 12.44 17.08 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.468 0.175 . . . . 0.0 111.025 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.552 HD22 ' C ' ' A' ' 142' ' ' ASP . 3.6 m120 -119.75 146.6 45.5 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.726 0.298 . . . . 0.0 110.951 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 144' ' ' VAL . 7.4 p -85.57 125.19 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.434 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -75.21 -52.66 10.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.717 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -173.23 172.49 3.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -104.84 141.18 36.96 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.028 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -134.49 136.74 43.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.991 0.424 . . . . 0.0 111.206 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 23.1 tp -111.55 135.63 51.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.724 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.53 134.97 42.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.252 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.0 m -121.49 141.36 51.11 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.097 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.7 128.88 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 120.853 0.359 . . . . 0.0 110.871 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.8 m -146.31 148.86 32.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.415 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -112.54 151.1 30.4 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.833 0.349 . . . . 0.0 110.357 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -150.37 103.95 3.19 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.873 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 62.52 31.38 17.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.977 0.417 . . . . 0.0 110.68 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 89.01 2.27 78.22 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.306 -0.473 . . . . 0.0 111.925 179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.487 ' N ' ' CD ' ' A' ' 158' ' ' LYS . 1.7 mptp? -95.1 125.17 39.57 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.7 OUTLIER -88.62 118.22 28.13 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.4 mt -120.49 128.16 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.759 0.314 . . . . 0.0 110.499 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.5 m -130.52 136.51 49.02 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.723 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.86 110.47 20.82 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.976 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -105.47 111.88 24.77 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.559 0.219 . . . . 0.0 110.509 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 164' ' ' LEU . 5.5 mp -119.09 135.59 54.57 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.744 0.307 . . . . 0.0 110.483 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -129.82 138.2 50.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.368 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.6 m -153.05 156.52 38.92 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.642 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.48 145.07 34.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.453 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.39 -29.07 65.61 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.325 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -59.33 -34.05 71.87 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.256 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.452 ' O ' HG22 ' A' ' 174' ' ' VAL . 60.7 mtp180 -113.79 -4.2 13.39 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.532 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 57.5 t-105 -49.54 -38.5 31.16 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.091 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -62.32 -43.11 99.59 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.183 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 77.9 m -65.58 -39.76 91.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.8 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 170' ' ' ARG . 11.3 m -108.45 21.11 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.521 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 176' ' ' SER . 17.4 pttp -51.75 -50.5 60.51 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.459 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.434 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 27.2 t -65.17 -29.67 70.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.734 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.6 tp -55.75 -43.6 76.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.233 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.532 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 28.5 m-85 -61.53 -49.58 76.14 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.385 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.64 -39.66 91.67 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.459 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.421 ' O ' ' OG ' ' A' ' 184' ' ' SER . 43.8 m -65.39 -47.35 76.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.277 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.34 -44.88 99.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.494 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.475 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -66.52 -45.36 79.78 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.283 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.0 t -69.96 -32.34 70.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.235 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 180' ' ' THR . 63.8 m -62.03 -30.08 70.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.306 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -49.9 157.08 0.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.522 -179.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -138.59 153.99 48.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.581 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.6 m -127.12 151.15 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.107 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 42.6 p90 . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.75 -179.875 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.55 -20.8 71.74 Favored 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.667 2.245 . . . . 0.0 111.819 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 mt -91.36 137.72 32.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.434 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.93 -179.68 39.42 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.9 t -143.45 141.75 30.94 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.451 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.6 p -177.64 102.44 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.608 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.75 44.81 37.34 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.13 -37.97 55.34 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 m -131.66 151.25 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.843 0.354 . . . . 0.0 110.477 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.38 -179.96 42.26 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.3 mm -84.97 36.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.323 0.582 . . . . 0.0 109.731 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -148.86 159.06 44.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.233 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.427 ' OG ' ' ND2' ' A' ' 48' ' ' ASN . 51.8 p -67.08 153.86 42.64 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.401 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 35.6 mt -113.61 145.3 41.49 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.61 ' NE2' ' N ' ' A' ' 33' ' ' GLN . 2.8 mp0 -109.92 151.89 26.51 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.272 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -120.24 143.14 48.45 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.565 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -130.43 133.63 46.48 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.068 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -140.81 151.2 44.18 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.401 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -140.73 120.26 13.22 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.408 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.8 p -71.33 -32.59 68.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.574 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.22 -49.45 74.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.115 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -87.37 -20.63 26.43 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.825 0.345 . . . . 0.0 110.729 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.34 41.16 91.58 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.91 -0.476 . . . . 0.0 111.91 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -139.75 152.71 46.84 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 117.264 0.532 . . . . 0.0 110.418 179.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -151.39 148.58 28.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.461 ' C ' HD22 ' A' ' 45' ' ' LEU . 45.5 p90 -152.33 155.91 38.58 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.044 0.45 . . . . 0.0 111.53 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.663 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.3 mm? -96.7 141.92 29.36 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.894 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -153.05 147.63 19.2 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.543 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.22 163.4 34.93 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.596 2.197 . . . . 0.0 112.968 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.596 ' ND2' ' NE2' ' A' ' 33' ' ' GLN . 68.6 m-80 -70.52 160.47 32.4 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.85 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.74 -6.19 57.04 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -97.08 141.84 29.73 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 51' ' ' ILE . 36.4 pt -123.13 147.28 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.423 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.42 137.39 13.23 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.19 136.19 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.895 0.379 . . . . 0.0 110.655 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -77.78 133.98 38.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.241 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.2 m -132.06 56.23 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.256 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -73.65 137.78 44.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.301 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.13 3.57 69.77 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.48 -164.22 0.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.798 0.332 . . . . 0.0 110.65 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.5 157.04 1.89 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.155 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.74 131.03 27.92 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.425 2.083 . . . . 0.0 111.722 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 94.3 -22.43 36.98 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.9 t -61.84 132.16 27.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.413 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -118.67 -58.4 1.97 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.033 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.3 m -146.87 165.81 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 121.178 0.514 . . . . 0.0 111.308 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.13 140.86 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.028 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -111.99 130.38 55.88 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -127.6 133.6 49.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.917 0.389 . . . . 0.0 111.132 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 71' ' ' GLU . 60.2 t0 -93.49 118.27 31.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.452 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 75.5 mt -63.62 -39.09 93.49 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.14 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 87.1 mt -63.06 -40.86 90.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' O ' ' O ' ' A' ' 68' ' ' ASP . 79.1 mm-40 -117.99 118.11 31.05 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.621 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -85.91 -43.0 13.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.417 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -58.43 -39.69 80.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.993 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 74' ' ' GLU . 33.9 mp0 -82.95 135.94 34.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.89 0.376 . . . . 0.0 110.355 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.84 157.77 38.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.904 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 77' ' ' SER . 9.5 tp -132.09 133.87 44.83 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.047 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.44 ' N ' HD12 ' A' ' 76' ' ' LEU . 42.6 t -123.54 131.32 53.6 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.7 t -113.41 126.97 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.61 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.506 HG23 ' C ' ' A' ' 61' ' ' GLY . 49.4 mt -122.33 121.41 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.21 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.4 mm -116.77 129.92 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.01 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 159' ' ' LEU . 9.6 m -148.79 164.36 34.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.161 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -103.66 138.12 40.75 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 83' ' ' ILE . 10.6 pt -92.92 149.26 37.37 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.788 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -43.77 139.64 5.18 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 C-N-CA 121.76 1.64 . . . . 0.0 111.487 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -69.01 -23.9 64.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.557 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 56.3 t0 -90.68 -18.38 25.17 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -128.73 157.32 41.73 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.104 0.478 . . . . 0.0 111.617 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.9 t -122.92 176.91 5.74 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.515 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 tp -51.0 -45.09 61.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.972 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.9 p -66.92 -44.99 79.29 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.089 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -66.36 -37.18 84.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.8 tp -55.91 -41.94 75.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.67 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.83 -179.41 48.35 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.425 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.2 p -96.05 171.9 8.33 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.73 73.57 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.133 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 48.3 m -73.05 -46.16 53.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.87 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.425 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.3 t0 -62.6 -50.97 69.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.164 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.6 t -59.36 -38.79 76.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.555 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -57.94 -56.12 26.87 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -59.52 -36.64 76.48 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.479 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -56.27 -40.26 73.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.099 0.476 . . . . 0.0 110.577 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -63.8 -41.58 97.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.127 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.674 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -54.98 -55.27 32.7 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.307 0.575 . . . . 0.0 110.096 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -61.29 -39.56 90.89 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.766 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 56.1 m -57.97 -45.63 86.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.41 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.7 t -71.7 -46.57 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.504 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 111' ' ' GLN . 1.6 m120 -60.83 -33.9 73.75 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.879 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -45.63 -35.52 4.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.06 0.457 . . . . 0.0 110.439 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.47 -48.5 22.41 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 m -122.31 22.94 9.96 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.3 pt20 -47.39 -18.59 0.12 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.632 0.253 . . . . 0.0 111.483 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -55.26 -61.44 7.38 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.167 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 38.1 p-10 -117.31 -30.84 5.47 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.072 0.436 . . . . 0.0 111.781 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.527 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 55.1 ttm-85 -80.19 136.92 36.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.868 0.366 . . . . 0.0 111.026 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -133.17 135.86 45.38 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.37 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.523 ' CB ' HD21 ' A' ' 107' ' ' ASN . . . -107.87 136.62 47.29 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.951 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -118.64 127.76 53.9 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 11.9 tp -82.84 108.18 15.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.899 0.38 . . . . 0.0 110.209 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.546 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 97.0 mt -71.0 -38.3 71.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.942 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.3 m-80 -178.52 163.7 1.57 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.165 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.9 120.53 4.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.197 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -137.6 170.71 15.6 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.035 0.445 . . . . 0.0 110.919 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.435 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -141.78 150.74 42.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.506 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -132.83 136.77 46.45 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.152 0.501 . . . . 0.0 110.802 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -103.97 113.62 27.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.7 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -138.26 137.62 37.67 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.429 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 129' ' ' GLN . 87.2 m-20 51.24 42.3 28.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.627 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.13 1.59 5.67 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.524 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 2.8 tm0? -102.28 130.71 49.06 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.13 130.0 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 110.693 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.524 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 45.8 m-85 -118.87 131.4 56.06 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.724 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.435 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.07 128.44 53.34 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.464 ' C ' HD12 ' A' ' 134' ' ' LEU . 94.0 m -110.13 123.62 50.06 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.982 0.42 . . . . 0.0 110.326 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.464 HD12 ' C ' ' A' ' 133' ' ' THR . 9.4 mp -115.45 127.51 55.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.992 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -123.43 120.49 33.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.297 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -150.31 169.68 20.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.471 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -133.73 152.92 52.01 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.989 0.423 . . . . 0.0 110.554 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.415 ' CG1' HH11 ' A' ' 114' ' ' ARG . 74.2 t -105.01 133.57 48.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.375 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.411 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.7 pp -140.57 135.13 31.49 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.283 0.563 . . . . 0.0 111.087 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 24.6 t -115.02 134.27 58.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.131 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.54 -122.1 21.87 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -111.31 13.45 21.65 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -128.86 156.74 43.17 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.077 0.465 . . . . 0.0 111.475 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 144' ' ' VAL . 9.9 p -87.62 126.98 41.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.63 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.412 ' OE1' ' NH1' ' A' ' 114' ' ' ARG . 84.2 tt0 -74.77 -54.63 6.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.472 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -174.46 173.83 2.87 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.207 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.416 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 51.2 m170 -103.99 138.66 40.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.025 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 81.5 m-20 -135.38 137.92 42.81 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.011 0.434 . . . . 0.0 111.291 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.4 tp -114.15 130.52 56.6 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.845 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.79 137.85 54.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.82 178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.1 t -126.82 126.02 42.66 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 52.4 t -114.83 129.94 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.071 0.462 . . . . 0.0 111.12 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.9 m -143.83 144.34 31.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.0 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.3 p -110.99 150.34 29.4 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.209 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -156.66 117.16 3.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.964 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.523 ' HE ' ' H ' ' A' ' 156' ' ' ARG . 4.8 mmp_? 58.94 24.85 13.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.767 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.11 7.88 72.92 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.1 125.82 43.27 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -88.97 121.47 31.35 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.42 ' N ' HD23 ' A' ' 159' ' ' LEU . 76.5 mt -122.87 129.08 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.565 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 37.7 m -129.07 136.47 50.3 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.454 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.85 99.9 8.03 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -96.81 107.55 20.06 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.762 0.315 . . . . 0.0 110.616 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.54 133.42 54.6 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.801 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 89.0 p -128.46 135.8 49.97 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.788 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 5.9 m -152.97 154.82 35.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.549 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -54.89 141.0 35.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.239 -179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -67.77 -34.19 76.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -57.55 -33.78 68.48 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.994 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 174' ' ' VAL . 63.9 mtt85 -109.9 -7.18 15.02 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.499 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 52.2 t-105 -49.51 -38.26 29.83 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.832 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -62.53 -42.96 99.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.142 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 58.6 m -65.53 -39.82 92.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.722 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 170' ' ' ARG . 13.6 m -108.28 21.27 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.35 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 171' ' ' TRP . 50.8 pttt -52.22 -46.78 65.82 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 84.8 p -69.52 -25.83 64.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.602 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.3 tp -58.99 -43.28 91.44 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.998 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.499 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 28.5 m-85 -61.7 -50.86 70.75 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.206 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.15 -41.05 99.19 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.558 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.445 ' O ' ' N ' ' A' ' 184' ' ' SER . 41.8 m -67.22 -48.52 67.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.321 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.95 -45.1 99.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.731 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.514 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -66.48 -43.94 84.06 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.313 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.0 m -72.8 -31.13 64.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.342 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.445 ' N ' ' O ' ' A' ' 180' ' ' THR . 40.3 m -61.82 -29.53 70.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.442 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -54.94 157.01 3.41 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.078 0.466 . . . . 0.0 110.944 -179.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -137.02 158.03 45.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.9 m -125.64 151.1 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.941 0.401 . . . . 0.0 111.008 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.524 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 38.1 p90 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.801 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.98 144.85 35.1 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.703 2.268 . . . . 0.0 111.905 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.6 mt -90.18 140.42 29.69 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.454 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.14 4.77 74.06 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 58.1 p -77.22 156.93 31.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 39.0 t -138.52 127.6 24.07 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.344 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.42 176.58 48.36 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.63 135.96 13.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -122.3 133.97 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.308 . . . . 0.0 110.416 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.87 143.36 26.47 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.4 mm -59.57 -45.08 94.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.93 0.395 . . . . 0.0 110.133 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -161.76 150.13 15.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.445 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.595 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 20.8 t -148.48 155.5 41.26 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.234 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mp -134.72 160.49 37.98 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.966 0.412 . . . . 0.0 110.909 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.13 166.39 24.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.62 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.5 ptt-85 -115.84 144.68 43.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.708 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -124.13 132.44 53.64 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.189 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.9 m -139.15 151.18 46.43 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.544 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -141.61 118.48 11.15 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.32 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.6 p -72.31 -30.53 64.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.719 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -62.53 -47.61 83.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.722 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -90.21 -20.4 23.07 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.937 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.78 41.94 81.2 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.403 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -141.1 152.98 45.2 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.239 0.519 . . . . 0.0 110.22 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -153.26 148.17 26.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -157.22 157.57 34.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.162 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.6 mt -96.38 152.19 18.83 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -161.19 130.08 3.08 Favored Pre-proline 0 CA--C 1.542 0.655 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.19 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -41.99 157.1 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.094 1.862 . . . . 0.0 112.507 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.595 ' ND2' ' H ' ' A' ' 31' ' ' SER . 6.1 p30 -80.8 160.31 24.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.869 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.84 12.53 63.91 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.532 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 28.2 m0 -91.24 151.68 20.82 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 110.479 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.0 pt -117.29 151.07 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.377 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -121.73 134.51 9.97 Favored Glycine 0 N--CA 1.466 0.651 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.3 m -129.62 141.19 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.62 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -87.03 144.72 26.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.181 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.69 49.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.308 0.575 . . . . 0.0 109.878 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -54.12 129.42 34.61 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.102 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.16 4.65 68.53 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.01 -164.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.12 157.89 2.78 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.249 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.8 130.62 25.13 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.341 2.027 . . . . 0.0 111.465 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 94.83 -22.47 37.81 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.423 ' N ' HG23 ' A' ' 79' ' ' ILE . 87.1 t -58.85 126.74 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 C-N-CA 120.548 -0.461 . . . . 0.0 109.783 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -119.05 -57.98 1.98 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.596 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.5 t -145.68 146.04 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.83 0.348 . . . . 0.0 111.035 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.8 t -120.67 135.9 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.123 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -111.25 132.07 54.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.276 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -122.74 141.31 51.94 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.388 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 49.0 m-20 -93.37 118.97 31.95 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.566 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.0 mt -68.47 -38.16 80.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.864 0.364 . . . . 0.0 110.623 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.16 -44.47 99.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.688 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -126.57 98.69 5.5 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.918 0.39 . . . . 0.0 110.621 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.765 ' NE ' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -61.77 -32.67 72.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.538 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.46 -36.25 73.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.575 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -86.76 131.5 34.11 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -146.66 138.86 24.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.445 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -118.89 134.56 55.09 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.688 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.9 t -122.6 138.28 54.63 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.213 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.6 t -118.28 124.08 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 121.001 0.429 . . . . 0.0 110.342 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.484 HG23 ' C ' ' A' ' 61' ' ' GLY . 54.6 mt -122.28 122.83 67.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.475 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' GLY . 72.2 mt -122.88 133.85 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.907 0.384 . . . . 0.0 111.059 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 15.9 t -148.46 167.77 24.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.097 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -105.58 136.63 44.81 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.762 0.315 . . . . 0.0 110.318 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 83' ' ' ILE . 10.1 pt -93.92 148.3 35.03 Favored Pre-proline 0 N--CA 1.465 0.279 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.264 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 87' ' ' LYS . 38.8 Cg_endo -66.07 136.88 46.21 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 121.728 1.619 . . . . 0.0 110.968 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.3 t -61.44 -27.18 68.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.979 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -67.8 -30.86 70.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.023 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' O ' ' O ' ' A' ' 84' ' ' PRO . 66.4 mttm -130.41 156.58 44.49 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.027 0.442 . . . . 0.0 111.119 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 91' ' ' ASP . 14.7 t -122.7 176.13 6.13 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.441 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.0 tp -52.65 -44.83 66.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.075 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.8 p -68.6 -46.51 69.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.204 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.424 ' H ' HG23 ' A' ' 88' ' ' THR . 21.9 t70 -66.24 -35.76 81.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.075 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -55.83 -43.07 76.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.505 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 175.05 44.48 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 38.0 p -92.82 170.69 9.49 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.61 77.99 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.118 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 74.7 m -72.03 -44.5 63.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.418 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.3 t0 -61.77 -51.26 69.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.405 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.22 -38.49 79.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.528 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.18 -46.78 92.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -67.24 -40.39 86.29 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.984 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -61.5 -41.4 97.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.028 0.442 . . . . 0.0 110.813 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -61.45 -40.33 94.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.755 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.7 mmt -58.64 -44.3 90.02 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.684 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -65.55 -45.51 83.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.005 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.9 m -59.2 -45.81 90.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.98 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.6 t -68.14 -47.12 79.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.995 0.426 . . . . 0.0 110.406 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.65 ' O ' ' N ' ' A' ' 111' ' ' GLN . 91.7 m-20 -63.36 -38.43 91.14 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.23 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -43.77 -36.28 2.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.809 0.337 . . . . 0.0 111.006 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.98 -47.65 67.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.011 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.5 m -123.66 23.44 8.8 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.65 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.6 tt0 -50.37 -28.72 8.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.596 0.236 . . . . 0.0 111.419 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.15 -61.72 2.62 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.098 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 34.3 p-10 -117.83 -35.27 3.95 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 117.046 0.423 . . . . 0.0 111.965 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.52 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 35.1 ttm180 -84.64 137.75 33.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 111.276 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -128.31 142.93 50.99 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.03 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.44 140.36 38.67 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.877 0.37 . . . . 0.0 110.421 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' CD ' ' CD2' ' A' ' 139' ' ' LEU . 93.3 mt-10 -121.32 123.54 42.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.459 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.7 tp -82.87 109.75 17.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.963 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.524 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.8 mt -72.44 -50.45 35.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.579 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 27.7 m120 -157.0 164.42 38.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.819 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.82 115.45 3.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.246 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -141.61 166.3 25.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.833 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.418 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -136.51 148.46 47.65 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.417 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -127.72 141.05 51.7 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.834 0.35 . . . . 0.0 110.872 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -108.35 112.14 24.42 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.614 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 127' ' ' ASP . 79.4 mm-40 -138.28 144.07 40.32 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.432 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 126' ' ' GLU . 3.7 p-10 46.53 39.32 6.59 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.212 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.28 1.47 21.15 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.44 ' NE2' ' O ' ' A' ' 154' ' ' THR . 68.1 tp60 -105.95 132.36 52.14 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.0 t -104.43 130.44 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.987 0.422 . . . . 0.0 110.41 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -117.2 130.64 56.72 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.673 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.418 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -103.52 125.58 50.16 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 66.0 m -107.45 122.74 47.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.327 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.27 120.49 38.39 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.971 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -115.47 123.42 48.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -152.07 166.9 30.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.837 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -134.37 153.85 51.67 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.922 0.392 . . . . 0.0 110.486 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 m -107.01 136.42 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.755 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.402 ' CD2' ' CD ' ' A' ' 117' ' ' GLU . 2.7 pp -139.59 138.96 36.64 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.181 0.515 . . . . 0.0 111.225 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.6 m -110.5 134.01 54.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.243 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 62.04 -117.54 11.78 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 56.7 t0 -116.2 13.59 15.72 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.456 0.17 . . . . 0.0 110.963 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -121.98 148.0 45.34 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.753 0.311 . . . . 0.0 111.068 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 144' ' ' VAL . 13.8 p -85.48 126.84 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.114 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.467 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -75.81 -53.4 8.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.705 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.422 HH21 ' N ' ' A' ' 166' ' ' THR . 14.7 ptm180 -174.19 171.08 3.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.0 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.412 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 35.7 m170 -103.11 140.53 37.2 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.203 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 78.6 m-20 -134.84 136.19 42.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.924 0.393 . . . . 0.0 111.043 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 28.6 tp -111.23 134.41 52.84 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.631 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.78 136.17 42.39 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.957 0.408 . . . . 0.0 110.553 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 52.8 m -123.66 140.47 52.96 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.6 t -121.68 129.56 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 120.871 0.367 . . . . 0.0 110.537 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 75.2 m -146.55 142.67 28.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.532 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.44 ' O ' ' NE2' ' A' ' 129' ' ' GLN . 16.7 p -106.0 151.8 24.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.805 0.335 . . . . 0.0 110.491 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -148.32 106.02 3.68 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.015 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 55.39 32.71 19.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.28 6.63 68.51 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -98.42 124.82 43.32 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.482 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.16 113.97 25.21 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 70.9 mt -120.02 126.5 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 89.6 m -122.68 132.26 54.18 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.295 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.56 111.15 22.19 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -114.6 133.98 55.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.962 0.411 . . . . 0.0 111.272 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 mp -129.87 144.33 51.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.426 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 82.5 p -134.98 134.04 40.11 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.763 0.316 . . . . 0.0 110.298 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.444 HG22 ' N ' ' A' ' 167' ' ' ALA . 20.7 m -152.98 159.33 42.91 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.676 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.444 ' N ' HG22 ' A' ' 166' ' ' THR . . . -56.78 141.42 44.38 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.227 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -66.18 -38.61 88.43 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.878 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -62.08 -33.38 74.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.298 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.531 ' O ' HG22 ' A' ' 174' ' ' VAL . 75.1 mtm180 -96.38 -17.28 20.73 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.243 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.583 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 46.6 t-105 -48.53 -41.42 30.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.732 0.301 . . . . 0.0 110.784 -179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -63.0 -41.46 99.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.932 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.1 m -66.14 -40.61 90.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.499 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.7 m -108.08 21.41 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.266 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 171' ' ' TRP . 49.3 pttt -49.19 -45.9 44.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.764 0.316 . . . . 0.0 111.38 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 83.8 p -67.91 -26.79 66.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.463 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.78 -45.35 86.11 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.922 -0.311 . . . . 0.0 110.926 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.583 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.1 m-85 -62.38 -49.73 74.36 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.244 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -62.35 -43.31 99.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.715 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.413 ' O ' ' OG ' ' A' ' 184' ' ' SER . 86.5 m -66.96 -50.62 61.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.824 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 76.1 t -67.49 -38.32 80.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.39 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.31 -36.67 82.86 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.055 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 17.7 t -85.02 -17.66 36.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.474 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 180' ' ' THR . 50.9 m -62.78 -36.13 82.11 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.388 -179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.451 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -58.66 148.82 27.8 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.39 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -138.71 160.18 40.28 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.4 m -128.18 151.66 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.952 0.406 . . . . 0.0 111.188 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.47 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 35.9 p90 . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.587 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.476 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.476 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 47.2 Cg_exo -54.35 -17.3 11.85 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.766 2.311 . . . . 0.0 111.951 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.672 HD12 ' N ' ' A' ' 21' ' ' LEU . 7.3 mp -82.48 139.19 34.08 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.355 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.29 -169.87 48.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.0 t -142.67 143.99 32.56 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.751 0.31 . . . . 0.0 110.543 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 40.1 m -90.04 115.38 27.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.229 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.75 -123.38 26.68 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.14 27.63 52.05 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -55.9 -36.09 42.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.785 0.326 . . . . 0.0 110.555 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.93 144.7 0.11 Allowed Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.56 HD13 ' N ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -67.45 -9.15 9.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.724 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.42 161.79 42.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.34 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 53.7 p -61.14 154.86 22.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.85 0.357 . . . . 0.0 110.562 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.2 mt -108.23 144.81 35.18 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.57 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.623 ' NE2' ' ND2' ' A' ' 48' ' ' ASN . 5.4 mp0 -106.83 159.07 16.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.581 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -128.27 138.87 52.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.352 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -129.56 136.29 49.63 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.943 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.7 p -144.3 157.77 44.1 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.78 0.324 . . . . 0.0 110.641 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -147.91 117.7 7.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.313 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.2 p -70.23 -31.96 69.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.354 . . . . 0.0 110.448 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -62.13 -48.68 79.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.065 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -88.24 -20.53 25.37 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.97 42.8 76.35 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.165 -0.54 . . . . 0.0 111.81 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.429 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -143.97 151.79 40.22 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 117.308 0.554 . . . . 0.0 110.629 179.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -154.84 144.49 21.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.966 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -149.55 157.38 43.22 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.859 0.361 . . . . 0.0 110.822 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 33' ' ' GLN . 8.5 tp -101.63 134.72 44.33 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.369 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -139.7 148.53 56.14 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -77.5 165.49 27.21 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.652 2.235 . . . . 0.0 112.945 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.623 ' ND2' ' NE2' ' A' ' 33' ' ' GLN . 70.3 m-80 -73.22 159.7 33.05 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.602 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.41 -5.11 62.5 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.404 ' HE1' ' CG ' ' A' ' 68' ' ' ASP . 41.5 m0 -93.45 143.83 25.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.725 0.297 . . . . 0.0 110.26 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.7 pt -122.17 147.49 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.701 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.85 132.53 11.0 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.5 t -112.33 133.76 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.929 0.395 . . . . 0.0 110.641 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -80.02 140.67 36.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.508 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.2 m -145.37 51.61 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.47 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -75.02 132.85 41.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.031 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.25 -3.36 84.11 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.45 -163.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.544 -0.328 . . . . 0.0 110.279 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.0 m -39.24 108.84 0.5 Allowed Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.68 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -45.51 136.55 11.96 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.569 1.512 . . . . 0.0 111.703 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.478 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 101.16 -31.91 8.1 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.51 129.22 28.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.125 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' OD2' HD12 ' A' ' 80' ' ' ILE . 55.7 t0 -100.24 -58.77 1.84 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.306 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.417 ' O ' HG22 ' A' ' 78' ' ' VAL . 65.1 t -150.13 149.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 111.152 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -118.71 135.72 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.4 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -112.08 138.69 48.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.298 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.3 ttt85 -131.01 129.83 42.56 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.302 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' CG ' ' HE1' ' A' ' 50' ' ' TRP . 60.4 t0 -87.58 118.26 26.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.559 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 mt -65.46 -37.79 87.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.58 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.5 mm -63.49 -43.96 98.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.46 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -124.74 97.8 5.44 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.459 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.2 mtt180 -60.47 -37.35 80.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.308 0.575 . . . . 0.0 109.769 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -58.48 -36.04 73.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.854 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -81.06 127.75 32.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.93 0.395 . . . . 0.0 110.311 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -156.01 165.15 37.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.528 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.427 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.3 pp -162.42 160.9 26.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.466 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.1 t -143.87 143.89 31.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.413 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.4 m -110.55 130.17 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.478 HG23 ' C ' ' A' ' 61' ' ' GLY . 25.5 mt -116.54 127.45 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.22 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.433 HD12 ' OD2' ' A' ' 63' ' ' ASP . 64.8 mt -118.23 127.95 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.968 0.413 . . . . 0.0 110.425 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.1 m -143.3 164.76 29.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.772 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -106.23 131.52 53.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.707 0.289 . . . . 0.0 110.293 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -94.08 150.32 38.26 Favored Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 87' ' ' LYS . 55.8 Cg_endo -70.75 137.49 32.69 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.739 1.626 . . . . 0.0 110.878 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.6 t -63.54 -29.17 70.47 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.371 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 87' ' ' LYS . 46.3 p30 -68.69 -29.29 67.71 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.599 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 99.1 mttt -132.03 144.89 51.09 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.025 0.44 . . . . 0.0 110.999 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 14.6 t -109.52 -179.8 3.92 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.31 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.6 tp -50.75 -44.63 58.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.82 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 33.2 p -66.27 -43.92 85.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.911 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -65.01 -38.92 92.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.924 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.2 tp -55.93 -43.15 77.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.504 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.75 173.86 43.58 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.405 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 36.1 p -91.72 171.61 9.04 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.08 -43.2 81.92 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.075 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.2 m -71.91 -44.21 64.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.925 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 94' ' ' THR . 45.8 t0 -61.43 -51.35 69.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.426 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.67 -38.53 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.573 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.78 -44.61 94.14 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -68.71 -43.08 76.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.101 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -61.37 -39.14 89.56 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.921 -0.311 . . . . 0.0 110.982 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -61.89 -40.65 96.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.526 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -59.22 -42.7 91.61 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.497 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 108' ' ' ASP . 2.2 mptm? -67.99 -42.74 80.32 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.398 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 59.0 m -57.02 -44.52 82.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.71 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.55 -43.67 71.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.956 0.408 . . . . 0.0 110.142 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.97 -31.68 72.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.037 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 104' ' ' LYS . 94.9 m-20 -42.39 -32.28 0.51 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.915 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -113.28 -33.32 6.0 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.537 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 114' ' ' ARG . 5.7 p -88.55 -6.36 57.62 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -55.92 -28.59 57.53 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.531 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -41.97 -63.74 1.67 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.009 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.1 p-10 -119.36 -45.01 2.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.025 0.44 . . . . 0.0 111.47 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.494 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 83.5 mtm180 -81.69 148.77 28.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.96 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -129.83 142.01 50.74 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.729 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.96 136.75 45.05 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.657 0.265 . . . . 0.0 110.51 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -122.71 128.91 51.17 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.6 tp -82.69 108.15 15.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.906 0.384 . . . . 0.0 110.325 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.0 mt -74.21 -43.35 50.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.536 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -164.38 164.84 22.03 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.281 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.72 114.44 3.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.207 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -139.03 170.51 15.85 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.63 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -142.62 151.0 41.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.765 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 71.2 mmt-85 -132.45 147.82 52.38 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.059 0.457 . . . . 0.0 111.016 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -114.51 114.63 26.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.561 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -138.22 142.53 39.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.918 0.389 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.7 t0 51.31 27.64 3.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.547 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.15 -2.37 84.51 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -100.37 146.95 26.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.055 0.455 . . . . 0.0 110.165 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.4 t -109.77 127.74 66.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.011 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.474 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 22.1 m-85 -116.88 126.77 53.49 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.841 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.4 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.69 126.4 51.73 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.7 m -108.43 122.15 46.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.214 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.6 mp -117.76 113.8 22.37 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.134 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -108.94 123.19 48.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.572 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -150.03 169.13 21.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.599 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -132.58 156.59 46.6 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.049 0.452 . . . . 0.0 110.837 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 48.7 t -106.38 129.75 59.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.167 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.16 135.81 54.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.043 0.449 . . . . 0.0 111.501 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.0 m -101.21 87.65 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 83.95 -106.02 2.82 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -112.79 7.49 18.5 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 111.488 0.181 . . . . 0.0 111.488 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -122.62 137.14 54.99 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.006 0.431 . . . . 0.0 111.585 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 144' ' ' VAL . 7.0 p -67.29 122.96 19.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.849 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -77.7 -56.17 4.74 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.343 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -169.57 169.58 8.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.783 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -103.49 134.87 46.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.075 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -129.71 137.76 50.76 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.042 0.448 . . . . 0.0 110.823 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.72 HD13 ' N ' ' A' ' 150' ' ' ALA . 3.2 tm? -111.99 138.78 48.16 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.707 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.72 ' N ' HD13 ' A' ' 149' ' ' LEU . . . -135.92 125.37 25.01 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.462 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t -118.34 124.46 47.81 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 44.6 t -110.61 128.91 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.902 0.382 . . . . 0.0 110.868 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 57.6 m -142.75 143.16 32.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.373 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.4 p -89.15 157.34 18.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.885 0.374 . . . . 0.0 110.596 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -150.26 93.97 2.07 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.602 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 57.91 33.61 23.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.583 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 93.16 3.8 65.11 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -101.6 137.59 39.71 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.787 0.327 . . . . 0.0 110.164 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.95 119.03 32.3 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.296 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.1 mt -119.36 126.63 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.5 m -126.27 137.22 53.49 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.817 0.342 . . . . 0.0 110.571 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.32 98.01 7.01 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.794 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -96.37 113.74 25.35 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.856 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.8 mp -116.13 140.58 49.14 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.439 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.5 t -133.1 132.76 42.08 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.141 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 11.1 m -152.42 158.99 43.43 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.489 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.413 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -52.73 141.34 21.39 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.342 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -67.8 -39.48 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -61.5 -33.38 73.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.343 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.444 ' O ' HG22 ' A' ' 174' ' ' VAL . 69.1 mtp180 -96.58 -17.27 20.56 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.17 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.523 ' O ' ' N ' ' A' ' 175' ' ' LYS . 52.2 t-105 -48.85 -40.08 28.13 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.931 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -61.22 -41.04 96.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.813 -0.355 . . . . 0.0 111.297 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 59.3 m -68.05 -38.92 83.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.629 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 170' ' ' ARG . 6.5 m -111.44 21.81 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.378 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 171' ' ' TRP . 11.1 ptmm? -51.26 -50.41 59.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 29.8 m -65.07 -28.97 69.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.656 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.5 tp -56.14 -44.16 78.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.253 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.51 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 26.2 m-85 -63.35 -51.05 67.55 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.352 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -63.58 -41.15 98.39 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.874 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 184' ' ' SER . 44.1 m -66.6 -48.83 68.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.051 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.4 t -62.43 -43.55 98.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.432 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.55 -41.34 98.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.362 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 84.2 p -79.22 -25.65 42.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.874 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 180' ' ' THR . 41.4 t -62.75 -31.01 71.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.028 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.527 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -55.9 158.17 3.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.103 0.477 . . . . 0.0 110.576 -179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.523 ' CD2' ' N ' ' A' ' 187' ' ' VAL . 6.0 t-160 -136.97 145.5 44.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.368 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.523 ' N ' ' CD2' ' A' ' 186' ' ' HIS . 6.8 m -122.27 147.96 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.449 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 35.5 p90 . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.722 -179.363 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.22 -22.21 73.79 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.724 2.283 . . . . 0.0 111.822 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.7 mt -59.89 -35.57 75.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.352 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.06 -169.24 47.94 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.9 t -148.45 18.38 1.05 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.845 0.355 . . . . 0.0 110.48 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.3 m -86.35 123.49 31.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.391 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -165.89 -179.93 39.74 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.45 3.57 78.02 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -121.12 135.87 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.803 0.335 . . . . 0.0 110.437 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -177.68 -174.11 43.74 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.761 -0.935 . . . . 0.0 110.761 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 29' ' ' ILE . 5.0 mp -86.21 80.22 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.01 166.44 6.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.9 m -107.98 154.54 21.48 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.865 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.58 152.42 47.66 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.029 0.442 . . . . 0.0 110.963 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.419 ' NE2' ' CB ' ' A' ' 48' ' ' ASN . 2.1 mp0 -106.73 146.19 31.13 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.008 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -117.42 131.0 56.83 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.738 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -115.3 134.43 55.13 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.487 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 94.2 p -145.35 153.06 40.83 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.947 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 36' ' ' SER . 97.9 m-20 -143.04 119.43 10.93 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.27 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.1 p -69.16 -33.9 74.12 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.272 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.84 -48.45 78.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.175 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -84.25 -20.64 31.88 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.958 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.9 42.06 93.04 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -143.97 149.1 36.23 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 117.175 0.488 . . . . 0.0 110.467 179.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -153.66 145.39 23.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.108 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -151.28 158.52 43.96 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 tp -104.24 135.01 46.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.402 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.422 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 14.7 p90 -136.88 143.78 43.94 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.859 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.87 150.7 2.51 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.819 1.679 . . . . 0.0 112.149 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.419 ' CB ' ' NE2' ' A' ' 33' ' ' GLN . 51.1 p-10 -79.87 160.67 25.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.497 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.6 4.69 60.52 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.1 m0 -92.38 147.57 22.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.851 0.358 . . . . 0.0 110.201 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.7 pt -116.5 144.44 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.415 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.33 133.49 11.4 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.0 t -108.22 133.67 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.823 0.344 . . . . 0.0 110.331 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -85.16 124.64 32.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.227 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 m -132.93 59.47 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.697 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -77.15 135.19 38.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.063 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.79 3.69 73.65 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.46 -164.4 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.492 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 m -45.93 154.38 0.58 Allowed Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.412 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.31 130.77 23.26 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.36 2.04 . . . . 0.0 111.855 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.482 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 96.47 -23.72 33.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.91 128.9 33.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.561 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -119.16 -57.88 1.98 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.749 -0.205 . . . . 0.0 111.502 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.2 t -143.49 141.66 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.884 0.373 . . . . 0.0 111.216 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.41 133.28 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.218 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -112.61 135.94 52.75 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.63 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.9 mtp180 -127.92 138.46 52.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.337 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -88.76 118.29 28.35 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.62 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 65.1 mt -66.37 -37.03 84.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.684 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.62 -42.43 91.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.486 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -122.36 99.72 6.57 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.58 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -62.59 -37.43 86.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.39 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -58.77 -35.05 72.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.753 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -81.62 131.29 35.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -140.1 139.19 35.78 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.994 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -126.26 135.26 51.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.071 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 t -128.02 139.41 52.57 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.84 126.55 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.961 0.41 . . . . 0.0 110.231 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.482 HG23 ' C ' ' A' ' 61' ' ' GLY . 26.2 mt -124.11 119.24 56.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.274 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 61' ' ' GLY . 33.4 mm -116.07 131.92 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.289 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.48 ' O ' ' N ' ' A' ' 159' ' ' LEU . 49.2 m -145.96 166.48 25.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.35 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -104.8 137.98 41.77 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.435 HG22 HD12 ' A' ' 159' ' ' LEU . 10.3 pt -93.51 149.32 37.04 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.656 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -45.38 134.96 12.22 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.641 1.561 . . . . 0.0 111.496 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.1 t -65.1 -26.75 68.35 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.307 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -85.11 -20.81 29.76 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -129.79 158.24 39.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.209 0.528 . . . . 0.0 111.863 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.426 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.9 t -122.69 175.65 6.39 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.468 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.5 tp -52.07 -45.06 64.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.017 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 p -66.01 -46.02 79.44 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.761 -0.375 . . . . 0.0 111.164 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.426 ' HB2' ' H ' ' A' ' 88' ' ' THR . 88.0 m-20 -66.79 -35.26 79.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.885 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.5 tp -55.83 -43.43 76.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.75 178.79 47.57 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 33.4 p -94.13 173.04 7.85 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.43 -41.56 76.61 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.15 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.3 m -72.53 -46.25 55.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.002 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' A' ' 94' ' ' THR . 44.4 t0 -61.64 -50.89 70.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.431 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.32 -38.27 80.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.694 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.73 -44.03 96.04 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -67.24 -42.61 83.66 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.665 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -61.45 -38.45 87.25 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.664 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -62.39 -41.61 98.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.38 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.55 -43.2 93.59 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.187 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -64.89 -38.51 91.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.35 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.9 m -58.56 -47.62 83.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.883 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.1 t -72.45 -46.41 56.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.052 0.453 . . . . 0.0 110.503 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.4 m-20 -60.82 -30.41 70.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.285 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -43.59 -38.93 3.23 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.329 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.29 -39.68 9.52 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.724 0.297 . . . . 0.0 111.624 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.463 ' C ' ' H ' ' A' ' 112' ' ' GLY . 8.9 p -86.13 -1.19 57.18 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.549 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.4 pt20 -58.39 -0.55 0.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.984 -0.286 . . . . 0.0 111.438 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -73.7 -64.37 2.49 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.134 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -118.42 -45.23 2.63 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.79 0.329 . . . . 0.0 111.46 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 110' ' ' SER . 69.9 mtm180 -85.24 144.81 27.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.481 -178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -123.98 143.85 50.16 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.796 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.85 132.38 45.23 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -114.11 128.81 56.54 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 39.0 tp -81.78 109.86 16.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.67 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.455 ' CG1' ' HE ' ' A' ' 137' ' ' ARG . 88.2 mt -74.09 -53.33 17.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.237 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.549 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 9.2 p30 -160.69 176.51 11.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.84 127.14 5.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.225 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 57.6 mp0 -141.43 159.35 42.41 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.701 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -140.29 147.77 40.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.941 0.4 . . . . 0.0 110.651 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -132.57 146.4 51.87 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.572 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -121.01 114.95 22.24 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.3 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -142.19 144.68 33.51 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.946 0.403 . . . . 0.0 110.921 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.6 t0 51.25 34.44 11.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.533 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.45 -0.24 55.73 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.288 -0.725 . . . . 0.0 111.288 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -101.85 146.87 27.21 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 120.988 0.423 . . . . 0.0 110.188 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.3 t -114.47 128.86 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.214 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -118.09 122.64 43.63 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.54 132.05 51.24 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 52.8 m -112.55 132.25 55.2 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.053 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.32 110.34 12.72 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.065 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.549 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 69.9 tt0 -104.19 122.95 46.43 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -147.47 170.07 18.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.306 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.455 ' HE ' ' CG1' ' A' ' 119' ' ' ILE . 18.7 ptp180 -138.14 161.26 37.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.946 0.403 . . . . 0.0 110.926 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 93.0 t -108.16 133.46 53.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.092 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.436 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.5 pp -136.4 135.47 38.76 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.149 0.5 . . . . 0.0 111.622 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.37 128.1 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.116 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.65 -118.2 13.68 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -109.66 9.27 25.03 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.87 -0.194 . . . . 0.0 110.949 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -114.93 143.85 44.5 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.854 0.359 . . . . 0.0 111.492 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 44.4 t -78.29 130.13 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.465 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.436 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 2.0 tm-20 -83.28 -54.68 4.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.443 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.614 HH21 ' CA ' ' A' ' 166' ' ' THR . 15.2 ptm180 -170.3 173.29 5.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.123 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.414 ' NE2' ' CZ ' ' A' ' 137' ' ' ARG . 50.7 m80 -105.49 142.81 34.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.128 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 13.5 t70 -139.88 150.75 44.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.022 0.439 . . . . 0.0 110.767 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.6 tp -125.49 136.32 53.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.041 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.02 119.81 19.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.847 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.1 t -106.03 138.36 42.35 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.35 130.06 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.908 0.385 . . . . 0.0 111.007 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 85.5 m -148.44 150.94 34.36 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.413 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 18.1 p -118.95 152.34 36.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.523 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -159.54 118.07 2.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.637 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 59.45 27.88 17.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.33 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.93 9.8 83.88 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -100.46 127.17 46.88 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.51 121.46 31.75 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.135 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.402 ' N ' HD23 ' A' ' 159' ' ' LEU . 77.4 mt -119.45 127.64 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.304 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 46.1 m -129.66 135.28 48.33 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.663 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.0 103.84 11.31 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.895 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -100.12 110.0 22.28 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.573 0.225 . . . . 0.0 110.432 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.432 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 5.3 mp -115.0 136.05 53.56 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.408 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.5 t -127.47 134.1 49.85 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.885 0.374 . . . . 0.0 110.546 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.614 ' CA ' HH21 ' A' ' 146' ' ' ARG . 9.5 m -152.53 154.9 36.38 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.611 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -57.14 144.29 35.5 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.547 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.431 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 1.2 pp20? -70.32 -30.55 67.56 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.024 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.431 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 92.5 m-20 -59.86 -33.9 72.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.957 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 174' ' ' VAL . 1.1 mpt_? -111.88 -5.3 14.38 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.501 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 52.4 t-105 -49.55 -39.17 33.74 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.786 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.42 -41.64 98.85 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.19 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.0 m -65.72 -39.87 91.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.699 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 170' ' ' ARG . 11.6 m -108.86 21.64 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.278 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 171' ' ' TRP . 10.2 ptmm? -51.38 -50.0 60.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.392 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.1 t -64.92 -30.7 71.71 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.17 -44.16 74.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.303 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.501 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 27.9 m-85 -60.95 -49.83 75.84 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.308 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -64.59 -38.91 92.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.492 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 42.7 m -65.38 -49.01 70.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.476 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.8 t -61.29 -45.16 99.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.659 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.459 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -64.85 -42.18 95.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.909 0.385 . . . . 0.0 110.371 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 21.2 t -73.87 -31.47 63.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.231 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 91.7 p -63.12 -24.13 67.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.308 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -57.34 156.11 8.13 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.498 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -136.0 156.75 48.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.522 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.6 m -126.82 151.42 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.831 0.348 . . . . 0.0 111.107 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.519 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 38.3 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.736 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.475 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 37.5 Cg_endo -64.55 147.21 90.23 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.919 2.413 . . . . 0.0 112.079 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.861 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -130.65 170.84 13.77 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.323 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.23 -178.09 51.47 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 86.9 p -141.6 156.13 45.7 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.834 0.349 . . . . 0.0 110.576 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 72.7 m -63.03 -36.35 83.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.733 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -179.46 -172.13 43.26 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -154.56 -123.73 0.89 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.811 -0.915 . . . . 0.0 110.811 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.7 p -131.13 142.89 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.722 0.296 . . . . 0.0 110.333 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -79.09 -91.87 0.37 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.9 pt -128.71 168.39 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.01 0.433 . . . . 0.0 111.143 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' HB3' HD21 ' A' ' 48' ' ' ASN . . . -114.54 -85.85 0.6 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.347 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.0 m -124.29 144.43 49.99 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.529 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 62.9 mt -101.28 144.12 30.52 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.377 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.501 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 20.5 mp0 -108.42 154.26 22.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.497 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -125.96 143.71 50.98 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.312 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -130.07 139.87 50.91 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.046 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 12.6 t -149.75 148.57 29.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.926 0.393 . . . . 0.0 110.63 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -137.89 121.45 17.29 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.481 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.5 p -70.98 -33.22 70.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.504 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -61.93 -48.25 81.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.028 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -88.6 -20.47 24.94 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.784 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.84 42.02 93.18 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.489 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.73 150.72 42.18 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 117.153 0.477 . . . . 0.0 110.662 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -149.67 147.15 27.74 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.717 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.462 ' C ' HD22 ' A' ' 45' ' ' LEU . 48.3 p90 -146.75 154.86 41.89 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.935 0.398 . . . . 0.0 110.983 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.651 ' N ' HD22 ' A' ' 45' ' ' LEU . 3.1 mm? -98.02 141.66 30.7 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.101 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -151.31 146.84 19.42 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.317 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.12 160.02 51.09 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 122.455 2.103 . . . . 0.0 112.347 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.405 HD21 ' HB3' ' A' ' 30' ' ' ALA . 27.1 p30 -69.83 160.81 31.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.709 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.18 0.28 57.14 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.528 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 32.6 m0 -91.22 141.3 28.95 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.425 HD13 ' N ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -115.68 128.37 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.999 0.428 . . . . 0.0 110.141 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.53 137.33 13.21 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.9 m -128.52 141.75 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.72 0.295 . . . . 0.0 110.57 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -88.17 122.61 31.93 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.05 0.452 . . . . 0.0 110.413 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 m -121.56 32.07 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.676 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -50.09 136.82 18.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.94 4.1 69.64 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.11 -164.33 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.636 0.255 . . . . 0.0 110.541 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.1 m -46.36 137.08 6.93 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.65 130.47 9.61 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.708 1.606 . . . . 0.0 112.717 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.465 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 96.0 -33.15 5.76 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.451 ' N ' HG23 ' A' ' 79' ' ' ILE . 92.0 t -62.31 125.43 18.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.916 -0.313 . . . . 0.0 110.273 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -119.78 -57.22 1.98 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.68 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 38.7 t -136.32 142.03 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.082 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.01 132.97 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.419 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 76' ' ' LEU . 90.7 m-85 -112.78 133.19 54.91 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.263 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -124.82 140.93 52.48 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.443 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 81.9 m-20 -88.36 118.76 28.2 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.546 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 tp -67.35 -40.87 85.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.47 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.8 mt -61.62 -43.43 97.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.017 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -117.34 121.2 40.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.928 0.394 . . . . 0.0 110.371 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -80.95 -37.55 29.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.634 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 41.1 p-10 -62.57 -31.32 72.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.959 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 85.3 tt0 -85.89 131.3 34.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.939 0.399 . . . . 0.0 110.787 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -142.31 139.6 31.88 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.144 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PHE . 7.5 tt -123.78 134.81 53.58 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.7 t -128.74 138.91 52.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.559 -0.292 . . . . 0.0 110.334 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -113.18 123.82 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.465 HG23 ' C ' ' A' ' 61' ' ' GLY . 12.4 mt -125.77 120.54 57.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.195 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.4 mt -121.1 132.64 70.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.172 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.4 m -136.15 164.7 27.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.47 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -103.73 135.36 45.43 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.504 ' CG2' HD12 ' A' ' 159' ' ' LEU . 9.6 pt -102.23 150.21 37.31 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.943 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -44.51 145.37 2.63 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 121.841 1.694 . . . . 0.0 111.222 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.6 p -80.08 -13.91 58.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.598 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -96.35 -20.93 18.12 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.765 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -124.06 157.14 35.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.099 0.476 . . . . 0.0 111.385 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.408 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.5 t -122.66 177.82 5.28 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.612 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.9 tp -51.66 -45.43 63.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.061 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.2 p -64.42 -44.55 90.87 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.098 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.2 m-20 -65.76 -38.12 88.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.968 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.4 tp -56.23 -43.85 79.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.701 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.86 176.52 45.93 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.418 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 39.8 p -94.86 171.11 8.97 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.632 -0.506 . . . . 0.0 109.632 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.91 -41.6 78.42 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.126 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 49.2 m -72.03 -44.93 62.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.747 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.418 ' HB3' ' H ' ' A' ' 94' ' ' THR . 16.4 t70 -61.84 -51.78 66.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.409 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.16 -38.01 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.668 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.33 -47.21 90.98 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -67.53 -41.63 84.05 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -62.35 -40.79 97.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.981 0.42 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -61.67 -41.3 97.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.857 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -58.99 -45.46 90.56 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.661 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -64.35 -43.01 95.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.873 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.1 m -60.85 -47.04 88.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.879 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.1 t -71.87 -46.11 61.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.602 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.608 ' O ' ' N ' ' A' ' 111' ' ' GLN . 91.7 m-20 -61.43 -39.57 91.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.632 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -46.61 -36.25 6.74 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.533 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.87 -45.36 89.78 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.885 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 114' ' ' ARG . 8.6 m -123.7 22.18 9.08 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.608 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.6 tt0 -52.53 -28.48 20.88 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.673 0.273 . . . . 0.0 111.452 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.86 -62.1 2.75 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.138 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -117.74 -40.51 3.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.929 0.365 . . . . 0.0 111.681 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 110' ' ' SER . 52.6 ttp180 -92.09 146.2 23.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.046 0.451 . . . . 0.0 110.904 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -143.76 151.63 40.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.517 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.463 ' HB3' ' OD1' ' A' ' 107' ' ' ASN . . . -103.04 139.85 38.05 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.569 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -113.18 130.8 56.1 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.497 ' C ' HD23 ' A' ' 118' ' ' LEU . 3.5 tt -81.21 106.01 12.86 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.082 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 83.7 mt -70.8 -51.06 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.378 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.549 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 7.5 p30 -160.66 173.91 14.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.953 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.1 122.92 4.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.189 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -142.09 159.56 41.99 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.689 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.42 147.83 43.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.524 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.7 141.55 47.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.705 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -110.61 112.81 24.96 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.393 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -137.59 144.33 41.94 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.97 0.414 . . . . 0.0 110.76 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.3 t0 50.98 33.28 8.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.35 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.84 0.97 61.08 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -104.05 146.94 27.99 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.978 0.418 . . . . 0.0 110.252 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.05 128.53 69.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.142 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 27.8 m-85 -118.06 124.47 48.18 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.853 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.62 128.13 50.95 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.0 m -109.02 122.25 46.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.201 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 5.8 mp -118.36 112.74 20.41 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.102 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.549 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 60.7 tt0 -106.46 123.96 48.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.426 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -148.94 169.66 20.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.499 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -135.85 156.3 49.0 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.76 0.314 . . . . 0.0 110.541 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.1 m -102.89 125.78 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.993 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 144' ' ' VAL . 6.7 mt -107.75 123.35 48.41 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 86.5 t -117.31 130.36 72.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 65.66 -122.27 22.02 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 88.4 m-20 -116.33 21.95 13.21 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.982 -0.128 . . . . 0.0 111.217 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.402 ' OD1' ' O ' ' A' ' 142' ' ' ASP . 78.2 m-20 -144.1 161.87 37.72 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.893 0.377 . . . . 0.0 111.17 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 144' ' ' VAL . 7.8 p -79.49 120.46 30.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -69.98 -51.77 29.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.06 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -173.56 171.37 3.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.083 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -104.83 140.91 37.42 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.07 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 164' ' ' LEU . 18.0 t70 -133.61 150.86 51.6 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.144 0.497 . . . . 0.0 110.543 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.73 HD13 ' N ' ' A' ' 150' ' ' ALA . 3.2 tm? -125.97 138.58 53.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.578 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.73 ' N ' HD13 ' A' ' 149' ' ' LEU . . . -136.54 117.47 14.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.356 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t -104.1 126.22 51.05 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 26.5 t -112.45 129.02 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.902 0.382 . . . . 0.0 110.918 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.7 m -145.02 148.03 33.27 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.244 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 p -109.64 143.48 39.32 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.922 0.391 . . . . 0.0 110.551 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -152.64 112.97 4.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.152 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 62.44 33.45 16.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.035 0.445 . . . . 0.0 110.507 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.65 11.57 84.59 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -109.34 131.59 54.92 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.721 0.296 . . . . 0.0 110.597 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.504 HD12 ' CG2' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -87.75 120.36 28.99 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.5 mm -108.8 124.86 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.6 m -127.25 132.31 50.4 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.9 0.381 . . . . 0.0 110.792 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.83 99.71 7.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.56 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -98.03 111.69 23.91 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.654 0.264 . . . . 0.0 110.572 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 164' ' ' LEU . 5.4 mp -116.91 136.9 52.59 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.28 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.2 m -126.56 136.19 52.23 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.858 0.361 . . . . 0.0 110.592 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.4 m -152.87 155.69 37.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.283 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -55.24 143.57 27.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.093 0.473 . . . . 0.0 111.197 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -71.19 -28.77 64.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.028 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -59.11 -34.28 71.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.232 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.416 ' O ' HG22 ' A' ' 174' ' ' VAL . 89.6 mtt-85 -114.62 -3.07 12.94 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.482 ' CE3' ' CE2' ' A' ' 178' ' ' PHE . 50.3 t-105 -49.79 -38.21 33.37 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.851 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -61.58 -41.83 97.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.263 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 52.6 m -66.84 -39.2 87.56 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.79 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 170' ' ' ARG . 8.2 m -108.4 21.32 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.294 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 176' ' ' SER . 19.4 ptmt -52.03 -49.73 62.84 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.862 -0.335 . . . . 0.0 111.331 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.41 ' N ' ' CG ' ' A' ' 175' ' ' LYS . 25.0 t -65.67 -29.41 69.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.358 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 tt -54.76 -45.69 74.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.036 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.482 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 25.7 m-85 -61.9 -49.78 74.84 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.53 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -64.03 -38.39 90.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.478 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 39.2 m -64.33 -47.95 77.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.353 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t -61.07 -45.08 99.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.624 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.47 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.45 -44.42 94.55 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.208 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.5 t -71.31 -32.76 69.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.1 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 95.3 p -63.1 -24.82 68.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.196 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -56.4 156.96 5.39 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.332 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -134.76 153.3 52.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 19.4 m -126.47 148.79 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.808 0.337 . . . . 0.0 111.115 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.676 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.77 150.31 88.53 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.795 2.33 . . . . 0.0 111.841 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.6 mt -84.21 145.41 28.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.328 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.13 32.98 33.91 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -56.39 -33.06 65.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.951 0.405 . . . . 0.0 110.645 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.9 p -150.61 19.01 0.82 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.24 -128.31 30.63 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -171.82 -102.5 0.16 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.4 p -129.78 143.32 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 120.859 0.362 . . . . 0.0 110.422 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -80.91 -169.56 41.54 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.009 -0.837 . . . . 0.0 111.009 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 30' ' ' ALA . 35.0 pt -76.4 141.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 110.66 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 29' ' ' ILE . . . -52.68 -107.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.942 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.6 m -122.8 146.92 47.1 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.31 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.4 mt -66.89 148.67 51.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.125 0.488 . . . . 0.0 110.798 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.482 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 1.7 pm0 -127.54 164.77 21.23 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.861 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 33.2 ptt-85 -125.61 144.38 50.61 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.815 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -122.2 133.22 54.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.797 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.446 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 92.4 p -145.63 153.48 41.08 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.867 0.365 . . . . 0.0 110.795 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 36' ' ' SER . 99.9 m-20 -143.06 113.23 7.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.278 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 55.0 p -65.43 -32.96 74.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.886 0.374 . . . . 0.0 110.075 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -62.24 -45.19 94.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -89.36 -20.47 23.96 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.09 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.72 40.63 90.0 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.45 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -143.48 150.81 39.51 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 117.286 0.543 . . . . 0.0 110.443 179.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -156.73 146.35 20.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.113 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -155.57 158.27 38.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.127 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.2 mt -95.03 154.14 17.31 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.684 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.46 ' N ' ' CD1' ' A' ' 46' ' ' TYR . 13.0 p90 -156.85 142.94 12.98 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.53 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.9 153.83 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.993 1.795 . . . . 0.0 112.462 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 49' ' ' GLY . 32.4 t-20 -81.44 157.15 25.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.426 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.441 ' N ' ' OD1' ' A' ' 48' ' ' ASN . . . 92.64 6.79 63.69 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.539 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 30.5 m0 -89.16 149.13 23.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.851 0.357 . . . . 0.0 110.262 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.5 pt -117.26 145.69 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.366 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.16 128.75 9.01 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.0 t -113.9 132.99 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.858 0.361 . . . . 0.0 110.462 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -81.59 134.26 35.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.288 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.6 m -129.31 55.2 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.42 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -73.33 136.02 44.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.229 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.15 69.26 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.79 -164.32 0.5 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.708 0.29 . . . . 0.0 110.484 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.63 158.15 0.88 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.181 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.33 128.8 20.08 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.442 2.095 . . . . 0.0 111.922 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.52 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 97.14 -24.05 33.02 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t -63.49 130.63 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -119.19 -58.75 1.91 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.682 -0.235 . . . . 0.0 111.537 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 95.2 t -151.45 151.44 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 120.753 0.311 . . . . 0.0 111.143 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.26 144.27 33.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.264 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.454 ' HB2' HD11 ' A' ' 76' ' ' LEU . 84.8 m-85 -112.77 134.64 54.19 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.448 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.31 141.04 52.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.413 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.539 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 45.8 m-20 -89.28 118.99 29.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.587 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.67 -40.02 91.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.577 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.6 mm -61.86 -46.97 95.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.682 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -122.8 103.81 8.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.973 0.416 . . . . 0.0 110.413 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.43 -38.38 83.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.263 0.554 . . . . 0.0 110.007 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -58.53 -36.37 73.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.901 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -82.83 125.9 31.84 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.932 0.396 . . . . 0.0 110.454 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -161.01 174.05 14.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.524 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.601 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.3 pp -159.98 158.76 31.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.1 t -127.68 139.36 52.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.22 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.3 t -111.15 123.71 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.86 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.52 HG23 ' C ' ' A' ' 61' ' ' GLY . 51.4 mt -121.59 124.86 72.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.962 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 61' ' ' GLY . 76.3 mt -122.91 131.89 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.81 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.473 ' O ' ' N ' ' A' ' 159' ' ' LEU . 51.1 m -146.06 166.97 24.52 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.086 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 2.0 pm0 -106.14 132.44 52.21 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 110.019 -0.364 . . . . 0.0 110.019 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 83' ' ' ILE . 8.8 pt -88.75 148.93 42.77 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.506 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.71 136.68 43.07 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 121.629 1.553 . . . . 0.0 110.866 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -61.17 -27.15 68.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.947 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -67.8 -30.9 70.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.134 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -130.14 150.5 51.37 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.221 0.534 . . . . 0.0 111.576 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.476 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 81.4 p -112.6 174.87 5.68 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.713 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 53.6 tp -56.85 -41.2 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.01 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 71.3 p -69.82 -44.32 70.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.418 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.476 ' HB3' ' H ' ' A' ' 88' ' ' THR . 44.4 t0 -64.28 -34.81 78.99 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.532 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.439 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -54.92 -52.14 63.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.214 -179.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.56 179.04 47.6 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.8 p -88.09 170.64 10.9 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.51 -41.88 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.836 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.3 m -72.14 -44.1 63.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.748 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -61.71 -52.88 62.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.35 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.3 t -61.1 -38.6 79.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.678 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.99 -43.98 94.75 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -67.14 -41.65 85.71 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.82 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.4 mmt85 -61.87 -38.95 90.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.665 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -62.29 -40.84 97.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.655 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.6 mmt -58.12 -45.68 86.86 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.499 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -65.29 -43.03 92.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 58.4 m -60.79 -45.67 93.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.945 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.7 t -69.56 -47.99 68.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.636 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.643 ' O ' ' N ' ' A' ' 111' ' ' GLN . 93.5 m-20 -62.6 -37.58 86.8 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.676 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -44.26 -37.0 2.98 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.309 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.38 -47.26 70.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.135 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.3 m -123.71 23.22 8.83 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.643 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.8 tt0 -50.32 -28.83 8.55 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.579 0.228 . . . . 0.0 111.328 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.67 -61.39 2.95 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.083 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -117.08 -35.94 3.94 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.929 0.364 . . . . 0.0 111.933 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -83.98 137.55 33.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.962 0.41 . . . . 0.0 111.266 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -129.13 139.9 51.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.959 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.54 135.15 44.68 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.333 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -114.51 125.18 53.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.182 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.535 ' C ' HD23 ' A' ' 118' ' ' LEU . 3.8 tt -84.58 109.83 18.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.252 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.518 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.9 mt -74.6 -53.84 15.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.683 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 27.7 m120 -155.08 164.41 38.9 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.728 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.83 115.79 3.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.486 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -139.76 170.52 15.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.882 0.372 . . . . 0.0 110.69 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.401 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -141.28 150.52 42.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.645 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -132.45 139.07 47.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.915 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -108.46 114.19 27.83 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.452 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.94 142.98 34.31 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.96 0.41 . . . . 0.0 110.782 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 51.67 37.37 19.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.282 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.85 0.77 35.41 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -104.46 147.87 27.08 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.897 0.38 . . . . 0.0 110.115 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.8 t -114.71 128.56 71.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.108 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -117.16 126.83 53.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.822 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.3 m-85 -104.41 126.3 51.38 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.408 ' C ' HD12 ' A' ' 134' ' ' LEU . 89.9 m -109.26 122.66 47.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.055 0.455 . . . . 0.0 110.321 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 133' ' ' THR . 8.3 mp -116.78 122.22 43.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.826 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -116.77 119.45 35.49 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -148.97 167.32 26.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.589 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -135.53 152.93 51.78 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.927 0.394 . . . . 0.0 110.635 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.3 m -105.86 136.03 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.909 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.45 137.08 38.36 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.173 0.511 . . . . 0.0 111.2 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.25 133.35 60.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.393 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.42 -119.19 11.0 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -116.53 15.28 15.61 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.851 -0.205 . . . . 0.0 111.174 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -129.03 153.86 47.19 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.896 0.379 . . . . 0.0 110.965 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 144' ' ' VAL . 14.9 p -86.85 127.42 40.46 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.377 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -74.89 -52.22 11.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.631 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -174.55 173.9 2.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.087 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -109.2 137.31 47.28 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.163 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -130.87 142.65 50.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.884 0.373 . . . . 0.0 110.942 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.2 tp -114.4 131.28 56.63 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.03 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -125.38 130.81 52.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.965 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.4 t -124.31 126.95 46.9 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 48.0 t -113.04 127.87 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.955 0.407 . . . . 0.0 111.101 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.8 m -141.31 139.4 33.62 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.108 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.1 p -103.27 150.25 23.92 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.799 0.333 . . . . 0.0 110.342 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -149.14 106.07 3.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.006 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 57.04 30.89 18.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.814 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 91.06 5.22 68.12 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -95.61 123.56 39.22 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.06 118.0 28.47 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.76 126.68 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.863 0.364 . . . . 0.0 110.463 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.1 m -126.92 137.61 53.16 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.085 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.6 98.72 6.69 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.247 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -95.87 112.4 24.13 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.651 0.262 . . . . 0.0 110.58 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.6 mp -115.0 138.99 50.22 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.502 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 81.8 p -132.65 133.83 44.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.221 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.45 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 15.6 m -152.82 161.13 42.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.568 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.45 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -54.99 140.73 36.56 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.013 0.435 . . . . 0.0 111.181 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -67.66 -39.06 84.55 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 170' ' ' ARG . 37.8 p-10 -63.87 -32.58 74.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.164 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.525 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 15.1 tpt180 -94.65 -19.53 20.36 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.71 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.542 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 50.5 t-105 -47.95 -41.08 24.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.213 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.43 -42.09 98.2 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.172 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 46.9 m -66.68 -40.32 88.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.559 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 170' ' ' ARG . 11.2 m -108.77 21.48 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.332 -179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 171' ' ' TRP . 11.1 ptmm? -50.43 -49.81 53.78 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.284 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 22.2 m -64.86 -29.72 70.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.661 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 tp -55.5 -44.49 76.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.368 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.542 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 25.3 m-85 -62.55 -50.29 71.91 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.308 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -63.22 -41.31 99.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.757 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 184' ' ' SER . 45.2 m -66.65 -49.04 67.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.056 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 68.7 t -62.7 -43.85 98.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.457 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.509 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -64.63 -39.65 94.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.424 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 t -80.2 -28.18 38.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.144 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 180' ' ' THR . 67.4 m -62.43 -30.97 71.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.385 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.509 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -55.22 156.8 3.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.468 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.9 t60 -139.25 160.65 39.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.621 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 14.1 m -128.41 150.21 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 111.035 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 39.5 p90 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.689 179.747 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.17 144.06 91.27 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.705 2.27 . . . . 0.0 111.833 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.544 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.7 mm? -63.8 -34.82 78.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.215 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.45 118.79 0.11 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.5 t -147.4 150.82 35.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.822 0.344 . . . . 0.0 110.433 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.1 m -80.0 108.44 13.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.384 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.89 -33.58 63.85 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.79 -179.61 52.76 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -174.12 -20.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.88 0.372 . . . . 0.0 110.548 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.26 107.96 0.01 OUTLIER Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.6 mt -59.76 -36.24 64.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.728 0.299 . . . . 0.0 110.708 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.79 66.11 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.761 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 m -136.98 21.52 3.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.491 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.445 ' O ' ' OE1' ' A' ' 33' ' ' GLN . 55.9 mt -112.8 137.14 51.57 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.804 0.335 . . . . 0.0 110.825 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.549 ' NE2' ' OD1' ' A' ' 48' ' ' ASN . 1.8 mp0 -110.16 156.64 20.34 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.416 ' H ' ' HD2' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -120.77 140.56 51.52 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.384 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -125.03 135.36 52.68 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.037 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 t -146.02 147.89 32.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.903 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -138.37 118.35 13.37 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 68.9 p -70.99 -31.44 67.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.896 0.379 . . . . 0.0 110.247 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -62.29 -49.8 74.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.979 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -86.2 -20.61 28.29 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.884 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.37 40.24 80.26 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.83 149.91 39.21 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 117.219 0.509 . . . . 0.0 110.705 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -151.06 144.44 24.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.713 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -151.12 159.48 44.45 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.048 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.8 mt -100.2 151.28 21.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.394 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' A' ' 46' ' ' TYR . 11.2 p90 -150.91 146.74 19.62 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.535 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.24 161.36 44.73 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.441 2.094 . . . . 0.0 112.483 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.549 ' OD1' ' NE2' ' A' ' 33' ' ' GLN . 52.7 m-20 -73.5 159.29 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.553 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.9 -2.18 63.91 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -93.67 144.53 25.31 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 pt -118.47 141.78 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.309 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.84 133.67 11.48 Favored Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.532 HG21 ' NH1' ' A' ' 67' ' ' ARG . 22.8 t -111.68 133.19 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.924 0.392 . . . . 0.0 110.745 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -83.45 138.86 33.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.201 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 m -147.69 54.14 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.152 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -78.29 129.21 34.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.645 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.95 -4.52 75.1 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.21 -162.89 0.44 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.518 -0.341 . . . . 0.0 110.141 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.0 m -36.79 111.19 0.5 Allowed Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.815 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -45.2 134.47 11.59 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.752 1.635 . . . . 0.0 112.101 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.489 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 101.91 -35.97 4.57 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 87.1 t -63.28 134.32 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -115.48 -58.43 2.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.236 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.6 t -143.46 143.38 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.798 0.333 . . . . 0.0 111.113 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.487 HG11 ' NH2' ' A' ' 67' ' ' ARG . 44.2 t -120.35 131.75 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.417 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -112.81 133.39 54.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.418 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.532 ' NH1' HG21 ' A' ' 53' ' ' VAL . 73.5 mtt85 -131.56 138.91 49.08 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.54 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -87.4 118.73 27.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.358 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 tp -61.41 -38.97 89.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.534 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.4 mm -61.62 -48.44 88.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.68 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.467 ' CD ' HH12 ' A' ' 170' ' ' ARG . 96.0 mt-10 -126.85 102.71 7.14 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.971 0.415 . . . . 0.0 110.568 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -69.56 -25.49 64.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.976 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -57.85 -38.97 76.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.204 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -98.29 139.59 33.84 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.718 0.294 . . . . 0.0 110.381 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.87 147.65 18.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.001 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.1 tt -115.11 134.7 54.94 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.193 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.1 t -131.8 144.47 50.94 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.33 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -122.44 132.5 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.072 0.463 . . . . 0.0 110.493 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.489 HG23 ' C ' ' A' ' 61' ' ' GLY . 28.0 mt -120.95 126.06 74.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.684 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.86 130.83 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.851 0.358 . . . . 0.0 110.486 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.9 m -139.63 161.96 36.25 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.953 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -105.44 132.54 51.49 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.738 0.304 . . . . 0.0 110.369 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -96.22 150.54 37.3 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.361 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.43 137.94 31.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.018 1.812 . . . . 0.0 111.045 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.7 t -63.28 -28.2 69.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.074 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.67 -31.14 70.92 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -129.97 158.41 39.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.139 0.495 . . . . 0.0 111.599 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.449 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.8 t -122.6 176.34 5.98 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.449 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.8 tp -52.36 -44.72 65.39 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.179 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.9 p -66.13 -45.59 80.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.92 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.449 ' HB2' ' H ' ' A' ' 88' ' ' THR . 86.4 m-20 -67.56 -35.44 79.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.737 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.0 tp -55.88 -42.09 75.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.5 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.95 175.79 45.41 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.415 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 38.0 p -93.93 171.19 9.02 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.09 -42.01 76.06 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.186 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 87.0 m -72.39 -44.93 61.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.029 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.415 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.3 t0 -62.1 -51.24 68.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.45 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.94 -38.76 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.558 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.5 -45.91 93.86 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.031 -0.827 . . . . 0.0 111.031 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -66.03 -41.21 91.22 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.642 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -62.29 -38.56 89.82 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.685 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -62.41 -41.46 98.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.46 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.1 mmt -58.81 -44.41 90.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.949 0.404 . . . . 0.0 110.34 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -64.97 -39.87 94.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.495 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 46.0 m -59.48 -47.26 86.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.857 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 95.6 t -71.59 -45.61 66.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.993 0.425 . . . . 0.0 110.331 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.465 ' O ' ' N ' ' A' ' 111' ' ' GLN . 86.6 m-20 -62.06 -31.96 72.43 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.277 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -42.61 -36.15 1.3 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.219 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -106.82 -16.25 14.52 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.016 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.503 ' C ' ' H ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -101.48 -3.33 28.77 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 107' ' ' ASN . 32.7 tt0 -67.12 13.84 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.961 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -84.99 -64.25 1.55 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.208 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.2 p-10 -118.59 -39.06 3.03 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.53 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 20.2 ptp180 -101.43 159.79 14.98 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.01 0.433 . . . . 0.0 111.24 -178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -130.0 150.24 51.37 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.518 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.411 ' HB3' ' OD1' ' A' ' 107' ' ' ASN . . . -104.25 138.28 40.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.15 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -123.44 130.32 52.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.536 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.1 tt -84.13 108.88 17.3 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.014 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.417 ' N ' HD23 ' A' ' 118' ' ' LEU . 96.6 mt -71.12 -54.95 15.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.783 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.55 ' ND2' ' OE1' ' A' ' 135' ' ' GLU . 11.4 p30 -156.65 176.78 12.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.976 0.417 . . . . 0.0 111.122 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.6 128.4 6.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.327 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -142.07 160.74 39.61 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.505 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -137.29 144.68 42.78 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.904 0.383 . . . . 0.0 110.47 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -131.94 152.46 51.08 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -124.91 116.34 22.04 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.562 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -141.87 144.5 33.87 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.013 0.435 . . . . 0.0 110.825 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.1 t0 52.29 28.99 6.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.58 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 79.96 -1.79 77.86 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 18.1 mm100 -100.83 146.6 27.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.874 0.369 . . . . 0.0 110.263 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.8 129.72 65.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.159 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -118.45 123.65 45.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.322 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.63 124.2 48.39 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 58.3 m -102.76 133.12 48.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.822 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.91 108.0 9.8 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.963 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.55 ' OE1' ' ND2' ' A' ' 120' ' ' ASN . 70.6 tt0 -100.12 126.17 46.32 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -148.22 168.74 21.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.159 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -137.77 160.0 40.46 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.479 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.51 133.73 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.461 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.453 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 3.0 pp -134.06 143.86 48.3 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.335 0.588 . . . . 0.0 111.1 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 140' ' ' VAL . 14.5 p -108.54 133.29 54.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.248 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 51.75 -108.34 0.6 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -116.96 12.53 14.67 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.357 0.132 . . . . 0.0 111.357 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -119.13 146.15 45.37 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.858 0.361 . . . . 0.0 111.704 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.8 t -76.6 128.28 37.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.816 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 70.5 tt0 -83.48 -53.51 5.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.823 0.344 . . . . 0.0 110.406 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.474 ' HE ' ' HG ' ' A' ' 165' ' ' SER . 6.5 ptm85 -172.64 171.99 4.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.424 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 63.7 m80 -108.89 137.44 46.8 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.256 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 84.4 m-20 -135.85 141.4 44.65 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.9 0.381 . . . . 0.0 110.865 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 57.7 tp -116.49 136.71 52.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.905 -0.588 . . . . 0.0 109.986 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.87 132.82 39.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.938 0.399 . . . . 0.0 110.56 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.8 t -119.08 135.75 54.49 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.692 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.87 130.16 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 120.963 0.411 . . . . 0.0 110.542 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 59.8 m -148.86 146.26 27.86 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.84 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.3 p -90.7 156.63 17.95 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.579 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.461 ' N ' ' O ' ' A' ' 158' ' ' LYS . 9.1 t-20 -150.87 95.9 2.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.787 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 55.65 39.24 30.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.8 7.57 77.98 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.071 -0.811 . . . . 0.0 111.071 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 155' ' ' ASN . 68.9 mmtt -110.61 137.73 47.91 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 110.017 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.24 117.46 26.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.816 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.1 mm -107.92 119.97 58.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.1 m -120.49 132.22 55.1 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.814 0.34 . . . . 0.0 110.185 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.01 103.95 11.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.622 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -103.37 120.19 40.32 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.899 0.38 . . . . 0.0 111.562 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 mp -115.58 142.92 46.08 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.083 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.474 ' HG ' ' HE ' ' A' ' 146' ' ' ARG . 31.1 t -137.06 131.95 33.48 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.432 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 167' ' ' ALA . 21.3 m -152.87 159.06 42.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.696 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.447 ' N ' HG22 ' A' ' 166' ' ' THR . . . -54.31 145.41 17.89 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.155 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -71.28 -36.68 71.78 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.8 -33.14 75.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.183 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.544 ' O ' HG22 ' A' ' 174' ' ' VAL . 80.1 mtp180 -97.53 -16.69 19.98 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.515 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.604 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 48.4 t-105 -48.03 -41.73 26.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.822 0.344 . . . . 0.0 110.691 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -63.38 -41.69 98.8 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.062 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 47.3 m -65.68 -40.39 92.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.382 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 170' ' ' ARG . 7.9 m -107.2 21.51 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 171' ' ' TRP . 20.8 pttm -48.94 -45.38 41.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.412 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 86.7 p -67.89 -27.49 66.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.574 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.5 tp -57.63 -44.61 85.7 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.917 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.604 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.4 m-85 -62.29 -50.01 73.4 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.388 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -62.24 -41.53 98.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.665 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 63.8 m -68.75 -49.62 57.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.4 -38.55 79.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.348 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.89 -40.55 97.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.294 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 83.2 p -80.96 -17.77 49.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.346 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -62.77 -37.76 87.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.193 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.481 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -54.29 146.09 16.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.771 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -135.91 154.95 50.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.6 m -127.22 151.56 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.903 0.382 . . . . 0.0 111.336 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 43.5 p90 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.768 -179.731 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.498 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 31.7 Cg_endo -62.65 147.02 95.33 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.761 2.308 . . . . 0.0 111.831 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 36.4 tp -93.68 128.5 39.91 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.235 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.89 11.58 0.17 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.3 m -64.25 154.77 34.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.602 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.4 p -150.56 -11.7 0.25 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.541 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.85 -128.25 28.88 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.43 -170.7 46.89 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.78 157.32 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.799 0.333 . . . . 0.0 110.47 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.05 -178.14 49.95 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 mm -77.73 51.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.097 0.475 . . . . 0.0 110.024 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.28 157.17 41.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.202 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.708 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 25.7 t -84.76 136.32 33.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.878 0.37 . . . . 0.0 110.582 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.7 mt -100.57 146.14 27.49 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.401 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.522 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.3 pm0 -138.51 165.51 26.67 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.062 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -119.09 139.89 51.01 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.086 0.469 . . . . 0.0 111.411 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -122.44 130.15 52.78 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.73 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.9 m -131.2 150.18 52.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.829 0.347 . . . . 0.0 110.821 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -139.1 122.08 16.7 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.448 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.1 p -75.36 -29.09 59.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.287 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.25 -48.35 81.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.56 ' OD2' HD12 ' A' ' 80' ' ' ILE . 49.6 t0 -93.12 -20.06 20.87 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.85 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.52 42.6 72.3 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -141.02 148.49 40.35 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 117.056 0.428 . . . . 0.0 110.199 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -146.51 142.07 27.68 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -154.03 158.17 40.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.075 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 45' ' ' LEU . 11.1 mp -100.96 144.63 29.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.153 0.501 . . . . 0.0 110.424 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -148.4 148.15 27.84 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.866 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.59 155.86 68.45 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.298 1.999 . . . . 0.0 112.159 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.708 ' ND2' ' H ' ' A' ' 31' ' ' SER . 20.6 p30 -72.71 160.69 31.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.93 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.28 1.77 59.26 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.519 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 33.2 m0 -92.76 145.12 24.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.659 0.266 . . . . 0.0 110.296 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.4 pt -121.26 145.1 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.356 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -101.27 131.0 10.42 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.57 132.19 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.951 0.405 . . . . 0.0 110.521 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -81.84 135.73 35.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.196 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.59 56.25 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.412 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -74.94 132.9 41.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.112 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.8 2.62 71.91 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.06 -164.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.445 ' OG ' ' CG2' ' A' ' 62' ' ' VAL . 79.5 p -39.96 123.65 1.6 Allowed Pre-proline 0 CA--C 1.541 0.598 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.51 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -42.04 121.48 1.84 Allowed 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.957 1.772 . . . . 0.0 112.823 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 107.69 -42.39 1.95 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.445 ' CG2' ' OG ' ' A' ' 59' ' ' SER . 56.1 t -63.88 122.04 14.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.202 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -120.0 -48.57 2.34 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.516 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 39.6 t -128.64 137.93 55.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.959 0.409 . . . . 0.0 110.889 -179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.56 135.03 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.646 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -112.74 132.95 54.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.071 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' NH1' ' OD1' ' A' ' 75' ' ' ASN . 53.4 ttt85 -130.86 132.56 45.25 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.434 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.519 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 75.3 m-20 -92.27 118.86 31.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.536 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.58 -36.92 83.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.548 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.1 mm -62.84 -42.51 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.82 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -117.51 105.78 12.45 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.891 0.376 . . . . 0.0 110.693 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.72 -37.57 67.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.607 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 40.3 p-10 -62.59 -33.11 74.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.081 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 83.4 tt0 -87.16 130.42 34.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.888 0.375 . . . . 0.0 110.585 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.433 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 10.9 m-80 -140.85 139.18 34.42 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.089 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.9 tt -126.14 134.32 51.34 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.8 m -126.87 146.69 50.19 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.306 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -121.32 128.41 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.952 0.406 . . . . 0.0 110.278 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.467 HG23 ' C ' ' A' ' 61' ' ' GLY . 5.5 mt -117.12 116.84 53.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.974 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.56 HD12 ' OD2' ' A' ' 40' ' ' ASP . 33.4 mm -116.01 123.97 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 120.922 0.392 . . . . 0.0 110.469 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 159' ' ' LEU . 75.3 m -146.67 160.59 42.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.05 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.575 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 1.9 pm0 -103.95 132.7 49.95 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 13.6 pt -88.54 148.33 41.79 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.661 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 87' ' ' LYS . 39.0 Cg_endo -66.7 138.02 47.78 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.716 1.611 . . . . 0.0 110.612 178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.9 p -63.69 -26.11 68.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.994 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -68.08 -31.02 70.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.959 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 84' ' ' PRO . 97.4 mttt -130.62 155.63 46.24 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.046 0.45 . . . . 0.0 111.228 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.8 t -122.82 174.97 6.8 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.346 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 49.3 tp -53.05 -43.53 66.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.125 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.6 p -67.39 -44.43 78.93 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.756 -0.377 . . . . 0.0 111.044 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 88' ' ' THR . 89.9 m-20 -68.44 -34.81 76.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.979 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -55.57 -42.33 74.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.478 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.65 177.99 46.89 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.411 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.0 p -92.69 172.22 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.39 76.0 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.434 -0.507 . . . . 0.0 110.222 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 59.5 m -72.68 -45.21 59.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.854 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.9 t0 -62.33 -51.62 66.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.22 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.68 -38.83 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.543 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -57.8 -53.26 46.74 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -62.24 -36.41 81.92 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 121.126 -0.23 . . . . 0.0 111.57 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -57.16 -38.37 73.46 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.599 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -63.37 -41.12 98.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.865 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.678 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -55.84 -54.06 49.18 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.396 0.617 . . . . 0.0 109.802 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -61.92 -38.42 88.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.802 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 47.5 m -59.42 -46.98 87.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.858 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.7 t -71.29 -46.23 66.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.085 0.469 . . . . 0.0 110.384 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.0 m-20 -62.23 -31.02 71.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.053 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -43.99 -36.91 2.68 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.089 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -109.06 -11.1 14.98 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.234 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -121.32 18.11 11.44 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.506 -178.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.548 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.4 pt20 -75.64 2.13 12.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.105 -0.238 . . . . 0.0 111.563 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.67 -62.5 2.38 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.802 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 33.4 p-10 -117.25 -38.11 3.41 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.844 0.354 . . . . 0.0 111.477 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.531 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 40.4 ttm180 -79.2 141.28 37.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.28 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -129.5 132.48 46.91 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.959 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.77 134.11 46.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.895 0.378 . . . . 0.0 110.334 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.66 122.51 40.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.319 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 tp -81.29 111.11 17.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.327 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.525 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 97.0 mt -71.57 -42.75 72.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.891 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 4.0 m-80 177.76 174.47 0.52 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.297 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.81 144.15 22.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.161 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.411 ' N ' ' OE1' ' A' ' 122' ' ' GLU . 57.5 mp0 -144.07 145.86 32.45 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.857 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -115.32 135.65 53.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.311 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -116.86 159.2 22.73 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.668 -0.494 . . . . 0.0 109.668 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -139.51 107.29 5.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.516 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.43 144.91 38.28 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.933 0.397 . . . . 0.0 111.052 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 59.1 t0 52.8 30.24 8.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.59 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.69 0.92 75.76 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -102.9 146.68 27.94 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 120.903 0.382 . . . . 0.0 110.154 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.0 t -112.34 129.23 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.344 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -117.63 127.97 54.47 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.185 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -105.88 122.44 46.12 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.427 ' C ' HD12 ' A' ' 134' ' ' LEU . 87.1 m -105.55 123.33 47.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.234 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.427 HD12 ' C ' ' A' ' 133' ' ' THR . 9.5 mp -114.38 125.01 53.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.93 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -120.36 117.99 29.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.362 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -146.48 162.5 38.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.27 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.521 ' HE ' ' CG1' ' A' ' 119' ' ' ILE . 19.8 ptp180 -124.54 149.05 47.37 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.015 0.436 . . . . 0.0 110.803 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 84.4 t -105.05 133.87 48.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.352 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -139.91 134.86 32.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.242 0.544 . . . . 0.0 110.923 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.442 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 32.0 t -116.57 135.64 56.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.387 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.27 -122.39 18.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -112.31 14.91 20.51 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.694 0.257 . . . . 0.0 111.694 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 140' ' ' VAL . 21.7 p-10 -133.5 160.14 38.3 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.024 0.44 . . . . 0.0 111.509 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.457 ' O ' HG13 ' A' ' 144' ' ' VAL . 13.2 p -87.07 127.88 40.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.453 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.411 ' HG2' ' HE ' ' A' ' 146' ' ' ARG . 82.7 tt0 -76.45 -55.2 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.756 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.475 ' NH1' ' O ' ' A' ' 73' ' ' ASP . 20.1 ptp180 -174.82 174.58 2.55 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.078 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 61.7 m170 -103.01 139.0 39.14 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.011 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -132.84 133.36 43.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.974 0.416 . . . . 0.0 111.161 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 13.5 tp -111.52 133.96 53.43 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.908 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.39 131.49 48.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.921 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 29.5 t -120.97 123.04 41.47 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 46.6 t -109.2 129.04 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.015 0.436 . . . . 0.0 111.186 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 46.5 m -143.69 146.19 33.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.29 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 16.5 p -111.15 152.02 27.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.751 0.31 . . . . 0.0 110.263 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -158.46 119.85 3.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 55.94 29.74 14.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.892 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.77 14.28 78.05 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.8 mmtm -105.38 128.43 53.5 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -90.02 119.29 30.25 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.39 128.1 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.7 0.286 . . . . 0.0 110.738 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.8 m -131.18 139.44 49.74 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.394 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.75 103.99 11.76 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.224 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -99.31 110.27 22.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.627 0.251 . . . . 0.0 110.422 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.4 mp -116.2 134.63 54.71 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.58 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 55.7 m -125.91 136.63 53.26 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.058 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 4.6 m -152.86 157.33 40.56 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.548 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -58.46 142.28 49.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.375 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -69.09 -30.64 68.98 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.033 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.86 -34.12 71.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.053 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.45 ' O ' HG22 ' A' ' 174' ' ' VAL . 71.0 mtp85 -113.24 -3.85 13.81 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.498 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.9 t-105 -49.78 -39.16 37.14 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.882 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.98 -42.18 99.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.751 -0.38 . . . . 0.0 111.091 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 56.9 m -64.78 -39.81 94.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.74 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.466 HG23 ' CZ ' ' A' ' 178' ' ' PHE . 14.7 m -107.97 21.08 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.262 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -50.06 -49.48 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.806 -0.358 . . . . 0.0 111.285 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.3 t -64.63 -30.72 71.74 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.846 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -55.21 -44.06 75.03 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.217 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.498 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 24.3 m-85 -61.56 -50.33 73.07 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.348 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -64.47 -40.17 95.19 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.656 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 184' ' ' SER . 41.9 m -66.84 -47.11 72.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.501 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 63.9 t -62.7 -45.49 98.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.664 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.47 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -67.01 -46.8 73.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.208 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 26.1 m -68.72 -33.14 73.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.382 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 180' ' ' THR . 17.8 t -62.2 -27.55 69.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.699 -178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.47 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -56.11 159.18 3.52 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.779 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 45.4 t60 -135.77 157.89 45.74 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.8 151.04 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 111.098 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.485 ' CD2' ' OXT' ' A' ' 188' ' ' TYR . 46.2 p90 . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.785 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -63.03 147.53 94.38 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.771 2.314 . . . . 0.0 111.796 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.673 HD12 ' N ' ' A' ' 21' ' ' LEU . 7.2 mp -86.01 143.82 27.92 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.52 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 21' ' ' LEU . . . -57.31 -118.71 0.01 OUTLIER Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m -115.08 148.63 38.68 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.811 0.338 . . . . 0.0 110.445 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 48.9 m -86.67 125.04 33.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.53 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.32 -177.04 51.25 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.71 155.06 46.19 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 28' ' ' GLY . 42.7 t -120.7 134.85 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 110.378 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 27' ' ' VAL . . . 57.39 113.53 0.01 OUTLIER Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.9 mt -59.79 -36.35 65.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.953 0.406 . . . . 0.0 110.616 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -155.95 84.64 1.02 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.272 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.549 ' OG ' ' O ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -162.03 46.13 0.16 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.605 0.717 . . . . 0.0 110.334 -179.605 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' C ' ' NE2' ' A' ' 33' ' ' GLN . 19.2 mt -135.37 131.96 36.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.705 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.631 ' NE2' ' N ' ' A' ' 33' ' ' GLN . 1.0 OUTLIER -130.68 162.48 29.32 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.251 179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -121.25 145.77 47.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.574 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -129.38 134.96 48.13 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.342 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 83.9 p -143.19 157.12 44.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.637 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -146.3 119.23 8.72 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.417 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.1 p -70.49 -32.82 70.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.586 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -62.65 -48.86 77.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.078 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -87.67 -20.75 25.87 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.804 0.335 . . . . 0.0 110.869 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.03 39.83 88.8 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.649 -0.58 . . . . 0.0 111.649 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.31 151.45 45.06 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 117.299 0.549 . . . . 0.0 110.415 179.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -153.24 143.78 22.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.799 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -150.73 157.71 43.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.827 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 mt -98.5 150.96 21.13 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.558 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -152.17 146.11 18.19 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.003 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.48 153.62 69.96 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.397 2.065 . . . . 0.0 112.508 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -69.37 159.37 33.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.997 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.13 -2.51 63.65 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.533 ' CD1' ' OD1' ' A' ' 68' ' ' ASP . 35.8 m0 -94.91 147.13 23.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.772 0.32 . . . . 0.0 110.276 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.8 pt -120.4 149.88 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.324 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -114.98 141.8 17.25 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.7 144.9 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.756 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -84.38 134.87 34.47 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.379 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.91 55.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.491 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -70.89 135.01 47.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.82 2.34 69.58 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.44 -164.61 0.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.641 0.258 . . . . 0.0 110.485 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.76 154.36 1.24 Allowed Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.215 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.18 131.24 24.6 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.277 1.985 . . . . 0.0 111.915 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.516 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 95.47 -22.28 39.78 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.1 t -62.43 133.85 28.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.751 -0.379 . . . . 0.0 110.176 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -118.65 -58.3 1.98 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.639 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 78' ' ' VAL . 44.2 t -145.16 148.99 17.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 120.928 0.394 . . . . 0.0 111.504 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.56 136.45 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.655 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -112.36 143.11 44.01 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.292 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -145.09 145.78 31.56 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.847 0.356 . . . . 0.0 110.682 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.533 ' OD1' ' CD1' ' A' ' 50' ' ' TRP . 62.8 m-20 -101.73 122.01 43.13 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.685 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.42 -39.92 95.78 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.231 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.6 -38.59 82.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.61 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -126.43 94.62 4.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.46 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -62.19 -38.44 89.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.15 0.5 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 42.1 p-10 -61.78 -32.48 72.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.198 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.525 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 14.0 tm-20 -86.21 125.94 33.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.946 0.403 . . . . 0.0 110.202 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.718 ' N ' HD22 ' A' ' 75' ' ' ASN . 0.0 OUTLIER -171.76 168.91 6.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.574 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.557 ' C ' HD12 ' A' ' 76' ' ' LEU . 4.6 pp -157.23 157.12 33.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.509 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 43.7 m -131.16 147.86 52.65 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.215 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 m -115.67 128.19 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.188 0.518 . . . . 0.0 109.987 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.516 HG23 ' C ' ' A' ' 61' ' ' GLY . 56.3 mt -117.08 124.37 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.805 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' GLY . 66.0 mt -118.25 128.8 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.473 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.3 m -138.38 163.38 32.02 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.93 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.77 134.72 47.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.688 0.28 . . . . 0.0 110.403 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.447 ' CG2' HD12 ' A' ' 159' ' ' LEU . 10.8 pt -103.23 149.21 36.72 Favored Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.679 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.43 ' O ' ' O ' ' A' ' 87' ' ' LYS . 48.4 Cg_endo -68.24 137.57 40.67 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.105 1.87 . . . . 0.0 111.327 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.4 t -62.46 -27.66 69.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.15 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -67.48 -31.36 71.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.897 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 84' ' ' PRO . 67.9 mttm -128.73 151.96 48.96 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.077 0.465 . . . . 0.0 111.047 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.414 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.0 t -120.54 178.22 4.76 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.491 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.404 HD21 ' CG ' ' A' ' 132' ' ' TYR . 47.0 tp -50.12 -44.32 52.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.094 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.0 p -65.33 -42.95 92.41 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.936 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HB2' ' H ' ' A' ' 88' ' ' THR . 86.6 m-20 -65.45 -39.13 91.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.804 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.8 tp -56.4 -43.53 79.4 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.585 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.7 176.25 45.57 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.412 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 33.5 p -93.2 172.58 8.21 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.74 79.17 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 89.1 m -72.26 -44.48 62.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.2 t0 -61.92 -50.98 69.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.303 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 82.1 t -60.49 -38.67 78.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.498 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.69 -44.02 94.21 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -69.33 -42.45 75.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.896 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -61.29 -39.05 89.01 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.961 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -62.03 -40.63 96.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.38 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.3 mmt -59.78 -44.26 94.01 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.404 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.28 -39.45 93.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.266 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.3 m -60.19 -47.63 85.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.811 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 97.4 t -71.52 -45.4 68.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.96 0.41 . . . . 0.0 110.496 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 111' ' ' GLN . 85.1 m-20 -62.41 -30.35 71.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.244 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -45.03 -39.91 6.09 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.972 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.48 -4.28 29.12 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.693 0.282 . . . . 0.0 110.8 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -121.44 14.65 11.17 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.052 -179.226 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 107' ' ' ASN . 6.5 tt0 -72.03 3.06 4.76 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.092 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -86.37 -64.6 1.44 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.67 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -117.71 -48.6 2.57 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.996 0.427 . . . . 0.0 111.379 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 110' ' ' SER . 84.4 mtt180 -70.12 149.02 48.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.508 -178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -134.43 129.83 35.87 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.849 179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.76 128.21 46.89 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.76 0.314 . . . . 0.0 110.223 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -115.08 128.77 56.44 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 36.1 tp -81.98 108.99 15.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.081 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.39 -53.76 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.547 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.572 ' C ' HD22 ' A' ' 120' ' ' ASN . 0.3 OUTLIER -163.11 167.77 21.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.645 179.302 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.94 124.38 5.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.418 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -141.78 162.89 34.35 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.628 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.405 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.64 148.4 50.37 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.47 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -130.64 141.47 50.43 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.176 0.512 . . . . 0.0 111.258 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -107.65 112.69 25.52 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.275 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.25 141.47 35.86 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.945 0.403 . . . . 0.0 110.693 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 51.69 38.95 24.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.207 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.59 0.7 25.95 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.074 -0.811 . . . . 0.0 111.074 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -105.54 147.35 28.46 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.983 0.42 . . . . 0.0 110.189 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.19 128.38 72.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.011 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 21.2 m-85 -116.68 129.36 56.09 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.844 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.405 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.5 m-85 -104.11 128.23 51.75 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.3 m -110.93 123.89 51.04 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.248 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.6 mp -117.49 124.42 48.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.938 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.459 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 71.1 tt0 -118.07 120.2 37.06 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -147.05 170.02 18.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.075 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.551 ' NH2' ' NE2' ' A' ' 147' ' ' HIS . 11.6 ptm180 -138.18 155.56 48.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 110.8 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.62 133.52 47.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.374 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -142.71 136.37 28.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.197 0.522 . . . . 0.0 111.498 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.3 t -108.2 130.49 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.003 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 60.62 -119.52 18.98 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -110.02 10.52 24.14 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.816 -0.226 . . . . 0.0 111.228 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -117.74 147.35 43.05 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.761 0.315 . . . . 0.0 111.149 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.468 HG11 HH21 ' A' ' 137' ' ' ARG . 43.2 t -88.14 127.0 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.743 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -76.2 -54.03 7.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.714 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -173.7 174.36 3.15 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.181 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.551 ' NE2' ' NH2' ' A' ' 137' ' ' ARG . 29.9 m170 -104.87 139.86 38.99 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.055 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 83.9 m-20 -134.64 136.9 43.2 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.845 0.355 . . . . 0.0 110.951 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -113.62 132.43 55.76 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.114 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -127.16 131.95 50.62 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.008 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.9 t -125.12 127.67 47.23 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 45.1 t -113.74 128.12 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.987 0.422 . . . . 0.0 110.939 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 31.8 m -139.72 141.84 36.88 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.035 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.7 p -104.76 152.6 22.35 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.909 0.385 . . . . 0.0 110.463 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -162.75 122.87 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.89 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 55.67 29.34 13.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.354 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 81.69 13.21 80.37 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -107.84 140.63 40.66 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.678 0.275 . . . . 0.0 110.354 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.447 HD12 ' CG2' ' A' ' 83' ' ' ILE . 0.5 OUTLIER -97.67 120.39 37.97 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 80.5 mt -118.46 124.48 73.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.049 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.2 m -125.93 136.18 52.74 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.314 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.07 99.85 7.74 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.061 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -97.2 111.63 23.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.668 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.07 138.25 51.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.831 0.348 . . . . 0.0 110.48 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.521 ' OG ' ' ND2' ' A' ' 75' ' ' ASN . 61.4 p -134.57 135.35 42.2 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.967 179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.455 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 6.4 m -152.93 161.67 42.26 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.634 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.619 ' CB ' HH21 ' A' ' 170' ' ' ARG . . . -54.22 144.31 20.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.313 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -70.41 -36.34 73.98 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.055 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -62.76 -33.42 75.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.356 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.619 HH21 ' CB ' ' A' ' 167' ' ' ALA . 0.3 OUTLIER -97.68 -19.89 17.96 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.896 -179.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.492 ' O ' ' N ' ' A' ' 175' ' ' LYS . 59.5 t-105 -45.58 -40.34 8.67 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.77 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -63.12 -42.61 99.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.199 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 55.0 m -66.96 -39.32 87.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.539 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 170' ' ' ARG . 6.0 m -109.55 21.48 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 171' ' ' TRP . 16.9 pttm -51.69 -47.62 63.82 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.006 -0.277 . . . . 0.0 111.497 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 85.8 p -69.61 -24.09 63.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.467 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 181' ' ' VAL . 11.3 tp -59.07 -42.57 90.69 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.994 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.415 ' CE2' ' CE3' ' A' ' 171' ' ' TRP . 20.2 m-85 -66.9 -50.22 63.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.485 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -62.47 -41.22 98.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.579 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 184' ' ' SER . 47.8 m -67.91 -49.32 62.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 177' ' ' LEU . 55.9 t -61.55 -42.99 96.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.462 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.61 -40.32 96.62 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.924 0.392 . . . . 0.0 110.287 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 39.1 m -79.63 -28.42 40.91 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.349 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.414 ' N ' ' O ' ' A' ' 180' ' ' THR . 87.8 p -63.19 -23.55 67.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.505 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -63.24 157.55 22.4 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.437 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -139.6 160.26 40.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.731 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.4 m -127.46 151.12 33.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.826 0.346 . . . . 0.0 110.854 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 38.0 p90 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.72 -179.812 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.04 147.94 93.91 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 122.827 2.351 . . . . 0.0 111.593 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.63 HD12 ' N ' ' A' ' 21' ' ' LEU . 7.9 mp -58.63 -36.99 74.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.316 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.07 21.85 69.85 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.467 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 43.1 m -61.77 147.72 45.36 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.402 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 23' ' ' SER . 43.9 m -159.78 46.2 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.257 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.95 -105.57 1.3 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.41 32.57 27.76 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.8 m -60.26 137.14 23.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.726 0.298 . . . . 0.0 110.218 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.95 138.7 48.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.6 mt -82.35 82.6 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.678 0.275 . . . . 0.0 110.38 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.93 -140.7 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.289 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.513 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 44.0 t -117.34 136.22 53.29 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.366 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.0 mt -112.49 146.07 39.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.252 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.586 HE22 ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -131.16 152.52 50.36 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.229 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -109.67 128.4 55.23 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.008 0.432 . . . . 0.0 110.958 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -114.31 119.04 35.62 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.544 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.419 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 50.0 m -126.98 149.07 50.04 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.934 0.397 . . . . 0.0 110.949 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 36' ' ' SER . 87.4 m-20 -138.18 111.4 7.94 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.245 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.9 p -64.41 -34.05 77.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.46 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.468 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 26.2 mtpp -60.9 -43.87 97.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.51 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -89.6 -20.41 23.76 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.092 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.34 37.56 90.68 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.1 151.12 45.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.095 0.448 . . . . 0.0 110.384 179.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -150.54 147.28 27.27 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.898 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.531 ' CE2' ' O ' ' A' ' 45' ' ' LEU . 43.3 t80 -160.77 147.57 15.33 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.067 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' O ' ' CE2' ' A' ' 44' ' ' PHE . 9.9 mp -93.77 143.3 26.46 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.943 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -149.51 130.63 7.2 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.991 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.97 157.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.221 1.947 . . . . 0.0 112.892 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.586 ' N ' HE22 ' A' ' 33' ' ' GLN . 66.9 m-80 -81.41 158.13 24.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.987 179.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.24 0.83 61.27 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.5 m0 -81.05 149.73 29.12 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.5 pt -113.4 142.25 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.376 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -106.34 133.47 11.64 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.4 t -108.85 133.33 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.853 0.359 . . . . 0.0 110.412 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.63 124.39 32.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.271 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.84 55.77 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.606 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -80.48 130.17 34.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.744 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.66 -3.57 78.47 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.402 ' O ' ' C ' ' A' ' 59' ' ' SER . . . -80.25 -162.84 0.48 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.299 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.402 ' C ' ' O ' ' A' ' 58' ' ' ALA . 28.2 m -36.43 109.24 0.41 Allowed Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.94 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -44.76 135.04 10.13 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 121.865 1.71 . . . . 0.0 111.997 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 102.19 -36.0 4.57 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.96 127.08 22.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.116 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.44 ' OD2' HD12 ' A' ' 80' ' ' ILE . 31.3 t0 -103.55 -59.11 1.77 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.693 0.283 . . . . 0.0 110.927 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 67.4 t -150.56 141.21 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.958 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 46.1 t -110.17 130.95 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.76 133.91 55.53 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.521 ' NH2' ' OD1' ' A' ' 75' ' ' ASN . 76.2 mtp85 -124.55 140.89 52.52 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.719 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -88.48 118.31 28.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.391 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -62.42 -39.23 92.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.335 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.6 mm -63.46 -42.3 95.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.792 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -112.86 107.04 15.49 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.816 0.341 . . . . 0.0 110.85 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -73.76 -45.9 48.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.309 0.576 . . . . 0.0 110.278 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -58.41 -37.24 74.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.096 -0.957 . . . . 0.0 111.206 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -84.08 129.53 34.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.382 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.521 ' OD1' ' NH2' ' A' ' 67' ' ' ARG . 7.4 m-80 -130.29 148.07 52.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.007 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.661 HD13 ' N ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -124.63 133.75 53.14 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.661 ' N ' HD13 ' A' ' 76' ' ' LEU . 1.9 p -136.31 138.23 41.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.96 0.409 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 20.9 t -122.08 130.62 74.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.931 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.45 HG23 ' C ' ' A' ' 61' ' ' GLY . 28.0 mt -121.02 131.83 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.462 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.44 HD12 ' OD2' ' A' ' 63' ' ' ASP . 60.8 mt -122.54 133.05 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.621 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 159' ' ' LEU . 49.2 m -143.53 164.1 31.3 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.239 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -105.5 138.23 42.04 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.522 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.82 153.37 38.28 Favored Pre-proline 0 N--CA 1.468 0.446 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.253 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 87' ' ' LYS . 72.4 Cg_endo -75.68 141.49 24.81 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.379 2.052 . . . . 0.0 110.892 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.8 p -68.44 -26.45 65.52 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.918 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -69.22 -32.0 70.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.972 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 84' ' ' PRO . 64.9 mttm -130.87 157.95 41.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.999 0.428 . . . . 0.0 111.302 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.7 t -123.12 175.47 6.61 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.834 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.5 tp -49.98 -45.31 51.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.07 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 40.1 p -65.61 -44.45 86.52 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.79 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -65.72 -36.26 83.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.99 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 92' ' ' LEU . 4.9 tt -55.87 -47.7 76.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.0 0.429 . . . . 0.0 110.245 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 178.19 177.5 46.95 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.0 p -90.94 170.13 10.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.93 74.47 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.96 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 77.0 m -71.43 -45.07 63.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.58 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.5 -53.29 58.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.299 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 80.0 t -61.25 -39.73 83.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.705 179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.09 -45.11 92.81 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -66.28 -41.62 89.58 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.92 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.6 mmt85 -62.21 -39.38 92.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -62.2 -40.54 96.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.703 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 36.8 mmt -58.16 -44.93 88.18 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.599 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -64.55 -44.49 90.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.999 0.428 . . . . 0.0 110.066 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.7 m -60.2 -44.76 94.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.837 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.75 -46.21 79.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.461 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 111' ' ' GLN . 87.8 m-20 -64.36 -42.12 96.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.053 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -43.6 -20.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.37 . . . . 0.0 110.748 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 107' ' ' ASN . . . -91.1 -43.67 9.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.607 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.8 p -119.38 19.63 12.69 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.2 tt0 -56.38 -28.78 60.26 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.337 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -42.53 -62.64 2.12 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.23 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -117.63 -44.3 2.75 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.766 0.317 . . . . 0.0 111.336 -179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.4 mtt85 -80.47 144.95 32.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.469 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -131.53 142.55 49.96 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.162 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.16 135.41 44.86 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -116.73 129.64 56.24 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.468 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.9 tt -81.5 104.28 11.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.12 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.4 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.4 mt -70.35 -45.88 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.334 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.4 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 3.1 m-80 -169.65 166.71 9.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.363 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.14 126.3 5.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.413 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -142.9 163.5 32.62 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.748 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.17 149.69 46.08 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.506 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.1 mmt180 -131.65 144.89 51.36 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.143 0.497 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -111.53 114.53 27.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.557 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -140.91 138.57 33.97 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.504 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 52.05 40.97 29.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.788 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.78 2.29 7.7 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -103.32 133.19 48.81 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.63 130.45 55.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.389 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -118.02 128.39 54.73 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -105.51 129.83 53.71 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.436 ' C ' HD12 ' A' ' 134' ' ' LEU . 87.4 m -113.21 122.92 48.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.436 HD12 ' C ' ' A' ' 133' ' ' THR . 9.3 mp -115.39 126.1 53.99 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.739 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -118.81 122.12 41.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.768 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -150.44 171.3 17.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.29 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -136.5 156.58 48.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.936 0.398 . . . . 0.0 110.494 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.2 t -106.39 135.01 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.025 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.79 136.25 30.48 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 121.163 0.506 . . . . 0.0 111.58 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.2 t -97.79 121.79 48.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 59.74 -110.89 3.08 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -113.31 10.56 18.45 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.565 0.222 . . . . 0.0 110.871 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -113.34 137.16 51.91 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.684 0.278 . . . . 0.0 111.317 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 144' ' ' VAL . 7.2 p -78.73 126.63 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.136 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.637 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -81.05 -55.04 5.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.474 ' NH2' ' C ' ' A' ' 166' ' ' THR . 6.5 ptm85 -172.56 174.22 3.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.117 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.417 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 56.2 m170 -105.05 138.38 41.34 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.131 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 82.2 m-20 -135.36 130.93 35.71 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.725 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.4 tp -110.89 128.16 55.7 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.9 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -121.6 134.84 55.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.24 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.0 t -125.68 121.73 34.3 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.1 t -105.67 129.44 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 120.934 0.397 . . . . 0.0 110.874 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 59.8 m -142.79 144.42 32.57 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.0 p -86.93 156.82 19.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.871 0.367 . . . . 0.0 110.762 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -150.35 95.94 2.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.721 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 54.2 43.32 30.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.479 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.43 18.25 66.89 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.728 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 40.9 mtpt -121.71 137.26 54.83 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.952 0.376 . . . . 0.0 111.108 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 81' ' ' SER . 1.2 mt -91.81 119.28 31.47 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 72.1 mt -123.29 122.14 64.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.2 m -115.72 133.24 56.23 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.941 0.401 . . . . 0.0 110.245 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -105.2 110.23 22.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.612 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -102.82 122.14 43.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.951 0.405 . . . . 0.0 111.675 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mt -115.64 132.91 56.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.543 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.4 m -130.26 130.62 44.8 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.859 0.361 . . . . 0.0 110.31 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.474 ' C ' ' NH2' ' A' ' 146' ' ' ARG . 3.7 m -153.02 158.12 41.52 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.34 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -57.0 143.38 38.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.205 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -69.85 -29.64 66.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.166 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.19 -33.77 72.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.215 -178.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.491 ' O ' HG22 ' A' ' 174' ' ' VAL . 86.8 mtt180 -111.84 -6.48 14.27 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.557 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 53.7 t-105 -48.25 -39.52 21.67 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.811 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.85 -42.04 97.66 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 56.6 m -65.47 -39.99 92.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.569 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 170' ' ' ARG . 8.5 m -107.71 21.44 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.255 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 48.3 pttt -49.21 -48.19 45.57 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.447 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.0 m -64.2 -32.08 73.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.649 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.9 tp -53.81 -44.94 70.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.045 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.557 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 18.9 m-85 -62.45 -49.04 77.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.477 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -62.92 -41.58 99.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 184' ' ' SER . 48.8 m -67.72 -47.62 68.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.095 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.438 HG13 ' CZ ' ' A' ' 44' ' ' PHE . 56.0 t -62.81 -43.73 99.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.627 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.524 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -61.6 -38.45 87.64 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.571 -0.452 . . . . 0.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.7 t -85.14 -20.4 30.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 180' ' ' THR . 45.5 t -62.11 -33.58 74.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.059 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.524 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.2 OUTLIER -57.21 159.56 4.42 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.321 -179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.8 t60 -138.28 152.77 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 13.9 m -128.0 151.49 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.931 0.396 . . . . 0.0 111.082 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.623 -179.734 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 28.2 Cg_endo -61.67 -23.61 76.57 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.721 2.281 . . . . 0.0 111.766 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 23' ' ' SER . 2.5 pp -59.9 -35.64 75.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.462 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.34 33.71 0.96 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 21' ' ' LEU . 54.0 p -65.18 160.32 21.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 110.605 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 41.2 m -93.82 130.71 39.74 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.48 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.82 -122.87 23.21 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.4 2.38 63.74 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 m -129.79 158.05 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.773 0.32 . . . . 0.0 110.142 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 154.98 3.35 0.11 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' O ' ' C ' ' A' ' 30' ' ' ALA . 15.8 mm -100.36 154.5 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.598 ' HB3' HD21 ' A' ' 48' ' ' ASN . . . -30.09 -69.09 0.07 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.578 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 87.8 p -149.68 152.48 35.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.754 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 65.3 mt -117.18 143.51 45.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.404 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.605 ' NE2' ' N ' ' A' ' 48' ' ' ASN . 2.1 pm0 -139.53 160.48 39.75 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.078 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -129.98 147.83 51.77 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.138 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.664 ' CZ ' ' CD1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER -124.93 158.38 33.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.453 178.683 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -144.74 161.2 39.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.834 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 41' ' ' GLY . 45.0 t0 -145.52 109.06 4.68 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.646 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.6 m -59.64 -37.81 79.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.885 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 62.5 mttp -58.7 -47.06 85.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.25 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.48 ' OD2' HD13 ' A' ' 80' ' ' ILE . 47.2 t0 -89.75 -20.26 23.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.921 0.391 . . . . 0.0 110.507 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . 66.66 40.27 93.96 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.503 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -140.2 150.11 43.77 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 117.139 0.47 . . . . 0.0 110.608 179.391 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -153.42 147.31 25.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.376 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.419 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 28.6 p90 -161.27 158.91 27.93 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.619 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.5 mt -81.06 153.49 27.34 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.412 0.625 . . . . 0.0 111.667 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.664 ' CD1' ' CZ ' ' A' ' 35' ' ' TYR . 16.8 p90 -162.41 141.79 7.18 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.457 178.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.27 156.52 58.88 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.276 1.984 . . . . 0.0 112.422 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.605 ' N ' ' NE2' ' A' ' 33' ' ' GLN . 44.6 p30 -74.25 160.7 30.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.216 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 100.43 -4.78 56.93 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.532 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 36.0 m0 -85.02 139.63 31.63 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.1 pt -113.61 134.39 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.158 0.504 . . . . 0.0 110.638 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -91.99 127.81 9.09 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.3 t -105.26 135.35 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 0.0 110.324 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 51.3 p30 -71.0 149.16 46.9 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.243 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.4 m -152.66 48.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.42 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -76.68 128.24 34.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.022 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.53 7.6 78.74 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.14 -164.68 0.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.637 0.256 . . . . 0.0 110.568 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.78 156.39 1.64 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.115 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -67.2 127.84 17.42 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.499 2.133 . . . . 0.0 112.253 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 97.51 -22.68 39.53 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.6 t -68.79 128.79 32.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -118.98 -57.5 2.02 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.8 t -142.21 142.54 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.86 0.362 . . . . 0.0 111.157 -179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.6 t -117.09 134.31 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.215 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -111.67 131.63 55.15 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.953 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 75.0 ttt-85 -129.83 138.57 51.08 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.483 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.532 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 72.2 m-20 -89.26 118.77 29.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.625 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.8 tp -66.83 -39.3 87.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.981 0.42 . . . . 0.0 110.328 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 85.9 mt -62.11 -43.16 97.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.345 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -117.98 108.87 15.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.828 0.346 . . . . 0.0 110.817 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.3 mtm180 -65.43 -43.19 91.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.354 0.597 . . . . 0.0 110.379 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 91.4 m-20 -58.2 -37.42 74.75 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.338 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.455 ' CD ' ' HG1' ' A' ' 166' ' ' THR . 47.4 tp10 -74.85 132.38 41.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.32 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 73' ' ' ASP . 19.7 m-80 -149.23 139.0 21.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.539 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.7 tt -129.83 134.69 47.7 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.862 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.3 t -127.86 138.51 52.72 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.1 t -116.01 125.24 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.507 HG23 ' C ' ' A' ' 61' ' ' GLY . 54.7 mt -124.5 122.04 62.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.48 HD13 ' OD2' ' A' ' 40' ' ' ASP . 72.6 mt -120.88 135.33 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.703 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -148.08 164.68 33.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.37 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -103.49 134.44 46.84 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 83' ' ' ILE . 12.5 pt -92.8 148.77 36.63 Favored Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.455 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.409 ' O ' ' O ' ' A' ' 87' ' ' LYS . 40.1 Cg_endo -66.51 136.51 43.19 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.541 1.494 . . . . 0.0 110.49 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.5 p -63.86 -26.09 68.46 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.854 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -68.57 -30.96 69.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.815 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' O ' ' O ' ' A' ' 84' ' ' PRO . 28.5 mtmm -130.92 148.94 52.74 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.132 0.491 . . . . 0.0 111.544 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.472 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 71.6 p -109.35 179.06 4.26 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.652 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.69 -41.07 73.21 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.284 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.4 p -72.52 -44.66 61.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.014 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.472 ' HB3' ' H ' ' A' ' 88' ' ' THR . 44.4 t0 -64.68 -38.45 91.02 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.947 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.5 tp -55.9 -44.71 78.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.822 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.58 178.64 47.33 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 43.2 p -94.76 171.11 8.98 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.73 -38.23 72.07 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.044 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.3 m -72.03 -45.24 61.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -65.11 -50.84 64.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.353 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.568 HG22 ' NH2' ' A' ' 101' ' ' ARG . 72.0 t -59.4 -37.3 68.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.554 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -62.8 -63.6 4.49 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.557 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -46.96 -42.99 18.76 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.889 -0.324 . . . . 0.0 110.793 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.568 ' NH2' HG22 ' A' ' 98' ' ' VAL . 84.0 mtm180 -59.38 -43.34 92.93 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.533 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -59.45 -42.66 92.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.904 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.659 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -53.97 -54.86 33.1 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.301 0.572 . . . . 0.0 110.098 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -62.04 -39.22 91.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.872 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.3 m -58.43 -45.59 88.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.907 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 88.4 t -70.88 -46.73 66.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.619 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 111' ' ' GLN . 85.1 m-20 -60.59 -37.04 80.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.947 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.526 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 22.3 t70 -44.38 -17.34 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 107' ' ' ASN . . . -109.31 -27.2 9.65 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.383 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.438 ' O ' ' O ' ' A' ' 114' ' ' ARG . 3.8 t -121.32 21.59 11.05 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.605 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.543 ' H ' ' CD ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -69.97 4.17 2.24 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.079 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.1 -63.07 2.76 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.206 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -117.24 -45.14 2.75 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.852 0.358 . . . . 0.0 111.419 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.438 ' O ' ' O ' ' A' ' 110' ' ' SER . 93.4 mtm-85 -85.09 148.4 26.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.504 -179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -129.16 148.64 51.12 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.175 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.16 136.2 43.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.379 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 77.3 tt0 -122.74 127.96 49.89 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.9 tt -82.66 108.74 16.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.854 0.359 . . . . 0.0 110.09 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.573 ' C ' HD22 ' A' ' 120' ' ' ASN . 96.1 mt -72.73 -58.88 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.836 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.573 HD22 ' C ' ' A' ' 119' ' ' ILE . 1.8 m-80 -146.29 164.0 33.74 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.132 0.491 . . . . 0.0 110.647 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.25 112.48 2.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.183 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -138.97 170.44 15.99 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.876 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -142.36 151.16 41.63 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.737 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.3 140.94 47.72 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.773 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 35.6 p30 -109.21 112.72 25.03 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.672 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -139.93 142.55 36.41 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.991 0.424 . . . . 0.0 110.738 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 52.35 37.73 23.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.316 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.17 1.77 36.26 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -106.28 147.86 28.65 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 110.092 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -115.33 128.19 72.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.003 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -116.52 127.77 54.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.72 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.41 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -104.09 126.22 51.03 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 62.2 m -107.12 124.45 49.7 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.247 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.446 HD21 ' HA2' ' A' ' 99' ' ' GLY . 5.9 mp -118.3 123.61 45.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.839 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -119.25 122.46 41.98 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -149.15 168.57 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.299 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -138.64 160.03 40.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.752 0.311 . . . . 0.0 110.206 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 85.1 t -105.37 125.32 60.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.489 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 144' ' ' VAL . 8.0 mt -104.85 137.73 42.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.168 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.63 136.39 60.83 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.92 -110.49 0.74 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -117.31 18.11 14.51 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -140.88 160.22 40.52 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.322 0.582 . . . . 0.0 112.432 -178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 144' ' ' VAL . 12.7 p -72.37 122.51 25.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.39 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.526 ' OE1' ' NE ' ' A' ' 146' ' ' ARG . 2.0 tm-20 -75.11 -53.59 8.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.172 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.526 ' NE ' ' OE1' ' A' ' 145' ' ' GLU . 15.0 ptp180 -172.46 169.64 5.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.127 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -109.04 136.07 49.16 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.04 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -135.17 135.89 41.41 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.888 0.375 . . . . 0.0 111.046 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.8 tp -111.11 133.94 53.09 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.004 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.37 131.14 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.503 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.7 m -119.31 136.71 54.12 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 58.4 t -121.36 127.69 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.083 0.468 . . . . 0.0 111.288 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 62.5 m -144.83 144.21 31.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.08 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 13.0 p -107.48 145.59 32.88 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 110.446 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -146.73 111.45 5.28 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.138 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.452 ' CZ ' ' OXT' ' A' ' 188' ' ' TYR . 80.5 mtm180 55.74 31.86 18.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.81 8.71 75.88 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.471 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 31.7 mmtp -99.71 124.43 44.96 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.66 114.61 23.51 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.8 mm -109.76 128.6 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.5 m -130.42 134.46 47.14 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.729 0.299 . . . . 0.0 110.838 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.29 102.17 9.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.829 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -102.53 111.86 24.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.741 0.305 . . . . 0.0 110.474 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 164' ' ' LEU . 5.3 mp -117.16 137.51 52.28 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.653 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 54.4 m -126.85 134.35 50.53 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.031 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.455 ' HG1' ' CD ' ' A' ' 74' ' ' GLU . 17.2 m -153.11 156.31 38.43 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.006 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.65 143.79 19.38 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.257 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.21 -36.98 72.08 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.295 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.9 -33.29 73.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.516 -179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.423 ' O ' HG22 ' A' ' 174' ' ' VAL . 56.4 ttt-85 -100.88 -12.51 18.93 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.601 0.239 . . . . 0.0 111.29 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.529 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.7 t-105 -50.36 -39.79 47.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.757 0.313 . . . . 0.0 111.01 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -60.3 -42.05 94.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.152 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 48.1 m -66.18 -39.67 89.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.634 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 170' ' ' ARG . 12.3 m -110.18 21.35 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.406 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 171' ' ' TRP . 47.2 pttt -51.37 -48.76 62.41 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.39 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.1 t -65.98 -29.03 69.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.686 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 181' ' ' VAL . 11.1 tp -56.46 -44.25 80.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.191 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.529 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 28.3 m-85 -61.77 -50.95 70.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.122 0.486 . . . . 0.0 110.403 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -63.82 -40.91 97.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.562 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 184' ' ' SER . 41.6 m -66.26 -46.71 76.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.591 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 177' ' ' LEU . 55.8 t -61.05 -46.16 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.828 -0.349 . . . . 0.0 111.097 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -65.96 -49.43 67.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.492 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.3 t -67.77 -34.04 76.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.148 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 180' ' ' THR . 16.5 t -62.61 -29.29 70.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.633 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.49 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -51.19 157.47 0.92 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.562 -179.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -132.61 154.16 50.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.57 152.43 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.844 0.354 . . . . 0.0 111.274 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.452 ' OXT' ' CZ ' ' A' ' 156' ' ' ARG . 38.2 p90 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.727 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.47 -22.41 74.0 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.695 2.264 . . . . 0.0 111.758 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.0 mt -89.84 143.99 26.33 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.288 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.2 19.9 59.95 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.5 t -109.94 141.53 42.57 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.819 0.343 . . . . 0.0 110.404 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.3 p -83.94 106.35 15.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.663 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.67 -177.29 49.42 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 44.83 77.54 0.09 OUTLIER Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 m -60.68 135.4 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.8 0.334 . . . . 0.0 110.363 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -74.87 165.09 54.72 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.7 mm -107.93 105.4 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.53 14.46 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.312 0.382 . . . . 0.0 110.455 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 48' ' ' ASN . 73.8 m -80.74 4.93 17.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.912 0.387 . . . . 0.0 110.753 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.4 mt -116.26 137.64 51.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.951 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -131.47 159.07 39.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.289 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 30.4 ptt-85 -121.35 146.38 46.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.602 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -129.88 137.64 50.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.921 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.427 ' OG ' ' OH ' ' A' ' 188' ' ' TYR . 22.2 t -149.5 149.24 30.45 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.826 0.346 . . . . 0.0 110.644 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -142.76 110.59 5.89 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.706 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 56.9 m -61.54 -37.31 83.3 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.568 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -58.68 -52.57 65.11 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.965 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.48 ' OD2' HD13 ' A' ' 80' ' ' ILE . 38.9 t0 -83.08 -21.07 33.82 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.762 0.315 . . . . 0.0 110.709 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.58 42.12 81.86 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.16 147.94 37.45 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.359 0.58 . . . . 0.0 110.129 179.082 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -153.1 141.38 20.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.803 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -151.91 156.66 40.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.75 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.7 mt -96.7 152.03 19.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.447 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -154.86 146.43 16.9 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.488 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.07 161.77 41.22 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.23 1.953 . . . . 0.0 112.101 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.475 ' N ' ' O ' ' A' ' 31' ' ' SER . 43.0 p-10 -76.9 160.59 29.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.575 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.4 0.93 58.01 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.52 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 31.2 m0 -88.48 141.25 28.69 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.8 pt -118.06 145.69 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.637 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.95 136.51 12.74 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.2 t -112.94 136.51 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 110.392 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -66.55 140.07 57.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.15 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.6 m -114.03 24.75 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.646 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -60.74 119.57 8.41 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.218 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.63 8.81 76.28 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.41 -164.58 0.65 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.931 0.396 . . . . 0.0 110.855 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.14 157.77 67.93 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.503 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.45 128.32 16.13 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.382 2.054 . . . . 0.0 111.742 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.424 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 98.24 -17.79 58.05 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.08 123.99 25.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.641 -0.424 . . . . 0.0 109.891 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -100.87 -58.24 1.93 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.7 p -152.08 148.06 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 111.312 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.1 t -115.27 136.31 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.301 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -111.79 136.15 51.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.243 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -129.78 138.54 51.11 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.321 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 74.3 m-20 -82.46 118.58 23.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.79 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.04 -40.16 71.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.39 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 28.7 mm -61.4 -40.75 87.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.544 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' OE1' ' A' ' 74' ' ' GLU . 9.9 pt-20 -133.53 84.41 2.12 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.08 0.467 . . . . 0.0 110.284 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -52.16 -21.81 3.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.462 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -57.76 -37.82 74.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.537 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' OE1' ' OE2' ' A' ' 71' ' ' GLU . 97.7 mt-10 -84.33 141.35 30.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.991 0.424 . . . . 0.0 110.627 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -153.23 149.69 28.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.733 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.687 ' C ' HD12 ' A' ' 76' ' ' LEU . 1.7 pp -151.91 146.5 25.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.285 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.7 m -124.21 145.94 49.02 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.019 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.9 t -116.08 125.03 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.473 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 79' ' ' ILE . 3.5 mp -122.6 127.78 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.299 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.48 HD13 ' OD2' ' A' ' 40' ' ' ASP . 79.2 mt -122.65 132.08 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.664 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.3 m -145.82 167.25 23.65 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.115 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -106.05 137.21 44.36 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 33.9 pt -96.37 148.33 34.32 Favored Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.569 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 87' ' ' LYS . 36.9 Cg_endo -66.22 135.77 41.4 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.589 1.526 . . . . 0.0 110.759 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.6 t -62.1 -29.17 70.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.133 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -68.09 -31.3 70.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.306 -0.406 . . . . 0.0 112.037 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 84' ' ' PRO . 97.0 mttt -131.38 143.68 50.65 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.033 0.444 . . . . 0.0 111.008 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 13.9 t -110.46 -179.44 3.77 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.32 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.451 HD21 ' CG ' ' A' ' 132' ' ' TYR . 45.9 tp -51.05 -44.08 61.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.893 -179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.5 p -68.28 -43.35 77.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.433 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.415 ' HB2' ' H ' ' A' ' 88' ' ' THR . 89.0 m-20 -65.54 -40.45 92.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.41 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.2 mt -57.01 -41.29 78.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.639 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.87 178.18 47.2 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.648 -0.786 . . . . 0.0 111.394 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.407 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 32.9 p -93.37 173.83 7.51 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.7 -41.03 76.66 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 69.4 m -73.08 -46.0 54.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.034 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 94' ' ' THR . 44.6 t0 -63.14 -52.14 63.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.506 -179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 72.6 t -59.2 -37.93 71.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.72 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.539 ' O ' ' SD ' ' A' ' 103' ' ' MET . . . -60.15 -55.69 28.83 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -53.53 -39.77 64.96 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.875 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -58.58 -36.79 74.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.191 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -65.08 -41.98 94.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.721 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.654 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -54.22 -55.71 25.39 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.336 0.589 . . . . 0.0 109.826 -179.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -62.1 -40.98 97.68 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.664 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.5 m -58.1 -47.09 84.28 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.929 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.2 t -72.19 -47.35 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.773 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 111' ' ' GLN . 95.8 m-20 -60.97 -39.51 89.86 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.792 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -44.41 -37.13 3.21 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.448 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.25 -45.06 74.22 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 90.9 p -123.37 22.09 9.36 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.633 ' N ' ' O ' ' A' ' 107' ' ' ASN . 48.8 tt0 -51.15 -28.88 12.08 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.5 0.19 . . . . 0.0 111.281 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -42.5 -61.74 2.39 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.287 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -117.2 -38.01 3.44 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 117.01 0.405 . . . . 0.0 111.74 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -88.39 138.33 31.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.019 0.437 . . . . 0.0 111.146 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -131.87 149.73 52.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.112 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.424 ' H ' ' ND2' ' A' ' 107' ' ' ASN . . . -106.83 138.07 43.68 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -115.39 129.7 56.66 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 20.9 tp -82.61 111.99 19.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.909 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.494 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 96.5 mt -79.64 -50.29 18.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.569 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.9 m-80 -158.41 164.52 36.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.398 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.47 114.66 3.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.592 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.64 167.25 22.52 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.685 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -134.41 150.5 50.88 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.504 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -128.53 142.16 51.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.787 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -109.43 113.27 25.93 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.183 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -138.92 141.13 38.51 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.89 0.376 . . . . 0.0 110.755 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 50.52 38.9 19.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.366 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.42 0.34 29.93 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -105.21 147.41 28.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 120.916 0.389 . . . . 0.0 110.124 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.1 t -113.3 129.64 68.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.27 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 131' ' ' TYR . 20.7 m-85 -117.06 130.49 56.7 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.755 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.451 ' CG ' HD21 ' A' ' 89' ' ' LEU . 2.4 m-85 -104.13 124.48 49.16 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 54.2 m -103.29 130.26 50.5 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.59 106.37 8.92 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.234 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -101.14 124.5 46.95 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -152.71 172.77 16.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.408 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 37.0 ptt-85 -141.2 158.78 43.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.154 0.502 . . . . 0.0 110.448 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.16 137.32 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.501 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.419 ' CD1' ' O ' ' A' ' 141' ' ' GLY . 2.7 pp -135.04 131.69 37.34 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 121.049 0.452 . . . . 0.0 111.332 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 140' ' ' VAL . 1.4 m -91.74 103.76 14.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' CD1' ' A' ' 139' ' ' LEU . . . 74.02 -113.64 4.23 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -107.91 7.35 27.98 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 122.818 -0.225 . . . . 0.0 111.483 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -116.14 138.97 50.8 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.707 0.289 . . . . 0.0 111.249 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 144' ' ' VAL . 7.3 p -78.72 122.21 33.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.344 179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.13 -52.93 9.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.607 HH21 ' N ' ' A' ' 166' ' ' THR . 15.3 ptm180 -172.27 173.13 4.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.9 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.7 m170 -102.97 138.92 39.21 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.328 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -133.72 134.18 42.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.855 0.36 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.6 tp -111.32 131.21 55.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.079 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -127.65 125.72 40.65 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.029 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 27.8 t -118.74 132.57 56.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.678 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 44.0 t -118.07 127.56 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 120.99 0.424 . . . . 0.0 110.751 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.5 m -137.97 140.94 40.46 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.998 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.8 p -105.37 151.52 24.09 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.727 0.299 . . . . 0.0 110.364 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -161.53 119.07 2.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.117 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 55.17 32.1 17.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.298 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.67 14.31 80.06 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -105.26 128.8 53.62 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.42 119.06 31.58 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.3 mt -117.92 127.59 75.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.875 0.369 . . . . 0.0 110.732 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 39.5 m -126.76 136.08 51.94 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.017 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -117.37 98.41 6.41 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -91.74 111.99 23.73 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.549 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.4 mt -111.93 137.39 49.98 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.5 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 146' ' ' ARG . 32.3 t -136.27 129.45 31.5 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.365 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.607 ' N ' HH21 ' A' ' 146' ' ' ARG . 11.9 m -152.43 158.72 43.03 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.478 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.41 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -51.93 143.32 13.79 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -71.84 -36.78 70.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.043 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -63.32 -33.5 75.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.123 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.464 ' CD ' ' N ' ' A' ' 170' ' ' ARG . 0.8 OUTLIER -96.95 -16.49 20.62 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.274 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.546 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 50.6 t-105 -48.56 -39.82 24.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.831 0.348 . . . . 0.0 110.769 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -61.69 -42.12 98.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.092 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 58.7 m -66.66 -40.0 88.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.657 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.2 m -109.55 21.17 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.149 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 171' ' ' TRP . 19.2 ptmt -50.59 -48.72 57.63 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.279 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 25.5 t -65.78 -29.75 70.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.773 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.8 tp -55.73 -44.45 77.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.374 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 26.3 m-85 -62.3 -50.47 71.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.088 0.47 . . . . 0.0 110.41 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.31 -41.41 98.93 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.605 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 184' ' ' SER . 50.7 m -66.07 -47.86 72.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.31 -43.63 97.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.523 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -62.94 -37.67 87.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.905 0.383 . . . . 0.0 110.306 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.2 t -83.62 -25.3 30.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.892 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.413 ' N ' ' O ' ' A' ' 180' ' ' THR . 46.9 t -62.49 -30.03 70.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.17 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -59.76 157.58 11.86 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.463 -179.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -135.53 156.64 48.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.602 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 18.2 m -127.1 149.81 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.041 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.427 ' OH ' ' OG ' ' A' ' 36' ' ' SER . 38.9 p90 . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.744 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.508 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 28.3 Cg_endo -61.43 -23.67 77.13 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.754 2.302 . . . . 0.0 111.811 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -66.0 -35.38 80.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.096 179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.402 ' O ' ' O ' ' A' ' 19' ' ' GLY . . . -177.53 -175.68 44.96 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 83.6 p -145.98 163.21 35.91 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.764 0.316 . . . . 0.0 110.459 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 46.4 t -129.37 139.81 51.57 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.432 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -161.1 -176.93 33.75 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.07 136.86 19.64 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.67 136.53 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.813 0.339 . . . . 0.0 110.393 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.01 23.16 59.83 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.1 pt -67.94 -16.28 20.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 0.0 110.812 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.14 159.7 42.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.506 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.2 t -65.58 137.36 57.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.506 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 57.7 mt -108.79 143.37 38.03 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.701 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.693 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.4 pm0 -137.98 163.9 30.39 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.857 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -117.69 133.94 55.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.727 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -112.48 135.13 53.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.846 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.435 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 93.8 p -146.79 153.89 40.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.924 0.392 . . . . 0.0 110.855 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 36' ' ' SER . 99.2 m-20 -141.2 114.18 8.51 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.15 179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 54.6 p -64.89 -33.95 77.24 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.434 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -62.49 -48.44 79.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -85.91 -20.48 28.95 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.101 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 67.51 40.54 90.98 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.211 -0.518 . . . . 0.0 111.83 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.431 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.2 OUTLIER -141.97 151.56 42.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.332 0.566 . . . . 0.0 110.61 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -155.6 146.52 22.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.847 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -151.74 161.58 42.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.994 0.426 . . . . 0.0 111.18 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.651 ' N ' HD22 ' A' ' 45' ' ' LEU . 2.0 mm? -92.61 143.5 26.26 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.116 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -154.71 147.25 17.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.518 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.73 157.98 58.58 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.282 1.988 . . . . 0.0 112.24 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.693 ' N ' HE22 ' A' ' 33' ' ' GLN . 47.3 p-10 -71.35 160.42 32.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.563 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 96.99 6.45 57.94 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.435 ' HE1' ' CG ' ' A' ' 68' ' ' ASP . 27.2 m0 -93.6 142.79 26.94 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.922 0.391 . . . . 0.0 110.301 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.7 pt -126.02 146.31 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.334 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.63 139.32 15.06 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -120.69 134.64 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 120.856 0.36 . . . . 0.0 110.526 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -79.08 137.74 37.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.683 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.86 55.7 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.065 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -72.81 135.07 45.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.072 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.41 4.76 70.42 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.64 -164.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.698 0.285 . . . . 0.0 110.72 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.12 153.74 3.09 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.562 -179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.27 133.08 27.44 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.264 1.976 . . . . 0.0 111.102 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 96.01 -21.88 42.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 67.2 t -62.22 122.22 12.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.92 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -99.11 -58.55 1.91 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.566 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.76 168.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.492 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.0 135.79 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.058 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -112.18 128.54 56.26 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -122.91 135.56 54.55 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.802 -178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' CG ' ' HE1' ' A' ' 50' ' ' TRP . 60.3 t0 -88.53 118.43 28.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.849 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.11 -38.65 91.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.387 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.35 -42.15 92.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.78 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 68' ' ' ASP . 96.1 mt-10 -117.86 120.62 38.45 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.457 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -88.93 -40.26 13.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.32 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -58.47 -36.27 73.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.548 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -89.22 129.77 35.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.421 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -129.75 149.04 51.67 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.997 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 77' ' ' SER . 0.3 OUTLIER -125.84 134.12 51.75 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.722 ' N ' HD13 ' A' ' 76' ' ' LEU . 13.3 t -136.82 142.79 42.9 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.3 t -129.4 132.86 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-O 120.933 0.396 . . . . 0.0 110.674 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.504 HG23 ' C ' ' A' ' 61' ' ' GLY . 50.4 mt -121.89 123.38 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.34 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.92 132.18 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.314 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.529 ' O ' ' N ' ' A' ' 159' ' ' LEU . 4.1 m -151.68 166.75 30.33 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.406 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -105.71 135.82 46.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 83' ' ' ILE . 10.0 pt -91.47 148.93 38.55 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.97 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -43.73 143.21 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.869 1.712 . . . . 0.0 111.382 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.3 t -73.1 -20.64 60.9 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.636 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 86' ' ' ASP . 57.2 t0 -94.98 -17.18 22.18 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -129.94 156.26 44.71 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.933 0.397 . . . . 0.0 111.348 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 91' ' ' ASP . 13.8 t -122.88 176.36 6.04 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.823 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.2 tp -49.92 -45.73 51.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.944 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.3 p -66.43 -44.13 83.76 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.988 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 88' ' ' THR . 57.8 t0 -65.71 -37.55 86.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.98 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.9 tp -55.85 -43.26 76.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.577 -179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.68 178.92 47.61 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.396 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.406 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 43.4 p -92.29 170.44 9.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -41.54 74.96 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.412 -0.515 . . . . 0.0 109.91 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.8 m -72.02 -44.43 63.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.804 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 94' ' ' THR . 47.3 t0 -62.22 -52.68 62.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.431 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.8 t -60.12 -39.11 79.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.595 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.73 -43.3 94.57 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -67.78 -41.41 83.28 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.04 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -60.72 -38.6 85.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -62.98 -39.61 95.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.585 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.5 mmt -59.1 -45.37 91.06 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.863 0.363 . . . . 0.0 110.536 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -64.72 -41.82 95.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.487 . . . . 0.0 109.872 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.8 m -60.86 -46.13 91.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.7 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 90.6 t -69.99 -47.5 68.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.102 0.477 . . . . 0.0 110.472 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.641 ' O ' ' N ' ' A' ' 111' ' ' GLN . 89.6 m-20 -61.05 -34.29 74.65 Favored 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.39 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -47.59 -38.71 15.02 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.189 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.32 -46.41 73.58 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.53 0.566 . . . . 0.0 112.53 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -123.03 22.15 9.62 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.641 ' N ' ' O ' ' A' ' 107' ' ' ASN . 2.3 pt20 -51.23 -15.55 0.38 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.994 -0.283 . . . . 0.0 111.27 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -56.01 -61.27 7.63 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.814 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 38.0 p-10 -117.46 -35.51 3.97 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 117.035 0.417 . . . . 0.0 111.74 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.528 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 58.9 ttm-85 -84.62 137.89 33.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.923 0.392 . . . . 0.0 111.24 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -129.03 139.29 52.12 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.106 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.9 136.53 42.56 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 tm-20 -116.54 128.28 55.28 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.477 ' C ' HD23 ' A' ' 118' ' ' LEU . 2.4 tt -82.99 106.31 14.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.926 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.405 ' N ' HD23 ' A' ' 118' ' ' LEU . 96.5 mt -70.28 -43.47 78.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.362 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.402 ' N ' HD23 ' A' ' 118' ' ' LEU . 14.9 m-20 -179.7 173.22 1.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.452 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.67 139.62 15.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.453 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -144.19 163.99 32.03 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.453 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.8 146.87 46.2 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.522 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -133.13 139.6 47.17 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.655 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -109.67 113.44 26.2 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.55 179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -138.74 144.33 39.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.014 0.435 . . . . 0.0 110.956 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 60.6 t0 51.59 32.11 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.405 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 76.03 1.58 68.81 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -105.57 148.95 26.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.94 0.4 . . . . 0.0 110.114 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.2 t -114.37 128.54 71.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.009 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -118.05 126.81 53.0 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.54 125.88 50.35 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.2 m -105.17 125.41 50.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.332 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.2 mp -115.69 126.53 54.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.928 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -119.52 122.67 42.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.433 179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -152.9 171.65 17.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.522 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -139.94 157.92 44.91 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.186 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -110.24 135.28 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.979 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 pp -136.04 136.9 40.63 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.109 0.481 . . . . 0.0 111.107 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.42 134.48 57.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.223 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.43 -120.95 16.46 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -114.47 14.42 17.82 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 122.92 -0.165 . . . . 0.0 111.415 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -129.05 155.6 45.17 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.92 0.391 . . . . 0.0 111.143 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 144' ' ' VAL . 14.7 p -86.66 126.93 40.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.324 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.539 ' OE1' ' NE ' ' A' ' 146' ' ' ARG . 2.1 tm-20 -76.01 -51.69 11.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.68 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.539 ' NE ' ' OE1' ' A' ' 145' ' ' GLU . 10.5 ptp180 -172.31 174.02 4.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.992 0.425 . . . . 0.0 111.192 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.404 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 73.8 m80 -107.21 139.44 41.64 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.013 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.404 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 78.3 m-20 -134.41 136.92 43.65 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.02 0.438 . . . . 0.0 111.477 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 8.3 tp -112.81 138.93 48.91 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.632 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.98 147.08 43.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.34 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.5 t -131.55 138.48 48.91 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.552 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 52.8 t -119.05 126.9 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.533 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 41.6 m -142.42 148.09 37.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.475 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 17.2 p -113.61 152.81 29.83 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.831 0.348 . . . . 0.0 110.641 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -151.12 107.44 3.47 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.274 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 59.35 32.16 21.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.791 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 87.1 6.21 79.21 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -97.27 123.26 41.02 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 81' ' ' SER . 1.0 OUTLIER -85.39 118.01 24.66 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.416 ' N ' HD23 ' A' ' 159' ' ' LEU . 81.4 mt -121.94 120.55 61.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.8 m -123.87 133.99 53.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.011 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -106.91 125.02 50.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.866 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -112.3 114.99 28.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.897 0.38 . . . . 0.0 110.654 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.434 HD23 ' CD2' ' A' ' 76' ' ' LEU . 11.8 mt -111.33 130.17 55.76 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.1 m -133.59 129.82 37.51 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.475 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 8.0 m -153.41 152.66 31.29 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.441 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -62.15 147.95 46.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.588 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -70.27 -24.05 62.99 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.268 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -55.54 -34.11 64.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.173 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.455 ' O ' HG22 ' A' ' 174' ' ' VAL . 96.6 mtt180 -124.79 0.09 8.03 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.519 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 44.9 t-105 -48.22 -39.11 20.14 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.852 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -63.43 -41.95 98.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.138 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 49.3 m -65.4 -39.94 92.82 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.627 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' A' ' 178' ' ' PHE . 12.8 m -105.22 21.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.176 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.36 -47.97 55.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.384 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 24.6 m -65.51 -31.9 73.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.652 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -54.52 -44.03 72.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.091 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.519 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 23.4 m-85 -61.07 -49.84 75.7 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.356 -179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -64.3 -40.38 95.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.591 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 184' ' ' SER . 50.1 m -67.65 -47.54 69.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.35 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.23 -43.46 98.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.891 -0.323 . . . . 0.0 110.614 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.52 ' O ' ' CD1' ' A' ' 185' ' ' PHE . . . -63.77 -40.15 96.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 110.287 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 42.2 m -80.32 -27.72 38.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.249 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 180' ' ' THR . 40.1 t -62.26 -29.8 70.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.524 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.52 ' CD1' ' O ' ' A' ' 182' ' ' ALA . 0.1 OUTLIER -58.22 157.79 7.93 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.295 -179.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -138.57 159.47 42.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.61 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 15.9 m -127.48 149.5 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.996 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 38.3 p90 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.682 179.83 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.506 ' N ' ' CD ' ' A' ' 20' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.506 ' CD ' ' N ' ' A' ' 19' ' ' GLY . 29.7 Cg_endo -62.28 -23.39 75.25 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.725 2.283 . . . . 0.0 111.753 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' O ' HD12 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -91.8 169.96 10.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.396 179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -163.56 -173.35 32.15 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 26.1 t -56.67 -28.13 60.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.04 0.447 . . . . 0.0 110.402 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 94.1 m -49.11 -26.18 2.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.74 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.49 -178.92 52.6 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.99 22.94 62.51 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.1 m -65.39 137.63 24.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.918 0.389 . . . . 0.0 110.89 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -158.42 144.79 10.77 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.2 mt -99.33 91.51 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.603 0.239 . . . . 0.0 110.399 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -173.64 147.4 1.4 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.214 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.496 ' H ' ' ND2' ' A' ' 48' ' ' ASN . 48.9 m -65.79 141.51 58.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 0.0 110.609 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.8 mt -114.92 142.57 46.41 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.195 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.512 HE22 ' N ' ' A' ' 48' ' ' ASN . 1.6 pm0 -141.18 163.02 34.1 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.313 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -115.14 140.13 49.33 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.866 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -117.36 130.8 56.74 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.531 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.426 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 50.5 m -120.83 146.58 46.41 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.022 0.439 . . . . 0.0 111.022 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 36' ' ' SER . 98.8 m-20 -140.67 103.71 4.57 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.393 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.7 p -68.78 -15.1 63.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.52 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -57.25 -43.23 82.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.358 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -116.35 -13.33 11.03 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.058 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.79 50.04 6.19 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -148.64 148.76 30.47 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.033 0.444 . . . . 0.0 111.128 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -144.41 151.62 39.51 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.693 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -151.84 157.28 41.69 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.999 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 45' ' ' LEU . 10.7 mp -103.13 143.53 32.48 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.373 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.483 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 7.0 p90 -149.91 148.18 24.48 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.937 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.07 154.44 62.48 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.017 1.812 . . . . 0.0 111.849 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.512 ' N ' HE22 ' A' ' 33' ' ' GLN . 11.7 p30 -69.57 160.52 31.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.36 3.97 58.5 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.527 ' CD2' ' OD1' ' A' ' 68' ' ' ASP . 32.0 m0 -92.27 146.58 23.6 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.796 0.331 . . . . 0.0 110.358 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.0 pt -117.92 139.93 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.301 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.29 139.87 14.79 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.8 t -113.6 134.76 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.895 0.378 . . . . 0.0 110.463 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -74.46 138.28 43.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.437 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 63' ' ' ASP . 26.8 m -132.84 46.75 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.966 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -76.75 124.38 27.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.055 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.3 11.83 82.91 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.65 -164.41 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.757 0.313 . . . . 0.0 110.658 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.4 m -54.13 153.54 9.17 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.173 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.92 128.56 17.99 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.384 2.056 . . . . 0.0 112.137 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 98.15 -25.1 29.04 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.13 131.39 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.642 -0.423 . . . . 0.0 109.985 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' O ' ' CG2' ' A' ' 55' ' ' VAL . 58.7 t0 -111.09 -58.01 2.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.0 t -147.81 145.26 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-O 120.868 0.366 . . . . 0.0 111.287 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.448 HG23 HG11 ' A' ' 55' ' ' VAL . 86.5 t -122.16 134.93 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.527 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -112.18 141.27 46.08 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.081 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' NH2' ' CD2' ' A' ' 69' ' ' LEU . 68.3 ttp85 -129.12 129.33 45.03 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.269 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.527 ' OD1' ' CD2' ' A' ' 50' ' ' TRP . 78.4 m-20 -92.23 118.89 31.32 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.7 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.572 ' CD2' ' NH2' ' A' ' 67' ' ' ARG . 70.2 mt -65.52 -37.45 86.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.256 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.4 mt -63.51 -38.07 81.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.754 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -128.56 88.84 2.8 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.461 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -61.17 -35.73 77.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.561 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 39.2 p-10 -62.38 -32.67 73.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.863 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 11.6 tm-20 -92.55 132.75 36.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.663 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -146.68 139.59 25.33 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.636 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 tt -114.26 133.51 55.59 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.086 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.0 m -133.07 149.01 52.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.37 129.7 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-O 121.176 0.513 . . . . 0.0 110.288 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.511 HG23 ' C ' ' A' ' 61' ' ' GLY . 55.7 mt -120.5 124.14 71.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.361 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.4 mm -113.78 136.42 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.437 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.2 t -139.86 161.03 38.56 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.233 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.73 134.31 48.1 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.421 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.515 ' CG2' HD12 ' A' ' 159' ' ' LEU . 11.7 pt -106.75 150.15 39.33 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.956 -179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.05 137.92 42.34 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.008 1.805 . . . . 0.0 111.337 178.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 t -63.42 -27.19 69.13 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.076 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -67.44 -31.31 71.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.927 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -128.8 152.0 48.96 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.154 0.502 . . . . 0.0 111.315 -179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.431 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.1 t -117.46 179.8 3.95 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.21 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.2 tp -50.92 -44.64 60.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.192 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 50.3 p -66.5 -44.83 81.49 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.147 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.431 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.2 m-20 -65.32 -38.41 90.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.9 tp -56.15 -43.43 78.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.646 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.69 177.99 46.93 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.403 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.9 p -93.6 172.33 8.33 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.31 -42.26 77.33 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.369 -0.533 . . . . 0.0 110.227 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.1 m -71.65 -44.91 63.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 94' ' ' THR . 44.6 t0 -62.3 -51.54 67.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.522 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.71 -39.99 83.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -57.22 -45.33 92.78 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -66.75 -41.78 87.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.994 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 21.5 mmt85 -61.62 -39.19 90.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.612 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -62.73 -40.27 96.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.74 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.1 mmt -58.14 -43.79 87.51 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.294 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -64.85 -45.28 86.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.302 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 57.4 m -59.91 -45.14 93.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.961 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 96.2 t -68.18 -47.52 77.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.396 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.644 ' O ' ' N ' ' A' ' 111' ' ' GLN . 96.0 m-20 -62.73 -36.52 83.27 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.233 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -43.61 -36.92 2.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.718 0.294 . . . . 0.0 111.004 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.54 -46.49 69.38 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.2 m -123.34 23.28 9.09 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.644 ' N ' ' O ' ' A' ' 107' ' ' ASN . 47.1 tt0 -51.96 -28.83 18.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.633 0.254 . . . . 0.0 111.357 -178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -41.55 -61.46 2.15 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.15 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -117.24 -38.97 3.26 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.93 0.365 . . . . 0.0 111.779 -179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -77.39 146.44 36.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.491 . . . . 0.0 111.793 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -135.01 133.47 39.46 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.927 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.14 134.29 43.29 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.52 ' OE1' ' NH2' ' A' ' 137' ' ' ARG . 75.8 tt0 -115.3 128.71 56.3 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.977 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.9 tp -81.24 106.94 13.62 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.335 -0.393 . . . . 0.0 109.994 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.533 ' O ' ' ND2' ' A' ' 120' ' ' ASN . 95.6 mt -71.03 -38.61 72.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.057 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 119' ' ' ILE . 1.9 m-80 178.44 166.35 0.82 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.343 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.98 132.46 12.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.473 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -143.12 165.58 27.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.602 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -138.15 148.87 45.34 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.458 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -130.33 142.12 50.55 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.884 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 34.9 p30 -110.18 110.62 21.54 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.791 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -136.93 143.8 43.1 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.475 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 127' ' ' ASP . 22.6 t70 50.43 35.54 11.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.99 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 69.75 2.63 38.0 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.523 ' OE1' ' CE1' ' A' ' 131' ' ' TYR . 5.7 tm0? -106.43 136.54 46.0 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.458 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 44.7 t -106.69 129.41 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.852 0.358 . . . . 0.0 110.708 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.523 ' CE1' ' OE1' ' A' ' 129' ' ' GLN . 48.2 m-85 -117.24 131.11 56.91 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.57 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.13 130.14 51.85 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.8 m -110.42 124.33 51.55 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.181 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.73 125.32 52.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.982 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -117.58 122.34 43.37 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.537 179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -150.82 172.74 15.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.562 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.52 ' NH2' ' OE1' ' A' ' 117' ' ' GLU . 38.3 ptt180 -140.4 158.09 44.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.945 0.402 . . . . 0.0 110.729 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.37 132.84 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.122 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.6 pp -140.52 135.7 32.15 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.05 0.452 . . . . 0.0 111.427 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.6 t -111.18 131.07 63.46 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.202 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.52 -120.6 21.21 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -109.38 11.17 25.29 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -124.1 152.68 42.45 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.024 0.44 . . . . 0.0 111.48 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 144' ' ' VAL . 9.9 p -88.31 127.34 41.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.786 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -77.0 -53.64 7.57 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.544 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.556 HH21 ' CA ' ' A' ' 166' ' ' THR . 13.0 ptm180 -170.49 173.78 5.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.008 0.432 . . . . 0.0 111.384 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.418 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 52.2 m80 -108.02 137.7 45.55 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.055 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 147' ' ' HIS . 79.1 m-20 -135.04 137.91 43.39 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.015 0.436 . . . . 0.0 111.018 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.5 tp -111.22 134.91 52.45 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.546 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -135.64 141.24 45.01 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.428 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 26.0 t -124.86 141.32 52.2 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.179 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 43.6 t -121.13 132.12 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.837 0.351 . . . . 0.0 110.438 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 27.0 m -146.21 153.49 40.68 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.555 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.6 p -116.84 145.19 43.72 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.858 0.361 . . . . 0.0 110.52 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.407 ' ND2' ' OXT' ' A' ' 188' ' ' TYR . 38.0 t30 -160.04 122.37 3.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.927 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 60.15 30.91 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.097 0.475 . . . . 0.0 110.276 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 77.47 11.8 85.14 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -109.89 135.26 51.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.515 HD12 ' CG2' ' A' ' 83' ' ' ILE . 0.6 OUTLIER -89.52 114.74 26.31 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 19.9 mm -103.99 120.23 53.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 49.0 m -120.52 129.58 53.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.101 0.477 . . . . 0.0 110.561 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.28 117.32 32.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -120.1 122.96 42.2 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.978 0.418 . . . . 0.0 111.578 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.3 mp -119.93 140.57 50.69 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.382 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 63.1 m -130.87 135.65 47.89 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.365 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.556 ' CA ' HH21 ' A' ' 146' ' ' ARG . 16.6 m -153.06 153.93 33.85 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.57 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.27 145.71 42.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.358 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -69.98 -25.45 63.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.414 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 170' ' ' ARG . 55.4 p30 -60.56 -33.45 72.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.552 ' N ' ' OD1' ' A' ' 169' ' ' ASP . 22.7 mmt85 -118.89 -1.12 11.07 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.576 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 46.9 t-105 -48.26 -40.62 25.32 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.693 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.98 -41.39 97.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.029 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 46.3 m -63.71 -39.41 94.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.438 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 170' ' ' ARG . 6.9 m -105.85 21.17 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.964 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.412 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 19.1 ptmt -50.19 -45.19 53.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.978 0.418 . . . . 0.0 110.823 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.433 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 24.2 t -63.13 -31.45 72.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.694 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 12.0 tp -59.43 -45.55 91.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.273 -0.421 . . . . 0.0 112.109 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 18.2 m-85 -60.89 -50.14 74.61 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.873 -178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 176' ' ' SER . 0.6 OUTLIER -69.27 -43.24 74.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.757 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 60.6 m -62.36 -48.36 80.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.704 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 80.5 t -71.57 -38.39 67.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.474 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -62.98 -38.98 93.33 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.353 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 81.4 p -80.18 -18.98 48.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.226 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 19.8 t -62.84 -39.04 93.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.699 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.493 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -54.77 149.03 11.8 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.08 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 41.4 t60 -133.88 159.02 41.95 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.3 m -126.57 150.45 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.67 0.272 . . . . 0.0 110.795 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.407 ' OXT' ' ND2' ' A' ' 155' ' ' ASN . 41.2 p90 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.882 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.478 ' N ' HH22 ' A' ' 124' ' ' ARG . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.41 142.56 85.72 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.722 2.281 . . . . 0.0 111.684 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.542 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.6 mm? -63.41 -37.89 89.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.946 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.24 -8.01 80.55 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.0 p -156.35 168.18 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.822 0.344 . . . . 0.0 110.687 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 36.8 m -83.06 165.95 19.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.152 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.39 170.02 54.89 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.26 -175.05 48.91 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.8 m -128.78 157.25 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.743 0.306 . . . . 0.0 110.212 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.89 94.4 1.93 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.2 pt -76.56 -15.7 14.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.04 0.448 . . . . 0.0 110.619 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.63 163.34 40.15 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.123 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.1 m -56.39 140.36 45.77 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.485 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 67.4 mt -115.19 141.44 48.01 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.382 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.535 ' OE1' ' N ' ' A' ' 33' ' ' GLN . 21.0 mp0 -103.58 148.45 25.97 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.908 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -119.3 136.49 54.22 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.184 0.516 . . . . 0.0 110.946 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -125.63 136.19 52.99 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.825 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.0 p -145.64 156.05 43.41 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.491 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -148.05 119.15 7.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.556 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.8 p -70.53 -32.61 70.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.879 0.371 . . . . 0.0 110.218 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.473 ' O ' ' NZ ' ' A' ' 158' ' ' LYS . 63.9 tttm -62.03 -49.94 74.0 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.799 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -86.87 -20.63 27.17 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.904 0.383 . . . . 0.0 110.567 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.28 43.34 93.1 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.681 -0.568 . . . . 0.0 111.681 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.512 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -142.16 147.61 36.91 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.225 0.513 . . . . 0.0 110.377 179.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -148.18 155.96 42.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.024 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.538 ' CZ ' ' O ' ' A' ' 45' ' ' LEU . 57.6 t80 -173.02 143.52 1.17 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.15 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.538 ' O ' ' CZ ' ' A' ' 44' ' ' PHE . 9.9 mp -92.58 141.38 28.56 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -134.16 141.2 38.52 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.638 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -44.58 152.44 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.893 1.728 . . . . 0.0 112.484 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.415 ' HB3' HE22 ' A' ' 33' ' ' GLN . 54.2 p30 -81.41 158.75 24.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.234 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.29 8.84 74.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.437 ' NE1' ' OD1' ' A' ' 68' ' ' ASP . 27.7 m0 -94.1 149.03 21.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 110.451 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.2 pt -114.64 140.46 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.475 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.75 134.24 11.8 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.15 132.45 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 121.015 0.436 . . . . 0.0 110.569 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -83.88 137.96 33.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.339 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.83 52.86 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.371 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -72.81 134.06 44.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.357 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.64 4.72 82.58 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.81 -164.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.707 0.289 . . . . 0.0 110.694 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.5 m -45.1 152.1 0.62 Allowed Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.556 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.78 132.98 26.19 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 122.23 1.953 . . . . 0.0 111.654 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.543 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 95.76 -27.63 15.4 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.55 133.9 26.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.085 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' OD2' HD12 ' A' ' 80' ' ' ILE . 53.4 t0 -115.78 -58.57 2.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.646 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 78' ' ' VAL . 65.8 t -149.49 147.28 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.057 0.456 . . . . 0.0 111.522 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.18 134.87 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.158 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -112.13 138.16 49.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.406 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -128.95 133.63 47.9 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.531 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.437 ' OD1' ' NE1' ' A' ' 50' ' ' TRP . 60.1 t0 -88.15 119.07 28.18 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.444 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.9 mt -60.24 -37.82 81.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.737 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.647 ' H ' HD12 ' A' ' 70' ' ' ILE . 4.9 mp -67.13 -42.21 87.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.822 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 68' ' ' ASP . 90.6 mt-10 -121.24 124.24 44.17 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.009 0.433 . . . . 0.0 110.639 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -87.19 -39.58 15.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.549 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -59.45 -37.02 77.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.984 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' OE1' ' OE1' ' A' ' 71' ' ' GLU . 84.6 tt0 -85.12 132.68 34.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.409 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -155.58 138.78 15.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.945 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 76' ' ' LEU . 10.2 tt -112.57 133.29 54.7 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.044 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.9 m -128.44 147.0 50.64 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.015 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.7 m -124.07 131.45 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.105 0.478 . . . . 0.0 110.616 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.543 HG23 ' C ' ' A' ' 61' ' ' GLY . 51.0 mt -119.13 124.26 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.587 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 61' ' ' GLY . 63.1 mt -119.07 128.26 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 110.788 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.453 ' O ' ' CB ' ' A' ' 159' ' ' LEU . 74.5 m -149.09 166.31 29.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.043 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -104.57 137.01 43.04 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.44 HG22 HD12 ' A' ' 159' ' ' LEU . 10.4 pt -92.44 149.55 38.46 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.394 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -45.42 136.71 11.54 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.649 1.566 . . . . 0.0 111.862 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.8 t -65.62 -27.3 68.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.392 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.2 p30 -88.61 -16.23 33.03 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -131.22 157.23 43.8 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.043 0.449 . . . . 0.0 111.375 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.417 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.4 t -122.81 176.61 5.89 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.49 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.6 tp -51.83 -44.74 63.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.171 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.5 p -65.51 -44.61 86.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.933 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.417 ' HB2' ' H ' ' A' ' 88' ' ' THR . 85.3 m-20 -67.16 -34.27 77.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.866 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.473 ' O ' HD13 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -55.05 -50.01 70.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.893 -179.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.37 179.18 47.52 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.421 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 35.3 p -90.91 171.69 9.12 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.26 -41.41 75.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.367 -0.533 . . . . 0.0 109.869 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.7 m -72.61 -45.17 60.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.421 ' HB3' ' H ' ' A' ' 94' ' ' THR . 46.7 t0 -61.57 -51.74 67.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.294 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 77.3 t -61.96 -38.77 81.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.514 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.02 -43.94 94.82 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -67.64 -42.36 82.38 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.945 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -62.33 -38.65 90.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.0 110.718 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.87 -40.77 96.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.541 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 37.6 mmt -58.9 -44.4 91.19 Favored 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.521 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' O ' ' CG ' ' A' ' 108' ' ' ASP . 43.9 tptt -65.46 -45.76 82.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.976 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.8 m -59.17 -46.12 89.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.015 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.29 -47.16 79.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 110.273 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.656 ' O ' ' N ' ' A' ' 111' ' ' GLN . 90.1 m-20 -63.39 -37.83 88.78 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.266 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.403 ' CG ' ' O ' ' A' ' 104' ' ' LYS . 88.8 m-20 -44.29 -38.31 3.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.729 0.299 . . . . 0.0 111.224 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.88 74.6 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 58.6 m -123.93 23.45 8.59 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.656 ' N ' ' O ' ' A' ' 107' ' ' ASN . 49.4 tt0 -48.5 -28.79 3.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.557 0.218 . . . . 0.0 111.544 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -44.05 -61.24 3.16 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.152 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -116.91 -36.01 3.97 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.956 0.378 . . . . 0.0 111.872 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -78.43 139.54 38.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.865 0.364 . . . . 0.0 111.242 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -132.55 137.03 46.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.962 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.0 140.38 42.58 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.817 0.342 . . . . 0.0 110.458 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.418 ' OE1' ' NE ' ' A' ' 137' ' ' ARG . 83.4 mt-10 -124.8 123.4 39.89 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.734 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 tp -80.43 110.75 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.054 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.582 ' C ' HD22 ' A' ' 120' ' ' ASN . 96.9 mt -76.32 -55.71 10.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.846 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.582 HD22 ' C ' ' A' ' 119' ' ' ILE . 1.7 m-80 -145.23 163.22 35.1 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.083 0.468 . . . . 0.0 110.693 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.18 116.12 3.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.237 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -139.17 162.55 34.68 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.548 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -136.99 150.19 47.97 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.96 0.41 . . . . 0.0 110.878 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.478 HH22 ' N ' ' A' ' 19' ' ' GLY . 65.4 mtp180 -129.5 160.35 33.45 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.385 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -134.83 114.22 12.38 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.721 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -138.84 142.5 38.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.608 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 127' ' ' ASP . 22.3 t70 50.49 36.57 13.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.082 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.02 2.66 48.24 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.525 ' OE1' ' CE2' ' A' ' 131' ' ' TYR . 4.4 tm0? -101.29 134.74 43.88 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.436 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 46.2 t -106.22 130.08 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-O 120.831 0.348 . . . . 0.0 110.565 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.525 ' CE2' ' OE1' ' A' ' 129' ' ' GLN . 58.1 m-85 -119.41 128.24 53.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.045 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -106.61 129.93 54.45 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.7 m -112.37 122.8 48.76 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.522 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 8.4 mp -116.37 125.05 51.52 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.048 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -117.09 123.81 47.71 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -151.75 164.04 37.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.945 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.418 ' NE ' ' OE1' ' A' ' 117' ' ' GLU . 39.5 ptt180 -126.62 156.97 40.1 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.083 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.09 130.71 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.01 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.3 mt -112.25 125.3 54.0 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.883 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 79.5 t -123.49 129.68 74.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 67.04 -121.64 16.77 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -116.44 22.35 12.87 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -148.35 161.5 41.43 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.955 0.407 . . . . 0.0 111.486 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 52.5 t -71.34 125.52 29.96 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.271 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' A' ' 146' ' ' ARG . 83.3 tt0 -73.9 -52.71 12.06 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.014 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' A' ' 145' ' ' GLU . 11.4 ptp85 -172.41 170.43 4.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.609 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -105.0 138.96 40.41 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.007 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' OD2' ' O ' ' A' ' 164' ' ' LEU . 13.4 t70 -135.52 147.58 48.86 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.146 0.498 . . . . 0.0 110.563 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 tp -123.17 124.96 44.21 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.556 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -123.81 134.74 53.56 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.234 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.5 t -122.84 134.27 54.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 60.2 t -114.35 129.93 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.157 0.503 . . . . 0.0 110.852 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.438 ' CG2' ' NE2' ' A' ' 129' ' ' GLN . 24.0 m -143.76 142.71 31.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.101 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 14.1 p -108.36 149.6 28.48 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.782 0.325 . . . . 0.0 110.215 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.606 HD21 ' CA ' ' A' ' 188' ' ' TYR . 56.5 t30 -147.46 106.71 3.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.735 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 57.42 31.74 20.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.894 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 89.59 4.89 72.59 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 39' ' ' LYS . 32.1 mmtp -96.05 123.85 39.82 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.453 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.9 OUTLIER -89.36 114.38 25.79 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 64.0 mt -121.89 127.41 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.103 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 29.7 m -123.67 135.91 54.17 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.037 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -107.07 105.51 15.56 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.886 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -99.19 120.06 38.9 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.876 0.37 . . . . 0.0 111.47 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.432 ' O ' ' OD2' ' A' ' 148' ' ' ASP . 19.2 mt -117.62 135.3 54.07 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.9 t -133.56 134.07 42.88 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.913 0.387 . . . . 0.0 110.89 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.419 ' CG2' ' N ' ' A' ' 167' ' ' ALA . 14.6 m -152.52 158.88 43.17 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.295 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 166' ' ' THR . . . -59.18 144.31 46.29 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.07 0.462 . . . . 0.0 111.422 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -74.44 -17.81 60.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.071 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 57.4 p30 -77.93 -9.77 59.25 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.902 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.498 ' O ' HG22 ' A' ' 174' ' ' VAL . 77.3 mtp180 -133.61 -6.8 2.86 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.729 0.299 . . . . 0.0 110.742 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.617 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 45.3 t-105 -49.19 -39.02 27.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.624 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -63.48 -42.32 98.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.08 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 53.7 m -65.37 -40.74 93.91 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.526 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 170' ' ' ARG . 9.3 m -105.33 21.21 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.848 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -48.77 -47.24 41.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.203 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 91.8 p -67.08 -28.61 68.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.81 -179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.8 tp -56.23 -43.18 78.38 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.627 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.617 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 19.4 m-85 -62.78 -49.49 74.77 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.451 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -63.4 -40.85 98.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.706 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.4 m -68.09 -51.49 45.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.401 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' A' ' 184' ' ' SER . 4.0 p -69.96 -32.52 51.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.683 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.56 -40.29 96.59 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.101 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 76.0 p -85.11 -16.1 41.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.743 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 181' ' ' VAL . 88.4 p -64.72 -34.09 77.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.492 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -53.7 150.37 7.3 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.558 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.1 t60 -130.75 149.93 52.16 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.0 m -126.48 151.99 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.781 0.324 . . . . 0.0 110.814 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.606 ' CA ' HD21 ' A' ' 155' ' ' ASN . 43.7 p90 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.622 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.46 146.23 92.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.73 2.286 . . . . 0.0 111.804 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.668 HD12 ' N ' ' A' ' 21' ' ' LEU . 7.2 mp -89.51 140.16 29.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.553 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.96 120.54 0.69 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 m -66.22 155.85 35.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.754 0.311 . . . . 0.0 110.621 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 38.9 t -129.2 133.82 47.73 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.273 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.26 -35.15 59.9 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.2 -143.05 32.53 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -132.01 141.18 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.883 0.373 . . . . 0.0 110.449 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -169.12 47.81 0.22 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 29' ' ' ILE . 23.4 pt -68.27 -16.58 21.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.584 0.231 . . . . 0.0 111.216 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -166.3 56.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.816 -0.353 . . . . 0.0 110.972 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.7 p -149.98 11.31 0.73 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.885 0.374 . . . . 0.0 110.606 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 42.5 mt -115.2 138.69 50.65 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.344 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -134.4 158.88 42.72 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.365 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.483 HH21 ' CD ' ' A' ' 43' ' ' GLU . 72.7 ttt180 -119.29 138.11 53.23 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.653 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -118.89 136.27 54.13 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.276 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 84.7 p -143.72 157.52 44.33 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.426 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' GLY . 42.1 t0 -148.28 108.58 4.11 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.65 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.6 m -60.31 -36.76 78.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.694 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -58.66 -51.01 71.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.184 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -85.64 -20.17 29.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.821 0.343 . . . . 0.0 110.643 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 37' ' ' ASP . . . 68.68 41.44 83.65 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 155.73 45.69 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 117.199 0.5 . . . . 0.0 110.727 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' CD ' HH21 ' A' ' 34' ' ' ARG . 3.0 pp20? -156.03 147.83 23.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.752 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -152.9 156.1 38.3 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.653 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt -94.4 158.96 15.33 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.397 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -170.57 144.88 2.03 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.689 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.01 158.73 56.12 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 122.349 2.033 . . . . 0.0 111.952 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.6 p-10 -71.92 160.34 32.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.6 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.26 4.53 58.43 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.535 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 25.1 m0 -89.16 145.11 25.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 pt -115.11 138.29 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.503 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -100.73 121.98 7.43 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.53 134.75 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-O 120.942 0.401 . . . . 0.0 110.499 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.443 ' O ' ' OD1' ' A' ' 54' ' ' ASP . 52.9 p30 -84.07 151.16 25.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.356 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 m -149.61 48.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.086 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -68.58 134.03 49.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.147 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.63 -0.63 83.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.3 -163.66 0.59 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 110.464 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.2 m -40.14 116.69 1.25 Allowed Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.586 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.04 132.89 8.6 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.703 1.602 . . . . 0.0 112.22 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 101.99 -40.48 2.41 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.2 135.18 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -118.55 -57.56 2.05 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.54 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -147.63 143.06 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.684 0.278 . . . . 0.0 111.048 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.47 137.93 54.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.928 0.395 . . . . 0.0 110.045 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.93 134.92 54.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.84 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -121.95 143.7 49.31 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.8 0.333 . . . . 0.0 110.758 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.535 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 11.2 m-20 -94.75 118.94 32.55 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.514 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.5 mt -65.5 -38.7 90.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.559 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 26.5 mm -65.12 -41.77 92.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.748 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -124.42 95.16 4.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.753 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.0 ptt85 -64.4 -34.8 79.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.349 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -58.21 -37.37 74.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.81 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -89.44 128.9 36.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 110.604 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -141.08 139.05 33.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.297 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.593 HD13 ' N ' ' A' ' 77' ' ' SER . 0.2 OUTLIER -106.93 132.91 52.35 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.593 ' N ' HD13 ' A' ' 76' ' ' LEU . 4.9 p -120.12 138.84 53.34 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.3 t -125.45 124.21 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.125 0 CA-C-O 120.883 0.373 . . . . 0.0 110.446 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.494 HG23 ' C ' ' A' ' 61' ' ' GLY . 15.7 mt -125.1 117.75 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.802 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.2 mm -114.94 135.87 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.995 0.426 . . . . 0.0 110.643 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.9 m -145.36 166.03 26.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.935 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -107.93 141.47 39.51 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.652 0.263 . . . . 0.0 110.673 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.2 pt -107.72 149.63 39.19 Favored Pre-proline 0 N--CA 1.469 0.475 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.697 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.422 ' O ' ' O ' ' A' ' 87' ' ' LYS . 54.9 Cg_endo -69.19 139.96 43.58 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 122.101 1.867 . . . . 0.0 111.141 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 59.8 p -65.98 -24.96 66.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.979 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -68.29 -31.28 70.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.635 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 84' ' ' PRO . 29.5 mtmm -130.33 157.48 42.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.121 0.486 . . . . 0.0 111.263 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.407 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 14.7 t -122.48 178.1 5.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.366 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 tp -50.99 -44.65 60.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.16 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.3 p -64.9 -45.53 85.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.037 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 88' ' ' THR . 84.6 m-20 -68.02 -36.15 79.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.6 tt -56.13 -42.77 77.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.776 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.67 174.68 44.24 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.41 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 41.8 p -91.72 168.87 11.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.98 -42.3 76.09 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.998 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 90.7 m -71.82 -43.95 64.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.823 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 94' ' ' THR . 47.7 t0 -61.57 -52.69 63.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.486 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.48 -38.51 78.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.738 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -58.02 -47.35 89.65 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -65.17 -42.86 93.26 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -62.74 -37.76 87.86 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.878 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -62.92 -41.12 99.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.611 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.9 mmt -59.88 -44.29 94.29 Favored 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.299 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -64.76 -41.71 95.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.213 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 52.6 m -59.23 -46.25 88.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.704 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.87 -47.12 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.048 0.451 . . . . 0.0 110.498 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.625 ' O ' ' N ' ' A' ' 111' ' ' GLN . 92.9 m-20 -61.54 -35.41 77.68 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.36 -179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -45.71 -36.74 5.21 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.193 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.04 -45.86 76.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.417 ' C ' ' H ' ' A' ' 112' ' ' GLY . 48.1 m -123.39 22.65 9.22 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.625 ' N ' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -52.43 -10.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.133 -179.015 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 110' ' ' SER . . . -59.97 -61.47 7.14 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.718 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -117.17 -40.53 3.09 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.794 0.331 . . . . 0.0 111.452 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 ttp85 -86.37 138.9 31.44 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.167 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -132.72 150.68 52.13 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.154 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -103.05 139.69 38.27 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' OE1' ' NE ' ' A' ' 137' ' ' ARG . 79.1 tt0 -113.23 130.9 56.09 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.9 tp -83.79 117.94 23.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.434 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 97.3 mt -85.48 -59.42 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.313 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.56 ' C ' HD22 ' A' ' 120' ' ' ASN . 0.4 OUTLIER -158.53 172.17 18.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.35 134.68 11.43 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.34 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -142.88 161.1 39.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.728 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.401 ' HB1' ' CE1' ' A' ' 132' ' ' TYR . . . -139.36 143.49 37.78 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.427 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -135.65 146.23 47.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.482 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -120.05 112.68 19.45 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.515 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -136.6 139.61 42.24 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.567 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 51.2 40.71 26.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.724 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 67.07 2.3 17.45 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.522 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 2.9 tm0? -101.79 134.67 44.6 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.461 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 43.6 t -106.37 129.6 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.944 0.402 . . . . 0.0 110.542 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.522 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 70.0 m-85 -118.95 123.53 44.83 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.904 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CE1' ' HB1' ' A' ' 123' ' ' ALA . 2.5 m-30 -104.94 118.88 37.64 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 56.7 m -93.66 132.57 37.88 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.2 107.0 8.31 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.269 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.442 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 74.7 tt0 -103.37 126.02 50.3 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -153.38 171.23 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.315 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.422 ' NE ' ' OE1' ' A' ' 117' ' ' GLU . 40.0 ptt180 -141.5 161.49 37.78 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.865 0.364 . . . . 0.0 110.262 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.78 139.99 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.006 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 pp -145.0 150.63 37.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.188 0.518 . . . . 0.0 111.087 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.92 134.86 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.558 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 48.68 -107.04 0.23 Allowed Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 56.1 t0 -117.46 13.3 14.4 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.323 0.12 . . . . 0.0 111.323 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -117.84 142.67 47.05 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.738 0.304 . . . . 0.0 111.019 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.69 125.77 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.016 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -78.05 -53.74 7.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.703 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.534 ' NH1' ' OG ' ' A' ' 165' ' ' SER . 44.8 ptt85 -173.83 171.81 3.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.011 0.434 . . . . 0.0 111.403 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -108.07 141.52 39.65 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.526 ' OD2' ' NH1' ' A' ' 146' ' ' ARG . 74.5 m-20 -135.57 144.02 45.97 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.006 0.431 . . . . 0.0 111.11 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 64.5 tp -116.79 134.47 54.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.53 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.43 ' CB ' ' OD1' ' A' ' 163' ' ' ASP . . . -134.1 128.21 33.72 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.008 0.433 . . . . 0.0 110.925 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.7 t -115.2 127.76 55.73 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.12 131.72 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 120.941 0.401 . . . . 0.0 110.875 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.52 ' OG1' ' NE2' ' A' ' 129' ' ' GLN . 6.8 t -146.67 161.93 39.53 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.687 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 11.8 p -122.22 152.79 39.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.23 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -165.74 123.25 1.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.618 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 58.67 26.09 14.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.004 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 83.72 9.12 83.52 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 179.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -106.69 141.19 38.35 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.898 0.38 . . . . 0.0 110.385 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.43 117.81 31.04 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 71.0 mt -117.44 121.88 68.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 92.8 m -122.55 130.1 52.66 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.27 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -110.01 110.43 21.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.43 ' OD1' ' CB ' ' A' ' 150' ' ' ALA . 90.2 m-20 -115.48 124.84 52.12 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.919 0.39 . . . . 0.0 110.951 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 mp -116.56 146.12 42.87 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.681 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.534 ' OG ' ' NH1' ' A' ' 146' ' ' ARG . 45.7 t -132.08 131.31 42.28 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.583 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.8 m -152.4 155.7 38.07 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.647 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -53.57 144.68 16.77 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.254 -179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -71.5 -34.38 70.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.154 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.91 -33.61 74.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.712 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.519 ' O ' HG22 ' A' ' 174' ' ' VAL . 78.9 mtm180 -103.01 -12.68 17.27 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.564 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 51.3 t-105 -47.69 -40.37 19.92 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.379 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -64.07 -42.28 97.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 50.5 m -65.52 -40.96 93.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.465 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 170' ' ' ARG . 10.5 m -106.42 21.45 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.12 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 171' ' ' TRP . 24.0 pttm -49.45 -45.63 46.84 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.222 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 84.8 p -67.45 -28.56 67.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.457 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 tp -56.1 -45.14 79.55 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.564 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.1 m-85 -62.5 -48.07 81.18 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.221 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -62.57 -42.55 99.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.547 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 91.7 m -67.49 -49.02 65.41 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.02 -37.32 72.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.511 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.24 -38.58 91.71 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.374 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 75.4 p -84.72 -16.03 43.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.217 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.4 t -62.78 -37.9 88.51 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.432 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.421 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.1 OUTLIER -59.66 155.49 15.57 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.066 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -137.86 161.18 37.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -128.4 151.06 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.956 0.408 . . . . 0.0 111.257 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.468 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 39.3 p90 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.624 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -52.4 145.4 36.61 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.731 2.287 . . . . 0.0 111.997 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 37.2 tp -57.14 -37.35 71.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.232 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -83.97 -177.86 51.58 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.5 p -136.08 156.4 48.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.532 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 89.7 m -87.79 0.4 55.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.81 -91.28 1.48 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.5 -159.92 35.54 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.69 135.4 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.797 0.332 . . . . 0.0 110.487 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -138.71 -122.21 2.0 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.0 pt -121.62 156.72 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-O 120.802 0.334 . . . . 0.0 110.634 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.86 140.81 49.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.724 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.406 ' H ' ' H ' ' A' ' 32' ' ' LEU . 14.9 t -171.34 6.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.325 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.406 ' H ' ' H ' ' A' ' 31' ' ' SER . 40.8 mt -107.04 139.79 40.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.36 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' CD ' ' N ' ' A' ' 33' ' ' GLN . 3.2 mp0 -116.89 154.49 30.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.547 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.55 138.53 50.96 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.34 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -126.73 131.07 51.43 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.944 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.3 m -141.12 152.36 44.67 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 110.769 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -143.58 118.69 10.1 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.388 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 62.4 p -71.31 -32.69 68.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.529 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.48 -47.58 83.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.025 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -88.36 -20.33 25.47 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.857 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 68.1 42.06 85.36 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 42' ' ' TYR . 0.1 OUTLIER -143.07 149.29 37.99 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 117.338 0.569 . . . . 0.0 110.356 179.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -151.66 144.19 24.21 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.77 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -152.71 158.09 41.84 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 51.7 mt -98.52 150.01 22.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.093 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -158.17 145.99 13.74 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.359 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -67.19 156.4 66.43 Favored 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.309 2.006 . . . . 0.0 112.187 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.453 ' N ' HE22 ' A' ' 33' ' ' GLN . 39.2 p30 -71.78 160.36 32.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.57 2.13 58.8 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.53 ' CE2' ' OD1' ' A' ' 68' ' ' ASP . 33.9 m0 -91.81 144.5 25.43 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.793 0.33 . . . . 0.0 110.436 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.6 pt -120.65 144.54 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.359 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.32 141.56 15.68 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.2 m -129.88 143.63 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 120.934 0.397 . . . . 0.0 110.525 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -90.61 144.55 25.64 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.44 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.61 51.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.491 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -66.98 136.08 54.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.094 0.473 . . . . 0.0 110.337 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.36 1.62 71.66 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.86 -164.19 0.69 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.64 0.257 . . . . 0.0 110.53 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.1 m -41.54 124.29 2.33 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.337 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.03 132.32 6.0 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.785 1.657 . . . . 0.0 112.694 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.448 ' C ' HG23 ' A' ' 79' ' ' ILE . . . 97.98 -33.69 5.76 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.9 t -62.42 122.84 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.114 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -120.22 -50.06 2.26 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.467 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.3 t -129.95 139.5 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.879 0.371 . . . . 0.0 110.91 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.2 t -127.82 138.35 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.49 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.66 135.01 52.83 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.859 179.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -121.64 134.77 54.99 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.26 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.53 ' OD1' ' CE2' ' A' ' 50' ' ' TRP . 66.1 m-20 -86.18 118.75 25.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.483 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -67.47 -39.36 85.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.593 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.577 ' H ' HD12 ' A' ' 70' ' ' ILE . 4.1 mp -61.11 -48.14 90.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.083 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.76 118.01 28.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.908 0.385 . . . . 0.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.42 -36.59 65.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.777 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 74' ' ' GLU . 2.7 p30 -62.47 -34.62 77.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.864 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 84.3 tt0 -86.13 133.33 33.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.811 0.339 . . . . 0.0 110.254 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -154.25 139.66 17.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.852 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -114.54 134.62 54.89 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.932 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.7 m -120.13 145.1 47.25 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.3 t -122.17 127.63 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-O 121.002 0.429 . . . . 0.0 110.315 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.448 HG23 ' C ' ' A' ' 61' ' ' GLY . 5.8 mt -114.82 122.57 69.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.699 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 82.1 mt -122.08 127.88 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-O 120.996 0.427 . . . . 0.0 110.796 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 159' ' ' LEU . 21.9 t -153.29 164.29 38.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.045 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -103.47 136.42 43.25 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.0 pt -92.89 148.42 35.85 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.347 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' LYS . 37.1 Cg_endo -65.28 136.17 46.24 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.64 1.56 . . . . 0.0 110.821 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.8 t -60.99 -29.12 69.5 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.038 -179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -67.57 -31.52 71.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.999 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.433 ' O ' ' O ' ' A' ' 84' ' ' PRO . 68.0 mttm -130.61 144.84 51.7 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.046 0.451 . . . . 0.0 111.138 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.451 ' H ' ' HB2' ' A' ' 91' ' ' ASP . 15.1 t -113.24 179.18 4.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.173 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.3 tp -52.75 -43.83 66.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.859 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 47.1 p -69.04 -45.03 71.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.447 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.451 ' HB2' ' H ' ' A' ' 88' ' ' THR . 82.4 m-20 -68.77 -34.92 76.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.78 0.324 . . . . 0.0 111.106 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.6 tp -55.39 -44.35 76.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.394 -179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 177.17 178.06 46.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.412 ' H ' ' HB3' ' A' ' 97' ' ' ASP . 43.9 p -92.85 169.8 10.18 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.46 72.62 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.966 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 91.4 m -72.36 -44.64 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.851 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 94' ' ' THR . 45.7 t0 -62.54 -50.97 69.22 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.425 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.629 HG22 HH21 ' A' ' 101' ' ' ARG . 79.4 t -62.65 -38.56 81.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.604 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -59.27 -47.05 92.74 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.37 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -62.8 -45.36 92.98 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.82 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.629 HH21 HG22 ' A' ' 98' ' ' VAL . 85.4 mtm180 -62.96 -43.86 97.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.041 0.448 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -57.0 -41.14 77.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.804 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 38.4 mmt -61.12 -43.46 98.85 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.143 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -64.93 -38.83 92.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.423 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.1 m -56.88 -45.71 82.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.599 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 91.7 t -71.28 -46.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.13 0.491 . . . . 0.0 110.449 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.657 ' O ' ' N ' ' A' ' 111' ' ' GLN . 1.4 m120 -62.43 -32.98 73.92 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.272 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -43.81 -37.64 2.87 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.675 0.274 . . . . 0.0 111.537 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.26 -47.27 71.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.6 m -123.53 24.17 8.66 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.657 ' N ' ' O ' ' A' ' 107' ' ' ASN . 16.9 tt0 -46.55 -28.77 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.597 0.237 . . . . 0.0 111.536 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -43.71 -61.18 3.04 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.02 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 114' ' ' ARG . 31.7 p-10 -117.02 -36.3 3.85 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.069 0.435 . . . . 0.0 111.711 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.578 HH11 ' CG1' ' A' ' 138' ' ' VAL . 59.7 ttm-85 -84.18 142.05 30.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.394 . . . . 0.0 111.051 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -148.82 149.09 30.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.886 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.578 ' CB ' HD21 ' A' ' 107' ' ' ASN . . . -108.47 138.99 43.85 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.168 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -107.94 129.85 55.08 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.546 ' C ' HD23 ' A' ' 118' ' ' LEU . 4.1 tt -81.54 108.09 14.83 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.953 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.426 HD12 ' HG2' ' A' ' 135' ' ' GLU . 97.4 mt -70.68 -56.32 11.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.112 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.567 ' C ' HD22 ' A' ' 120' ' ' ASN . 0.3 OUTLIER -156.29 169.9 23.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.901 179.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.7 119.85 4.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.336 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -141.34 163.18 33.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.73 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.402 ' CB ' ' CE1' ' A' ' 132' ' ' TYR . . . -139.12 149.45 44.52 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.473 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -131.72 144.49 51.02 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.1 0.476 . . . . 0.0 110.821 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -111.42 114.3 27.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.572 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -140.3 141.88 35.71 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.702 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 127' ' ' ASP . 22.6 t70 49.67 37.2 12.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.03 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 68.59 1.49 23.26 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.52 ' OE1' ' CZ ' ' A' ' 131' ' ' TYR . 3.7 tm0? -103.18 133.48 48.21 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 129' ' ' GLN . 46.6 t -105.59 130.43 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.855 0.359 . . . . 0.0 110.721 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.52 ' CZ ' ' OE1' ' A' ' 129' ' ' GLN . 48.4 m-85 -119.04 129.59 55.19 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.823 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.402 ' CE1' ' CB ' ' A' ' 123' ' ' ALA . 2.4 m-85 -105.4 127.47 53.0 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 55.6 m -105.03 129.66 53.42 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.69 107.12 9.42 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.12 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.467 ' OE1' ' OD1' ' A' ' 120' ' ' ASN . 79.4 tt0 -101.79 127.22 48.68 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -150.87 170.37 19.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.411 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -136.81 156.75 48.08 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.052 0.453 . . . . 0.0 110.37 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.578 ' CG1' HH11 ' A' ' 114' ' ' ARG . 58.3 t -104.7 135.17 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.443 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.407 ' HA ' ' H ' ' A' ' 145' ' ' GLU . 2.7 pp -145.2 135.02 23.59 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 121.189 0.518 . . . . 0.0 111.251 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.3 t -111.6 132.52 59.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.869 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 63.54 -122.05 25.56 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -110.73 11.83 22.58 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 122.854 -0.204 . . . . 0.0 111.139 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -120.02 149.97 41.31 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.829 0.347 . . . . 0.0 111.225 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.0 t -88.35 126.03 41.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.415 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.407 ' H ' ' HA ' ' A' ' 139' ' ' LEU . 47.4 tp10 -75.08 -53.85 8.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.416 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -173.94 173.6 3.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.051 0.453 . . . . 0.0 111.26 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -105.21 143.58 33.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.133 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.426 ' OD2' ' O ' ' A' ' 164' ' ' LEU . 12.0 t70 -141.21 151.16 43.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.055 0.455 . . . . 0.0 110.841 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 65.8 tp -124.1 135.0 53.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.034 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -134.51 132.51 39.28 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.895 0.378 . . . . 0.0 110.431 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 69.3 m -119.93 137.39 54.07 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.59 130.29 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.985 0.421 . . . . 0.0 110.683 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.415 HG23 HE22 ' A' ' 129' ' ' GLN . 24.5 m -146.97 144.85 29.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.322 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 15.3 p -110.9 150.36 29.3 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.192 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -151.14 106.7 3.37 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.264 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 61.83 34.84 16.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.066 0.46 . . . . 0.0 110.526 179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 82.06 8.29 86.74 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -98.42 127.17 44.23 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 81' ' ' SER . 0.8 OUTLIER -89.81 113.13 24.65 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 67.9 mt -122.25 124.29 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.328 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.0 m -124.62 134.27 52.98 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.14 111.04 23.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -111.65 119.97 40.48 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.902 0.382 . . . . 0.0 111.428 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.426 ' O ' ' OD2' ' A' ' 148' ' ' ASP . 2.9 mp -115.47 142.64 46.44 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.136 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.0 p -132.96 135.05 45.28 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.871 0.367 . . . . 0.0 110.547 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.0 m -152.88 157.02 40.08 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.248 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.29 143.69 55.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.04 0.448 . . . . 0.0 111.4 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.427 ' OE2' ' OD1' ' A' ' 169' ' ' ASP . 1.3 pp20? -69.82 -27.11 64.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.222 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.427 ' OD1' ' OE2' ' A' ' 168' ' ' GLU . 90.3 m-20 -59.36 -34.15 72.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.256 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.448 ' O ' HG22 ' A' ' 174' ' ' VAL . 73.8 mtm180 -117.66 -1.59 11.59 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.554 ' CD2' ' CE2' ' A' ' 178' ' ' PHE . 44.5 t-105 -48.64 -39.34 23.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.554 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -63.26 -42.11 99.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.958 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 39.8 m -64.49 -40.47 95.73 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.559 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.458 HG23 ' CZ ' ' A' ' 178' ' ' PHE . 12.8 m -105.11 20.87 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.902 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -49.33 -45.61 45.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.89 0.376 . . . . 0.0 110.952 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 85.1 p -68.07 -27.69 66.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.598 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.9 tp -56.84 -44.34 81.99 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.583 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.554 ' CE2' ' CD2' ' A' ' 171' ' ' TRP . 17.2 m-85 -63.59 -49.82 71.88 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.239 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -62.0 -42.28 98.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.579 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 65.0 m -67.6 -49.77 61.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.038 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.82 -37.92 74.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.38 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 178' ' ' PHE . . . -63.46 -39.04 93.41 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.234 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.5 m -80.71 -19.54 44.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.273 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -62.53 -36.22 81.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.718 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' A' ' 185' ' ' PHE . 0.2 OUTLIER -55.93 148.76 16.48 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.11 -179.555 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -136.85 155.53 49.67 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.22 150.61 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.183 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.489 ' O ' ' CG ' ' A' ' 188' ' ' TYR . 40.9 p90 . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.548 -179.82 . . . . . . . . 1 1 . 1 stop_ save_